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This edition of the AICPA Audit and Accounting Guide  
Health Care Entities, which was originally issued 
in 1996, has been modified by the AICPA staff to include 
certain changes necessary because of the issuance of au-
thoritative pronouncements since the guide was originally 
issued and other changes necessary to keep the guide  
current on industry and regulatory matters. The changes 
made are identified in a schedule in appendix H of the  
guide. The changes do not include all those that might 
be considered necessary if the guide were subjected to a  
comprehensive review and revision. 
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Notice to Readers
This AICPA Audit and Accounting Guide has been prepared by the AICPA
Health Care Committee to assist preparers of financial statements in preparing
financial statements in conformity with generally accepted accounting princi-
ples (GAAP) and to assist auditors in auditing and reporting on such financial
statements in accordance with generally accepted auditing standards.
The AICPA Accounting Standards Executive Committee has found this guide
to be consistent with existing standards and principles covered by Rule 202,
Compliance with standards (AICPA, Professional Standards, vol. 2, ET sec. 202
par. 01), and Rule 203, Accounting principles (AICPA, Professional Standards,
vol. 2, ET sec. 203 par. 01), of the AICPA Code of Professional Conduct. AICPA
members should be prepared to justify departures from GAAP, as discussed in
AU section 411, The Meaning of Present Fairly in Conformity With Generally
Accepted Accounting Principles. Members should be alert to significant devel-
opments in the accounting standards that define the source of authoritative
accounting standards, a discussion of which can be found subsequently in this
notice to readers.
Auditing guidance is included in this AICPA Audit and Accounting Guide, which
is an interpretive publication pursuant to AU section 150, Generally Accepted
Auditing Standards (AICPA, Professional Standards, vol. 1). Interpretive pub-
lications are recommendations on the application of Statements on Auditing
Standards (SASs) in specific circumstances, including engagements for entities
in specialized industries. An interpretive publication is issued under the au-
thority of the Auditing Standards Board (ASB) after all ASB members have
been provided an opportunity to consider and comment on whether the pro-
posed interpretive publication is consistent with the SASs. The members of the
ASB have found this guide to be consistent with existing SASs.
The auditor should be aware of and consider interpretive publications appli-
cable to his or her audit. If an auditor does not apply the auditing guidance
included in an applicable interpretive publication, the auditor should be pre-
pared to explain how he or she complied with the SAS provisions addressed by
such auditing guidance.
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Guidance Considered in This Edition
This edition of the guide has been modified by the AICPA staff to include cer-
tain changes necessary due to the issuance of authoritative pronouncements
since the guide was originally issued. Authoritative guidance issued through
August 1, 2009, has been considered in the development of this edition of the
guide. This includes relevant guidance issued up to and including the follow-
ing:
 Financial Accounting Standards Board (FASB) Accounting Stan-
dards Updates (ASUs) issued through August 1, 2009
 Governmental Accounting Standards Board (GASB) Statement
No. 56, Codification of Accounting and Financial Reporting
Guidance Contained in the AICPA Statements on Auditing
Standards
 GASB Interpretation No. 6, Recognition and Measurement of Cer-
tain Liabilities and Expenditures in Governmental Fund Finan-
cial Statements—an interpretation of NCGA Statements 1, 4, and
5; NCGA Interpretation 8; and GASB Statements No. 10, 16,
and 18
 GASB Technical Bulletin 2008-1, Determining the Annual
Required Contribution Adjustment for Postemployment Bene-
fits
 GASB Comprehensive Implementation Guide as of June 30, 2008
 SAS No. 116, Interim Financial Information (AICPA, Professional
Standards, vol. 1, AU sec. 722)
 Interpretation No. 19, "Financial Statements Prepared in Confor-
mity With International Financial Reporting Standards as Issued
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by the International Accounting Standards Board," of AU section
508, Reports on Audited Financial Statements (AICPA, Profes-
sional Standards, vol. 1, AU sec. 9508 par. .93–.97)
 Revised interpretations issued through August 1, 2009, includ-
ing Interpretation No. 1, "Use of Electronic Confirmations," of AU
section 330, The Confirmation Process (AICPA, Professional Stan-
dards, vol. 1, AU sec. 9330 par. .01–.08)
 Statement of Position (SOP) 07-2, Attestation Engagements That
Address Specified Compliance Control Objectives and Related Con-
trols at Entities That Provide Services to Investment Companies,
Investment Advisers, or Other Service Providers (AICPA, Technical
Practice Aids, AUD sec. 14,430)
 Public Company Accounting Oversight Board (PCAOB) Auditing
Standard No. 6, Evaluating Consistency of Financial Statements
(AICPA, PCAOB Standards and Related Rules, Auditing Stan-
dards)
Users of this guide should consider guidance issued subsequent to those items
in the preceding list to determine its effect on entities covered by this guide.
In determining the applicability of a pronouncement, its effective date should
also be considered.
The changes made to this edition of the guide are identified in appendix H,
"Schedule of Changes Made to the Text From the Previous Edition." The changes
do not include all those that might be considered necessary if the guide were
subjected to a comprehensive review and revision.
References to Professional Standards
In citing the professional standards, references are made to the AICPA Pro-
fessional Standards publication. In those sections of the guide where specific
auditing standards of the PCAOB are referred to, references are made to the
AICPA's PCAOB Standards and Related Rules publication. Please refer to ap-
pendix G, "Major Existing Differences Between AICPA Standards and PCAOB
Standards," of this guide for a summary of major existing differences between
AICPA standards and PCAOB standards. Additionally, when referencing pro-
fessional standards, this guide cites section numbers and not the original state-
ment number, as appropriate. For example, SAS No. 54, Illegal Acts by Clients
(AICPA, Professional Standards, vol. 1, AU sec. 317), is referred to as AU section
317, Illegal Acts by Clients (AICPA, Professional Standards, vol. 1).
This edition includes SOP 99-1, Guidance to Practitioners in Conducting and
Reporting on an Agreed-Upon Procedures Engagement to Assist Management
in Evaluating the Effectiveness of Its Corporate Compliance Program (appendix
C), and SOP 00-1, Auditing Health Care Third-Party Revenues and Related Re-
ceivables (appendix D). In using this guide, readers should refer to the material
in these SOPs.
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FASB Accounting Standards Codification™
The accounting guidance in this guide has been conformed to reflect
reference to FASB Accounting Standards Codification™ (ASC) as it
existed on August 1, 2009.
The illustrative financial statements and footnote disclosures included
in this guide have been updated to reflect FASB ASC. However, in
FASB's notice to constituents, it suggests the use of plain English to
describe broad FASB ASC topic references. They suggest a reference
similar to "as required by the Derivatives and Hedging Topic of the
FASB Accounting Standards Codification™." Entities might consider
revising their financial statement references to reflect this plain En-
glish referencing, rather than use specific FASB ASC references. We
have provided these detailed references in the 2009 editions as a learn-
ing tool to familiarize constituents with the new system.
An exception to this is when the guide discusses GASB pronounce-
ments that have made certain AICPA and FASB pronouncements
specifically applicable to governmental entities and thus require the
application of certain pronouncements of the FASB and its predeces-
sor standards-setting organizations issued before November 30, 1989,
and permit the application of later FASB pronouncements in certain
situations.
FASB ASC Overview
On June 30, 2009, FASB issued FASB Statement No. 168, The FASB Account-
ing Standards Codification™ and the Hierarchy of Generally Accepted Account-
ing Principles—a replacement of FASB Statement No. 162, which is codified
in FASB ASC 105, Generally Accepted Accounting Principles. On the effective
date of this statement, FASB ASC will become the authoritative source of U.S.
accounting and reporting standards for nongovernmental entities, in addition
to guidance issued by the Securities and Exchange Commission (SEC). At that
time, FASB ASC will supersede all then-existing, non-SEC accounting and re-
porting standards for nongovernmental entities. Once effective, all other non-
grandfathered, non-SEC accounting literature not included in FASB ASC will
become nonauthoritative. This statement is effective for financial statements
issued for interim and annual periods ending after September 15, 2009.
FASB ASC is a major restructuring of accounting and reporting standards de-
signed to simplify user access to all authoritative U.S. GAAP by providing the
authoritative literature in a topically organized structure. FASB ASC disas-
sembled thousands of nongovernmental accounting pronouncements (including
those of the FASB, Emerging Issues Task Force [EITF], and the AICPA) and
reassembled them under approximately 90 topics.
FASB ASC also includes relevant portions of authoritative content issued by the
SEC, as well as select SEC staff interpretations, and administrative guidance
issued by the SEC; however, FASB ASC is not the official source of SEC guid-
ance and does not contain the entire population of SEC rules, regulations, inter-
pretive releases, and staff guidance. Moreover, FASB ASC does not include gov-
ernmental accounting standards and is not applicable to governmental entities.
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FASB ASC is not intended to change U.S. GAAP or any requirements of the
SEC; rather, it is part of FASB's efforts to reduce the complexity of accounting
standards and also to facilitate international convergence. Additionally, FASB
ASC essentially flattens the GAAP hierarchy to two levels: one that is author-
itative (in FASB ASC) and one that is nonauthoritative (not in FASB ASC).
Among other things, FASB ASC aims to
 reduce the amount of time and effort required to solve an account-
ing research issue
 mitigate the risk of noncompliance with standards through im-
proved usability of the literature
 provide accurate information with real-time updates as new stan-
dards are released
 assist FASB with the research and convergence efforts required
during the standard-setting process
 become the authoritative source of literature for the completed
eXtensible Business Reporting Language taxonomy
 make clear that guidance not contained in FASB ASC is not con-
sidered authoritative
FASB ASC features a notice to constituents that explains the scope, structure,
and usage of consistent terminology of FASB ASC. Constituents are encouraged
to read this notice because it answers many common questions about FASB
ASC. FASB also posted questions and answers on its Web site to address items
such as the following:
 Status of basis for conclusions, which will still be available for
reference even though they have been effectively superseded
 Availability of archived guidance on the FASB Web site or in the
archive section of FASB ASC
 Free access to a basic view of FASB ASC and enhanced access
to search and retrieval functions, personal annotations, and dy-
namic linking capabilities, which will require a professional view
subscription (an annual subscription is available for $850)
 Plans that FASB has to issue FASB ASC in print (expected to be
available by the end of August 2009)
Scope of FASB ASC
The following is a summary of content included within the scope of FASB ASC:
 All level A–D GAAP issued by a standard setter for nongovern-
mental entities.
 GAAP guidance only. FASB ASC does not include guidance for
non-GAAP matters, such as other comprehensive basis of account-
ing (for example, cash basis and income tax basis) or regulatory
accounting principles.
 Relevant authoritative content issued by the SEC and select SEC
staff interpretations and administrative guidance. An "S" precedes
SEC guidance. However, FASB ASC does not include all SEC con-
tent because it is not intended to be a replacement for using the
SEC standards themselves. Rather, some SEC content has been
AAG-HCO
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included for ease of use because the content is presented in a top-
ical structure.
 The source of the standards is the as-amended versions provided
by the standard setter. Therefore, FASB ASC does not identify
documents that solely amend other standards.
The following is a summary of content excluded from FASB ASC:
 Standards for governmental entities.
 Certain content that was outdated or superseded by December
31, 2008. An example would be FASB Statement No. 141, Business
Combinations, which was superseded by FASB Statement No. 141
(revised 2007), Business Combinations.
 Nonessential material, such as redundant summaries of exist-
ing standards, historical content, discussions of previous practice,
summaries of constituent feedback, and similar content.
 Grandfathered material in FASB ASC. An example of grandfa-
thered material includes the pooling of interests in a business
combination described in paragraph B217 of FASB Statement No.
141. Other grandfathered items are identified in FASB Statement
No. 168. FASB Statement No. 168 explains that certain grandfa-
thered guidance is still considered authoritative even though it
has not been included in FASB ASC.
 Transition guidance for all guidance that is fully effective as of De-
cember 31, 2008. Entities applying GAAP for the first time may
need to access the original standards to determine relevant tran-
sition guidance. Transition guidance will be emphasized in FASB
ASC and removed after the transition period lapses.
 References to audit guidance in FASB ASC.
 As of the date FASB Statement No. 168 was issued, FASB ASC did
not include the following statements (they remain authoritative
until integrated into FASB ASC):
— FASB Statement No. 164, Not-for-Profit Entities: Merg-
ers and Acquisitions—Including an amendment of FASB
Statement No. 142
— FASB Statement No. 166, Accounting for Transfers of Fi-
nancial Assets—an amendment of FASB Statement No.
140
— FASB Statement No. 167, Amendments to FASB Inter-
pretation No. 46(R)
FASB ASC Topical Structure and Referencing
FASB ASC uses a topical structure in which guidance is organized into areas,
topics, subtopics, sections, subsections, and paragraphs.
 Areas are the broadest category in FASB ASC and represent a
grouping of topics.
 Topics are the broadest categorization of related guidance.
 Subtopics represent subsets of a topic and are generally distin-
guished by type or scope.
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 Sections represent the nature of the content in a subtopic such as
recognition, measurement, or disclosure.
 Subsections allow further segregation and navigation of content.
Topics, subtopics, and sections are numerically referenced and correlate very
closely to International Financial Reporting Standards. This structure effec-
tively organizes the content without regard to the original standard setter
or standard from which the content was derived. An example of the numer-
ical referencing is FASB ASC 305-10-05, in which 305 is the Cash and Cash
Equivalents topic, 10 represents the "Overall" subtopic, and 05 represents the
"Overview and Background" section. Accounting guidance in this guide has
been conformed to reflect reference to FASB ASC.
FASB Statement No. 168
As previously stated, FASB Statement No. 168 is effective for financial state-
ments issued for interim and annual periods ending after September 15, 2009.
Nonpublic nongovernmental entities that have not previously followed the
guidance included in AICPA Technical Questions and Answers (TIS) section
5100.38–.76 (AICPA, Technical Practice Aids), which is now included in FASB
ASC as authoritative, should account for the adoption of that guidance as a
change in accounting principle, on a prospective basis, for revenue arrange-
ments entered into or materially modified in those fiscal years beginning on or
after December 15, 2009, and interim periods within those years.
Except for nonpublic nongovernmental entities adopting the guidance included
in TIS section 5100.38–.76, any effect of applying the provisions of FASB State-
ment No. 168 should be accounted for as a change in accounting principle or
correction of an error, as applicable, in accordance with FASB ASC 250-10-50.
An entity should follow the applicable disclosure requirements and disclose
the accounting principles that were used before and after the application of
the provisions of FASB Statement No. 168 and the reason that applying that
statement resulted in a change in accounting principle or correction of an error.
FASB Statement No. 168 is the final standard that will be issued by FASB
in that form and creates topic 105 in FASB ASC. It was added to FASB ASC
through ASU No. 2009-02, Omnibus Update—Amendments to Various Topics
for Technical Corrections, on June 30, 2009. Going forward, no new standards
in the form of statements, staff positions, EITF abstracts, or AICPA accounting
SOPs, for example, will be issued. Instead, FASB will issue ASUs. FASB will
not consider ASUs as authoritative in their own right. Instead, they will serve
only to update FASB ASC, provide background information about the guidance,
and provide the basis for conclusions on changes made to FASB ASC.
If an entity finds that guidance for a transaction or event is not specified within a
source of authoritative GAAP for that entity, FASB Statement No. 168 provides
that an entity shall first consider accounting principles for similar transactions
or events within a source of authoritative GAAP for that entity and then con-
sider nonauthoritative guidance from other sources. An entity shall not follow
the accounting treatment specified in accounting guidance for similar transac-
tions or events in cases in which those accounting principles either prohibit the
application of the accounting treatment to the particular transaction or event
or indicate that the accounting treatment should not be applied by analogy.
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FASB Accounting Standards Codification™ Research System
In January 2008, FASB first launched its Internet-based research system,
FASB Accounting Standards Codification™ Research System. FASB now has
two versions available on its site. The first is the basic, free version (referred
to as the basic view). The second is the enhanced version (referred to as the
professional view and available for a fee) and includes additional features such
as an enhanced cross-reference tool with linking capability, the "Go to" feature,
"the printer-friendly with sources" option, and enhanced search features.
The cross-reference tool allows users to identify where current standards re-
side in FASB ASC or the source material that populates a specific location.
This tool is available in both the basic view and the professional view of FASB
ASC. However, only the professional view includes links to the FASB ASC sec-
tions. Standards that served only to amend other literature are not presented
in FASB ASC or the cross-reference tool because, as noted in the "Scope of
FASB ASC" section, the source of the standards is the as-amended version. For
example, FASB Statement No. 151, Inventory Costs—an amendment of ARB
No. 43, Chapter 4, was an amendment of chapter 4 of Accounting Research
Bulletin (ARB) No. 43, Restatement and Revision of Accounting Research Bul-
letins. FASB Statement No. 151 does not appear in the cross-reference tool; the
amended material is simply reflected as ARB No. 43, which is located in the
cross-reference tool. Users should be aware of this when reviewing FASB ASC
because some standards may appear to be missing but are, in fact, incorporated
into the standard(s) that they amended.
FASB ASC Feedback
FASB offers an electronic feedback feature in the research system to allow users
the ability to provide ongoing feedback in both the basic view and professional
view. In the notice to constituents, FASB has requested feedback on overall
non-content-related matters, as well as content-related matters. Any overall
non-content-related matters having to do with system functionality and perfor-
mance should be submitted through the general feedback feature on the FASB
ASC home page. Any feedback related to fatal content flaws or questions or
concerns about GAAP requirements should be submitted using the paragraph
level feedback feature. This feature is available in both the basic view and
professional view of FASB ASC.
Issuance of New Standards
After the effective date of FASB Statement No. 168, FASB will no longer con-
sider new standards authoritative in their own right. Instead, new standards
will be issued through ASUs and will serve only to update FASB ASC and pro-
vide the historical basis for conclusions of a new standard. New standards will
be in the form of ASU No. 20YY-XX, in which "YY" is the last two digits of the
year and "XX" is the sequential number for each update. For example, ASU
No. 2010-01 is the first update in the year 2010. New standards will include
the standard and an appendix of update instructions. FASB will organize the
contents of each ASU using the same section headings as those used in FASB
ASC.
Pending Content in FASB ASC
Any ASU issued by FASB, or other authoritative guidance issued prior to the ef-
fective date of FASB ASC, not yet fully effective is reflected as "Pending Content"
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in FASB ASC. All pending content is clearly noted as such and also includes
links to the transition information. When that content becomes fully effective,
the outdated guidance will be removed, and the amended paragraph will re-
main. FASB will keep any outdated guidance in the applicable archive section
of FASB ASC for historical purposes.
Pending content represents content that is not yet fully effective for all entities
or transactions within its scope. Because not all entities have the same fiscal
year-ends, and certain guidance is effective on different dates for public and
nonpublic entities (or the effective date of certain guidance may be different
for nonpublic entities that are not SEC registrants), the pending content will
remain in place for quite some time. Entities cannot disregard content that
displays as pending. Instead, all entities must review the transition guidance
to determine if and when the content is applicable to them.
GASB Codification of Pre-November 30, 1989,
FASB Pronouncements
GASB pronouncements have made certain AICPA and FASB pro-
nouncements specifically applicable to governmental entities. For ex-
ample, GASB Statements No. 20, Accounting and Financial Reporting
for Proprietary Funds and Other Governmental Entities That Use Pro-
prietary Fund Accounting, as amended, and No. 34, Basic Financial
Statements—and Management's Discussion and Analysis—for State
and Local Governments, require the application of certain pronounce-
ments of the FASB and its predecessor standards-setting organiza-
tions issued before November 30, 1989, and permit the application of
later FASB pronouncements in certain situations.
In April 2008, GASB added to its Technical Plan a project called Cod-
ification of Pre-November 30, 1989, FASB Pronouncements, the pur-
pose of which is to specifically identify and, when appropriate, modify
provisions in FASB statements and interpretations, Accounting Prin-
ciples Board Opinions, and ARBs, issued on or before November 30,
1989 (collectively, the "FASB pronouncements") as referenced in GASB
Statement No. 34, that do not conflict with or contradict GASB pro-
nouncements as they apply to financial reporting for governmental
and business-type activities. Based on the outcome of the research por-
tion of this project, GASB will then determine which of the provisions
should be incorporated into GASB pronouncements.
AAG-HCO
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Preface
Purpose
This guide has been prepared to assist providers of health care services in
preparing financial statements in conformity with generally accepted account-
ing principles (GAAP) and to assist independent auditors1 in auditing and re-
porting on those financial statements.
Applicability
This guide applies to health care entities that are either (a) investor-owned
businesses or (b) not-for-profit entities that have no ownership interest and are
essentially self-sustaining from fees charged for goods and services, as defined
in paragraph 8 of Financial Accounting Standards Board (FASB) Statement
of Financial Accounting Concepts No. 4, Objectives of Financial Reporting by
Nonbusiness Organizations,2 or (c) governmental. This guide applies to entities
whose principal operations consist of providing or agreeing to provide health
care services and that derive all or almost all of their revenues from the sale
of goods or services; it also applies to entities whose primary activities are the
planning, organization, and oversight of such entities, such as parent or holding
companies of health care providers.
This guide applies to the following types of health care entities:
 Clinics, medical group practices, individual practice associations,
individual practitioners, emergency care facilities, laboratories,
surgery centers, and other ambulatory care organizations
 Continuing care retirement communities
 Health maintenance organizations and similar prepaid health
care plans
 Home health agencies
 Hospitals
 Nursing homes that provide skilled, intermediate, and less inten-
sive levels of health care
 Drug and alcohol rehabilitation centers and other rehabilitation
facilities
This guide also applies to integrated delivery systems that include one or more
of the above types of entities.
This guide does not apply to voluntary health and welfare entities, as defined
in the FASB Accounting Standards Codification (ASC) glossary. These entities
should follow the AICPA Audit and Accounting Guide Not-for-Profit Entities.
Related fund-raising foundations that meet the definition of a not-for-profit
1 A member performing an attest engagement must be independent pursuant to Rule 101, In-
dependence (AICPA, Professional Standards, vol. 2, ET sec. 101 par. 01), of the AICPA Code of Pro-
fessional Conduct. Other applicable independence rules and regulations may also apply to members
and accountants while performing attest engagements (for example, Securities and Exchange Com-
mission (SEC), Public Company Accounting Oversight Board (PCAOB), Government Accountability
Office, and state licensing boards).
2 See paragraph 1.03 of this guide.
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entities given in the FASB ASC glossary also should follow the AICPA Audit
and Accounting Guide Not-for-Profit Entities.
When separate financial statements are issued for a state or local governmen-
tal health care entity that uses enterprise fund accounting and reporting, the
accounting, reporting, and disclosure requirements set forth in this guide and
by pronouncements of the Governmental Accounting Standards Board (GASB)
apply. (See chapter 1 for a discussion of the application of GAAP.) GASB State-
ment No. 34, Basic Financial Statements—and Management's Discussion and
Analysis—for State and Local Governments, replaces the previous definition
with a new definition of enterprise funds. Based on paragraph 67 of GASB
Statement No. 34, as amended, any activity that charges a fee to external users
for goods or services may be reported as an enterprise fund. In addition, para-
graph 67 requires governments to report activities in enterprise funds if any
one of the following three criteria, as summarized in the following list, is met:
(a) The activity is financed with debt that is secured solely by a pledge
of the net revenues from fees and charges of the activity.
(b) Laws or regulations require the activity's costs of providing ser-
vices, including capital costs, to be recovered with fees and charges
rather than with taxes or similar revenues.
(c) The pricing policies of the activity establish fees and charges that
are designed to recover the activity's costs of providing services,
including capital costs.
The primary focus of these criteria is on fees charged to external users. Also,
paragraph 67 of GASB Statement No. 34 requires that these criteria should be
applied in the context of the activity's principal revenue sources.
This guide is not the only industry-specific AICPA Audit and Accounting Guide
that auditors should consider when performing an audit of a governmental
health care entity. The Audit and Accounting Guide State and Local Govern-
ments, includes governmental health care entities in its scope and was cleared
by the GASB. Therefore, certain accounting and financial reporting guidance
in that guide constitutes category (b) guidance for governmental health care
entities, and the auditing guidance in that guide should also be considered dur-
ing an audit of a governmental health care entity that is included in the scope
of this guide. In practice, auditors of governmental health care entities that
issue separate financial statements using enterprise fund accounting and re-
porting may use this guide as the primary source of guidance because this guide
addresses transactions that are unique to or prevalent in the health care indus-
try. The Audit and Accounting Guide State and Local Governments, however,
contains information about governmental accounting and financial reporting
standards and other matters that are unique to or prevalent in government
and not included in this guide.3
Many governmental health care entities are considered to be special-purpose
governments as defined in paragraph 134 of GASB Statement No. 34.4
3 See paragraphs 1.21 and 12.11–.13 in the Audit and Accounting Guide State and Local Gov-
ernments.
4 Governmental Accounting Standards Board (GASB) Statement No. 34, Basic Financial
Statements—and Management's Discussion and Analysis—for State and Local Governments, does
not provide guidance on separate reporting by individual enterprise funds of a government. Although
this discussion of the guidance in GASB Statement No. 34 is written in terms of special-purpose
(continued)
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Special-purpose governments are legally separate entities, as that term is de-
scribed in paragraph 15 of GASB Statement No. 14, The Financial Reporting
Entity. They may be component units of another governmental entity or they
may be other stand-alone governments. (Both terms component units and other
stand-alone governments are also defined by GASB Statement No. 14.) Because
GASB Statement No. 34 is written from the perspective of general-purpose
governments, paragraph 138 of GASB Statement No. 34 discusses how those
requirements apply to special-purpose governments engaged only in business-
type activities, such as certain governmental health care entities. Governmen-
tal health care entities that are special-purpose governments engaged only in
business-type activities should present only the financial statements required
for enterprise funds. These financial statements are discussed further in para-
graph 1.14 of this guide.
Limitations
This guide does not discuss the application of all GAAP and all generally ac-
cepted auditing standards (GAAS) that are relevant to the preparation and
audit of financial statements of health care entities. The guide is directed pri-
marily to those aspects of the preparation and audit of health care entities'
financial statements that may be unique to those entities or areas considered
particularly significant to them.
Other Literature
This guide incorporates certain provisions of FASB ASC 958, Not-for-Profit En-
tities, GASB Statement No. 33, Accounting and Financial Reporting for Nonex-
change Transactions, as amended, and GASB Statement No. 34 and related
pronouncements. Not all guidance included in FASB ASC or those statements,
however, is incorporated, repeated, or summarized in this guide. Accordingly,
FASB ASC, those statements, and all authoritative guidance5 should be read
in conjunction with this guide.
Office of Management and Budget (OMB) Circular A-133, Audits of States, Lo-
cal Governments, and Non-Profit Organizations, sets forth audit requirements
(footnote continued)
business-type activities that are governmental health care entities, the accounting, financial reporting,
and auditing considerations are usually equally applicable when the health care activity is conducted
as a function or program of a general-purpose government and reported in an enterprise fund. See
footnote 7 to the section heading "Specific Guidance for Special-Purpose Governments" in chapter 12
of the Audit and Accounting Guide State and Local Governments. Reporting guidance on separate
reporting by individual enterprise funds of a government is provided in the Audit and Accounting
Guide State and Local Governments.
5 On June 30, 2009, the Financial Accounting Standards Board (FASB) issued FASB Statement
No. 168, The FASB Accounting Standards Codification™ and the Hierarchy of Generally Accepted
Accounting Principles—a replacement of FASB Statement No. 162, which is codified at FASB Account-
ing Standards Codification (ASC) 105, Generally Accepted Accounting Principles. On the effective
date of this statement, FASB ASC will become the authoritative source of U.S. accounting and re-
porting standards for nongovernmental entities, in addition to guidance issued by the SEC. At that
time, FASB ASC will supersede all then-existing, non-SEC accounting and reporting standards for
nongovernmental entities. Once effective, all other nongrandfathered, non-SEC accounting literature
not included in FASB ASC will become nonauthoritative. This statement is effective for financial
statements issued for interim and annual periods ending after September 15, 2009.
Other authoritative literature for governmental health care entities includes GASB statements,
interpretations, and technical bulletins; FASB and AICPA guidance specifically made applicable to
state and local governmental entities by GASB; and AICPA Audit and Accounting Guides, Industry
Audit Guides, Statements of Position, and Practice Bulletins made applicable to governmental entities
and cleared by GASB.
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for health care entities expending federal awards. Institutions covered by OMB
Circular A-133 include not-for-profit hospitals, public hospitals, and institu-
tions of higher education, and their affiliated hospitals, voluntary health and
welfare entities, and other community-based organizations.6 Auditors of health
care entities that are subject to the audit requirements of OMB Circular A-133
should refer to the Audit Guide Government Auditing Standards and Circular
A-133 Audits.
Applicability of Requirements of the Sarbanes-Oxley
Act of 2002
Publicly held companies and other issuers (see the definition that follows) are
subject to the provisions of the Sarbanes-Oxley Act of 2002 and related Se-
curities and Exchange Commission (SEC) regulations implementing the act.
Their outside auditors are also subject to the provisions of the act and to the
rules and standards issued by the Public Company Accounting Oversight Board
(PCAOB).
The following sections summarize certain key areas addressed by the act, the
SEC, and the PCAOB that are particularly relevant to the preparation and
issuance of an issuer's financial statements and the preparation and issuance
of an audit report on those financial statements. However, the provisions of the
act, the regulations of the SEC, and the rules and standards of the PCAOB are
numerous and are not all addressed in this section or in this guide.
Definition of an issuer. The act states that the term issuer means an issuer (as
defined in Section 3 of the Securities Exchange Act of 1934 (15 U.S.C. 78c)),
the securities of which are registered under Section 12 of that act (15 U.S.C.
78l), or that is required to file reports under Section 15(d) (15 U.S.C. 78o(d)), or
that files or has filed a registration statement that has not yet become effective
under the Securities Act of 1933 (15 U.S.C. 77a et seq.), and that it has not
withdrawn.
Issuers, as defined by the act, and other entities when prescribed by the rules
of the SEC (collectively referred to in this guide as issuers or issuer) and their
public accounting firms (who must be registered with the PCAOB) are subject
to the provisions of the act, implementing SEC regulations, and the rules and
standards of the PCAOB, as appropriate.
Nonissuers are those entities not subject to the act or the rules of the SEC.
Guidance for Issuers
Management Assessment of Internal Control Over
Financial Reporting
As directed by Section 404 of the Sarbanes-Oxley Act of 2002, the SEC adopted
final rules requiring companies subject to the reporting requirements of the Se-
curities Exchange Act of 1934, other than registered investment companies and
6 The Codification of Office of Management and Budget (OMB) Circular A-133 by the U.S. De-
partment of Health and Human Services (HHS) also includes audit requirements for commercial
organizations (including for-profit hospitals) that receive federal awards under HHS programs. Gen-
erally, the organization has 2 options regarding audits: (1) a financial-related audit of a particular
award in accordance with Government Auditing Standards, or (2) an audit that meets the require-
ments of OMB Circular A-133. See Section 74.26(d) of Title 45, Public Welfare, of the U.S. Code of
Federal Regulations for further information.
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certain other entities, to include in their annual reports a report of management
on the company's internal control over financial reporting. The SEC rules clarify
that management's assessment and report is limited to internal control over
financial reporting. The SEC's definition of internal control encompasses the
Committee of Sponsoring Organizations of the Treadway Commission (COSO)
definition, but the SEC does not mandate that the entity use COSO as its cri-
teria for judging effectiveness.
The auditor's attestation on the effectiveness of the internal control over finan-
cial reporting is currently required for large accelerated filers and accelerated
filers. As established by Rule 12b-2 of the Securities Exchange Act of 1934, the
auditor's attestation for large accelerated and accelerated filers is currently ef-
fective; however, for nonaccelerated filers, the auditor's attestation is required
for annual reports for fiscal years ending on or after June 15, 2010.
In its Interpretive Release No. 33-8810, Commission Guidance Regarding Man-
agement's Report on Internal Control Over Financial Reporting Under Section
13(a) or 15(d) of the Securities Exchange Act of 1934, dated June 20, 2007, the
SEC provides guidance for management regarding its evaluation and assess-
ment of internal control over financial reporting. This guidance is organized
around two broad principles. The first principle is that management should
evaluate whether it has implemented controls that adequately address the
risk that a material misstatement of the financial statements would not be
prevented or detected in a timely manner. This guidance describes a top-down,
risk-based approach to this principle. The second principle is that manage-
ment's evaluation of evidence about the operation of its controls should be based
on its assessment of risk. This guidance provides an approach for making risk-
based judgments about the evidence needed for the evaluation.
In its Final Rule Release No. 33-8809, Amendments to Rules Regarding Man-
agement's Report on Internal Control Over Financial Reporting, dated June 20,
2007, the SEC establishes, among other significant provisions, that a company
performing an evaluation in accordance with the aforementioned interpretive
guidance also satisfies the annual evaluation required by Securities Exchange
Act of 1934 Rules 13a-15 and 15d-15. Also, the SEC defined the term material
weakness and revised the requirements regarding the auditor's attestation re-
port on the effectiveness of internal control over financial reporting to require
the auditor to express an opinion directly on the effectiveness of internal control
over financial reporting and not on management's evaluation process.
In its Final Rule Release No. 33-8829, Definition of the Term Significant Defi-
ciency, dated August 3, 2007, the SEC defined the term significant deficiency
for the purpose of implementing Section 302 and Section 404 of the Sarbanes-
Oxley Act of 2002. By including a definition of significant deficiency in SEC
rules, in addition to the definition of material weakness, the SEC has enabled
management to refer to its rules and guidance for information on the meaning
of these terms rather than referring to the auditing standards. Readers should
refer to the SEC Web site at www.sec.gov/ for more information.
Guidance for Auditors
The Sarbanes-Oxley Act of 2002 mandates a number of requirements concern-
ing auditors of issuers, including mandatory registration with the PCAOB,
the setting of auditing standards, inspections, investigations, disciplinary pro-
ceedings, prohibited activities, partner rotation, and reports to audit commit-
tees, among others. The PCAOB continues to establish rules and standards
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implementing provisions of the act concerning the auditors of issuers. For
additional information, readers should refer to the PCAOB Web site at
www.pcaob.org.
Applicability of GAAS and PCAOB Standards
Subject to SEC oversight, Section 103 of the Sarbanes-Oxley Act of 2002 autho-
rizes the PCAOB to establish auditing and related attestation, quality control,
ethics, and independence standards to be used by registered public accounting
firms in the preparation and issuance of audit reports for entities subject to
the act or the rules of the SEC. Accordingly, public accounting firms registered
with the PCAOB are required to adhere to all PCAOB standards in the audits
of issuers and other entities when prescribed by the rules of the SEC.
For those entities not subject to the act or the rules of the SEC, the prepara-
tion and issuance of audit reports remain governed by GAAS as issued by the
Auditing Standards Board.
Major Existing Differences Between GAAS and PCAOB Standards
Major differences between GAAS and PCAOB standards are described in both
part I of volume 1 of the AICPA publication Professional Standards and in
part I of the AICPA publication PCAOB Standards and Related Rules. Please
refer to appendix G, "Major Existing Differences Between AICPA Standards
and PCAOB Standards," of this guide for a summary of the major existing
differences between AICPA standards and PCAOB standards.
Select SEC Developments
International Financial Reporting Standards
International Financial Reporting Standards (IFRSs) is a set of accounting
standards developed by International Accounting Standards Board (IASB) that
is becoming the global standard for the preparation of public company finan-
cial statements. IASB is an independent accounting standards body, based in
London, that consists of 14 members from 9 countries, including the United
States. IASB began operations in 2001, when it succeeded the International
Accounting Standards Committee (IASC). IASC was formed in 1973, soon after
the formation of FASB. In 2001, IASC was disbanded and a new oversight body,
the IASC Foundation, was created to oversee the IASB. This oversight role is
very similar to that of the Financial Accounting Foundation in its capacity as
the oversight body of FASB, GASB, and other advisory councils.
The term IFRSs has both a narrow and a broad meaning. Narrowly, IFRSs
refers to the new numbered series of pronouncements that the IASB is issuing,
as differentiated from the International Accounting Standards (IASs) issued by
its predecessor. More broadly, IFRSs refer to the entire body of IASB pronounce-
ments, including standards and interpretations approved by IASB as well as
IASs and the related interpretations issued by the Standing Interpretations
Committee as approved by the IASC.
Timeline of SEC Activities Towards Adoption of IFRSs
A significant step forward toward acceptance of IFRSs in the United States
occurred when, in 2005, the then chief accountant of the SEC published a
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"roadmap" for the possible elimination of the requirement for foreign private
issuers (FPIs) to reconcile financial statements prepared under IFRSs to U.S.
GAAP. The roadmap sets forth a series of steps and standards to be met before
IFRSs will be accepted by the SEC as equivalent to U.S. GAAP for FPIs.
In December 2007, the SEC made further progress towards convergence with
the issuance of Final Rule Release No. 33-8879, Acceptance From Foreign Pri-
vate Issuers of Financial Statements Prepared in Accordance With International
Financial Reporting Standards Without Reconciliation to U.S. GAAP, that per-
mits FPIs in their filings with the SEC to use financial statements prepared
in accordance with IFRSs as issued by the IASB without reconciliation to U.S.
GAAP. The rule amendments are effective for annual financial statements for
financial years ending after November 15, 2007.
In August 2007, the SEC issued Concept Release 33-8831, Concept Release
On Allowing U.S. Issuers To Prepare Financial Statements In Accordance With
International Financial Reporting Standards, to gather input regarding the
role of IFRSs as a basis of financial reporting in the U.S. public capital market
by U.S. issuers. This action reflected the growing interest in equitable treatment
of U.S. issuers to adopt IFRSs as the basis of accounting in financial statements
filed with the SEC just as their foreign counterparts have the option to do.
In November 2008, the SEC issued Proposed Rule Release No. 33-8982,
Roadmap for the Potential Use of Financial Statements Prepared in Accordance
with International Financial Reporting Standards by U.S. Issuers, that sets
forth seven milestones that, if achieved, could lead to the mandatory adoption
of IFRSs by U.S. issuers. These seven milestones relate to
 improvements in accounting standards;
 the accountability and funding of the IASC Foundation;
 the improvement in the ability to use interactive data for IFRSs
reporting;
 education and training relating to IFRSs;
 limited early use of IFRSs where this would enhance comparabil-
ity for U.S. investors;
 the anticipated timing of future rulemaking by the SEC; and
 the implementation of the mandatory use of IFRSs by U.S. issuers.
The implementation of the proposed rule provides for a staged transition rather
than having all U.S. issuers transition at once. Provisionally, under the proposed
transition period, IFRSs filings would begin for SEC registrants as follows:
 Large accelerated filers would begin IFRSs filings for fiscal years
ending on or after December 15, 2014.
 Accelerated filers would begin IFRSs filings for years ending on or
after December 15, 2015.
 Nonaccelerated filers, including smaller reporting companies,
would begin IFRSs filings for years ending on or after December
15, 2016.
This proposed rule indicates that in 2011, the SEC, after reviewing the sta-
tus of the milestones and considering whether the adoption of IFRSs is in the
public interest and promotes investor protection, would determine whether to
proceed with rules requiring U.S. public companies to file financial statements
prepared in accordance with IFRSs. Given the recent changes in the political
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administration as well as the SEC leadership, readers are encouraged to mon-
itor developments related to the adoption of IFRSs on the SEC's Web site at
www.sec.gov/spotlight.shtml.
FASB and IASB Memorandum of Understanding
In September 2008, FASB and IASB updated their Memorandum of Under-
standing (MoU), originally published in 2006 to reaffirm their respective com-
mitments to the development of high quality, compatible accounting standards
that could be used for both domestic and cross-border financial reporting. In de-
veloping the original MoU, FASB and IASB agreed on priorities and established
milestones as part of a joint work program to develop new common standards
that improve the financial information reported to investors.
FASB and IASB agreed that the goal of joint projects is to produce common,
principles-based standards, subject to the required due process. In the MoU,
the boards identified the following 11 convergence topics on which to focus:
 Business combinations
 Financial instruments
 Financial statement presentation
 Intangible assets
 Leases
 Liabilities and equity distinctions
 Revenue recognition
 Consolidations
 Derecognition
 Fair value measurement
 Postemployment benefits (including pensions)
Both FASB and IASB note that their individual and joint efforts are not limited
to the preceding items, but they remain committed to the MoU.
Readers are also encouraged to monitor developments on the AICPA's Web site,
www.ifrs.com, in addition to FASB, IASB, and SEC Web sites. The growing
acceptance of IFRSs as a basis for U.S. financial reporting could represent a
fundamental change for the U.S. accounting profession. Acceptance of a single
set of high quality accounting standards for worldwide use by public companies
has been gaining momentum around the globe for the past few years.
Electronic Municipal Market Access
In December 2008, the SEC finalized changes to Rule 15c-2-12 that are in-
tended to improve the availability of information about municipal securities to
investors, market professionals, and the general public by providing for a single
centralized repository for the electronic collection and availability of informa-
tion about municipal securities outstanding in the secondary market. The new
changes were effective July 1, 2009. The changes amend certain requirements
regarding the information that underwriters must reasonably determine that
an issuer has undertaken to provide for the benefit of the holders of the issuer's
municipal securities. Specifically, the amendments require the underwriter to
reasonably determine that the issuer or obligated person has undertaken in its
continuing disclosure (also referred to as secondary market disclosure by some
literature) agreement to provide continuing disclosure documents (1) solely to
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the Municipal Securities Rulemaking Board (MSRB) and (2) in an electronic
format and accompanied by identifying information as prescribed by the MSRB.
Concurrently, the SEC approved a companion proposal by the MSRB establish-
ing a continuing disclosure service of the MSRB's Electronic Municipal Market
Access (EMMA) system. The MSRB's EMMA will receive electronic submissions
of, and make publicly available, continuing disclosure documents and related in-
formation on the EMMA Web site at http://emma.msrb.org. This change means
that issuers or obligated persons will be required by the SEC to provide contin-
uing disclosure information to the MSRB via EMMA instead of providing them
to multiple nationally recognized municipal securities information repositories
and state information depositories (SIDs). However, the changes to Rule 15c2-
12 requiring issuers to file with the MSRB (using the EMMA system) will not
affect the legal obligation of issuers and obligated persons to provide continu-
ing disclosure documents, along with any other submissions, to the appropriate
SID, if any, as required under the appropriate state law. In addition, the amend-
ments will have no effect on the obligations of issuers and obligated persons
under outstanding continuing disclosure agreements entered into prior to the
effective date of the amendments to the rule to submit continuing disclosure
documents to the appropriate SID, if any, as stated in their existing continuing
disclosure agreements. The amendments will also not affect their obligation to
make any other submissions that may be required under the appropriate state
law.
The changes to Rule 15c2-12 also amend the exemptive provisions that gen-
erally relate to issuers with less than $10 million in outstanding debt who,
in the past, entered into a limited undertaking to provide certain information
upon request (or at least annually to the appropriate SID). Changes to Rule
15c2-12(d)(2)(ii) (the exemptive provision) require the limited undertaking to
provide annual financial information or operating data (if customarily prepared
and made publicly available) to the MSRB (that is, using the EMMA system).
See Release No. 34-59062; File No. S7-21-08, section III.6 for additional infor-
mation.
Interactive Data to Improve Financial Reporting
SEC Final Rule Release No. 33-9002, Interactive Data to Improve Financial
Reporting, issued in January 2009, requires domestic and foreign public com-
panies that prepare their financial statements in accordance with U.S. GAAP,
and FPIs that prepare their financial statements in accordance with IFRSs as
issued by the IASB, to use interactive data for financial information. Compa-
nies will provide their financial statements to the SEC and on their corporate
Web sites in interactive data format using the eXtensible Business Reporting
Language. This will allow investors to use interactive data to receive important
information in a fast, more reliable manner at a reduced cost. In the past, com-
panies voluntarily filed SEC financial information in interactive data format.
This approval requires that for public companies, interactive data financial
reporting will occur on a phased-in schedule beginning in 2009. The largest
companies who file using U.S. GAAP with a public float above $5 billion (ap-
proximately 500 companies) will be required to provide interactive data reports
starting with their first quarterly report for fiscal periods ending on or after
June 15, 2009. The remaining companies who file using U.S. GAAP will be re-
quired to file with interactive data on a phased-in schedule over the next 2
years. Companies reporting in IFRSs issued by the IASB will be required to
provide their interactive data reports starting with fiscal years ending on or
AAG-HCO
P1: G.Shankar
ACPA125-FM ACPA125.cls February 25, 2010 15:30
xxii
after June 15, 2011. Companies can adopt interactive data earlier than their
required start date. All U.S. public companies will have filed interactive data
financial information by December 2011 for use by investors. The full text of the
final rule is available on the SEC's Web site at www.sec.gov/rules/final/2009/33-
9002.pdf.
Select PCAOB Developments*
PCAOB Auditing Standard No. 6, Evaluating Consistency
of Financial Statements
In January 2008, the PCAOB adopted PCAOB Auditing Standard No. 6, Evalu-
ating Consistency of Financial Statements (AICPA, PCAOB Standards and Re-
lated Rules, Auditing Standards), and related conforming amendments, which
became effective November 15, 2008. This standard and its related amend-
ments, among other significant provisions, update the auditor's responsibilities
to evaluate and report on the consistency of a company's financial statements
and align the auditor's responsibilities with FASB Statement No. 154, Account-
ing Changes and Error Corrections—a replacement of APB Opinion No. 20, and
FASB Statement No. 3. FASB Statement No. 154 has been codified primarily at
FASB ASC 250-10. Auditing Standard No. 6 requires the auditor to recognize,
in the auditor's report, a company's correction of a material misstatement, re-
gardless of whether it involves the application of an accounting principle. This
standard also clarifies that the auditor's report should indicate whether an ad-
justment to previously issued financial statements results from a change in
accounting principle or the correction of a misstatement.
In the conforming amendments, the PCAOB removed the GAAP hierarchy from
its standards because it believes the hierarchy is more appropriately located in
the accounting standards. These amendments do not change the principles in
AU section 411, The Meaning of Present Fairly in Conformity With Generally
Accepted Accounting Principles (AICPA, PCAOB Standards and Related Rules,
Interim Standards), for evaluating fair presentation of the financial statements
in conformity with GAAP. This action was prompted by and issued concurrently
with FASB's issuance of FASB Statement No. 162, The Hierarchy of Gener-
ally Accepted Accounting Principles, which also became effective November 15,
2008. Refer to the related discussion in the notice to readers for more infor-
mation on FASB Statement No. 168, The FASB Accounting Standards Codifi-
cation™ and the Hierarchy of Generally Accepted Accounting Principles—a re-
placement of FASB Statement No. 16, which replaced FASB Statement No. 162.
* In July 2009, the PCAOB adopted PCAOB Auditing Standard No. 7, Engagement Quality Re-
view. PCAOB Auditing Standard No. 7 provides a framework for the engagement quality reviewer to
objectively evaluate the significant judgments made and related conclusions reached by the engage-
ment team in forming and overall conclusion about the engagement. PCAOB Auditing Standard No. 7
applies to all audit engagements and engagements to review interim financial information conducted
pursuant to the standards of the PCAOB. PCAOB Auditing Standard No. 7 supersedes the PCAOB's
quality control standard, SEC Practice Section Requirements of Membership, sections 1000.08(f) and
1000.39 and appendix E. PCAOB Auditing Standard No. 7, if approved by the SEC, will become ef-
fective for audit engagements and engagements to review interim financial information conducted
pursuant to the standards of the PCAOB for fiscal years beginning on or after December 15, 2009.
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Overview and General Accounting Considerations 1
Chapter 1
Overview and General Accounting
Considerations
Overview
1.01 Financial statements of health care entities should be prepared in
conformity with generally accepted accounting principles (GAAP).1
Classification of Health Care Entities
1.02 Health care entities usually can be classified into the following cate-
gories on the basis of their operating characteristics:
a. Investor-owned health care entities. According to Financial Account-
ing Standards Board (FASB) Accounting Standards Codification
(ASC) 954-10-05-2, these are owned by investors or others with a
private equity interest and provide goods or services with the ob-
jective of making a profit.
b. Not-for-profit, business-oriented entities. According to FASB ASC
954-10-05-2, these are characterized by no ownership interests and
essentially are self-sustaining from fees charged for goods and ser-
vices. The fees charged by such entities generally are intended to
help the entity maintain its self-sustaining status rather than to
maximize profits for the owner's benefit. Such entities often are ex-
empt from federal income taxes and may receive contributions of
relatively small amounts from resource providers that do not expect
commensurate or proportionate pecuniary return.
1 Governmental health care entities only. Governmental Accounting Standards Board (GASB)
Statement No. 34, Basic Financial Statements—and Management's Discussion and Analysis—for
State and Local Governments, paragraphs 93–95 indefinitely extend the provisions of GASB State-
ment No. 20, Accounting and Financial Reporting for Proprietary Funds and Other Governmental
Entities That Use Proprietary Fund Accounting. GASB Statement No. 20 paragraph 6, as amended,
requires that proprietary funds should apply all applicable GASB pronouncements as well as any
Financial Accounting Standards Board (FASB) statements and interpretations, Accounting Princi-
ples Board (APB) opinions, and Accounting Research Bulletins (ARBs) issued on or before November
30, 1989, that do not conflict with or contradict GASB pronouncements. Furthermore, paragraph 7,
as amended, of GASB Statement No. 20 provides that governmental enterprise funds and activities
reported using enterprise fund accounting and financial reporting may apply all FASB statements
and interpretations issued after November 30, 1989, that do not conflict with or contradict GASB
pronouncements. Entities that choose to apply these new FASB pronouncements must apply them
on an "all or none" basis (that is, they may not select which pronouncements to apply). In addition,
GASB Statement No. 29, The Use of Not-for-Profit Accounting and Financial Reporting Principles
by Governmental Entities, provides that governmental enterprise funds and activities reported us-
ing enterprise fund accounting and financial reporting that apply the provisions of paragraph 7, as
amended, of GASB Statement No. 20 should apply only those FASB statements and interpretations
issued after November 30, 1989, that are developed for business enterprises (see paragraph 1.83 in
this guide). They should not apply FASB statements and interpretations whose provisions are lim-
ited to not-for-profit entities, such as FASB Statement No. 117, Financial Statements of Not-for-Profit
Organizations, or address issues concerning primarily such organizations, such as FASB Statement
No. 116, Accounting for Contributions Received and Contributions Made, which have been primarily
codified in FASB Accounting Standards Codification (ASC) 958, Not-for-Profit Entities. The require-
ments set forth in this guide for governmental health care entities generally apply to such entities
that apply paragraph 7, as amended, of GASB Statement No. 20.
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2 Health Care Entities
c. Governmental health care entities. These are public corporations2
and bodies corporate and politic. Other entities are governmental
entities if they have one or more of the following characteristics:
i. Popular election of officers or appointment (or approval)
of a controlling majority of the members of the entity's
governing body by officials of one or more state or local
governments;
ii. The potential for unilateral dissolution by a government
with the net assets reverting to a government; or
iii. The power to enact and enforce a tax levy.
Furthermore, entities are presumed to be governmental if they have
the ability to issue directly (rather than through a state or munici-
pal authority) debt that pays interest exempt from federal taxation.
However, entities possessing only that ability (to issue tax-exempt
debt) and none of the other governmental characteristics may rebut
the presumption that they are governmental if their determination
is supported by compelling, relevant evidence.
d. Not-for-profit, nonbusiness-oriented entities. According to FASB
ASC 954-10-15-3, these are voluntary health and welfare entities
(see the glossary) as defined in the FASB ASC glossary. Such enti-
ties are within the scope of FASB ASC 958, Not-for-Profit Entities.
Additional accounting guidance may be obtained in the AICPA Au-
dit and Accounting Guide Not-for-Profit Entities rather than this
guide.
Financial Reporting of Nongovernmental Health
Care Entities
1.03 The nature of the entity and its operating structure have a significant
effect on the needs of financial statement users. According to FASB Statement
of Financial Accounting Concepts No. 4, Objectives of Financial Reporting by
Nonbusiness Organizations, paragraph 8
Some organizations have no ownership interests but are essentially
self-sustaining from fees they charge for goods and services. Examples
are those private nonprofit hospitals . . . that may receive relatively
small amounts of contributions and grants but finance their capital
needs largely from the proceeds of debt issues and their operating
needs largely from service charges rather than from private philan-
thropy or governmental grants. As a result, assessment of amounts,
timing, and uncertainty of cash flows becomes the dominant interest of
their creditors and other resource providers and profitability becomes
2 Black's Law Dictionary defines a public corporation as: "An artificial person (e.g., [a] munici-
pality or a governmental corporation) created for the administration of public affairs. Unlike a private
corporation it has no protection against legislative acts altering or even repealing its charter. Instru-
mentalities created by [the] state, formed and owned by it in [the] public interest, supported in whole
or part by public funds, and governed by managers deriving their authority from [the] state." Sharon
Realty Co. v. Westlake, Ohio Com.Pl., 188 N.E.2d 318, 323, 25, O.O.2d 322. "A public corporation is an
instrumentality of the state, founded and owned in the public interest, supported by public funds and
governed by those deriving their authority from the state." York County Fair Ass'n v. South Carolina
Tax Commission, 249 S.C. 337, 154 S.E.2d 361, 362.
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Overview and General Accounting Considerations 3
an important indicator of performance. Consequently, the objectives
of FASB Concepts Statement No. 1, Objectives of Financial Reporting
by Business Enterprises, may be more appropriate for those organiza-
tions. [Footnote reference omitted.]
1.04 The financial reporting for not-for-profit, business-oriented entities
and investor-owned health care entities generally is consistent except for trans-
actions that clearly are not applicable. For example, not-for-profit, business en-
tities would have nothing to report for shareholders' equity. On the other hand,
investor-owned health care entities typically would not have anything to report
for contributions.
1.05 The basic financial statements of health care entities generally con-
sist of a balance sheet, a statement of operations, a statement of changes in
equity (or net assets), a statement of cash flows, and notes to the financial
statements.3
1.06 According to FASB ASC 954-225-45-4, the statement of operations
for not-for-profit, business-oriented health care entities should include a perfor-
mance indicator (see paragraphs 10.36–.37). Those entities should report the
performance indicator in a statement that also presents the total changes in
unrestricted net assets. FASB ASC 954-205-45-1 indicates that the basic finan-
cial statements of health care entities consist of a balance sheet, a statement of
operations, a statement of changes in equity (or net assets), a statement of cash
flows, and notes to the financial statements. Illustrative financial statements
are included in appendix A of this guide.
1.07 As indicated in FASB ASC 954-210-45-1, health care entities, includ-
ing not-for-profit, business-oriented health care entities, should classify assets
and liabilities as current and noncurrent as discussed in FASB ASC 210-10-45.
FASB ASC 954-210-45-1 also indicates that rather than presenting a classified
balance sheet, a continuing care retirement community instead may sequence
assets according to their nearness of conversion to cash and may sequence lia-
bilities according to the nearness of the maturity and resulting use of cash.
1.08 FASB ASC 230, Statement of Cash Flows, establishes standards for
cash flow reporting. In addition, not-for-profit, business-oriented health care
entities should apply the standards for cash flow reporting in FASB ASC 958-
230. According to FASB ASC 230-10-45, the statement of cash flows may be
prepared using the direct or indirect method of reporting cash flows.
1.09 A health care entity may be a part of another entity, such as a medical
school or a university, or a subsidiary of a corporation. The recommendations in
this guide apply to the separate financial statements of these entities as defined
previously.
Financial Reporting of Governmental Health Care Entities
1.10 This section of the guide discusses the financial reporting require-
ments applicable to governmental health care entities within the scope of this
3 The terms balance sheet and statement of operations indicate the content and purpose of the
respective statements and serve as possible titles for those statements. Other appropriately descrip-
tive titles may also be used. For example, a statement reporting financial position could be called
a statement of financial position as well as a balance sheet. Current practice and purpose suggest,
however, that a statement of cash flows only be titled "Statement of Cash Flows."
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guide, including the financial reporting requirements of Governmental Ac-
counting Standards Board (GASB) Statement No. 34, Basic Financial
Statements—and Management's Discussion and Analysis—for State and Lo-
cal Governments, as amended, and GASB Statement No. 38, Certain Financial
Statement Note Disclosures.*
1.11 A health care entity may be a part of another entity, such as a
general-purpose-government or medical school or a university. The recommen-
dations in this guide apply to the separate financial statements of these entities.
Therefore, when separate financial statements are prepared for a governmental
health care entity that uses enterprise fund accounting and reporting, the ac-
counting and disclosure requirements set forth by GASB pronouncements and
this guide apply. The requirements in this guide presume that governmental
health care entities apply paragraph 7 of GASB Statement No. 20, Account-
ing and Financial Reporting for Proprietary Funds and Other Governmental
Entities That Use Proprietary Fund Accounting (see footnote 1 to this chapter).
1.12 This guide makes various references to implementation guides pub-
lished by the GASB staff. Those implementation guides are category (d) guid-
ance in the hierarchy of GAAP applicable to state and local governments, as
discussed in paragraph 1.77–.84 in this chapter. References to the guidance in
GASB staff implementation guides in this guide do not elevate that guidance to
category (b) guidance. Similarly, references in this guide to discussions or exam-
ples in the nonauthoritative appendixes of GASB pronouncements or its staff 's
implementation guides do not elevate that guidance from "other accounting
literature."
1.13 GASB issued Technical Bulletin 2006-1, Recognition and Measure-
ment of Asbestos-Related Cleanup Costs, in June 2006. This technical bulletin
is effective immediately, except for portions of answers pertaining specifically
to measurement, recognition, or required supplementary information require-
ments of GASB Statement No. 43, Financial Reporting for Postemployment
* GASB Statement No. 51, Accounting and Financial Reporting for Intangible Assets, requires
that all intangible assets not specifically excluded by its scope provisions be classified as capital as-
sets. Accordingly, existing authoritative guidance related to the accounting and financial reporting
for capital assets should be applied to these intangible assets, as applicable. This statement also pro-
vides authoritative guidance that specifically addresses the nature of these intangible assets. Such
guidance should be applied in addition to the existing authoritative guidance for capital assets. The
guidance specific to intangible assets referred to previously includes guidance on recognition. This
statement requires that an intangible asset be recognized in the statement of net assets only if it
is considered identifiable. Additionally, this statement establishes a specified-conditions approach to
recognizing intangible assets that are internally generated. Effectively, outlays associated with the
development of such assets should not begin to be capitalized until certain criteria are met. Outlays
incurred prior to meeting these criteria should be expensed as incurred. This statement also provides
guidance on recognizing internally generated computer software as an intangible asset. This guidance
serves as an application of the specified-conditions approach described previously to the development
cycle of computer software. This statement also establishes guidance specific to intangible assets re-
lated to amortization and provides guidance on determining the useful life of intangible assets when
the length of their life is limited by contractual or legal provisions.
GASB Statement No. 51 is effective for financial statements for periods beginning after June 15,
2009. The provisions of this statement generally are required to be applied retroactively. For govern-
ments that were classified as phase 1 or phase 2 governments for the purpose of implementing GASB
Statement No. 34, retroactive reporting is required for intangible assets acquired in fiscal years ending
after June 30, 1980, except for those considered to have indefinite useful lives as of the effective date
of this statement and those that would be considered internally generated. Retroactive reporting of
these intangible assets by phase 3 governments is encouraged but not required. Retroactive reporting
is not required but is permitted for intangible assets considered to have indefinite useful lives as of
the effective date of this statement and those considered to be internally generated.
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Benefit Plans Other Than Pension Plans, or GASB Statement No. 45, Account-
ing and Financial Reporting by Employers for Postemployment Benefits Other
Than Pensions. Those provisions should be applied simultaneously with the im-
plementation of GASB Statement Nos. 43 or 45. This technical bulletin clarifies
the application of existing standards of accounting and financial reporting to
payments that an employer or a defined benefit other postemployment benefit
plan receives from the federal government pursuant to the retiree drug sub-
sidy provisions of Medicare Part D, as established in the Medicare Prescription
Drug, Improvement, and Modernization Act of 2003.
GASB Statement No. 34 and Related Pronouncements
1.14 GASB Statement No. 34 and related pronouncements require that
the separately issued financial reports of governmental health care entities
that are special-purpose governments engaged only in business-type activities
 present a management's discussion and analysis (MD&A) before
the basic financial statements as required supplementary infor-
mation (RSI).
 present a classified statement of net assets/balance sheet.
 report three categories of net assets—(a) net assets invested in
capital assets net of related debt, (b) restricted net assets, and (c)
unrestricted net assets.
 apply the definition of restricted provided in GASB Statement No.
34 in determining restricted assets and restricted net assets.
 present a statement of revenues, expenses, and changes in net
assets/equity that reports on changes in net assets, including per-
manent endowments. The focus of this statement is to present all
changes in net assets.
 report transfers as interfund transfers after nonoperating revenues
and expenses. Under GASB Statement No. 34, there is no distinc-
tion as to the type of transfer.
 report revenues by major source and separately identify revenue
used as security for revenue bonds.
 distinguish between operating and nonoperating revenues and ex-
penses and provide an intermediate total for operating income or
loss.
 separately report capital contributions and contributions to term
and permanent endowments as components of the all-inclusive
statement of revenues, expenses, and changes in net assets/equity.
 separately report special items and extraordinary items at the
bottom of the statement of revenues, expenses, and changes in net
assets/equity.
 report operating cash flows using the direct method in the state-
ment of cash flows.
 present certain note disclosures, including the entity's policy for
defining operating revenues and expenses, policy regarding the
use of restricted resources, schedules of changes in capital as-
sets and long term liabilities, disaggregated information about
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accounts receivable and payable, and short-term debt activity dur-
ing the year. (Disclosure of disaggregated information about ac-
counts receivable and payable is required by GASB Statement
No. 38.)
 present segment information based on the definition of a segment
in GASB Statement No. 34, if the entity has segments.
The requirements in this paragraph do not apply to health care units that are
not legally separate entities.
1.15 GASB Statement No. 34 requires governmental health care entities
that are special-purpose governments engaged only in business-type activities
to present three basic financial statements, notes to the financial statements,
and RSI:4
a. MD&A as RSI
b. A statement of net assets or balance sheet
c. A statement of revenues, expenses, and changes in net assets/equity
d. A statement of cash flows
e. Notes to financial statements
f. RSI other than MD&A, as established by GAAP, such as GASB
Statement No. 27, Accounting for Pensions by State and Local Gov-
ernmental Employers
Management’s Discussion and Analysis
1.16 GASB Statement No. 34 paragraphs 8–11, as amended, establish
eight required elements of MD&A for general-purpose governments. However,
certain of those elements are not applicable to governmental health care enti-
ties that are special-purpose governments engaged only in business-type activ-
ities. These governmental health care entities should limit their discussion in
MD&A to the elements that are applicable to their entity. Because it is RSI, no
additional information should be presented within MD&A.
1.17 Many health care entities that are special-purpose governments
engaged only in business-type activities present comparative financial state-
ments. When comparative financial statements are presented, MD&A should
present an analysis of both current- and prior-year net assets and changes
in them, as discussed in the GASB staff document, Comprehensive Imple-
mentation Guide—2007 (GASB Q&A—2007 Edition), item 7.5.4. (See para-
graph 1.12 in this chapter regarding references in this guide to discussions in
GASB staff implementation guides.) Two completely separate MD&As are not
required. When comparative financial statements are presented, the MD&A
should present the current year, prior year, and preceding year financial infor-
mation summarized in the MD&A, and discuss the fluctuations. If comparative
4 GASB Statement No. 34 does not provide guidance on separate reporting by individual enter-
prise funds of a government. Although this discussion of the guidance in GASB Statement No. 34 is
written in terms of special-purpose business-type activities that are governmental health care enti-
ties, the accounting, financial reporting, and auditing considerations are usually equally applicable
when the health care activity is conducted as a function or program of a general-purpose govern-
ment and reported in an enterprise fund. See footnote 7 to the section heading "Specific Guidance for
Special-Purpose Governments" in chapter 12 of the Audit and Accounting Guide State and Local Gov-
ernments. Reporting guidance on separate reporting by individual enterprise funds of a government
is provided in the Audit and Accounting Guide State and Local Governments.
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financial data is presented, as distinguished from a complete set of compara-
tive statements, notes, and RSI, the requirements for MD&A in paragraph 11
of GASB Statement No. 34 should be met for the current year with comparisons
to the prior year, as discussed in the GASB Q&A—2007 Edition, item 7.5.6.
Measurement Focus and Basis of Accounting
1.18 GASB Statement No. 34 paragraph 92 requires activities reported us-
ing enterprise fund accounting and reporting to use the accrual basis of account-
ing and the economic resources measurement focus. GASB Statement No. 34
paragraphs 93–95 indefinitely extend the provisions of GASB Statement No. 20
(see footnote 1 to paragraph 1.01 in this chapter). GASB Statement No. 20, as
amended, requires governmental health care entities that use enterprise fund
accounting and reporting to apply all GASB pronouncements as well as FASB
pronouncements issued on or before November 30, 1989 that do not conflict
with or contradict GASB pronouncements. In addition, those entities may also
apply to all FASB statements and interpretations issued after November 30,
1989, except for those that conflict with or contradict GASB pronouncements.
Only those FASB statements and interpretations issued after November 30,
1989 that are developed for business entities should be applied, as discussed
in GASB Statement No. 29, The Use of Not-for-Profit Accounting and Finan-
cial Reporting Principles by Governmental Entities, paragraph 7, as amended.
GASB Statement No. 34 paragraph 115 requires disclosure in the summary of
significant accounting policies of the policy for applying FASB pronouncements
issued after November 30, 1989, to business-type activities and to enterprise
funds. The requirements in this guide presume that governmental health care
entities apply paragraph 7 of GASB Statement No. 20.
Statement of Net Assets or Balance Sheet
1.19 GASB Statement No. 34 paragraphs 97–99 provide guidance on
the statement of net assets or balance sheet. Governmental health care en-
tities that are special-purpose governments engaged only in business-type ac-
tivities may use either a balance sheet format—assets equal liabilities plus
net assets/equity—or a net assets format—assets less liabilities equal net as-
sets/equity. Assets and liabilities are required to be presented in a classified
format.5
1.20 Either term net assets or equity may be used to refer to the differ-
ence between assets and liabilities. Regardless of the label, net assets/equity
is required to be reported in three broad components: (a) invested in capital
assets, net of related debt; (b) restricted, and (c) unrestricted. When permanent
endowments are reported in restricted net assets, two additional components—
expendable and nonexpendable are required, as discussed in paragraph 35 of
GASB Statement No. 34.
1.21 The term restricted is defined by GASB Statement No. 34 para-
graph 34 as amended, and paragraph 99. A restriction is a constraint placed
on the use of assets or net assets that is either externally imposed (such as
by creditors through debt covenants) or imposed by law through constitutional
5 Guidance regarding the classification of certain specific assets or liabilities can be found in
the chapters of the guide. For example, see paragraph 4.56 in this guide regarding the reporting of
securities as current and noncurrent.
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provisions or enabling legislation. Internally designated net assets should be
reported as unrestricted net assets and should not be displayed separately in
the net assets section of the statement of net assets/balance sheet, as discussed
in paragraph 37 of GASB Statement No. 34. (Designated assets, however, may
be reported in the statement of net assets/balance sheet, as discussed in para-
graph 3.01–.04 in this guide.)
Statement of Revenues, Expenses, and Changes
in Net Assets/Equity
1.22 The operating statement of governmental health care entities that
are special-purpose governments engaged only in business-type activities is the
statement of revenues, expenses, and changes in net assets/equity. Changes in
both restricted and unrestricted net assets should be reported in this state-
ment using an all inclusive format, illustrated in GASB Statement No. 34
paragraph 101:
Operating revenues (detailed)
Total operating revenues
Operating expenses (detailed)
Total operating expenses
Operating income (loss)
Nonoperating revenues and expenses (detailed)
Income before other revenues, expenses, gains, losses, and transfers
Capital contributions (grant, developer, and other), additions to permanent
and term
endowments, special and extraordinary items (detailed) and transfers
Increase (decrease) in net assets
Net assets—beginning of period
Net assets—end of period
In a change in net assets approach, the increase or decrease in net assets for
the period and net income are not necessarily the same amount (for example,
because of capital contributions), as noted in GASB Statement No. 34 para-
graph 433. However, GASB Statement No. 34 paragraph 434 indicates that
this required format does not preclude governments from presenting differ-
ent subtotals before the comprehensive performance measure—increase (de-
crease) in net assets. (See paragraph 1.12 in this chapter regarding references
in this guide to discussions in the nonauthoritative appendixes in GASB pro-
nouncements.) The subtotals required by GASB Statement No. 34 must be
presented.
1.23 As discussed in paragraph 100 and footnote 41 in GASB Statement
No. 34, governmental health care entities are required to report revenues (net
of discounts and allowances) by major source and separately identify revenues
that provide security for revenue bonds. (See further discussion in chapter 10
of this guide.) As illustrated in paragraph 1.22 of this guide, separate subtotals
are required for operating revenues, operating expenses and operating income
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(loss). Governmental health care entities are required by GASB Statement
No. 34 paragraph 102 to establish a policy that defines operating revenues and
expenses that is appropriate to the nature of the activity being reported and to
disclose that policy in the notes to the financial statements. Factors that may be
considered in establishing that policy are discussed in chapter 10 of this guide.
1.24 Revenues from capital contributions as well as contributions to the
principal of permanent and term endowments should be reported after nonop-
erating revenues and expenses, as discussed in GASB Statement No. 34 para-
graph 100. Income from permanent or term endowments should be recorded
as nonoperating revenue, as discussed in the GASB Q&A—2007 Edition, item
7.74.3. (See paragraph 1.12 in this chapter regarding references in this guide
to discussions in GASB staff implementation guides.)
1.25 Governmental health care entities that apply paragraph 7 of GASB
Statement No. 20 should be aware that FASB ASC 220, Comprehensive Income,
conflicts with the all-inclusive format required by GASB Statement No. 34, as
discussed in the GASB Q&A—2007 Edition, item 7.72.1. (See paragraph 1.12
in this chapter regarding references in this guide to discussions in GASB staff
implementation guides.)
Land and Other Real Estate Held as Investments by Endowments
1.26 GASB Statement No. 52, Land and Other Real Estate Held as In-
vestments by Endowments, requires that land and other real estate held by
endowments as investments be accounted for at fair value with changes in fair
value reported in the appropriate change statements as investment income or
loss.
Statement of Cash Flows
1.27 GASB Statement No. 9, Reporting Cash Flows of Proprietary and
Nonexpendable Trust Funds and Governmental Entities That Use Proprietary
Fund Accounting, established standards for cash flow reporting for govern-
mental entities. GASB Statement No. 34 paragraph 105 requires governmen-
tal health care entities that are special-purpose governments engaged only in
business-type activities to present a statement of cash flows using the direct
method, discussed in GASB Statement No. 9 paragraph 31, as amended. A
reconciliation of operating income (loss) to operating cash flows also should be
presented.
Revenue From Health Care Services
1.28 According to FASB ASC 954-605-25-3, in general, gross service rev-
enue is recorded in the accounting records on an accrual basis at the provider's
established rates, regardless of whether the health care entity expects to collect
that amount. According to FASB ASC 958-605-25-4, the provision for contrac-
tual adjustments (that is, the difference between established rates and third
party payor payments) and discounts (that is, the difference between estab-
lished rates and the amount collectible) are recognized on an accrual basis and
deducted from gross service revenue to determine net service revenue. (See
examples in paragraph 5.03.) According to FASB ASC 954-605-45-2, gross rev-
enue should not include charity care and service revenue should be reported net
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of contractual and other adjustments in the statement of operations, including
patient service revenue. (See discussion in paragraph 10.03.)
1.29 Accounting and auditing issues related to receivables and revenue
from health care services are discussed in chapters 5 and 10, respectively.
1.30 As discussed in FASB ASC 954-605-05-6, in many cases, revenues are
generated as a result of an agreement to provide health care rather than from
the actual provision of services. For example, an integrated delivery system
may agree to provide all health-related services for a specified group residing
within its primary service area for an agreed-upon amount per member per
month. These revenues are premium revenues, not patient service revenues,
because they are earned by agreeing to provide care, regardless of whether
services actually are rendered.
Third-Party Payor Considerations
1.31 In accordance with FASB ASC 958-310-05-3, a reasonable estimate of
the amount receivable from or payable to third-party payors should be made in
the same period that the related services are rendered. Some third-party payors
retrospectively determine final amounts reimbursable for services rendered to
their beneficiaries based on allowable costs. These payors reimburse the health
care entity on the basis of interim payment rates until the retrospective deter-
mination of allowable costs can be made. In most instances, the accumulation
and allocation of allowable costs and other factors result in final settlements
different from the interim payment rates. Final settlements are determined af-
ter the close of the fiscal periods to which they apply and may affect materially
the health care entity's financial position and results of operations.
1.32 Accounting and auditing issues related to receivables from third par-
ties are discussed in chapter 5.
Classification and Reporting of Net Assets
by Not-for-Profit Health Care Entities
1.33 Currently, many not-for-profit health care entities use fund account-
ing for purposes of internal recordkeeping and managerial control. Many indi-
vidual funds may be established by an entity to help in monitoring compliance
with donor or grantor restrictions due to the fiduciary accountability associated
with these resources. Each fund consists of a self-balancing group of accounts
composed of assets, liabilities, and net assets. Some not-for-profit entities may
choose to classify assets and liabilities into fund groups for general-purpose ex-
ternal financial reporting. For additional discussion on financial reporting for
net assets in mergers and acquisitions see chapter 11 of this guide.
1.34 FASB ASC 958-205-45-3 states that reporting by fund groups is not a
necessary part of general-purpose external financial reporting; however, FASB
ASC 958-205 does not preclude providing disaggregated information by fund
groups.
1.35 Although not-for-profit entities may use fund accounting for internal
recordkeeping and reporting, for purposes of external financial reporting each
of the individual internal funds must be classified into one or more of the three
broad classes of net assets: unrestricted net assets, temporarily restricted net
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assets, and permanently restricted net assets. These classifications are related
to the existence or absence of donor-imposed restrictions and are discussed in
more detail in paragraphs 1.36–.45 and also chapter 9.
1.36 Unrestricted net assets. The FASB ASC glossary defines unrestricted
net assets as the part of net assets of a not-for-profit entity that is neither
permanently restricted nor temporarily restricted by donor-imposed stipula-
tions. FASB ASC 954-210-45-2 states that unrestricted net assets include assets
whose use is contractually limited, such as
 proceeds of debt issues and funds of the health care entity de-
posited with a trustee and limited to use in accordance with the
requirements of an indenture or a similar agreement. (See para-
graph 7.23.)
 other assets limited to use for identified purposes through an
agreement between the health care entity and an outside party
other than a donor or grantor. Examples include assets set aside
under debt agreements, assets set aside under self-insurance
(risk-retention) funding arrangements, and assets set aside to
meet statutory reserve requirements (such as those required
under state law for many health maintenance organizations
[HMOs]). (See paragraph 8.31.)
1.37 According to FASB ASC 958-210-50-2, not-for-profit health care enti-
ties should disclose information about significant limits resulting from contrac-
tual agreements with suppliers, creditors, and others, including the existence
of loan covenants.
1.38 For example, information about debt covenants and self-insurance
trusts generally is disclosed in the notes to the financial statements. Similarly,
internally designated funds should be reported separately from externally des-
ignated funds either on the face of the balance sheet or in the notes to the
financial statements.
1.39 Temporarily restricted and permanently restricted net assets. The
FASB ASC glossary defines two classes of donor-restricted net assets: tem-
porarily restricted and permanently restricted. The distinction between these
two types of restricted net assets is based on the nature of the donor's restric-
tion. All donor-restricted net assets must be classified into one of these two
broad categories for external reporting. Not-for-profit entities may want to fur-
ther classify temporarily and permanently restricted net assets into distinct
groups that distinguish the nature or purpose of the donor's restriction.
1.40 The FASB ASC glossary defines temporarily restricted net assets as
the part of the net assets of a not-for-profit entity that result from the following:
(a) contributions and other inflows of assets whose use by the not-for-profit is
limited by donor-imposed stipulations that either expire by passage of time or
can be fulfilled and removed by actions of the not-for-profit pursuant to those
stipulations, (b) other asset enhancements and diminishments subject to the
same kinds of stipulations, and (c) reclassifications from or to other classes of
net assets as a consequence of donor-imposed stipulations, their expiration by
passage of time, or their fulfillment and removal by actions of the not-for-profit
pursuant to those stipulations. The FASB ASC glossary defines permanently
restricted net assets as the part of net assets of a not-for-profit entity resulting
from the following: (a) contributions and other inflows of assets whose use by the
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not-for-profit entity is limited by donor-imposed stipulations that neither expire
by passage of time nor can be fulfilled or otherwise removed by the actions of the
not-for-profit entity, (b) other asset enhancements and diminishments subject to
the same kinds of stipulations, and (c) reclassifications from or to other classes
of net assets as a consequence of donor-imposed stipulations.
1.41 A not-for-profit health care entity can use temporarily restricted net
assets for their specified purpose once the donor's restriction is met. Generally,
these restrictions are met either by the passage of time or by actions taken by
the entity, such as use of the funds for the purpose intended. Donor restrictions
on permanently restricted net assets (for example, endowment funds) do not ex-
pire with the passage of time and cannot be removed by any actions taken by the
entity.6 Accounting and reporting considerations pertaining to gifts and grants
that are externally restricted for identified purposes by donors and grantors
are discussed in paragraphs 9.06–.08 and 10.10–.27.
1.42 According to FASB ASC 954-305-45-3, donor restrictions generally
relate to limitations on the use of net assets rather than on the use of specific
assets.
1.43 According to FASB Concepts Statement No. 6 paragraphs 101–102:
Restrictions impose responsibilities on management to ensure that
the organization uses donated resources in the manner stipulated by
resource providers. Sometimes donor-imposed restrictions limit an or-
ganization's ability to sell or exchange the particular asset received.
For example, a donor may give a painting to a museum stipulating that
it must be publicly displayed, properly maintained, and never sold.
More commonly, donors' stipulations permit the organization to pool
the donated assets with other assets and to sell or exchange the do-
nated assets for other suitable assets as long as the economic ben-
efits of the donated assets are not consumed or used for a purpose
that does not comply with the stipulation. For example, a donor may
contribute 100 shares of Security A to an organization's endowment,
thereby requiring that the amount of the gift be retained permanently
but not requiring that the specified shares be held indefinitely. Thus,
permanently restricted net assets and temporarily restricted net as-
sets generally refer to amounts of net assets that are restricted by
donor-imposed limits, not to specific assets.
6 FASB Staff Position (FSP) FAS 117-1, Endowments of Not-for-Profit Organizations: Net Asset
Classification of Funds Subject to an Enacted Version of the Uniform Prudent Management of Insti-
tutional Funds Act, and Enhanced Disclosures for All Endowment Funds, is effective for fiscal years
ending after December 15, 2008. Earlier application is permitted provided that annual financial state-
ments for that fiscal year have not been previously issued. FSP FAS 117-1 provides guidance on the net
asset classification of donor-restricted endowment funds for an not-for-profit health care entity that is
subject to an enacted version of the Uniform Prudent Management of Institutional Funds Act of 2006
(UPMIFA). The FSP also improves disclosures about a not-for-profit health care entity's endowment
funds (both donor-restricted endowment funds and board-designated endowment funds), whether or
not the not-for-profit health care entity is subject to an enacted version of UPMIFA. Paragraphs 16–17
of the FSP discuss the display of the reclassification upon implementation of the guidance and the
reinstatement of purpose restrictions on unappropriated net appreciation if the not-for-profit health
care entity is subject to an enacted version of UPMIFA.
FSP FAS 117-1 is located primarily in sections 45, 50, and 55 of FASB ASC 958-205 and is
labeled as "Pending Content" due to the transition and open effective date information discussed in
FASB ASC 958-205-65-1. For more information on FASB ASC, please see the notice to readers in this
guide.
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1.44 FASB ASC 958-210-45-9 requires that information about the nature
and amounts of different types of permanent restrictions or temporary restric-
tion be provided either by reporting their amounts on the face of the statement
of financial position or by including relevant details in notes to financial state-
ments. Examples of different types of temporary and permanent restrictions
are provided in FASB ASC 958-210-45.
1.45 A not-for-profit health care entity's internal fund accounting can be
used to account for these different types of resources within a specific class of
net assets. For example, a not-for-profit health care entity may want to disclose
the amount of temporarily restricted net assets restricted for a specific purpose
such as indigent care.
Health Care Contracting
1.46 As discussed in FASB ASC 954-405-05-2, contracts between a health
care provider and a payor based on anything other than full charges require
the provider to accept some financial risk. The nature and degree of risk for the
provider varies depending on the contract terms (for example, the definition of
the unit of service or the basis for payment).
1.47 In planning the audit of the health care provider, the auditor con-
siders the audit risk associated with the entity's health care contracts. For
example, contracts with payments for services based on a discount from the
provider's established rates may have different risks than contracts with pay-
ments for services based on a capitated arrangement.
1.48 FASB ASC 954-605-05-3 states that generally, capitation payments
are made at the beginning of each month and obligate the provider to render
covered services during the month. According to FASB ASC 954-605-25-7, rev-
enue from capitation fees is earned as a result of agreeing to provide services
to qualified beneficiaries and not as a result of actually providing the care. If
the provider's accounting system records patient charges and establishes pa-
tient receivables as services are rendered, appropriate valuation allowances
or adjustments should be recorded so only the amount of contract revenue is
recorded.
1.49 FASB ASC 954-405-25-1 states that if a capitation contract obligates
the provider to assume the risk of physician referrals and other outside services,
a liability for unpaid claims, including incurred but not reported claims, should
be established. A lag analysis may be helpful in estimating the liability.
1.50 According to FASB ASC 954-605-25-8, in addition to the capitation
payments, the amount of contract revenue may be affected by factors such as
reinsurance recoveries, deductibles, coinsurance, and risk pool adjustments.
Risk pool adjustments may be based on factors such as utilization or cost
targets.
1.51 FASB ASC 954-450-25-1 states that sometimes health care providers
enter preferred provider arrangements with self-insured employers whereby
the provider guarantees that the employer's health care cost will not increase
over a specified amount or percentage. In substance, these providers may have
provided aggregate stop-loss insurance to the self-insured employer, and a ma-
terial liability to the provider may exist. FASB ASC 450, Contingencies, provides
guidance on accounting for these contingencies for nongovernmental entities.
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GASB Statement No. 10, Accounting and Financial Reporting for Risk Financ-
ing and Related Insurance Issues, provides guidance on accounting for contin-
gencies by governmental entities.
GAAP Hierarchy for Health Care Entities
FASB Accounting Standards Codification™ Overview
1.52 On June 30, 2009, FASB issued FASB Statement No. 168, The FASB
Accounting Standards Codification™ and the Hierarchy of Generally Accepted
Accounting Principles—a replacement of FASB Statement No. 162, which is
codified at FASB ASC 105, Generally Accepted Accounting Principles. On the
effective date of this statement, FASB ASC will become the authoritative source
of U.S. accounting and reporting standards for nongovernmental entities, in ad-
dition to guidance issued by the Securities and Exchange Commission (SEC). At
that time, FASB ASC will supersede all then-existing, non-SEC accounting and
reporting standards for nongovernmental entities. Once effective, all other non-
grandfathered, non-SEC accounting literature not included in FASB ASC will
become nonauthoritative. This statement is effective for financial statements
issued for interim and annual periods ending after September 15, 2009.
1.53 FASB ASC is a major restructuring of accounting and reporting stan-
dards designed to simplify user access to all authoritative U.S. GAAP by provid-
ing the authoritative literature in a topically organized structure. FASB ASC
disassembled thousands of nongovernmental accounting pronouncements (in-
cluding those of FASB, the Emerging Issues Task Force [EITF], and the AICPA)
and reassembled them under approximately 90 topics.
1.54 FASB ASC also includes relevant portions of authoritative content
issued by the SEC, as well as select SEC staff interpretations, and administra-
tive guidance issued by the SEC; however, FASB ASC is not the official source
of SEC guidance and does not contain the entire population of SEC rules, reg-
ulations, interpretive releases, and staff guidance. Moreover, FASB ASC does
not include governmental accounting standards and is not applicable to gov-
ernmental entities.
1.55 FASB ASC is not intended to change U.S. GAAP or any require-
ments of the SEC; rather, it is part of FASB's efforts to reduce the complexity
of accounting standards and also to facilitate international convergence. Addi-
tionally, FASB ASC essentially flattens the GAAP hierarchy to two levels: one
that is authoritative (in FASB ASC) and one that is nonauthoritative (not in
FASB ASC). Among other things, FASB ASC aims to
 reduce the amount of time and effort required to solve an account-
ing research issue.
 mitigate the risk of noncompliance with standards through im-
proved usability of the literature.
 provide accurate information with real-time updates as new stan-
dards are released.
 assist FASB with the research and convergence efforts required
during the standard-setting process.
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 become the authoritative source of literature for the completed
eXtensible Business Reporting Language (XBRL) taxonomy.
 make clear that guidance not contained in FASB ASC is not con-
sidered authoritative.
1.56 FASB published a notice to constituents (NTC) that explains the
scope, structure, and usage of consistent terminology of FASB ASC. Con-
stituents are encouraged to read this NTC because it answers many common
questions about FASB ASC. FASB also posted questions and answers on its
Web site to address items such as the following:
 Status of basis for conclusions, which will still be available for
reference even though they have been effectively superseded
 Availability of archived guidance on the FASB Web site or in the
archive section of FASB ASC
 Free access to a basic view of FASB ASC, but enhanced access
to search and retrieval functions, personal annotations, and dy-
namic linking capabilities, which will require a professional view
subscription (an annual subscription is available for $850)
 Plans that FASB has to issue FASB ASC in print
Scope of FASB ASC
1.57 The following is a summary of content included within the scope of
FASB ASC:
 All level A–D GAAP issued by a standard setter.
 GAAP guidance only. FASB ASC does not include guidance for
non-GAAP matters, such as other comprehensive basis of account-
ing (for example, cash basis and income tax basis) or regulatory
accounting principles.
 Relevant authoritative content issued by the SEC and select SEC
staff interpretations and administrative guidance. An "S" precedes
SEC guidance. However, FASB ASC does not include all SEC con-
tent because it is not intended to be a replacement for using the
SEC standards themselves. Rather, some SEC content has been
included for ease of use because the content is presented in a top-
ical structure.
 The source of the standards is the as-amended versions provided
by the standard setter. Therefore, FASB ASC does not identify
documents that solely amend other standards.
1.58 The following is a summary of content excluded from FASB ASC:
 Standards for governmental entities.
 Certain content that was outdated or superseded by December
31, 2008. An example would be FASB Statement No. 141, Business
Combinations, which was superseded by FASB Statement No. 141
(revised 2007), Business Combinations.
 Nonessential material, such as redundant summaries of exist-
ing standards, historical content, discussions of previous practice,
summaries of constituent feedback, and similar content.
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 Grandfathered material in FASB ASC. An example of grandfa-
thered material includes the pooling of interests in a business
combination described in paragraph B217 of FASB Statement No.
141. Other grandfathered items are identified in FASB Statement
No. 168. FASB Statement No. 168 explains that certain grandfa-
thered guidance is still considered authoritative even though it
has not been included in FASB ASC.
 Transition guidance for all guidance that is fully effective as of De-
cember 31, 2008. Entities applying GAAP for the first time may
need to access the original standards to determine relevant tran-
sition guidance. Transition guidance will be emphasized in FASB
ASC and removed after the transition period lapses.
 References to audit guidance in FASB ASC.
 As of the date FASB Statement No. 168 was issued, FASB ASC did
not include the following statements (they remain authoritative
until integrated into the codification):
— FASB Statement No. 164, Not-for-Profit Entities: Merg-
ers and Acquisitions—Including an amendment of FASB
Statement No. 142
— FASB Statement No. 166, Accounting for Transfers of
Financial Assets—an amendment of FASB Statement
No. 140
— FASB Statement No. 167, Amendments to FASB Inter-
pretation No. 46(R)
FASB ASC Topical Structure and Referencing
1.59 FASB ASC uses a topical structure in which guidance is organized
into areas, topics, subtopics, sections, subsections, and paragraphs.
 Areas are the broadest category in FASB ASC and represent a
grouping of topics.
 Topics are the broadest categorization of related guidance.
 Subtopics represent subsets of a topic and are generally distin-
guished by type or scope.
 Sections represent the nature of the content in a subtopic such as
recognition, measurement, or disclosure.
 Subsections allow further segregation and navigation of content.
1.60 Topics, subtopics, and sections are numerically referenced and corre-
late very closely to International Financial Reporting Standards. This structure
effectively organizes the content without regard to the original standard setter
or standard from which the content was derived. An example of the numeri-
cal referencing is FASB ASC 305-10-05, in which 305 is the Cash and Cash
Equivalents topic, 10 represents the "Overall" subtopic, and 05 represents the
"Overview and Background" section. Accounting guidance in this guide has
been conformed to reflect reference to FASB ASC.
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FASB Statement No. 168
1.61 As previously stated, FASB Statement No. 168 is effective for finan-
cial statements issued for interim and annual periods ending after Septem-
ber 15, 2009. Nonpublic nongovernmental entities that have not previously
followed the guidance included in AICPA Technical Questions and Answers
(TIS) sections 5100.38–.76 in TIS section 5100, "Revenue Recognition" (AICPA,
Technical Practice Aids), which is now included in FASB ASC as authoritative,
should account for the adoption of that guidance as a change in accounting
principle, on a prospective basis, for revenue arrangements entered into or ma-
terially modified in those fiscal years beginning on or after December 15, 2009,
and interim periods within those years.
1.62 Except for nonpublic nongovernmental entities adopting the guid-
ance included in TIS sections 5100.38–.76, any effect of applying the provisions
of FASB Statement No. 168 should be accounted for as a change in accounting
principle or correction of an error, as applicable, in accordance with FASB ASC
250-10-50. An entity should follow the applicable disclosure requirements and
disclose the accounting principles that were used before and after the applica-
tion of the provisions of FASB Statement No. 168 and the reason that applying
that statement resulted in a change in accounting principle or correction of an
error.
1.63 FASB Statement No. 168 is the final standard that will be issued by
FASB in that form and creates Topic 105, Generally Accepted Accounting Prin-
ciples, in FASB ASC. It was added to FASB ASC through Accounting Standards
Update No. 2009-02 on June 30, 2009. Going forward, no new standards in the
form of statements, staff positions, EITF abstracts, or AICPA accounting State-
ments of Position (SOPs), for example, will be issued. Instead, FASB will issue
Accounting Standards Updates. FASB will not consider Accounting Standards
Updates as authoritative in their own right. Instead, they will serve only to
update FASB ASC, provide background information about the guidance, and
provide the basis for conclusions on changes made to FASB ASC.
1.64 If an entity finds that guidance for a transaction or event is not spec-
ified within a source of authoritative GAAP for that entity, FASB Statement
No. 168 provides that an entity shall first consider accounting principles for
similar transactions or events within a source of authoritative GAAP for that
entity and then consider nonauthoritative guidance from other sources. An en-
tity shall not follow the accounting treatment specified in accounting guidance
for similar transactions or events in cases in which those accounting principles
either prohibit the application of the accounting treatment to the particular
transaction or event or indicate that the accounting treatment should not be
applied by analogy.
1.65 The notice to readers of this guide includes additional information
regarding FASB Accounting Standards Codification™ Research System, how
users can provide feedback on FASB ASC, issuance of new standards, and pend-
ing content in FASB ASC.
FASB ASC and Not-for-Profit Health Care Entities
1.66 Not-for-profit health care entities should follow the guidance in
all effective provisions of FASB ASC unless the provision explicitly exempts
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not-for-profit entities or their subject matter precludes such applicability. FASB
ASC 954, Health Care Entities, provides specific incremental reporting guid-
ance for not-for-profit, business-oriented health care entities. FASB ASC 954-
10-05-3 states that the guidance in FASB ASC 958 applies to all not-for-
profit entities, regardless of whether the entity is essentially self-sustaining
from fees charged for goods and services. Guidance in FASB ASC 958 on all
of the following is applicable to not-for-profit, business-oriented health care
entities:
a. Contributions (see the "Contributions Received" subsections of
FASB ASC 958-605), which include all of the following:
i. Permanent endowments
ii. Gifts in kind
iii. Contributed utilities, facilities, or use of long-lived assets
b. Transfers to a not-for-profit or charitable trust that raises or holds
contributions for others (see the "Transfers of Assets" subsections
of FASB ASC 958-605)
c. Contributions received by agents, trustees, and intermediaries (see
the "Transfers of Assets" subsections of FASB ASC 958-605)
d. Split-interest agreements (see FASB ASC 958-30)
e. Financial statements of not-for-profits (see FASB ASC 958), which
include all of the following:
i. Presentation in financial statements (see FASB ASC 958-
205)
ii. Statement of financial position (see FASB ASC 958-210)
iii. Statement(s) of operations and changes in net assets (see
FASB ASC 958-225)
iv. Statement of cash flows (see FASB ASC 958-230)
f. Promises to give (see FASB ASC 958-310)
g. Consolidation (see FASB ASC 958-810)
1.67 FASB Accounting Standards Updates issued by FASB subsequent
to this guide's effective date apply to not-for-profit entities unless those pro-
nouncements explicitly exempt not-for-profit entities or their subject matter
precludes such applicability.
1.68 Not-for-profit entities may follow and are not prohibited from follow-
ing the guidance in effective provisions of FASB ASC that specifically exempt
not-for-profit entities from their application, unless FASB ASC 954 or FASB
ASC 958 provide different guidance. The guidance that specifically exempts
not-for-profits includes guidance on earnings per share, reporting comprehen-
sive income, segment disclosure, business combinations, and variable interest
entities among others. However, the guidance included in the effective provi-
sions of FASB ASC that specifically exempt not-for-profit entities applies to all
for-profit entities owned, whether owned all or in part, by not-for-profit entities.
The discussion in paragraphs 1.70–.76 should be considered in determining the
hierarchy of such guidance and of guidance issued by the AICPA.
1.69 Certain financial reporting guidance, such as that concerning com-
mon stock, convertible debt, stock purchase warrants, share-based payments,
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and certain financial instruments with characteristics of both liabilities and
equity, generally does not apply to the kinds of not-for-profit entities covered
by this guide because such entities do not enter into the kinds of transactions
covered by that guidance. However, the guidance included in the effective provi-
sions of those pronouncements applies to all for-profit entities owned, whether
owned all or in part, by not-for-profit entities. Also, not-for-profit entities should
follow the effective provisions of those pronouncements if they enter into the
kinds of transactions covered by that guidance.
1.70 Certain FASB ASC guidance applies primarily to entities operating
in certain industries. An example of such guidance is FASB ASC 944, Financial
Services—Insurance. However, some not-for-profit entities conduct activities7 in
some of those industries and should apply the guidance in the pronouncements
concerning the recognition and measurement of assets, liabilities, revenues,
expenses, and gains and losses to the transactions unique to those industries.
However, in applying that guidance, not-for-profit entities should follow the
financial statement display guidance in FASB ASC 954 and FASB ASC 958,
even though it may conflict with display that would result from applying the
industry guidance.
1.71 Certain other FASB ASC guidance, although it does not exempt not-
for-profit entities and does cover transactions conducted by not-for-profit enti-
ties, include some provisions whose application by not-for-profit entities may
be unclear. Nevertheless, not-for-profit entities are required to follow those ef-
fective provisions. These provisions and their applicability are discussed in the
following paragraphs.
1.72 Some provisions of FASB ASC specify the financial statement display
of certain financial statement elements or items (such as gains and losses, ex-
traordinary items, translation adjustments, income tax expense, and prepaid
or deferred income taxes) without considering the net asset reporting model in-
cluded in FASB ASC 954 and FASB ASC 958. Therefore, preparers of financial
statements of not-for-profit health care entities should consider the reporting
objectives of those provisions when exercising judgment about how to best dis-
play elements, such as in which net asset class to display the element. Examples
of those provisions are
 subtopic 20 of FASB ASC 205, Presentation of Financial State-
ments
 subtopic 20 of FASB ASC 225, Income Statement
 FASB ASC 250, Accounting Changes and Error Corrections
 subtopic 50 of FASB ASC 470, Debt
 FASB ASC 740, Income Taxes
 FASB ASC 830, Foreign Currency Matters
7 Such activities may be conducted by (a) for-profit entities owned and consolidated by not-for-
profit entities, (b) divisions of not-for-profit entities, or (c) entire not-for-profit entities.
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APB Opinion No. 16, Business Combinations†,‡
1.73 Regarding mergers and acquisitions involving two or more not-for-
profit entitites or the acquisition of a for-profit business entity by a not-for-profit
entity, not-for-profit health care entities should
 continue to follow the guidance in the following three paragraphs.
 follow the guidance in APB Opinion No. 16, as amended by pro-
nouncements prior to the issuance of FASB Statement No. 141. In
applying the guidance included in APB Opinion No. 16, not-for-
profit entities should continue to apply the amendments to APB
Opinion No. 16 that were included in FASB Statement No. 121,
Accounting for the Impairment of Long-Lived Assets and for Long-
Lived Assets to Be Disposed Of, even though FASB Statement
No. 121 was superseded by FASB Statement No. 144, Account-
ing for the Impairment or Disposal of Long-Lived Assets. (FASB
† In May 2009, FASB issued FASB Statement No. 164, Not-for-Profit Entities: Mergers and
Acquisitions—Including an amendment of FASB Statement No. 142, which supersedes APB Opin-
ion No. 16, Business Combinations, and provides guidance on an acquisition of a business or nonprofit
activity by a not-for-profit entity. The guidance in FASB Statement No. 164 relating to combinations
of not-for-profit entity combinations should be applied prospectively to
a. mergers for which the merger date is on or after the beginning of an initial reporting
period beginning on or after December 15, 2009.
b. acquisitions for which the acquisition date is on or after the beginning of the first
annual reporting period beginning on or after December 15, 2009.
In addition, the guidance makes effective for not-for-profit entities
a. the requirements of FASB Statement No. 142, Goodwill and Other Intangible Assets,
on subsequent accounting for goodwill and other intangible assets acquired in an ac-
quisition.
b. the amendments FASB Statement No. 160, Noncontrolling Interests in Consolidated
Financial Statements—an amendment of ARB No. 51, made to ARB No. 51, Consoli-
dated Financial Statements, and to other existing pronouncements.
c. the amendments that appendix D of FASB Statement No. 164 made to ARB No. 51 on
disclosure and presentation of noncontrolling interests.
d. the amendments FASB Statement No. 141(R), Business Combinations, made to exist-
ing pronouncements.
Those provisions are effective for reporting periods beginning on or after December 15, 2009.
Until the effective date of the provisions of FASB Statement No. 164, not-for-profit entities should
continue to apply the provisions of APB Opinion No. 16 as well as the guidance in this guide and the
guidance in other pronouncements superseded by FASB Statement No. 141(R). Pronouncements that
were amended by FASB Statement No. 141, Business Combinations, and No. 141(R) should be applied
as though FASB Statement Nos. 141 and 141(R) had not amended them. In addition, in applying
the guidance included in APB Opinion No. 16, not-for-profit entities should continue to apply the
amendments to APB Opinion No. 16 that were included in FASB Statement No. 121, Accounting for
the Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of, even though FASB
Statement No. 121 was superseded by FASB Statement No. 144, Accounting for the Impairment or
Disposal of Long-Lived Assets.
As of the date of this guide, August 1, 2009, this guidance has not yet been included in FASB
ASC. Readers are encouraged to visit the FASB ASC Web site at http://asc.fasb.org/home and monitor
Accounting Standards Updates (ASUs).
‡ In April 2009, FASB issued FASB FSP FAS 141(R)-1, Accounting for Assets Acquired and Li-
abilities Assumed in a Business Combination That Arise from Contingencies. FSP 141(R)-1 amends
and clarifies FASB Statement No. 141(R) to address application issues raised by preparers, auditors,
and members of the legal profession on initial recognition and measurement, subsequent measure-
ment and accounting, and disclosure of assets and liabilities arising from contingencies in a business
combination. FSP 141(R)-1 is effective for assets or liabilities arising from contingencies in business
combinations for which the acquisition date is on or after the beginning of the first annual reporting
period beginning on or after December 15, 2008.
This guidance is located primarily in sections 25, 30, and 35 of FASB ASC 805-20 and is labeled
as "Pending Content" due to the transition and open effective date information discussed in FASB
ASC 805-10-65-1. For more information on FASB ASC, please see the notice to readers in this guide.
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Statement No. 144 did not carry forward the amendments to APB
Opinion No. 16 because APB Opinion No. 16 had been superseded.)
 follow the guidance in the other pronouncements superseded by
FASB Statement Nos. 141 and 141(R).
 apply pronouncements that were amended by FASB Statement
Nos. 141 and 141(R) as though FASB Statement Nos. 141 and
141(R) had not amended them.
1.74 Because the conditions for applying the pooling of interests method
of accounting described in APB Opinion No. 16 for a business combination
generally include an exchange of common stock of the combining entities, not-
for-profit entities generally would not meet the conditions for applying that
method. The AICPA Accounting Standards Executive Committee believes that
circumstances exist under which reporting on the combination of two or more
not-for-profit organizations entities (or that of a not-for-profit organization en-
tity with a formerly for-profit entity) by the pooling of interests method better
reflects the substance of the transaction than reporting by the purchase method.
Therefore, a not-for-profit entity is, under certain circumstances, permitted to
report by the pooling of interests method, even though it generally does not
issue common stock. Such circumstances include the combination of two or
more entities to form a new entity without the exchange of consideration. See
paragraph 11.60 for further guidance.
1.75 An example of acceptable practice, in some circumstances, for re-
porting business combinations by not-for-profit entities if there has been no
exchange of consideration is to report the (a) assets, (b) liabilities, and (c) net
asset balances of the combined entities as of the beginning of the year and dis-
close the information that would be required to be disclosed for a pooling of
interests under APB Opinion No. 16. APB Opinion No. 16 is available in the
FASB publication Original Pronouncements.
1.76 In addition, the provisions of FASB ASC 350-20 and FASB ASC 350-
30 should not be applied to goodwill and intangible assets||,# arising from a
merger or acquisition between two or more not-for-profit entities or acquired
in the acquisition of a for-profit business entity by a not-for-profit. Thus, the
|| In November 2008, FASB issued Emerging Issues Task Force (EITF) Issue No. 08-7, "Account-
ing for Defensible Intangible Assets." EITF Issue No. 08-7 clarifies how to account for defensive
intangible assets subsequent to initial measurement and is effective for intangible assets acquired on
or after the beginning of the first annual reporting period beginning on or after December 15, 2008.
This guidance is located in sections 15, 20, 25, 35, and 55 of FASB ASC 350-30 and is labeled as
"Pending Content" due to the transition and open effective date information discussed in FASB ASC
350-30-65-2. For more information on FASB ASC, please see the notice to readers in this guide.
# The staff of FASB issued FSP FAS 142-3, Determination of the Useful Life of Intangible Assets.
This FSP should be effective for financial statements issued for fiscal years beginning after December
15, 2008, and interim periods within those fiscal years. Early adoption is prohibited. The guidance
for determining the useful life of a recognized intangible asset in paragraphs 7–11 of this FSP should
be applied prospectively to intangible assets acquired after the effective date. The disclosure require-
ments in paragraphs 13–15 should be applied prospectively to all intangible assets recognized as of,
and subsequent to, the effective date.
This FSP amends the factors that should be considered in developing renewal or extension as-
sumptions used to determine the useful life of a recognized intangible asset under FASB Statement
No. 142, Goodwill and Other Intangible Assets. The intent of this FSP is to improve the consistency
between the useful life of a recognized intangible asset under FASB Statement No. 142 and the period
of expected cash flows used to measure the fair value of the asset under FASB Statement No. 141(R)
and other generally accepted accounting principles.
This guidance is located in FASB ASC 350-30-35-3 and is labeled as "Pending Content" due
to the transition and open effective date information discussed in FASB ASC 305-30-65-1. For more
information on FASB ASC, please see the notice to readers in this guide.
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guidance in APB Opinion No. 17, Intangible Assets, remains in effect for such
assets. In addition, when applying APB Opinion No. 17, an NFP should continue
to apply the amendments to that opinion found in other literature even though
that other literature may have been superseded by FASB Statement Nos. 141,
141(R), 142, and 144. For example, when applying APB Opinion No. 17, an
NFP should continue to apply the amendments to that opinion found in FASB
Statement No. 121 even though that FASB statement was superseded by FASB
Statement No. 144. APB Opinion No. 17 is available in the FASB publication
Original Pronouncements. FASB ASC 350-30 is effective for intangible assets
acquired in transactions other than combinations, for example, the purchase or
gift of patent or royalty rights from the holder of the patent or copyright.
GAAP Hierarchy for Governmental Health Care Entities
1.77 GASB Statement No. 55, The Hierarchy of Generally Accepted Ac-
counting Principles for State and Local Governments, establishes the hierar-
chy of GAAP for state and local governmental entities and provides that, for
state or local governmental entities, officially established accounting principles
consist of GASB statements and interpretations as well as AICPA and FASB
pronouncements specifically made applicable to state and local governmental
entities by GASB statements or interpretations.
1.78 For financial statements of state and local governmental entities, the
GAAP hierarchy is summarized as follows:
 Category (a). Officially established accounting principles—GASB
statements and interpretations. GASB statements and interpre-
tations are periodically incorporated in the Codification of Gov-
ernmental Accounting and Financial Reporting Standards.8
 Category (b). This consists of GASB technical bulletins and, if
specifically made applicable to state and local governmental en-
tities by the AICPA and cleared9 by the GASB, AICPA Industry
Audit and Accounting Guides and AICPA SOPs.
 Category (c). This consists of AICPA Practice Bulletins if specifi-
cally made applicable to state and local governmental entities and
cleared10 by the GASB, as well as consensus positions of a group
of accountants organized by the GASB that attempts to reach con-
sensus positions on accounting issues applicable to state and local
governmental entities.11
 Category (d). Includes implementation guides (Q&As) published
by the GASB staff, as well as practices that are widely recognized
and prevalent in state and local government.
1.79 If the accounting treatment for a transaction or other event is not
specified by a pronouncement in category (a), a governmental entity should con-
sider whether the accounting treatment is specified by an accounting principle
from a source in another category. In such cases, if categories (b)–(d) contain
8 Category (a) standards are the subject of Rule 203 of the AICPA's Code of Professional Conduct,
and this statement does not affect the application of that rule.
9 Such pronouncements specifically made applicable to state and local governments are presumed
to have been cleared by GASB unless the pronouncement indicates otherwise.
10 See footnote 8.
11 As of the date of this guide, the GASB had not organized such a group.
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accounting principles that specify accounting treatments for a transaction or
other event, the governmental entity should follow the accounting treatment
specified by the accounting principle from the source in the highest category—
for example, follow category (b) treatment over category (c) treatment.
1.80 If the accounting treatment for a transaction or other event is not
specified by a pronouncement or established in practice as described in cate-
gories (a)–(d), a governmental entity should consider accounting principles for
similar transactions or other events within categories (a)–(d) and may consider
other accounting literature. A governmental entity should not follow the ac-
counting treatment specified in accounting principles for similar transactions
or other events in cases in which those accounting principles either prohibit the
application of the accounting treatment to the particular transaction or other
event or indicate that the accounting treatment should not be applied by analogy.
1.81 Other accounting literature includes, for example, GASB Concepts
Statements; the pronouncements referred to in categories (a)–(d) of the GAAP
hierarchy for nongovernmental entities if not specifically made applicable to
state and local governmental entities by the GASB; FASB Concepts State-
ments; Federal Accounting Standards Advisory Board Statements, Interpre-
tations, technical bulletins, and concepts statements; AICPA Issues Papers;
International Public Sector Accounting Standards of the International Public
Sector Accounting Standards Board or International Financial Reporting Stan-
dards of the International Accounting Standards Board, or pronouncements of
other professional associations or regulatory agencies; Technical Information
Service Inquiries and Replies included in AICPA Technical Practice Aids; and
accounting textbooks, handbooks, and articles. The appropriateness of other
accounting literature depends on its relevance to particular circumstances, the
specificity of the guidance, and the general recognition of the issuer or author
as an authority. For example, GASB Concepts Statements would normally be
more influential than other sources in this category.
1.82 GASB Statement Nos. 20 and 29 provide guidance on the applicability
of FASB and AICPA pronouncements to governmental health care entities that
use enterprise fund accounting and financial reporting. Footnote 1 and para-
graph 1.18 of this chapter discusses the guidance in GASB Statement No. 20.
1.83 GASB Statement No. 29 provides that governmental enterprise funds
and activities reported using enterprise fund accounting and financial reporting
that apply the provisions of paragraph 7, as amended, of GASB Statement No.
20 should apply only those "new" (issued after November 30, 1989) FASB state-
ments and interpretations that are developed for business enterprises, rather
than those whose provisions are limited to not-for-profit entities or address
issues primarily concerning such entities (such as FASB Statement No. 116,
Accounting for Contributions Received and Contributions Made, No. 117, Finan-
cial Statements of Not-for-Profit Organizations, No. 124, Accounting for Certain
Investments Held by Not-for-Profit Organizations, and No. 136, Transfers of As-
sets to a Not-for-Profit Organization or Charitable Trust That Raises or Holds
Contributions for Others). (See paragraph 1.18 of this chapter.)
1.84 Paragraph 33 in the "Basis for Conclusions" of GASB Statement
No. 20 also provides that AICPA pronouncements issued after November 30,
1989, and not specifically made applicable to governmental entities should
be applied using the same logic used in the application of FASB standards.
That is, AICPA pronouncements that do not conflict with or contradict GASB
pronouncements should be applied on an "all or none" basis and constitute
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level (b) in the GAAP hierarchy for governmental entities. Many of the AICPA
pronouncements issued after November 30, 1989 provide guidance on spe-
cialized industries, including this guide. However, users of this guide should
note the provisions of SOP 94-6, Disclosure of Certain Significant Risks and
Uncertainties12 (AICPA, Technical Practice Aids, ACC sec. 10,640), discussed
in paragraph 8.44 of this guide.
GASB Codification of Pre-November 30, 1989,
FASB Pronouncements
1.85 GASB pronouncements have made certain AICPA and FASB pro-
nouncements specifically applicable to governmental entities. For example,
GASB Statement No. 20, as amended, and GASB Statement No. 34 require the
application of certain pronouncements of FASB and its predecessor standards-
setting organizations issued before November 30, 1989, and permit the appli-
cation of later FASB pronouncements in certain situations.
1.86 In April 2008, GASB added to its Technical Plan a project, Codifica-
tion of Pre-November 30, 1989, FASB Pronouncements, the purpose of which
is to specifically identify and, when appropriate, modify provisions in FASB
statements and interpretations, APB Opinions, and Accounting Research Bul-
letins (ARBs), issued on or before November 30, 1989 (collectively, the "FASB
pronouncements") as referenced in GASB Statement No. 34, that do not conflict
with or contradict GASB pronouncements as they apply to financial reporting
for governmental and business-type activities. Based on the outcome of the re-
search portion of this project, GASB will then determine which of the provisions
should be incorporated into GASB pronouncements.
Fair Value Measurements—Nongovernmental
Health Care Entities**
1.87 FASB ASC 820, Fair Value Measurements and Disclosures, defines
fair value, establishes a framework for measuring fair value, and expands
12 AICPA Statement of Position 94-6, Disclosure of Certain Significant Risks and Uncertainties
(AICPA, Technical Practice Aids, ACC sec. 10,640), has been included in various topics in FASB ASC.
** In September 2009, FASB issued ASU No. 2009–12, Investments in Certain Entities That
Calculate Net Asset Value per Share (or Its Equivalent). FASB ASU No. 2009-12 provides guidance
permitting reporting entities to use, as a practical expedient, the net asset value per share (or its
equivalent) to estimate the fair value of an investment that is within the scope of the amendments
in this ASU on the basis of the net asset value per share of the investment (or its equivalent) if the
net asset value of the investment (or its equivalent) is calculated in a manner consistent with the
measurement principles of FASB ASC 946, Financial Services—Investment Companies. FASB ASU
No. 2009-12 provides amendments requiring disclosures by major category of investments about the
attributes of those investments. Readers should consult FASB ASU No. 2009-12 for further guidance.
FASB ASU No. 2009-12 is effective for interim and annual periods ending after December 15,
2009. Early application is permitted in financial statements for earlier interim and annual periods
that have not been issued. If an entity early adopts the measurement amendments of FASB ASU
No. 2009-12, the entity is permitted to defer the adoption of the disclosure provisions of FASB ASC
820-10-50-6A until periods ending after December 15, 2009.
This guidance is located in FASB ASC 820-10-15, FASB ASC 820-10-35, FASB ASC 820-10-50
and FASB ASC 820-10-55 and is labeled as "Pending Content" due to the transition and open effective
date information discussed in FASB ASC 820-10-65-6.
In December 2009 the AICPA issued nonauthoritative guidance in the form of Technical Ques-
tions and Answers (TIS) sections 2220.18–.27 (AICPA, Technical Practice Aids). TIS sections 2220.18–
.27 are intended to assist reporting entities when implementing the provisions of FASB ASC 820, Fair
Value Measurements and Disclosures, to estimate the fair value of their investments. Specifically, the
nonauthoritative guidance addresses the use of net asset value, as a practical expedient, to measure
the fair value of investments.
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disclosures about fair value measurements.††,‡‡ The following paragraphs sum-
marize FASB ASC 820 but are not intended as a substitute for the reading of
FASB ASC 820.
Definition of Fair Value
1.88 The FASB ASC glossary defines fair value as "the price that would be
received to sell an asset or paid to transfer a liability in an orderly transaction
between market participants at the measurement date." That definition retains
the exchange price notion in earlier definitions of fair value, but clarifies that
the exchange price is the price in a hypothetical transaction at the measurement
date in the market in which the reporting entity would transact for the asset or
liability. FASB ASC 820-10-35-5 states that a fair value measurement assumes
that the transaction to sell the asset or transfer the liability either occurs in
the principal market for the asset or liability or, in the absence of a principal
market, the most advantageous market for the asset or liability. The FASB
ASC glossary defines the principal market as the market in which the reporting
entity would sell the asset or transfer the liability with the greatest volume and
level of activity for the asset or liability. The principal market (and thus, market
participants) should be considered from the perspective of the reporting entity,
thereby allowing for differences between and among entities with different
activities.
1.89 FASB ASC 820-10-35-10 provides that a fair value measurement of
an asset assumes the highest and best use of the asset by market participants,
considering the use of the asset that is physically possible, legally permissi-
ble, and financially feasible at the measurement date. Highest and best use is
determined based on the use of the asset by market participants that would
maximize the value of the asset or the group of assets within which the asset
would be used, even if the intended use of the asset by the reporting entity is
different.
†† FASB ASC 820-10-15-1A states that the guidance of FASB ASC 820 does not apply to non-
financial assets and nonfinancial liabilities, except for items that are recognized or disclosed at fair
value in an entity's financial statements on a recurring basis (at least annually). According to FASB
820-10-65-1, that scope exception expires for fiscal years beginning after November 15, 2008.
‡‡ FASB ASC 820 is effective for financial statements issued for fiscal years beginning after
November 15, 2007, and interim periods within those fiscal years. Earlier application is encouraged,
provided that the reporting entity has not yet issued financial statements for that fiscal year, includ-
ing financial statements for an interim period within that fiscal year. However,as provided by FASB
ASC 820-10-65-1, FSP FAS 157-2, Effective Date of FASB Statement No. 157, permits the delayed
application of FASB ASC 820 for fair value measurements of all nonfinancial assets and nonfinancial
liabilities, except those that are recognized or disclosed at fair value in the financial statements on a
recurring basis (at least annually), until fiscal years beginning after November 15, 2008, and interim
periods within those fiscal years. An entity that has issued interim or annual financial statements
reflecting the application of the measurement and disclosure provisions of FASB ASC 820 prior to the
issuance of FSP FAS 157-2 must continue to apply all of the provisions of FASB ASC 820. Examples
of items to which the deferral applies include, but are not limited to: contributed nonfinancial assets
and nonfinancial liabilities initially measured at fair value but not measured at fair value in subse-
quent periods, indefinite-lived intangible assets measured at fair value for impairment assessment,
nonfinancial long-lived assets (asset groups) measured at fair value for an impairment assessment,
asset retirement obligations initially measured at fair value, and nonfinancial liabilities for exit or
disposal activities initially measured at fair value. Examples of items to which the deferral would not
apply include, but are not limited to: items within the scope of FASB ASC 825-10-15-4 that are recog-
nized or disclosed at fair value on a recurring basis; financial and nonfinancial derivatives within the
scope of FASB ASC 815, Derivatives and Hedging; items within the scope of FASB ASC 825, Financial
Instruments, whether recognized or not; certain servicing assets and servicing liabilities; and loans
measured for impairment based on the fair value of collateral, even if the underlying collateral is non-
financial. Any entity applying the deferral provisions of FSP FAS 157-2 should provide the disclosure
provisions set forth in FASB ASC 820-10-50-8A.
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1.90 FASB ASC 820-10-35-10 provides that the highest and best use for
an asset is established by one of two valuation premises: value in-use or value
in-exchange. The highest and best use of the asset is in-use if the asset would
provide maximum value to market participants principally through its use in
combination with other assets as a group (as installed or otherwise configured
for use). For example, value in-use might be appropriate for certain nonfinancial
assets. The highest and best use of the asset is in-exchange if the asset would
provide maximum value to market participants principally on a standalone
basis. For example, value in-exchange might be appropriate for a financial asset.
According to paragraphs 12–13 of FASB ASC 820-10-35, an asset's value in-use
should be based on the price that would be received in a current transaction
to sell the asset assuming that the asset would be used with other assets as a
group and that those other assets would be available to market participants.
An asset's value in-exchange is determined based on the price that would be
received in a current transaction to sell the asset standalone.
1.91 Paragraphs 17–18 of FASB ASC 820-10-35 provide that a fair value
measurement for a liability reflects its nonperformance risk (the risk that the
obligation will not be fulfilled).|||| Because nonperformance risk includes the
reporting entity's credit risk, the reporting entity should consider the effect of
its credit risk (credit standing) on the fair value of the liability in all periods in
which the liability is measured at fair value.
1.92 FASB ASC 820-10-35-3 provides that the hypothetical transaction
to sell the asset or transfer the liability is considered from the perspective of
a market participant that holds the asset or owes the liability. Therefore, the
definition of fair value focuses on the price that would be received to sell the
asset or paid to transfer the liability (an exit price), not the price that would
be paid to acquire the asset or received to assume the liability (an entry price).
Conceptually, entry prices and exit prices are different. However, FASB ASC
820-10-30-3 explains that, in many cases, at initial recognition a transaction
price (entry price) will equal the exit price and, therefore, will represent the
fair value of the asset or liability at initial recognition. In determining whether
a transaction price represents the fair value of the asset or liability at initial
recognition, the reporting entity shall consider facts specific to the transaction
and the asset or liability.
1.93 Paragraphs 7–8 of FASB ASC 820-10-35 provide that the price should
not be adjusted for transaction costs. If location is an attribute of the asset
or liability (as might be the case for a commodity), the price in the principal
(or most advantageous) market used to measure the fair value of the asset
or liability should be adjusted for the costs, if any, that would be incurred to
transport the asset or liability to (or from) its principal (or most advantageous)
market.
|||| In August 2009, FASB issued ASU No. 2009-05, Fair Value Measurements and Disclosures
(Topic 820)—Measuring Liabilities at Fair Value. FASB ASU No. 2009-05 provides amendments to
FASB ASC 820-10 for the fair value measurement of liabilities and includes specific guidance on
valuation techniques and the related fair valuation hierarchy for liabilities. It is effective for the first
reporting period (including interim periods) beginning after issuance. Readers should consult the full
text of FASB ASU No. 2009-05 for further guidance. This guidance is located in FASB ASC 820-10-35
and FASB ASC 820-10-55 and is labeled as "Pending Content" due to the transition and effective date
information discussed in FASB ASC 820-10-65-5.
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Valuation Techniques
1.94 Paragraphs 24–35 of FASB ASC 820-10-35 describe the valuation
techniques that should be used to measure fair value. Valuation techniques con-
sistent with the market approach, income approach, and cost approach should
be used to measure fair value, as follows:
 The market approach uses prices and other relevant information
generated by market transactions involving identical or compa-
rable assets or liabilities. Valuation techniques consistent with
the market approach include matrix pricing and often use market
multiples derived from a set of comparables.
 The income approach uses valuation techniques to convert future
amounts (for example, cash flows or earnings) to a single present
amount (discounted). The measurement is based on the value indi-
cated by current market expectations about those future amounts.
Valuation techniques consistent with the income approach include
present value techniques, option-pricing models, and the multi-
period excess earnings method.
 The cost approach is based on the amount that currently would be
required to replace the service capacity of an asset (often referred
to as current replacement cost). Fair value is determined based on
the cost to a market participant (buyer) to acquire or construct a
substitute asset of comparable utility, adjusted for obsolescence.
1.95 FASB ASC 820-10-35-24 states valuation techniques that are appro-
priate in the circumstances and for which sufficient data are available should
be used to measure fair value. In some cases, a single valuation technique will
be appropriate (for example, when valuing an asset or liability using quoted
prices in an active market for identical assets or liabilities). In other cases,
multiple valuation techniques will be appropriate (for example, as might be the
case when valuing a reporting unit) and the respective indications of fair value
should be evaluated and weighted, as appropriate, considering the reasonable-
ness of the range indicated by those results. Example 3 (paragraphs 35–38) of
FASB ASC 820-10-55 illustrates the use of multiple valuation techniques. A fair
value measurement is the point within that range that is most representative
of fair value in the circumstances.
1.96 Valuation techniques used to measure fair value should be consis-
tently applied. However, a change in a valuation technique or its application
is appropriate if the change results in a measurement that is equally or more
representative of fair value in the circumstances. Such a change would be ac-
counted for as a change in accounting estimate in accordance with the provisions
of FASB ASC 250, Accounting Changes and Error Corrections.
Present Value Techniques
1.97 Paragraphs 4–20 of FASB ASC 820-10-55 provide guidance on present
value techniques. Those paragraphs neither prescribe the use of one specific
present value technique nor limit the use of present value techniques to the
three techniques discussed therein. They say that a fair value measurement of
an asset or liability using present value techniques should capture the following
elements from the perspective of market participants as of the measurement
date: an estimate of future cash flows, expectations about possible variations
in the amount or timing (or both) of the cash flows, the time value of money,
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the price for bearing the uncertainty inherent in the cash flows (risk premium),
other case-specific factors that would be considered by market participants,
and in the case of a liability, the nonperformance risk relating to that liability,
including the reporting entity's (obligor's) own credit risk.
1.98 FASB ASC 820-10-55-6 provides the general principles that govern
any present value technique, as follows:
 Cash flows and discount rates should reflect assumptions that
market participants would use in pricing the asset or liability.
 Cash flows and discount rates should consider only factors at-
tributed to the asset (or liability) being measured.
 To avoid double counting or omitting the effects of risk factors,
discount rates should reflect assumptions that are consistent with
those inherent in the cash flows. For example, a discount rate that
reflects expectations about future defaults is appropriate if using
the contractual cash flows of a loan, but is not appropriate if the
cash flows themselves are adjusted to reflect possible defaults.
 Assumptions about cash flows and discount rates should be in-
ternally consistent. For example, nominal cash flows (that include
the effects of inflation) should be discounted at a rate that includes
the effects of inflation.
 Discount rates should be consistent with the underlying economic
factors of the currency in which the cash flows are denominated.
1.99 FASB ASC 820-10-55-9 describes how present value techniques differ
in how they adjust for risk and in the type of cash flows they use. For exam-
ple, the discount rate adjustment technique (also called the traditional present
value technique) uses a risk-adjusted discount rate and contractual, promised,
or most likely cash flows. In contrast, Method 1 of the expected present value
techniques uses a risk-free rate and risk-adjusted discount rate (which is dif-
ferent from the rate used in the discount rate adjustment technique) and ex-
pected cash flows. In the expected present value technique, the probability-
weighted average of all possible cash flows is referred to as the expected cash
flows. The traditional present value technique and two methods of expected
present value techniques are discussed more fully in paragraphs 4–20 of FASB
ASC 820-10-55.
1.100 This guide includes guidance about measuring assets (promises to
give and beneficial interests in trusts) and liabilities (split-interest obligations)
using traditional present value techniques. That guidance is not intended to
suggest that the income approach is the only one of the three approaches that
is appropriate in the circumstances, nor is it intended to suggest that the tra-
ditional present value technique described in the guide is preferred over other
present value techniques.
The Fair Value Hierarchy
1.101 "Pending Content" in FASB ASC 820-10-35-51D emphasizes that
fair value is a market-based measurement, not an entity-specific measure-
ment. Therefore, as stated by FASB ASC 820-10-35-9, a fair value measure-
ment should be determined based on the assumptions that market participants
would use in pricing the asset or liability (referred to as inputs). Paragraphs 37–
57 of FASB ASC 820-10-35 establish a fair value hierarchy that distinguishes
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between (1) market participant assumptions developed based on market data
obtained from sources independent of the reporting entity (observable inputs)
and (2) the reporting entity's own assumptions about market participant as-
sumptions developed based on the best information available in the circum-
stances (unobservable inputs). Valuation techniques used to measure fair value
should maximize the use of relevant observable inputs (that is, level 1, and level
2 inputs that do not require significant adjustment) and minimize the use of
unobservable inputs.
1.102 The fair value hierarchy in FASB ASC 820 prioritizes the inputs to
valuation techniques used to measure fair value into three broad levels, which
are described in paragraphs 39–57 of FASB ASC 820-10-35. The 3 levels are
described in the following list:
a. Paragraphs 40–41 of FASB ASC 820-10-35 state that level 1 in-
puts are quoted prices (unadjusted) in active markets for identical
assets or liabilities that the reporting entity has the ability to ac-
cess at the measurement date. An active market, as defined by the
FASB ASC glossary, is a market in which transactions for the asset
or liability occur with sufficient frequency and volume to provide
pricing information on an ongoing basis. A quoted price in an ac-
tive market provides the most reliable evidence of fair value and
should be used to measure fair value whenever available, except as
discussed in paragraphs 42–43 of FASB ASC 820-10-35. FASB ASC
820-10-35-44 provides guidance on how the quoted price should not
be adjusted because of the size of the position relative to trading vol-
ume (blockage factor), but rather would be measured within level
1 as the product of the quoted price for the individual instrument
times the quantity held. The fair value of the position should be
measured within level 1 as the product of the quoted price for the
individual instrument and the quantity held. The use of a blockage
factor is prohibited, even if a market's normal daily trading vol-
ume is not sufficient to absorb the quantity held and placing orders
to sell the position in a single transaction might affect the quoted
price.
b. FASB ASC 820-10-35-47 explains that level 2 inputs are inputs
other than quoted prices included within level 1 that are observable
for the asset or liability, either directly or indirectly.
c. "Pending Content" in FASB ASC 820-10-35-48 indicates that if the
asset or liability has a specified (contractual) term, a level 2 input
must be observable for substantially the full term of the asset or
liability. Level 2 inputs include all of the following:
i. Quoted prices for similar assets or liabilities in active mar-
kets
ii. Quoted prices for identical or similar assets or liabilities
in markets that are not active (FASB ASC 820-10-35-51A
includes example factors that may indicate a market is
not active or that there has been a significant decrease in
the volume and level of activity for the asset or liability
when compared to normal market activity for the asset or
liability (or similar assets or liabilities), depending on the
degree to which the factors exist.)
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iii. Inputs other than quoted prices that are observable for the
asset or liability, for example
(1) interest rates and yield curves observable at com-
monly quoted intervals
(2) volatilities
(3) prepayment speeds
(4) loss severities
(5) credit risks
(6) default rates
iv. inputs that are derived principally from or corroborated
by observable market data by correlation or other means
(market corroborated inputs), as defined in the FASB ASC
glossary.
d. According to FASB ASC 820-10-35-50, adjustments to level 2 inputs
will vary depending on factors specific to the asset or liability. Those
factors include the following:
i. Condition and location of the asset or liability
ii. The extent to which the inputs relate to items that are
comparable to the asset or liability
iii. The volume and level of activity in the markets within
which the inputs are observed.
e. FASB ASC 820-10-35-51 states that an adjustment that is signifi-
cant to the fair value measurement in its entirety might render the
measurement a level 3 measurement, depending on the level in the
fair value hierarchy within which the inputs used to determine the
adjustment fall.
f. FASB ASC 820-10-35-52 states that level 3 inputs are unobservable
inputs for the asset or liability.
g. "Pending Content" in FASB ASC 820-10-35-53 indicates that unob-
servable inputs should be used to measure fair value to the extent
that relevant observable inputs are not available, thereby allowing
for situations in which there is little, if any, market activity for the
asset or liability at the measurement date. Unobservable inputs
should be developed based on the best information available in the
circumstances, which might include the entity's own data. In devel-
oping unobservable inputs, the reporting entity need not undertake
all possible efforts to obtain information about market participant
assumptions. Unobservable inputs should reflect the reporting en-
tity's own assumptions about the assumptions that market partici-
pants would use in pricing the asset or liability (including assump-
tions about risk). Assumptions about risk include the risk inherent
in the inputs to the valuation technique. A measurement (for ex-
ample, a mark-to-model measurement) that does not include an
adjustment for risk would not represent a fair value measurement
if market participants would include one in pricing the related as-
set or liability. The reporting entity should not ignore information
about market participant assumptions that is reasonably available
without undue cost and effort. Therefore, the entity's own data used
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to develop unobservable inputs should be adjusted if information is
readily available without undue cost and effort that indicates that
market participants would use different assumptions.
h. As explained in FASB ASC 820-10-35-37, in some cases, the inputs
used to measure fair value might fall in different levels of the fair
value hierarchy. The level in the fair value hierarchy within which
the fair value measurement in its entirety falls should be deter-
mined based on the lowest level input that is significant to the fair
value measurement in its entirety.
1.103 As discussed in FASB ASC 820-10-35-38, the availability of inputs
relevant to the asset or liability and the relative reliability of the inputs might
affect the selection of appropriate valuation techniques. However, the fair value
hierarchy prioritizes the inputs to valuation techniques, not the valuation tech-
niques. For example, a fair value measurement using a present value technique
might fall within level 2 or level 3, depending on the inputs that are significant
to the measurement in its entirety and the level in the fair value hierarchy
within which those inputs fall.
1.104 As stated by FASB ASC 820-10-35-15, the effect on a fair value
measurement of a restriction on the sale or use of an asset by a reporting
entity will differ depending on whether the restriction would be considered
by market participants in pricing the asset. Example 6 (paragraphs 51–55) of
FASB ASC 820-10-55 explains that restrictions that are an attribute of an asset,
and therefore would transfer to a market participant, are the only restrictions
reflected in fair value. Donor restrictions that are specific to the donee are
reflected in the classification of net assets, not in the measurement of fair value.
Fair Value Determination When the Volume or Level of Activity
Has Significantly Decreased
1.105 "Pending Content" in FASB ASC 820-10-35-51A–H clarifies the ap-
plication of FASB ASC 820 in determining fair value when the volume and level
of activity for the asset or liability has significantly decreased. Guidance is also
included in identifying transactions that are not orderly. In addition, select
paragraphs of "Pending Content" in FASB ASC 820-10-55-59A–M and "Pend-
ing Content" in paragraphs 61–62 of FASB ASC 820-10-55 provide illustrations
on the application of this guidance.
1.106 This guidance does not apply to quoted prices for an identical asset
or liability in an active market (level 1 inputs). For example, although the
volume and level of activity for an asset or liability may significantly decrease,
transactions for the asset or liability may still occur with sufficient frequency
and volume to provide pricing information on an ongoing basis.
1.107 "Pending Content" in FASB ASC 820-10-35-51A lists a number of
factors that may be evaluated to determine whether there has been a significant
decrease in the volume and level of activity for the asset or liability (or similar
assets or liabilities) when compared with normal market activity. The factors
include, but are not limited to, the following:
a. There are few recent transactions.
b. Price quotations are not based on current information.
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c. Price quotations vary substantially either over time or among mar-
ket makers (for example, some brokered markets).
d. Indexes that previously were highly correlated with the fair values
of the asset or liability are demonstrably uncorrelated with recent
indications of fair value for that asset or liability.
e. There is a significant increase in implied liquidity risk premiums,
yields, or performance indicators (such as delinquency rates or loss
severities) for observed transactions or quoted prices when com-
pared with the reporting entity's estimate of expected cash flows,
considering all available market data about credit and other non-
performance risk for the asset or liability.
f. There is a wide bid-ask spread or significant increase in the bid-ask
spread.
g. There is a significant decline or absence of a market for new is-
suances (that is, a primary market) for the asset or liability or sim-
ilar assets or liabilities.
h. Little information is released publicly (for example, a principal-to-
principal market).
The reporting entity should evaluate the significance and relevance of the fac-
tors to determine whether, based on the weight of the evidence, there has been a
significant decrease in the volume and level of activity for the asset or liability.
1.108 According to "Pending Content" in FASB ASC 820-10-35-51B, if,
after evaluating the factors, the conclusion is reached that there has been a
significant decrease in the volume and level of activity for the asset or liability
in relation to normal market activity for the asset or liability (or similar assets
or liabilities), transactions or quoted prices may not be determinative of fair
value (for example, there may be increased instances of transactions that are
not orderly). Further analysis of the transactions or quoted prices is needed, and
a significant adjustment to the transactions or quoted prices may be necessary
to estimate fair value in accordance with FASB ASC 820-10. Significant adjust-
ments also may be necessary in other circumstances (for example, if a price for
a similar asset requires significant adjustment to make it more comparable to
the asset being measured or when the price is stale.)
1.109 According to "Pending Content" in FASC ASC 820-10-35-51C, FASB
ASC 820-10 does not prescribe a methodology for making significant adjust-
ments to transactions or quoted prices when estimating fair value. The guid-
ance in paragraphs 24–35 of FASB ASC 820-10-35 discuss the use of and types
of valuation techniques for estimating fair value. If there has been a signif-
icant decrease in the volume and level of activity for the asset or liability, a
change in valuation technique or the use of multiple valuation techniques may
be appropriate (for example, the use of a market approach and a present value
technique.) When weighting indications of fair value resulting from the use of
multiple valuation techniques, the reporting entity should consider the reason-
ableness of the range of fair value estimates. the objective is to determine the
point within the range of fair value estimates that is most representative of fair
value under the current market conditions. A wide range of fair value estimates
may be an indication that further analysis is needed.
1.110 Consistent with "Pending Content" in FASB ASC 820-10-35-51D,
when determining fair value, regardless of the valuation technique(s) used,
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when the volume and level of activity for the asset or liability has significantly
decreased, the objective of a fair value measurement remains the same. The
FASB ASC glossary defines fair value as the price that would be received to
sell an asset or paid to transfer a liability in an orderly transaction (that is,
not a forced liquidation or distressed sale) between market participants at the
measurement date under current market conditions.
1.111 "Pending Content" in FASB ASC 820-10-35-51D also states that
determining the price at which willing market participants would transact at
the measurement date under current market conditions, if there has been a
significant decrease in the volume and level of activity for the asset or liabil-
ity, depends on the facts and circumstances and requires the use of significant
judgment. The reporting entity's intention to hold the asset or liability is not
relevant in estimating fair value because fair value is a market-based measure-
ment, not an entity-specific measurement.
1.112 According to "Pending Content" in FASB ASC 820-10-35-51E, even
if there has been a significant decrease in the volume and level of activity for
the asset or liability, it is not appropriate to conclude that all transactions are
not orderly (that is, distressed or forced). Circumstances that may indicate that
a transaction is not orderly include, but are not limited to, the following:
a. There was not adequate exposure to the market for a period be-
fore the measurement date to allow for marketing activities that
are usual and customary for transactions involving such assets or
liabilities under current market conditions.
b. There was a usual and customary marketing period, but the seller
marketed the asset or liability to a single market participant.
c. The seller is in or near bankruptcy or receivership (that is, dis-
tressed.)
d. The seller was required to sell to meet regulatory or legal require-
ments (that is, forced.)
e. The transaction price is an outlier when compared with other recent
transactions for the same or similar asset or liability.
The reporting entity should evaluate the circumstances to determine whether
the transaction is orderly based on the weight of the evidence.
1.113 According to "Pending Content" in FASB ASC 820-10-35-51F, the
determination of whether a transaction is orderly (or not orderly) is more diffi-
cult if there has been a significant decrease in the volume and level of activity
for the asset or liability. Accordingly, the reporting entity shall consider of all
of the following guidance:
a. If the weight of the evidence indicates the transaction is not orderly,
the reporting entity shall place little, if any, weight (compared with
other indications of fair value) on that transaction price when esti-
mating fair value or market risk premiums.
b. If the weight of the evidence indicates the transaction is orderly,
the reporting entity shall consider that transaction price when es-
timating fair value or market risk premiums. The amount of weight
placed on that transaction price when compared with other indica-
tions of fair value will depend on the facts and circumstances such
as all of the following:
i. The volume of the transaction
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ii. The comparability of the transaction to the asset or liabil-
ity being measured at fair value
iii. The proximity of the transaction to the measurement date.
c. If the reporting entity does not have sufficient information to con-
clude that the transaction is orderly or that the transaction is not
orderly, it shall consider that transaction price when estimating fair
value or market risk premiums. However, that transaction price
may not be determinative of fair value (that is, that transaction
price may not be the sole or primary basis for estimating fair value
or market risk premiums). The reporting entity shall place less
weight on transactions on which the reporting entity does not have
sufficient information to conclude whether the transaction is or-
derly when compared with other transactions that are known to be
orderly.
In making the determination as to whether a transaction is orderly, a reporting
entity does not need to undertake all possible efforts, but should not ignore
information that is available without undue cost and effort. The reporting en-
tity would be expected to have sufficient information to conclude whether a
transaction is orderly when it is party to the transaction.
1.114 "Pending Content" in FASB ASC 820-10-35-51G states that regard-
less of the valuation technique(s) used, the reporting entity should include ap-
propriate risk adjustments (See FASB ASC 820-10-55-8 for related implemen-
tation guidance.) Risk premiums should be reflective of an orderly transaction
(that is, not a forced or distressed sale) between market participants at the
measurement date under current market conditions.
1.115 According to "Pending Content" in FASB ASC 820-10-35-51H, when
estimating fair value, FASB ASC 820-10 does not preclude the use of quoted
prices provided by third parties, such as pricing services or brokers, if the re-
porting entity has determined that the quoted prices provided by those parties
are determined in accordance with FASB ASC 820-10. However, if there has
been a significant decrease in the volume or level of activity for the asset or
liability, the reporting entity should evaluate whether those quoted prices are
based on current information that reflects orderly transactions or a valuation
technique that reflects market participant assumptions (including assumptions
about risks). In weighting a quoted price as an input to a fair value measure-
ment, the reporting entity should place less weight (when compared with other
indications of fair value that are based on transactions) on quotes that do not
reflect the result of transactions. Furthermore, the nature of the quote (for ex-
ample, whether the quote is an indicative price or a binding offer) should be
considered when weighting the available evidence, with more weight given to
quotes based on binding offers.
Fair Value Option
1.116 The fair value option subsections of FASB ASC 825-10 permit an
entity to irrevocably elect fair value as the initial and subsequent measure for
many financial instruments and certain other items, with changes in fair value
recognized in the statement of activities as those changes occur. Paragraphs
4–6 of FASB ASC 815-15-25 similarly permit an elective fair value remeasure-
ment for any hybrid financial instrument that contains an embedded derivative,
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if that embedded derivative would otherwise have to be separated from its
debt host in conformity with FASB ASC 815-15##. An election is made on an
instrument-by-instrument basis (with certain exceptions), generally when an
instrument is initially recognized in the financial statements.
1.117 The fair value option subsection of FASB ASC 825-10-15 describes
the financial assets and liabilities for which the option is available. Most finan-
cial assets and financial liabilities are eligible to be recognized using the fair
value option, as are firm commitments for financial instruments and certain
nonfinancial contracts. Specifically excluded from eligibility is an investment
in a subsidiary that the entity is required to consolidate, employer's and plan's
obligations under postemployment, postretirement plans (including health care
and life insurance benefits), and deferred compensation arrangements (or as-
sets representing overfunded positions in those plans), financial assets and
liabilities recognized under leases (this does not apply to a guarantee of a third-
party lease obligation or a contingent obligation arising from a cancelled lease),
deposit liabilities of depository institutions, and financial instruments that are,
in whole or in part, classified by the issuer as a component of shareholder's eq-
uity (including temporary equity). Additionally, the election cannot be made for
most nonfinancial assets and liabilities or for current or deferred income taxes.
1.118 FASB ASC 825-10-45 and FASB ASC 825-10-50 establish presen-
tation and disclosure requirements designed to facilitate comparisons between
entities that choose different measurement attributes for similar types of as-
sets and liabilities. Paragraphs 1–2 of FASB ASC 825-10-45 state that enti-
ties should report assets and liabilities that are measured using the fair value
option in a manner that separates those reported fair values from the car-
rying amounts of similar assets and liabilities measured using another mea-
surement attribute. To accomplish that, an entity should either (a) report the
aggregate carrying amount for both fair value and non-fair-value items on a
single line, with the fair value amount parenthetically disclosed or (b) present
## In March 2008, FASB issued FASB Statement No. 161, Disclosures about Derivative Instru-
ments and Hedging Activities—an amendment of FASB Statement No. 133. The statement was issued
due to the significant increase in the use and complexity of derivative instruments over the past sev-
eral years. FASB believes that FASB Statement No. 133, Accounting for Derivative Instruments and
Hedging Activities, does not provide adequate information about how derivatives and hedging activi-
ties affect an entity's financial position, income statement, and statement of cash flows. Accordingly,
FASB Statement No. 161 increases disclosures about an entity's derivative and hedging activities
in order to improve financial transparency. FASB Statement No. 161 is effective for financial state-
ments issued for fiscal years and interim periods beginning after November 15, 2008. Early adoption
is encouraged. FASB Statement No. 161 encourages, but does not require, comparative disclosures for
earlier periods at initial adoption.
The new disclosures are located in FASB ASC 815-10-50 and are labeled as "Pending Content"
due to the transition and open effective date information discussed in FASB ASC 815-10-65-1. For
more information on FASB ASC, please see the notice to readers in this guide and the preceding
discussion in this chapter.
Governmental health care entities only. In June 2008 the GASB issued GASB Statement No.
53, Accounting and Financial Reporting for Derivative Instruments, which established requirements
regarding recognition, measurement and disclosure of information related to derivative transactions.
GASB Statement No. 53 defines derivatives similar to GASB Technical Bulletin 2003-1, Disclosure
Requirements for Derivatives Not Reported at Fair Value on the Statement of Net Assets. GASB State-
ment No. 53 requires governmental entities to report most derivatives or derivative instruments at
their fair value as either assets or liabilities in the statement of net assets. However, this requirement
does not apply to derivatives of governmental funds reported in the governmental fund statements.
Generally, changes in fair value are reported in the flow of resources statements (that is, statement of
activities, statement of revenues, expenses, and changes in net assets, and so on) as investment gains
or losses. Annual changes in the fair value of hedging derivative instruments, however, are reported
as deferred inflows or deferred outflows until there is a termination event. GASB Statement No. 53
is effective for fiscal periods beginning after June 15, 2009. Early implementation is encouraged.
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separate lines for the fair value carrying amounts and the non-fair-value car-
rying amounts.
Fair Value Disclosures—Nongovernmental
Health Care Entities13
1.119 Paragraphs 1–9 of FASB ASC 820-10-50 expand the disclosures
required for assets and liabilities measured at fair value. For assets and liabili-
ties that are measured at fair value on a recurring basis in periods subsequent
to initial recognition or that are measured on a nonrecurring basis in periods
subsequent to initial recognition, FASB ASC 810-10-50 requires the reporting
entity to disclose certain information that enables users of its financial state-
ments to assess the inputs used to develop those measurements. For recurring
fair value measurements using significant unobservable inputs (level 3), the
reporting entity is required to disclose certain information to help users assess
the effect of the measurements on earnings (or changes in net assets) for the
period.
1.120 Paragraphs 1-32 of FASB ASC 825-10-50 provide financial instru-
ment disclosures required in the notes to the financial statements. "Pending
Content" in FASB ASC 825-10-50-2A provides that for interim reporting peri-
ods, the disclosure requirements in FASB ASC 825-10-50 applies to all entities
but is optional for those entities that do not meet the definition of a publicly
traded company. "Pending Content" in the FASB ASC glossary defines a pub-
licly traded company as any company whose securities trade in a public market
on either of the following:
a. A stock exchange (domestic or foreign)
b. In the over-the-counter market (including securities quoted only
locally or regionally), or any company that is a conduit bond obligor
for conduit debt securities that are traded in a public market (a
domestic or foreign stock exchange or an over-the-counter market,
including local or regional markets).
Additionally, when a company is required to file or furnish financial statements
with the SEC or makes a filing with a regulatory agency in preparation for sale
of its securities in a public market it is considered a publicly traded company
for this purpose.
Conduit debt securities refers to certain limited-obligation revenue bonds, cer-
tificates of participation, or similar debt instruments issued by a state or local
governmental entity for the express purpose of providing financing for a spe-
cific third party (the conduit bond obligor) that is not a part of the state or
local government's financial reporting entity. Although conduit debt securities
bear the name of the governmental entity that issues them, the governmental
entity often has no obligation for such debt beyond the resources provided by a
13 FSP FAS 157-4, Determining Fair Value When the Volume and Level of Activity for the Asset
or Liability Have Significantly Decreased and Identifying Transactions That Are Not Orderly, amends
the disclosure requirements of FASB ASC 820 to disclose in interim and annual periods the inputs and
valuation technique(s) used to measure fair value and a discussion of changes in valuation techniques
and related inputs, if any, during the period. It also states that for equity and debt securities "major
category" should be defined as major security type as described in "Pending Content" in FASB ASC
942-230-50-2 even if the equity securities or debt securities are not within the scope of FASB ASC
942-320. The revised disclosure requirements can be found as "Pending Content" at paragraphs 2 and
5 of FASB ASC 820-10-50.
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lease or loan agreement with the third party on whose behalf the securities are
issued. Further, the conduit bond obligor is responsible for any future financial
reporting requirements.
1.121 "Pending Content" in FASB ASC 825-10-50-3 indicates that for an-
nual reporting periods, the disclosure requirements in FASB ASC 825-10-50
applies to all entities but is optional for an entity that meets the following
criteria:
a. The entity is a nonpublic entity.
b. The entity's total assets are less than $100 million on the date of
the financial statements.
c. The entity has no instrument that, in whole or in part, is accounted
for as a derivative instrument under FASB ASC 815, Derivatives
and Hedging, other than commitments related to the origination of
the mortgage loans to be held for sale during the reporting period.
1.122 "Pending Content" in FASB ASC 825-10-50-10 indicates that an
entity should disclose all of the following:
a. Either in the body of the financial statements or in the accompa-
nying notes, the fair value of financial instruments for which it is
practicable to estimate that value
b. The method(s) and significant assumptions used to estimate the
fair value of financial instruments
c. A description of the changes in the method(s) and significant as-
sumptions used to estimate the fair value of financial instruments,
if any, during the period
For financial instruments recognized at fair value in the statement of financial
position, the disclosure requirements of FASB ASC 820 also apply.
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Chapter 2
General Auditing Considerations
Overview
2.01 In accordance with AU section 150, Generally Accepted Auditing Stan-
dards (AICPA, Professional Standards, vol. 1), an independent auditor plans,
conducts, and reports the results of an audit in accordance with generally ac-
cepted auditing standards (GAAS). Auditing standards provide a measure of
audit quality and the objectives to be achieved in an audit. This section of
the guide provides guidance, primarily on the application of the standards
of fieldwork. Specifically, this section provides guidance on the risk assessment
process (which includes, among other things, obtaining an understanding of the
entity and its environment, including its internal control) and general auditing
considerations for health care entities.
Auditing Guidance in the Audit and Accounting Guide
State and Local Governments
2.02 Governmental health care entities only. This guide is not the only
industry-specific AICPA Audit and Accounting Guide that auditors consider
when performing an audit of a governmental health care entity. The Audit and
Accounting Guide State and Local Governments, includes governmental health
care entities in its scope, and the auditing guidance in that guide may also be
considered during an audit of a governmental health care entity that is included
in the scope of this guide.
Registered Public Accounting Firms
2.03 The Public Company Accounting Oversight Board (PCAOB) provides
guidance for registered public accounting firms in connection regarding the
preparation or issuance of any audit report on the financial statements of an
issuer, as defined by the Sarbanes-Oxley Act of 2002, and other entities when
prescribed by the rules of the Securities and Exchange Commission (collec-
tively referred to as issuers). (See the preface to this guide for more detailed
information.)
Planning and Other Auditing Considerations
2.04 The objective of an audit of a health care entity's financial statements
is to express an opinion as to whether its financial statements present fairly,
in all material respects, the financial position, results of operations, changes
in net assets, and cash flows for the specified period ended in conformity with
U.S. generally accepted accounting principles (U.S. GAAP) or an other com-
prehensive basis of accounting. To accomplish that objective, the independent
auditor's responsibility is to plan and perform the audit to obtain reasonable
assurance (a high, but not absolute, level of assurance) that material misstate-
ments, whether caused by error or fraud, are detected. This section addresses
general planning considerations and other auditing considerations relevant to
health care entities.
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Audit Planning
2.05 The first standard of field work states, "The auditor must adequately
plan the work and must properly supervise any assistants." AU section 311,
Planning and Supervision (AICPA, Professional Standards, vol. 1), establishes
requirements and provides guidance on the considerations and activities appli-
cable to planning and supervision of an audit conducted in accordance with
GAAS, including appointment of the independent auditor; preliminary en-
gagement activities; establishing an understanding with the client; prepar-
ing a detailed, written audit plan; determining the extent of involvement of
professionals with specialized skills; and communicating with those charged
with governance and management. Audit planning also involves developing
an overall audit strategy for the expected conduct, organization, and staffing
of the audit. The nature, timing, and extent of planning vary with the size
and complexity of the entity, and with the auditor's experience with the entity
and understanding of the entity and its environment, including its internal
control.
2.06 Paragraph .03 of AU section 311 (AICPA, Professional Standards,
vol. 1) states that the auditor must plan the audit so that it is responsive to
the assessment of the risks of material misstatement based on the auditor's
understanding of the entity and its environment, including its internal control.
Planning is not a discrete phase of the audit, but rather an iterative process
that begins with engagement acceptance and continues throughout the audit as
the auditor performs audit procedures and accumulates sufficient appropriate
audit evidence to support the audit opinion.
Considerations for Audits Performed in Accordance With PCAOB Stan-
dards
Paragraph .01 of AU section 311, Planning and Supervision (AICPA,
PCAOB Standards and Related Rules, Interim Standards), states that
when performing an integrated audit of financial statements and in-
ternal control over financial reporting, refer to paragraph 9 of PCAOB
Auditing Standard No. 5, An Audit of Internal Control Over Financial
Reporting That Is Integrated with An Audit of Financial Statements
(AICPA, PCAOB Standards and Related Rules, Auditing Standards),
regarding planning considerations in addition to the planning consid-
erations set forth in AU section 311 (AICPA, PCAOB Standards and
Related Rules, Interim Standards).1
2.07 Planning procedures usually include reviewing the independent au-
ditor's files relating to the entity and holding discussions with audit person-
nel and the personnel of the entity. Examples of these procedures include the
following:
1 Public Company Accounting Oversight Board (PCAOB) Staff Audit Practice Alert No. 3, Audit
Considerations in the Current Economic Environment (AICPA, PCAOB Standards and Related Rules,
PCAOB Staff Guidance, sec. 400 par. .03), was issued on December 5, 2008. The purpose of this
Staff Audit Practice Alert is to assist auditors in identifying matters related to the current economic
environment that might affect audit risk and require additional emphasis. This practice alert is
organized into 6 sections: (1) overall audit considerations; (2) auditing fair value measurements; (3)
auditing accounting estimates; (4) auditing the adequacy of disclosures; (5) auditor's consideration of
a company's ability to continue as a going concern; and (6) additional audit considerations for selected
financial reporting areas. PCAOB Staff Audit Practice Alerts are not rules of the board, nor have they
been approved by the board.
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 Review correspondence files, the prior year's audit documentation,
permanent files, financial statements, and independent auditors'
reports.
 Review the minutes of meetings of those charged with governance.
 Review the relationship of affiliated entities to the health care en-
tity and determine the extent to which their financial information
should be included in the financial statements of the entity. (See
the related discussion in chapter 11.)
 Review the status of unsettled cost (reimbursement) reports for
prior periods filed with third-party payors.
 Discuss matters that may affect the audit with the firm's personnel
responsible for any nonaudit services to the entity.
 Identify situations for which accounting estimates are required
and relevant factors that may affect those estimates.
 Inquire about current business developments affecting the entity.
 Read the current year's interim financial statements and 10-Q
forms.
 Review periodic reports to third-party payors or other regulatory
bodies.
 Discuss the nature, scope, and timing of the engagement with
the entity's management, audit committee, or those charged with
governance.
 Consider the effects of all applicable accounting and auditing pro-
nouncements, particularly recent pronouncements.
 Coordinate the assistance of entity personnel in data preparation.
 Determine the extent of involvement, if any, of consultants, spe-
cialists, and internal auditors.
 Establish the timing of the audit work.
2.08 The independent auditor may find it helpful to maintain a permanent
file that includes copies of the following documents relating to the health care
entity:
a. Articles of incorporation.
b. Bylaws.
c. Chart of accounts.
d. Organization chart.
e. Specific documents concerning restrictions on donor gifts and be-
quests.
f. Contracts and agreements, including leases, agreements with
physicians, agreements with third-party payors, and agreements
with affiliated entities.
g. Description of internal control.
h. Loan agreements, bond indentures, and other debt instruments.
2.09 AU section 350, Audit Sampling (AICPA, Professional Standards,
vol. 1), establishes requirements and provides guidance to the independent
auditor intending to use audit-sampling procedures when planning the work to
be done. The AICPA Audit Guide Audit Sampling presents recommendations on
AAG-HCO 2.09
P1: PjU
ACPA125-02 ACPA125.cls February 25, 2010 15:38
42 Health Care Entities
the application of GAAS to audits involving the use of audit sampling methods,
and guidance on applying audit sampling in accordance with AU section 350.
2.10 If the health care entity has an internal audit function, AU section
322, The Auditor's Consideration of the Internal Audit Function in an Audit
of Financial Statements (AICPA, Professional Standards, vol. 1), establishes
requirements and provides guidance for the independent auditor when consid-
ering the work of internal auditors and using internal auditors to provide direct
assistance to the auditor in an audit performed in accordance with GAAS.
Considerations for Audits Performed in Accordance With PCAOB Stan-
dards
Paragraph .01 of AU section 322, The Auditor's Consideration of the
Internal Audit Function in an Audit of Financial Statements (AICPA,
PCAOB Standards and Related Rules, Interim Standards), states
when performing an integrated audit of financial statements and in-
ternal control over financial reporting, refer to paragraphs 16–19 of
PCAOB Auditing Standard No. 5 for discussion on using the work of
others to alter the nature, timing, and extent of the work that other-
wise would have been performed to test controls.
Individual Practice Associations
2.11 In planning the audit of an individual practice association (IPA), the
auditor may consider the following matters:
 The size of a typical IPA accounting department and business of-
fice often is not large enough to result in effective segregation of
duties. However, most IPAs have an active office manager who can
exercise a high degree of influence and control over the operations.
 Physician compensation arrangements often use incentives or
other features with complicated methodologies and formulas.
 Contracts with managed care plans, often with capitated payment
and risk pool settlement terms, frequently represent a significant
amount of revenue for the IPA.
2.12 IPAs with capitated contracts accrue costs when the services are
rendered, including cost estimates of claims incurred but not reported (IBNR).
The IBNR accrual includes an estimate of the costs of services for which the
IPA is responsible, including referrals outside the IPA. Risk pool settlements
should be accrued during the contract period based on relevant factors, such as
experience to date.
Scope of the Engagement
2.13 AU section 311 (AICPA, Professional Standards, vol. 1) establishes
requirements and provides guidance on the considerations and activities ap-
plicable to planning and supervision of an audit conducted in accordance with
GAAS, including establishing a written understanding with the client regard-
ing the services to be performed for each engagement, the objectives of the
engagement, management's responsibilities, the auditor's responsibilities, and
limitations of the engagement. If the auditor believes an understanding with
the client has not been established, he or she may decline to accept or perform
the engagement.
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Considerations for Audits Performed in Accordance With PCAOB Stan-
dards
Paragraph .06 of AU section 310, Appointment of the Independent Au-
ditor (AICPA, PCAOB Standards and Related Rules, Interim Stan-
dards), establishes requirements regarding the auditor's understand-
ing with the client.
2.14 In addition to reporting on the entity's basic financial statements, the
independent auditor may be asked to report on the following special reports:
(a) cost-reimbursement reports; (b) cost reports related to research grants; (c)
reports for contributors; (d) reports for local, state, or federal authorities; (e)
reports related to bond indentures and other debt instruments; and (f) other
special-purpose reports. The nature, timing, and extent of auditing procedures
to be performed and the type of reports to be issued are based on the scope of
services required by the entity.
2.15 Governmental health care entities only. Chapter 4 in the Audit and
Accounting Guide State and Local Governments and paragraph 2.01 in this
chapter discuss the need to establish an understanding with the client. That
discussion states that the auditor considers holding a preaudit conference with
the auditee to discuss the responsibilities of both the auditee and the auditor.
That discussion also provides a listing of topics for the preaudit conference that
have elements that are unique to or significant in a governmental audit.
Audit Risk
2.16 AU section 312, Audit Risk and Materiality in Conducting an Audit
(AICPA, Professional Standards, vol. 1), states that audit risk is a function
of the risk that the financial statements prepared by management are mate-
rially misstated and the risk that the auditor will not detect such material
misstatement. The auditor should consider audit risk in relation to the rele-
vant assertions related to individual account balances, classes of transactions,
and disclosures and at the overall financial statement level.
2.17 At the account balance, class of transactions, relevant assertion, or
disclosure level, audit risk consists of (a) the risks of material misstatement
(consisting of inherent risk and control risk) and (b) the detection risk. Para-
graph .23 of AU section 312 (AICPA, Professional Standards, vol. 1) states that
auditors should assess the risk of material misstatement at the relevant as-
sertion level as a basis to design and perform further audit procedures (tests
of controls or substantive procedures). It is not acceptable to simply deem risk
to be "at the maximum." This assessment may be in qualitative terms such as
high, medium, and low, or in quantitative terms such as percentages.
2.18 In considering audit risk at the overall financial statement level,
the auditor should consider risks of material misstatement that relate perva-
sively to the financial statements taken as a whole and potentially affect many
relevant assertions. Risks of this nature often relate to the entity's control envi-
ronment and are not necessarily identifiable with specific relevant assertions at
the class of transactions, account balance, or disclosure level. Such risks may
be especially relevant to the auditor's consideration of the risks of material
misstatement arising from fraud, for example, through management override
of internal control.
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Planning Materiality
2.19 The auditor's consideration of materiality is a matter of professional
judgment and is influenced by the auditor's perception of the needs of users
of financial statements. Materiality judgments are made in light of surround-
ing circumstances and necessarily involve both quantitative and qualitative
considerations.
2.20 In accordance with paragraph .27 of AU section 312 (AICPA, Profes-
sional Standards, vol. 1), the auditor should determine a materiality level for
the financial statements taken as a whole when establishing the overall audit
strategy for the audit. The auditor often may apply a percentage to a chosen
benchmark as a step in determining materiality for the financial statements
taken as a whole.
Considerations for Audits Performed in Accordance With PCAOB Stan-
dards
Paragraph .03 of AU section 312, Audit Risk and Materiality in Con-
ducting an Audit (AICPA, PCAOB Standards and Related Rules, In-
terim Standards), states that when performing an integrated audit
of financial statements and internal control over financial reporting,
refer to paragraph 20 of PCAOB Auditing Standard No. 5 regarding
materiality considerations.
2.21 Governmental health care entities only. The Audit and Accounting
Guide State and Local Governments and paragraph 2.01 in this chapter pro-
vide additional guidance on audit materiality determinations, including opinion
units, as that term is described in the Audit and Accounting Guide State and
Local Governments.
Tolerable Misstatement
2.22 The initial determination of materiality is made for the financial
statement taken as a whole. However, the auditor should allow for the possibil-
ity that some misstatements of lesser amounts than the materiality levels could,
in the aggregate, result in a material misstatement of the financial statements.
To do so, the auditor should determine one or more levels of tolerable misstate-
ment. Paragraph .34 of AU section 312 (AICPA, Professional Standards, vol. 1)
defines tolerable misstatement (or tolerable error) as the maximum error in a
population (for example, the class of transactions or account balance) that the
auditor is willing to accept. Such levels of tolerable misstatement are normally
lower than the materiality levels.
Qualitative Aspects of Materiality
2.23 As indicated previously, judgments about materiality include both
quantitative and qualitative information. As a result of the interaction of
quantitative and qualitative considerations in materiality judgments, misstate-
ments of relatively small amounts that come to the auditor's attention could
have a material effect on the financial statements. For example, an illegal pay-
ment of an otherwise immaterial amount could be material if there is a reason-
able possibility that it could lead to a material contingent liability or a material
loss of revenue.
2.24 Qualitative considerations also influence the auditor in reaching
a conclusion about whether misstatements are material. Paragraph .60 of AU
section 312 (AICPA, Professional Standards, vol. 1) provides qualitative factors
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that the auditor may consider relevant in determining whether misstatements
are material.
Use of a Specialist
2.25 AU section 336, Using the Work of a Specialist (AICPA, Professional
Standards, vol. 1), establishes requirements and provides guidance to the au-
ditor who uses the work of a specialist in performing an audit in accordance
with GAAS. Requirements and guidance are provided on deciding when to use
a specialist, the auditor's responsibilities for evaluating the qualifications and
the work of the specialist, and using the findings of the specialist. AU section
336 states that the auditor should evaluate the relationship of the specialist
to the client and that the auditor should perform additional procedures if the
auditor concludes that the objectivity of the specialist may be impaired by such
a relationship.
Use of Assertions in Obtaining Audit Evidence
2.26 Paragraphs .14–.19 of AU section 326, Audit Evidence (AICPA, Pro-
fessional Standards, vol. 1), discuss the use of assertions in obtaining audit
evidence. In representing that the financial statements are fairly presented in
accordance with U.S. GAAP, management implicitly or explicitly makes asser-
tions regarding the recognition, measurement, and disclosure of information in
the financial statements and related disclosures. Assertions used by the auditor
fall into the following categories:
Categories of Assertions
Description of Assertions
Classes of
Transactions and
Events During the
Period
Account Balances
at the End of the
Period
Presentation
and Disclosure
Occurrence/
Existence
Transactions and
events that have
been recorded have
occurred and
pertain to the
entity.
Assets, liabilities,
and equity
interests exist.
Disclosed events
and transactions
have occurred.
Rights and
Obligations
— The entity holds or
controls the rights
to assets, and
liabilities are the
obligations of the
entity.
Disclosed events
and transactions
pertain to the
entity.
(continued)
Completeness All transactions
and events that
should have been
recorded have been
recorded.
All assets,
liabilities, and
equity interests
that should have
been recorded have
been recorded.
All disclosures
that should have
been included in
the financial
statements have
been included.
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Categories of Assertions—continued
Description of Assertions
Classes of
Transactions and
Events During the
Period
Account Balances
at the End of the
Period
Presentation
and Disclosure
Accuracy/
Valuation
and
Allocation
Amounts and other
data relating to
recorded
transactions and
events have been
recorded
appropriately.
Assets, liabilities,
and equity
interests are
included in the
financial
statements at
appropriate
amounts and any
resulting valuation
or allocation
adjustments are
recorded
appropriately.
Financial and
other
information is
disclosed fairly
and at
appropriate
amounts.
Cut-off Transactions and
events have been
recorded in the
correct accounting
period.
— —
Classification
and Under-
standability
Transactions and
events have been
recorded in the
proper accounts.
— Financial
information is
appropriately
presented and
described and
information in
disclosures is
expressed
clearly.
2.27 The auditor should use relevant assertions for classes of transactions,
account balances, and presentation and disclosures in sufficient detail to form
a basis for the assessment of risks of material misstatement and the design
and performance of further audit procedures. The auditor should use relevant
assertions in assessing risks by considering the different types of potential
misstatements that may occur, and then designing further audit procedures
that are responsive to the assessed risks.
Understanding the Entity, Its Environment,
and Its Internal Control
2.28 AU section 314, Understanding the Entity and Its Environment and
Assessing the Risks of Material Misstatement (AICPA, Professional Standards,
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vol. 1), establishes requirements and provides guidance about implementing
the second standard of field work, as follows:
The auditor must obtain a sufficient understanding of the entity and
its environment, including its internal control, to assess the risks of
material misstatement of the financial statements whether due to er-
ror or fraud, and to design the nature, timing, and extent of further
audit procedures.
2.29 Obtaining an understanding of the entity and its environment, in-
cluding its internal control, is a continuous, dynamic process of gathering,
updating, and analyzing information throughout the audit. AU section 316,
Consideration of Fraud in a Financial Statement Audit (AICPA, Professional
Standards, vol. 1), establishes requirements and provides guidance for the au-
ditor when obtaining an understanding of the entity and its environment, in-
cluding its internal control. See paragraphs 2.71–.73 for additional guidance
pertaining to AU section 316 (AICPA, Professional Standards, vol. 1).
Considerations for Audits Performed in Accordance With PCAOB Stan-
dards
Paragraph .01 of AU section 316, Consideration of Fraud in a Finan-
cial Statement Audit (AICPA, PCAOB Standards and Related Rules,
Interim Standards), states that when performing an integrated audit
of financial statements and internal control over financial reporting,
refer to paragraphs 14–15 of PCAOB Auditing Standard No. 5 regard-
ing fraud considerations, in addition to the fraud considerations set
forth in AU section 316 (AICPA, PCAOB Standards and Related Rules,
Interim Standards).
2.30 Paragraphs 2.31–.54 address the unique aspects of health care enti-
ties that may be helpful in developing the required understanding of the entity,
its environment, and its internal control.
Risk Assessment Procedures
2.31 As described in AU section 326, audit procedures performed to ob-
tain an understanding of the entity and its environment, including its internal
control, to assess the risks of material misstatement at the financial statement
and relevant assertion levels are referred to as risk assessment procedures.
Paragraph .21 of AU section 326 states that the auditor must perform risk as-
sessment procedures to provide a satisfactory basis for the assessment of risks
at the financial statement and relevant assertion levels. Risk assessment pro-
cedures by themselves do not provide sufficient appropriate audit evidence on
which to base the audit opinion and must be supplemented by further audit
procedures in the form of tests of controls, when relevant or necessary, and
substantive procedures.
2.32 In accordance with paragraph .06 of AU section 314, the auditor
should perform the following risk assessment procedures to obtain an under-
standing of the entity and its environment, including its internal control:
a. Inquiries of management and others within the entity.
b. Analytical procedures.
c. Observation and inspection.
Paragraphs .06–.13 of AU section 314 establish requirements and provide guid-
ance on risk assessment procedures.
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Analytical Procedures
2.33 AU section 329, Analytical Procedures (AICPA, Professional Stan-
dards, vol. 1), establishes requirements and provides guidance on the use of
analytical procedures and requires their use in the planning and overall re-
view stages of all audits. For planning purposes, these procedures should focus
on (a) enhancing the independent auditor's understanding of the client's busi-
ness and the transactions and events that have occurred since the last audit
date and (b) identifying areas that may represent specific risks relevant to
the audit. Thus, the objective of the procedures is to identify such things as
the existence of unusual transactions and events, as well as amounts, ratios,
and trends that might indicate matters that have financial statement and au-
dit planning ramifications. For overall review purposes, these procedures may
focus on considering the adequacy of the evidence gathered in response to un-
usual or unexpected balances or relationships. The objective of the procedures
is to assist the auditor in assessing the conclusions reached and evaluating the
overall financial statement presentation.
2.34 Analytical procedures also may be used as substantive tests to iden-
tify potential misstatements. These procedures focus on comparing actual bal-
ances with expected balances and investigating and evaluating significant dif-
ferences from the balances expected. Paragraph .22 of AU section 329 (AICPA,
Professional Standards, vol. 1) states that the auditor should document all of
the following when an analytical procedure is used as the principal substantive
test of a significant financial statement assertion:
a. The expectation, where that expectation is not otherwise readily
determinable from the documentation of the work performed, and
factors considered in its development.
b. Results of the comparison of the expectation to the recorded
amounts or ratios developed from recorded amounts.
c. Any additional auditing procedures performed in response to signif-
icant unexpected differences arising from the analytical procedure
and the results of such additional procedures.
Considerations for Audits Performed in Accordance With PCAOB Stan-
dards
Paragraph .09 of AU section 329, Analytical Procedures (AICPA,
PCAOB Standards and Related Rules, Interim Standards), provides
that for significant risks of material misstatement, it is unlikely that
audit evidence obtained from substantive analytical procedures alone
will be sufficient.
2.35 Examples of sources of information for developing expectations in-
clude prior-period financial information, budgets, and health care financial
and statistical ratios. Additional information is available from the Center for
Healthcare Industry Performance Studies' Financial Analysis Service, which
is published annually, as well as other health care industry associations.
2.36 Following are examples of analytical procedures the independent au-
ditor may find useful:
 Comparison of account balances with budget and prior-period
amounts.
 Analysis of changes in revenues during the current period based
on statistical data (for example, admissions, patient days, visits,
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and professional service procedure counts for laboratory, radiology,
and surgery) and information concerning price changes.
 Comparison between periods of the number of days of revenue in
receivables.
 Relationship between periods of the allowance for uncollectible ac-
counts to the balance of patient accounts receivable in the aggre-
gate, based on known changes in the accounts receivable's aging
and composition by payor.
 Relationship between periods of the liability for claims IBNR to
the related expense.
2.37 The AICPA Audit Guide Analytical Procedures provides practical
guidance to auditors on the effective use of analytical procedures. That audit
guide includes a discussion of AU section 329 (AICPA, Professional Standards,
vol. 1); concepts and definitions; a series of questions and answers; and a case
study illustrating trend analysis, ratio analysis, reasonableness testing, and
regression analysis.
Considerations for Audits Performed in Accordance With PCAOB Stan-
dards
When performing an integrated audit of financial statements and in-
ternal control over financial reporting, refer to paragraph B6 of ap-
pendix B of Auditing Standard No. 5 for guidance on the effect of tests
of controls on substantive procedures, including analytical procedures.
Discussion Among the Audit Team
2.38 In obtaining an understanding of the entity and its environment,
including its internal control, AU section 314 states that there should be dis-
cussion among the audit team. In accordance with paragraph .14 of AU section
314, the members of the audit team, including the auditor with final respon-
sibility for the audit, should discuss the susceptibility of the entity's financial
statements to material misstatements. This discussion could be held concur-
rently with the discussion among the audit team that is specified by AU section
316 (AICPA, Professional Standards, vol. 1) to discuss the susceptibility of the
entity's financial statements to fraud.
Understanding of the Entity and Its Environment
2.39 AU section 314 states the auditor must obtain an understanding of
the entity and its environment, including its internal control. In accordance
with paragraph .04 of AU section 314, the auditor should use professional judg-
ment to determine the extent of the understanding required of the entity and
its environment, including its internal control. The auditor's primary consid-
eration is whether the understanding that has been obtained is sufficient (1)
to assess risks of material misstatement of the financial statements and (2) to
design and perform further audit procedures (tests of controls and substantive
tests).
2.40 The auditor's understanding of the entity and its environment con-
sists of an understanding of the following aspects:
a. Industry, regulatory, and other external factors.
b. Nature of the entity.
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c. Objectives and strategies and the related business risks that may
result in a material misstatement of the financial statements.
d. Measurement and review of the entity's financial performance.
e. Internal control, which includes the selection and application of
accounting policies (see the following section for further discussion).
Appendix A of AU section 314 provides examples of matters that the auditor
may consider in obtaining an understanding of the entity and its environment
relating to the preceding categories (a)–(d).
2.41 Some examples of matters that the auditor may consider in obtaining
an understanding of the health care entity and its environment include
 conditions that might lead to extension or modification of audit
tests (such as the existence of related party transactions or the
existence of uninsured malpractice risks).
 the entity's experience with payment denials and other matters
subject to review by medical review organizations.
2.42 In obtaining an understanding of the health care entity and its en-
vironment, the independent auditor also may consider certain aspects of the
health care entity's operations that are usually subject to higher or lower levels
of inherent risk.
In many health care entities, certain accounts typically (a) will have a low vol-
ume of transactions, (b) will consist of transactions that are not complex, and
(c) do not require the use of significant accounting estimates. Accounts such as
inventories, marketable securities, assets whose use is limited, property and
equipment, long term debt, and equity frequently have these characteristics and
may allow the auditor to assess inherent risk as being at a relatively low level.
However, in certain circumstances, such as investments in complex derivative
financial instruments, inherent risk may be higher. The auditor should use pro-
fessional judgment in evaluating the factors relevant to assessments of inherent
risk.
2.43 Statement of Position (SOP) 00-1, Auditing Health Care Third-Party
Revenues and Related Receivables (AICPA, Technical Practice Aids, AUD sec.
14,360), provides guidance to auditors regarding uncertainties inherent in
health care third-party revenue recognition. SOP 00-1 is included as appendix D
to this guide.
2.44 AU section 332, Auditing Derivative Instruments, Hedging Activities,
and Investments in Securities (AICPA, Professional Standards, vol. 1), among
other matters, establishes requirements and provides guidance to auditors in
planning and performing auditing procedures for assertions about derivative
instruments that are made in an entity's financial statements, and presents
examples of factors that affect inherent risk for assertions about derivatives.
In addition, a companion Audit Guide, Auditing Derivative Instruments, Hedg-
ing Activities, and Investments in Securities, provides practical guidance for
implementing AU section 332 (AICPA, Professional Standards, vol. 1).
Considerations for Audits Performed in Accordance With PCAOB Stan-
dards
Paragraph .11 of AU section 332, Auditing Derivative Instruments,
Hedging Activities, and Investments in Securities (AICPA, PCAOB
Standards and Related Rules, Interim Standards), states that when
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performing an integrated audit of financial statements and internal
control over financial reporting, paragraph 39 of PCAOB Auditing
Standard No. 5 states "[t]he auditor should test those controls that
are important to the auditor's conclusion about whether the company's
controls sufficiently address the assessed risk of material misstate-
ment to each relevant assertion." Therefore, in an integrated audit
of financial statements and internal control over financial reporting,
if there are relevant assertions related to the company's investments
in derivatives and securities, the auditor's understanding of controls
should include controls over derivatives and securities transactions
from their initiation to their inclusion in the financial statements and
should encompass controls placed in operation by the entity and ser-
vice organizations whose services are part of the entity's information
system.
2.45 Interpretation No. 1, "Auditing Investments in Securities Where a
Readily Determinable Fair Value Does Not Exist," of AU section 332 (AICPA,
Professional Standards, vol. 1, AU sec. 9332 par. .01–.04), provides guidance for
auditors of nonissuers regarding the adequacy of audit evidence with respect to
the existence and valuation assertions in AU section 332 (AICPA, Professional
Standards, vol. 1), in confirmations received from third parties when auditing
investments in securities where a readily determinable fair value does not exist,
and the auditor determines auditing procedures should include verifying the
existence and testing the measurement of the investments. Further guidance
for auditors of nonissuers is provided in the AICPA Practice Aid Alternative
Investments—Audit Considerations. The guidance focuses on the existence and
valuation assertions associated with auditing investments for which a readily
determinable fair value does not exist (collectively referred to in the Practice
Aid as alternative investments).2 Appendix 1 of that practice aid provides an
example confirmation for alternative investments for use by practitioners. The
auditing portion of that practice aid is an other auditing publication as defined
in AU section 150. Other auditing publications have no authoritative status;
however, they may help the auditor understand and apply Statements on Au-
diting Standards (SASs).
2.46 Because of the large monetary amounts and the complexity of deter-
mining health care service revenue and receivables, there are risks associated
with health care service revenue recognition and the valuation of the related
receivables. A significant portion of services usually is paid for by third par-
ties such as Medicare, Medicaid, and various health insurance carriers under
statutory provisions or other arrangements in amounts that can be significantly
different from, and frequently less than, the entity's established rates.
2.47 Risks are associated with recognizing the liability for costs incurred
by providers of prepaid health care services (for example, health maintenance
organizations) because such costs may have been incurred but not yet reported
to the providers. It is therefore necessary to estimate the liability for those
costs. These estimates often involve a high degree of management judgment.
Management generally should consider historical experience as well as the
effects of any changes in conditions such as seasonality trends and changes in
subscriber population and in the services and benefits provided.
2 The AICPA Practice Aid Alternative Investments—Audit Considerations can be found at
www.aicpa.org/download/members/div/auditstd/Alternative_Investments_Practice_Aid.pdf.
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2.48 Risks also are associated with contingencies for uninsured medical
malpractice losses and obligations under continuing care contracts. A high de-
gree of management judgment and complex analyses usually are involved in
evaluating the related financial statement assertions.
2.49 The independent auditor should understand the specific cost-finding
or other rate-setting methods used by third-party payors to determine final
amounts reimbursable to the health care entity. These payment methods may
require that a health care entity accumulate and report various statistical data,
such as admissions, discharges, patient days, visits, beds, square footage, and
pounds of laundry.
Understanding of Internal Control3
2.50 Paragraph .40 of AU section 314 states that the auditor should obtain
an understanding of the five components of internal control sufficient to assess
the risks of material misstatement of the financial statements whether due
to error or fraud, and to design the nature, timing, and extent of further audit
procedures. The auditor should obtain a sufficient understanding by performing
risk assessment procedures to
a. evaluate the design of controls relevant to an audit of financial
statements and
b. determine whether they have been implemented.
2.51 The auditor should use such knowledge to
 identify types of potential misstatements,
 consider factors that affect the risks of material misstatement,
and
 design tests of controls, when applicable, and substantive proce-
dures.
2.52 Obtaining an understanding of controls is different than testing the
operating effectiveness of controls. The objective of obtaining an understand-
ing of controls is to evaluate the design of controls and determine whether they
have been implemented for the purpose of assessing the risks of material mis-
statement. In contrast, the objective of testing the operating effectiveness of
controls is to determine whether the controls, as designed, prevent or detect a
material misstatement.
2.53 Paragraph .41 of AU section 314 defines internal control as "a
process—effected by those charged with governance, management, and other
personnel—designed to provide reasonable assurance about the achievement
of the entity's objectives with regard to reliability of financial reporting, effec-
tiveness and efficiency of operations, and compliance with applicable laws and
regulations." Internal control consists of 5 interrelated components:
a. The control environment
b. Risk assessment
c. Information and communication systems
3 For additional nonauthoritative guidance pertaining to internal control and the risk assessment
standards (Statement on Auditing Standards (SAS) Nos. 104-111), refer to Technical Questions and
Answers (TIS) sections 8200.05–.16 in TIS section 8200, "Internal Control" (AICPA, Technical Practice
Aids), issued in March and April 2008.
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d. Control activities
e. Monitoring
Refer to paragraphs .40–.101 of AU section 314 for a detailed discussion of the
internal control components.
2.54 AU section 314 also states that, in obtaining an understanding of
internal control sufficient to assess the risks of material misstatement, the au-
ditor should obtain an understanding of how an entity's use of IT and manual
procedures may affect controls relevant to the audit. Information technology
encompasses automated means of originating, processing, storing, and commu-
nicating information, and includes recording devices, communication systems,
computer systems, and other electronic devices. The auditor is primarily inter-
ested in the entity's use of IT to initiate, authorize, record, process, and report
transactions or other financial data.
Assessment of Risks of Material Misstatement and the
Design of Further Audit Procedures
2.55 As discussed previously, risk assessment procedures allow the au-
ditor to gather the information necessary to obtain an understanding of the
entity and its environment, including its internal control. This knowledge pro-
vides a basis for assessing the risks of material misstatement of the financial
statements. These risk assessments are then used to design further audit proce-
dures, such as tests of controls, substantive tests, or both. This section provides
guidance on assessing the risks of material misstatement and how to design
further audit procedures that effectively respond to those risks.
Assessing the Risks of Material Misstatement
2.56 Paragraph .102 of AU section 314 states that the auditor should iden-
tify and assess the risks of material misstatement at the financial statement
level and at the relevant assertion level related to classes of transactions, ac-
count balances, and disclosures. For this purpose, the auditor should
a. identify risks throughout the process of obtaining an understand-
ing of the entity and its environment, including relevant controls
that relate to the risks, and considering the classes of transactions,
account balances, and disclosures in the financial statements.
b. relate the identified risks to what can go wrong at the relevant
assertion level.
c. consider whether the risks are of a magnitude that could result in
a material misstatement of the financial statements.
d. consider the likelihood that the risks could result in a material
misstatement of the financial statements.
2.57 The auditor should use information gathered by performing risk as-
sessment procedures, including the audit evidence obtained in evaluating the
design of controls and determining whether they have been implemented, as
audit evidence to support the risk assessment. The auditor should use the risk
assessment to determine the nature, timing, and extent of further audit proce-
dures to be performed.
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Identification of Significant Risks
2.58 As part of the assessment of the risks of material misstatement, the
auditor should determine which of the risks identified are, in the auditor's judg-
ment, risks that require special audit consideration (such risks are defined as
significant risks). One or more significant risks normally arise on most audits.
In exercising this judgment, the auditor should consider inherent risk to de-
termine whether the nature of the risk, the likely magnitude of the potential
misstatement including the possibility that the risk may give rise to multiple
misstatements, and the likelihood of the risk occurring are such that they re-
quire special audit consideration. Paragraphs .45 and .53 of AU section 318,
Performing Audit Procedures in Response to Assessed Risks and Evaluating the
Audit Evidence Obtained (AICPA, Professional Standards, vol. 1), establish re-
quirements and provide guidance for further audit procedures pertaining to
significant risks.
Designing and Performing Further Audit Procedures
2.59 AU section 318 establishes requirements and provides guidance
about implementing the third standard of field work, as follows:
The auditor must obtain sufficient appropriate audit evidence by per-
forming audit procedures to afford a reasonable basis for an opinion
regarding the financial statements under audit.
2.60 To reduce audit risk to an acceptably low level, the auditor (1) should
determine overall responses to address the assessed risks of material misstate-
ment at the financial statement level and (2) should design and perform fur-
ther audit procedures whose nature, timing, and extent are responsive to the
assessed risks of material misstatement at the relevant assertion level. The
purpose is to provide a clear linkage between the nature, timing, and extent
of the auditor's further audit procedures and the assessed risks. The overall
responses and the nature, timing, and extent of the further audit procedures to
be performed are matters for the professional judgment of the auditor.
Overall Responses
2.61 The auditor's overall responses to address the assessed risks of mate-
rial misstatement at the financial statement level may include emphasizing to
the audit team the need to maintain professional skepticism in gathering and
evaluating audit evidence, assigning more experienced staff or those with spe-
cialized skills or using specialists, providing more supervision, or incorporating
additional elements of unpredictability in the selection of further audit proce-
dures to be performed. Additionally, the auditor may make general changes to
the nature, timing, or extent of further audit procedures as an overall response,
for example, performing substantive procedures at period end instead of at an
interim date.
Further Audit Procedures
2.62 Further audit procedures provide important audit evidence to sup-
port an audit opinion. These procedures consist of tests of controls and substan-
tive tests. The nature, timing, and extent of the further audit procedures to be
performed by the auditor should be based on the auditor's assessment of risks
of material misstatement at the relevant assertion level.
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2.63 In some cases, an auditor may determine that performing only sub-
stantive procedures is appropriate. However, the auditor often will determine
that a combined audit approach using both tests of the operating effectiveness of
controls and substantive procedures is an effective audit approach. Regardless
of the audit approach selected, the auditor should design and perform sub-
stantive procedures for all relevant assertions related to each material class of
transactions, account balance, and disclosure.
2.64 The auditor should perform tests of controls when the auditor's risk
assessment includes an expectation of the operating effectiveness of controls or
when substantive procedures alone do not provide sufficient appropriate audit
evidence at the relevant assertion level.
2.65 The auditor's substantive procedures should include the following
audit procedures related to the financial statement reporting process:
 Agreeing the financial statements, including their accompanying
notes, to the underlying accounting records; and
 Examining material journal entries and other adjustments made
during the course of preparing the financial statements.
The nature and extent of the auditor's examination of journal entries and other
adjustments depend on the nature and complexity of the entity's financial re-
porting system and the associated risks of material misstatement.
2.66 The purpose of specific audit objectives and examples of control ac-
tivities in the auditing sections of the following chapters is to illustrate how
the independent auditor might obtain an understanding of internal control, as-
sess the risks of material misstatement, and perform audit procedures. There
is not necessarily a one-to-one relationship between audit objectives and pro-
cedures. Some procedures may relate to more than one objective. On the other
hand, a combination of procedures may be needed to achieve a single objective.
The auditing exhibits presented in subsequent chapters are not intended to be
all-inclusive or to suggest that specific audit objectives, control activities, and
audit procedures should be applied. Some of the objectives may not be relevant
to a particular entity because of the nature of its operations or the absence of
certain types of transactions. The absence of one or more of the illustrative con-
trols would not necessarily indicate a deficiency in internal control. The auditor
must perform procedures that are responsive to the auditor's risk assessment.
2.67 The auditing exhibits presented in subsequent chapters present
broad audit objectives for various assertions. These classifications may be useful
in the evaluation process, but the classifications are of secondary importance.
Some specific objectives may serve to achieve more than one broad objective.
2.68 Many of the illustrative control activities are premised on the exis-
tence of certain essential characteristics of internal control (for example, autho-
rization of transactions, segregation of duties, documentation, supervision and
review, and timeliness of procedures). To avoid repetition, these characteristics
have not been emphasized in the auditing exhibits presented in subsequent
chapters.
Evaluating Misstatements
2.69 Based on the results of substantive procedures, the auditor may iden-
tify misstatements in accounts or notes to the financial statement. Paragraph
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.42 of AU section 312 (AICPA, Professional Standards, vol. 1) states that au-
ditors must accumulate all known and likely misstatements identified during
the audit, other than those that the auditor believes are trivial and commu-
nicate them to the appropriate level of management. AU section 312 (AICPA,
Professional Standards, vol. 1) further states that auditors must consider the
effects, both individually and in the aggregate, of misstatements (known and
likely) that are not corrected by the entity. This consideration includes, among
other things, the effect of misstatements related to prior periods.
2.70 AU sections 312 and 326 (AICPA, Professional Standards, vol. 1)
establish requirements and provide guidance on evaluating audit findings and
audit evidence, respectively.
Consideration of Fraud in a Financial Statement Audit
2.71 AU section 316 (AICPA, Professional Standards, vol. 1) is the primary
source of authoritative guidance about an auditor's responsibilities concern-
ing the consideration of fraud in a financial statement audit. AU section 316
(AICPA, Professional Standards, vol. 1) establishes requirements and provides
guidance to auditors in fulfilling their responsibility to plan and perform the
audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement, whether caused by error or fraud, as stated
in paragraph .02 of AU section 110, Responsibilities and Functions of the Inde-
pendent Auditor (AICPA, Professional Standards, vol. 1). AU section 333, Man-
agement Representations (AICPA, Professional Standards, vol. 1), establishes
requirements and provides guidance regarding management representations
about fraud. See paragraphs 2.126–.127 in this chapter for a discussion of the
requirements and guidance contained in AU section 333 (AICPA, Professional
Standards, vol. 1).
2.72 There are two types of misstatements relevant to the auditor's con-
sideration of fraud in a financial statement audit:
 Misstatements arising from fraudulent financial reporting
 Misstatements arising from misappropriation of assets (some-
times referred to as theft or defalcation)
2.73 Three conditions generally are present when fraud occurs. First, man-
agement or other employees have an incentive or are under pressure, which
provides a reason to commit fraud. Second, circumstances exist—for example,
the absence of controls, ineffective controls, or the ability of management to
override controls—that provide an opportunity for a fraud to be perpetrated.
Third, those involved are able to rationalize committing a fraudulent act.
The Importance of Exercising Professional Skepticism
2.74 Because of the characteristics of fraud, the auditor's exercise of pro-
fessional skepticism is important when considering the risk of material mis-
statement due to fraud. Professional skepticism is an attitude that includes
a questioning mind and a critical assessment of audit evidence. The auditor
should conduct the engagement with a mindset that recognizes the possibility
that a material misstatement due to fraud could be present, regardless of any
past experience with the entity and regardless of the auditor's belief about man-
agement's honesty and integrity. Furthermore, professional skepticism requires
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an ongoing questioning of whether the information and evidence obtained sug-
gests that a material misstatement due to fraud has occurred.
Discussion Among Engagement Personnel Regarding the Risks
of Material Misstatement Due to Fraud4
2.75 Members of the audit team should discuss the potential for mate-
rial misstatement due to fraud in accordance with the requirements of para-
graphs .14–.18 of AU section 316 (AICPA, Professional Standards, vol. 1). The
discussion among the audit team members about the susceptibility of the en-
tity's financial statements to material misstatement due to fraud should in-
clude a consideration of the known external and internal factors affecting the
entity that might (a) create incentives/pressures for management and others
to commit fraud, (b) provide the opportunity for fraud to be perpetrated, and
(c) indicate a culture or environment that enables management to rationalize
committing fraud. Communication among the audit team members about the
risks of material misstatement due to fraud also should continue throughout
the audit.
Obtaining the Information Needed to Identify the Risks
of Material Misstatement Due to Fraud
2.76 AU section 314 establishes requirements and provides guidance
about how the auditor obtains an understanding of the entity and its envi-
ronment, including its internal control for the purpose of assessing the risks of
material misstatement. In performing that work, information may come to the
auditor's attention that should be considered in identifying risks of material
misstatement due to fraud. As part of this work, the auditor should perform
the following procedures to obtain information that is used (as described in
paragraphs .35–.42 of AU section 316 [AICPA, Professional Standards, vol. 1]),
to identify the risks of material misstatement due to fraud:
a. Make inquiries of management and others within the entity to
obtain their views about the risks of fraud and how they are ad-
dressed. (See paragraphs .20–.27 of AU section 316.)
b. Consider any unusual or unexpected relationships that have been
identified in performing analytical procedures in planning the au-
dit. (See paragraphs .28–.30 of AU section 316.)
c. Consider whether one or more fraud risk factors exist. (See para-
graphs .31–.33 of AU section 316, the appendix to AU section 316,
and paragraph 2.78 in this chapter.)
d. Consider other information that may be helpful in the identification
of risks of material misstatement due to fraud. (See paragraph .34
of AU section 316.)
2.77 In planning the audit, the auditor also should perform analytical
procedures relating to revenue with the objective of identifying unusual or un-
expected relationships involving revenue accounts that may indicate a material
misstatement due to fraudulent financial reporting.
4 The brainstorming session to discuss the entity's susceptibility to material misstatements due
to fraud could be held concurrently with the brainstorming session required under AU section 314,
Understanding the Entity and Its Environment and Assessing the Risks of Material Misstatement
(AICPA, Professional Standards, vol. 1), to discuss the potential of the risks of material misstatement.
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2.78 Considering fraud risk factors. As indicated in paragraph 2.76(c) in
this chapter, the auditor may identify events or conditions that indicate in-
centives/pressures to perpetrate fraud, opportunities to carry out the fraud, or
attitudes/rationalizations to justify a fraudulent action. Such events or condi-
tions are referred to as fraud risk factors. Fraud risk factors do not necessarily
indicate the existence of fraud; however, they often are present in circumstances
where fraud exists.
2.79 AU section 316 (AICPA, Professional Standards, vol. 1) provides fraud
risk factor examples that have been written to apply to most entities. Remember
that fraud risk factors are only one of several sources of information an auditor
considers when identifying and assessing risk of material misstatement due to
fraud.
Identifying Risks That May Result in a Material Misstatement
Due to Fraud5
2.80 In identifying risks of material misstatement due to fraud, it is help-
ful for the auditor to consider the information that has been gathered in accor-
dance with the requirements of paragraph .19–.34 of AU section 316 (AICPA,
Professional Standards, vol. 1). The auditor's identification of fraud risks may
be influenced by characteristics such as the size, complexity, and ownership
attributes of the entity. In addition, the auditor should evaluate whether iden-
tified risks of material misstatement due to fraud can be related to specific
financial-statement account balances or classes of transactions and related as-
sertions, or whether they relate more pervasively to the financial statements
as a whole. Certain accounts, classes of transactions, and assertions that have
high inherent risk because they involve a high degree of management judgment
and subjectivity also may present risks of material misstatement due to fraud
because they are susceptible to manipulation by management.
A Presumption That Improper Revenue Recognition Is a Fraud Risk
2.81 Material misstatements due to fraudulent financial reporting often
result from an overstatement of revenues (for example, through premature
revenue recognition or recording fictitious revenues) or an understatement of
revenues (for example, through improperly shifting revenues to a later period).
Therefore, the auditor should ordinarily presume that there is a risk of material
misstatement due to fraud relating to revenue recognition (see paragraph .41
of AU section 316 [AICPA, Professional Standards, vol. 1]).
A Consideration of the Risk of Management Override of Controls
2.82 Even if specific risks of material misstatement due to fraud are not
identified by the auditor, there is a possibility that management override of
controls could occur, and accordingly, the auditor should address that risk (see
paragraph .57 of AU section 316 [AICPA, Professional Standards, vol. 1]) apart
from any conclusions regarding the existence of more specifically identifiable
risks. Specifically, the procedures described in paragraph .58–.67 of AU section
5 Paragraph .102 of AU section 314 states that the auditor should identify and assess the risks of
material misstatement at the financial statement level and at the relevant assertion level related to
classes of transactions, account balances, and disclosures. This requirement provides a link between
the auditor's consideration of fraud and assessment of risk and the auditor's procedures in response
to those assessed risks.
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316 (AICPA, Professional Standards, vol. 1) should be performed to further ad-
dress the risk of management override of controls. These procedures include (1)
examining journal entries and other adjustments for evidence of possible ma-
terial misstatement due to fraud, (2) reviewing accounting estimates for biases
that could result in material misstatement due to fraud, and (3) evaluating the
business rationale for significant unusual transactions.
Assessing the Identified Risks After Taking Into Account
an Evaluation of the Entity’s Programs and Controls That
Address the Risks
2.83 Paragraphs .43–.45 of AU section 316 (AICPA, Professional Stan-
dards, vol. 1) establish requirements and provide guidance concerning an en-
tity's programs and controls that address identified risks of material misstate-
ment due to fraud.
2.84 The auditor should consider whether such programs and controls
mitigate the identified risks of material misstatement due to fraud or whether
specific control deficiencies exacerbate the risks. After the auditor has evaluated
whether the entity's programs and controls have been suitably designed and
placed in operation, the auditor should assess these risks taking into account
that evaluation. The assessment should be considered when developing the
auditor's response to the identified risks of material misstatement due to fraud.
Responding to the Results of the Assessment6
2.85 Paragraphs .46–.67 of AU section 316 (AICPA, Professional Stan-
dards, vol. 1) establish requirements and provide guidance about an auditor's
response to the results of the assessment of the risks of material misstatement
due to fraud. The auditor responds to risks of material misstatement due to
fraud in the following 3 ways:
a. A response that has an overall effect on how the audit is
conducted—that is, a response involving more general consider-
ations apart from the specific procedures otherwise planned (see
paragraph .50 of AU section 316).
b. A response to identified risks involving the nature, timing, and ex-
tent of the auditing procedures to be performed (see paragraphs
.51–.56 of AU section 316).
c. A response involving the performance of certain procedures to fur-
ther address the risk of material misstatement due to fraud involv-
ing management override of controls, given the unpredictable ways
in which such override could occur (see paragraphs .57–.67 of AU
section 316 and paragraph 2.82 in this chapter).
6 Paragraph .03 of AU section 318, Performing Audit Procedures in Response to Assessed Risks
and Evaluating the Audit Evidence Obtained (AICPA, Professional Standards, vol. 1), states that, to
reduce audit risk to an acceptably low level, the auditor should determine overall responses to address
the assessed risks of material misstatement at the financial statement level and should design and
perform further audit procedures whose nature, timing, and extent are responsive to the assessed
risks of material misstatement at the relevant assertion level. See paragraphs .04–.07 of AU section
318. This requirement provides a link between the auditor's consideration of fraud and the auditor's
assessment of risk and the auditor's procedures in response to those assessed risks.
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Evaluating Audit Evidence
2.86 Paragraphs .68–.78 of AU section 316 (AICPA, Professional Stan-
dards, vol. 1) establishes requirements and provides guidance for evaluating
audit evidence. The auditor should evaluate whether analytical procedures that
were performed as substantive tests or in the overall review stage of the audit
indicate a previously unrecognized risk of material misstatement due to fraud.
The auditor also should consider whether responses to inquiries throughout the
audit about analytical relationships have been vague or implausible, or have
produced evidence that is inconsistent with other audit evidence accumulated
during the audit.
2.87 At or near the completion of fieldwork, the auditor should evaluate
whether the accumulated results of auditing procedures and other observa-
tions affect the assessment of the risks of material misstatement due to fraud
made earlier in the audit. As part of this evaluation, the auditor with final
responsibility for the audit should ascertain that there has been appropriate
communication with the other audit team members throughout the audit re-
garding information or conditions indicative of risks of material misstatement
due to fraud.
Responding to Misstatements That May Be the Result of Fraud
2.88 When audit test results identify misstatements in the financial state-
ments, the auditor should consider whether such misstatements may be in-
dicative of fraud. Paragraphs .75–.78 of AU section 316 (AICPA, Professional
Standards, vol. 1) establish requirements and provide guidance about an audi-
tor's response to misstatements that may be the result of fraud. If the auditor
believes that misstatements are or may be the result of fraud, but the effect
of the misstatements is not material to the financial statements, the auditor
nevertheless should evaluate the implications, especially those dealing with
the organizational position of the person(s) involved.
2.89 If the auditor believes that the misstatement is or may be the re-
sult of fraud, and either has determined that the effect could be material to
the financial statements or has been unable to evaluate whether the effect is
material, the auditor should
a. attempt to obtain additional audit evidence to determine whether
material fraud has occurred or is likely to have occurred, and, if
so, its effect on the financial statements and the auditor's report
thereon.7
b. consider the implications for other aspects of the audit (see para-
graph .76 of AU section 316 [AICPA, Professional Standards,
vol. 1]).
7 AU section 508, Reports on Audited Financial Statements (AICPA, Professional Standards,
vol. 1), establishes requirements and provides guidance on auditor's reports issued in connection with
audits of financial statements and for an integrated audit.
Considerations for Audits Performed in Accordance With PCAOB Standards
Paragraph .01 of AU section 508, Reports on Audited Financial Statements (AICPA, PCAOB
Standards and Related Rules, Interim Standards), states that when performing an integrated
audit of financial statements and internal control over financial reporting, the auditor may
choose to issue a combined report or separate reports on the company's financial statements
and on internal control over financial reporting. Refer to paragraphs 85–98 of PCAOB Auditing
Standard No. 5, An Audit of Internal Control Over Financial Reporting That Is Integrated with
An Audit of Financial Statements (AICPA, PCAOB Standards and Related Rules, Auditing
Standards), for direction on reporting on internal control over financial reporting.
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c. discuss the matter and the approach for further investigation with
an appropriate level of management that is at least one level above
those involved, and with senior management and those charged
with governance.8
d. If appropriate, suggest that the client consult with legal counsel.
2.90 The auditor's consideration of the risks of material misstatement and
the results of audit tests may indicate such a significant risk of material mis-
statement due to fraud that the auditor should consider withdrawing from the
engagement and communicating the reasons for withdrawal to those charged
with governance. The auditor may wish to consult with legal counsel when
considering withdrawal from an engagement.
Communicating About Possible Fraud to Management
and Those Charged With Governance
2.91 Whenever the auditor has determined that there is evidence that
fraud may exist, that matter should be brought to the attention of an appro-
priate level of management. Paragraphs .79–.82 of AU section 316 (AICPA,
Professional Standards, vol. 1) establish requirements and provide guidance
about communications with management and those charged with governance.
Documenting the Auditor’s Consideration of Fraud
2.92 Paragraph .83 of AU section 316 (AICPA, Professional Standards,
vol. 1) lists certain items and events the auditor should document.
Additional Audit Considerations
Accounting Estimates
2.93 In determining the scope of audit procedures to be performed, the
independent auditor may recognize that certain areas of health care entity
operations include accounting estimates that may be material in the prepa-
ration and presentation of financial statements. Financial Accounting Stan-
dards Board (FASB) Accounting Standards Codification (ASC) 275, Risks and
Uncertainties,9 provides requirements and standards for entities to include in
their financial statements information about the use of estimates in the prepa-
ration of financial statements. In addition, if certain specified disclosure cri-
teria are met, entities should include the disclosures described in FASB ASC
275-10-50 about certain significant estimates in their financial statements. AU
section 342, Auditing Accounting Estimates (AICPA, Professional Standards,
vol. 1), provides guidance on obtaining and evaluating sufficient appropriate
audit evidence to support significant accounting estimates in an audit of finan-
cial statements in accordance with GAAS.
8 If the auditor believes senior management may be involved, discussion of the matter directly
with those charged with governance may be appropriate.
9 Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 275,
Risks and Uncertainties, does not pertain to governmental entities, unless the entity has elected to
follow all FASB pronouncements under paragraph 7 of Governmental Accounting Standards Board
Statement No. 20, Accounting and Financial Reporting for Proprietary Funds and Other Governmental
Entities That Use Proprietary Fund Accounting. (See chapter 1 footnote 1.)
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2.94 Although management is responsible for making estimates, the inde-
pendent auditor is responsible for evaluating the reasonableness of estimates
and should design appropriate procedures in planning and performing the au-
dit. These procedures should include both subjective and objective factors.
2.95 The independent auditor should acquire an understanding of the
relevance of internal control to the accumulation of data and the preparation of
accounting estimates. Internal control should also provide for adequate review
and approval of accounting estimates by appropriate levels of authority.
2.96 Although significant accounting estimates may affect many elements
of a health care entity's financial statements, examples would include, but not
be limited to, the following:
a. The provision for third-party payor contractual adjustments and al-
lowances and the provision for estimated receivables and payables
for final settlements with those payors.
b. The provision for uncollectible accounts.
c. Accruals for uninsured medical malpractice claims.
d. Accruals for obligations under continuing care contracts.
e. Accruals by providers of prepaid health care services for IBNR costs.
Considerations for Audits Performed in Accordance With PCAOB Stan-
dards
Paragraph .10 of AU section 342, Auditing Accounting Estimates
(AICPA, PCAOB Standards and Related Rules, Interim Standards),
states when performing an integrated audit of financial statements
and internal control over financial reporting, the auditor may use any
of 3 approaches. However, the work that the auditor performs as part
of the audit of internal control over financial reporting should nec-
essarily inform the auditor's decisions about the approach he or she
takes to auditing an estimate because, as part of the audit of internal
control over financial reporting, the auditor would be required to ob-
tain an understanding of the process management used to develop the
estimate and to test controls over all relevant assertions related to the
estimate.
f. Fair value measurements
g. Impairments of fair value
h. Business combinations
2.97 SOP 00-1 provides guidance for auditors regarding the sufficiency of
audit evidence supporting accounting estimates recorded for the proper valu-
ation of health care third-party revenues and related receivables. SOP 00-1 is
included as appendix D to this guide.
Transactions Processed by Service Organizations
2.98 Health care entities may engage outside service organizations to per-
form services that are part of the health care provider's information system. A
service organization's services are part of an entity's information system if they
affect any of the following:
 The classes of transactions in the entity's operations that are sig-
nificant to the entity's financial statements.
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 The procedures, both automated and manual, by which the entity's
transactions are initiated, authorized, recorded, processed, and
reported from their occurrence to their inclusion in the financial
statements.
 The related accounting records, whether electronic or manual,
supporting information, and specific accounts in the entity's fi-
nancial statements involved in initiating, recording, processing,
and reporting the entity's transactions.
 How the entity's information system captures other events and
conditions that are significant to the financial statements.
 The financial reporting process used to prepare the entity's finan-
cial statements, including significant accounting estimates and
disclosures.
2.99 Examples of service organizations used by health care entities include
the following:
 Bank trust departments that invest and service assets for health
care entities.
 Service organizations that process payroll.
 Billing entities that prepare reimbursement claims to insurers
and other third parties.
 Administrators of employee benefit plans who process and pay
benefit claims and maintain participant records.
2.100 AU section 314 states that the auditor should obtain an under-
standing of the 5 components of internal control sufficient to assess the risks
of material misstatement of the financial statements whether due to error or
fraud, and to design the nature, timing, and extent of further audit procedures.
This understanding may encompass controls placed in operation by the health
care entity and service organizations whose services are part of the health care
entity's information system. The auditor should use such knowledge to
 identify types of potential misstatements.
 consider factors that affect the risks of material misstatement.
 design tests of controls, when applicable.
 design substantive procedures.
2.101 AU section 324, Service Organizations (AICPA, Professional Stan-
dards, vol. 1), establishes requirements and provides guidance for auditors
when obtaining an understanding of internal control and assessing control risk
for entities that use a service organization to process transactions. The AICPA
Audit Guide Service Organizations: Applying SAS No. 70, as Amended provides
additional guidance for user auditors engaged to audit the financial statements
of entities that use service organizations.
Considerations for Audits Performed in Accordance With PCAOB Stan-
dards
Paragraph .01 of AU section 324, Service Organizations (AICPA,
PCAOB Standards and Related Rules, Interim Standards), states
when performing an integrated audit of financial statements and in-
ternal control over financial reporting, refer to paragraphs B17–B27
of appendix B of PCAOB Auditing Standard No. 5 regarding the use
of service organizations.
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2.102 The auditor of a health care entity should determine whether the
health care entity uses a service organization. Information about the nature of
the services provided by the service organization and the service organization's
controls over those services may be available from sources such as user manu-
als, system overviews, technical manuals, the contract between the health care
entity and the service organization, and reports by service auditors, internal
auditors, or regulatory authorities on the service organization's controls.
2.103 After considering the available information, the auditor of the health
care entity may conclude that he or she has the means to obtain a sufficient un-
derstanding of internal control to assess the risks of material misstatement. If
the auditor of the health care entity concludes that information is not available
to obtain a sufficient understanding to assess the risks of material misstate-
ment, he or she may consider contacting the service organization, through the
health care entity, to obtain specific information or request that a service auditor
be engaged to perform procedures that will supply the necessary information,
or the auditor of the health care entity may visit the service organization and
perform such procedures. If the auditor of the health care entity is unable to
obtain sufficient appropriate audit evidence to achieve his or her audit objec-
tives, the auditor of the health care entity should qualify his or her opinion or
disclaim an opinion on the financial statements because of a scope limitation.
2.104 After obtaining an understanding of internal control, the auditor
may assess control risk at the maximum level for some or all financial state-
ment assertions related to the service organization's processing because, he or
she believes controls are unlikely to pertain to an assertion, are unlikely to be
effective, or because evaluating their effectiveness would be inefficient. Proce-
dures to evaluate operating effectiveness include one or any combination of the
following:
a. Performing tests of controls over the activities of the service orga-
nization at the health care entity.
b. Performing tests of controls at the service organization.
c. Obtaining a service auditor's report that describes the results of
tests of the operating effectiveness of controls performed by the
service auditor.
Illegal Acts
2.105 The Social Security Act provides for criminal penalties for individu-
als or entities that offer, pay, solicit, or receive remuneration to induce business
that is reimbursed under Medicare or state health care programs. The types
of remuneration covered by the Medicare Anti-Kickback Statute include, with
certain exceptions, kickbacks, bribes, and rebates made directly or indirectly,
overtly or covertly, and in cash or in kind. In addition, prohibited conduct in-
cludes not only remuneration intended to induce referrals or patients but also
remuneration intended to induce the purchasing, leasing, ordering, or arrang-
ing for any good, facility, service, or item paid for by Medicare or state health
care programs. In addition, fraudulent activities may exist that are unrelated to
Medicare or state programs, such as fraudulent billing and admitting practices.
2.106 The auditor's procedures will vary based on his or her assessment of
the risks of material misstatement resulting from such illegal acts. AU section
317, Illegal Acts by Clients (AICPA, Professional Standards, vol. 1), establishes
requirements and provides guidance for planning and performing the audit to
AAG-HCO 2.102
P1: PjU
ACPA125-02 ACPA125.cls February 25, 2010 15:38
General Auditing Considerations 65
provide reasonable assurance of detecting illegal acts having a direct and ma-
terial effect on the determination of financial statement amounts. AU section
317 also notes that an audit in accordance with GAAS does not include audit
procedures specifically designed to detect illegal acts that have only an indirect
effect on the financial statements (for example, illegal acts that have a material
effect as the result of fines or penalties that may be imposed on the entity) and
establishes requirements and provides guidance on the auditor's responsibili-
ties when specific information concerning the possible existence of this type of
illegal act comes to the auditor's attention.
2.107 Examples of laws and regulations that are generally recognized by
auditors to have a direct and material effect on the determination of amounts
in financial statements of health care entities include tax laws affecting tax
accruals and tax expense as well as Medicare and Medicaid laws directly af-
fecting the amount of revenue recognized during the accounting period (such
as those concerning the submission of bills for fictitious patients).
2.108 Health care entities also may be affected by many other laws and
regulations such as those related to Medicare and Medicaid fraud and abuse, se-
curities trading, occupational safety and health, food and drug administration,
environmental protection, equal employment opportunities, and price-fixing or
other antitrust violations. Generally, these laws and regulations relate more
to an entity's operating aspects than to its financial and accounting aspects,
and their financial statement effect is only indirect. An auditor ordinarily does
not have sufficient basis for recognizing possible violations of such laws and
regulations. Their indirect effect is normally the result of the need to disclose a
contingent liability because of the allegation or determination of illegality. For
example, patients may be obtained based on illegal arrangements with physi-
cians or other providers. Although the direct effects of the services rendered
may be recorded appropriately, their indirect effects, the possible contingent li-
ability for violating Medicare and Medicaid fraud and abuse statutes, may not
be appropriately disclosed. Even when violations of such laws and regulations
can have consequences material to the financial statements, auditors may not
become aware of the existence of the illegal act unless he or she is informed by
the client, or there is evidence of a governmental agency investigation or en-
forcement proceeding in the records, documents, or other information normally
inspected in an audit of financial statements.
2.109 Whether an act is, in fact, illegal, is a determination that is nor-
mally beyond the auditor's professional competence. The auditor's training, ex-
perience, and understanding of the client and the industry may provide a basis
for recognizing that some acts coming to the auditor's attention may be illegal.
However, determining whether a particular client act is illegal generally would
be based on the advice of an informed expert qualified to practice law or may
have to await final determination by a court of law. For example, determining
whether admitting a patient or providing a service is medically necessary or
whether a particular procedure or device was properly approved is not within
the auditor's professional competence.
Clinical Coding Validations
2.110 Typically, a number of clinicians (for example, the attending physi-
cian, consulting physicians, radiologists, pathologists, therapists, and nurses)
add documentation to a patient's medical record. Provider personnel generally
review the medical record and assign a code (ICD-9-CM or CPT-4 code) to the
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record. The provider prepares and submits a bill that includes, among other
things, the assigned ICD-9-CM or CPT-4 code. The Medicare Fiscal Intermedi-
ary or other third-party payor typically reviews the bill and assigns it a specific
payment code, such as a Diagnostic Related Group (DRG) number. Payment is
based on the DRG or other payment code assigned. The provider may check the
payment code assigned and follow up on any discrepancies identified. However,
because the assignment of the payment code is made by the third-party payor,
responsibility for correct assignment rests with that payor.
2.111 Errors can occur throughout this process. Physicians or other clini-
cians may not document the appropriate procedure. Coding personnel may not
notice or interpret certain items in the medical record correctly. Accordingly, an
incorrect code may be assigned and an erroneous amount may be paid.
2.112 An auditor ordinarily would not find it necessary to consider the pro-
cess of assigning codes in planning and performing an audit of the provider's
financial statements. However, the auditor should be alert for indications of
potential material misstatements of the financial statements resulting indi-
rectly from such matters. For example, the auditor may become aware that
a retrospective review has been performed or that an investigation has been
completed or is in process. In such circumstances, the auditor should consider
whether performance of additional substantive audit procedures is necessary
to reduce audit risk to an acceptable level.
Going-Concern Considerations
2.113 AU section 341, The Auditor's Consideration of an Entity's Abil-
ity to Continue as a Going Concern (AICPA, Professional Standards, vol. 1),
establishes requirements and provides guidance to the auditor on evaluating
whether there is substantial doubt about the entity's ability to continue as a go-
ing concern. Continuation of an entity as a going concern is assumed in financial
reporting in the absence of significant information to the contrary. Ordinarily,
information that significantly contradicts the going-concern assumption relates
to the entity's inability to continue to meet its obligations as they become due
without substantial disposition of assets outside the ordinary course of busi-
ness, restructuring of debt, externally forced revision of its operations, or similar
actions. Paragraph .02 of AU section 341 states that the independent auditor
has a responsibility to evaluate whether there is substantial doubt about the
entity's ability to continue as a going concern for a reasonable period of time,
not to exceed one year beyond the date of the financial statements being au-
dited. Paragraph .18 of AU section 341 establishes requirements and provides
guidance for the auditor to document certain matters if, after considering the
identified conditions and events in the aggregate, the auditor believes there is
substantial doubt about the ability of the entity to continue as a going concern
for a reasonable period of time, not to exceed one year beyond the date of the
financial statements being audited.
2.114 FASB ASC 958-450-50-2 requires noncompliance with donor-
imposed restrictions to be disclosed if either of the following is true: (a) there is
a reasonable possibility that a material contingent liability has been incurred
at the date of the financial statements or (b) there is at least a reasonable pos-
sibility that the noncompliance could lead to a material loss of revenue or could
cause an entity to be unable to continue as a going concern. That paragraph re-
quires that if the noncompliance results from an entity's failure to maintain an
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appropriate composition of assets in amounts needed to comply with all donor
restrictions, the amounts and circumstances be disclosed.
Audit Documentation
Audits Conducted in Accordance With GAAS
2.115 AU section 339, Audit Documentation (AICPA, Professional Stan-
dards, vol. 1), establishes requirements and provides guidance on audit doc-
umentation. AU section 339 states that the auditor must prepare audit docu-
mentation in connection with each engagement in sufficient detail to provide a
clear understanding of the work performed (including the nature, timing, ex-
tent, and results of audit procedures performed), the audit evidence obtained
and its source, and the conclusion reached. Audit documentation
a. provides the principal support for the representation in the audi-
tor's report that the auditor performed the audit in accordance with
GAAS.
b. provides that principal support for the opinion expressed regard-
ing the financial information or the assertion to the effect that an
opinion cannot be expressed.
2.116 Audit documentation is an essential element of audit quality. Al-
though documentation alone does not guarantee audit quality, the process of
preparing sufficient and appropriate documentation contributes to the quality
of an audit.
2.117 Audit documentation is the record of audit procedures performed,
relevant audit evidence obtained, and conclusions the auditor reached. Audit
documentation, also known as working papers or workpapers, may be recorded
on paper or on electronic or other media. When transferring or copying paper
documentation to another media, the auditor should apply procedures to gen-
erate a copy that is faithful in form and content to the original paper document.
2.118 Audit documentation includes, for example, audit plans, analyses,
issues memoranda, summaries of significant findings or issues, letters of con-
firmation and representation, checklists, abstracts or copies of important doc-
uments, correspondence (including e-mail) concerning significant findings or
issues, and schedules of the work the auditor performed. Abstracts or copies of
the entity's records (for example, significant and specific contracts and agree-
ments) should be included as part of the audit documentation if they are needed
to enable an experienced auditor to understand the work performed and conclu-
sions reached. The audit documentation for a specific engagement is assembled
in an audit file.
Form, Content, and Extent of Audit Documentation
2.119 The auditor should prepare audit documentation that enables an
experienced auditor, having no previous connection to the audit, to understand
(paragraph .10 of AU section 339)
a. the nature, timing, and extent of auditing procedures performed
to comply with SASs and applicable legal and regulatory require-
ments;
b. the results of the audit procedures performed and the audit evi-
dence obtained;
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c. the conclusions reached on significant matters; and
d. that the accounting records agree or reconcile with the audited fi-
nancial statements or other audited information.
Dating of the Auditor’s Report
2.120 Paragraph .23 of AU section 339 states that the auditor's report
should not be dated earlier than the date on which the auditor has obtained suf-
ficient appropriate audit evidence to support the opinion. Among other things,
sufficient appropriate audit evidence includes evidence that the audit documen-
tation has been reviewed and that the entity's financial statements, including
disclosures, have been prepared and that management has asserted that it has
taken responsibility for them. This ordinarily will result in a report date that
is close to the date the auditor grants the entity permission to use the auditor's
report in connection with the financial statements (report release date).
2.121 AU section 339 provides additional requirements and guidance re-
lated to the following:
 Form, content, and extent of audit documentation
 Significant findings and issues
 Identification of preparer and reviewer
 Documentation of specific items tested
 Documentation of departures from statements on auditing stan-
dards
 Revisions to audit documentation after the date of the auditor's
report
 Ownership and confidentiality of audit documentation
Appendix A to AU section 339 lists the audit documentation requirements con-
tained in other areas of AICPA professional standards.
Considerations for Audits Performed in Accordance With PCAOB Stan-
dards
When performing an integrated audit of financial statements and in-
ternal control over financial reporting, PCAOB Auditing Standard
No. 3, Audit Documentation (AICPA, PCAOB Standards and Related
Rules, Auditing Standards), provides general requirements for docu-
mentation preparation and retention. Such engagements include au-
dit of financial statements, an audit of internal control over financial
reporting, and a review of interim financial information. PCAOB Au-
diting Standard No. 3 establishes requirements and provides guidance
for accounting firms to retain for seven years documentation prepared
in connection with engagements conducted pursuant to the PCAOB
standards.
PCAOB Auditing Standard No. 5 establishes requirements and pro-
vides guidance for documentation related to the audit of internal con-
trol over financial reporting in addition to the documentation require-
ments and guidance contained in PCAOB Auditing Standard No. 3.
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Subsequent Events
2.122 Paragraph .01 of AU section 560, Subsequent Events (AICPA, Profes-
sional Standards, vol. 1), states that an independent auditor's report ordinarily
is issued in connection with historical financial statements that purport to
present financial position at a stated date and results of operations and cash
flows for a period ended on that date. However, events or transactions some-
times occur subsequent to the balance-sheet date, but prior to the issuance
of the financial statements, that have a material effect on the financial state-
ments and therefore require adjustment or disclosure in the statements. These
occurrences are referred to as subsequent events.10
2.123 Paragraph .10 of AU section 560 (AICPA, Professional Standards,
vol. 1) states that there is a period after the balance-sheet date with which the
auditor must be concerned in completing various phases of his audit. This period
is known as the subsequent period and is considered to extend to the date of
the auditor's report. Its duration will depend upon the practical requirements
of each audit and may vary from a relatively short period to one of several
months. Also, all auditing procedures are not carried out at the same time
and some phases of an audit will be performed during the subsequent period,
whereas other phases will be substantially completed on or before the balance-
sheet date.
Considerations for Audits Performed in Accordance With PCAOB Stan-
dards
Paragraph .01 of AU section 560, Subsequent Events (AICPA, PCAOB
Standards and Related Rules, Interim Standards), states when per-
forming an integrated audit of financial statements and internal con-
trol over financial reporting refer to paragraphs 93–97 of PCAOB
Auditing Standard No. 5, which provide direction with respect to sub-
sequent events in an audit of internal control over financial reporting.
10 When performing audit procedures in accordance with AU section 560, Subsequent Events
(AICPA, Professional Standards, vol. 1), the auditor should understand that in May 2009, FASB issued
FASB Statement No. 165, Subsequent Events, which establishes general standards of accounting for
and disclosure of events that occur after the balance sheet date but before financial statements are
issued or are available to be issued. FASB Statement No. 165 provides that management evaluate
events or transactions occurring after the balance sheet date through the date that the financial
statements are issued or available to be issued. However, under AU section 560 the auditor considers
subsequent events through the date of the auditor's report.
FASB Statement No. 165 sets forth the following guidance for management:
1. The period after the balance sheet date during which management of a reporting
entity should evaluate events or transactions that may occur for potential recognition
or disclosure in the financial statements.
2. The circumstances under which an entity should recognize events or transactions
occurring after the balance sheet date in its financial statements.
3. The disclosures that an entity should make about events or transactions that occurred
after the balance sheet date.
FASB Statement No. 165 introduces the concept of financial statements being available to be
issued. It also requires disclosure of the date through which an entity has evaluated subsequent events
and the basis for that date (that is, whether that date represents the date the financial statements
were issued or were available for issue).
FASB Statement No. 165 is effective for interim or annual financial periods ending after June
15, 2009. For additional information, please visit the FASB Web site at www.fasb.org.
FASB Statement No. 165 has been codified in FASB ASC 855, Subsequent Events.
Additional nonauthoritative auditing and accounting guidance pertaining to subsequent events
can be found at TIS sections 8700.01–.02 in TIS section 8700, "Subsequent Events" (AICPA, Technical
Practice Aids), which was issued in September 2009.
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Communication of Matters Related to Internal Control
2.124 AU section 325A, Communicating Internal Control Related Matters
Identified in an Audit (AICPA, Professional Standards, vol. 1),* provides, among
other matters, the following requirements and guidance:
 Definitions of the terms control deficiency, significant deficiency,
and material weakness used in PCAOB Auditing Standard No. 5.
 Written communication of significant deficiencies and material
weaknesses to management and those charged with governance.
2.125 AU section 325A establishes requirements and provides guidance
on evaluating and communicating matters related to an entity's internal con-
trol over financial reporting identified during an audit of financial statements.
AU section 325A establishes requirements and provides guidance for control
deficiencies identified during the audit that upon evaluation are considered
significant deficiencies or material weaknesses be communicated in writing to
management and those charged with governance as a part of each audit, includ-
ing significant deficiencies and material weaknesses that were communicated
to management and those charged with governance in previous audits, and have
not yet been remediated. A control deficiency exists when the design or opera-
tion of a control does not allow management or employees, in the normal course
of performing their assigned functions, to prevent or detect misstatements on
a timely basis. A significant deficiency is a control deficiency, or combination
of control deficiencies, that adversely affects the entity's ability to initiate, au-
thorize, record, process, or report financial data reliably in accordance with
U.S. GAAP such that there is more than a remote likelihood that a misstate-
ment of the entity's financial statements that is more than inconsequential will
not be prevented or detected by the entity's internal control. A material weak-
ness is a significant deficiency, or combination of significant deficiencies, that
results in more than a remote likelihood that a material misstatement of the
financial statements will not be prevented or detected by the entity's internal
control. AU section 325A provides that the communication should state that it
is intended solely for the information and use of management, those charged
with governance, and others within the entity and is not intended to be and
should not be used by anyone other than these specified parties. If an entity is
required to furnish such auditor communications to a governmental authority,
specific reference to such governmental authorities may be made.
* In October 2008, the Auditing Standards Board issued SAS No. 115, Communicating Internal
Control Related Matters Identified in an Audit (AICPA, Professional Standards, vol. 1, AU sec. 325).
SAS No. 115 supersedes SAS No. 112, Communicating Internal Control Related Matters Identified in
an Audit (AICPA, Professional Standards, vol. 1, AU sec. 325A), and revises the information in AU
section 325A. SAS No. 115 was issued to eliminate differences within the AICPA's Audit and Attest
Standards resulting from the issuance of Statement on Standards for Attestation Engagements No.
15, An Examination of an Entity's Internal Control Over Financial Reporting That is Integrated With
an Audit of Its Financial Statements (AICPA, Professional Standards, vol. 1, AT sec. 501). SAS No.
115 is effective for audits of financial statements for periods ending on or after December 15, 2009.
Earlier application is permitted. Due to the issuance of SAS No. 115, extant AU section 325 has been
moved to AU section 325A of the Professional Standards until the effective date of SAS No. 115. This
guide references the "A" sections as appropriate because the changes due to SAS No. 115 have not
been incorporated into this edition of the manual.
Note: Due to the passage of time, AU section 325A is no longer available in Professional Stan-
dards. To view the last existing version of AU section 325A, see the publication AICPA Professional
Standards as of June 1, 2009 (product no. 005109).
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Considerations for Audits Performed in Accordance With PCAOB Stan-
dards
AU section 325, Communications About Control Deficiencies in an Au-
dit of Financial Statements (AICPA, PCAOB Standards and Related
Rules, Interim Standards), states when performing an integrated audit
of financial statements and internal control over financial reporting,
when evaluating whether a deficiency exists and whether deficiencies,
either individually or in combination with other deficiencies, are mate-
rial weaknesses, the auditor should follow the direction in paragraphs
62–70 of PCAOB Auditing Standard No. 5.
Communication With Those Charged With Governance
2.126 AU section 380, The Auditor's Communication With Those Charged
With Governance (AICPA, Professional Standards, vol. 1), establishes require-
ments and provides guidance on the auditor's communication with those
charged with governance in relation to an audit of financial statements. Para-
graph .05 of AU section 380 states the auditor must communicate with those
charged with governance matters related to the financial statement audit that
are, in the auditor's professional judgment, significant and relevant to the re-
sponsibilities of those charged with governance in overseeing the financial re-
porting process. The term those charged with governance is defined as the per-
son(s) with responsibility for overseeing the strategic direction of the entity
and obligations related to the accountability of the entity. AU section 380 is
applicable to all health care entities being audited under GAAS, regardless of
their governance structure or size. AU section 380 states the auditor should
communicate with those charged with governance
 the auditor's responsibilities under GAAS.
 an overview of the planned scope and timing of the audit.
 significant finding from the audit.
Although the communication can be oral, it should be in writing when, in the
auditor's judgment, oral communication would not be adequate. AU section 380
also contains information on the communication process, timing of communi-
cation, and specific examples of the types of communication. (See paragraphs
.23–.44 of AU section 380 for examples of items to be communicated). Para-
graph .40 of AU section 380 states that the auditor should communicate with
those charged with governance uncorrected misstatements and the effect that
they may have on the opinion in the auditor's report, and may request their
correction. Paragraphs .40–.41 of AU section 380 contain more information re-
lated to the communication of misstatements. AU section 380 also states that
open and constructive communication about qualitative aspects of the entity's
significant account practices may include comment of the acceptability of sig-
nificant account practices. Appendix B of AU section 380 provides guidance on
the matters that may be included in this communication. AU section 532, Re-
stricting the Use of an Auditor's Report (AICPA, Professional Standards, vol. 1),
refers to reports issued under AU section 380 paragraph .40 as by-product re-
ports, and states that the use of such reports should be restricted.
Management Representations
2.127 AU section 333 (AICPA, Professional Standards, vol. 1) establishes
a requirement that an auditor performing an audit in accordance with GAAS,
obtain written representations from management for all financial statements
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and periods covered by the auditor's report. The specific written representa-
tions to be obtained depend on the circumstances of the engagement and the
nature and basis of presentation of the financial statements. Paragraph .06 of
AU section 333 (AICPA, Professional Standards, vol. 1) lists matters ordinar-
ily included in management's representation letter, including representations
from management regarding fraud. AU section 333 (AICPA, Professional Stan-
dards, vol. 1) includes several examples as well. Paragraph .16 of AU section
333 includes an illustrative management representation letter, paragraph .17
of AU section 333 (AICPA, Professional Standards, vol. 1) provides illustrative
wording for additional representations that may be appropriate in certain sit-
uations, and paragraph .18 of AU section 333 (AICPA, Professional Standards,
vol. 1) provides an illustrative updating management representation letter.
Considerations for Audits Performed in Accordance With PCAOB Stan-
dards
Paragraph .05 of AU section 333, Management Representations
(AICPA, PCAOB Standards and Related Rules, Interim Standards),
states when performing an integrated audit of financial statements
and internal control over financial reporting, refer to paragraphs 75–
77 of PCAOB Auditing Standard No. 5 for additional required repre-
sentations to be obtained from management.
2.128 Independent auditors of health care entities also might obtain rep-
resentations, if applicable, of the following:
 The health care entity is in compliance with the provisions of Inter-
nal Revenue Code (IRC) sec. 501(c)(3) and is exempt from federal
income tax under IRC sec. 501(a), as evidenced by a determination
letter.
 Information returns have been filed on a timely basis.
 Provision has been made, when material, for estimated retroactive
adjustments by third-party payors under reimbursement agree-
ments.
 The health care entity is in compliance with bond indentures or
other debt instruments.
 Pending changes in the organizational structure, financing ar-
rangements, or other matters that could have a material effect
on the financial statements of the entity are properly disclosed.
 The health care entity is in compliance with contractual agree-
ments, grants, and donor restrictions.
 The health care entity has maintained an appropriate composition
of assets in amounts needed to comply with all donor restrictions.
 All assets and liabilities under the entity's control have been in-
cluded in the financial statements.
 The internal controls over the receipt and recording of contribu-
tions received are adequate.
 Reclassifications between net asset classes is proper.
2.129 SOP 00-1 provides the following examples of specific representations
for receivables, cost reports filed with third parties, and contingencies related
to health care third-party revenue recognition:
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 Receivables
— Adequate consideration has been given to, and appro-
priate provision made for, estimated adjustments to rev-
enue, such as for denied claims and changes to DRG as-
signments.
— Recorded valuation allowances are necessary, appropri-
ate, and properly supported.
— All peer review organizations, fiscal intermediary, and
third-party payor reports and information have been
made available.
 Cost reports filed with third parties
— All required Medicare, Medicaid, and similar reports
have been properly filed.
— Management is responsible for the accuracy and propri-
ety of all cost reports filed.
— All costs reflected on such reports are appropriate and al-
lowable under applicable reimbursement rules and regu-
lations and are patient-related and properly allocated to
applicable payors.
— The reimbursement methodologies and principles em-
ployed are in accordance with applicable rules and regu-
lations.
— Adequate consideration has been given to, and appropri-
ate provision made for, audit adjustments by intermedi-
aries, third-party payors, or other regulatory agencies.
— All items required to be disclosed, including disputed
costs that are being claimed to establish a basis for a
subsequent appeal, have been fully disclosed in the cost
report.
— Recorded third-party settlements include differences be-
tween filed (and to be filed) cost reports and calculated
settlements, which are necessary based on historical
experience or new or ambiguous regulations that may
be subject to differing interpretations. Although man-
agement believes the entity is entitled to all amounts
claimed on the cost reports, management also believes
the amounts of these differences are appropriate.
 Contingencies
— There are no violations or possible violations of laws or
regulations, such as those related to the Medicare and
Medicaid antifraud and abuse statutes, including but
not limited to the Medicare and Medicaid Anti-Kickback
Statute, Limitations on Certain Physician Referrals (the
Stark law), and the False Claims Act, in any jurisdic-
tion, whose effects should be considered for disclosure in
the financial statements or as a basis for recording a loss
contingency other than those disclosed or accrued in the
financial statements.
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— Billings to third-party payors comply in all material re-
spects with applicable coding guidelines (for example,
ICD-9-CM and CPT-4) and laws and regulations (includ-
ing those dealing with Medicare and Medicaid antifraud
and abuse), and billings reflect only charges for goods
and services that were medically necessary; properly ap-
proved by regulatory bodies (for example, the Food and
Drug Administration), if required; and properly rendered.
— There have been no communications (oral or written)
from regulatory agencies, governmental representatives,
employees, or others concerning investigations or allega-
tions of noncompliance with laws and regulations in any
jurisdiction (including those related to the Medicare and
Medicaid antifraud and abuse statutes), deficiencies in
financial reporting practices, or other matters that could
have a material adverse effect on the financial state-
ments.
2.130 Governmental health care entities only. Auditors of governmental
health care entities also should consider obtaining representations concerning
the information provided in management discussion and analysis, as provided
in paragraph .07c of AU section 558A, Required Supplementary Information
(AICPA, Professional Standards, vol. 1).
Single Audit Act and Related Audit Considerations
2.131 An independent auditor may be engaged to audit the financial state-
ments of a health care entity that expends federal awards from a governmen-
tal agency in accordance with the Single Audit Act Amendments of 1996 and
Office of Management and Budget (OMB) Circular A-133, Audits of States,
Local Governments, and Non-Profit Organizations. Federal awards may take
the form of grants, contracts, loans, loan guarantees, property, cooperative
agreements, interest subsidies, and insurance or direct appropriations.
2.132 OMB Circular A-133 prescribes policies, procedures, and guidelines
to implement the Single Audit Act Amendments of 1996 and provides require-
ments and guidance to state and local governments and not-for-profit entities
that expend total federal awards equal to or in excess of $500,000 in a fiscal
year to have an audit performed in accordance with the act and OMB Circular
A-133.
2.133 Institutions covered by OMB Circular A-133 include not-for-profit
hospitals and public hospitals and institutions of higher education, and their
affiliated hospitals, voluntary health and welfare entities and other community-
based organizations.11 Medicare payments to a nonfederal entity for providing
patient care services to Medicare eligible individuals are not considered federal
11 The Codification of Office of Management and Budget (OMB) Circular A-133, Audits of States,
Local Governments, and Non-Profit Organizations, by the U.S. Department of Health and Human
Services (HHS) also includes audit requirements for commercial entities (including for-profit hospitals)
that receive federal awards under HHS programs. Generally, the entity has 2 options regarding audits:
(1) a financial-related audit of a particular award in accordance with Government Auditing Standards,
or (2) an audit that meets the requirements of OMB Circular A-133. See Title 45 of the Code of Federal
Regulations Section 74.26(d) for further information.
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awards expended under OMB Circular A-133. Medicaid payments to a subre-
cipient for providing patient care services to Medicaid eligible individuals are
not considered federal awards expended under OMB Circular A-133 unless a
state requires the funds to be treated as federal awards expended because re-
imbursement is on a cost-reimbursement basis.
2.134 OMB Circular A-110 establishes standard requirements (such as
insurance, record retention, and banking) for obtaining consistency and unifor-
mity among federal agencies in the administration of grants to and agreements
with public and private hospitals and other entities. OMB Circular A-87, Cost
Principles for State and Local Governments, establishes principles and stan-
dards for determining allowable costs incurred by state and local governments
under grants, contracts, and other agreements. OMB Circular A-21, Cost Prin-
ciples for Educational Institutions, and OMB Circular A-122, Cost Principles
for Nonprofit Organizations, establish principles and standards for determining
allowable costs incurred by educational institutions and not-for-profit entities
under grants, contracts, and other agreements. Federal research and develop-
ment awards under grants and contracts administered by hospitals are exempt
from OMB's cost principles circulars A-87, A-21, and A-122, but are subject to
requirements provided in the U.S. Department of Health and Human Services
regulations at 45 CFR Part 74, Appendix E, "Principles for Determining Costs
Applicable to Research and Development Under Grants and Contracts with
Hospitals."
2.135 AU section 801A, Compliance Auditing Considerations in Audits
of Governmental Entities and Recipients of Governmental Financial Assistance
(AICPA, Professional Standards, vol. 1), establishes requirements and provides
guidance for audits of governmental entities and entities that receive federal
awards. AU section 801A explains the requirements of the financial audit stan-
dards contained in Government Auditing Standards (the Yellow Book), issued
by the Comptroller General of the United States and their relationship to GAAS.
It also provides general guidance on testing compliance with requirements ap-
plicable to federal awards. AU section 801A clarifies that the entity, rather than
the independent auditor, is responsible for arranging for audits that meet all
applicable requirements and provides guidance on communications the audi-
tor makes upon becoming aware that the entity may be subject to an audit
requirement that may not be satisfied by his or her engagement.
2.136 The Audit Guide Government Auditing Standards and Circular A-
133 Audits provides guidance on the auditor's responsibilities when conducting
a single audit or program-specific audit in accordance with the Single Audit Act
Amendments of 1996 and OMB Circular A-133. It discusses the auditor's re-
sponsibility for considering internal control and for performing tests of compli-
ance with applicable laws, regulations, and program compliance requirements.
Further, it provides reporting guidance including examples of the reports re-
quired by Government Auditing Standards and OMB Circular A-133. The Gov-
ernment Accountability Office (GAO) provided guidance to entities that are
subject to audits conducted in accordance with both the standards issued by the
PCAOB and Government Auditing Standards. In May 2005, the GAO posted an
Internet notice titled "Guidance on Complying with Government Auditing Stan-
dards Reporting Requirements for the Report on Internal Control for Audits
of Certain Entities Subject to the Requirements of the Sarbanes-Oxley Act of
2002 and Government Auditing Standards" at www.gao.gov/govaud/ybk01.htm.
The Internet notice states that Government Auditing Standards may be used
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in conjunction with professional standards issued by other authoritative bodies
such as the PCAOB even though those standards are not incorporated into Gov-
ernment Auditing Standards. Further information about the Internet notice is
provided in the Audit Guide Government Auditing Standards and Circular
A-133 Audits.
Statutory Reporting Considerations for Managed
Care Organizations
Risk-Based Capital Requirements
2.137 Many managed care organizations (MCO) that bear financial risk
are regulated by state departments of insurance. The risk-based capital (RBC)
formula is one of the tools used by regulators to evaluate the financial health
of regulated entities.
2.138 The National Association of Insurance Commissioners (NAIC) for-
mula for the RBC of managed care organizations became effective in the filing
of 1998 annual statements. Five principal risk elements to the MCO RBC for-
mula are: affiliated investment risk, asset risk, underwriting risk, credit risk,
and general business risk. Four action levels (in order of increasingly stringent
level of regulatory response) are: company action level, regulatory action level,
authorized control level, and mandatory control level. At a minimum, the com-
pany action-level event requires the filing with the respective state insurance
commissioner an RBC plan detailing conditions leading to the event and pro-
posals of corrective action. State laws vary as to whether applicable legislation
pertaining to compliance with the RBC formula has been passed. Additional
information can be found on the NAIC Web site at www.naic.org.
Codification of Statutory Accounting Practices for Managed
Care Organizations
2.139 Generally speaking, regulated insurers have been required by their
state of domicile to submit annually a set of audited financial statements that
were prepared using that state's prescribed or permitted statutory account-
ing practices. These statutory accounting practices are considered to be an
other comprehensive basis of accounting under AU section 623, Special Reports
(AICPA, Professional Standards, vol. 1). Interpretation No. 12, "Evaluation
of the Appropriateness of Informative Disclosures in Insurance Enterprises'
Financial Statements Prepared on a Statutory Basis," of AU section 623
(AICPA, Professional Standards, vol. 1, AU sec. 9623 par. .60–.77), establishes
requirements and provides guidance in evaluating the adequacy and appro-
priateness of informative disclosures in financial statements prepared on a
statutory basis.
2.140 In 1999, the NAIC completed a process to codify statutory account-
ing practices for certain insurance entities (including regulated MCO), resulting
in a revised Accounting Practices and Procedures Manual effective January 1,
2001 (the revised manual). This manual has also been updated on an annual
basis and a new Accounting Practices and Procedure Manual reflecting revi-
sions or additions to statutory accounting principles is published in March of
each year. It is expected that most states will require insurers to comply with
most, if not all, provisions of the manual. States may adopt the manual in
whole, or in part, as an element of prescribed statutory accounting practices in
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those states. If, however, the requirements of state laws, regulations, and ad-
ministrative rules differ from guidance provided in the manual or those state
laws, regulations, and administrative rules will take precedence. Preparers of
financial statements and auditors should monitor the status of the adoption of
the manual by the domiciliary state insurance regulatory authority.
2.141 Practitioners should consider whether going-concern issues exist as
a result of the financial statement effect of adoption. This includes consideration
of the effect on RBC.
2.142 Nine of the Statements of Statutory Accounting Principles (SSAPs)
included in the revised manual have been specifically modified or written to
address issues related to managed care. These include SSAPs No. 25, Account-
ing for and Disclosures about Transactions with Affiliates and Other Related
Parties, No. 35, Guaranty Fund and Other Assessments, No. 47, Uninsured
Plans, No. 50, Classifications and Definitions of Insurance or Managed Care
Contracts in Force, No. 54, Individual and Group Accident and Health Con-
tracts, No. 55, Unpaid Claims, Losses and Loss Adjustment Expenses, No. 66,
Retrospectively Rated Contracts, No. 73, Health Care Delivery Assets-Supplies,
Pharmaceuticals and Surgical Supplies, Durable Medical Equipment, Furni-
ture, Medical Equipment and Fixtures, and Leasehold Improvements in Health
Care Facilities, and No. 84, Certain Health Care Receivables and Receivables
Under Government Insured Plans. All other SSAPs will apply if applicable to
the entity.
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Chapter 3
Cash and Cash Equivalents
Accounting and Financial Reporting
3.01 Cash and cash equivalents should include all cash and short term
highly liquid investments that have both of the following characteristics: (a)
readily convertible to known amounts of cash and (b) so near to maturity that
they present insignificant risk of changes in value because of changes in inter-
est rates, in accordance with the Financial Accounting Standards Board (FASB)
Accounting Standards Codification (ASC) glossary and paragraph 9 of Govern-
mental Accounting Standards Board (GASB) Statement No. 9, Reporting Cash
Flows of Proprietary and Nonexpendable Trust Funds and Governmental En-
tities That Use Proprietary Fund Accounting. FASB ASC 954-305-45-1 states
that cash and claims to cash that meet any of the following conditions should
be reported separately and should be excluded from current assets: (a) they
are restricted as to withdrawal or use for other than current operations, (b)
they are designated for expenditure in the acquisition or construction of non-
current assets, (c) they are required to be segregated for the liquidation of long
term debts, or (d) they are required by a donor-imposed restriction that limits
their use to long term purposes. See paragraph 10.19.) According to FASB ASC
954-210-45-4, internally designated funds should be reported separately from
externally designated funds either on the face of the balance sheet or in the
notes to the financial statements.
3.02 According to FASB ASC 954-210-50-2, when designated funds are
reported separately, if the form of the assets is not evident from the description
on the balance sheet, the form of the assets should be disclosed in the notes to
the financial statements.
3.03 For example, FASB ASC 958-210-45-6 states that the kind of asset
whose use is limited should be described in the notes to the financial state-
ments if its nature is not clear from the description on the face of the state-
ment of financial position. FASB ASC 954-305-45-3 states that for fiduciary
purposes, not-for-profit business-oriented health care entities may maintain
separate checking or savings accounts for restricted donations. Such accounts,
however, unless required by FASB ASC 954-305-45-1, are not reported on a
line separate from other cash and cash equivalents because donor restrictions
generally relate to limitations on the use of net assets rather than on the use
of specific assets. A columnar presentation that highlights the three classes of
net assets (that is, permanently restricted, temporarily restricted, and unre-
stricted) is not precluded if the totals for the reporting entity as a whole are
displayed.
3.04 GASB Statement No. 9 paragraph 8 provides that a governmental
health care enterprise's statement of cash flows should explain the change
in all cash and cash equivalents, regardless of any restrictions on their use.
For governmental health care entities, restricted cash and cash equivalents
should be reported when restrictions on the use of those assets change the
nature or normal understanding of those assets, as discussed in GASB State-
ment No. 34, Basic Financial Statements—and Management's Discussion and
Analysis—for State and Local Governments, paragraph 99. For example, cash
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and investments that can only be used to pay debt principal and interest would
be reported as restricted cash and investments or as cash and investments held
by trustee for debt service. The term restricted is defined by GASB Statement
No. 34 paragraphs 34, as amended, and 99. A restriction is a constraint placed
on the use of assets or net assets that is either externally imposed (such as
by creditors through debt covenants) or imposed by law through constitutional
provisions or enabling legislation.
3.05 Paragraphs 20–21 of FASB ASC 825-10-50 require an entity to dis-
close all significant concentrations of credit risk arising from all financial in-
struments. Cash is included in the FASB ASC glossary definition of financial
instrument.
3.06 Examples of potential exposure to credit risk include funds deposited
with a single financial institution in excess of Federal Deposit Insurance Corpo-
ration limits and investments in obligations that are not insured or guaranteed
by the government.
3.07 Governmental health care entities only. For governmental health
care entities, GASB Statement No. 3, Deposits with Financial Institutions, In-
vestments (including Repurchase Agreements), and Reverse Repurchase Agree-
ments, as amended, requires certain disclosures about deposits, including de-
posits exposed to custodial credit risk.*
Auditing
3.08 There are no unique auditing considerations with respect to cash and
cash equivalents recorded by health care entities.
* In June 2008, the Governmental Accounting Standards Board (GASB) issued GASB Statement
No. 53, Accounting and Financial Reporting for Derivative Instruments, which established require-
ments regarding recognition, measurement, and disclosure of information related to derivative trans-
actions. GASB Statement No. 53 defines derivatives in a similar way as GASB Technical Bulletin No.
2003-1, Disclosure Requirements for Derivatives Not Reported at Fair Value on the Statement of Net As-
sets. GASB Statement No. 53 requires governmental entities to report most derivatives or derivative
instruments at their fair value as either assets or liabilities in the statement of net assets. However,
this requirement does not apply to derivatives of governmental funds reported in the governmental
fund statements. Generally, changes in fair value are reported in the flow of resources statements
(that is, statement of activities, statement of revenues, expenses, changes in net assets, and so on) as
investment gains or losses. Annual changes in the fair value of hedging derivative instruments, how-
ever, are reported as deferred inflows or deferred outflows until there is a termination event. GASB
Statement No. 53 is effective for fiscal periods beginning after June 15, 2009. Early implementation
is encouraged.
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Chapter 4
Investments1
Accounting
4.01 This chapter discusses the accounting and reporting for investments
of health care entities other than (a) equity investments accounted for under
the equity method or (b) investments in consolidated subsidiaries. Discussions
pertaining to those 2 types of investments are included in chapter 11. In some
cases, nongovernmental health care entities may transfer assets to a not-for-
profit entity (such as a community foundation or a financially interrelated en-
tity) or a trust for investment and management. Paragraphs 4.53–.55 discuss
a nongovernmental health care entity's reporting of investments held on its
behalf by unrelated foundations and trusts or by related entities that are not
financially interrelated. Paragraphs 11.39–.42 and 11.49–.55 discuss the re-
porting by a nongovernmental health care entity of investments held on its
behalf by financially interrelated entities.
4.02 The accounting for investments in equity securities that have readily
determinable fair values2 and all investments in debt securities is discussed in
paragraphs 4.03–.17.
4.03 According to Financial Accounting Standards Board (FASB) Account-
ing Standards Codification (ASC) 954-325-35-1, other types of investments that
are not financial instruments (such as real estate or certain oil and gas interests)
are reported at amortized cost and are subject to impairment considerations
consistent with the "Impairment or Disposal of Long-Lived Assets" subsections
of FASB ASC 360-10.3
4.04 Paragraphs 4.18–.52 discuss the guidance for nongovernmental enti-
ties about other-than-temporary impairment of investments and its application
to certain debt and equity securities.
1 Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 820,
Fair Value Measurements and Disclosures, defines fair value, establishes a framework for measur-
ing fair value in generally accepted accounting principles, and expands disclosures about fair value
measurements. Refer to the discussion in chapter 1.
2 The "Fair Value Option" subsections of FASB ASC 825-10 permit all entities, including not-for-
profit entities, to choose to measure eligible items at fair value at specified election dates. Refer to the
discussion in chapter 1.
3 Governmental health care entities only. This pronouncement is not applicable to govern-
mental health care entities that do not apply paragraph 7 of Governmental Accounting Stan-
dards Board (GASB) Statement No. 20, Accounting and Financial Reporting for Proprietary Funds
and Other Governmental Entities That Use Proprietary Fund Accounting. (See footnote 1 in
chapter 1.)
AAG-HCO 4.04
P1: G.Shankar
ACPA125-04 ACPA125.cls February 25, 2010 15:44
82 Health Care Entities
Investments in Debt Securities and Certain
Equity Securities
4.05 This section discusses the accounting and reporting for investments
in equity securities that have readily determinable fair values and all in-
vestments in debt securities held by (a) investor-owned entities, (b) not-for-
profit entities, and (c) governmental entities. Guidance for nongovernmen-
tal entities for impairment of certain investments is discussed in paragraphs
4.18–.52.
Investor-Owned Entities
4.06 Investor-owned providers are subject to the accounting and report-
ing requirements of FASB ASC 320, Investments—Debt and Equity Securities.
FASB ASC 320-10-25-1 states that at acquisition, an entity should classify its
debt and equity securities into one of 3 categories: trading, available for sale,
and held to maturity. Investments in debt securities should be classified as
held-to-maturity only if the reporting entity has the positive intent and ability
to hold those securities to maturity. According to FASB ASC 320-10-35-1, in-
vestments in debt securities classified as held to maturity should be measured
subsequently at amortized cost in the statement of financial position. FASB
ASC 320-10-25-1 states that a security that is acquired with the intent of sell-
ing it within hours or days should be classified as trading, although at acquisi-
tion an entity is not precluded from classifying as trading a security it plans to
hold for a longer period. According to FASB ASC 320-10-35-1, trading securities
that have readily determinable fair values should be measured subsequently at
fair value in the statement of financial position, and unrealized holding gains
and losses for trading securities should be included in earnings. FASB ASC
320-10-25-1 states that investments in debt securities and equity securities
that have readily determinable fair values not classified as trading securities
or as held-to-maturity securities should be classified as available-for-sale se-
curities. According to FASB ASC 320-10-35-1, available-for-sale securities that
have readily determinable fair values should be measured subsequently at fair
value in the statement of financial position, and unrealized holding gains and
losses for available-for-sale securities (including those classified as current as-
sets) excluded from earnings and reported in other comprehensive income until
realized, except as indicated in the following sentence. All or a portion of the
unrealized holding gain and loss of an available-for-sale security that is desig-
nated as being hedged in a fair value hedge should be recognized in earnings
during the period of the hedge, pursuant to paragraphs 1–4 of FASB ASC 815-
25-35.
4.07 Investor-owned entities should follow the disclosure requirements
of FASB ASC 320-10-50, which according to "Pending Content" in FASB ASC
320-10-50-1A, are required for all interim and annual periods.
Not-for-Profit Entities
4.08 Not-for-profit entities should report investments in equity securities
with readily determinable fair values and all investments in debt securities at
fair value on the balance sheet consistent with FASB ASC 958-320-35-1. FASB
ASC 958-320 does not apply to investments in derivative instruments that
are subject to the requirements of FASB ASC 815, Derivatives and Hedging.
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FASB ASC 815 establishes accounting and reporting standards for derivative
instruments,*,† including certain derivative instruments embedded in other
contracts, and for hedging activities.‡,||
* In March 2008, FASB issued FASB Statement No. 161, Disclosures about Derivative Instru-
ments and Hedging Activities—an amendment of FASB Statement No. 133. This statement requires
enhanced disclosures about (i) how and why an entity uses derivative instruments; (ii) how derivative
instruments and related hedged items are accounted for under FASB Statement No. 133, Account-
ing for Derivative Instruments and Hedging Activities, and its related interpretations; and (iii) how
derivative instruments and related hedged items affect an entity's financial position, financial per-
formance, and cash flows. To meet these objectives, FASB Statement No. 161 requires qualitative
disclosures about objectives and strategies for using derivatives; quantitative disclosures about fair
value amounts of, and gains and losses on, derivative instruments; and disclosures about credit-
risk-related contingent features in derivative agreements. These further disclosures are intended to
improve the transparency of financial reporting.
FASB Statement No. 161 is effective for fiscal years and interim periods beginning after Novem-
ber 15, 2008. Early adoption is encouraged. FASB Statement No. 161 encourages, but does not require,
comparative disclosures for earlier periods at initial adoption. FASB Statement No. 161 applies to all
entities and derivative instruments, including bifurcated derivative instruments and related hedge
items accounted for under FASB Statement No. 133 and its related interpretations.
This guidance is located in FASB ASC 815-10-50 and is labeled as "Pending Content" due to
the transition and open effective date information discussed in FASB ASC 815-10-65-1. For more
information on FASB ASC, please see the notice to readers in this guide.
† In June 2008, FASB issued Emerging Issues Task Force (EITF) Issue No. 07-5, "Determining
Whether an Instrument (or Embedded Feature) Is Indexed to an Entity's Own Stock." The objective
of EITF Issue No. 07-5 is to provide guidance for determining whether an equity-linked financial
instrument (or embedded feature) is indexed to an entity's own stock and it applies to any freestanding
financial instrument or embedded feature that has all the characteristics of a derivative in paragraphs
6-9 of FASB Statement No. 133. It also applies to any freestanding financial instrument that is
potentially settled in an entity's own stock.
EITF Issue No. 07-5 is effective for financial statements issued for fiscal years beginning after
December 15, 2008, and interim periods within those fiscal years. Earlier application by an entity
that has previously adopted an alternative accounting policy is not permitted.
This guidance is located in FASB ASC 718-10-60-1B and sections 15, 20, and 55 of FASB ASC 815-
40-15 and is labeled as "Pending Content" due to the transition and open effective date information
discussed in FASB ASC 815-10-65-3. For more information on FASB ASC, please see the notice to
readers in this guide.
‡ In November 2008, FASB issued EITF Issue No. 08-8, "Accounting for an Instrument (or an
Embedded Feature) with a Settlement Amount That Is Based on the Stock of an Entity's Consolidated
Subsidiary." EITF Issue No. 08-8 clarifies whether a financial instrument for which the payoff to the
counterparty is based, in whole or in part, on the stock of an entity's consolidated subsidiary is indexed
to the reporting entity's own stock and therefore should not be precluded from qualifying for the first
part of the scope exception in paragraph 11(a) of FASB Statement No. 133, or from being within
the scope of EITF Issue No. 00-19, "Accounting for Derivative Financial Instruments Indexed to,
and Potentially Settled in, a Company's Own Stock." EITF Issue No. 08-8 is effective for fiscal years
beginning on or after December 15, 2008, and interim periods within those fiscal years. Early adoption
is not permitted.
This guidance is located primarily in sections 5, 25, 35, 40, and 45 of FASB ASC 810-10 and
sections 10 and 40 of FASB ASC 815, Derivatives and Hedging, some of which is labeled as "Pending
Content" due to the transition and open effective date information discussed in FASB ASC 815-10-
65-4. For more information on FASB ASC, please see the notice to readers in this guide.
|| In September 2008, FASB issued FASB Staff Position (FSP) FAS 133-1 and FIN 45-4, Disclo-
sures about Credit Derivatives and Certain Guarantees; An Amendment of FASB Statement No. 133
and FASB Interpretation No. 45; and Clarification of the Effective Date of FASB Statement No. 161.
The provisions of this FSP that amend FASB Statement No. 133 and FASB Interpretation No. 45,
Guarantor's Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees
of Indebtedness of Others—an interpretation of FASB Statements No. 5, 57, and 107 and rescission
of FASB Interpretation No. 34, should be effective for reporting periods (annual or interim) ending
after November 15, 2008. This FSP encourages that the amendments to FASB Statement No. 133 and
FASB Interpretation No. 45 be applied in periods earlier than the effective date to facilitate compar-
isons at initial adoption. In periods after initial adoption, this FSP requires comparative disclosures
only for periods ending subsequent to initial adoption. This FSP amends FASB Interpretation No. 45
to require an additional disclosure about the current status of the payment or performance risk of a
guarantee.
This guidance is located in FASB ASC 460-10-50-4 and is labeled as "Pending Content" due
to the transition and open effective date information discussed in FASB ASC 815-10-65-2. For more
information on FASB ASC, please see the notice to readers in this guide.
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4.09 According to FASB ASC 954-320-45-1, investment return (including
realized and unrealized gains and losses) not restricted by donors or by law
should be classified as changes in unrestricted net assets as follows:
a. Included in the performance indicator (see paragraphs 10.36–.38)
are
i. dividend, interest, and other similar investment income
ii. realized gains and losses
iii. unrealized gains and losses on trading securities, as de-
fined in FASB ASC 320
iv. other than temporary impairment losses4
b. Excluded from the performance indicator are
i. unrealized gains and losses on other than trading securi-
ties
4.10 Pursuant to paragraphs 1–2 of FASB ASC 958-320-45, except as
described in paragraphs 4.11–.14, dividend, interest, and other investment in-
come and gains and losses should be reported as increases or decreases in un-
restricted net assets unless their use is temporarily or permanently restricted
by explicit donor stipulations or by law. Donor-restricted investment income
should be reported as an increase in temporarily or permanently restricted net
assets, depending on the type of restriction.
4.11 FASB ASC 958-320-45-3 states that gains and investment income
that are limited to specific uses by donor-imposed restrictions may be reported
as increases in unrestricted net assets if the restrictions are met in the same
reporting period as the gains and income are recognized, provided that the not-
for-profit entity has a similar policy for reporting contributions received (see
paragraphs 3–5 of FASB ASC 958-605-45), reports consistently from period to
period, and discloses its accounting policy.
4.12 FASB ASC 958-205-45-22 states that in the absence of donor stipu-
lations or law to the contrary, losses on the investments of a donor-restricted
endowment fund5 should reduce temporarily restricted net assets to the ex-
tent that donor-imposed temporary restrictions on net appreciation of the fund
have not been met before the loss occurs. Any remaining loss should reduce
4 FASB ASC 954-320-35-1 states that investors that report a performance indicator as defined
in FASB ASC 954-205 should refer to FASB ASC 320-10, FASB ASC 325-20, and FASB ASC 958-325
when determining impairment and evaluating whether the impairment is other than temporary.
5 In August 2008, FASB issued FSP FAS 117-1, Endowments of Not-for-Profit Organizations:
Net Asset Classification of Funds Subject to an Enacted Version of the Uniform Prudent Management
of Institutional Funds Act, and Enhanced Disclosures for All Endowment Funds. FSP FAS 117-1 is
effective for fiscal years ending after December 15, 2008. Earlier application is permitted provided
that annual financial statements for that fiscal year have not been previously issued. FSP FAS 117-1
provides guidance on the net asset classification of donor-restricted endowment funds for a not-for-
profit entity that is subject to an enacted version of the Uniform Prudent Management of Institutional
Funds Act of 2006 (UPMIFA). The FSP also improves disclosures about a not-for-profit entity's en-
dowment funds (both donor-restricted endowment funds and board-designated endowment funds),
whether or not the not-for-profit entity is subject to an enacted version of UPMIFA. Paragraphs 16–17
of the FSP discuss the display of the reclassification upon implementation of the guidance and the
reinstatement of purpose restrictions on unappropriated net appreciation if the not-for-profit entity
is subject to an enacted version of UPMIFA.
FSP FAS 117-1 is located primarily in sections 45, 50, and 55 of FASB ASC 958-205 and is
labeled as "Pending Content" due to the transition and open effective date information discussed in
FASB ASC 958-205-65-1. For more information on FASB ASC, please see the notice to readers in this
guide.
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unrestricted net assets. FASB ASC 958-205-45-24 states that if losses reduce
the assets of a donor-restricted endowment fund below the level required by
the donor stipulations or law, gains that restore the fair value of the assets
of the endowment fund to the required level should be classified as increases
in unrestricted net assets.
4.13 In applying the guidance in paragraph 4.10, FASB ASC 958-205-45-
33 indicates it is generally understood that at least the amount of the orig-
inal gift(s) and any required accumulations of a donor-restricted endowment
fund are not expendable, although the value of the investments purchased may
occasionally fall below that amount. Future appreciation of the investments
generally restores the value to the required level. In states that have enacted
its provisions, the Uniform Prudent Management of Institutional Funds Act of
2006 describes historic dollar value as the amount that is not expendable.
4.14 If the guidance in paragraph 4.11 requires the classification of gains
and investment income in unrestricted net assets, the presentation should be
consistent with paragraph 4.09. If the guidance in paragraph 4.12 requires the
classification of investment losses as a reduction of unrestricted net assets, the
losses should be excluded from the determination of the performance indicator.
If losses reduce the assets of a donor-restricted endowment fund below the level
required by the donor stipulations or law, gains that restore the fair value of
the assets of the endowment fund to the required level should be excluded from
the determination of the performance indicator. See chapter 9 of this guide for
additional discussion on the reporting of net assets (equity).
4.15 Not-for-profit health care entities should follow the disclosure re-
quirements of FASB ASC 958-320-50.
Governmental Entities
4.16 Governmental health care entities are subject to the accounting and
reporting requirements of Governmental Accounting Standards Board (GASB)
Statement No. 31, Accounting and Financial Reporting for Certain Investments
and for External Investment Pools. Governmental health care entities should
report investments in (a) participating interest-earning investment contracts,
(b) external investment pools, (c) open-ended mutual funds, (d) debt securi-
ties, and (e) equity securities, option contracts, stock warrants, and stock rights
that have readily determinable fair values at fair value on the balance sheet.
Governmental entities are permitted to report certain money market invest-
ments and participating interest-earning investment contracts at amortized
cost, provided that the investment has a remaining maturity of one year or less
at time of purchase. All investment income, including changes in the fair value
of investments, shall be recognized as revenue in the statement of revenues, ex-
penses, and changes in net assets or equity, or both. Governmental health care
entities are required to distinguish between operating revenues and expenses
and nonoperating revenues and expenses. (See further discussion in paragraph
10.42 of this guide.) Governmental health care entities should follow the dis-
closure requirements of GASB Statement No. 31. Also, GASB Statement No.
34, Basic Financial Statements—and Management's Discussion and Analysis—
for State and Local Governments, paragraph 121 requires that governmental
health care entities that receive donor-restricted endowments make certain dis-
closures about their use of investment income generated by those endowments.
4.17 GASB Statements No. 3, Deposits with Financial Institutions,
Investments (Including Repurchase Agreements), and Reverse Repurchase
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Agreements, No. 28, Accounting and Financial Reporting for Securities Lend-
ing Transactions, and No. 40, Deposit and Investment Risk Disclosures—an
amendment of GASB Statement No. 3, and GASB Interpretation No. 3, Finan-
cial Reporting for Reverse Repurchase Agreements—an interpretation of GASB
Statement No. 3, provide guidance on investment-related disclosures required
by governmental entities as well as accounting for securities lending and re-
verse repurchase agreements.#
Impairment of Investments**
4.18 Paragraphs 17–43 of FASB ASC 320-10-35 provide guidance for non-
governmental entities about the meaning of other-than-temporary impairment
and its application to certain debt and equity securities. FASB ASC 320-10-35-
17 states that the guidance is applicable for investments in:
 debt and equity securities that are within the scope of FASB ASC
320-10 and FASB ASC 958, Not-for-Profit Entities (applicable to
not-for-profit health care entities in the scope of this guide that
report a performance indicator).
 equity securities that are not subject to the scope of FASB ASC
320-10 and FASB ASC 958 and not accounted for under the equity
# In June 2008, GASB issued GASB Statement No. 53, Accounting and Financial Reporting for
Derivative Instruments, which established requirements regarding recognition, measurement, and
disclosure of information related to derivative transactions. GASB Statement No. 53 defines deriva-
tives in a similar way as GASB Technical Bulletin No. 2003-1, Disclosure Requirements for Derivatives
Not Reported at Fair Value on the Statement of Net Assets. GASB Statement No. 53 requires govern-
mental entities to report most derivatives or derivative instruments at their fair value as either assets
or liabilities in the statement of net assets. However, this requirement does not apply to derivatives of
governmental funds reported in the governmental fund statements. Generally, changes in fair value
are reported in the flow of resources statements (that is, statement of activities, statement of revenues,
expenses, changes in net assets, and so on) as investment gains or losses. Annual changes in the fair
value of hedging derivative instruments, however, are reported as deferred inflows or deferred outflows
until there is a termination event. GASB Statement No. 53 is effective for fiscal periods beginning
after June 15, 2009. Early implementation is encouraged.
** On April 9, 2009, FSP FAS 115-2 and FAS 124-2, Recognition and Presentation of Other-
Than-Temporary Impairments, was issued to bring greater consistency to the timing of impairment
recognition and to provide greater clarity to investors about the credit and noncredit components of
impaired debt securities that are not expected to be sold.
The FSP is effective for interim and annual reporting periods ending after June 15, 2009, with
early adoption permitted for periods ending after March 15, 2009. Earlier adoption for periods ending
before March 15, 2009, is not permitted. The provisions of this guidance have been incorporated into
this edition of the guide.
This FSP includes amendments to FASB Statement No. 115, Accounting for Certain Invest-
ments in Debt and Equity Securities, and FSP FAS 115-1 and FAS 124-1, The Meaning of Other-
Than-Temporary Impairment and Its Application to Certain Investments, and conforming changes to
other standards, including EITF Issue No. 99-20, "Recognition of Interest Income and Impairment on
Purchased Beneficial Interests and Beneficial Interests That Continue to Be Held by a Transferor in
Securitized Financial Assets," and AICPA Statement of Position 03-3, Accounting for Certain Loans
or Debt Securities Acquired in a Transfer (AICPA, Technical Practice Aids, ACC sec. 10,880).
Entities should apply the guidance in FSP FAS 115-2 and FAS 124-2 to determine whether the
decline in fair value is other than temporary and how an other-than-temporary impairment should be
recognized. When an other-than-temporary impairment has occurred, FSP FAS 115-2 and FAS 124-2
states that the amount of the other-than-temporary impairment recognized in earnings depends on
whether an investor intends to sell the debt security or more likely than not will be required to sell
the security before recovery of its amortized cost basis less any current-period credit loss. This FSP
does not amend existing recognition and measurement guidance related to other-than-temporary im-
pairments of equity securities. Readers are encouraged to visit the FASB Web site for the full text of
this FSP and to monitor additional developments regarding this topic.
This guidance is located in FASB ASC 320-10 and is labeled as "Pending Content" due to the tran-
sition and open effective date information discussed in FASB ASC 820-10-65-1. For more information
on FASB ASC, please see the notice to readers in this guide.
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method pursuant to FASB ASC 323, Investments—Equity Method
and Joint Ventures, referred to as cost-method investments.
4.19 According to FASB ASC 320-10-35-20, impairment should be assessed
at the individual security level (referred to as an investment). Individual secu-
rity level means the level and method of aggregation used by the reporting
entity to measure realized and unrealized gains and losses on its debt and eq-
uity securities. FASB ASC 320-10-35-21 states that an investment is impaired
if the fair value of the investment is less than its cost.
4.20 As explained in FASB ASC 320-10-35-25, because the fair value of
cost-method investments is not readily determinable, the evaluation of whether
an investment is impaired should be determined as follows.
a. If an entity has estimated the fair value of a cost-method invest-
ment (for example, for disclosure under FASB ASC 825-10-50),††
that estimate should be used to determine if the investment is im-
paired for the reporting periods in which the entity estimates fair
value.
b. For reporting periods in which an entity has not estimated the
fair value of a cost-method investment, the entity should evalu-
ate whether an event or change in circumstances has occurred in
that period that may have a significant adverse effect on the fair
value of the investment (an impairment indicator). According to
FASB ASC 320-10-35-29, if an impairment indicator is present, the
entity should estimate the fair value of the investment. ("Pending
Content" in FASB ASC 320-10-35-26 explains that an entity may
not estimate the fair value of a cost-method investment during a
reporting period for FASB ASC 825-10-50 disclosure for any of sev-
eral reasons, including that the entity is exempt from providing the
disclosures.)
FASB ASC 320-10-35-28 states that in addition, if an investment was previously
tested for impairment (pursuant to the guidance in paragraphs 30–33I of FASB
ASC 320-10-35, as discussed further in paragraphs 4.21–.33), and the entity
concluded that the investment was not other-than-temporarily impaired, the
entity should continue to evaluate whether the investment is impaired (that is,
†† FSP FAS 107-1 and APB 28-1, Interim Disclosures about Fair Value of Financial Instruments,
was issued on April 9, 2009. FSP FAS 107-1 and APB 28-1 amends FASB Statement No. 107, Disclo-
sures about Fair Value of Financial Instruments, which is codified in FASB ASC 825-10-50, to require
disclosures about fair value of financial instruments for interim reporting periods of publicly traded
companies as well as in annual financial statements. This FSP also amends Accounting Principles
Board Opinion No. 28, Interim Financial Reporting, which is primarily codified in FASB ASC 270-10,
to require those disclosures in summarized financial information at interim reporting periods.
This FSP is effective for interim reporting periods ending after June 15, 2009, with early adop-
tion permitted for periods ending after March 15, 2009. An entity may early adopt this FSP only if
it also elects to early adopt FSP FAS 157-4, Determining Fair Value When the Volume and Level of
Activity for the Asset or Liability Have Significantly Decreased and Identifying Transactions That Are
Not Orderly, and FSP FAS 115-2 and FAS 124-2. The provisions of this guidance have been incorpo-
rated into this edition of the guide.
This FSP does not require disclosures for earlier periods presented for comparative purposes at
initial adoption. In periods after initial adoption, this FSP requires comparative disclosures only for
periods ending after initial adoption.
This guidance is located primarily in FASB ASC 825-10-50 and is labeled as "Pending Content"
due to the transition and open effective date information discussed in FASB ASC 825-10-65-1. For
more information on FASB ASC, please see the notice to readers in this guide.
See paragraphs 1.119–.122 of this guide for additional discussion regarding fair value disclosures
of financial instruments.
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should estimate the fair value of the investment) in each subsequent reporting
period until either of the following occurs: (a) the investment experiences a
recovery of fair value up to (or beyond) its cost or (b) the entity recognizes an
other-than-temporary impairment loss.
4.21 "Pending Content" in the FASB ASC glossary defines amortized cost
basis as the amount at which an investment is acquired, adjusted for accretion,
amortization, collection of cash, previous other-than-temporary impairments
recognized in earnings (less any cumulative effect adjustments), foreign ex-
change, and fair value hedge accounting adjustments. "Pending Content" in
FASB ASC 320-10-35-30 states that if the fair value of an investment is less
than its amortized cost basis at the balance sheet date of the reporting period
for which impairment is assessed, the impairment is either temporary or other
than temporary. An entity should apply guidance in FASB ASC 320-10-35 and
other guidance that is pertinent to the determination of whether an impair-
ment is other than temporary, such as the guidance in FASB ASC 325-40-35,
as applicable. (Other than temporary does not mean permanent.)
4.22 Other guidance that is pertinent to the determination of whether an
impairment is other than temporary includes Securities and Exchange Com-
mission (SEC) Staff Accounting Bulletin Topic 5M, Other Than Temporary Im-
pairment of Certain Investments in Debt and Equity Securities, paragraphs 1A
and 2 of FASB ASC 325-20-35, and FASB ASC 325-40.‡‡
4.23 "Pending Content" in FASB ASC 320-10-35-32A states that for equity
securities, an entity should apply guidance that is pertinent to the determina-
tion of whether an impairment is other than temporary, such as FASB ASC
325-40-35.
4.24 In applying that guidance, "Pending Content" in FASB ASC 320-10-
35-33 states that an entity should recognize an impairment loss when the im-
pairment is deemed other than temporary even if a decision to sell has not been
made. Questions sometimes arise about whether an entity should recognize an
other-than-temporary impairment only when it intends to sell a specifically
identified available-for-sale security at a loss shortly after the balance sheet
date. When an entity has decided to sell an impaired available-for-sale security
and the entity does not expect the fair value of the security to fully recover
before the expected time of sale, the security should be deemed other-than-
temporarily impaired in the period in which the decision to sell is made, not in
the period in which the sale occurs.
4.25 The FASB ASC glossary defines debt security as any security rep-
resenting a creditor relationship with an entity. The FASB ASC glossary also
provides examples of debt securities. According to "Pending Content" in FASB
‡‡ In January 2009, FASB issued FSP EITF 99-20-1, Amendments to the Impairment Guidance of
EITF Issue No. 99-20. FSP EITF 99-20-1 amends the impairment guidance in EITF Issue No. 99-20,
which is primarily codified at FASB ASC 325-40, to achieve more consistent determination of whether
an other-than-temporary impairment has occurred. The FSP also retains and emphasizes the objective
of an other-than-temporary impairment assessment and the related disclosure requirements in FASB
Statement No. 115 and other related guidance.
FSP EITF 99-20-1 is effective for interim and annual reporting periods ending after December
15, 2008, and should be applied prospectively. Retrospective application to a prior interim or annual
reporting period is not permitted. The provisions of this guidance have been incorporated into this
edition of the guide.
This guidance is located in FASB ASC 325-40-35 and 820-10-55-59F and is labeled as "Pending
Content" due to the transition and open effective date information discussed in FASB ASC 325-40-
65-1. For more information on FASB ASC, please see the notice to readers in this guide.
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ASC 320-10-35-33A, if an entity intends to sell the debt security (that is, it has
decided to sell the security), an other-than-temporary impairment should be
considered to have occurred.
4.26 According to "Pending Content" in FASB ASC 320-10-33B, if an entity
does not intend to sell the debt security, the entity should consider available
evidence to assess whether it more likely than not will be required to sell the
security before the recovery of its amortized cost basis (for example, whether
its cash or working capital requirements or contractual or regulatory obliga-
tions indicate that the security will be required to be sold before a forecasted
recovery occurs). If the entity more likely than not will be required to sell the
security before recovery of its amortized cost basis, an other-than-temporary
impairment should be considered to have occurred.
4.27 "Pending Content" in FASB ASC 320-10-35-33C states that if an
entity does not expect to recover the entire amortized cost basis of the security,
the entity would be unable to assert that it will recover its amortized cost basis
even if it does not intend to sell the security. Therefore, in those situations,
an other-than-temporary impairment should be considered to have occurred.
In assessing whether the entire amortized cost basis of the security will be
recovered, an entity should compare the present value of cash flows expected to
be collected from the security with the amortized cost basis of the security. If the
present value of cash flows expected to be collected is less than the amortized
cost basis of the security, the entire amortized cost basis of the security will
not be recovered (that is, a credit loss exists), and an other-than-temporary
impairment should be considered to have occurred.
4.28 According to "Pending Content" in FASB ASC 320-10-35-33D, in de-
termining whether a credit loss exists, an entity should use its best estimate of
the present value of cash flows expected to be collected from the debt security.
One way of estimating that amount would be to consider the methodology de-
scribed in FASB ASC 310-10-35 for measuring an impairment on the basis of
the present value of expected future cash flows. FASB ASC 310-10-35 provides
guidance on this calculation. Briefly, the entity would discount the expected
cash flows at the effective interest rate implicit in the security at the date of
acquisition.
4.29 "Pending Content" in FASB ASC 320-10-35-33E indicates that for
debt securities that are beneficial interests in securitized financial assets within
the scope of FASB ASC 325-40, an entity should determine the present value
of cash flows expected to be collected considering the guidance in paragraphs
4–9 of FASB ASC 325-40-35 for determining whether there has been a decrease
in cash flows expected to be collected from cash flows previously projected. In
other words, the cash flows estimated at the current financial reporting date
should be discounted at a rate equal to the current yield used to accrete the
beneficial interest. Additionally, for debt securities accounted for in accordance
with FASB ASC 310-30, an entity should consider the guidance in FASB ASC
310-30 in estimating the present value of cash flows expected to be collected
from the debt security. A decrease in cash flows expected to be collected on
an asset-backed security that results from an increase in prepayments on the
underlying assets should be considered in the estimate of the present value of
cash flows expected to be collected.
4.30 "Pending Content" in FASB ASC 320-10-35-33F indicates that there
are numerous factors to be considered when estimating whether a credit loss
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exists and the period over which the debt security is expected to recover. The
list of factors that should be considered include, but are not limited to, the
following:
a. The length of time and the extent to which the fair value has been
less than the amortized cost basis.
b. Adverse conditions specifically related to the security, an industry,
or geographic area (for example, changes in the financial condition
of the issuer of the security, or in the case of an asset-backed debt
security, changes in the financial condition of the underlying loan
obligors). Examples of those changes include any of the following:
i. Changes in technology
ii. The discontinuance of a segment of the business that may
affect the future earnings potential of the issuer or under-
lying loan obligors of the security
iii. Changes in the quality of the credit enhancement
c. The historical and implied volatility of the fair value of the security.
d. The payment structure of the debt security (for example, nontra-
ditional loan terms as described in paragraphs 1–2 of FASB ASC
825-10-55 and FASB ASC 310-10-50-25) and the likelihood of the
issuer being able to make payments that increase in the future.
e. Failure of the issuer of the security to make scheduled interest or
principal payments.
f. Any changes to the rating of the security by a rating agency.
g. Recoveries or additional declines in fair value after the balance
sheet date.
4.31 "Pending Content" in FASB ASC 320-10-35-33G states that in mak-
ing its other-than-temporary impairment assessment, an entity should consider
all available information relevant to the collectibility of the security, including
information about past events, current conditions, and reasonable and sup-
portable forecasts, when developing the estimate of cash flows expected to be
collected. That information should include all of the following:
a. The remaining payment terms of the security
b. Prepayment speeds
c. The financial condition of the issuer(s)
d. Expected defaults
e. The value of any underlying collateral.
4.32 "Pending Content" in FASB ASC 320-10-35-33H states that to achieve
the objective in FASB ASC 320-10-35-33G, the entity should consider, for ex-
ample, all of the following:
a. Industry analyst reports and forecasts
b. Sector credit ratings
c. Other market data that are relevant to the collectibility of the se-
curity
4.33 According to "Pending Content" in FASB ASC 320-10-35-33I, an en-
tity also should consider how other credit enhancements affect the expected
performance of the security, including consideration of the current financial
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condition of the guarantor of a security (if the guarantee is not a separate con-
tract as discussed in FASB ASC 320-10-35-23) or whether any subordinated
interests are capable of absorbing estimated losses on the loans underlying the
security. The remaining payment terms of the security could be significantly
different from the payment terms in prior periods (such as for some securities
backed by nontraditional loans; see FASB ASC 825-10-55-1). Thus, an entity
should consider whether a security backed by currently performing loans will
continue to perform when required payments increase in the future (including
balloon payments). An entity also should consider how the value of any collat-
eral would affect the expected performance of the security. If the fair value of
the collateral has declined, an entity should assess the effect of that decline on
the ability of the entity to collect the balloon payment.
4.34 If it is determined that the impairment is other than temporary, then,
according to "Pending Content" in FASB ASC 320-10-35-34, an impairment loss
should be recognized in earnings equal to the entire difference between the
investment's cost and its fair value at the balance sheet date of the reporting
period for which the assessment is made. The measurement of the impairment
should not include partial recoveries after the balance sheet date. The fair
value of the investment would then become the new amortized cost basis of the
investment and should not be adjusted for subsequent recoveries in fair value.
4.35 According to "Pending Content" in FASB ASC 320-10-35-34A, if an
other-than-temporary impairment has occurred, the amount of the other-than-
temporary impairment recognized in earnings depends on whether an entity
intends to sell the security or more likely than not will be required to sell the
security before recovery of its amortized cost basis less any current-period credit
loss.
4.36 "Pending Content" in FASB ASC 320-10-35-34B indicates that if an
entity intends to sell the security or more likely than not will be required to
sell the security before recovery of its amortized cost basis less any current-
period credit loss, the other-than-temporary impairment should be recognized
in earnings equal to the entire difference between the investment's amortized
cost basis and its fair value at the balance sheet date. In assessing whether the
entity more likely than not will be required to sell the security before recovery of
its amortized cost basis less any current-period credit losses, the entity should
consider the factors in FASB ASC 320-10-35-33F (see paragraph 4.30).
4.37 "Pending Content" in FASB ASC 320-10-35-34C states that if an en-
tity does not intend to sell the security and it is not more likely than not that the
entity will be required to sell the security before recovery of its amortized cost
basis less any current-period credit loss, the other-than-temporary impairment
should be separated into both of the following:
a. The amount representing the credit loss
b. The amount related to all other factors
4.38 According to "Pending Content" in FASB ASC 320-10-35-34D, the
amount of the total other-than-temporary impairment related to the credit loss
should be recognized in earnings. The amount of the total other-than-temporary
impairment related to other factors should be recognized in other comprehen-
sive income, net of applicable taxes.
4.39 "Pending Content" in FASB ASC 320-10-35-34E indicates that
the previous amortized cost basis less the other-than-temporary impairment
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recognized in earnings should become the new amortized cost basis of the in-
vestment. That new amortized cost basis should not be adjusted for subsequent
recoveries in fair value. However, the amortized cost basis should be adjusted
for accretion and amortization as prescribed in FASB ASC 320-10-35-35.
4.40 According to "Pending Content" in FASB ASC 320-10-35-35, in peri-
ods after the recognition of an other-than-temporary impairment loss for debt
securities, an entity should account for an other-than-temporarily impaired
debt security as if the debt security had been purchased on the measurement
date of the other-than-temporary impairment at an amortized cost basis equal
to the previous amortized cost basis less the other-than-temporary impairment
recognized in earnings. For debt securities for which other-than-temporary im-
pairments were recognized in earnings, the difference between the new amor-
tized cost basis and the cash flows expected to be collected should be accreted
in accordance with existing applicable guidance as interest income. An entity
should continue to estimate the present value of cash flows expected to be col-
lected over the life of the debt security. For debt securities accounted for in
accordance with FASB ASC 325-40, an entity should look to FASB ASC 325-
40 to account for changes in cash flows expected to be collected. For all other
debt securities, if upon subsequent evaluation, there is a significant increase in
the cash flows expected to be collected or if actual cash flows are significantly
greater than cash flows previously expected, such changes should be accounted
for as a prospective adjustment to the accretable yield in accordance with FASB
ASC 310-30 even if the debt security would not otherwise be within the scope
of that FASB ASC 310-30. Subsequent increases and decreases (if not an other-
than-temporary impairment) in the fair value of available-for-sale securities
should be included in other comprehensive income. FASB ASC 320-10-35 does
not address when a holder of a debt security would place a debt security on
nonaccrual status or how to subsequently report income on a nonaccrual debt
security.
4.41 "Pending Content" in FASB ASC 320-10-35-35A states that the other-
than-temporary impairment recognized in other comprehensive income for debt
securities classified as held-to-maturity should be accreted over the remaining
life of the debt security in a prospective manner on the basis of the amount
and timing of future estimated cash flows. That accretion should increase the
carrying value of the security and should continue until the security is sold, the
security matures, or there is an additional other-than-temporary impairment
that is recognized in earnings. If the security is sold, FASB ASC 320-10-25
provides guidance on the effect of changes in circumstances that would not call
into question the entity's intent to hold other debt securities to maturity in the
future.
4.42 "Pending Content" in FASB ASC 320-10-45-8A states that in periods
in which an entity determines that a security's decline in fair value below its
amortized cost basis is other than temporary, the entity should present the total
other-than-temporary impairment in the statement of earnings with an offset
for the amount of the total other-than-temporary impairment that is recognized
in other comprehensive income, in accordance with the "Pending Content" in
FASB ASC 320-10-35-34D (see paragraph 4.38), if any. Example 2A included in
the "Pending Content" in FASB ASC 320-10-55-21A illustrates the application
of this guidance.
4.43 "Pending Content" in FASB ASC 320-10-45-9A states that an entity
should separately present, in the financial statement in which the components
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of accumulated other comprehensive income are reported, amounts recognized
therein related to held-to-maturity and available-for-sale debt securities for
which a portion of an other-than-temporary impairment has been recognized
in earnings.
4.44 "Pending Content" in FASB ASC 320-10-50-1A indicates that disclo-
sures in FASB ASC 320-10-50 are required for all interim and annual periods.
4.45 "Pending Content" in paragraphs 6–8B of FASB ASC 320-10-50 pro-
vide disclosure requirements related to impairment of securities.
4.46 According to "Pending Content" in FASB ASC 320-10-50-6, for all
investments in an unrealized loss position, including those that fall within the
scope of FASB ASC 325-40, for which other-than-temporary impairments have
not been recognized in earnings (including investments for which a portion of an
other-than-temporary impairment has been recognized in other comprehensive
income), an entity should disclose all of the following in its annual financial
statements:
a. As of each date for which a statement of financial position is
presented, quantitative information, aggregated by category of
investment—each major security type that the entity discloses in
accordance with FASB ASC 320-10 and cost-method investments—
in tabular form
i. the aggregate related fair value of investments with unre-
alized losses.
ii. the aggregate amount of unrealized losses (that is, the
amount by which amortized cost basis exceeds fair value.)
b. As of the date of the most recent statement of financial position, the
entity should provide additional information (in narrative form)
that provides sufficient information to allow financial statement
users to understand the quantitative disclosures and the infor-
mation that the entity considered (both positive and negative) in
reaching the conclusion that the impairment or impairments are
not other than temporary. The application of the guidance in FASB
ASC 320-10-35-30 (see paragraph 4.21) should provide insight into
the entity's rationale for concluding that unrealized losses are not
other-than-temporary impairments. The required disclosures may
be aggregated by investment categories, but individually signifi-
cant unrealized losses generally should not be aggregated. This
disclosure could include all of the following:
i. The nature of the investment(s)
ii. The cause(s) of the impairment(s)
iii. The number of investment positions that are in an unre-
alized loss position
iv. The severity and duration of the impairment(s)
v. Other evidence considered by the investor in reaching
its conclusion that the investment is not other-than-
temporarily impaired, including, for example, any of the
following:
(1) Performance indicators of the underlying as-
sets in the security, including default rates,
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delinquency rates, and percentage of nonperform-
ing assets
(2) Loan-to-collateral-value ratios
(3) Third-party guarantees
(4) Current levels of subordination
(5) Vintage
(6) Geographic concentration
(7) Industry analyst reports
(8) Sector credit ratings
(9) Volatility of the security's fair value
(10) Any other information the investor considers rel-
evant
4.47 According to "Pending Content" in FASB ASC 320-10-50-7, the disclo-
sures should be segregated by those investments that have been in a continuous
unrealized loss position for less than 12 months and those that have been in
a continuous unrealized loss position for 12 months or longer. "Pending Con-
tent" in FASB ASC 320-10-50-8, the reference point for determining how long
an investment has been in a continuous unrealized loss position is the balance
sheet date of the reporting period in which the impairment is identified. For
entities that do not prepare interim financial information, the reference point
is the annual balance sheet date of the period during which the impairment
was identified. The continuous unrealized loss position ceases upon either of
the following: (a) the recognition of the total amount by which amortized cost
basis exceeds fair value as an other-than-temporary impairment in earnings or
(b) the investor becoming aware of a recovery of fair value up to (or beyond) the
amortized cost basis of the investment during the period.
4.48 "Pending Content" in FASB ASC 320-10-50-8A indicates that for
interim and annual periods in which an other-than-temporary impairment of
a debt security is recognized and only the amount related to a credit loss was
recognized in earnings, an entity should disclose by major security type, the
methodology and significant inputs used to measure the amount related to
credit loss. Examples of significant inputs include, but are not limited to perfor-
mance indicators of the underlying assets in the security (such as, default rates,
delinquency rates, and percentage of nonperforming assets), loan-to-collateral-
value ratios, third-party guarantees, current levels of subordination, vintage,
geographic concentration, and credit ratings.
4.49 According to "Pending Content" in FASB ASC 320-10-50-8B, for each
interim and annual reporting period presented, an entity should disclose a tab-
ular rollforward of the amount related to credit losses recognized in earnings in
accordance with FASB ASC 320-10-35-34D (see paragraph 4.38), which should
include at a minimum, all of the following:
a. The beginning balance of the amount related to credit losses on debt
securities held by the entity at the beginning of the period for which
a portion of an other-than-temporary impairment was recognized
in other comprehensive income
b. Additions for the amount related to the credit loss for which an
other-than-temporary impairment was not previously recognized
c. Reductions for securities sold during the period (realized)
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d. Reductions for securities for which the amount previously recog-
nized in other comprehensive income was recognized in earnings
because the entity intends to sell the security or more likely than
not will be required to sell the security before recovery of its amor-
tized cost basis
e. If the entity does not intend to sell the security and it is not more
likely than not that the entity will be required to sell the security be-
fore recovery of its amortized cost basis, additional increases to the
amount related to the credit loss for which an other-than-temporary
impairment was previously recognized
f. Reductions for increases in cash flows expected to be collected that
are recognized over the remaining life of the security (see FASB
ASC 320-10-35-35)
g. The ending balance of the amount related to credit losses on debt
securities held by the entity at the end of the period for which a
portion of an other-than-temporary impairment was recognized in
other comprehensive income
4.50 As of each date for which a statement of financial position is pre-
sented in its annual financial statements, FASB ASC 325-20-50-1 requires the
investor to disclose (if applicable) for cost-method investments all of the follow-
ing additional information:
a. the aggregate carrying amount of all cost-method investments,
b. the aggregate carrying amount of cost-method investments that the
investor did not evaluate for impairment, and
c. the fact that the fair value of a cost-method investment is not esti-
mated if there are no identified events or changes in circumstances
that may have a significant adverse effect on the fair value of the
investment, and
i. the investor determined, in accordance with paragraphs
16–19 of FASB ASC 825-10-50, that it is not practicable to
estimate the fair value of the investment,
ii. the investor is exempt from estimating fair values under
FASB ASC 825-10, or
iii. the investor is exempt from estimating interim fair values
because it does not meet the definition of a publicly traded
company.
4.51 "Pending Content" in the FASB ASC glossary defines a publicly
traded company as any company whose securities trade in a public market
on either of the following:
a. A stock exchange (domestic or foreign)
b. In the over-the-counter market (including securities quoted only
locally or regionally) or any company that is a conduit bond obligor
for conduit debt securities that are traded in a public market (a
domestic or foreign stock exchange or an over-the-counter market,
including local or regional markets)
Additionally, when a company is required to file or furnish financial statements
with the SEC or makes a filing with a regulatory agency in preparation for sale
of its securities in a public market, it is considered a publicly traded company
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for this purpose. The term conduit debt securities refers to certain limited-
obligation revenue bonds, certificates of participation, or similar debt instru-
ments issued by a state or local governmental entity for the express purpose of
providing financing for a specific third party (the conduit bond obligor) that is
not a part of the state or local government's financial reporting entity. Although
conduit debt securities bear the name of the governmental entity that issues
them, the governmental entity often has no obligation for such debt beyond the
resources provided by a lease or loan agreement with the third party on whose
behalf the securities are issued. Further, the conduit bond obligor is responsible
for any future financial reporting requirements.
4.52 Implementation guidance in FASB ASC 320-10-55-22 illustrates the
guidance set forth in FASB ASC 320-10-50, and "Pending Content" in FASB
ASC 320-10-55-23 provides illustrative narrative disclosures.
Transfers of Assets to a Not-for-Profit Entity or Charitable
Trust for Investment
4.53 Sometimes a nongovernmental health care entity transfers assets to
a not-for-profit entity or charitable trust (called a recipient entity) that accepts
those assets and agrees to use them on behalf of or transfer them, their invest-
ment return, or both back to the health care entity or its affiliate.6 Examples
of that type of reciprocal transfer include (a) a nongovernmental health care
entity transfers assets to a community foundation to establish an endowment
for the benefit of the nongovernmental health care entity (or its affiliate) and
(b) a nongovernmental health care entity transfers assets to a foundation it
creates to hold those assets.
4.54 FASB ASC 958-605-25-33 states that a transfer of assets to a recipient
entity is not a contribution if the resource provider (the nongovernmental health
care entity) specifies itself or its affiliate as the beneficiary of the transfer.
Paragraphs 4–7 of FASB ASC 958-20-25 describe 2 types of reciprocal transfers,
which are
 an equity transaction—A transfer of assets to a recipient entity
that meets all of the following conditions: (a) The resource provider
(nongovernmental health care entity) specifies itself or its affili-
ate as the beneficiary, (b) the resource provider (nongovernmental
health care entity) and the recipient entity are financially interre-
lated entities (paragraph 11.40 discusses financially interrelated
entities), and (c) neither the resource provider (nongovernmen-
tal health care entity) nor its affiliate expects payment of the
transferred assets, although payment of investment return on the
transferred assets may be expected.
 the resource provider (nongovernmental health care entity) spec-
ifies itself or its affiliate as the beneficiary and one or both of the
conditions (b) and (c) in the previous bullet is not met (that is, the
transfer is not an equity transaction).
4.55 According to FASB ASC 958-605-25-33, if the transfer in which the
resource provider specifies itself or its affiliate as the beneficiary is not an
equity transaction, the resource provider (the nongovernmental health care
6 Governmental health care entities only. This pronouncement is not applicable to governmental
health care entities. (See footnote 1 in chapter 1).
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entity) should report an asset and the recipient entity should report a liability.
(Accounting for equity transactions is discussed in paragraphs 11.39–.42 of this
guide.) If the nongovernmental health care entity transfers assets to a recipient
entity and specifies itself or its affiliate as the beneficiary, it should disclose the
following information for each period for which a statement of financial position
is presented, in accordance with FASB ASC 958-605-50-6:
 The identity of the recipient entity to which the transfer was made
 Whether variance power was granted to the recipient entity and,
if so, a description of the terms of the variance power7
 The terms under which amounts will be distributed to the non-
governmental health care entity or its affiliate
 The aggregate amount recognized in the statement of financial
position for those transfers and whether that amount is recorded
as an interest in the net assets of the recipient entity or as another
asset (for example, as a beneficial interest in assets held by others
or a refundable advance)
Financial Statement Presentation
4.56 Securities should be reported as either current or noncurrent, as
appropriate, under the provisions of FASB ASC 210-10-45.8
4.57 According to FASB ASC 230-10-45-19, for cash flow reporting pur-
poses by nongovernmental entities, cash receipts and cash payments resulting
from purchases and sales of securities classified as trading securities (as dis-
cussed in FASB ASC 320) should be classified based on the nature and pur-
pose for which the securities were acquired; governmental entities should clas-
sify these items as investing activities. According to FASB ASC 230-10-45-11,
cash flows from purchases, sales, and maturities of available-for-sale securities
should be classified as cash flows from investing activities and reported gross
in the statement of cash flows. Governmental entities should classify cash flows
from purchases, sales, and maturities of all other securities as cash flows from
7 According to FASB ASC 958-605-55-110, if a resource provider transfers assets to a recipient
entity and specifies itself or its affiliate as the beneficiary, a presumption that the transfer is reciprocal,
and therefore not a contribution, is necessary even if the resource provider explicitly grants the
recipient entity variance of power.
8 According to the FASB ASC glossary, the term current assets is used to designate cash and other
assets or resources commonly identified as those that are reasonably expected to be realized in cash or
sold or consumed during the normal operating cycle of the business. According to FASB ASC 210-10-
45-1, current assets include marketable securities representing the investment of cash available for
current operations, including investments in debt and equity securities classified as trading securities
under FASB ASC 320-10. FASB ASC 210-10-45-3 indicates that a 1 year time period should be used
as a basis for the segregation of current assets in cases where there are several operating cycles
occurring within a year. FASB ASC 210-10-45-4 states that the concept of the nature of current assets
contemplates the exclusion from that classification of cash and claims to cash that are restricted as to
withdrawal or use for other than current operations, are designated for expenditure in the acquisition
or construction of noncurrent assets, or are segregated for the liquidation of long term debts. Even
though not actually set aside in special accounts, funds that are clearly to be used in the near future
for the liquidation of long term debts, payments to sinking funds, or for similar purposes should
also, under this concept, be excluded from current assets. However, if such funds are considered to
offset maturing debt that has properly been set up as a current liability, they may be included within
the current asset classification. FASB ASC 958-205-55-7 explains that when a statement of financial
position that sequences assets and liabilities based on their relative liquidity is presented, cash and
cash equivalents of permanent endowment funds held temporarily until suitable long term investment
opportunities are identified are included in the classification long term investments.
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investing activities. FASB ASC 320-10-45-13 states that entities that report cer-
tain investments in debt securities as cash equivalents in accordance with the
provisions of FASB ASC 230, Statement of Cash Flows, can continue that prac-
tice, provided that the notes reconcile the reporting classifications used in the
statement of financial position. If a governmental entity reports investments
in debt securities as cash equivalents in accordance with GASB Statement No.
9, Reporting Cash Flows of Proprietary and Nonexpendable Trust Funds and
Governmental Entities That Use Proprietary Fund Accounting, the notes to the
financial statements should reconcile the reporting classifications used in the
statement of financial position.
4.58 All health care entities with investments that meet the definition of
financial instruments set forth in the FASB ASC glossary are subject to the
disclosure requirements of FASB ASC 825-10-50.9 Entities with derivative in-
struments that meet the definition of derivative instruments set forth in the
FASB ASC glossary are subject to the disclosure requirements in FASB ASC
815-10-50 and FASB ASC 954-815-50.10 FASB ASC 954-815-50-1 requires that
not-for-profit business-oriented health care entities separately disclose the be-
ginning and ending accumulated derivative gain or loss that has been excluded
from the performance indicator, the related net change associated with current-
period hedging transactions, and the net amount of any reclassifications into
the performance indicator in a manner similar to that described in FASB ASC
815-30-50-2. Similarly, FASB ASC 954-815-50-1 requires not-for-profit health
care entities to provide disclosures that are analogous to those required by
paragraphs 1–3 of FASB ASC 815-30-50 and paragraphs 1–2 of FASB ASC
815-35-50 for for-profit entities, including the disclosure of anticipated reclas-
sifications into the performance indicator of gains and losses that have been
excluded from that measure and reported in accumulated derivative gain or
loss as of the reporting date.
4.59 Governmental health care entities are also required to disclose in-
formation about their investments in accordance with GASB Statement Nos.
3, 28, 31, and 40; GASB Technical Bulletin No. 87-1, Applying Paragraph 68
of GASB Statement No. 3, No. 2003-1, Disclosure Requirements for Derivatives
Not Reported at Fair Value on the Statement of Net Assets, and No. 97-1, Clas-
sification of Deposits and Investments into Custodial Credit Risk Categories for
Certain Bank Holding Company Transactions; and GASB Interpretation No. 3.
Among the required disclosures are the following:
 The types of investments authorized by legal or contractual pro-
visions (GASB Statement No. 3, as amended, paragraph 65)
 Investment policies related to the risks that GASB Statement No.
40 requires to be disclosed (If a government has no investment
policy that addresses a specific type of risk that it is exposed to,
the disclosure should indicate that fact.) (GASB Statement No. 40
paragraph 6)
 Significant violations during the period of legal or contractual pro-
visions for investments, and the actions taken to address such
9 Disclosures about the fair value of financial instruments prescribed in FASB ASC 825-10-50
are optional for an entity that meets the criteria in FASB ASC 825-10-50-3.
10 Governmental health care entities only. FASB ASC 825, Financial Instruments, and FASB ASC
815 are not applicable to governmental health care entities that do not apply paragraph 7 of GASB
Statement No. 20. (See footnote 1 in chapter 1.)
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violations (GASB Statement No. 3 paragraph 66 and No. 38, Cer-
tain Financial Statement Note Disclosures, paragraph 9)
 The accounting methods for investments (GASB Statement No.
31 paragraph 15)
 The credit quality ratings of investments in debt securities as de-
scribed by nationally recognized statistical rating organizations—
rating agencies—as of the date of the financial statements (This
disclosure does not apply to investments issued or explicitly guar-
anteed by the U.S. government, but it does apply to investments
in external investment pools, money market funds, bond mutual
funds, and other pooled investments of fixed-income securities. If
a credit quality disclosure is required and the investment is un-
rated, the disclosure should indicate that fact.) (GASB Statement
No. 40 paragraph 7)
 For investment securities, including securities underlying repur-
chase agreements, at the end of the period that are exposed to cus-
todial credit risk, the investment's type, the reported amount, and
how the investments are held (This disclosure does not apply to
investments in external investment pools and in open-end mutual
funds or to securities underlying reverse repurchase agreements.)
(GASB Statement No. 40 paragraph 9)
 Investments in any one issuer, by amount and issuer, that repre-
sent 5 percent or more of total investments (This disclosure does
not apply to investments issued or explicitly guaranteed by the
U.S. government or investments in mutual funds, external invest-
ment pools, or other pooled investments. (GASB Statement No. 40
paragraph 11)
 Information about interest rate risk using one of the five meth-
ods listed in GASB Statement No. 40 (If a method requires an
assumption regarding timing of cash flows, interest rate changes,
or other factors that affect interest rate information, that assump-
tion should be disclosed. This disclosure does apply to investments
in mutual funds, external investment pools, or other pooled invest-
ments that do not meet the definition of a 2a7-like pool.) (GASB
Statement No. 40 paragraphs 14–15)
 The terms of investments with fair values that are highly sensitive
to changes in interest rates to the extent investment terms are
not considered in the interest rate risk disclosure requirements of
GASB Statement No. 40 paragraph 15 (GASB Statement No. 40
paragraphs 14 and 16)
 Certain information about investments in external investment
pools (GASB Statement No. 31 paragraph 15)
4.60 The following example from paragraphs 1–4 of FASB ASC 954-320-
55 illustrates the accounting treatment and financial statement presentation
for other-than-trading securities of a not-for-profit health care entity:
Other than trading securities are purchased in year 1 at a cost of $100. At the
end of year 1, the fair value of the securities is $300. In year 2, the securities
are sold for $400.
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The journal entries are as follows:
 Entry at the end of year 1 to adjust the recorded value of the secu-
rities to fair value:
Valuation allowance 200
Change in net unrealized gains and losses on investments 200
 Entry at the end of year 2 to record the sale of the securities:
Cash 400
Realized gain 300
Investments 100
Change in net unrealized gains and losses on
investments 200
Valuation allowance 200
As discussed in FASB ASC 954-320-45-1 (paragraph 4.09), unrealized gains
and losses on other than trading securities are reported in the statement of
operations below the performance indicator and realized gains and losses are
reported in the statement of operations above the performance indicator.
Auditing
4.61 Auditing objectives and procedures for investments of health care
entities generally are similar to those of other entities. AU section 332, Audit-
ing Derivative Instruments, Hedging Activities, and Investments in Securities
(AICPA, Professional Standards, vol. 1), among other matters, provides guid-
ance to auditors in planning and performing auditing procedures for assertions
about investments in securities that are made in an entity's financial state-
ments. The guidance in AU section 332 (AICPA, Professional Standards, vol. 1),
applies to all debt and equity securities. AU section 332 (AICPA, Professional
Standards, vol. 1), uses the definitions of debt security and equity security that
are in the FASB ASC glossary but applies to debt and equity securities without
regard to whether they are subject to the requirements of FASB ASC 320-10,
such as, for example, assertions about securities accounted for under the eq-
uity method following the requirements of FASB ASC 323, Investments—Equity
Method and Joint Ventures. A companion Audit Guide, Auditing Derivative In-
struments, Hedging Activities, and Investments in Securities, provides practical
guidance for implementing AU section 332 (AICPA, Professional Standards,
vol. 1).
Considerations for Audits Performed in Accordance with PCAOB Standards
Paragraph .11 of AU section 332 Auditing Derivative Instruments, Hedg-
ing Activities, and Investments in Securities (AICPA, PCAOB Standards
and Related Rules, Interim Standards), states that when performing an
integrated audit of financial statements and internal control over financial
reporting, paragraph 39 of Public Company Accounting Oversight Board
(PCAOB) Auditing Standard No. 5, An Audit of Internal Control Over Fi-
nancial Reporting That Is Integrated with An Audit of Financial Statements
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(AICPA, PCAOB Standards and Related Rules, Auditing Standards), states
"[t]he auditor should test those controls that are important to the audi-
tor's conclusion about whether the company's controls sufficiently address
the assessed risk of material misstatement to each relevant assertion."
Therefore, in an integrated audit of financial statements and internal con-
trol over financial reporting, if there are relevant assertions related to the
company's investments in derivatives and securities, the auditor's under-
standing of controls should include controls over derivatives and securities
transactions from their initiation to their inclusion in the financial state-
ments and should encompass controls placed in operation by the entity
and service organizations whose services are part of the entity's informa-
tion system.11
4.62 Interpretation No. 1, "Auditing Investments in Securities Where a
Readily Determinable Fair Value Does Not Exist," of AU section 332 (AICPA,
Professional Standards, vol. 1, AU sec. 9332 par. .01–.04), provides guidance for
auditors of nonissuers regarding the adequacy of audit evidence with respect to
the existence and valuation assertions in AU section 332 (AICPA, Professional
Standards, vol. 1), in confirmations received from third parties when audit-
ing investments in securities where a readily determinable fair value does not
exist, and the auditor determines auditing procedures include verifying the
existence and testing the measurement of the investments. Further guidance
for auditors of nonissuers is provided in the AICPA Practice Aid Alternative
Investments—Audit Considerations. The guidance focuses on the existence and
valuation assertions associated with auditing investments for which a readily
determinable fair value does not exist (collectively referred to in the practice
aid as alternative investments).12 The auditing portion of that practice aid is
an other auditing publication as defined in AU section 150, Generally Accepted
Auditing Standards (AICPA, Professional Standards, vol. 1). Other auditing
publications have no authoritative status; however, they may help the auditor
understand and apply Statements on Auditing Standards.
4.63 In addition, the independent auditor may need to consider the ex-
amples of specific auditing objectives, selected control activities, and auditing
procedures that are presented in exhibit 4-1.
11 Public Company Accounting Oversight Board (PCAOB) Staff Audit Practice Alert No. 2, Mat-
ters Related to Auditing Fair Value Measurements of Financial Instruments and the Use of Specialists
(AICPA, PCAOB Standards and Related Rules, PCAOB Staff Guidance, sec. 400 par. .02), provides
guidance on auditors' responsibilities for auditing fair value measurements of financial instruments
and when using the work of specialists under the existing standards of the PCAOB. This practice
alert is focused on specific matters that are likely to increase audit risk related to the fair value
of financial instruments in a rapidly changing economic environment. This practice alert highlights
certain requirements in the Auditing Standards related to fair value measurements and disclosures
in the financial statements and certain aspects of generally accepted accounting principles that are
particularly relevant to the current economic environment. PCAOB practice alerts are not rules of
the board, nor have they been approved by the PCAOB.
PCAOB Staff Audit Practice Alert No. 4, Auditor Considerations Regarding Fair Value Measure-
ments, Disclosures, and Other-Than-Temporary Impairments (AICPA, PCAOB Standards and Related
Rules, PCAOB Staff Guidance, sec. 400 par. .04), was issued on April 21, 2009. The purpose of this
Staff Audit Practice Alert is to inform auditors about potential implications of the FSPs on reviews of
interim financial information and annual audits. This alert addresses the following topics: (1) reviews
of interim financial information ("reviews"); (2) audits of financial statements, including integrated
audits; (3) disclosures; and (4) auditor reporting considerations. PCAOB practice alerts are not rules
of the board, nor have they been approved by the PCAOB.
12 The AICPA Practice Aid Alternative Investments—Audit Considerations can be found at
www.aicpa.org/download/members/div/auditstd/Alternative_Investments_Practice_Aid.pdf.
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Exhibit 4-1
The following table illustrates the use of assertions in developing au-
dit objectives and designing substantive tests. The examples are not
intended to be all inclusive nor is it expected that all the procedures
would necessarily be applied in an audit. The auditor should design
and perform substantive procedures for all relevant assertions related
to each material class of transactions, account balance, and disclosure
to obtain sufficient appropriate audit evidence. The use of assertions in
assessing risks and designing appropriate audit procedures to obtain
audit evidence is described in paragraphs .14–.26 of AU section 326,
Audit Evidence (AICPA, Professional Standards, vol. 1). Various audit
procedures and the purposes for which they may be performed are de-
scribed in paragraphs .27–.41 of AU section 326.
Auditing Considerations
Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities
Auditing
Procedures
Account Balances
Existence;
completeness;
rights and
obligations; and
valuation and
allocation
Marketable
securities are
fairly stated,
properly
classified,
described, and
disclosed.
An independent
trustee manages
the investments.
The trustee's
reports are
reviewed by a
responsible
employee.
Verify existence
through confirmation.
Test the valuation of
equity and debt
securities not
intended to be held to
maturity by
comparing the
recorded values with
the fair market
values reported by
the trustee or
another independent
source. For fair value
estimates obtained
from third-party
sources, the auditor
should consider the
applicability of the
guidance in AU
section 336, Using the
Work of a Specialist
(AICPA, Professional
Standards, vol. 1), or
AU section 324,
Service Organizations
(AICPA, Professional
Standards, vol. 1;
AICPA, PCAOB
Standards and
Related Rules,
Interim Standards)1
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Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities
Auditing
Procedures
Valuation and
allocation, rights
and obligations
Endowment
funds are
properly stated
at their required
value and
related gains
and losses are
properly
classified.
Value of
endowment
funds are
reviewed
periodically to
ensure that the
balance is at its
required level.
Verified that value of
endowments are at
required levels
through confirmation.
Review treatment of
gains and losses on
endowment funds to
ensure that they are
properly classified.
Transactions
Accuracy and
completeness
Investment
income and
gains or losses,
or both, are
recorded in
accordance with
donor
restrictions.
Review of
investment
transactions to
ensure they are
recorded in
compliance with
donor
restrictions.
Test the recording of
selected transactions
to ensure amounts
are properly classified
in accordance with
donor restrictions.
Presentation and Disclosure
Classification and
understandability
Securities are
properly
classified.
Classification is
monitored
periodically and
is based on
management's
intent or ability
to dispose of
excess funds
that are
available for
operations
within an
operating cycle.
1 Paragraphs .35–.46 of AU section 332, Auditing Derivative Instruments,
Hedging Activities, and Investments in Securities (AICPA, Professional Stan-
dards, vol. 1), establishes requirements and provides guidance to auditors
on audit evidence that may be used to support assertions about the fair value
of securities. Paragraphs 6.15–.37 in the companion Audit Guide Auditing
Derivative Instruments, Hedging Activities, and Investments in Securities
also provides guidance on that topic. That guidance should be considered in
the context of specific accounting requirements. AU section 328, Auditing
Fair Value Measurements and Disclosures (AICPA, Professional Standards,
vol. 1), establishes requirements and provides guidance on auditing fair
value measurements and disclosures contained in financial statements. AU
section 328 does not address specific types of assets, liabilities, components
of equity, transactions, or industry-specific practices.
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Chapter 5
Receivables
5.01 Receivables may include amounts due for (a) health care services from
patients, residents, third-party payors, and employers; (b) premiums and stop-
loss insurance recoveries; (c) intercompany transactions; (d) promises to give
in future periods (pledges); and (e) amounts due from employees, physicians, or
others. All loans, such as loans to physicians, should be evaluated periodically
for impairment.
5.02 Nongovernmental health care entities should apply the guidance in
Financial Accounting Standards Board (FASB) Accounting Standards Codi-
fication (ASC) 310, Receivables, except when it conflicts with the specialized
guidance in FASB ASC 954-310. Loans that are included in FASB ASC 310-
10-35-131 should be evaluated for impairment based on paragraphs 14–40 of
FASB ASC 310-10-35. According to FASB ASC 310-10-35-16, a loan is im-
paired when, based on current information and events, it is probable that
a creditor (the provider) will be unable to collect all amounts due according
to the contractual terms of the loan agreement. All amounts due according
to the contractual terms means that both the contractual interest payments
and the contractual principal payments of a loan will be collected as scheduled
in the loan agreement. According to FASB ASC 310-10-35-22, when a loan is
impaired as defined in paragraphs 16–17 of FASB ASC 310-10-35, a creditor
[provider] should measure impairment based on the present value of expected
future cash flows discounted at the loan's effective interest rate, except that as
a practical expedient, a creditor [provider] may measure impairment based on
a loan's observable market price, or the fair value of the collateral if the loan
is a collateral-dependent loan.
5.03 As described in FASB ASC 954-310-05-2, amounts realizable from
third-party payors for health care services are usually less than the provider's
full established rates for those services. The receivable amounts may be deter-
mined by any of the following: (a) contractual agreement with others (such as
Blue Cross plans, Medicare, Medicaid, or health maintenance organizations),
(b) legislation or regulation (such as workers' compensation or no-fault insur-
ance), or (c) provider policy or practice (such as courtesy discounts to medical
staff members and employees or other administrative adjustments).
5.04 According to FASB ASC 954-310-25-1, receivables for health care
services usually are recorded in the accounting records at the provider's full
established rates. As discussed in paragraph 10.03, the provision of charity
care does not qualify for recognition as receivables in the financial statements.
5.05 According to FASB ASC 954-605-25-4, the provision for contractual
adjustments (that is, the difference between established rates and third-party
payor payments) and discounts (that is, the difference between established
rates and the amount collectible) are recognized on an accrual basis and de-
ducted from gross service revenue to determine net service revenue. According
1 Governmental health care entities only. This pronouncement is not applicable to governmental
health care entities that do not apply paragraph 7 of Governmental Accounting Standards Board
(GASB) Statement No. 20, Accounting and Financial Reporting for Proprietary Funds and Other
Governmental Entities That Use Proprietary Fund Accounting. (See footnote 1 in chapter 1.)
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to FASB ASC 954-310-30-1 and FASB ASC 954-310-35-1, contractual adjust-
ments, discounts, and an allowance for uncollectibles should be recorded to
measure the receivables for health care services initially and subsequently at
net realizable value. As discussed in FASB ASC 954-605-25-6, estimates of con-
tractual adjustments, other adjustments, and the allowance for uncollectibles
should be reported in the period during which the services are provided even
though the actual amounts may become known at a later date. This later date
may be any one of the following: (a) when the person is discharged, (b) subse-
quent to discharge or completion of service, (c) when the third party is billed,
or (d) when payment or partial payment is received.
5.06 Nongovernmental health care entities with loans and trade receiv-
ables should follow the recognition and measurement guidance in FASB ASC
310, Receivables, to the extent that that guidance is applicable.
Rate Setting
5.07 As part of obtaining a sufficient understanding of the entity and its
environment, including its internal control, to assess the risk of material mis-
statement of the financial statements, whether due to error or fraud, and to
design the nature, timing, and extent of further audit procedures, the auditor
should be familiar with the rate-setting environment in which the entity oper-
ates and the regulations and contractual agreements that determine payments
to be received for health care services.
5.08 As discussed in FASB ASC 954-605-05-5, payment rates established
by regulations or contractual agreements may be determined either prospec-
tively or retrospectively. The FASB ASC glossary defines prospective rate
setting as
a method used to set payment rates in advance of the delivery of health
care services. Such payment rates determine what third parties will
pay for health care services during the rate period (generally one year).
Prospective rate setting may result from a contractual agreement with
a third party, such as a Blue Cross plan, or it may be mandated through
legislation. The intent of prospective rate setting is to establish pay-
ment rates before the period to which they will apply and that are not
subject to change.
5.09 The FASB ASC glossary states that under retrospective rate setting
third parties usually determine an interim payment rate and, during
the rate period (generally one year), pay the health care entity for ser-
vices rendered using that rate. After the rate period has ended, a final
settlement is made in accordance with federal or state regulations or
contractual agreements. Under a retrospective system, an entity may
be entitled to receive additional payments or may be required to re-
fund amounts received in excess of amounts earned under the system.
Although final settlements are not made until a subsequent period,
they are usually subject to reasonable estimations and are reported in
the financial statements in the period in which services are rendered.
5.10 The independent auditor should be aware, however, that some rate-
setting methods described as prospective may include provision for retrospec-
tive adjustments and that some third parties pay prospective rates for certain
services and retrospective rates for other services.
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Estimated Final Settlements
5.11 FASB ASC 954-605-35-1 states that differences between original es-
timates and subsequent revisions (including final settlements) are included in
the statement of operations in the period in which the revisions are made. FASB
ASC 954-605-50-1 indicates that those differences should be disclosed.
5.12 Those differences are reported as a correction of an error in previously
issued financial statements, as defined in the FASB ASC glossary if the errors
result from mathematical mistakes, mistakes in the application of generally
accepted accounting principles (GAAP), or oversight or misuse of facts that
existed at the time the financial statements were prepared.
5.13 Paragraph .37 of Statement of Position (SOP) 00-1, Auditing Health
Care Third-Party Revenues and Related Receivables (AICPA, Technical Practice
Aids, AUD sec. 14,360), provides a sample disclosure for material differences
between an original estimate and subsequent revisions. SOP 00-1 is included
in appendix D to this guide.
5.14 According to FASB ASC 954-605-25-9, rate-setting methods that are
described as prospective but provide for retrospective adjustments should be
accounted for as retrospective rate-setting systems for the services to which
they apply.
State Waiver Contingencies Under Medicare
5.15 Certain states (referred to as waiver states) have received permis-
sion to determine rates of payment for Medicare patients in accordance with
a statewide rate-setting method different from the method used by the federal
program. A condition for Medicare participation in a state waiver program typ-
ically requires that Medicare expenditures in that state not exceed prescribed
limits. If Medicare expenditures exceed prescribed limits, the excess, depending
on the conditions of the waiver, may be recoverable by the federal government.
FASB ASC 450, Contingencies, provides guidance with respect to accounting
for loss contingencies, such as those arising under state Medicare waivers. Gov-
ernmental Accounting Standards Board (GASB) Statement No. 10, Accounting
and Financial Reporting for Risk Financing and Related Insurance Issues, pro-
vides guidance with respect to accounting for contingencies by governmental
entities.
Premiums and Stop-Loss Insurance Receivables
5.16 As discussed in FASB ASC 954-310-05-4, some health care entities,
for example, providers of prepaid health care services, contract to provide com-
prehensive health care services for a fixed period in return for fixed periodic
premiums. Many of those entities may transfer a portion of their financial risks
under the contract to another entity by purchasing stop-loss insurance. FASB
ASC 954-310-25-2 states that any uncollected premiums and amounts recov-
erable from stop-loss insurers reduced by appropriate valuation allowances
should be included in receivables.
5.17 Chapter 13 provides guidance on applying GAAP for stop-loss insur-
ance costs of providers of prepaid health care services.
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5.18 FASB ASC 944-20 also provides guidance on accounting for reinsur-
ance contracts. Governmental entities should comply with the provisions of
GASB Statement No. 10.
Promises to Give in Future Periods (Pledges)
5.19 Providers involved in fund-raising campaigns frequently are the re-
cipients of promises to give with payments due in future periods; pledge drives
are a common example. Providers may also be the beneficiaries of fund-raising
campaigns conducted by others.
5.20 FASB ASC 958-3102 establishes the accounting and financial report-
ing guidance for promises to give (contributions receivable). The "Transfers
of Assets to a Not-for-Profit Entity or Charitable Trust that Raises or Holds
Contributions for Others" subsections of FASB ASC 958-6053 provide guid-
ance for transactions in which an entity—the donor—makes a contribution by
transferring assets to a not-for-profit entity or charitable trust—the recipient
entity—that accepts the assets from the donor and agrees to use those assets
on behalf of or transfer those assets, the return on investment of those as-
sets, or both to an unaffiliated entity—the beneficiary—that is specified by the
donor.4 In general, FASB ASC 958-605-25-28 requires that a specified benefi-
ciary (a nongovernmental health care entity that is specified as a beneficiary)
recognize its rights to the assets held by a recipient entity as an asset unless
that recipient entity is explicitly granted variance power (see the discussion
at paragraph 10.07). Those rights are any one of the following: (a) an inter-
est in the net assets of the entity (see the discussion at paragraphs 11.49–.55
of this guide), (b) a beneficial interest, or (c) a receivable. According to FASB
ASC 958-605-25-29, if the beneficiary has an unconditional right to receive all
or a portion of the specified cash flows from a charitable trust or other identi-
fiable pool of assets, the beneficiary should recognize that beneficial interest.
According to FASB ASC 958-605-25-30, if the beneficiary's rights are neither
an interest in the net assets of the recipient entity nor a beneficial interest, a
beneficiary should recognize its rights to the assets held by a recipient entity as
a receivable and contribution revenue in accordance with paragraphs 8–10 of
FASB ASC 958-605-25 and FASB ASC 958-605-45-5 for unconditional promises
to give.
5.21 A brief summary of the provisions of FASB ASC 958-605 for promises
to give is presented in the following paragraphs but is not intended as a sub-
stitute for the reading of FASB ASC 958-605. Additional guidance is provided
in chapter 5 of the AICPA Audit and Accounting Guide Not-for-Profit Entities.
5.22 The recognition guidance in paragraphs 7–15 of FASB ASC 958-605-
25 depends on whether the promise to give is unconditional or conditional.
Conditional promises to give, which depend on the occurrence of a specified
2 Governmental health care entities only. This guidance is not applicable to governmental health
care entities. (See footnote 1 in chapter 1.)
3 See footnote 2.
4 Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 958-
605 also establishes standards for transactions that take place in a similar manner but are not con-
tributions because the transfers are revocable, repayable, or reciprocal. Those standards and trans-
actions are discussed in paragraphs 4.53–.55, 11.39, and 11.41–.42 of this guide. If the transfer of
asset is not a contribution or not yet a contribution, FASB ASC 958-605 and this guide use the term
resource provider rather than the term donor to refer to the entity that transfers the assets to the
recipient entity.
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future and uncertain event to bind the promisor, should be recognized when
the conditions on which they depend are substantially met, that is, when the
conditional promise becomes unconditional. Imposing a condition creates a bar-
rier that must be overcome before the recipient of the transferred assets has
an unconditional right to retain those promised assets. For example, a transfer
of cash with a promise to contribute that cash if a like amount of new gifts are
raised from others within 30 days and a provision that the cash be returned if
the gifts are not raised imposes a condition on which a promised gift depends.
A transfer of assets with a conditional promise to contribute them should be
accounted for as a refundable advance until the conditions have been substan-
tially met or explicitly waived by the donor.5
5.23 According to FASB ASC 958-605-25-8, pursuant to FASB ASC 958-
605-25-7, an unconditional promise to give should be recognized when it is
received. However, to be recognized there must be sufficient evidence in the
form of verifiable documentation that a promise was made and received. Ac-
cording to FASB 958-605-45-5, contributions of unconditional promises to give
with payments due in future periods should be reported as restricted support
unless explicit donor stipulations or circumstances surrounding the receipt of
a promise make clear that the donor intended it to be used to support activi-
ties of the current period). It is reasonable to assume that by specifying future
payment dates donors indicate that their gift is to support activities in each
period in which a payment is scheduled. For example, receipts of unconditional
promises to give cash in future years generally increase temporarily restricted
net assets.
5.24 The expiration of those restrictions (or the expiration of a portion
of the restriction) is recognized as the donor makes the future payment or
payments. If the promise is to be paid in one future payment, the related tem-
porarily restricted net assets will be transferred to unrestricted net assets in
the period in which the payment is received. If the donor sets forth a sched-
ule of future payments, a transfer from temporarily restricted net assets to
unrestricted net assets is made in each period a payment is received. If other
explicit donor restrictions are attached to the promise, such as that the gift
be used for a specific purpose, the expiration of the restriction is recognized in
the time period(s) when the donor makes the future payment(s) and when the
stipulated purpose for which the assets were restricted has been fulfilled. The
temporarily restricted net assets (or the portion of the temporarily restricted
net assets that relate to the particular payment installment) are reclassified
as unrestricted net assets and reported in the statement of operations as net
assets released from restriction.
5.25 FASB ASC 958-205-45-9 states that a not-for-profit entity should
recognize the expiration of a donor-imposed restriction on a contribution in the
period in which the restriction expires. A restriction expires when the stipu-
lated time has elapsed, when the stipulated purpose for which the resource
was restricted has been fulfilled, or both. If two or more temporary restrictions
are imposed on a contribution, the effect of the expiration of those restrictions
5 According to FASB ASC 958-605-25-12, a conditional promise to give is considered uncondi-
tional if the possibility that the condition will not be met is remote. FASB ASC 958-605-25-14 states
that in cases of ambiguous donor stipulations, a promise containing stipulations that are not clearly
unconditional should be presumed to be a conditional promise. Additional guidance on distinguish-
ing conditional promises from unconditional promises is provided in paragraphs 14-15 of FASB ASC
958-605-25 and in paragraphs 15-17 of FASB ASC 958-605-55.
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should be recognized in the period in which the last remaining restriction has
expired.
5.26 Paragraphs 4–7 of FASB ASC 958-605-30 provide guidance for ini-
tially measuring unconditional promises to give. If present value techniques
are used to measure the fair value of unconditional promises to give, a not-for-
profit entity should determine the amount and timing of the future cash flows
of unconditional promises to give cash (or, for promises to give noncash assets,
the quantity and nature of assets expected to be received). In making that de-
termination, the not-for-profit entity should consider all the elements in FASB
ASC 820-10-55-5, including the following: (a) when the receivable is expected
to be collected, (b) the creditworthiness of the other parties, (c) the entity's past
collection experience and its policies concerning the enforcement of promises to
give, (d) expectations about possible variations in the amount or timing of the
cash flows (that is, the uncertainty inherent in the cash flows), and (e) other
factors concerning the receivable's collectibility. Unconditional promises to give
that are expected to be collected in less than one year may be measured at their
net realizable value because that amount results in a reasonable estimate of
fair value.
5.27 Paragraphs 4–13 of FASB 958-310-35 discuss subsequent measure-
ment of contributions receivable. According to FASB ASC 958-310-35-7, if the
fair value of a contribution receivable decreases because of changes in the quan-
tity or nature of assets expected to be received, the decrease should be recog-
nized in the period(s) in which the expectation changes. That decrease should
be reported as an expense or loss (bad debt) in accordance with FASB ASC 958-
310-45-3.6 According to FASB ASC 958-310-35-6, if an unconditional promise
to give cash is initially measured using a present value technique, subsequent
accruals of the interest element should be accounted for as contribution revenue
by donees, pursuant to FASB ASC 835-30-5.
5.28 Chapter 5 of the Audit and Accounting Guide Not-for-Profit Entities
provides further guidance regarding accounting for promises to give in future
periods and for assets held by not-for-profit entities or charitable trusts that
raise or hold contributions for others.
Governmental Health Care Entities
5.29 GASB Statement No. 33, Accounting and Financial Reporting for
Nonexchange Transactions, as amended, provides guidance on accounting and
reporting contributions to governmental health care entities. Promises of cash
or other assets that nongovernmental entities, including individuals, voluntar-
ily make to governments may be referred to in practice as pledges, promises
to give, promised donations, or by some other term. Promised assets may in-
clude permanently nonexpendable additions to endowments and other trusts;
term endowments; contributions of works of art and similar assets to capital-
ized collections; or other kinds of capital or financial assets, with or without
purpose restrictions or time requirements. For purposes of reporting under
GASB Statement No. 33, these are classified as voluntary nonexchange trans-
actions. Governmental health care enterprises that receive promises to give
6 According to FASB ASC 958-310-45-3, because all expenses are reported as decreases in the
unrestricted net asset class, those decreases should be reported as losses if they are decreases in
temporarily restricted net assets or permanently restricted net assets.
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from nongovernmental entities to provide cash or other assets should recog-
nize receivables and revenues (net of estimated uncollectible amounts) when
all eligibility requirements are met, provided that the promise is verifiable and
the resources are measurable and probable of collection. Transactions that are
not recognizable because they are not measurable should be disclosed.
5.30 As discussed in GASB Statement No. 33 paragraph 20, eligibility
requirements comprise one or more of the following:
a. Required characteristics of recipients
b. Time requirements
c. Reimbursements
d. Contingencies
Detailed guidance on the application of eligibility requirements is provided in
GASB Statement No. 33 paragraphs 21–26.
Financial Statement Presentation
Accounts Receivable
5.31 FASB 954-310-45-1 states that receivables should be reported net of
an allowance for doubtful accounts. Although the aggregate amount of receiv-
ables may include balances due from patients and third-party payors (including
final settlements and appeals), the amounts due from third-party payors for
retroactive adjustments of items such as final settlements or appeals should be
reported separately in the financial statements.
5.32 Accounts receivable of health care entities generally are subject to
the same financial disclosure requirements as other business entities.7
5.33 Nongovernmental health care entities with loans and trade receiv-
ables should follow the presentation and disclosure guidance in FASB ASC
310-10-50 to the extent that guidance is applicable. Sections 50 and 55 of FASB
ASC 825-108 set forth disclosure requirements regarding the carrying amount
of patient accounts receivable.* Loans and trade receivables should be reported
7 See discussion of SOP 00-1 in paragraph 5.57.
8 Governmental health care entities only. This pronouncement is not applicable to governmental
health care entities that do not apply paragraph 7 of GASB Statement No. 20. (See footnote 1 in
chapter 1.)
* FSP FAS 107-1 and APB 28-1, Interim Disclosures about Fair Value of Financial Instruments,
was issued on April 9, 2009. FSP FAS 107-1 and APB 28-1 amends FASB Statement No. 107, Disclo-
sures about Fair Value of Financial Instruments, which is codified at FASB ASC 825-10-50, to require
disclosures about fair value of financial instruments for interim reporting periods of publicly traded
companies as well as in annual financial statements. This FSP also amends Accounting Principles
Board Opinion No. 28, Interim Financial Reporting, which is primarily codified at FASB ASC 270-10,
to require those disclosures in summarized financial information at interim reporting periods.
This FSP shall be effective for interim reporting periods ending after June 15, 2009, with early
adoption permitted for periods ending after March 15, 2009. An entity may early adopt this FSP only
if it also elects to early adopt FSP FAS 157-4 and FSP FAS 115-2 and FAS 124-2. This FSP does
not require disclosures for earlier periods presented for comparative purposes at initial adoption. In
periods after initial adoption, this FSP requires comparative disclosures only for periods ending after
initial adoption.
This guidance is located primarily in FASB ASC 825-10-50 and is labeled as "Pending Content"
due to the transition and open effective date information discussed in FASB ASC 825-10-65-1. For
more information on FASB ASC, please see the notice to readers in this guide.
See paragraphs 1.119–.122 of this guide for additional discussion regarding fair value disclosures
of financial instruments.
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at fair value if an election is made in conformity with the fair value option sub-
sections of FASB ASC 825-10. The fair value option subsections of FASB ASC
825-10 permit all entities, including not-for-profit entities, to choose to mea-
sure eligible items at fair value at specified election dates. See the discussion
in chapter 1 regarding fair value.
5.34 Governmental health care entities only. GASB Statement No. 38, Cer-
tain Financial Statement Note Disclosures, paragraph 13 requires that gov-
ernmental health care entities provide details in the notes to their financial
statements about receivable balances when significant components of those
receivables have been obscured by aggregation.
Concentrations of Credit Risk
5.35 FASB ASC 954-310-50-29 states that FASB ASC 825, Financial In-
struments, provides guidance on the required disclosures about significant con-
centrations of credit risk arising from all financial instruments, including trade
accounts receivable. Concentration of credit risk frequently is an issue because
most health care entities generally tend to treat patients from their local or
surrounding communities. Accordingly, disclosure should be made of the pri-
mary geographic sources of patients. It should be noted that concentration of
credit risk may be a significant issue in stand-alone financial statements issued
for a member hospital of a large national multihospital system but may not be
an issue for financial statements prepared for the hospital system. When the
individual facilities' financial statements are consolidated into statements pre-
pared for the entire system, the credit risk is dispersed over a much larger base
of health plans, patients, and geographies and, therefore, is not as concentrated.
Health care entities with significant concentrations of credit risk should comply
with the disclosure provisions of paragraphs 20–22 of FASB ASC 825-10-50.
Off-Balance Sheet Arrangements
5.36 Off-balance-sheet risk exists when the possible accounting loss from
a financial instrument is not reflected on the balance sheet. Health care entities
(most notably hospitals) may enter into arrangements where they will finance
their patient accounts receivable as a cash flow management strategy.
5.37 Nongovernmental health care entities should follow the presenta-
tion and disclosure guidance in paragraphs 1–3 of FASB ASC 825-10-35 and
paragraphs 9–10 of FASB ASC 310-10-50 regarding credit losses on off-balance-
sheet instruments to the extent that guidance is applicable.
9 Governmental health care entities only. See footnote 8.
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Derivative Instruments
5.38 Not-for-profit health care entities should apply the provisions of
FASB ASC 815, Derivatives and Hedging,†,‡,||,#,10 (including the provisions
† In March 2008, FASB issued FASB Statement No. 161, Disclosures about Derivative Instru-
ments and Hedging Activities—an amendment of FASB Statement No. 133. This statement requires
enhanced disclosures about (i) how and why an entity uses derivative instruments; (ii) how derivative
instruments and related hedged items are accounted for under FASB Statement No. 133, Account-
ing for Derivative Instruments and Hedging Activities, and its related interpretations; and (iii) how
derivative instruments and related hedged items affect an entity's financial position, financial per-
formance, and cash flows. To meet these objectives, FASB Statement No. 161 requires qualitative
disclosures about objectives and strategies for using derivatives; quantitative disclosures about fair
value amounts of, and gains and losses on, derivative instruments; and disclosures about credit risk
related contingent features in derivative agreements. These further disclosures are intended to im-
prove the transparency of financial reporting.
FASB Statement No. 161 is effective for fiscal years and interim periods beginning after Novem-
ber 15, 2008. Early adoption is encouraged. FASB Statement No. 161 encourages, but does not require,
comparative disclosures for earlier periods at initial adoption. FASB Statement No. 161 applies to all
entities and derivative instruments, including bifurcated derivative instruments and related hedge
items accounted for under FASB Statement No. 133 and its related interpretations.
The guidance is located in FASB ASC 815-10-50 and is labeled as "Pending Content" due to
the transition and open effective date information discussed in FASB ASC 815-10-65-1. For more
information on FASB ASC, please see the notice to readers in this guide.
‡ In November 2008, FASB issued Emerging Issues Task Force (EITF) Issue No. 08-8, "Accounting
for an Instrument (or an Embedded Feature) with a Settlement Amount That Is Based on the Stock of
an Entity's Consolidated Subsidiary." EITF Issue No. 08-8 clarifies whether a financial instrument for
which the payoff to the counterparty is based, in whole or in part, on the stock of an entity's consolidated
subsidiary is indexed to the reporting entity's own stock and therefore should not be precluded from
qualifying for the first part of the scope exception in paragraph 11(a) of FASB Statement No. 133, or
from being within the scope of EITF Issue No. 00-19, "Accounting for Derivative Financial Instruments
Indexed to, and Potentially Settled in, a Company's Own Stock." EITF Issue No. 08-8 is effective for
fiscal years beginning on or after December 15, 2008, and interim periods within those fiscal years.
Early adoption is not permitted.
This guidance is located primarily in sections 5, 25, 35, 40, and 45 of FASB ASC 810-10 and
sections 10 and 40 of FASB ASC 815, Derivatives and Hedging, some of which is labeled as "Pending
Content" due to the transition and open effective date information discussed in FASB ASC 815-10-
65-4. For more information on FASB ASC, please see the notice to readers in this guide.
|| In September 2008, FASB issued FASB Staff Position (FSP) FAS 133-1 and FIN 45-4, Disclo-
sures about Credit Derivatives and Certain Guarantees: An Amendment of FASB Statement No. 133
and FASB Interpretation No. 45; and Clarification of the Effective Date of FASB Statement No. 161.
The provisions of this FSP that amend FASB Statement No. 133 and FASB Interpretation No. 45,
Guarantor's Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees
of Indebtedness of Others—an interpretation of FASB Statements No. 5, 57, and 107 and rescission of
FASB Interpretation No. 34, should be effective for reporting periods (annual or interim) ending after
November 15, 2008. This FSP encourages that the amendments to FASB Statement No. 133 and FASB
Interpretation No. 45 be applied in periods earlier than the effective date to facilitate comparisons at
initial adoption. In periods after initial adoption, this FSP requires comparative disclosures only for
periods ending subsequent to initial adoption. This FSP amends FASB Interpretation No. 45 to require
an additional disclosure about the current status of the payment or performance risk of a guarantee.
This guidance is located in FASB ASC 460-10-50-4 and is labeled as "Pending Content" due
to the transition and open effective date information discussed in FASB ASC 815-10-65-2. For more
information on FASB ASC, please see the notice to readers in this guide.
# In June 2008, FASB issued EITF Issue No. 07-5, "Determining Whether an Instrument (or
Embedded Feature) Is Indexed to an Entity's Own Stock." The objective of EITF Issue No. 07-5 is to
provide guidance for determining whether an equity-linked financial instrument (or embedded fea-
ture) is indexed to an entity's own stock and it applies to any freestanding financial instrument or
embedded feature that has all the characteristics of a derivative in paragraphs 6-9 of FASB State-
ment No. 133, Accounting for Derivative Instruments and Hedging Activities. It also applies to any
freestanding financial instrument that is potentially settled in an entity's own stock.
EITF Issue No. 07-5 is effective for financial statements issued for fiscal years beginning after
December 15, 2008, and interim periods within those fiscal years. Earlier application by an entity
that has previously adopted an alternative accounting policy is not permitted.
This guidance is located in FASB ASC 718-10-60-1B and sections 15, 20, and 55 of FASB ASC
815-40-15 and is labeled as "Pending Content" due to the transition and open effective date informa-
tion discussed in FASB ASC 815-10-65-3. For more information on FASB ASC, please see the notice
to readers in this guide.
10 Governmental health care entities only. See footnote 8.
AAG-HCO 5.38
P1: PjU
ACPA125-05 ACPA125.cls February 25, 2010 15:47
114 Health Care Entities
pertaining to cash flow hedge accounting) in the same manner as for-profit
entities. That is, the gain or loss items that affect a for-profit entity's income
from continuing operations similarly should affect the not-for-profit health care
entity's performance indicator, and the gain or loss items that are excluded from
a for-profit entity's income from continuing operations (such as items reported
in other comprehensive income) similarly should be excluded from the perfor-
mance indicator by the not-for-profit health care organization.
5.39 FASB ASC 954-815-50-1 requires that not-for-profit business-oriented
health care entities separately disclose the beginning and ending accumulated
derivative gain or loss that has been excluded from the performance indicator,
the related net change associated with current period hedging transactions, and
the net amount of any reclassifications into the performance indicator in a man-
ner similar to that described in FASB ASC 815-30-50-2. Similarly, FASB ASC
954-815-50-1 requires not-for-profit health care entities to provide disclosures
that are analogous to those required by paragraphs 1–3 of FASB ASC 815-30-50
and paragraphs 1–2 of FASB ASC 815-35-50 for for-profit enterprises, including
the disclosure of anticipated reclassifications into the performance indicator of
gains and losses that have been excluded from that measure and reported in ac-
cumulated derivative gain or loss as of the reporting date. Not-for-profit health
care entities are not otherwise required to report changes in the components of
comprehensive income pursuant to FASB ASC 220-10-45-14.
5.40 Governmental health care entities only. GASB Technical Bulletin No.
2003-1, Disclosure Requirements for Derivatives Not Reported at Fair Value on
the Statement of Net Assets, applies to governmental health care enterprises.**
Interfund Receivables
5.41 FASB ASC 954-210-45-3 states that interfund receivables (or
payables) may exist in internal records. However, because general-purpose fi-
nancial statements of not-for-profit, business-oriented health care entities do
not classify assets and liabilities into fund groups, interfund receivables (or
payables) are eliminated.
5.42 Governmental health care entities only. Such interfund balances and
transactions are different from interfund transactions between a governmen-
tal health care enterprise fund and another fund, such as the general fund
or a special revenue fund of a primary government, when the two funds are
included in the same financial reporting entity. Governmental health care en-
tities that are funds or component units of another governmental entity may
report receivables (or payables) from other funds or from the primary govern-
ment or other component units. (The term primary government is defined in
GASB Statement No. 14, The Financial Reporting Entity.) Interfund balances
** In June 2008, GASB issued GASB Statement No. 53, Accounting and Financial Reporting for
Derivative Instruments, which established requirements regarding recognition, measurement and dis-
closure of information related to derivative transactions. GASB Statement No. 53 defines derivatives
similar to GASB Technical Bulletin 2003-1, Disclosure Requirements for Derivatives Not Reported at
Fair Value on the Statement of Net Assets. GASB Statement No. 53 requires governmental entities to
report most derivatives or derivative instruments at their fair value as either assets or liabilities in
the statement of net assets. However, this requirement does not apply to derivatives of governmental
funds reported in the governmental fund statements. Generally, changes in fair value are reported in
the flow of resources statements (that is, statement of activities, statement of revenues, expenses, and
changes in net assets, and so on) as investment gains or losses. Annual changes in the fair value of
hedging derivative instruments, however, are reported as deferred inflows or deferred outflows until
there is a termination event. GASB Statement No. 53 is effective for fiscal periods beginning after
June 15, 2009. Early implementation is encouraged.
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are eliminated in the government-wide financial statements of the financial
reporting entity, when presented.11 Discretely presented component units that
report amounts receivable (or payable) from the primary government or from
other component units should report those assets on a separate line from other
receivables (payables), as discussed in GASB Statement No. 34, Basic Finan-
cial Statements—and Management's Discussion and Analysis—for State and
Local Governments, paragraph 61. GASB Statement No. 38 paragraph 14 also
requires disclosures about interfund balances and transfers.
Promises to Give in Future Periods (Pledges)
5.43 Consistent with the guidance in FASB ASC 310-10-45-4, contri-
butions receivable should be reported net of an allowance for uncollectible
amounts. As illustrated in FASB ASC 958-605-55-22, the allowance for un-
collectible promises to give does not include amounts determined to be uncol-
lectible when the contributions receivable were initially measured. For exam-
ple, assume that, on the last day of its fiscal year, a not-for-profit entity receives
promises to give $100 in five years, that the estimated future cash flows from
the promises are $70, and that the present value of the estimated future cash
flows is $50. The notes to the financial statements should disclose unconditional
promises to give of $70 and unamortized discount of $20.
5.44 The allowance for uncollectible amounts may be based on the re-
ceivable's age, the creditworthiness of the parties, the entity's past collection
experience and its policies concerning the enforcement of promises to give, and
other factors concerning the receivable's collectibility. After the date of initial
measurement, bad debt expense should be reported for the amount of promises
to give that are expected to be uncollectible.
5.45 In accordance with FASB ASC 958-310-50-1, investor owned health
care enterprises and not-for-profit health care entities that are recipients of
unconditional pledges (promises to give in future periods) should disclose all of
the following:
a. The amounts of promises receivable in less than one year, in one to
five years, and in more than five years
b. The amount of the allowance for uncollectible promises receivable
c. The discount that arises if measuring a promise to give at present
value, if that discount is not separately disclosed by reporting it as a
deduction from contributions receivable on the face of the statement
of financial position
5.46 In accordance with FASB ASC 958-310-50-4, investor owned health
care enterprises and not-for-profit health care entities that are recipients of
conditional promises to give should disclose both of the following:
a. The total of the amounts promised
b. A description and amount for each group of promises having sim-
ilar characteristics, such as amounts of promises conditioned on
establishing new programs, completing a new building, or raising
matching gifts by a specified date
5.47 Governmental health care entities only. GASB Statement No.
48, Sales and Pledges of Receivables and Future Revenues and Intra-Entity
11 If a governmental health care entity reports using multiple enterprise funds, interfund bal-
ances between those funds are eliminated in the total enterprise fund column.
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Transfers of Assets and Future Revenues, provides standards on recognizing and
displaying sales of existing governmental entity receivables and sales of future
revenues. GASB Statement No. 48 discusses exchanges by governmental enti-
ties of interests in their expected cash flows from collecting specific receivables
or specific future revenues for immediate cash payments. The statement pro-
vides standards for determining whether such exchanges should be classified
as sales or as collateralized borrowing transactions. The statement further pro-
vides that assets and future revenues transferred in an intra-entity transaction
should be reported at their carrying value; that is, they should not be revalued.
5.48 GASB Statement No. 48 makes a basic distinction between sales of
receivables and future revenues and the pledging of receivables and future rev-
enues to repay a borrowing (a collateralized borrowing). It establishes that a
transaction is a collateralized borrowing unless it meets criteria that demon-
strate that the governmental entity is no longer actively involved with the re-
ceivables or future revenues it has transferred to the other party. Paragraphs
6–10 of GASB Statement No. 48 set forth the criteria for determining that a
governmental entity does not continue to be involved.
5.49 If a transaction does not meet the criteria to be a sale, the govern-
mental entity pledging the receivables or future revenues should report the
proceeds it receives as a liability, not as revenue. It continues to report pledged
receivables as assets and pledged revenues as revenues, as appropriate under
GAAP. The liability is reduced as cash is collected from the pledged receiv-
ables or revenues and transferred to the other party. If the other party to the
transaction—the lender (transferee)—also is a governmental entity, it should
report a receivable for the amounts paid to the pledging governmental entity.
The receivable is reduced as the governmental entity transferee receives the
payments from the pledging governmental entity.
5.50 As noted in paragraphs 11–12 of GASB Statement No. 48, receivables
that are sold should be removed from the assets in the selling governmental en-
tity's financial statements. If there is a difference between the proceeds received
by the selling governmental entity and the amount of the receivables reported
on its financial statements (the carrying value), the difference is reported as a
gain or loss in the accrual-based financial statements (and as revenue in the
modified-accrual-based governmental entity fund financial statements). If the
buyer of a receivable is a governmental entity that is not a part of the sell-
ing governmental entity's financial reporting entity, it adds a receivable to its
financial statements equal to the purchase price.
5.51 As noted in paragraphs 13–14 of GASB Statement No. 48, in a sale of
future revenues, rather than being reported as revenue at the time of the sale,
the proceeds from the sale of a future revenue source generally will be reported
as deferred revenue and recognized over the life of the sale agreement. In each
year of the agreement, a portion of the deferred amount would be recognized
as revenue. The purchasing governmental entity in a sale of future revenues
(if it is not part of the reporting entity of the selling governmental entity) rec-
ognizes the acquisition at cost and amortizes the amount over the life of the
agreement and realizes receivables and revenue when the recognition crite-
ria under GAAP are met—the revenue stream now belongs to the purchasing
government. Paragraph 16 of GASB Statement No. 48 discusses amortization
of the deferred amounts.
5.52 GASB Statement No. 48 discusses exchanges by governmental enti-
ties of interests in their expected cash flows from collecting specific receivables
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or specific future revenues for immediate cash payments. Paragraph 15 of GASB
Statement No. 48 discusses how such exchanges occurring within a reporting
entity should be accounted for.
5.53 If the purchasing governmental entity is a part of the same financial
reporting entity as the selling governmental entity, then the sale is an intra-
entity transaction. For example, a governmental entity might sell receivables
to one of its component units. In this case, the component unit purchasing
the governmental unit entity's receivables should recognize assets equal to the
governmental entity's carrying value of the receivables. The difference between
the purchase price and the carrying value would be accounted for as a revenue,
expense, or expenditure by the component unit in its separately issued financial
statements. However, in the financial statements of the governmental entity's
reporting entity (of which both the governmental entity and the component unit
are a part), these amounts would be classified as transfers or subsidies between
the two governmental entities.
5.54 In the case of a sale of future revenues between components of the
same reporting entity, the buyer does not add an asset to its financial state-
ments because no carrying value is reported by the seller. Assets and revenues
would not be reported by the purchasing governmental entity until appropriate
under GAAP. The purchasing governmental entity would report the amount it
paid as a deferred charge that would be spread over the life of the sale agree-
ment. Each year a portion of the charge would be recognized as an expense or
expenditure. The selling governmental entity likewise defers the revenue and
recognizes revenue over the duration of the sales agreement. Paragraph 16 of
GASB Statement No. 48 discusses amortization of the deferred amounts.
5.55 GASB Statement No. 48 also discusses, intra-entity transfers of as-
sets, including capital assets. It states that when accounting for the transfer of
capital assets within the same financial reporting entity, the transferee should
recognize the assets received at the carrying value of the transferor (that is,
they should not be revalued).12
Auditing
5.56 In general, receivables, particularly those arising from health care
services, are material to the financial position of health care entities. Examples
of specific auditing objectives, selected control activities, and auditing proce-
dures that may be considered by the independent auditor as they relate to the
major components of receivables of health care entities are presented in exhibit
5-1 at the end of this chapter.
5.57 SOP 00-1 provides guidance to auditors in evaluating the reasonable-
ness of management's estimates regarding the proper valuation of health care
third-party revenues and receivables embodied in the financial statements.
5.58 Interpretation No. 1, "Auditing Interests in Trusts Held by a Third-
Party Trustee and Reported at Fair Value," of AU section 328, Auditing Fair
12 The GASB staff document Comprehensive Implementation Guide, items Z.48.4–Z.48.6 describe
situations in which two parts of the same reporting entity have differing capitalization polices and
reiterates that the transfers are to be made at the transferor's net book value, regardless of whether
the receiving function would have, or would not have, capitalized the asset under its own capitalization
policy at some other value, or no value, had it purchased it or otherwise acquired it, such as through
donation, from a party outside the reporting entity.
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Value Measurements and Disclosures (AICPA, Professional Standards, vol. 1,
AU sec. 9328 par. .01–.04), provides guidance for auditors of nonissuers when
the auditor determines auditing procedures should include verifying the exis-
tence and testing the measurement of investments held by a trust (for example,
when auditing beneficial interests reported at fair value, see paragraph 5.19–
.20 of this chapter). That interpretation includes guidance regarding the ade-
quacy of audit evidence in confirmations received from trustees with respect to
the existence assertion and requirements for auditing fair value measurements
in accordance with AU section 328.13
Accounts Receivable Confirmations
5.59 Direct confirmation of amounts due from discharged patients and
third-party payors may be an appropriate audit procedure for obtaining evi-
dence about the existence and accuracy of amounts due.14 However, many pa-
tients whose accounts are expected to be paid by a third-party payor may not
have received bills, and many third-party payors may be unable to respond to
confirmation requests on specific account balances. In addition, obtaining con-
firmation of receivables from patients who are not discharged may be imprac-
ticable because those patients may not know the amount of their indebtedness
until they are discharged.
5.60 If confirmation of amounts due from patients and third-party payors
is impracticable or determined not to be effective, AU section 330, The Confir-
mation Process (AICPA, Professional Standards, vol. 1), provides requirements
and guidance for documenting this decision, and using alternate procedures
such as
 performing an analytical procedure or testing the details of sub-
sequent receipts.
 reviewing third-party contracts or payment agreements.
 comparing billings with documentation in medical records.
 reviewing the results of third-party payor audits and, if available,
peer review organization reports.
 examining or confirming interim payments with third-party payors.
13 Public Company Accounting Oversight Board (PCAOB) Staff Audit Practice Alert No. 2, Mat-
ters Related to Auditing Fair Value Measurements of Financial Instruments and the Use of Specialists
(AICPA, PCAOB Standards and Related Rules, PCAOB Staff Guidance, sec. 400 par. .02), provides
guidance on auditors' responsibilities for auditing fair value measurements of financial instruments
and when using the work of specialists under the existing standards of the PCAOB. This alert is
focused on specific matters that are likely to increase audit risk related to the fair value of finan-
cial instruments in a rapidly changing economic environment. This practice alert highlights certain
requirements in the auditing standards related to fair value measurements and disclosures in the
financial statements and certain aspects of generally accepted accounting principles that are particu-
larly relevant to the current economic environment. PCAOB Staff Audit Practice Alerts are not rules
of the board, nor have they been approved by the board.
PCAOB Staff Audit Practice Alert No. 4, Auditor Considerations Regarding Fair Value Measure-
ments, Disclosures, and Other-Than-Temporary Impairments (AICPA, PCAOB Standards and Related
Rules, PCAOB Staff Guidance, sec. 400 par. .04), was issued on April 21, 2009. The purpose of this
staff audit practice alert is to inform auditors about potential implications of the FSPs on reviews of
interim financial information and annual audits. This alert addresses the following topics: (1) reviews
of interim financial information (reviews); (2) audits of financial statements, including integrated au-
dits; (3) disclosures; and (4) auditor reporting considerations. PCAOB Staff Audit Practice Alerts are
not rules of the board, nor have they been approved by the board.
14 Interpretation No. 1, "Use of Electronic Confirmations," of AU section 330, The Confirmation
Process (AICPA, Professional Standards, vol. 1, AU sec. 9330 par. .01–.08), states that properly con-
trolled electronic confirmations may be considered to be reliable audit evidence and discusses auditor
considerations when using electronic confirmations.
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Exhibit 5-1
The following table illustrates the use of assertions in developing audit ob-
jectives and designing substantive tests. The examples are not intended to
be all-inclusive nor is it expected that all the procedures would necessarily be
applied in an audit. The auditor should design and perform substantive pro-
cedures for all relevant assertions related to each material class of transac-
tions, account balance, and disclosure to obtain sufficient appropriate audit
evidence. The use of assertions in assessing risks and designing appropriate
audit procedures to obtain audit evidence is described in paragraphs .14–.26
of AU section 326, Audit Evidence (AICPA, Professional Standards, vol. 1).
Various audit procedures and the purposes for which they may be performed
are described in paragraph .27–.41 of AU section 326.
Auditing Considerations
Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities
Auditing
Procedures
Receivables for Health Care Services
Account Balances
Existence Amounts reported
in the financial
statements
represent valid
receivables, which
do not include
charity care
balances.
Charges are
generated
automatically
when services
are performed.
Review and test
subsequent
receipts.
A medical record
is prepared.
Compare billing
information to the
documentation
contained in the
medical records.
Procedures
ensure that
amounts due
from third-party
payors for
individual
accounts are
supported
properly.
Review the results
of the peer review
organization, if
available, and
insurance
company reviews
for evidence that
might indicate
receivables may
not be realized.
Procedures
ensure the
proper recording
of cash receipts.
Trace the receipts
applicable to
patient accounts to
the accounts
receivable records.
(continued)
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Auditing Considerations—continued
Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities
Auditing
Procedures
Procedures
ensure charity
care balances are
identified and
excluded from
gross
receivables.
Review the
management
policy for
determining
charity care.
Review policy and
reasonableness of
charity care
measurement.
Completeness Amounts reported
in the financial
statements are
complete and are
calculated and
accumulated
properly.
Procedures
ensure that (a)
detailed accounts
receivable
records are
compared
routinely with
control accounts
and third-party
payor logs, (b)
differences are
investigated and
reconciled, and
(c) adjustments,
if necessary, are
made promptly.
Compare detailed
accounts
receivable records
with control
accounts and
third-party payor
logs, and
investigate
reconciling items.
Valuation and
allocation
Receivables are
reported in the
financial
statements at net
realizable value.
Allowances for
uncollectibles
and contractual
adjustments are
reviewed
periodically by
management to
ensure that
receivables are
reported at
estimated net
realizable value.
Review third-party
contracts and
recompute patient
receivables.
Examine contracts
or confirm interim
third-party
payments with
third-party payors.
Write-offs and
allowances for
uncollectibles
are identified
and approved in
accordance with
the entity's
established
policy.
Review and test
the method used to
determine the
allowances for
uncollectible
accounts.
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Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities
Auditing
Procedures
Determine that
patient accounts
are classified
appropriately by
payor (for
example, Medicare
or self-pay) to
evaluate
collectibility.
Test Medicare logs
for accuracy and
completeness.
Test and analyze
aged accounts
receivable trial
balances,
collection trends,
delinquent
accounts,
subsequent period
write-offs and
economic or other
factors used to
determine
allowance for
uncollectible
accounts.
Review pledges
and other
receivables for
collectibility.
Presentation and Disclosure
Classification and
understandability
Significant
contractual
arrangements
with third parties
are disclosed.
Determine that
significant
contractual
arrangements
with third parties
are disclosed.
(continued)
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Auditing Considerations—continued
Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities
Auditing
Procedures
Estimated Third-Party Settlements
Account Balances
Existence Amounts reported
in the financial
statements
represent valid
receivables or
payables.
Procedures
ensure that
estimated
third-party
settlements are
determined in
accordance with
the
reimbursement
and rate-setting
methodologies
applicable to the
entity.
Review
correspondence
from significant
third-party payors
related to (a)
interim payment
rates applicable to
periods for which
final settlements
have not been
made and (b) the
amount of interim
or final
settlements made
during the period.
Transactions
Completeness and
accuracy/
valuation and
allocation
Amounts included
in the financial
statements are
accurate and
complete.
Procedures
ensure that
estimated
third-party
settlements are
reasonably
calculated and
reported.
Test the
reasonableness of
settlement
amounts,
including specific
and unallocated
reserves, in light
of the payors
involved, the
nature of the
payment
mechanism, the
risks associated
with future audits,
and other relevant
factors.
Review third-party
payor audit
reports and
adjustments for
prior years' cost
reports or
settlements to
consider whether
(a) the effect of
such adjustments
has been reported
properly in the
financial
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Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities
Auditing
Procedures
statements and (b)
adjustments of a
similar nature
apply to the
current period.
Obtain a
representation
from management
that provisions for
estimated
retroactive
adjustments by
third-party payors
under
reimbursement
agreements for
open years are
adequate.
Presentation and Disclosure
Classification and
understandability
Amounts reported
in the financial
statements are
presented
properly and all
required
disclosures are
made.
Determine that
the tentative
nature of
third-party
settlement
amounts is
disclosed properly.
Determine that
differences
between original
estimates and
subsequent
revisions
(including final
settlements) are
included in the
statement of
operations in the
period in which
the revisions are
made and
disclosed, if
material.
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Chapter 6
Property and Equipment, Supplies,
and Other Assets
Overview
6.01 Health care entities use various types of property and equipment.
Those assets may be material to the financial position of institutional health
care entities, such as hospitals and nursing homes. Typical accounts used to
record property and equipment transactions are land, land improvements,
buildings and improvements, leasehold improvements, equipment (fixed and
movable), leased property and equipment, accumulated depreciation and amor-
tization, and construction in progress.
6.02 Supplies usually are not material to the financial position of health
care entities. However, because of the volume of supply transactions, they may
materially affect operations. Supplies typically include medical and surgical
supplies; pharmaceuticals; linens, uniforms, and garments; food and other com-
modities; and housekeeping, maintenance, and office supplies.
6.03 Financial Accounting Standards Board (FASB) Accounting Stan-
dards Codification (ASC) 954-340-05-2 states that other assets may include
prepaid expenses, deposits, and deferred expenses. Prepaid costs may include
amounts paid to physicians for future services (for example, administering a
hospital department or providing community services that further the entity's
mission). According to FASB ASC 954-340-45-1, prepaid expenses, deposits, de-
ferred expenses, and prepaid costs should be classified as current or noncurrent
as appropriate.
6.04 FASB ASC 954-340-35-2 states that prepaid costs, if deferred, should
be amortized over the period benefited.
Accounting
6.05 Accounting for property and equipment, supplies, and other assets
of health care entities is similar to that used by other business entities. Non-
governmental health care entities should apply the guidance in FASB ASC 360,
Property, Plant, and Equipment, and FASB ASC 340, Other Assets and Deferred
Costs, except when the guidance conflicts with the specialized guidance in FASB
ASC 954, Health Care Entities.
6.06 Paragraphs 2–11 of FASB ASC 360-10-35 discuss depreciation and
amortization of property and equipment. Depreciation accounting intends to
distribute the cost or other basic value of tangible capital assets, less salvage (if
any), over the estimated useful life of the unit (which may be a group of assets) in
a systematic and rational manner. It is a process of allocation, not of valuation.
6.07 Useful lives assigned to depreciable assets should be reasonable,
based on the circumstances. The American Hospital Association publishes use-
ful guidelines for classifications and estimated useful lives for property and
equipment used by hospitals. Those guidelines also may be useful to other
health care entities.
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6.08 If there is a potential that an asset is impaired, nongovernmental
health care entities should consider the guidance in the impairment or disposal
of long-lived assets subsections of FASB ASC 360-10,1 Those subsections of
FASB ASC 360-10 require that nongovernmental health care entities review
long-lived assets for impairment whenever events or changes in circumstances
indicate that the carrying amount of the asset may not be recoverable.
6.09 Governmental health care entities only. Governmental health care
entities should also consider the guidance in Governmental Accounting Stan-
dards Board (GASB) Statement No. 42, Accounting and Financial Reporting
for Impairment of Capital Assets and for Insurance Recoveries, for impairment
of capital assets, as defined in paragraph 19 of GASB Statement No. 34, Basic
Financial Statements—and Management's Discussion and Analysis—for State
and Local Governments. GASB Statement No. 42 requires the evaluation of
prominent events or changes in circumstances affecting capital assets to deter-
mine whether impairment has occurred.
6.10 With respect to leases, FASB ASC 840, Leases, provides account-
ing guidance.* Paragraphs 10–11 of FASB ASC 840-20-25 provide guidance
for rental costs associated with ground and building operating leases that are
incurred during a construction period.
6.11 Governmental health care entities only. NCGA Statement No. 5, Ac-
counting and Financial Reporting Principles for Lease Agreements of State and
Local Governments, requires the application of FASB Statement No. 13, Ac-
counting for Leases, for proprietary activities and provides additional guidance
on specific matters unique to governmental entities. GASB Statement No. 13,
Accounting for Operating Leases with Scheduled Rent Increases, provides addi-
tional guidance for operating leases of governmental health care entities.
6.12 The recognition of contribution income related to donated long-lived
assets (or assets recognized to be acquired with donated funds) is discussed in
chapter 10 of this guide.
6.13 FASB ASC 410-20 establishes accounting standards for recognition
and measurement of a liability for an asset retirement obligation and the asso-
ciated asset retirement cost. FASB ASC 410-20 also addresses the accounting
for an environmental remediation liability that results from the normal oper-
ation of a long-lived asset.2 Paragraph 6.14 provides a very brief summary of
1 Governmental health care entities only. This pronouncement is not applicable to governmental
health care entities that do not apply paragraph 7 of Governmental Accounting Standards Board
(GASB) Statement No. 20, Accounting and Financial Reporting for Proprietary Funds and Other
Governmental Entities That Use Proprietary Fund Accounting. (See footnote 1 in chapter 1.)
* In June 2008, the Financial Accounting Standards Board (FASB) issued Emerging Issues Task
Force (EITF) Issue No. 08-3, "Accounting by Lessees for Maintenance Deposits." EITF Issue No. 08-3
clarifies how a lessee shall account for a maintenance deposit under an arrangement accounted for
as a lease and is effective for financial statements issued for fiscal years beginning after December
15, 2008, including interim periods within those fiscal years. Earlier application by an entity that has
previously adopted an alternative accounting policy is not permitted.
This guidance is located in sections 5, 25, and 35 of FASB Accounting Standards Codification
(ASC) 840-10, some of which is labeled as "Pending Content" due to the transition and open effective
date information discussed in FASB ASC 840-10-65-1. For more information on FASB ASC, please
see the notice to readers in this guide.
2 Governmental health care entities only. This pronouncement does not apply to governmen-
tal health care entities' conditional asset retirement obligations, such as asbestos removal, unless
probable of occurrence as discussed in National Council on Governmental Accounting Statement 4,
(continued)
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FASB ASC 410-20, but is not intended as a substitute for the reading of FASB
ASC 410-20.
6.14 Paragraphs 2–3 of FASB ASC 410-20-15 define the scope of FASB
ASC 410-20, which includes legal obligations associated with the retirement
of a tangible long-lived asset that result from the acquisition, construction,
development, and (or) normal operation of a long-lived asset, including any
legal obligations that require disposal of a replaced part that is a component of
a tangible long-lived asset. FASB ASC 410-20-25-4 states that an entity should
recognize the fair value of a liability for an asset retirement obligation in the
period in which it is incurred if a reasonable estimate of fair value can be made.3
In accordance with paragraphs 7–13 of FASB ASC 410-20-25, if there is a legal
obligation to perform an asset retirement activity in which the timing and (or)
method of settlement are conditional on a future event that may or may not
be within the control of the entity—a conditional asset retirement obligation—
the entity should recognize a liability if the fair value of the liability can be
reasonably estimated. If a reasonable estimate of fair value cannot be made in
the period the asset retirement obligation is incurred, the liability should be
recognized when a reasonable estimate of fair value can be made. FASB ASC
410-20-25-5 indicates that upon initial recognition of a liability for an asset
retirement obligation, an entity should capitalize an asset retirement cost by
increasing the carrying amount of the related long-lived asset by the same
amount as the liability. FASB ASC 410-20-50 includes disclosure requirements.
Financial Statement Presentation
6.15 Financial statement presentation of property and equipment of
health care entities is similar to that of other business entities. Donor or le-
gal restrictions on the proceeds from the disposition of donated property and
equipment (or of property and equipment purchased with cash restricted for
acquisition of long-lived assets) are disclosed.
6.16 According to FASB ASC 954-360-45-1, property held for investment
purposes should be presented as part of investments.
6.17 Financial statement presentation of supplies and other assets of
health care entities is similar to that of other business entities.
6.18 Governmental health care entities only. Capital assets for governmen-
tal health care entities that are not being depreciated, if significant, should be
reported separately in the statement of net assets from capital assets being de-
preciated, as discussed in GASB Statement No. 34 paragraph 20. GASB State-
ment No. 34 also establishes 2 capital-asset related-disclosure requirements
for governmental health care entities. First, GASB Statement No. 34 para-
graph 115e requires entities to disclose their policy for capitalizing assets and
for estimating the useful lives of those assets in their summary of significant
accounting policies. Second, GASB Statement No. 34 paragraphs 116–117 re-
quire certain information to be presented about major classes of capital assets,
(footnote continued)
Accounting and Financial Reporting Principles for Claims and Judgments and Compensated
Absences, as amended, paragraphs 9 and 14. This pronouncement is not applicable to governmental
health care entities that do not apply paragraph 7 of GASB Statement No. 20. (See footnote 1 in
chapter 1.)
3 For additional discussion on fair value measurements, refer to chapter 1.
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including beginning and ending balances, capital acquisitions, sales or other
dispositions, current period depreciation expense, and accumulated deprecia-
tion. Capital assets that are not being depreciated should be disclosed sepa-
rately from those that are being depreciated. GASB Statement No. 42 para-
graph 20 requires disclosure of the carrying amount of impaired capital assets
that are idle at year-end and the financial statement classification of impair-
ment losses.
Auditing
6.19 Auditing objectives for property and equipment, supplies, and other
assets of health care entities are similar to those in audits of other business
entities. The auditor may be able to assess the risks of material misstatement
for these accounts as being relatively low because the transactions therein are
generally small in number, relatively simple in nature, and do not involve the
use of complex estimates. The auditor must obtain a sufficient understanding
of the entity and its environment, including its internal control, to assess the
risk of material misstatement for these accounts.
6.20 A health care entity may have access to the use of property and equip-
ment under a variety of arrangements. It may (a) own property and equipment,
(b) rent property and equipment from an independent or related entity, (c) use
property and equipment provided by a related entity (such as a religious order)
or by an unrelated entity under an affiliation program, or (d) use property and
equipment provided by a government agency or unit or a government-related
hospital district. The independent auditor should inquire into (and the financial
statements should disclose) the nature of any relationship between the health
care entity and lessors, bailors, or other owners of property.
6.21 In evaluating capitalization policies, the independent auditor should
consider whether interest has been capitalized in accordance with FASB ASC
835-20.
6.22 In evaluating the entity's depreciation policies, the auditor may wish
to refer to the American Hospital Association's Estimated Useful Lives of Depre-
ciable Hospital Assets, which is revised periodically and sets forth plant asset
classifications and the estimated useful lives of depreciable assets. Additionally,
social, economic, and scientific advances in the health care industry make ob-
solescence an important factor to be considered when evaluating depreciation
policies and methods.
6.23 In considering a nongovernmental health care entity's application of
the impairment or disposal of long-lived assets subsections of FASB ASC 360-
10, auditors may obtain an understanding of the policies and procedures used
by management to determine whether all impaired assets have been properly
identified. In addition to evaluating the entity's procedures for identifying in-
dicators of impairment, the auditor may consider information obtained during
the audit in determining whether the health care entity has identified appro-
priate indicators of impairment. For example, a change in the use of a facility
from an acute-care hospital to an ambulatory surgery center may require that
the asset be reviewed for impairment.
6.24 In obtaining sufficient appropriate audit evidence with respect to
property and equipment, supplies, and other assets, the auditor may consider
the examples of specific auditing objectives, selected control activities, and au-
diting procedures that are presented in exhibit 6-1.
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Exhibit 6-1
The following table illustrates the use of assertions in developing audit ob-
jectives and designing substantive tests. The examples are not intended to
be all-inclusive nor is it expected that all the procedures would necessarily be
applied in an audit. The auditor should design and perform substantive pro-
cedures for all relevant assertions related to each material class of transac-
tions, account balance, and disclosure to obtain sufficient appropriate audit
evidence. The use of assertions in assessing risks and designing appropriate
audit procedures to obtain audit evidence is described in paragraphs .14–.26
of AU section 326, Audit Evidence (AICPA, Professional Standards, vol. 1).
Various audit procedures and the purposes for which they may be performed
are described in paragraph .27–.41 of AU section 326.
Auditing Considerations
Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities
Auditing
Procedures
Donated Property Equipment
Account Balances
Valuation and
allocation
Donated property
and equipment is
reported at fair
market value at
the date of
donation.4
Procedures
ensure that the
donation of
property and
equipment is
known and
recorded and that
documentation
supports the
determination of
the fair market
value.
Review the
documentation
supporting the
determination of
the fair market
value.1
Presentation and Disclosure
Classification and
understandability
The receipt of
donated property
and equipment is
properly reported.
Review material
donated property
and equipment
transactions to
ensure the
propriety of the
reporting.
(continued)
4 See footnote 3 in paragraph 6.14.
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Auditing Considerations—continued
Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities
Auditing
Procedures
Property and Equipment Not Held for Use in Operations
Presentation and Disclosure
Classification and
understandability
Property and
equipment not
used for
operations is
reported
separately.
Property records
segregate
property and
equipment not
used for operating
purposes.
Determine that
property held for
nonoperating
purposes is
reported
separately.
Property and Equipment Additions
Account Balances
Rights and
obligations
The appropriate
health care
planning agency
or other
regulatory agency
approvals, if
required, have
been obtained for
property and
equipment
additions.
Management
regularly
monitors
compliance with
health care
planning agency
regulations
related to
additions of
property and
equipment.
For material new
construction,
determine
compliance with
health care
planning agency
or other
regulatory agency
requirements.
Additions are
authorized in the
capital budget.
Existence and
valuation and
allocation
Recorded
property and
equipment are
owned by the
entity and are
carried at the
appropriate
amounts.
Inventory of fixed
assets is taken
periodically.
Detailed property
records
periodically are
reconciled to the
recorded
amounts.
Review a
summary of
property and
equipment (cost
and accumulated
depreciation)
including
additions,
deletions, and
transfers.
1 AU section 328, Auditing Fair Value Measurements and Disclosures (AICPA,
Professional Standards, vol. 1), establishes requirements and provides guid-
ance on auditing fair value measurements and disclosures contained in fi-
nancial statements. AU section 328 does not address specific types of assets,
liabilities, components of equity, transactions, or industry-specific practices
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Considerations for Audits Performed in Accordance with PCAOB Standards†
PCAOB Staff Audit Practice Alert No. 2, Matters Related to Auditing Fair
Value Measurements of Financial Instruments and the Use of Specialists
(AICPA, PCAOB Standards and Related Rules, PCAOB Staff Guidance, sec.
400 par. .02), provides guidance on auditors' responsibilities for auditing fair
value measurements of financial instruments and when using the work of
specialists under the existing standards of the PCAOB. This alert is focused
on specific matters that are likely to increase audit risk related to the fair
value of financial instruments in a rapidly changing economic environment.
This practice alert highlights certain requirements in the auditing stan-
dards related to fair value measurements and disclosures in the financial
statements and certain aspects of GAAP that are particularly relevant to
the current economic environment. PCAOB Staff Audit Practice Alerts are
not rules of the board, nor have they been approved by the board.
† Public Company Accounting Oversight Board (PCAOB) Staff Audit Practice Alert No. 4, Au-
ditor Considerations Regarding Fair Value Measurements, Disclosures, and Other-Than-Temporary
Impairments (AICPA, PCAOB Standards and Related Rules, PCAOB Staff Guidance, sec. 400 par.
.04), was issued on April 21, 2009. The purpose of this staff audit practice alert is to inform auditors
about potential implications of the FSPs on reviews of interim financial information and annual au-
dits. This alert addresses the following topics: (1) reviews of interim financial information ("reviews");
(2) audits of financial statements, including integrated audits; (3) disclosures; and (4) auditor report-
ing considerations. PCAOB Staff Audit Practice Alerts are not rules of the board, nor have they been
approved by the board.
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Chapter 7
Current Liabilities, Tax Considerations,
and Long Term Obligations
Overview
7.01 Current liabilities may include notes payable to banks; the cur-
rent portion of long term debt; accounts payable; advances from and amounts
payable to third-party payors for estimated and final reimbursement settle-
ments; refunds to and deposits from patients and others; deferred revenue;
accrued salaries and payroll taxes; and other accruals such as pension or profit-
sharing contributions, compensated absences, and income and other taxes. In
addition, there may be a current portion of estimated malpractice costs and
risk-contract recognized losses (see chapter 8).
7.02 As discussed in paragraphs 1.116–.118 of this guide, the fair value op-
tion subsections of Financial Accounting Standards Board (FASB) Accounting
Standards Codification (ASC) 825-10 permit a nongovernmental health care
entity to irrevocably elect fair value, as defined by FASB ASC glossary as the
price that would be received to sell an asset or paid to transfer a liability in
an orderly transaction between market participants at the measurement date,
with changes in fair value recognized in the statement of activities as those
changes occur.1 Liabilities that require the entity to provide services, rather
than cash or another financial asset, to the obligee are outside the scope of the
statement and thus may not be reported at fair value.
7.03 Long term obligations may include notes, mortgages, capital leases,
bonds, and obligations under continuing care contracts. They also may include
estimated malpractice cost and risk-contract recognized losses.
Accounting
7.04 Accounting for current liabilities of health care entities is similar to
that of other business entities. Health care entities are usually labor-intensive
and provide employees with compensated absences, such as for holidays, vaca-
tions, and illnesses. Liabilities related to such absences are accounted for in ac-
cordance with FASB ASC 710, Compensation—General. Governmental health
care entities should follow the guidance in Governmental Accounting Standards
Board (GASB) Statement No. 16, Accounting for Compensated Absences.
7.05 FASB ASC 712, Compensation—Nonretirement Postemployment
Benefits and FASB ASC 715, Compensation—Retirement Benefits,* provide
1 For additional discussion of the fair value option subsections of Financial Accounting Standards
Board (FASB) Accounting Standards Codification (ASC) 825-10, see chapter 1.
* On December 30, 2008, FASB issued FASB Staff Position (FSP) FAS 132(R)-1, Employers'
Disclosures about Postretirement Benefit Plan Assets, to provide guidance on a health care entity's
disclosures about plan assets of a defined benefit pension or other postretirement plan. FSP FAS
132(R)-1 also includes a technical amendment to FASB Statement No. 132(R), Employers' Disclosures
about Pensions and Other Postretirement Benefits—an amendment of FASB Statements No. 87, 88,
and 106, that requires a nonpublic entity to disclose net periodic benefit cost for each annual period
(continued)
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guidance on employee benefits. In addition, investor-owned health care enti-
ties should account for share-based payment transactions with employees in
accordance with FASB ASC 718, Compensation—Stock Compensation.
7.06 Governmental health care entities only. Governmental health care en-
tities are not required to apply FASB Statement No. 158, Employers'Accounting
for Defined Benefit Pension and Other Postretirement Plans—an amendment of
FASB Statements No. 87, 88, 106, and 132(R), which has been codified in FASB
ASC 715. GASB Statement No. 45, Accounting and Financial Reporting by Em-
ployers for Postemployment Benefits Other Than Pensions, provides guidance
and requirements for disclosures about postemployment benefits. The require-
ments of GASB Statement No. 45 are effective in 3 phases based on revenues:
periods beginning after December 15, 2006, for phase 1 governments (total an-
nual revenues of $100 million or more); periods beginning after December 15,
2007, for phase 2 governments (total annual revenues of $10 million or more
but less than $100 million); and periods beginning after December 31, 2008, for
phase 3 governments (total annual revenues of less than $10 million). GASB
Statement No. 47, Accounting for Termination Benefits, establishes account-
ing standards for the measurement, recognition, and disclosure of voluntary
termination benefits and involuntary termination benefits.
7.07 Governmental health care entities only. Governmental health care en-
tities sometimes report government-mandated or voluntary nonexchange rev-
enues, such as expenditure-driven grants. These revenues are recognized when
all eligibility requirements have been met, as discussed in GASB Statement
No. 33, Accounting and Financial Reporting for Nonexchange Transactions. In
some cases, it may become apparent after revenue has been recognized in the
financial statements that the eligibility requirements are no longer met, for ex-
ample, because an audit of a particular grant program determined that certain
expenses did not meet purpose restrictions. GASB Statement No. 33 provides
that, if it is probable that the recipient must return all or part of the resources,
a liability (or reduction of receivables) and an expense should be recognized
for the amount that the resource provider (grantor) is expected to cancel or
reclaim. (See paragraphs 5.29–.30, 10.08, and 10.22 for further discussion of
GASB Statement No. 33.)
Tax Considerations for Health Care Entities
7.08 Health care entities that are owned and operated by a state or local
government are exempt from federal income tax pursuant to Internal Revenue
Code (IRC) sec. 115 and also are exempt from the federal income tax filing
requirements. Such entities are exempt not only from regular federal income
tax but also from the tax on unrelated business income. If a health care entity is
owned and operated by a separately constituted authority or other legal entity,
the entity's management ordinarily should consider whether such authority
(footnote continued)
for which a statement of income is presented, which is effectively immediately and located in FASB
ASC 715-20-50-5(gg). FSP FAS 132(R)-1 is required for fiscal years ending after December 15, 2009.
Upon initial application, the provisions of FSP FAS 132(R)-1 are not required for earlier periods that
are presented for comparative purposes. Early application of FSP FAS 132(R)-1 is permitted.
This guidance is located in sections 50 and 55 of FASB ASC 715-20 and FASB ASC 820-10-50-10
and is labeled as "Pending Content" due to the transition and open effective date information
discussed in FASB ASC 715-20-65-2. For more information on FASB ASC, please see the notice to
readers in this guide.
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or other legal entity is organized properly to preserve qualification of the tax
exemption pursuant to IRC sec. 115. In some cases, state or local governmental
entities will secure tax-exempt status as an IRC sec. 501(c)(3) organization. If
such an exemption is secured, the entity may become subject to federal income
tax and the related filing requirements on the same basis as other tax-exempt
entities.
7.09 Entities take many tax positions relative to tax laws, including those
taken in determining whether tax is due, a refund is owed, a tax return needs
to be filed, or the characterization of income as taxable (for example, unrelated
business income—see paragraph 7.16) or nontaxable. A tax position could result
in or affect the measurement of a current or deferred tax asset or liability in
the statement of financial position.
7.10 According to FASB ASC 740-10-25-6, an entity should initially rec-
ognize the financial statement effects of a tax position when it is more likely
than not, based on the technical merits, that the position will be sustained upon
examination. The term more likely than not means a likelihood of more than
50 percent; the terms examined and upon examination also include resolution
of the related appeals or litigation processes, if any.†
7.11 The AICPA has prepared a practice guide to help in understanding
the recognition of uncertain tax positions. The practice guide is available at
http://tax.aicpa.org/Resources.
Tax-Exempt Entities
7.12 Nongovernmental not-for-profit health care entities usually seek
exemption from federal income tax under IRC sec. 501(a). Under IRC sec.
501(a), entities organized and operated exclusively for religious, charitable, or
† FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes—an interpretation of
FASB Statement No. 109, is included within FASB ASC 740-10 and is effective for fiscal years be-
ginning after December 15, 2006. However, FSP FIN 48-3, Effective Date of FASB Interpretation No.
48 for Certain Nonpublic Enterprises, defers the effective date of that interpretation to fiscal years
beginning after December 15, 2008, for certain nonpublic enterprises as defined by the glossary of
FASB ASC 740-10, including nonpublic not-for-profit health care entities. If a nonpublic health care
entity decides to defer in accordance with the FSP, it should disclose that fact and its accounting policy
for evaluating uncertain tax positions. Earlier application of FASB Interpretation No. 48 is permitted.
Health care entities that have already adopted the provisions of FASB Interpretation No. 48 are not
eligible for the deferral.
This guidance is located in sections 15 and 65 of FASB ASC 740-10. The AICPA has prepared a
practice guide to help in understanding the interpretation. The practice guide is available by following
the "Professional Standards and Ethics" link at http://tax.aicpa.org/Resources.
In September 2009, FASB issued Accounting Standards Update (ASU) No. 2009-6, Implementa-
tion Guidance on Accounting for Uncertainty in Income Taxes and Disclosure Amendments for Nonpub-
lic Entities. ASU No. 2009-6 addresses the need for additional implementation guidance on accounting
for uncertainty in income taxes by answering the following questions:
1. Is the income tax paid by the entity attributable to the entity or its owners?
2. What constitutes a tax position for a pass-through entity or a tax-exempt not-for-profit
entity?
3. How should accounting for uncertainty in income taxes be applied when a group of
related entities comprise both taxable and nontaxable entities?
ASU No. 2009-6 also eliminates the disclosures required by FASB ASC 740-10-50-15(a).
For entities that are currently applying the standards for accounting for uncertainty in income
taxes, ASU No. 2009-6 is effective for financial statements issued for interim and annual periods
ending after September 15, 2009. For those entities that have deferred the application of accounting for
uncertainty in income taxes in accordance with FASB ASC 740-10-65-1(e), the guidance and disclosure
amendments are effective upon adoption of those standards.
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educational purposes, as described in IRC sec. 501(c)(3), are exempt from fed-
eral income taxes. The following are additional requirements for such entities:
a. No part of the entity's net earnings, either directly or indirectly,
inures to any private shareholder or individual.
b. No substantial part of the entity's activities consists of carrying on
propaganda or otherwise attempting to influence legislation. (IRC
sec. 501(h) provides a limited exception to the general rule that pub-
lic charities may not incur expenditures to influence legislation.)
c. The entity does not participate in, or intervene in, any political
campaign on behalf (or in opposition to) of any candidate for public
office.
7.13 The term charitable is used in IRC sec. 501(c)(3) in its generally
accepted legal sense. Providing health care to the community is considered a
charitable activity. Therefore, provided a health care entity is not organized or
operated for the benefit of private interests (such as designated individuals, the
founder or the founder's family, shareholders of the entity, or persons controlled
directly or indirectly by such private interests), it generally would qualify as
an IRC sec. 501(c)(3) organization.
7.14 The IRS has ruled that in order for a nursing home to establish its
exemption as a public charitable organization under IRC sec. 501(c)(3), it must
be operated to meet the primary needs of the elderly for housing, health care,
and financial security. Operating for financial security generally means that an
individual will be maintained in residence even if such individual can no longer
pay residence fees.
Private Inurement
7.15 Under IRC sec. 501(c)(3) no part of the net earnings of the charitable
organization shall inure to the benefit of any private shareholder or individ-
ual. A private shareholder or individual refers to a person or persons having a
private or personal interest in the activities of the organization. The IRS has
stated that physicians have a personal or private interest in the activities of a
hospital and could be subject to the private inurement proscription.
Unrelated Business Income Tax
7.16 Although not-for-profit entities may be exempt from federal income
tax, they nevertheless may be subject to tax on unrelated business income.
The objective of the tax on unrelated business is to place such activities on the
same basis as that of taxable entities. Unrelated business income is the income
from any regularly carried-on trade or business, the conduct of which is not
substantially related to the exercise or performance of the entity's tax-exempt
purpose or function. The fact that proceeds from an activity are used exclusively
for the entity's tax-exempt purpose does not make the activity substantially
related to its tax-exempt purpose or function. As is the case with most tax-
related definitions, there are qualifications and exceptions. Some of the more
significant exclusions from this tax include
 an annual specific deduction for certain limited activities.
 income from activities of which substantially all the work is per-
formed by unpaid volunteers.
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 income from activities carried on for the convenience of the entity's
patients, officers, or employees.
 dividends, interest, annuities, royalties, capital gains and losses,
and rents from real property—with two major exceptions. The first
exception is that income from investments that are debt-financed
and otherwise not functionally related to the tax-exempt purpose
is taxable. The second major exception makes taxable the interest,
annuities, royalties, and rents received from a controlled (50 per-
cent owned) taxable corporation or partnership unless this entity
is engaged in an activity that would have been exempt if it were
carried on directly by the not-for-profit entity.
Financial Statement Presentation
7.17 Financial reporting and disclosure requirements for current liabili-
ties and long term obligations of health care entities are the same as for other
business entities. Taxable entities have the same financial reporting and dis-
closure requirements as other commercial entities.
7.18 In addition, FASB ASC 954-740-50-1 requires that tax-exempt en-
tities disclose their tax-exempt status. FASB ASC 954-430-50-1 requires that
continuing care retirement communities (CCRCs) disclose the method of ac-
counting for advance fees, the method of calculating the obligation to provide
future services and use of facilities, and the refund policy for refundable fees in
the financial statements. Chapter 14 describes other disclosure requirements
applicable to CCRCs.
7.19 Governmental health care entities only. GASB Statement No. 34,
Basic Financial Statements—and Management's Discussion and Analysis—for
State and Local Governments, and GASB Statement No. 38, Certain Finan-
cial Statement Note Disclosures, provide guidance about required disclosures
for governmental health care entities about current and long term liabilities,
including the following:
 GASB Statement No. 38 paragraph 13 requires disclosures about
accounts payable balances when significant components of those
balances have been obscured by aggregation.
 GASB Statement No. 38 paragraph 12 requires disclosures about
short-term debt activity during the year, even if no short-term
debt is outstanding at year-end. For this purpose, short-term debt
consists of anticipation notes, use of lines of credit, and similar
loans. Disclosures should include a schedule of changes in short-
term debt as well as a discussion of the purposes for which short-
term debt was issued.
 GASB Statement No. 34 paragraphs 116, 119, and 120 require
information to be presented about both long term debt, such as
bonds payable, and about long term liabilities, such as compen-
sated absences and claims and judgments. Required disclosures
include beginning and ending balances, increases, decreases, and
the portions of each item that are due within one year.
 GASB Statement No. 38 paragraphs 10–11 require disclosure of
debt service requirements to maturity for each of the five sub-
sequent years and in five-year increments thereafter. Principal
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and interest requirements are required to be disclosed separately.
Similar requirements apply to obligations under capital leases and
noncancelable operating leases.
 GASB Statement No. 38 paragraph 9 requires disclosure of actions
taken to remedy significant violations of finance-related legal or
contractual provisions.
Long Term Debt
7.20 Significant sums of money are required to replace and upgrade build-
ings and expand the facilities of health care entities. As a result, health care
entities are dependent on external sources of funds to satisfy their capital needs.
Many health care entities finance acquisitions, additions, and renovations with
long term debt.
7.21 In addition to serving as a financing source for government opera-
tions, tax-exempt debt frequently is issued by state and local governments on
behalf of nongovernmental entities (for example, not-for-profit entities) to fos-
ter private-sector participation in certain desirable community activities such
as the provision of health care services. Tax-exempt bonds usually can be is-
sued to obtain a higher ratio of project financing (up to 100 percent), a longer
maturity period (up to 30 years), and a lower interest cost than taxable bonds.
The majority of tax-exempt bonds issued by a health care entity are revenue
bonds, which are bonds secured by a pledge of the entity's revenues. General
obligation bonds are secured by the revenues of the issuing authority.
Financing Authorities2
7.22 Because most providers legally cannot issue tax-exempt revenue
bonds directly, a significant number of states have enacted legislation permit-
ting health care entities to borrow funds for capital projects by issuing bonds
through financing authorities. Financing authorities are authorized to issue
tax-exempt bonds or other obligations and use the proceeds for the benefit
of the health care entity. To obtain project financing, a health care entity some-
times is required by a financing authority to enter into a lease arrangement, a
sublease arrangement, or both. At other times, a lease or sublease arrangement
is not required.
7.23 As discussed in FASB ASC 954-470-25-1, When a financing authority
issues tax-exempt bonds or similar debt instruments and uses the proceeds
for the benefit of a health care entity, the obligation should be reported as a
liability in the entity's balance sheet if the health care entity is responsible
for repayment. In some cases, this obligation may take the form of a liability
arising from a capital lease. If a health care entity has no obligation to make
payments of principal and interest on the debt or capital or operating lease
payments on related buildings or equipment, the entity should not reflect the
liability on its balance sheet. In such circumstances, proceeds from the bond
issue should be reported as contributions from the sponsoring entity.
2 FSP FAS 126-1, Applicability of Certain Disclosure and Interim Reporting Requirements for
Obligors for Conduit Debt Securities, clarifies the definition of a public entity in certain accounting
standards to include entities that are conduit bond obligors for conduit debt securities that are traded
in a public market.
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Assets Whose Use Is Limited
7.24 Among the many provisions normally included in the bond inden-
tures of tax-exempt issues are the requirements to set aside funds annually
from operations to ensure that bond principal, interest payments, and other re-
quirements are met. The treatment of funds established by not-for-profit health
care entities under the terms of debt-financing instruments is discussed in para-
graphs 1.36–.38.
Advance Refundings
7.25 In an advance refunding, new debt is issued for the purpose of replac-
ing an existing debt issue. Advance refundings enable providers to restructure
their long term liabilities, take advantage of reduced interest rates, or termi-
nate restrictive bond covenants. The terms by which the debt may be satisfied
legally and the related lien released without the debt necessarily being retired
are spelled out in the debt instrument. Under the Tax Reform Act of 1986,
bonds issued before January 1, 1986, may be advance refunded only twice.
Bonds issued on or after that date may be advance refunded only once. There
are several types of advance refundings, including net advance refundings, full
cash advance refundings, and crossover refundings (see the glossary).
7.26 The accounting, financial reporting, and disclosure requirements for
advance refundings entered into by nongovernmental health care entities are
described in FASB ASC 405-20 (extinguishments) and FASB ASC 470-50 (mod-
ifications, exchanges of debt instruments, and extinguishments).‡ According to
paragraphs 1–2 of FASB ASC 470-50-45, gains and losses from extinguishment
of debt that meet the criteria in FASB ASC 225-20 are not precluded from being
classified as extraordinary items; however, any charges to earnings resulting
from modifications to or exchanges of line-of-credit or revolving-debt arrange-
ments resulting in either a new line-of-credit or revolving-debt arrangement
or resulting in a traditional term-debt arrangement should not be classified as
extraordinary.
7.27 Acccording to FASB ASC 954-470-40-1, in a crossover refunding, be-
cause the old bonds are not defeased until the crossover date, no immediate
gain or loss should be recognized. If the retirement dates of the old debt have
‡ In June 2009, FASB issued FASB Statement No. 166, Accounting for Transfers of Financial
Assets—an amendment of FASB Statement No. 140. FASB Statement No. 166 was issued to improve
the relevance, representational faithfulness, and comparability of the information that a reporting
entity provides in its financial statements about a transfer of financial assets; the effects of a transfer
on its financial position, financial performance, and cash flows; and a transferor's continuing involve-
ment, if any, in transferred financial assets. FASB undertook this project to address
1. practices that have developed since the issuance of FASB Statement No. 140, Ac-
counting for Transfers and Servicing of Financial Assets and Extinguishments of
Liabilities—a replacement of FASB Statement No. 125, that are not consistent with
the original intent and key requirements of that statement and
2. concerns of financial statement users that many of the financial assets (and related
obligations) that have been derecognized should continue to be reported in the financial
statements of transferors.
This statement must be applied as of the beginning of each reporting entity's first annual reporting
period that begins after November 15, 2009, for interim periods within that first annual reporting
period and for interim and annual reporting periods thereafter. Earlier application is prohibited. This
statement must be applied to transfers occurring on or after the effective date.
As of the date of this guide, August 1, 2009, this guidance has not yet been included in FASB
ASC. Readers are encouraged to visit the FASB ASC Web site at http://asc.fasb.org/home and monitor
codification updates.
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been established, the call premium, unamortized premium or discount, and
initial issue costs should be recognized systematically in the income statement
over the remaining life of the old debt as an adjustment of the cost of borrowing
related to the old debt. In addition, the income earned on the funds used to
consummate the advance refunding and the interest expense on both the old
and new debts should be recognized in the statement of operations. The funds
used to consummate the advance refunding should be reported as an asset and
both the old and new debts should be reported as liabilities. The assets and
liabilities should not be offset.
7.28 According to FASB ASC 405-20-40-1, a debtor should derecognize a
liability if and only if it has been extinguished. A liability has been extinguished
if either of the following conditions are met:
a. The debtor pays the creditor and is relieved of its obligation for
the liability. Paying the creditor includes delivery of cash, other
financial assets, goods, or services or reacquisition by the debtor of
its outstanding debt securities whether the securities are canceled
or held as so-called treasury bonds.
b. The debtor is legally released from being the primary obligor un-
der the liability, either judicially or by the creditor. For purposes
of applying FASB ASC 405-20, a sale and related assumption ef-
fectively accomplish a legal release if nonrecourse debt (such as
certain mortgage loans) is assumed by a third party in conjunction
with the sale of an asset that serves as sole collateral for that debt.
FASB ASC 405-20-40-2 provides guidance if a creditor releases a debtor from
primary obligation on the condition that a third party assumes the obligation
and that the original debtor becomes secondarily liable.
7.29 FASB ASC 470-50-50-1 states that if debt was considered to be extin-
guished by an in-substance defeasance under the provisions of FASB Statement
No. 76, Extinguishment of Debt-an amendment of APB Opinion No. 26, before
the effective date of FASB Statement No. 125, Accounting for Transfers and
Servicing of Financial Assets and Extinguishments of Liabilities (generally de-
feasances prior to December 31, 1996), a general description of the transaction
and the amount of debt that is considered extinguished at the end of the period
so long as that debt remains outstanding should be disclosed.
7.30 The accounting, financial reporting, and disclosure requirements for
advance refundings (and for current refundings) entered into by governmental
health care entities are set forth in GASB Statement No. 23, Accounting and
Financial Reporting for Refundings of Debt Reported by Proprietary Activities,
and GASB Statement No. 7, Advance Refundings Resulting in Defeasance of
Debt. Generally speaking, governmental entities are required to amortize any
gain or loss resulting from a current or advance refunding to interest expense
over the shorter of the life of the new bonds or the remaining life of the old
bonds.
Arbitrage Rebate Liabilities
7.31 Advance refundings involving tax-exempt debt are subject to arbi-
trage rules under the IRC sec. 103(c) and related regulations. Compliance with
those rules is necessary for the interest on the debt to be exempt from federal
income tax and, possibly, from state and local tax.
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7.32 As discussed in FASB ASC 954-470-25-2, IRS regulations concerning
tax-exempt debt prohibit the yield realized from the investment of the proceeds
of such debt from exceeding the interest rate to be paid on such debt. Whenever
a provider invests tax-exempt bond proceeds and the ultimate yield is higher
than the interest rate on the bonds, the provider may be subject to an arbitrage
rebate liability. The arbitrage determination is made as of the date of the issue;
however, intentional acts undertaken after the date of the issue can disqualify
the issue retroactively. The earnings in excess of interest expense represent a
liability that must be paid to the U.S. Treasury in order for the bonds to maintain
their tax-exempt status. The arbitrage rebate liability may be a substantial
amount if the bond proceeds are not spent as quickly as planned. For example,
this may occur if a provider encounters a delay in a major construction project.
Auditing
7.33 Auditing objectives and procedures for long term debt issued by
health care entities generally are similar to those of other entities. In obtaining
sufficient appropriate audit evidence with respect to current liabilities, tax con-
siderations, and long term obligations, the auditor may consider the examples of
specific auditing objectives, selected control activities, and auditing procedures
that are presented in exhibit 7-1.
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Exhibit 7-1
The following table illustrates the use of assertions in developing audit ob-
jectives and designing substantive tests. The examples are not intended to
be all inclusive nor is it expected that all the procedures would necessarily be
applied in an audit. The auditor should design and perform substantive pro-
cedures for all relevant assertions related to each material class of transac-
tions, account balance, and disclosure to obtain sufficient appropriate audit
evidence. The use of assertions in assessing risks and designing appropriate
audit procedures to obtain audit evidence is described in paragraphs .14–.26
of AU section 326, Audit Evidence (AICPA, Professional Standards, vol. 1).
Various audit procedures and the purposes for which they may be performed
are described in paragraph .27–.41 of AU section 326.
Auditing Considerations
Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities
Auditing
Procedures
Tax-Exempt Debt
Presentation and Disclosure
Classification and
understandability
Amounts related
to tax-exempt
debt are properly
classified in the
financial
statements and
related
disclosures are
adequate.
Procedures
ensure that the
providers
monitor their
compliance with
restrictive debt
covenants.
Review the debt
instruments for
the presence of any
restrictive debt
covenants.Test
compliance with
restrictive debt
covenants.
Income Taxes
Account Balances
Rights and
obligations
The not-for-profit
entity has
obtained a
qualifying income
tax exemption
from the
governmental
authority.
Management
monitors
compliance with
applicable tax
regulations.
Transactions are
reviewed for
their effect on
tax status and
tax liabilities.
Determine that the
not-for-profit
entity has obtained
a determination of
its tax-exempt
status. Inquire if
tax returns have
been filed on a
timely basis.
Determine the
status of the tax
returns under
examination.
Read the prior
years' tax returns.
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Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities
Auditing
Procedures
Read the minutes
and the accounting
for evidence of
significant
unrelated business
activities.
Review for
reasonableness the
unrelated business
income tax
liability.
Presentation and Disclosure
Classification and
understandability
The entity's
tax-exempt status
and its tax
contingencies are
disclosed in the
notes to the
financial
statements.
Determine that the
entity's tax-exempt
status is disclosed
in the notes to the
financial
statements.
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Chapter 8
Commitments and Contingencies
Overview
8.01 Commitments and contingencies may include (a) losses arising from
litigation, including malpractice and other claims; (b) contingencies related to
risk contracting; (c) third-party payment and rate-setting programs; (d) con-
struction contract commitments; (e) the Hill-Burton Act obligation to provide
uncompensated care; (f) commitments and guarantees that include contractual
agreements with physicians, specialists, and others who perform services by
arrangement with health care entities; and (g) commitments and contingent
liabilities related to pension plans, operating leases, purchase commitments,
and loan guarantees.
8.02 As discussed in paragraphs 1.116–.118 of this guide, the fair value op-
tion subsections of Financial Accounting Standards Board (FASB) Accounting
Standards Codification (ASC) 825-10 permit a nongovernmental health care
entity to irrevocably elect fair value, as defined by FASB ASC glossary as the
price that would be received to sell an asset or paid to transfer a liability in
an orderly transaction between market participants at the measurement date,
with changes in fair value recognized in the statement of activities as those
changes occur.1 Liabilities that require the entity to provide services, rather
than cash or another financial asset, to the obligee are outside the scope of the
statement and thus may not be reported at fair value.
8.03 FASB ASC 450, Contingencies, provides general guidance regarding
gain and loss contingencies. FASB ASC 460, Guarantees, applies to minimum
revenue guarantees, which FASB ASC glossary defines as a guarantee granted
to a business or its owners that the revenue of the business (or a specific por-
tion of the business) for a specified period of time will be at least a specified
minimum amount. According to FASB ASC 460-10-55-11, an example of a min-
imum revenue guarantee is a guarantee granted to a nonemployee physician by
a not-for-profit health care facility that has recruited the physician to move to
the facility's geographical area to establish a practice. The health care facility,
as the guarantor, has agreed to make payments to the newly arrived physician
(the guaranteed party) at the end of specific periods of time if gross revenues
(gross receipts) generated by the physician's new practice during that period of
time do not equal or exceed a specific dollar amount. FASB ASC 460 applies to
minimum revenue guarantees granted to physicians regardless of whether the
physician's practice qualifies as a business, as defined in FASB ASC glossary.
8.04 FASB ASC 944-40* discusses accounting for claims costs, includ-
ing estimates of costs relating to incurred but not reported (IBNR) claims.
1 For additional discussion of the fair value option subsections of Financial Accounting Standards
Board (FASB) Accounting Standards Codification (ASC) 825-10, see chapter 1.
* In May 2008, FASB issued FASB Statement No. 163, Accounting for Financial Guarantee
Insurance Contracts—an interpretation of FASB Statement No. 60, to require that an insurance en-
terprise recognize a claim liability prior to an event of default (insured event) when there is evidence
that credit deterioration has occurred in an insured financial obligation. This statement clarifies the
recognition and measurement of premium revenue and claim liabilities as it applies to financial guar-
antee insurance contracts. It also requires expanded disclosures about financial guarantee insurance
(continued)
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Governmental health care entities generally should consider the accounting
and disclosure requirements of Governmental Accounting Standards Board
(GASB) Statement No. 10, Accounting and Financial Reporting for Risk Fi-
nancing and Related Insurance Issues, as amended.
Medical Malpractice Claims
8.05 The extent of risk transfer is key in determining whether a liability
should be recognized in a provider's financial statements pertaining to mal-
practice claims. The existence of an insurance policy, by itself, is no assurance
that the risk of financial loss is transferred.
8.06 FASB ASC 340-30-05-2 states that the transfer of insurance risk
requires transferring both timing risk and underwriting risk. Paragraphs 3–8
of FASB ASC 340-30-05 and paragraphs 40–61 of FASB ASC 944-20-15 provide
guidance useful in determining whether an insurance contract transfers risk.
8.07 According to FASB ASC 954-450-25-2, if the health care entity has
not transferred risk to an external third party, it should evaluate its exposure
to losses arising from malpractice claims and record a liability, if appropriate.
8.08 Further guidance is provided in this chapter as follows:
 Claims-made insurance policies are discussed in paragraphs 8.20–
.21.
 Retrospectively rated insurance policies are discussed in para-
graphs 8.22–.25.
 Policies by captive insurance companies are discussed in para-
graphs 8.26–.30.
Accruing Malpractice Liabilities
8.09 According to FASB ASC 954-450-25-2, the ultimate costs of malprac-
tice claims, which include costs associated with litigating or settling claims,
should be accrued when the incidents that give rise to the claims occur. FASB
ASC 954-450-30-1 states that estimated losses from asserted and unasserted
medical malpractice claims should be accrued either individually or on a group
basis, based on the best estimates of the ultimate costs of the claims and the re-
lationship of past reported incidents to eventual claims payments. All relevant
information, including industry experience, the entity's own historical experi-
ence, the entity's existing asserted claims, and reported incidents, should be
used in estimating the expected amount of claims. The accrual includes an esti-
mate of the losses that will result from unreported incidents, which are probable
of having occurred before the end of the reporting period.
8.10 According to FASB ASC 954-450-30-2, in estimating the probability
that unreported incidents have occurred, some health care entities may develop
a range of possible estimates of the number of unreported incidents, including
zero. However, the greater the volume of a health care entity's operations, the
(footnote continued)
contracts. FASB Statement No. 163 is effective for financial statements issued for fiscal years
beginning after December 15, 2008, and interim periods within those fiscal years. Except for certain
disclosures set forth in FASB Statement No. 160, Noncontrolling Interests in Consolidated Financial
Statements—an amendment of ARB No. 51, earlier application is not permitted.
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greater the likelihood that the entity's minimum estimate of the number of
probable unreported incidents will be greater than zero. In estimating losses
from malpractice claims, a health care entity may need to modify data drawn
from industry experience so it is relevant to developing an estimate that is
specific to the entity. Various factors (such as the nature of operations, size, and
the provider's past experience) should be considered in assessing comparability.
Further, industry data that are not current may not be relevant.
8.11 FASB ASC 450-20-25-5 states that when it is probable that a loss
has been incurred and information available indicates the estimated amount
of loss is within a range of amounts, it follows that some amount of loss has oc-
curred and can be reasonably estimated. According to FASB ASC 450-20-30-1,
if some amount within a range of loss appears at the time to be a better estimate
than any other amount within the range, that amount should be accrued. When
no amount within the range is a better estimate than any other amount, how-
ever, the minimum amount in the range should be accrued. FASB ASC 450-20-
50-3 requires that disclosure of the contingency be made if there is at least a
reasonable possibility that a loss or an additional loss may have been incurred
and an exposure to loss exists in excess of the amount accrued.
8.12 According to FASB ASC 954-720-25-3, an accrual for malpractice
losses should be based on estimated ultimate losses and costs associated with
settling claims. FASB ASC 954-450-25-2A indicates that accruals should not
be based on recommended funding amounts, which in addition to a provision
for the actuarially determined liability also include a provision for (a) credit for
investment income and (b) a margin for risk of adverse deviation. FASB ASC
954-720-25-2B provides the following examples of factors to consider and ad-
justments that may be required to convert actuarially determined malpractice
funding amounts to an appropriate loss accrual to be reported in the financial
statements:
 The risk of adverse deviation is an additional cost factor applied
to bring a funding requirement to a selected confidence level. This
factor does not meet the criteria for recognition as a liability in
accordance with FASB ASC 450.
 An evaluation should be made of the extent and validity of indus-
try data when the credibility factor actuarial technique is used.
The lower the credibility factor, the greater the blending of indus-
try data. This may create an unacceptable level of industry data
at lower confidence levels. Further, a low credibility factor may
indicate that provider-specific data is not sufficient to support the
claims liability estimation process.
 A review of the discounting approach used is necessary to develop
the required disclosure. The impact on the discounting calcula-
tion of any other adjustment made to the actuarially determined
amounts (such as risk of adverse deviation or the credibility of the
risk management system) has to be evaluated.
 A review of the expenses included in the loss estimation process
should be made. Such expenses include the expense of settlement
and litigation (that is, allocated loss adjustment expenses).
8.13 According to FASB ASC 954-450-35-1, estimated losses are reviewed
and changed, if necessary, at each reporting date. The amounts of the changes
are recognized currently as additional expense or as a reduction of expense.
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8.14 Consistent with the guidance in FASB ASC 210-10-45-6, accrued
unpaid claims and expenses that are expected to be paid during the normal
operating cycle (generally within one year of the date of the financial state-
ments) are classified as current liabilities. All other accrued unpaid claims and
expenses are classified as noncurrent liabilities.
8.15 FASB ASC 954-450-50-1 requires that health care entities disclose
their program of medical malpractice insurance coverages. Disclosures should
be consistent with the requirements of FASB ASC 450-20-50. FASB ASC 450-
20-50-5 states that disclosure is preferable to accrual when a reasonable esti-
mate of loss cannot be made. FASB ASC 450-20-50-3 states that disclosure of
a contingency should be made if there is at least a reasonable possibility that
a loss or an additional loss may have been incurred and an accrual is not made
for a loss contingency because any of the conditions in FASB ASC 450-20-25-2
are not met.
8.16 Thus, if the entity cannot estimate losses relating to a particular cat-
egory of malpractice claims (for example, asserted claims, reported incidents,
or unreported incidents) in accordance with paragraphs 8.05–.15, the potential
losses related to that category of claims are not accrued. However, the contin-
gency is disclosed in the notes to the financial statements.
8.17 FASB ASC 954-450-50-2 requires that health care entities that dis-
count accrued malpractice claims disclose in the notes to the financial state-
ments the carrying amount of accrued malpractice claims that are discounted
in the financial statements and the interest rate or rates used to discount those
claims.
8.18 FASB Statement of Financial Accounting Concepts No. 7, Using Cash
Flow Information and Present Value in Accounting Measurements, provides use-
ful discussion of general principles governing the use of present value, and of the
objective of present value in accounting measurements. Statements of Finan-
cial Accounting Concepts are not sources of established accounting principles
and, thus, do not amend, modify, or justify a change from generally accepted
accounting principles (GAAP) currently in effect.2
Accounting for Claims-Made Insurance Policies
and Tail Coverage
8.19 A claims made insurance policy represents a transfer of risk within
the policy limits to the insurance carrier for asserted claims and incidents not
reported to the insurance carrier. However, the policy does not represent a
transfer of risk for claims and incidents not reported to the insurance carrier
during the policy period.
8.20 The claims-made contract subsections of FASB ASC 720-20 apply if
a health care entity purchases a claims-made insurance policy. According to
FASB ASC 720-20-25-9, in claims-made insurance, the insured event is the re-
porting to the insurer, within the period specified by the policy, of a claim for a
loss covered by the insurance contract. Accordingly, a prospective claims-made
insurance policy only covers claims for losses reportable to the insurer during
the policy term. FASB ASC 720-20-25-10 provides guidance for determining
2 See chapter 1 for additional information regarding the hierarchy of generally accounting prin-
ciples for nongovernmental health care entities.
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whether a claims-made insurance policy contains a retroactive provision (that
is, it provides coverage for previously reportable claims). As discussed in FASB
ASC 720-20-25-14, FASB ASC 450-20-25-2 requires that insured entities (ex-
cept as discussed in FASB ASC 944-20-15), including those that use a claims-
made approach for insuring certain risks, recognize a liability for the probable
losses from incurred but not reported claims and incidents if the loss is both
probable and reasonably estimable.
8.21 Consequently, a health care entity that is insured under a claims-
made insurance policy recognizes the estimated cost of those claims and in-
cidents not reported to the insurance carrier, in accordance with paragraphs
8.05–.18. This estimation is done unless the health care entity has bought tail
coverage (see the FASB ASC glossary) and included the cost of the premium as
an expense in the financial statements for that period.
Accounting for Retrospectively Rated Premiums
8.22 The economic substance of the terms of a retrospectively-rated insur-
ance policy may more closely resemble a claims funding mechanism than an
instrument that transfers risk of loss to an external third party (see paragraph
8.06).
8.23 FASB ASC 954-720-25-1 states that a health care entity with a retro-
spectively rated insurance policy whose ultimate premium is based primarily
on the health care entity's loss experience should account for the minimum pre-
mium as an expense over the period of coverage under the policy and should ac-
crue estimated losses from asserted and unasserted claims in excess of the min-
imum premium, as indicated in paragraphs 8.05–.18. Such estimated losses,
however, are not accrued in excess of a stipulated maximum premium. FASB
ASC 450-20-50-5 states that disclosure is preferable to accrual when a reason-
able estimate of loss cannot be made. If the health care entity cannot estimate
losses from asserted or unasserted malpractice claims, as indicated in para-
graphs 8.05–.18, and therefore an accrual is not made, FASB ASC 450-20-50-3,
requires disclosure of a contingency if there is at least a reasonable possibility
that a loss or an additional loss may have been incurred.
8.24 FASB ASC 954-720-35-1 requires that a health care entity insured
under a retrospectively rated policy whose ultimate premium is based primarily
on the experience of a group of health care entities amortize the initial premium
to expense on a pro rata basis over the policy term. FASB ASC 954-720-25-2
states that the entity also should accrue additional premiums or refunds on
the basis of the group's experience to date, which includes a provision for the
ultimate cost of asserted and unasserted claims before the financial statement
date, whether reported or unreported. FASB ASC 954-720-50-1 requires that
the health care entity disclose that (a) it is insured under a retrospectively rated
policy and (b) premiums are accrued based on the ultimate cost of the experience
to date of a group of entities. If the health care entity cannot estimate losses
from asserted or unasserted malpractice claims, as indicated in paragraphs
8.05–.18, and therefore an accrual is not made, FASB ASC 450-20-50-3, requires
disclosure of a contingency if there is at least a reasonable possibility that a
loss or an additional loss may have been incurred.
8.25 The retroactive contracts subsections of FASB ASC 720-20 provide
guidance for multiple-year retrospectively rated contracts.
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Accounting for Medical Malpractice Claims Insured by Captive
Insurance Companies
8.26 The economic substance of the terms of an insurance policy with a
captive insurance company may more closely resemble a claims funding mech-
anism than an instrument that transfers risk of loss to an external third party
(see paragraph 8.06).
8.27 A majority-owned captive insurance company (for example, a
wholly owned captive) is consolidated in accordance with FASB ASC 810,
Consolidation.3,†,‡ Multiprovider captives, in which the ownership percentage
is 50 percent or less, are accounted for in accordance with FASB ASC 323,
3 Not-for-profit entities are not subject to the "Variable Interest Entities" subsections of FASB
ASC 810, Consolidation, except that they may be related parties for purposes of applying paragraphs
42–44 of FASB ASC 810-10-25. Also, if a not-for-profit entity is used by a business entity in a manner
similar to a variable interest entity in an effort to circumvent the provisions of the "Variable Interest
Entities" subsections of FASB ASC 810 that not-for-profit entity is subject to that guidance.
† In December 2007, FASB issued FASB Statement No. 160. The objective of FASB Statement No.
160 is to improve comparability and transparency of consolidated financial statements by establishing
accounting and reporting standards that require the following:
1. Reporting of ownership interest in subsidiaries held by parties other than the parent
should be clearly identified, labeled, and presented in the consolidated balance sheet
within equity but separate from the parent's equity.
2. Consolidated net income should clearly identify the portion of income attributable to
the parent and the noncontrolling interest on the face of the income statement.
3. Changes in ownership interest should be accounted for consistently.
4. When a subsidiary is deconsolidated, any retained noncontrolling equity investment
in the former subsidiary should be measured at fair value.
5. Entities should provide all appropriate disclosures to distinguish between interest of
the parent and the interests of the noncontrolling owners.
Except for not-for-profit health care entities and entities that prepare consolidated financial state-
ments but do not have an outstanding noncontrolling interest in one or more subsidiaries or that
deconsolidate a subsidiary, FASB Statement No. 160 is effective for fiscal years, and interim peri-
ods within those fiscal years, beginning on or after December 15, 2008. Early adoption is prohibited.
Health care entities other than not-for-profit health care entities should apply FASB Statement No.
160 prospectively as of the beginning of the fiscal year in which the statement is initially adopted,
except for the presentation and disclosure requirements. Presentation and disclosure requirements
should be applied retrospectively for all periods presented.
As noted in FASB ASC 810-10-65-1, neither FASB Statement No. 160 nor its amendments to
ARB No. 51, Consolidated Financial Statements, APB Opinion No. 18, The Equity Method of Ac-
counting for Investments in Common Stock, and APB Opinion No. 29, Accounting for Nonmonetary
Transactions, and several other pronouncements, apply to not-for-profit entities. (See the "What Links
Here" tab of FASB ASC 810-10-65.) Not-for-profit entities should continue to apply the guidance de-
scribed in Accounting Research Bulletin (ARB) No. 51, Consolidated Financial Statements, before the
amendments made by FASB Statement No. 160; AICPA Statement of Position (SOP) 94-3, Reporting
of Related Entities by Not-for-Profit Organizations (AICPA, Technical Practice Aids, ACC sec. 10,610);
and other applicable standards, until FASB issues interpretative guidance.
FASB Statement No. 160 is primarily located in sections 45 and 55 of FASB ASC 810-10, and is
labeled as "Pending Content" due to the transition and open effective date information discussed in
FASB ASC 810-10-65-1. For more information on FASB ASC, please see the notice to readers in this
guide.
‡ In June 2009, FASB issued FASB Statement No. 167, Amendments to FASB Interpretation No.
46(R). FASB Statement No. 167 improves financial reporting by enterprises involved with variable
interest entities (VIEs) by amending certain requirements of FASB Interpretation No. 46(R), Con-
solidation of Variable Interest Entities (revised December 2003)—an interpretation of ARB No. 51.
FASB Statement No. 167 addresses the potential impacts on the provisions and application of FASB
Interpretation No. 46(R) as a result of the elimination of the qualifying special-purpose entity concept
in FASB Statement No. 166, Accounting for Transfers of Financial Assets—an amendment of FASB
Statement No. 140. Among other amendments, FASB Statement No. 167 amends FASB Interpre-
tation No. 46(R) to require an enterprise to perform an analysis to determine whether the entity's
variable interest or interests give it a controlling financial interest in a VIE, to require an additional
reconsideration event when determining whether an entity is a VIE when any changes in facts and
(continued)
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Investments—Equity Method and Joint Ventures. (See chapter 11 of this guide
for additional discussion of considerations related to consolidation and the use
of the equity method.)
8.28 A health care entity insured by an unconsolidated multiprovider cap-
tive insurance company for medical malpractice claims under a retrospectively
rated insurance policy whose ultimate premium is based primarily on the health
care entity's experience up to a maximum premium, if any, accounts for such
insurance as indicated in paragraph 8.23.
8.29 FASB ASC 954-720-35-2 states that a health care entity insured by
an unconsolidated multiprovider captive insurance company for medical mal-
practice claims under a retrospectively rated policy based primarily on the
experience of a group of health care entities should account for such insurance
as indicated in FASB ASC 954-720-25-2 (described in paragraph 8.24). How-
ever, the health care entity considers whether the economic substance of the
multiprovider captive insurance company is sufficient to relieve the health care
entity from further liability. According to FASB ASC 954-720-50-2, the health
care entity should disclose that (a) it is insured under a retrospectively rated
policy of a multiprovider captive insurance entity and (b) the premiums are
accrued based on the captive insurance entity's experience to date.
8.30 FASB ASC 954-720-50-3 requires that a health care entity that is
insured by a multiprovider captive insurance company disclose in its financial
statements: (a) that it is insured by such an entity, (b) its ownership percentage
in the captive entity, and (c) the method of accounting for its investment in, and
the operations of, the captive entity. In addition, if the health care entity cannot
make the necessary estimates of losses from asserted or unasserted claims, as
indicated in paragraphs 8.05–.18, and therefore an accrual is not made. FASB
ASC 450-20-50-3, requires disclosure of a contingency if there is at least a
reasonable possibility that a loss or an additional loss may have been incurred.
Accounting for Trust Funds
8.31 FASB ASC 954-810-45-4 states that, in general, a trust fund, whether
legally revocable or irrevocable, should be included in the financial statements
of the health care entity. A portion of the fund equal to the amount of assets ex-
pected to be liquidated to pay malpractice claims classified as current liabilities
should be classified as a current asset; the balance of the fund, if any, should be
classified as a noncurrent asset. Revenues and administrative expenses of the
trust fund are included in the statement of operations (see chapter 10). In some
circumstances, the foregoing may not be possible (for example, if a common
trust fund exists for a group of health care entities; if the health care entity
(footnote continued)
circumstances occur, and to require ongoing reassessments of whether an enterprise is the primary
beneficiary of a VIE.
FASB Statement No. 167 is effective as of the beginning of each reporting entity's first annual
reporting period that begins after November 15, 2009, for interim periods within that first annual
reporting period, and for interim and annual reporting periods thereafter. Early application of FASB
Statement No. 167 is prohibited.
As of the date of this guide, August 1, 2009, this guidance has not yet been included in FASB
ASC. Readers are encouraged to visit the FASB ASC Web site at http://asc.fasb.org/home and monitor
FASB ASC Accounting Standards Updates (ASUs).
In December 2009, FASB issued ASU No. 2009-17, Consolidations (Topic 810): Improvements
to Financial Reporting by Enterprises involved with Variable Interest Entities. The amendments in
ASU No. 2009-17 are the result of FASB Statement No. 167.
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is part of a common municipality risk-financing internal service fund; or if the
legal, regulatory, or indenture restrictions prevent the inclusion of a trust fund
in a health care entity's financial statements). In those circumstances, the pro-
visions of FASB ASC 954-450-25-3, FASB ASC 954-720-25-5, and FASB ASC
954-810-50-1 apply. (Those provisions are included in paragraphs 8.32–.33.)
8.32 FASB ASC 954-450-25-3 states that, in general, estimated losses from
asserted and unasserted claims should be accrued and reported, as indicated in
paragraphs 1–2 of FASB ASC 954-450-30. The estimated losses are not based on
payments to the trust fund. However, accounting for a health care entity that
participates in a pooled fund depends on the extent to which the associated
risks and rewards have been transferred to another party. FASB ASC 954-720-
25-5 states that an entity that transfers its risk of loss to a common trust fund
and forfeits its rights to any excess funding should expense its contributions
and account for its participation in the trust fund based on the type of coverage
obtained (for example, occurrence basis, claims-made, or retrospectively rated).
8.33 According to FASB ASC 954-810-50-1, the existence of the trust fund
and whether it is irrevocable should be disclosed in the financial statements.
Governmental Health Care Entities
8.34 Governmental health care entities that are component units of a
state or local governmental reporting entity and that participate in that entity's
risk-financing internal service fund should report claims expenses equal to the
charges from the internal service fund if those charges meet the requirements
of paragraphs 65–68, as amended, of GASB Statement No. 10. A governmental
health care entity that participates in a public entity risk pool with transfer or
pooling of risk should present its premium or required contribution as insurance
expense, as discussed in GASB Statement No. 10 paragraphs 69, as amended,
and 70. Governmental health care entities participating in public entity risk
pools without transfer or pooling of risk should report payments to pools as
deposits and recognize and measure claims liabilities in accordance with GASB
Statement No. 10 paragraphs 53–58, as amended. Paragraphs 116 and 119–120
of GASB Statement No. 34, Basic Financial Statements—and Management's
Discussion and Analysis—for State and Local Governments, require disclosures
about long term liabilities (such as claims and judgments). Information to be
presented includes beginning and ending balances, increases, decreases, and
the portions of each item that are due within 1 year.
Risks and Uncertainties
8.35 FASB ASC 275-10-50-1 states that entities should make disclosures
in their financial statements about the risks and uncertainties existing as of
the date of those statements in the following areas:
a. Nature of their operations.
b. Use of estimates in the preparation of financial estimates.
c. Certain significant estimates.
d. Current vulnerability due to certain concentrations.
Paragraphs 6–15 of FASB ASC 275-10-50 provide additional guidance about
disclosing significant estimates, including the criteria that, if met, require
those disclosures. Paragraphs 16–22 of FASB ASC 275-10-50 provide additional
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guidance about disclosing current vulnerability due to certain concentrations,
including the criteria that, if met, require those disclosures.
8.36 FASB ASC 275-10-50-15 provides examples of items that may be
based on estimates that are particularly sensitive to changes in the near term.
Examples of similar estimates that may be based on estimates that are partic-
ularly sensitive to changes in the near term that might be included in financial
statements of health care entities include, but are not limited to, the following:
 Third-party revenue and related receivables
 Assets subject to impairment, for example, goodwill
 Environmental remediation-related obligations
 Litigation-related contingencies, for example, fraud and abuse ac-
tions by regulators
 Estimated risk pool settlements arising from managed care con-
tracting
 Amounts reported for long term obligations such as amount re-
ported for pensions and postemployment benefits
 Estimated net proceeds recoverable, the provisions for expected
loss to be incurred, or both, on disposition of a business or assets
8.37 FASB ASC 275-10-50-18 provides examples of concentrations that
may meet the criteria of FASB ASC 275-10-50-16 that, if met, require disclosure
in the financial statements of health care entities, including the following:
 Concentrations in the volume of business transacted with a par-
ticular payor, supplier, lender, grantor, or contributor
 Concentrations in revenue from particular products, services, or
fund-raising events
 Concentrations in the available sources of supply of material, la-
bor, or services, or of licenses or other rights used in the entity's
operations
 Concentrations in the market or geographic area in which an en-
tity conducts its operations
Auditing Commitments and Contingencies
8.38 Auditing objectives and procedures for commitments and contingen-
cies generally are similar to those of other entities. In obtaining sufficient ap-
propriate audit evidence with respect to commitments and contingencies, the
auditor may consider the specific auditing objectives, selected control activities,
and auditing procedures presented in exhibit 8-1 at the end of this chapter.
Auditing Medical Malpractice Loss Contingencies
8.39 The existence of an insurance policy, by itself, is no assurance that
malpractice contingencies are assumed by others. The auditor should review
the insurance contracts and determine the extent of the risk retained by the
provider. Specific auditing procedures to consider include the following:
 Determine the type (such as occurrence basis or claims-made) and
level (per occurrence or in the aggregate) of insurance protection
the provider has obtained.
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 Determine if the coverage actually transfers the malpractice risks.
Is the insurance with a related party (for example, a captive in-
surance company)? Does it provide for retrospective premiums or
similar adjustments?
Once the extent of the risk retained is understood, the auditor will be able
to assess the risks of material misstatement which are used to determine the
nature, extent, and timing of other auditing procedures.
8.40 If a health care entity has transferred the risk of loss to a financially
viable third party by purchasing insurance coverage of sufficient limits on an
occurrence basis, no additional auditing procedures are necessary. If the entity
retains all or a portion of the risk through self-insurance or has purchased a
claims-made policy, the independent auditor should perform additional audit-
ing procedures to obtain reasonable assurance that the entity's accounting for
medical malpractice losses is in accordance with GAAP.
8.41 The independent auditor should consider the extent to which the re-
newal of a claims-made policy or the purchase of tail coverage after the balance-
sheet date prior to the issuance of the financial statements limits the entity's
liability exposure as of the balance-sheet date. If an entity either renews a
claims-made policy or purchases tail coverage, and the new policy covers claims
asserted during the new policy term (regardless of when the incident occurred),
the entity has transferred to the insurer the risk for that portion of the entity's
claims that is expected to be reported during the new policy term (up to the new
policy limits). Accordingly, the entity's liability for the IBNR claims transferred
would not exceed the premium on the new policy, except for anticipated claims
in excess of the new policy limits.
8.42 Management's intent to renew a claims-made policy is not sufficient
to constitute a limit on IBNR claims as of the balance-sheet date unless man-
agement contractually obligates itself for renewal before the issuance date of
the financial statements and the cost is expensed in the period covered by the
financial statements. The requirement to renew a claims-made policy or to pur-
chase and expense tail coverage applies even if state regulations require that
renewal of claims-made coverage be offered continually.
8.43 If the insured has the unilateral option to purchase tail coverage at a
premium that may not exceed a stipulated maximum, and the provider intends
to purchase that coverage, the amount of IBNR loss to be accrued may effectively
be limited to the maximum tail-coverage premium stated in the policy. However,
providers in these circumstances that do not intend to purchase tail coverage
may not accrue the cost of obtaining that coverage as a substitute for the IBNR
accrual.
Auditing Accounting Estimates
8.44 Management is responsible for making the accounting estimates
that are included in the financial statements. Management is also responsi-
ble for providing proper disclosure of (1) the use of estimates in the prepara-
tion of financial statements and (2) certain significant estimates in accordance
with FASB ASC 275, Risks and Uncertainties.4,5 The auditor is responsible for
4 See paragraphs 8.35–.37 and 8.54.
5 Governmental health care entities only. FASB ASC 275, Risks and Uncertainties, does not per-
tain to governmental entities unless the entity has elected to follow all FASB pronouncements under
(continued)
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evaluating the reasonableness of management's estimates and the adequacy of
the related disclosures. The auditor does this using one or more of the following
approaches:
a. Test the process used by management to develop the estimate.
b. Develop an independent expectation of the estimate to corroborate
the reasonableness of management's estimate.
c. Review subsequent events or transactions occurring prior to com-
pletion of fieldwork.
8.45 In evaluating management's estimates of asserted and unasserted
claims, the auditor should consider factors such as management's description
and evaluation of asserted claims and unasserted claims arising from reported
incidents; the lawyer's (and, if appropriate, the outside risk manager's) assess-
ment of asserted claims and reported incidents not covered by insurers; and
the actuary's evaluations of the aggregate liability covering asserted claims
and unasserted claims arising from reported and unreported incidents.
8.46 Paragraph .06 of AU section 333, Management Representations
(AICPA, Professional Standards, vol. 1), establishes requirements and provides
guidance for obtaining a specific written representation from management that
it has disclosed all liabilities and gain or loss contingencies required to be ac-
crued or disclosed by FASB ASC 450, Contingencies.
8.47 In evaluating the information provided by legal counsel, it may be
necessary to supplement the written representations with inquiries if the rep-
resentations are not clear regarding the probability of the litigation outcome or
the potential range of loss.6
8.48 The auditor should consider the frequency of losses due to unreported
incidents and the magnitude of prior losses and underlying causes for the IBNR
claims. If there is a basis for an accrual, the auditor should then determine
whether the entity's prior history supports the estimation of the number of
claims and the probable settlement value.
Use of Actuaries and Actuarial Methods
8.49 An actuary may be engaged to provide or review the estimate of the
medical malpractice loss amount or range of amounts or to assist in developing
certain factors and assumptions used in estimating the malpractice liability.
The decision to use an actuary may be based on a consideration of whether
(a) the estimated claim liability is potentially material to the fair presentation
of financial statements in conformity with GAAP and (b) special knowledge is
required to estimate the claim liability.
(footnote continued)
paragraph 7 of Governmental Accounting Standards Board Statement No. 20, Accounting and
Financial Reporting for Proprietary Funds and Other Governmental Entities That Use Proprietary
Fund Accounting. (See footnote 1 in chapter 1.)
6 According to AU section 337, Inquiry of a Client's Lawyer Concerning Litigation, Claims, and
Assessments (AICPA, Professional Standards, vol. 1), a letter of audit inquiry to the lawyer handling
the claims is the auditor's primary means of obtaining corroboration of the information furnished by
management concerning claims made and known incidents for which claims have not been made that
are either uninsured or in excess of the insurance coverage. Audit inquiry letters generally would
not be required with respect to reported contingencies that were not considered to have a material
potential loss. The inability or unwillingness of counsel to evaluate asserted claims and or reported
incidents would give rise to a modification of the auditor's opinion.
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8.50 AU section 336, Using the Work of a Specialist (AICPA, Professional
Standards, vol. 1), establishes requirements and provides guidance if an actu-
ary is involved in a substantial way in determining the amount of a provider's
malpractice self-insurance liability. The independent auditor should consider
the actuary's professional qualifications, reputation, prior experience in esti-
mating malpractice claim losses, and relationship to the client. There should
be an understanding among the auditor, the client, and the actuary of the ob-
jectives and scope of the analysis and the methods and assumptions used. The
independent auditor may consider (a) the limitations of assurances in actuarial
calculations due to uncertainties and (b) restrictions as to the use of the actu-
arial reports. The independent auditor is responsible for determining the ade-
quacy of the actuary's report for purposes of corroborating the representations
in the financial statements. The independent auditor should perform an appro-
priate test of the accounting data provided by the client to the actuary. Such
accounting data may include historical claim experience, policy terms (such as
coverage, expiration, deductibles, presence of retrospectively determined pre-
miums, and indemnity limitations), exposure data (such as the number of beds,
high risk medical specialties, outpatient visits, and emergency room visits), and
information about risk management systems, personnel, and procedures.
8.51 See paragraph 8.11 for examples of factors to consider and adjust-
ments that may be required to convert actuarially determined malpractice
funding amounts to an appropriate loss accrual to be reported in the finan-
cial statements.
8.52 Limitations on the availability of provider-specific data, lack of a suf-
ficient patient population for claims projection purposes, a very low credibility
factor, and a variety of other factors may cause the actuary's estimate of loss to
be of limited value in developing an estimate of the liability under GAAP.
Auditing Risks and Uncertainties
8.53 Uncertainties arise when the evidence available is insufficient for a
reasonable estimation of the effects of the outcome of a particular future event
on the current financial statements. Normally, the resolution of the uncertainty
is prospective, and sufficient evidence cannot be expected to exist at the time
of the audit. In these situations, it cannot be determined what adjustments, if
any, to the financial statements may be appropriate. If the auditor is unable to
obtain sufficient audit evidence to support management's assertions about the
nature of a matter involving an uncertainty and its presentation or disclosure
in the financial statements, the auditor should consider the need to express
a qualified opinion or to disclaim an opinion because of a scope limitation as
discussed in paragraph .31 of AU section 508, Reports on Audited Financial
Statements (AICPA, Professional Standards, vol. 1).
8.54 Statement of Position (SOP) 00-1, Auditing Health Care Third-Party
Revenues and Related Receivables (AICPA, Technical Practice Aids, AUD sec.
14,360), provides guidance to auditors regarding uncertainties inherent in
health care revenue recognition. Examples of risks unique to the government-
contracting environment are presented in paragraph .07 of the SOP. Also, in
the health care environment, it is almost always at least reasonably possible
that estimates regarding third-party payments could change in the near term
as a result of one or more future confirming events (for example, regulatory
action reflecting local or national audit or enforcement initiatives). For most
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entities with significant third-party revenues, the effect of the change could be
material to the financial statements. Where material exposure exists, the un-
certainty regarding revenue realization is disclosed in the notes to the financial
statements.7
Evaluating Lawyers’ Responses
8.55 Determining the outcome of pending or threatened litigation, claims
and assessments (including unasserted claims and assessments) normally is
beyond the auditor's professional competence. Accordingly, the auditor's eval-
uation of the need for disclosures or report modifications is based primarily
on the opinion of the lawyer handling the matter. The American Bar Associ-
ation (ABA) has adopted a Statement of Policy Regarding Lawyers' Responses
to Auditors' Requests for Information under which lawyers accept certain re-
sponsibility for responses to auditors' inquiries. However, the ABA Statement
of Policy is not enforceable by the ABA in the same way the AICPA is able to
enforce its standards under the accounting profession's Code of Professional
Conduct. As a result, lawyers' responses may vary widely.
8.56 Interpretation No. 7, "Assessment of a Lawyer's Evaluation of the
Outcome of Litigation," of AU section 337, Inquiry of a Client's Lawyer Con-
cerning Litigation, Claims, and Assessments (AICPA, Professional Standards,
vol. 1, AU sec. 9337 par. .18–.23), includes the following examples of evalua-
tions of litigation, which may be considered to communicate in a sufficiently
clear manner a remote likelihood of an unfavorable outcome:
 "We are of the opinion that this action will not result in any liability
to the company."
 "It is our opinion that the possible liability to the company in this
proceeding is nominal in amount."
 "We believe the company will be able to defend this action success-
fully."
 "We believe that the plaintiff 's case against the company is with-
out merit."
 "Based on the facts known to us, after a full investigation, it is our
opinion that no liability will be established against the company
in these suits."
8.57 On the other hand, the lawyer may use terms, such as meritorious
defenses, that have different meanings to different lawyers. Paragraph .22 of In-
terpretation No. 7 of AU section 337 includes the following examples of lawyers'
evaluations that are unclear regarding the likelihood of an unfavorable out-
come:
 "This action involves unique characteristics wherein authoritative
legal precedents do not seem to exist. We believe that the plaintiff
will have serious problems establishing the company's liability
7 A sample disclosure is provided in SOP 00-1, Auditing Health Care Third-Party Revenues and
Related Receivables (AICPA, Technical Practice Aids, AUD sec. 14,360), that among other things
indicates laws and regulations governing the Medicare and Medicaid programs are extremely complex
and subject to interpretation. As a result, there is at least a reasonable possibility that recorded
estimates will change by a material amount in the near term. SOP 00-1 is included as appendix D to
this guide.
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under the act; nevertheless, if the plaintiff is successful, the award
may be substantial."
 "It is our opinion that the company will be able to assert mer-
itorious defenses to this action." (The term meritorious defenses
indicates that the company's defenses will not be summarily dis-
missed by the court; it does not necessarily indicate the lawyer's
opinion that the company will prevail.)
 "We believe the action can be settled for less than the damages
claimed."
 "We are unable to express an opinion as to the merits of the litiga-
tion at this time. The company believes there is absolutely no merit
to the litigation." (If the company's lawyer, with the benefit of all
relevant information, is unable to conclude that the likelihood of
an unfavorable outcome is remote, it is unlikely that management
would be able to form a judgment to that effect.)
 "In our opinion, the company has a substantial chance of prevail-
ing in this action." (A substantial chance, a reasonable opportunity,
or similar terms indicate more uncertainty than an opinion that
the company will prevail.)
8.58 When the lawyer's response is unclear, the auditor may request a
conference to clarify the lawyer's opinion. Paragraphs .29–.32 of AU section 508
establish requirements and provide guidance if the response is still unclear or
the materiality of the uncertainty cannot be determined.
Auditing
8.59 The independent auditor may need to consider the examples of spe-
cific auditing objectives, selected control activities, and auditing procedures for
commitments and contingencies that are presented in exhibit 8-1.
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Exhibit 8-1
The following table illustrates the use of assertions in developing audit ob-
jectives and designing substantive tests. The examples are not intended to
be all inclusive nor is it expected that all the procedures would necessarily be
applied in an audit. The auditor should design and perform substantive pro-
cedures for all relevant assertions related to each material class of transac-
tions, account balance, and disclosure to obtain sufficient appropriate audit
evidence. The use of assertions in assessing risks and designing appropriate
audit procedures to obtain audit evidence is described in paragraphs .14–.26
of AU section 326, Audit Evidence (AICPA, Professional Standards, vol. 1).
Various audit procedures and the purposes for which they may be performed
are described in paragraph .27–.41 of AU section 326.
Auditing Considerations
Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities
Auditing
Procedures
Malpractice Loss Contingencies
Transactions/Account Balances/Presentation and Disclosure
Existence and
occurrence,
completeness,
rights and
obligations, and
valuation and
allocation
The liability for
malpractice
claims is reported
properly in the
balance sheet.
Insurance
coverage is
reviewed
regularly,
including the
financial
viability of the
insurer.
The risk
management
system identifies
and monitors
malpractice
incidents and
evaluates
associated losses.
Review the amount
of insurance
coverage, the type
of coverage
(claims-made or
occurrence), the
deductible
provisions, and so
forth, to determine
the level of risk
that is retained by
the entity.
Consider the
financial viability
of the insurance
carrier.
Outside legal
counsel and
insurance
carriers review
and monitor all
claims.
The adequacy of
malpractice
accruals is
reviewed
regularly by
Send letters of
inquiry to
malpractice
insurance carriers
and legal counsel
(in accordance
with AU section
337, Inquiry of a
Client's Lawyer
Concerning
Litigation, Claims,
(continued)
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Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities
Auditing
Procedures
management,
including
information
obtained from
qualified
specialists.
Information
supplied to
specialists is
reviewed for
accuracy and
completeness.
Actuarial
assumptions are
reviewed for
compliance with
GAAP.
Changes in the
risk
management
system are
communicated
on a timely basis.
and Assessments
[AICPA,
Professional
Standards, vol. 1]).
Review and test
the method of
estimating
accruals (for
example, review
actuarial reports
and prior historical
loss experience).
Determine that
additional
premiums charged
by insurers for
retrospectively
related policies are
reported as a
liability.
Review prior
estimates and
historical loss
experience.
Determine
whether
uncertainties
related to medical
malpractice claims
need to be
disclosed in the
auditor's report.
Presentation and Disclosure
Classification and
understandability
The program of
medical
malpractice
insurance
coverage and the
basis for any loss
accruals are
disclosed
adequately in the
financial
statements.
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Chapter 9
Net Assets (Equity)1
Investor-Owned Health Care Entities
9.01 The equity accounts of investor-owned health care entities are similar
to those of other investor-owned businesses.
Not-for-Profit Health Care Entities
9.02 According to Financial Accounting Standards Board (FASB) Account-
ing Standards Codification (ASC) 958-210-45-1, the statement of financial po-
sition (balance sheet) of a not-for-profit health care entity should focus on the
entity as a whole and should report separate amounts for each of three classes
of net assets: (a) permanently restricted net assets, (b) temporarily restricted
net assets, and (c) unrestricted net assets. FASB ASC 958-210-45-9 states that
the amounts for each of the three classes are based on the existence or absence
of donor-imposed restrictions.
9.03 Unrestricted net assets of not-for-profit healthcare entities generally
result from revenues from providing or agreeing to provide health care services,
receiving unrestricted contributions and grants, or receiving dividends or in-
terest from investing in income-producing assets minus expenses incurred in
providing or agreeing to provide health care services, providing other commu-
nity benefits, and performing administrative functions.
9.04 According to the FASB ASC glossary, the only limits on the use of un-
restricted net assets are the broad limits resulting from the nature of the not-
for-profit entity; the environment in which the not-for-profit entity operates; the
purposes specified in the not-for-profit entity's articles of incorporation or by-
laws; or limits resulting from contractual agreements with suppliers, creditors,
and others entered into by the not-for-profit entity in the course of its business.
FASB ASC 958-210-50-2 requires disclosure of information about significant
limits resulting from contractual agreements with suppliers, creditor, and oth-
ers, including the existence of loan covenants either in the notes to the financial
statements or the face of the statement of financial position. Similarly, FASB
ASC 958-210-45-11 states that information about self-imposed limits also may
be useful, including information about voluntary resolutions by the governing
board of an entity to designate a portion of its unrestricted net assets to func-
tion as an endowment (sometimes called a board-designated endowment). That
information may be provided in notes to or on the face of financial statements.
9.05 For example, a not-for-profit health care provider may include infor-
mation about voluntary resolutions by the entity's governing board to designate
a portion of its unrestricted net assets for funded depreciation.
9.06 FASB ASC 958-210-45-9 states that information about the nature
and amounts of different types of permanent restrictions or temporary restric-
tions should be provided either by reporting their amounts on the face of the
1 Though some health care entities may use other terms, such as equity, this guide uses the term
net assets to describe residual interest.
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statement or by including relevant details in notes to financial statements. Sep-
arate line items may be reported within permanently restricted net assets or in
notes to financial statements to distinguish between permanent restrictions for
holdings of (a) assets, such as land or works of art, donated with stipulations
that they be used for a specified purpose, be preserved, and not be sold, and (b)
assets donated with stipulations that they be invested to provide a permanent
source of income. (These result from gifts and bequests that create permanent
endowment funds.)
9.07 Similarly, FASB ASC 958-210-45-10 states that separate line items
may be reported within temporarily restricted net assets or in notes to finan-
cial statements to distinguish between the following temporary restrictions: (a)
support of particular operating activities, (b) investment for a specified term, (c)
use in a specified future period, and (d) acquisition of long-lived assets. Donors'
temporary restrictions may require that resources be used in a later period or
after a specified date (time restrictions) or that resources be used for a speci-
fied purpose (purpose restrictions) or both. For example, gifts of cash and other
assets with stipulations that they be invested to provide a source of income for
a specified term and that the income be used for a specified purpose are both
time and purpose restricted. These gifts often are called term endowments.2
9.08 Pursuant to FASB ASC 958-210-50-3, the nature of the restrictions
on donor-restricted resources should be disclosed in the financial statements.
Governmental Health Care Entities*
9.09 The statements of net assets/balance sheets of governmental health
care entities should report net assets/equity in 3 components: (1) invested in
capital assets, net of related debt; (2) restricted (distinguishing between major
categories of restrictions), and (3) unrestricted. Either term net assets or equity
may be used to refer to the difference between assets and liabilities. The term
fund balance should not be reported on the face of the statement. When gov-
ernmental health care entities first apply Governmental Accounting Standards
Boards (GASB) Statement No. 34, Basic Financial Statements—and Manage-
ment's Discussion and Analysis—for State and Local Governments, classifying
net assets into the 3 required categories should begin by adding together all
previously reported fund balance amounts. Calculating each of the 3 required
components is described in paragraphs 9.10–.12.
2 In August 2008, FASB issued FASB Staff Position (FSP) FAS 117-1, Endowments of Not-for-
Profit Organizations: Net Asset Classification of Funds Subject to an Enacted Version of the Uniform
Prudent Management of Institutional Funds Act, and Enhanced Disclosures for All Endowment Funds.
FSP FAS 117-1 is effective for fiscal years ending after December 15, 2008. Earlier application is per-
mitted provided that annual financial statements for that fiscal year have not been previously issued.
FSP FAS 117-1 provides guidance on the net asset classification of donor-restricted endowment funds
for a not-for-profit entity (NFP) that is subject to an enacted version of the Uniform Prudent Manage-
ment of Institutional Funds Act of 2006 (UPMIFA). The FSP also improves disclosures about an NFP's
endowment funds (both donor-restricted endowment funds and board-designated endowment funds),
whether or not the NFP is subject to an enacted version of UPMIFA. Paragraphs 16–17 of the FSP
discuss the display of the reclassification upon implementation of the guidance and the reinstatement
of purpose restrictions on unappropriated net appreciation if the NFP is subject to an enacted version
of UPMIFA. FSP FAS 117-1 is located primarily in sections 45, 50, and 55 of FASB ASC 958-205 and
is labeled as "Pending Content" due to the transition and open effective date information discussed
in FASB ASC 958-205-65-1. For more information on FASB ASC, please see the notice to readers in
this guide.
* This section contains guidance that is limited to governmental health care organizations that
report as proprietary activities. This section does not apply to governmental health care organizations
that report using governmental funds.
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9.10 As discussed in GASB Statement No. 34 paragraph 33, the net asset
component, invested in capital assets, net of related debt should be the sum of
capital assets (capital assets are defined in paragraph 19 of GASB Statement
No. 34), net of accumulated depreciation less any debt issued to finance those
assets. Invested in capital assets, net of related debt should not include any
restricted resources that must be used to acquire capital assets, (such as unex-
pended debt proceeds or capital grants and contributions), or debt attributable
to significant amounts of unexpended debt proceeds. Capitalized costs of is-
suance are included with the same category as the related debt, as discussed in
the GASB staff document Comprehensive Implementation Guide—2007 (GASB
Q&A—2007 Edition), item 7.23.3 (see paragraph 1.12 in this guide).
9.11 The term restricted is defined by GASB Statement No. 34 paragraphs
34, as amended, and 99. A restriction is a constraint placed on the use of assets
or net assets that is either externally imposed (such as by creditors through
debt covenants) or imposed by law through constitutional provisions or en-
abling legislation. Restricted net assets should be reported based on this defi-
nition of restricted. As discussed in paragraph 98 of GASB Statement No. 34,
major categories of restrictions should be reported on the face of the state-
ment of net assets/balance sheet, for example, net assets restricted for capital
acquisitions. As discussed in the GASB Q&A—2007 Edition item 7.23.2 (see
paragraph 1.12 in this guide), unexpended debt proceeds that must be used to
acquire or construct capital assets and the portion of the debt attributable to
the unexpended proceeds should be included in restricted net assets. When a
governmental health care entity reports restricted net assets arising from per-
manent endowments, restricted net assets should be reported in 2 additional
components—expendable and nonexpendable, as discussed in paragraph 35 of
GASB Statement No. 34. As discussed in the GASB Q&A—2007 Edition, item
7.24.13 (see paragraph 1.12 in this guide), no category of restricted net assets
can be negative. If liabilities that relate to restricted assets exceed those assets,
no balance should be reported. The negative amount should be reported as a
reduction of unrestricted net assets.
9.12 GASB Statement No. 34 paragraph 98 prohibits governmental en-
tities from reporting internal designations in the net assets section of their
statements of net assets/balance sheets. Designations are management's plans
for the use of resources. They should not be afforded the same status as re-
strictions. Internally designated net assets should be reported as unrestricted
net assets and should not be displayed separately in the net assets section
of the statement of net assets/balance sheet, as discussed in paragraph 37 of
GASB Statement No. 34. (Designated assets, however, may be reported in the
statement of net assets/balance sheet, as discussed in paragraph 3.01 in this
guide.)
9.13 As discussed in paragraph 6 of GASB Statement No. 46, Net Assets
Restricted by Enabling Legislation—an amendment of GASB Statement No.
34, net assets at the end of the reporting period that are restricted by enabling
legislation should be disclosed in the notes to the financial statements.
Auditing
9.12 The independent auditor may consider the examples of specific au-
diting objectives, selected control activities, and auditing procedures relating
to net assets (equity) that are presented in exhibit 9-1.
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Exhibit 9-1
The following table illustrates the use of assertions in developing audit ob-
jectives and designing substantive tests. The examples are not intended to
be all-inclusive nor is it expected that all the procedures would necessarily be
applied in an audit. The auditor should design and perform substantive pro-
cedures for all relevant assertions related to each material class of transac-
tions, account balance, and disclosure to obtain sufficient appropriate audit
evidence. The use of assertions in assessing risks and designing appropriate
audit procedures to obtain audit evidence is described in paragraphs .14–.26
of AU section 326, Audit Evidence (AICPA, Professional Standards, vol. 1).
Various audit procedures and the purposes for which they may be performed
are described in paragraph .27–.41 of AU section 326.
Auditing Considerations
Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities
Auditing
Procedures
Net Assets (Equity)
Account Balances
Rights and
obligations
Resources are
used and
accounted for in
accordance with
donor and grantor
restrictions.
Management
monitors
compliance with
these
restrictions.
Review the
minutes of board
and board
committee
meetings for
evidence of donor
restrictions.
Determine
compliance with
donor and grantor
restrictions.
Presentation and Disclosure
Classification and
understandability
Net assets are
presented and
disclosed properly
in the financial
statements.
Procedures
ensure proper
authorization,
recording, and
presentation.
Test significant net
asset transactions
to determine that
they are properly
authorized and
recorded.
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Chapter 10
Revenue, Expenses, Gains, and Losses
Conceptual Framework for Reporting Revenue, Expenses,
Gains, and Losses
10.01 Financial Accounting Standards Board (FASB) Concept No. 6, El-
ements of Financial Statements—a replacement of FASB Concepts Statement
No. 3 (incorporating an amendment of FASB Concepts Statement No. 2), pro-
vides a useful conceptual framework for preparers of financial statements to
distinguish among elements of financial statements for purposes of display. Ad-
ditionally, not-for-profit health care entities are subject to the requirements of
FASB Accounting Standards Codification (ASC) 954-225 and 958-225.1 This
chapter draws on the concepts contained in FASB Concept No. 6 and FASB
ASC 954-225 and 958-225 in discussing revenue, expenses, gains, and losses
with respect to health care entities. Expenses are not generally netted against
revenues, whereas gains and losses may be displayed as net amounts. The
application of these concepts to the classification of revenue, expenses, gains,
and losses in the statement of operations of health care entities is discussed in
paragraphs 10.02–.19.
10.02 Paragraph 78 of FASB Concept No. 6 defines revenues as "inflows
or other enhancements of assets of an entity or settlements of its liabilities (or
a combination of both) from delivering or producing goods, rendering services,
or other activities that constitute the entity's ongoing major or central opera-
tions." Similarly, paragraph 80 defines expenses as "outflows or other using up
of assets or incurrences of liabilities (or a combination of both) from deliver-
ing or producing goods, rendering services, or carrying out other activities that
constitute the entity's ongoing major or central operations."
Distinguishing Charity Care From Bad Debt Expense
or Allowance
10.03 FASB ASC glossary states that charity care represents health care
services that are provided but are never expected to result in cash flows. Charity
care is provided to a patient with demonstrated inability to pay. Each entity es-
tablishes its own criteria for charity care consistent with its mission statement
and financial ability. According to FASB ASC 954-605-25-10, charity care does
not qualify for recognition as revenue in the financial statements. Distinguish-
ing charity care from bad-debt expense (or allowance, for governmental health
care entities2) requires the exercise of judgment. Only the portion of a patient's
account that meets the entity's charity care criteria should be recognized as
charity. FASB ASC 954-605-25-11 states that although it is not necessary for
the entity to make this determination on admission or registration of an in-
dividual, at some point the entity must determine that the individual meets
the established criteria for charity care. (See paragraph 10.46 for disclosure
requirements relating to charity care.)
1 Governmental health care entities only. This pronouncement is not applicable to governmental
health care enterprises. (See footnote 1 in chapter 1.)
2 Governmental health care entities only. See paragraph 10.45 in this chapter for a discussion
about the reporting of allowances by governmental health care entities.
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Revenue
10.04 FASB ASC 954-605-25-2 states that revenue usually is recorded
when coverage is provided to an enrollee or the service is provided to a patient
or resident. An enrollee is an individual who is a subscriber or an eligible de-
pendent of a subscriber in a prepaid health care plan. FASB ASC 954-605-45-1,
states that revenue should be classified based on the type of service rendered
or contracted to be rendered. FASB ASC 954-605-05-2 provides the following
examples of revenue:
 patient service revenue, which is derived from fees charged for
patient care. This may be based on diagnosis related group pay-
ments, resource-based relative value scales payments, per diems,
discounts, or other fee-for-service arrangements.
 premium revenue, which is derived from capitation arrangements.
 resident service revenue, which may be related to maintenance
fees, rental fees, or amortization of advance fees.
10.05 Some not-for-profit health care entities may receive relatively small
amounts of contributions, grants, or tax support. The "Contributions Received"
subsections of FASB ASC 958-606 require that such amounts, whether tem-
porarily restricted, permanently restricted, or unrestricted, be recognized as
revenue or gains when they are received.
10.06 Special considerations pertaining to revenue recognition of promises
to give in future periods (pledges) are discussed in chapter 5 and in paragraphs
10.10–.19 in this guide.
10.07 The guidance in the "Transfers of Assets to a Not-for-Profit Entity
or Charitable Trust that Raises or Holds Contributions for Others" subsections
of FASB ASC 958-605,3 apply to transactions in which an entity—the donor—
makes a contribution by transferring assets to a not-for-profit entity or chari-
table trust—the recipient entity—that accepts the assets from the donor and
agrees to use those assets on behalf of or transfer those assets, the return on
investment of those assets, or both to an unaffiliated entity—the beneficiary—
that is specified by the donor.4 FASB ASC 958-605-25-28 requires that if a
donor transfers assets to an agent, trustee, or intermediary (recipient entity)
and specifies a nongovernmental health care entity as the ultimate recipient
3 Governmental health care entities only. This pronouncement is not applicable to governmental
health care entities. (See footnote 1 in chapter 1.)
4 The guidance in the "Transfers of Assets to a Not-for-Profit Entity or Charitable Trust that
Raises or Holds Contributions for Others" subsections of Financial Accounting Standards Board
(FASB) Accounting Standards Codification (ASC) 958-605 also establishes standards for transac-
tions that take place in a similar manner but are not contributions for either of the following reasons:
(a) the entity that transfers the assets to the recipient entity—the resource provider—is related to
the beneficiary in a way that causes the transfer to be reciprocal or (b) conditions imposed by the
resource provider or the relationships between the parties make the transfer of assets to the recip-
ient entity revocable or repayable. For example, FASB ASC 958-605-55-110 states that if a resource
provider transfers assets to a recipient organization and specified itself or its affiliate as beneficiary,
a presumption that the transfer is reciprocal, and therefore not a contribution, is necessary even
if the resource provider explicitly grants the recipient entity variance power. Those standards and
transactions are discussed in paragraphs 4.18–.19, 11.39, and 11.41–.42 of this guide. FASB ASC
958-605-15-12 explains that if the transfer of assets is not a contribution or not yet a contribution, the
"Transfers of Assets to a Not-for-Profit Entity or Charitable Trust that Raises or Holds Contributions
for Others subsections" of FASB ASC 958-605 use the term resource provider rather than the term
donor to refer to the entity that transfers the assets to the recipient entity. This guide adopts a similar
convention in discussing those transactions.
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(the specified beneficiary) of the contribution or grant, that specified health care
entity should recognize its rights to the assets (financial or nonfinancial) held
by a recipient entity as an asset and contribution revenue unless the recipient
entity is explicitly granted variance power. The FASB ASC glossary defines
variance power as the unilateral power to redirect the use of the transferred
assets to another beneficiary. A donor explicitly grants variance power if the
recipient entity's unilateral power to redirect the use of the assets is explicitly
referred to in the instrument transfering the assets. Unilateral power means
that the recipient entity can override the donor's instructions without approval
from the donor, specified beneficiary, or any other interested party. According to
FASB ASC 958-605-25-31, if the donor explicitly grants a recipient entity vari-
ance power, the specified health care entity (beneficiary) should not recognize
its potential for future distributions from the assets held by the recipient entity.
Those future distributions, if they occur, should be recognized as contributions
by the specified health care entity (beneficiary) when received or uncondition-
ally promised. (See further discussion at paragraph 5.19 in this guide. Also,
special considerations pertaining to transfers between related entities are dis-
cussed in paragraphs 10.10, 11.39–.42, and 11.49–.55 in this guide.)
10.08 Governmental health care entities may also receive contributions,
grants, or tax support. Governmental health care entities classify these transac-
tions into one of four classes of nonexchange transactions based on their princi-
pal characteristics, as discussed in Governmental Accounting Standards Board
(GASB) Statement No. 33, Accounting and Financial Reporting for Nonex-
change Transactions, as amended, paragraph 7. (GASB Statement No. 33,
as amended, applies to transactions involving financial and capital resources.
GASB Statement No. 33, as amended, does not apply to other resources, such
as contributed services.) Transactions that are not recognizable because they
are not measurable should be disclosed.
10.09 According to FASB ASC 954-605-05-4, other revenue, gains, or losses
are derived from services other than providing health care services or coverage
to patients, residents, or enrollees. These typically include the following:
 interest and dividends from all funds held by a trustee, malprac-
tice funds, or other miscellaneous investment activities.
 certain realized changes in market values of marketable securities
(see chapter 4).
 fees from educational programs, which include tuition for schools
(such as nursing) or laboratory and X-ray technology.
 rental of health care facility space.
 sales of medical and pharmaceutical supplies to employees, physi-
cians, and others.
 fees charged for transcripts for lawyers, insurance entities, and
others.
 proceeds from sale of cafeteria meals and guest trays to employees,
medical staff, and visitors.
 proceeds from sale of scrap, used X-ray film, and so forth.
 proceeds from sales at gift shops, snack bars, newsstands, parking
lots, vending machines, or other service facilities operated by the
health care entity.
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10.10 Pursuant to FASB ASC 958-320-45-2, dividend, interest, and other
investment income should be reported in the period earned as increases in
unrestricted net assets unless the use of the assets received is limited by donor-
imposed restrictions. FASB ASC 958-225-45-8 states that not-for-profit entities
should report gains and losses recognized on investments and other assets (or
liabilities) as increases or decreases in unrestricted net assets, unless their use
is temporarily or permanently restricted by explicit donor stipulation or by law.
Pursuant to FASB ASC 958-225-45-3, expirations of donor-imposed restrictions,
which simultaneously increase one class of net assets and decrease another
(reclassifications), should be reported as separate items.
10.11 Occasionally, nongovernmental health care entities may receive
funds from (or transfer funds to) a not-for-profit entity or a charitable trust.
If the not-for-profit entity is an affiliate, those transfers generally are either:
(a) an equity transfer, (b) an equity transaction, or (c) a loan or advance. Equity
transfers are discussed in paragraph 11.37. Equity transactions are discussed
in paragraphs 11.39–.42. Loans and advances to related entities are discussed
in paragraphs 11.44–.46. In limited circumstances, those transfers are contri-
butions. The circumstances in which a distribution from a not-for-profit entity
or charitable trust to an affiliated nongovernmental health care entity is a
contribution are described in paragraphs 11.52–.55. If the not-for-profit entity
or charitable trust is not an affiliate, the transaction is either (a) an invest-
ment transaction, (b) a refundable advance, or (c) a contribution. Investment
transactions are discussed in paragraphs 4.53–.55. The transfer is a refundable
advance if it is revocable or repayable. The transfer is a contribution only if it
meets the definition of a contribution in the FASB ASC glossary.
10.12 The FASB ASC glossary defines contribution as
An unconditional transfer of cash or other assets to an entity or a
settlement or cancellation of its liabilities in a voluntary nonrecipro-
cal transfer by another entity acting other than as an owner. Those
characteristics distinguish contributions from exchange transactions,
which are reciprocal transfers in which each party receives and sac-
rifices approximately equal value; from investments by owners and
distributions to owners, which are nonreciprocal transfers between an
entity and its owners; and from other nonreciprocal transfers, such
as impositions of taxes or fines and thefts, which are not voluntary
transfers. (Remainder of definition omitted.)
10.13 Pursuant to FASB ASC 958-605-25-2, contributions of noncash as-
sets that are not long-lived assets should be recognized as revenue or gains
in the period received and as assets, decreases in liabilities, or expenses, de-
pending on the form of the benefits received. Per FASB ASC 958-605-30-2,
contributions received should be measured at fair value.5
10.14 For example, a donation of supplies would be reflected as revenue
or gains and as an increase in inventory or supply expense.
10.15 FASB ASC 958-605-45 discusses classification of contributions.
Contributions without donor-imposed restrictions should be reported as un-
restricted support that increases unrestricted net assets in the statement of
5 FASB ASC 820, Fair Value Measurements and Disclosures, defines fair value, establishes a
framework for measuring fair value in generally accepted accounting principles, and expands disclo-
sures about fair value measurements. See discussion in chapter 1.
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operations. Contributions with donor-imposed restrictions should be reported
as restricted support, which increases permanently restricted net assets or tem-
porarily restricted net assets. Donations with explicit donor restrictions that
permanently limit the health care entity's use of the contributed assets (for
example, permanent endowments) are reported as increases in permanently
restricted net assets.6
10.16 Paragraphs 9–12 of FASB ASC 958-205-45 discuss expirations of
donor-imposed restrictions. A not-for-profit health care entity should recognize
the expiration of donor-imposed in the period in which the restriction expires. A
restriction expires when the stipulated time has elapsed, when the stipulated
purpose for which the resource was restricted has been fulfilled, or both. FASB
ASC 958-205-55-21 illustrates that when a donor restriction expires, that is,
when a stipulated time restriction ends or purpose restriction is accomplished,
temporarily restricted net assets are reclassified to unrestricted net assets and
reported in the statement of operations as "net assets released from restriction."
FASB ASC 958-605-45-4 states that donor-restricted contributions whose re-
strictions are met in the same reporting period may be reported as unrestricted
support provided that an entity reports consistently from period to period and
discloses its accounting policy.
10.17 Pursuant to FASB ASC 958-605-25-2, contributions of long-lived as-
sets, including the use of long-lived assets such as land, buildings, and equip-
ment, are reported as support or gains in the period received. According to
FASB ASC 958-605-30-2, contributions received should be measured at its fair
value.7 FASB ASC 958-605-45-6 states that in the absence of donor-imposed
restrictions on use of the asset, gifts of long-lived assets should be reported
as unrestricted support. Pursuant to FASB ASC 958-605-45-3, contributions of
long-lived assets with explicit donor restrictions are reported as temporarily or
permanently restricted support.
10.18 According to FASB 954-205-45-9, the expiration of donor-imposed
restrictions on long-lived assets should be recognized when the asset is placed
in service (rather than as depreciated as permitted by paragraph FASB ASC
958-205-45-12). Thus, if contributions of long-lived assets with explicit donor
restrictions are reported as temporarily restricted support, an not-for-profit
provider reports expirations of those donor restrictions when the stipulation
is fulfilled and the assets are placed in service. At that time, temporarily
6 In August 2008, FASB issued FASB Staff Position (FSP) FAS 117-1, Endowments of Not-for-
Profit Organizations: Net Asset Classification of Funds Subject to an Enacted Version of the Uniform
Prudent Management of Institutional Funds Act, and Enhanced Disclosures for All Endowment Funds.
FSP FAS 117-1 is effective for fiscal years ending after December 15, 2008. Earlier application is per-
mitted provided that annual financial statements for that fiscal year have not been previously issued.
FSP FAS 117-1 provides guidance on the net asset classification of donor-restricted endowment funds
for a not-for-profit entity (NFP) that is subject to an enacted version of the Uniform Prudent Manage-
ment of Institutional Funds Act of 2006 (UPMIFA). The FSP also improves disclosures about an NFP's
endowment funds (both donor-restricted endowment funds and board-designated endowment funds),
whether or not the NFP is subject to an enacted version of UPMIFA. Paragraphs 16–17 of the FSP
discuss the display of the reclassification upon implementation of the guidance and the reinstatement
of purpose restrictions on unappropriated net appreciation if the NFP is subject to an enacted version
of UPMIFA.
FSP FAS 117-1 is located primarily in sections 45, 50, and 55 of FASB ASC 958-205 and is
labeled as "Pending Content" due to the transition and open effective date information discussed in
FASB ASC 958-205-65-1. For more information on FASB ASC, please see the notice to readers in this
guide.
7 See footnote 5 in paragraph 10.13.
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restricted net assets are reclassified to unrestricted net assets and reported
in the statement of operations as "net assets released from restriction."
10.19 Similarly, FASB ASC 954-205-45-9 states that donations of cash
or other assets that must be used to acquire long-lived assets are reported as
temporarily restricted support in the period received, and expirations of donor
restrictions are reported when the acquired long-lived assets are placed in ser-
vice and donor-imposed restrictions are satisfied. The temporarily restricted net
assets are reclassified to unrestricted net assets and reported in the statement
of operations as "net assets released from restriction" when the restrictions
expire. As illustrated in FASB ASC 958-205-55-7, assets that are restricted
by donors for acquisition of long-lived assets (such as cash or contributions
receivable) are not included with the line items "cash and cash equivalents"
or "contributions receivable." Rather, those items are reported as "assets re-
stricted to investment in property and equipment," and are sequenced near the
"property and equipment" section of the balance sheet (see paragraph 3.01).
10.20 The nature and extent of donated services received by health care
entities varies and can range from the limited participation of many people in
fund-raising activities to active participation in the entity's service programs;
their values usually are not recorded. For example, health care entities may
receive accounting, financial, construction, educational, electrical, investment
advisory, legal, medical, and other services.
10.21 FASB ASC 958-605-25-16 states that contributions of services
should be recognized if the services received meet any of the following crite-
ria: (1) they create or enhance nonfinancial assets (for example, property and
equipment) or (2) they meet all of the following criteria:
a. Require specialized skills
b. Are provided by individuals possessing those skills (services requir-
ing specialized skills are provided by accountants, architects, car-
penters, doctors, electricians, lawyers, nurses, plumbers, teachers,
and other professionals and craftspeople)
c. Would typically need to be purchased by the entity if not provided
by donation
Additional guidance with regard to the accounting for and the reporting of
donated services is provided in FASB ASC 958-605.
10.22 Contributions to governmental health care entities are governed by
GASB Statement No. 33, discussed in paragraph 10.08. GASB Statement No.
33 applies to external transactions involving financial and capital resources.
As discussed in GASB Statement No. 33 paragraph 14, purpose restrictions
on nonexchange revenues (such as grants, contributions, and endowments) do
not affect when revenues are recognized. Rather, resulting net assets should be
reported as restricted until the resources have been used for the specified pur-
pose (see paragraph 9.10 of this guide) or for as long as the resource provider
requires (for example, for endowments). Unlike not-for-profit health care enti-
ties, the statement of revenues, expenses, and changes in net assets/equity does
not require disaggregation of transactions based on the types of restrictions
that may exist (such as unrestricted, temporarily restricted, or permanently
restricted revenues). Disaggregations such as "net assets released from restric-
tions," "changes in temporarily restricted net assets", and "changes in perma-
nently restricted net assets" should not be reported in either the statement
of revenues, expenses, and changes in net assets/equity or in the net assets
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section of the statement of net assets/balance sheet of governmental health
care entities. Interfund transfers are reported after "nonoperating revenues
and expenses" in the statement of revenues, expenses, and changes in net as-
sets/equity as discussed in paragraphs 101 and 112 of GASB Statement No. 34,
Basic Financial Statements—and Management's Discussion and Analysis—for
State and Local Governments (see paragraph 1.22 of this guide). Intra-entity
activity between a primary government and its component units are accounted
for in accordance with paragraph 61 of GASB Statement No. 34.
10.23 Additional guidance regarding accounting for contributions by non-
governmental health care entities can be found in the "Contributions Received"
subsections of FASB ASC 958-605, which include permanent endowments, gifts
in kind, and contributed utilities, facilities, or use of long-lived assets; and in the
"Transfers of Assets to a Not-for-Profit Entity or Charitable Trust that Raises
or Holds Contributions for Others" subsections of FASB ASC 958-605. FASB
ASC 958-30 provides guidance on split-interest gifts.
10.24 Additional guidance can also be found in chapters 5 and 6 of the
Audit and Accounting Guide Not-for-Profit Entities.
10.25 Foundations, business entities, and other types of entities may pro-
vide resources to health care entities under programs referred to as grants,
awards, or sponsorships. Those asset transfers are contributions if the resource
providers receive no value in exchange for the assets transferred or if the value
received by the resource provider is incidental to the potential public benefit
from using the assets transferred. Paragraphs 3–13 of FASB ASC 958-605-55
provide guidance on distinguishing contributions from exchange transactions.
10.26 For governmental health care entities, those transactions are re-
ferred to as nonexchange transactions, addressed in GASB Statement No. 33.
The asset transfers are exchange or exchange-like transactions if the potential
public benefit is secondary to the resource providers' potential direct benefits.
10.27 For example, a research grant made by a foundation to a hospital
would likely be a contribution if the research program is to be planned and
carried out by the hospital and the hospital has the right to publish the results.
If, however, the grant is made by a pharmaceutical manufacturer that provides
potential new medications to be tested in the hospital's research facilities and
retains the right to any patents or other results, the grant would likely be an
exchange transaction.
10.28 For governmental health care entities, capital contributions and
contributions to term and permanent endowments are reported as a compo-
nent of the all-inclusive statement of revenues, expenses, and changes in net
assets/equity. Contributions of capital assets or of financial resources required
to be used to acquire capital assets are required to be reported as revenues sep-
arately after "nonoperating revenues and expenses," in the statement of rev-
enues, expenses, and changes in net assets/equity, as illustrated in paragraph
1.20 of this guide. Contributions to term and permanent endowments should
be reported in the same manner as capital contributions. Capital contributions
received from other funds of the same financial reporting entity should be re-
ported last as interfund transfers, after "nonoperating revenues and expenses"
in the statement of revenues, expenses, and changes in net assets/equity, as
discussed in paragraph 101 of GASB Statement No. 34 and paragraph 10.22 in
this chapter.
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10.29 Revenues from capital contributions as well as contributions to the
principal of permanent and term endowments should be reported after "nonop-
erating revenues and expenses," as discussed in GASB Statement No. 34 para-
graph 100. Income from permanent or term endowments should be recorded
as "nonoperating revenue," as discussed in the GASB staff document Compre-
hensive Implementation Guide—2007 (GASB Q&A—2007 Edition), item 7.74.3
(see paragraph 1.12 in this guide).
Agency Funds
10.30 FASB ASC 954-305-45-4 states that health care entities may receive
and hold assets owned by others under agency relationships; for example, they
may perform billing and collection services for physicians. In accepting respon-
sibility for those assets, an entity incurs a liability to the principal under the
agency relationship to return the assets in the future or, if authorized, to dis-
burse them to another party on behalf of the principal. If held by not-for-profit,
business-oriented health care entities, such agency funds should be reported
as unrestricted assets.
10.31 In other cases, not-for-profit health care entities may act as agents,
trustees, or intermediaries helping donors to make a contribution to another
entity or individual. When acting in that capacity, those entities do not receive
a contribution when they receive the assets, nor do they make a contribution
when they disburse the assets to the other entity or individual. Instead, they
act as go-betweens, passing the assets from the donor through their entity to
the specified entity or individual.
10.32 The "Transfers of Assets to a Not-for-Profit Entity or Charitable
Trust that Raises or Holds Contributions for Others" subsections of FASB ASC
958-6058 establish standards for transactions in which an entity—the donor—
makes a contribution by transferring assets to a not-for-profit entity or char-
itable trust—a recipient entity—that accepts the assets from the donor and
agrees to use those assets on behalf of the donor or transfer those assets, the
return on investment of those assets, or both to an unaffiliated entity—the
beneficiary— that is specified by the donor.9 FASB ASC 958-605-55-76 states
that a recipient entity has discretion sufficient to recognize a contribution re-
ceived if it can choose the beneficiaries of the assets. Paragraphs 76–79 of FASB
ASC 958-605 provide guidance to help determine whether a recipient entity has
discretion to choose the beneficiary. FASB ASC 958-605-25-24 states that ex-
cept as described in FASB ASC 958-605-25-25 (variance power) and FASB ASC
958-605-25-27 (financially interrelated entities), a recipient entity that accepts
assets from a donor and agrees to use those assets on behalf of (a specified
beneficiary) or transfer those assets, the return on investment of those assets,
or both to a specified beneficiary is (an agent) and not a donee. (The exceptions
8 Governmental health care entities only. This pronouncement is not applicable to governmental
health care entities. (See footnote 1 in chapter 1.)
9 The "Transfers of Assets to a Not-for-Profit Entity or Charitable Trust that Raises or Holds
Contributions for Others" subsections of FASB ASC 958-605 also establish standards for transactions
that take place in a similar manner but are not contributions because the transfers are revocable,
repayable, or reciprocal. For example, if a resource provider transfers assets to a recipient entity and
names itself or its affiliate as beneficiary, that transaction is reciprocal even if the resource provider
grants variance power. Those standards and transactions are discussed in paragraphs 4.53–.55, 11.39,
and 11.41–.42 in this guide. If the transfer of asset is not a contribution or not yet a contribution,
FASB ASC 958-605 and this guide use the term resource provider rather than the term donor to refer
to the entity that transfers the assets to the recipient entity.
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for variance power are discussed at paragraphs 10.05–.09 in this guide and
for financially interrelated entities at paragraphs 11.49–.55 in this guide.) As
discussed in FASB ASC 958-605-25-24, the recipient entity should recognize its
liability to the specified beneficiary concurrent with its recognition of cash or
other financial assets received from the donor. According to paragraphs 12–13
of FASB ASC 958-605-30, both the liability and the asset should be measured
at the fair value of the assets received.10 FASB ASC 958-605-25-24 states that
except as described in paragraphs 25–26 of FASB ASC 958-605-25 and FASB
ASC 958-605-25-27, a recipient entity that receives nonfinancial assets is per-
mitted, but not required, to recognize its liability and those assets provided that
the recipient entity reports consistently from period to period and discloses its
accounting policy.
10.33 Thus, if the assets received from the donor are donated materials,
supplies, or other nonfinancial assets, the recipient entity may choose either
to (a) report the receipt of the assets as a liability to the beneficiary concur-
rent with recognition of the assets received or (b) not report the transaction at
all. The choice is an accounting policy that should be applied consistently from
period to period. An entity should consider the need for disclosure of its ac-
counting policy in the notes to the financial statements pursuant to FASB ASC
235-10-50-1 and FASB ASC 958-605-50-4. Standards for not-for-profit entities
that act as agents, trustees, or intermediaries are described further in chapters
5 and 6 of the Audit and Accounting Guide Not-for-Profit Entities.
Expenses
10.34 The basis and timing of the recognition of expenses for health care
entities generally are the same as for other business entities. Expenses aris-
ing from nonexchange transactions (such as grants, taxes, and contributions)
reported by governmental health care entities are recognized based on their ap-
propriate class of nonexchange transactions, as discussed in paragraph 10.08.
According to FASB ASC 958-225-45-7, a not-for-profit entity should report ex-
penses as decreases in unrestricted net assets.
10.35 The "Accounting for Costs of Activities that Include Fundraising"
subsections of FASB ASC 958-720 provide guidance for reporting joint activities
and requires financial statement disclosures about the nature of the activities
for which joint costs have been allocated and the amounts of joint costs. The
guidance applies to not-for-profit and state and local governmental entities (in-
cluding health care entities). The FASB ASC glossary defines joint activity as
an activity that is part of the fundraising function and has elements of one or
more other functions, such as program, management and general, membership
development, or any other functional category used by the entity. FASB ASC
958-720-45-29 states that if the criteria of purpose, audience, and content are
met, the costs of a joint activity should be classified as follows: (a) the costs that
are identifiable with a particular function should be charged to that function
and (b) joint costs should be allocated between fundraising and the appropriate
program or management and general function. If any of the criteria are not met,
all costs of the joint activity should be reported as fundraising costs, including
costs that otherwise might be considered program or management and general
costs if they had been incurred in a different activity, subject to the exception in
10 For additional discussion on fair value measurements, refer to chapter 1.
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the following sentence. Costs of goods or services provided in exchange trans-
actions that are part of joint activities, such as costs of direct donor benefits
of a special event (for example, a meal), should not be reported as fundraising.
The purpose, audience and content tests are described in paragraphs 33–53 of
FASB ASC 958-720-45.
Financial Statement Presentation
10.36 FASB ASC 954-225-45-4 states that the statement of operations for
not-for-profit, business-oriented health care entities should include a perfor-
mance indicator. The FASB ASC glossary states the following:
A performance indicator reports results of operations. A performance
indicator and the income from continuing operations reported by for-
profit health care entities generally are consistent, except for transac-
tions that clearly are not applicable to one kind of entity (for example,
for-profit health care entities typically would not receive contributions,
and not-for-profit health care entities would not award stock compen-
sation). That is, the performance indicator is analogous to income from
continuing operations of a for-profit entity.
10.37 FASB ASC 954-225-45-4 also states that because of the importance
of the performance indicator, it should be clearly labeled with a descriptive
term such as revenues over expenses, revenues and gains over expenses and
losses, earned income, or performance earnings. Not-for-profit entities should
report the performance indicator in a statement that also presents the total
changes in unrestricted net assets. Other changes in net assets may be pre-
sented separately or in the same statement. FASB ASC 958-205-50-1 states
that the notes to the financial statements should include a description of the
nature and composition of the performance indicator.
10.38 FASB ASC 954-225-45-7 requires that health care entities report
the following items separately from the performance indicator:
a. Transactions with owners acting in that capacity.
b. Equity transfers involving other entities that control the reporting
entity, are controlled by the reporting entity, or are under common
control with the reporting entity.
c. Receipt of restricted contributions, including temporary restric-
tions (such as time or purpose) or permanent restrictions.
d. Contributions of (and assets released from donor restrictions re-
lated to) long-lived assets.
e. Items that are required to be reported in or reclassified from other
comprehensive income, such as minimum pension liabilities in ac-
cordance with FASB ASC 715-30-25-3,* foreign currency trans-
lation adjustments, and the effective portion of the gain or loss
on derivative instruments designated and qualifying as cash flow
hedging instruments.
f. Items that are required to be reported separately under specialized
not-for-profit standards. These include extraordinary items and the
* As noted in FASB 958-715-65-1, the requirement to measure plan assets and benefit obligations
as of the date of the employer's fiscal year-end statement of financial position is effective for fiscal
years ending after December 15, 2008.
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effect of discontinued operations, discussed in FASB ASC 958-225-
55-6.
g. Unrealized gains and losses on investments on other than trading
securities, per FASB ASC 954-320-45-1b.
h. Investment returns restricted by donors or by law.
i. Investment losses that decrease unrestricted net assets if those
losses reduce the assets of a donor-restricted endowment fund below
the required level, as described in FASB ASC 958-205-45-22.
j. Investment gains that increase unrestricted net assets if those
gains restore the fair value of the assets of a donor-restricted en-
dowment fund to the required level, as described in FASB ASC
958-205-45-22.
10.39 Paragraphs 5–6 of FASB ASC 954-225-45 state that classifying rev-
enues, expenses, gains, and losses within classes of net assets does not preclude
incorporating additional classifications within the performance indicator. For
example, within a class or classes of changes in net assets, a not-for-profit entity
may classify items as operating and nonoperating, expendable and nonexpend-
able, earned and unearned, recurring and nonrecurring, or in other ways. This
guidance neither requires nor precludes reporting such intermediate measures
or subtotals.
10.40 However, FASB ASC 954-225-50-2 states that because terms such as
operating income are used with different meanings, if an intermediate measure
of operations is reported and its use is not apparent from the details provided
on the face of the statement, a note to the financial statements should describe
the nature of the reported measure of operations or the items excluded from
operations.
10.41 Governmental health care entities should separately report special
items and extraordinary items at the bottom of the statement of revenues,
expenses, and changes in net assets or equity, or both, as illustrated in GASB
Statement No. 34 paragraph 101. Governmental health care entities should
report special items separately after capital contributions and contributions
to permanent and term endowments but before extraordinary items, if any.
GASB Statement No. 34 paragraph 56 defines a special item as a significant
transaction or other event that is within the control of management and that
is either unusual in nature or infrequent in occurrence.
10.42 Governmental health care entities are required to distinguish be-
tween operating revenues and expenses and nonoperating revenues and ex-
penses and provide an intermediate total for operating income or loss. GASB
Statement No. 34 paragraph 102 does not establish a definition of operating.
Rather, governments are required to establish their own policy defining oper-
ating revenues and expenses that is appropriate to the nature of the activity
being reported. Once established, an entity's policy should be applied consis-
tently and disclosed in the notes to the financial statements. GASB Statement
No. 34 paragraph 102 notes that a consideration for determining which rev-
enues and expenses should be reported as operating is how those transactions
would be classified in the statement of cash flows. Using this approach, transac-
tions that are considered investing, capital and related financing, and noncap-
ital financing activities would normally not be reported as operating revenues
and expenses. This would include investment revenues and interest expense
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as well as most nonexchange transactions, including most grants, taxes, and
contributions.
10.43 For governmental health care entities, changes in accounting prin-
ciples, addressed in Accounting Principles Board Opinion No. 20, Accounting
Changes, as amended, should be reported as restatements of beginning net as-
sets or equity, or both, as discussed in footnote 13 to paragraph 17 of GASB
Statement No. 34.
10.44 Pursuant to FASB ASC 954-605-45-2, patient service revenue
should be reported net of contractual and other adjustments in the statement
of operations. FASB ASC 954-605-45-3 states that significant revenue earned
under capitation arrangements should be reported separately. FASB ASC 954-
605-50-1 states that the notes to financial statements should disclose the meth-
ods of revenue recognition (for example, policies related to capitation revenue,
patient service revenue, or contributions). In addition, FASB ASC 954-405-50-1
states that with regard to contractual adjustments and third-party settlements,
identification and explanation of the estimated amounts that are payable or re-
ceivable by the entity should be disclosed.
10.45 GASB Statement No. 34 paragraph 100 requires revenues to be
reported by major source, net of discounts and allowances, and separately iden-
tify pledged revenues. Therefore, governmental health care entities do not re-
port bad debt expense. The amount of discounts and allowances, including the
increase or decrease in the estimate of uncollectible accounts, should be re-
ported parenthetically on the face of the financial statements, as a separate
line directly below the revenue amount, or in the notes, as required by GASB
Statement No. 34 footnote 41 to paragraph 100. Paragraph 10.04 in this chap-
ter provides additional discussion on classification of revenue, and examples of
revenue, including patient service revenue. As discussed in paragraph 10.44 in
this chapter, patient service revenue is reported net of contractual and other
adjustments in the operating statement.
10.46 As discussed in paragraph 10.03, patient service revenue does not
include charity care. FASB ASC 954-605-50-3 requires that management's pol-
icy for providing charity care, as well as the level of charity care provided, should
be disclosed in the financial statements. Such disclosure generally is made in
the notes to the financial statements and is measured based on the provider's
rates, costs, units of service, or other statistical measure.
10.47 Expenses may be reported on the face of the financial statements
using either a natural classification or a functional presentation. Pursuant to
FASB ASC 958-205-55-11, not-for-profit entities that report using a natural
classification of expenses are required to disclose expenses by functional clas-
sification in the notes.
10.48 Public companies (that is, registrants with the Securities and Ex-
change Commission) are required to disclose segment information in accor-
dance with FASB ASC 280, Segment Reporting. FASB ASC glossary clarifies
the definition of a public entity in certain accounting standards to include an
entity that is a conduit bond obligors for conduit debt securities that are traded
in a public market (a domestic or foreign stock exchange or an over-the-counter
market, including local or regional markets).
10.49 For governmental health care entities, GASB Statement No. 34,
as amended, paragraph 122 defines a segment as an identifiable activity
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(or grouping of activities) reported as or within an enterprise fund or an other
stand-alone entity that
 has one or more bonds or other debt instruments outstanding with
a revenue stream pledged in support of that debt, and
 is required by an external party (such as through a bond inden-
ture) to account separately for its assets, liabilities, revenues, and
expenses.
GASB Statement No. 34 paragraph 122 also details the disclosure required for
segments.
10.50 Governmental health care entities that receive restricted resources
are required to disclose whether, when both restricted and unrestricted re-
sources are available, it is their policy to use restricted or unrestricted resources
first, as discussed in GASB Statement No. 34 paragraph 115(h).
10.51 GASB Statement No. 34 paragraph 121 requires governmental
health care entities that receive donor-restricted endowments to make certain
disclosures about their policy for use of investment income generated by those
endowments.
10.52 As noted in paragraph 10.42 of this chapter, governmental health
care entities should disclose their policy for defining operating revenues and
expenses.
10.53 FASB ASC 954-225-45-3 states that the extent of classification and
subclassification of expenses depends on many factors, such as the nature and
complexity of the health care entity. For example, in complying with the re-
quirements of FASB ASC 958-205-45-6, FASB ASC 958-720-05-4, and FASB
ASC 958-720-45-2, some not-for-profit health care entities may present only
two categories: (a) health services (including inpatient services, outpatient pro-
cedures, and home health services) and (b) general and administrative. Others
may present additional distinctions such as physician services, research, and
teaching. Functional allocations should be based on full cost allocations.
10.54 Pursuant to FASB ASC 958-205-50-3, if a not-for-profit health care
entity discloses in its financial statements a ratio of fundraising expenses to
amounts raised, it also should disclose how it computes that ratio.
Auditing11
10.55 The independent auditor may need to consider the examples of spe-
cific auditing objectives, selected control activities, and auditing procedures to
audit revenue, expenses, gains, and losses that are presented in exhibit 10-1.
11 Statement of Position (SOP) 00-1, Auditing Health Care Third-Party Revenues and Related
Receivables (AICPA, Technical Practice Aids, AUD sec. 14,360), discusses matters for auditors to
consider in testing third-party revenues and related receivables, and provides guidance to auditors
regarding the sufficiency of evidential matter and reporting on financial statements of health care
entities exposed to material uncertainties. SOP 00-1 is included as appendix D to this guide.
AAG-HCO 10.55
P1: PjU
ACPA125-10 ACPA125.cls February 25, 2010 15:58
178 Health Care Entities
Exhibit 10-1
The following table illustrates the use of assertions in developing audit ob-
jectives and designing substantive tests. The examples are not intended to
be all-inclusive nor is it expected that all the procedures would necessarily be
applied in an audit. The auditor should design and perform substantive pro-
cedures for all relevant assertions related to each material class of transac-
tions, account balance, and disclosure to obtain sufficient appropriate audit
evidence. The use of assertions in assessing risks and designing appropriate
audit procedures to obtain audit evidence is described in paragraphs .14–.26
of AU section 326, Audit Evidence (AICPA, Professional Standards, vol. 1).
Various audit procedures and the purposes for which they may be performed
are described in paragraphs .27–.41 of AU section 326.
Auditing Considerations
Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities
Auditing
Procedures
Revenue and Gains for Health Care Services
Transactions/Account Balances/Presentation and Disclosure
Existence and
occurrence,
completeness, and
classification and
understandability
Revenue and
gains are
reported in the
proper period
using the accrual
basis of
accounting and
are classified
properly by the
type of service
rendered.
Procedures help
ensure that
revenue is
accrued as
services are
performed or as
contractual
obligations are
satisfied.
Perform a
walk-through of the
revenue system.
Compare the current
period's revenue with
prior periods'
revenue or budgets,
or both, and obtain
explanations for
large or unusual
variances.
Management
establishes and
monitors
controls over the
recognition of
revenue.
Consider the
adequacy of the
controls over the
revenue recognition
process.
In the statement
of operations,
revenue from
health care
services is
reported, net of
contractual
adjustments and
other
adjustments, in
the proper period
and is classified
properly.
Controls ensure
that deductions
from revenue are
recorded in the
proper period
and are classified
properly.
Contractual and
other
adjustments are
authorized,
controlled, and
Review the financial
statements to
determine that
revenue is reported
net of contractual
adjustments and
other adjustments.
Test contractual
adjustments, other
adjustments, and
bad debts to
determine that they
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Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities Auditing Procedures
recorded
properly.
Charity care,
bad-debt
writeoffs, and
courtesy and
policy discounts
are authorized,
controlled, and
recorded
properly.
are accounted for
both in accordance
with the respective
contracts and the
entity's policy.
Determine that
specific and
unallocated reserves
appear reasonable
and comparable to
prior year.
Review third-party
payor contracts and
methods of payment
and test the entity's
computation of
estimated
adjustments to
revenue as required
under such contracts.
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Chapter 11
The Reporting Entity and Related Entities
Overview
11.01 Networks among health care entities, both vertical and horizontal,
are being formed continually and new organizational structures are being de-
veloped. The dynamics of change in the health care industry and their impact on
evolving organizational structures must be considered in defining the reporting
entity.
11.02 Financial Accounting Standards Board (FASB) Accounting Stan-
dards Codification (ASC) 954-810-05-2 states that an integrated health care
system typically consists of multiple related entities, operating both for-profit
and not-for-profit entities. A not-for-profit parent entity may be the sole corpo-
rate member or, through other means, it may control other entities such as a
not-for-profit hospital, a not-for-profit medical foundation that contracts with a
for-profit physician group, or other not-for-profit providers such as a long-term
care center, a substance abuse center, a surgery center, or an outpatient clinic.
The system also may own stock in various for-profit ventures such as health
maintenance organizations or insurance entities that may or may not provide
patient care. Fund-raising typically is accomplished through a separate foun-
dation. Foundations, auxiliaries, guilds, and similar entities frequently assist
and, in many instances, are related to the health care entities.
Financial Reporting of Governmental Health
Care Entities
11.03 The Governmental Accounting Standards Board (GASB) has issued
GASB Statement No. 14, The Financial Reporting Entity, which addresses is-
sues related to consolidations, application of the equity method of accounting,
and accounting for various types of joint ventures for governmental entities.
GASB Statement No. 14 establishes standards for defining and reporting for
the financial reporting entity and for reporting its participation in joint ven-
tures. GASB Statement No. 39, Determining Whether Certain Organizations
Are Component Units—an amendment of GASB Statement No. 14, amended
GASB Statement No. 14 to provide additional guidance for assessing potential
component units in determining the financial reporting entity. GASB Statement
No. 39 may require the reporting of certain hospital foundations in the finan-
cial statements of governmental health care entities, regardless of whether the
foundations follow FASB or GASB standards.
AAG-HCO 11.03
P1: G.Shankar
ACPA125-11 ACPA125.cls February 25, 2010 16:7
182 Health Care Entities
Financial Reporting of Nongovernmental Health
Care Entities∗,†,‡,||,#
11.04 The guidance that follows in this chapter relates to for-profit
and not-for-profit consolidations of parent-subsidiary relationships, whether
∗ In December 2007, the Financial Accounting Standards Board (FASB) issued Statement No.
141 (revised 2007), Business Combinations. The objective of FASB Statement No. 141(R) is to improve
the relevance, representational faithfulness, and comparability of the information that a reporting
entity provides in its financial reports about a business combination and its effects. FASB Statement
No. 141(R) establishes the following requirements:
1. Use the acquisition method of accounting for all business combinations.
2. Recognize and measure goodwill acquired in a business combination, or from a bargain
purchase.
3. Determine what information to disclose to enable users of the financial statements to
evaluate the nature and financial effects of the combination.
FASB Statement No. 141(R) defines the key terms associated with a business combination (for ex-
ample, acquiree). The statement requires entities to record assets acquired and liabilities assumed
as a result of a business combination at fair value, as defined by the FASB Accounting Standards
Codification (ASC) glossary. For additional information on fair value, see chapter 1. FASB Statement
No. 141(R) does not apply to the formation of a joint venture, the acquisition of an asset or a group of
assets that does not constitute a business, a combination between entities under common control, a
combination between not-for-profit entities, or the acquisition of a for-profit entity by a not-for-profit
entity. FASB Statement No. 141(R) is to be applied prospectively to business combinations for which
the acquisition date is on or after the beginning of the first annual reporting period beginning on or
after December 15, 2008, with early adoption prohibited.
FASB Statement No. 141(R) is located in FASB ASC 805, Business Combinations, and is labeled
as "Pending Content" due to the transition and open effective date information discussed in FASB
ASC 805-10-65-1. For more information on FASB ASC, please see the notice to readers in this guide.
In December 2007, FASB issued Statement No. 160, Noncontrolling Interests in Consolidated
Financial Statements—an amendment of ARB No. 51. The objective of FASB Statement No. 160 is
to improve comparability and transparency of consolidated financial statements by establishing ac-
counting and reporting standards that require
1. reporting of ownership interest in subsidiaries held by parties other than the parent
be clearly identified, labeled, and presented in the consolidated balance sheet within
equity but separate from the parent's equity.
2. consolidated net income should clearly identify the portion of income attributable to
the parent and the noncontrolling interest on the face of the income statement.
3. changes in ownership interest should be accounted for consistently.
4. when a subsidiary is deconsolidated, any retained noncontrolling equity investment
in the former subsidiary should be measured at fair value.
5. entities should provide all appropriate disclosures to distinguish between interest of
the parent and the interests of the noncontrolling owners.
Except for not-for-profit health care entities, FASB Statement No. 160 is effective for fiscal years, and
interim periods within those fiscal years, beginning on or after December 15, 2008. Earlier adoption
is prohibited. Health care entities other than not-for-profit health care entities should apply FASB
Statement No. 160 prospectively as of the beginning of the fiscal year in which the statement is ini-
tially adopted, except for the presentation and disclosure requirements. Presentation and disclosure
requirements should be applied retrospectively for all periods presented.
As noted in FASB ASC 810-10-65-1, neither FASB Statement No. 160 nor its amendments to Ac-
counting Research Bulletin (ARB) No. 51, Consolidated Financial Statements, Accounting Principles
Board (APB) Opinions No. 18, The Equity Method of Accounting for Investments in Common Stock,
and No. 29, Accounting for Nonmonetary Transactions, and several other pronouncements, apply to
not-for-profit entities. (See "What Links Here" tab of FASB ASC 810-10-65-1.) Not-for-profit entities
should continue to apply the guidance described in ARB No. 51 (which has been codified primarily
in FASB ASC 810-10) before the amendments made by FASB Statement No. 160; AICPA Statement
of Position (SOP) 94-3, Reporting of Related Entities by Not-for-Profit Organizations (AICPA, Techni-
cal Practice Aids, ACC sec. 10,610) (which has been codified primarily in sections 5, 15, 25, 50, and
55 of FASB ASC 958-810); and other applicable generally accepted accounting principles (GAAP),
until FASB issues related Accounting Standards Updates (ASUs). See footnote ## to the "Busi-
ness Combinations" heading in this chapter for additional effective date discussion for not-for-profit
entities.
FASB Statement No. 160 is primarily located in sections 45 and 55 of FASB ASC 810-10 and is
labeled as "Pending Content" due to the transition and open effective date information discussed in
(continued)
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through stock ownership or other means of control. Other circumstances may
exist in the health care industry where combined financial statements involving
commonly controlled entities are more meaningful than their separate financial
(footnote continued)
FASB ASC 810-10-65-1. For more information on FASB ASC, please see the notice to readers in this
guide.
† In June 2009, FASB issued FASB Statement No. 167, Amendments to FASB Interpretation No.
46(R). FASB Statement No. 167 improves financial reporting by enterprises involved with variable
interest entities (VIEs) by amending certain requirements of FASB Interpretation No. 46 (revised
December 2003), Consolidation of Variable Interest Entities—an interpretation of ARB No. 51. FASB
Statement No. 167 addresses the potential impacts on the provisions and application of FASB In-
terpretation No. 46(R) as a result of the elimination of the qualifying special-purpose entity concept
in FASB Statement No. 166, Accounting for Transfers of Financial Assets—an amendment of FASB
Statement No. 140. Among other amendments, FASB Statement No. 167 amends FASB Interpreta-
tion No. 46(R) to require an enterprise to perform an analysis to determine whether the health care
entity's variable interest or interests give it a controlling financial interest in a VIE, to require an
additional reconsideration event when determining whether an entity is a VIE when any changes in
facts and circumstances occur, and to require ongoing reassessments of whether an enterprise is the
primary beneficiary of a VIE.
FASB Statement No. 167 is effective as of the beginning of each reporting entity's first annual
reporting period that begins after November 15, 2009, for interim periods within that first annual
reporting period, and for interim and annual reporting periods thereafter. Early application of FASB
Statement No. 167 is prohibited.
As of the date of this guide, August 1, 2009, this guidance has not yet been included in FASB
ASC. Readers are encouraged to visit the FASB ASC Web site at http://asc.fasb.org/home and monitor
FASB ASC ASUs.
In December 2009, FASB issued ASU No. 2009-17, Consolidations (Topic 810): Improvements to
Financial Reporting by Enterprises Involved with Variable Interest Entities. The amendments in ASU
No. 2009-17 are the result of FASB Statement No. 167.
‡ In December 2008, FASB issued FASB Staff Position (FSP) FAS 140-4 and FIN 46(R)-8, Dis-
closures by Public Entities (Enterprises) about Transfers of Financial Assets and Interests in Variable
Interest Entities. This FSP is effective for the first reporting period (interim or annual) ending after
December 15, 2008. This FSP should apply for each annual and interim reporting period thereafter.
This FSP amends FASB Statement No. 140, Accounting for Transfers and Servicing of Finan-
cial Assets and Extinguishments of Liabilities—a replacement of FASB Statement No. 125, to require
public entities to provide additional disclosures about transfers of financial assets. (FASB Statement
No. 140 is primarily codified in FASB ASC 860, Transfers and Servicing.) It also amends FASB Inter-
pretation No. 46(R), which is codified in FASB ASC 810, Consolidation, to require public enterprises,
including sponsors that have a variable interest in a VIE, to provide additional disclosures about their
involvement with VIEs. See the FASB Web site for additional details.
This guidance is located in several sections within FASB ASC 810-10-50 and 860 and is labeled
as "Pending Content" due to the transition and open effective date information discussed in FASB
ASC 860-10-65-2. For more information on FASB ASC, please see the notice to readers in this guide.
|| In April 2009, FASB issued FSP FAS 141(R)-1, Accounting for Assets Acquired and Liabilities
Assumed in a Business Combination That Arise from Contingencies. FASB FSP FAS 141(R)-1 amends
and clarifies FASB Statement No. 141(R) to address application issues raised by preparers, auditors,
and members of the legal profession on initial recognition and measurement, subsequent measure-
ment and accounting, and disclosure of assets and liabilities arising from contingencies in a business
combination. FASB FSP FAS 141(R)-1 is effective for assets or liabilities arising from contingencies
in business combinations for which the acquisition date is on or after the beginning of the first annual
reporting period beginning on or after December 15, 2008.
This guidance is located primarily in sections 25, 30, and 35 of FASB ASC 805-20 and is labeled
as "Pending Content" due to the transition and open effective date information discussed in FASB
ASC 805-10-65-1. For more information on FASB ASC, please see the notice to readers in this guide.
# In May 2008, FASB issued FSP SOP 94-3-1 and AAG-HCO-1, Omnibus Changes to Consolida-
tion and Equity Method Guidance for Not-for-Profit Organizations, which makes several changes to
the guidance on consolidation and the equity method of accounting in AICPA SOP 94-3 and the AICPA
Audit and Accounting Guide Health Care Entities. FSP SOP 94-3-1 and AAG-HCO-1 should be applied
to all relationships, arrangements, and interests in existence as of the effective date, which is fiscal
years beginning after June 15, 2008, and interim periods therein. The guidance is located in FASB
ASC 954-810, 958-810, and 958-840 and is labeled as "Pending Content" due to the transition and
open effective date information discussed in FASB ASC 958-810-65-1. This section reflects expected
changes to FASB ASC as a result of this FSP. Readers should be alert to the issuance of ASUs, which
may differ from the expected changes included herein.
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statements. More specific guidance related to combined financial statements
can be found in FASB ASC 810, Consolidation.1
11.05 Per FASB ASC 954-810-45-1, whether the financial statements of
a reporting health care entity and those of one or more other for-profit enti-
ties or not-for-profit entities should be consolidated, whether those other en-
tities should be reported using the equity method, and the extent of disclo-
sure that should be required (if any) if consolidated financial statements are
not presented, should be based on the nature of the relationship between the
entities.
11.06 As discussed in paragraphs 11.07–.36, the existence of various forms
of control and economic interests result in various financial reporting. Certain
kinds of control result in consolidation (see paragraphs 11.09–.12). Other kinds
of control result in consolidation only if coupled with an economic interest (see
paragraphs 11.13–.18). Still other kinds of control result in consolidation being
permitted but not required, if coupled with an economic interest (see para-
graphs 11.19–.20). The existence of either control or an economic interest, but
not both, is discussed in paragraph 11.21; consolidation of variable interest enti-
ties (VIEs) is discussed in paragraph 11.22; disclosures concerning restrictions
on distributions are discussed in paragraph 11.23; reporting under the equity
method of accounting is discussed in paragraphs 11.25–.28 and reporting of a
special-purpose leasing entity is discussed in paragraphs 11.33–.36.
11.07 The FASB ASC glossary defines control as the direct or indirect
ability to determine the direction of management and policies through owner-
ship, contract, or otherwise. However, as discussed in FASB ASC 954-810-05-3,
the rights and powers of the controlling entity may vary depending on the le-
gal structure of the controlled entity and the nature of control. The majority
owner of a for-profit entity's voting stock or the sole corporate member of a
not-for-profit entity may not only have the ability to determine the direction
of the controlled entity but also have the proportionate right to (or the respon-
sibility for) operating results and a residual interest in the net assets upon
dissolution. However, in other situations, the rights of the controlling party
may be more limited. For example, in the case of a sole general partner in a
limited partnership, the limited partners—and not the general partner—may
be entitled to the net assets upon dissolution. As a result, whether the finan-
cial statements of a controlled entity should be consolidated with the report-
ing entity depends on the nature of control and whether an economic interest
exists.
11.08 The FASB ASC glossary states that an economic interest is a not-for-
profit entity's interest in another entity that exists if any of the following criteria
are met: (a) the other entity holds or utilizes significant resources that must be
used for the unrestricted or restricted purposes of the reporting entity—either
directly or indirectly—for producing income or providing services or (b) the not-
for-profit entity is responsible for the liabilities of the other entity. FASB ASC
958-810-55-6 provides the following examples of economic interests:
1 In some situations, debt agreements may require combined financial statements of affiliated
entities, the assets or revenues of which serve as collateral for the related debt (sometimes called an
obligated group). However, if debt or other agreements prescribe a financial presentation that varies
from GAAP (for example, exclusion of entities otherwise required to be consolidated), AU section
623, Special Reports (AICPA, Professional Standards, vol. 1), establishes requirements and provides
guidance regarding auditor's reports.
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a. Other entities solicit funds in the name of, and with the expressed or
implied approval of, the not-for-profit entity, and substantially all of
the funds solicited are intended by the contributor or are otherwise
required to be transferred to the not-for-profit entity or used at its
discretion or direction.
b. The not-for-profit entity transfers significant resources to another
entity whose resources are held for the benefit of the not-for-profit
entity.
c. The not-for-profit entity assigns certain significant functions to an-
other entity.
d. The not-for-profit entity provides or is committed to provide funds
for another entity or the not-for-profit entity guarantees significant
debt of another entity.
e. The not-for-profit entity has a right to, or the responsibility for, the
operating results of another entity. Or, upon dissolution, the not-
for-profit entity is entitled to the net assets, or is responsible for
any deficit, of another entity.
11.09 Pursuant to FASB ASC 810-10-15-10, a reporting entity should ap-
ply consolidation guidance for entities that are not in the scope of the "Variable
Interest Entities" subsections of FASB ASC 810-10 as follows: All majority-
owned subsidiaries—all entities in which a parent has a controlling financial
interest through direct or indirect ownership of a majority voting interest2
should be consolidated. However, FASB ASC 810-10-15-10(a)(1) provides an
exception to this general rule if control does not rest with the majority owner
(for example, if the subsidiary is in legal reorganization or in bankruptcy).3,4
In such situations, a majority-owned subsidiary should not be consolidated.
2 "Pending Content" in FASB ASC 810-10-15-10 eliminates the phrase "through direct or indirect
ownership of a majority voting interest" as a result of FASB Statement No. 160. Not-for-profit entities
should apply the guidance in FASB ASC 810-10-15-10 without regard to the elimination of the phrase.
See footnote * in the heading before paragraph 11.04 for additional information.
3 SOP 07-1, Clarification of the Scope of the Audit and Accounting Guide Investment Companies
and Accounting by Parent Companies and Equity Method Investors for Investments in Investment
Companies (AICPA, Technical Practice Aids, ACC sec. 10,930), provides guidance for determining
whether the specialized industry accounting principles of the guide might be retained in the financial
statements of a parent company of an investment company or an investor in an investment company
that has the ability to exercise significant influence over the investment company and applies the
equity method of accounting to its investment in the entity.
The guidance in SOP 07-1 is codified primarily in FASB ASC 946-10-15 and FASB ASC 946-
10-55 and is labeled as "Pending Content" due to the transition and open effective date information
discussed in FASB ASC 946-10-65-1, which explains that the pending content is delayed indefinitely.
FASB ASC 946-10-65-1 prohibits adoption of the pending content for an entity that had not early
adopted SOP 07-1. An entity that early adopted SOP 07-1 is permitted but not required to continue
to apply the provisions of SOP 07-1. Entities that elect not to rescind their early adoption of SOP 07-1
must also apply it to all consolidated entities going forward, including those formed or acquired after
the adoption of SOP 07-1.
4 According to FASB ASC 958-810-25-2(A), in some situations, certain actions require approval
by a supermajority vote of the board. Such voting requirements might overcome the presumption of
control by the owner or holder of a majority voting interest. See FASB ASC 958-810-55-4(A) for related
implementation guidance.
A not-for-profit health care entity should exercise judgment in evaluating such situations. If su-
permajority voting requirements exist (for example, a specified supermajority of the board is needed
to approve fundamental actions such as amending the articles of incorporation or dissolving the cor-
poration) organizations should consider whether those voting requirements have little or no effect
on the ability to control the other entity's operations or assets or, alternatively, whether those vot-
ing requirements are so restrictive as to call into question whether control rests with the holder of
the majority voting interest. The guidance beginning in FASB ASC 810-10-25-1 may be helpful in
(continued)
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In addition, as explained in FASB ASC 810-10-15-10(a)(1)(iv), minority rights
may have little or no impact on the ability of a shareholder with a majority
voting interest to control the investee's operations or assets, or, alternatively,
those rights may be so restrictive as to call into question whether control rests
with the majority owner. The guidance in paragraphs 1–14 of FASB ASC 810-
10-25 should be applied in assessing the impact on consolidation of minority
shareholder approval or veto rights.
11.10 FASB ASC 954-810-45-3(A) states that a parent corporation typi-
cally owns stock in a for-profit entity, whereas a sole corporate member holds
membership rights in a not-for-profit entity. Sole corporate membership in a
not-for-profit entity, like ownership of a majority voting interest in a for-profit
entity, should be considered a controlling financial interest, unless control does
not rest with the sole corporate member (for instance, if the other [membership]
entity is in bankruptcy or if other legal or contractual limitations are so severe
that control does not rest with the sole corporate member).
11.11 FASB ASC 810-20 discusses the potential consolidation of partner-
ships and similar entities. It provides a framework for the determination of
which, if any, general partner within the group controls and, therefore, should
consolidate a limited partnership. According to FASB ASC 810-20-15-2, the
guidance in the FASB ASC 810-20 applies to all reporting entities, including
not-for-profit entities that are required to apply the consolidation guidance in
the "General" subsections of FASB ASC 810-10 for their investments in part-
nership and similar entities (that includes not-for-profit health care entities
in the scope of this guide). FASB ASC 810-20-15-3 lists the circumstances in
which the guidance in the subtopic does not apply. Those circumstances include
(a) limited partnerships or similar entities (such as limited liability companies
that have governing provisions that are the functional equivalent of a limited
partnership) that are entities within the scope of the "Variable Interest Enti-
ties" subsections of FASB ASC 810-10; (b) a general partner that, in accordance
with generally accepted accounting principles (GAAP), carries its investment
in the limited partnership at fair value with changes in fair value reported in
a statement of operations or financial performance; (c) entities in industries in
which it is appropriate for a general partner to use the pro rata method of con-
solidation for its investment in a limited partnership; and (d) in circumstances
in which no single general partner in a group of general partners controls the
limited partnership.
11.12 The "Consolidation of Entities Controlled by Contract" subsections
of FASB ASC 810-10 address the issue of consolidation among physician prac-
tice management entities, and other situations in which one entity manages
another under similar circumstances and arrangements. The "Consolidation of
Entities Controlled by Contract" subsections do not apply if a physician prac-
tice is a VIE as described in the "Variable Interest Entities" subsections of
FASB ASC 810-10. Acccording to FASB ASC 810-10-15-17, not-for-profit en-
tities are not subject to the "Variable Interest Entities" subsections of FASB
ASC 810-10, except that they may be related parties for purposes of applying
paragraphs 42–44 of FASB ASC 810-10-25. Also, if a not-for-profit entity is
(footnote continued)
considering whether the inability of the majority voting interest to unilaterally approve certain ac-
tions due to supermajority voting requirements is substantial enough to overcome the presumption of
control.
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used by a business reporting entity in a manner similar to a VIE in an effort to
circumvent the provisions of the "Variable Interest Entities" subsections, that
not-for-profit entity should be subject to the guidance in the "Variable Interest
Entities" subsections.5
Relationships With Other Not-for-Profit Entities
11.13 FASB ASC 958-810-05-3 states that ownership of not-for-profit enti-
ties may be evidenced in various ways because not-for-profit entities may exist
in various legal forms, such as corporations issuing stock, corporations issuing
ownership certificates, membership corporations issuing membership certifi-
cates, joint ventures, partnerships, and other forms.
11.14 "Pending Content" in FASB ASC 958-810-25-1 states that a rela-
tionship with another not-for-profit entity can take any one of the following
forms, which determines the appropriate reporting:
a. A controlling financial interest through direct or indirect ownership
of a majority voting interest or sole corporate membership in the
other not-for-profit (see FASB ASC 958-810-25-2)
b. Control of a related but separate not-for-profit through a majority
voting interest in the board of that not-for-profit by means other
than ownership or sole corporate membership and an economic in-
terest in other such entities (see FASB ASC 958-810-25-3)
c. An economic interest in the other not-for-profit combined with con-
trol through means other than those listed in (a) and (b) (see FASB
ASC 958-810-25-4)
d. Either an economic interest in the other not-for-profit or control of
the other not-for-profit, but not both (see FASB ASC 958-810-25-5)
11.15 "Pending Content" in FASB ASC 958-810-25-2 states that a not-
for-profit with a controlling financial interest in another not-for-profit through
direct or indirect ownership of a majority voting interest or sole corporate mem-
bership in that other not-for-profit should consolidate that other not-for-profit,
unless control does not rest with the majority owner or sole corporate mem-
ber (for instance, if the other not-for-profit is in legal reorganization or in
bankruptcy), in which case consolidation is prohibited, as discussed in FASB
ASC 810-10-15-8. Sole corporate membership in a not-for-profit, like ownership
of a majority voting interest in a for-profit entity, should be considered a con-
trolling financial interest, unless control does not rest with the sole corporate
member (for instance, if the other [membership] entity is in bankruptcy or if
other legal or contractual limitations are so severe that control does not rest
with the sole corporate member).
11.16 According to "Pending Content" in FASB ASC 958-810-25-3, in the
case of control of a related but separate not-for-profit entity through a majority
voting interest in the board of the other not-for-profit entity by means other
than ownership or sole corporate membership6 and an economic interest in
5 The guidance in FASB Emerging Issues Task Force (EITF) Issue No. 97-2, "Application of FASB
Statement No. 94 and APB Opinion No. 16 to Physician Practice Management Entities and Certain
Other Entities with Contractual Management Arrangements," is the source for the "Consolidation of
Entities Controlled by Contract" subsections of FASB ASC 810-10.
6 A majority voting interest in the board of another entity by means other than ownership or
sole corporate membership is illustrated by the following example from FASB ASC 958-810-55-5.
(continued)
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other such entity, consolidation is required, unless control does not rest with
the majority holder of the majority voting interest, in which case consolidation
is prohibited.7 A not-for-profit health care entity has a majority voting inter-
est in the board of another health care entity if it has the direct or indirect
ability to appoint individuals that together constitute a majority of the votes of
the fully constituted board (that is, including any vacant board positions). See
paragraphs 11.09–.10 for additional discussion when control does not rest with
the majority owner.
11.17 "Pending Content" in FASB ASC 958-810-25-4 states that control
of a related but separate not-for-profit in which the reporting entity has an
economic interest may take forms other than majority ownership interest, sole
corporate membership, or majority voting interest in the board of the other
entity. For example, control may be through contract or affiliation agreement.
In circumstances such as these, consolidation is permitted but not required.8
Consolidation is encouraged if both of the following criteria are met:
a. The reporting entity controls a separate not-for-profit entity in
which it has an economic interest, and that control is not control
through either of the following means:
i. A controlling financial interest in the other not-for-profit
through direct or indirect ownership of a majority voting
interest
ii. A majority voting interest in the board of the other not-for-
profit
b. Consolidation would be meaningful
11.18 FASB ASC 958-810-25-5 states that the existence of control or an
economic interest, but not both, precludes consolidation. Pursuant to FASB
ASC 958-810-50-3, the reporting entity should disclose the information (about
related parties) required by paragraphs 1–6 of FASB ASC 850-10-50 for these
relationships.9
11.19 According to FASB ASC 958-810-50-2, if, as described in FASB ASC
958-810-25-4, a not-for-profit (the reporting entity) controls a related but sepa-
rate not-for-profit entity through a form other than majority ownership (para-
graphs 11.09–.12), sole corporate membership, or majority voting interest in
the board of the other entity, and has an economic interest in that other not-
for-profit, the reporting entity should disclose all of the following information
if it does not present consolidated financial statements:
(footnote continued)
Entity B has a 5-member board, and a simple voting majority is required to approve board actions.
Entity A will have a majority voting interest in the board of Entity B if Entity A has the ability
to appoint 3 or more of Entity B's board members. If 3 of Entity A's board members, employees, or
officers serve on the board of Entity B but Entity A does not have the ability to require that those
members serve on Entity B's board, Entity A does not have a majority voting interest in the board of
Entity B.
7 Paragraphs 3–4 of FASB ASC 958-810-25 retain the exception to consolidation for a temporarily
controlled subsidiary in circumstances in which consolidation is required or permitted based on control
through other than a controlling financial interest.
8 Also see paragraph 11.12 in this chapter.
9 FASB ASC 958-810-50-3 states that the existence of an economic interest does not necessarily
cause the entities to be related parties, as defined in the FASB ASC glossary. However, the disclosures
required by paragraphs 1–6 of FASB ASC 850-10-50 are required if an economic interest exists.
AAG-HCO 11.17
P1: G.Shankar
ACPA125-11 ACPA125.cls February 25, 2010 16:7
The Reporting Entity and Related Entities 189
a. Identification of the other not-for-profit and the nature of its rela-
tionship with the reporting entity that results in control
b. Summarized financial data of the other not-for-profit, which should
include total assets, liabilities, net assets, revenue, and expenses,
and resources that are held for the benefit of the reporting entity
or entities that are under its control
c. The related party disclosures set forth in paragraphs 1–6 of FASB
ASC 850-10-50.
11.20 Evidence of control by contract or affiliation agreement may include
authority to amend articles of incorporation and bylaws or authority to ap-
prove operating, capital, and construction budgets; capital acquisitions; strate-
gic plans, goals, and objectives; and mergers or dissolutions.
11.21 In some cases, one entity may have an economic interest in another
entity without controlling it (for example, the entity described in paragraph
11.08(a) may be a noncontrolled entity).
11.22 The "Variable Interest Entities" subsections of FASB ASC 810-10
address consolidation by business entities of VIEs. An investor-owned health
care entity should follow the guidance in the "Variable Interest Entities" sub-
sections if, by design, any of the conditions in FASB ASC 810-10-15-14 exist.
(The phrase by design refers to entities that meet the conditions in that para-
graph because of the way they are structured. For example, a legal entity under
the control of its equity investors that originally was not a VIE does not become
one because of operating losses. The design of the legal entity is important in
the application of these provisions.) According to FASB ASC 810-10-15-17, not-
for-profit entities are not subject to the "Variable Interest Entities" subsections
of FASB ASC 810-10 except that they may be related parties for purposes of
applying paragraphs 42–44 of FASB ASC 810-10-25. Also, if a not-for-profit
entity is used by a business reporting entity in a manner similar to a VIE in
an effort to circumvent the provisions of the "Variable Interest Entities" sub-
sections, that not-for-profit entity is subject to the guidance in the "Variable
Interest Entities" subsections.
11.23 According to FASB ASC 958-810-50-1, if consolidated financial
statements are presented, the reporting entity (parent) should disclose any re-
strictions made by entities outside of the reporting entity on distributions from
the controlled not-for-profit entity (subsidiary) to the parent and any resulting
unavailability of the net assets of the subsidiary for use by the parent.
11.24 According to FASB ASC 954-810-45-3B, when consolidated financial
statements are required or permitted by FASB ASC 958-810-25-6, a minority
interest should be provided if such interest is represented by an economic in-
terest whereby the minority interest would share in the operating results or
residual interest upon dissolution.
Relationships With For-Profit Entities
11.25 Investments in common stock of for-profit entities in which the re-
porting entity has 50 percent or less of the voting stock in the investee should be
reported under the guidance in FASB ASC 323, Investments—Equity Method
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and Joint Ventures.**,10 FASB ASC 323-10-15-3 requires that the equity method
of accounting should be used if investments in common stock or in-substance
common stock give the investor the ability to exercise significant influence over
operating and financial policies of an investee even though the investor holds
50 percent or less of the common stock or in-substance common stock (or both
common stock and in-substance common stock).
11.26 Except where an entity has irrevocably elected fair value as the
initial and subsequent measure under the "Fair Value" subsections of FASB
ASC 825-10, noncontrolling interests in for-profit real estate partnerships, lim-
ited liability companies, and similar entities over which the reporting entity
has more than a minor interest should be reported under the equity method in
accordance with the guidance in the "General" subsections of FASB ASC 970-
323.11,12 Not-for-profit entities should apply the guidance in paragraphs 1–3 of
FASB ASC 970-810-25 to help determine whether their interests in for-profit
partnerships, LLCs, and similar entities are controlling interests or noncontrol-
ling interests. Not-for-profit entities should apply the guidance in the "General"
subsections of FASB ASC 323-30 and FASB ASC 272-10 to determine whether
an LLC should be viewed as similar to a partnership, as opposed to a corpora-
tion, for purposes of determining whether noncontrolling interests in an LLC
or a similar entity should be accounted for in accordance with the "General"
subsections of FASB ASC 970-323 or FASB ASC 323.
11.27 Significant influence is defined by paragraphs 6–11 of FASB ASC
323-10-15. Determining the ability of an investor to exercise significant in-
fluence is not always clear, and applying judgment is necessary to assess the
status of each investment. An investment (direct or indirect) of 20 percent or
more of the voting stock of an investee should lead to a presumption that in the
absence of predominant evidence to the contrary, an investor has the ability
to exercise significant influence over an investee. However, this presumption
can be overcome in certain instances. Paragraphs 10–11 of FASB ASC 323-10-
15 provide examples of indications that an investor may be unable to exercise
significant influence. Conversely, an investment of less than 20 percent of the
** In November 2008, the FASB issued EITF Issue No. 08-6, "Equity Method Investment Ac-
counting Considerations." EITF Issue No. 08-6 clarifies the accounting for certain transactions and
impairment considerations involving equity method investments and is effective in fiscal years be-
ginning on or after December 15, 2008, and interim periods within those fiscal years. EITF Issue No.
08-6 should be applied prospectively. Earlier application by an entity that has previously adopted an
alternative accounting policy is not permitted. Transition disclosures in paragraphs 17–18 of FASB
Statement No. 154, Accounting Changes and Error Corrections—a replacement of APB Opinion No.
20 and FASB Statement No. 3, should be provided, if applicable.
This guidance is located in sections 25, 30, 35, and 40 of FASB ASC 323-10 and is labeled as
"Pending Content" due to the transition and open effective date information discussed in FASB ASC
323-10-65-1. For more information on FASB ASC, please see the notice to readers in this guide.
10 See footnote 3 in paragraph 11.09.
11 The Securities and Exchange Commission (SEC) staff 's position is that health care entities
that are registrants should follow applicable SEC guidance and the guidance in paragraphs 6–7 of
FASB ASC 970-323-25 for their noncontrolling interests in non-real estate limited partnerships.
12 FASB ASC 970-810-25-2 states that a noncontrolling investor in a general partnership should
account for its investment by the equity method and should be guided by the provisions of FASB ASC
323, Investments—Equity Method and Joint Ventures. FASB ASC 970-323-25-6 states that the equity
method of accounting for investments in general partnerships is generally appropriate for accounting
by limited partners for their investments in limited partnerships. A limited partner's interest may
be so minor that the limited partner may have virtually no influence over partnership operating
and financial policies. Such a limited partner is, in substance, in the same position with respect to the
investment as an investor that owns a minor common stock interest in a corporation, and, accordingly,
accounting for the investment using the cost method may be appropriate.
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voting stock of an investee should lead to a presumption that an investor does
not have the ability to exercise significant influence unless such ability can
be demonstrated. According to FASB ASC 323-10-25-2, the limitations under
which a majority-owned subsidiary should not be consolidated (see FASB ASC
810-10-15-8 and FASB ASC 810-10-15-10) should also be applied as limitations
to the use of the equity method. Health care entities that report investments
on the equity method should make the financial statement disclosures required
by FASB ASC 323-10-50.
11.28 Paragraphs 37–39 of FASB ASC 323-10-35 provide guidance on how
an investor should account for its proportionate share of an investee's equity ad-
justments for other comprehensive income in all of the following circumstances:
(a) a loss of significant influence, (b) a loss of control that results in the reten-
tion of a cost method investment, and (c) discontinuation of the equity method
for an investment in a limited partnership because the conditions in FASB
ASC 970-323-25-6 are met for applying the cost method. Those paragraphs do
not provide guidance for entities that have historically not recorded their pro-
portionate share of an investee's equity adjustments for other comprehensive
income.
11.29 FASB ASC 810-10-10-1 states that the purpose of consolidated fi-
nancial statements is to present, primarily for the benefit of the shareholders
and creditors of the parent entity, the results of operations and the financial
position of a parent entity and its subsidiaries essentially as if the group were
a single entity with one or more branches or divisions. There is a presumption
that consolidated financial statements are more meaningful than separate fi-
nancial statements and that they are usually necessary for a fair presentation
when one of the entities in the group directly or indirectly has a controlling
financial interest in the other entities.†† FASB ASC 810-10-55-1B states that
there are circumstances, however, in which combined financial statements (as
distinguished from consolidated financial statements) of commonly controlled
entities are likely to be more meaningful than their separate statements. Com-
bined statements would be useful if one individual owns a controlling financial
interest in several entities that are related in their operations. Combined finan-
cial statements might also be useful to present the financial position and the
results of operations of entities under common management. Pursuant to FASB
ASC 810-10-45-10, both consolidation and combination require elimination of
intra-entity transactions and profits and losses.
11.30 This guide prohibits consolidated financial statements in certain
circumstances. However, it provides no guidance concerning combined financial
statements of commonly controlled entities, which may be presented in certain
circumstances.
11.31 FASB ASC 810-10-45-11 states that in some cases, parent-entity
statements may be needed in addition to consolidated statements to indicate
adequately the position of bondholders and other creditors or preferred stock-
holders of the parent. Consolidating statements, in which one column is used for
the parent entity and other columns for particular subsidiaries or groups of sub-
sidiaries, often are an effective means of presenting the pertinent information.‡‡
†† See footnote * in the heading before paragraph 11.04 for discussion on FASB Statement No.
160.
‡‡ See footnote * in the heading before paragraph 11.04 for discussion on FASB Statement No.
160.
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11.32 However, neither GAAP nor this guide discuss the use of the parent
entity's financial statements as other than the general-purpose financial state-
ments for the primary reporting entity.13 GAAP do not preclude the issuance of
financial statements for the subsidiary only. However, care should be taken to
include all disclosures required by FASB ASC 850, Related Party Disclosures,
and other relevant pronouncements.
Consolidation of a Special-Purpose Leasing Entity14
11.33 "Pending Content" in FASB ASC 958-810-25-8 states that a not-
for-profit that is engaged in leasing transactions with a special-purpose entity
(SPE) lessor should consolidate such lessor if all of the following conditions
exist:
a. Substantially all of the activities of the SPE involve assets that are
to be leased to a single lessee.
b. The expected substantive residual risks and substantially all the
residual rewards of the leased asset(s) and the obligation imposed
by the underlying debt of the SPE reside directly or indirectly with
the lessee through means such as any of the following:
i. The lease agreement
ii. A residual value guarantee through, for example, the as-
sumption of first-dollar-of-loss provisions
iii. A guarantee of the SPE's debt
iv. An option granting the lessee a right either to purchase the
leased asset at a fixed price or at a defined price other than
fair value determined at the date of exercise or to receive
any of the lessor's sales proceeds in excess of a stipulated
amount
c. The owner or owners of record of the SPE have not made an initial
substantive residual equity capital investment that is at risk during
the entire term of the lease. This criterion should be considered met
if the majority owner or owners of the lessor are not independent
third parties, regardless of the level of capital investment.
11.34 According to "Pending Content" in FASB ASC 958-810-25-9, to
satisfy the at-risk requirement in item (c) of FASB ASC 958-810-25-8 (see
13 Contractual agreements or regulatory provisions may require parent company only financial
statements. AU section 623 provides guidance for reporting on financial presentations to comply with
contractual agreements or regulatory provisions.
14 Notwithstanding the guidance provided in paragraphs 11.33–.36, not-for-profit entities that
are engaged in leasing transactions with special-purpose entity lessors should consider whether they
should consolidate such lessors in accordance with the guidance contained in the following EITF
Issues:
a. No. 90-15, "Impact of Nonsubstantive Lessors, Residual Value Guarantees, and Other
Provisions in Leasing Transactions" (included in FASB ASC 958-840-55)
b. No. 96-21, "Implementation Issues in Accounting for Leasing Transactions involving
Special-Purpose Entities" (included primarily in sections 25, 30, 35, and 55 of FASB
ASC 840)
c. No. 97-1, "Implementation Issues in Accounting for Lease Transactions, including
Those involving Special-Purpose Entities" (included in FASB ASC 958-840-55)
In addition, the third criterion for consolidation in the consensus on EITF Issue No. 90-15 should
be considered met if the majority owner (or owners) of the lessor is not an independent third party,
regardless of the level of capital investment.
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paragraph 11.33), an initial substantive residual equity capital investment
should meet all of the following conditions:
a. It represents an equity interest in legal form.
b. It is subordinate to all debt interests.
c. It represents the residual equity interest during the entire lease
term.
11.35 "Pending Content" in FASB ASC 958-810-25-10 states that if all
of the conditions in FASB ASC 958-810-25-8 (see paragraph 11.33) exist, the
assets, liabilities, results of operations, and cash flows of the SPE should be con-
solidated in the lessee's financial statements. This conclusion should be applied
to SPEs that are established for both the construction and subsequent lease of
an asset for which the lease would meet all of the conditions in FASB ASC 958-
810-25-8 (see paragraph 11.33). In those cases, the consolidation by the lessee
should begin at the lease inception rather than the beginning of the lease term.
Implementation guidance may be found at FASB ASC 958-810-55-4A and FASB
ASC 958-840-55-1.
11.36 Governmental health care entities only. GASB Statement No. 56,
Codification of Accounting and Financial Reporting Guidance Contained in the
AICPA Statements on Auditing Standards, incorporates existing accounting
and financial reporting guidance on related party transactions into the GASB's
authoritative literature that is presented in the AICPA Statements on Auditing
Standards. Paragraphs 4–7 of GASB Statement No. 56 provide accounting and
financial reporting guidance on related party transactions for state and local
governmental health care entities.
Transfers
Equity Transfers
11.37 The FASB ASC glossary defines an equity transfer as follows:
An equity transfer is nonreciprocal. An equity transfer is a transac-
tion directly between a transferor and a transferee. Equity transfers
are similar to ownership transactions between a for-profit parent and
its owned subsidiary (for example, additional paid-in capital or divi-
dends). However, equity transfers can occur only between related not-
for-profit entities when one controls the other or both are under com-
mon control. An equity transfer embodies no expectation of repayment,
nor does the transferor receive anything of immediate economic value
(such as a financial interest or ownership).
Per FASB ASC 954-225-45-2, equity transfers are reported separately as
changes in net assets, are excluded from the performance indicator, and do
not result in any step-up in basis of the underlying assets transferred.
11.38 Certain transfers from a foundation to a related nongovernmental
health care entity are discussed in paragraphs 11.52–.55. Governmental health
care entities should see paragraphs 1.14 and 10.22 in this guide regarding the
reporting of transfers by governmental health care entities.
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Equity Transactions
11.39 According to FASB ASC 958-20-25-4, a transfer from a nongovern-
mental health care entity to a not-for-profit entity or charitable trust (referred
to as a recipient entity) is an equity transaction if all of the following conditions
are present:
 A nongovernmental health care entity transfers assets to a not-
for-profit entity or charitable trust (called a recipient entity) that
accepts those assets and agrees to use them on behalf of or transfer
them, their investment return, or both back to the nongovernmen-
tal health care entity or its affiliate (that is, the nongovernmental
health care entity specifies itself or its affiliate as the beneficiary
of the transfer).
 The nongovernmental health care entity and the recipient entity
are financially interrelated entities.
 Neither the nongovernmental health care entity nor its affiliate
expects payment of the transferred assets, although payment of
investment return on the transferred assets may be expected.
11.40 FASB ASC 958-20-15-2 provides that a recipient entity and a speci-
fied beneficiary are financially interrelated entities if the relationship between
them has both of the following characteristics: (a) one entity has the ability to
influence the operating and financial decisions of the other and (b) one entity
has an ongoing economic interest in the net assets of the other. The ability
to exercise that influence can be demonstrated in several ways, including the
following:
a. The entities are affiliates, as defined in the FASB ASC glossary.
b. One entity has considerable representation on the governing board
of the other entity.
c. The charter or bylaws of one entity limits its activities to those that
are beneficial to the other entity.
d. An agreement between the entities allows one entity to actively par-
ticipate in the policymaking processes of the other, such as setting
organizational priorities, budgets, and management compensation.
The FASB ASC glossary defines an ongoing economic interest in the net as-
sets of another as a residual right to another not-for-profit entity's net assets
that results from an ongoing relationship. The value of those rights increases
or decreases as a result of the investment, fundraising, operating, and other
activities of the other entity.15
11.41 An equity transaction differs from an equity transfer in that an eq-
uity transaction, as described in FASB ASC 958-20-25-4, involves a financially
interrelated party either as a third party in a transfer from an entity to one
of its affiliates or as a counterparty in a transfer from an entity to itself. An
equity transfer, as described in the guide, is a transaction directly between a
transferor and a transferee. In addition, an equity transaction is reciprocal; the
health care entity or its affiliate named as the beneficiary receives an ongoing
15 Although most of the relationships described in the definition of economic interest in the FASB
ASC glossary (see paragraph 11.08 of this guide) are potentially ongoing economic interests in the net
assets of the other, some are not. Only economic interests that are both ongoing and residual interests
in the net assets meet criterion (b) of FASB ASC 958-20-15-2 (see paragraph 11.40 of this guide).
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economic interest in the assets held by the recipient entity. As noted in the
FASB ASC glossary definition of equity transfer, an equity transfer is nonrecip-
rocal; there is no expectation of repayment and the transferor does not receive
a financial interest or ownership. (See paragraphs 11.37–.38 of this guide).
11.42 The reporting of an equity transaction depends upon whether the
resource provider or its affiliate is the specified beneficiary. As discussed in
FASB ASC 958-20-25-5, if the resource provider specifies itself as beneficiary,
it should report an equity transaction as an asset—an interest in the net assets
of the recipient entity (or an increase in a previously recognized interest).16
According to FASB ASC 958-20-25-6, if a resource provider specifies an affiliate
as beneficiary of an equity transaction, the resource provider should report an
equity transaction as a separate line in its statement of activities, and the
affiliate named as beneficiary should report an interest in the net assets of
the recipient entity.17 In accordance with FASB ASC 958-20-45-1, the recipient
entity should report an equity transaction as a separate line in its statement of
activities. The resource provider should disclose the information described in
FASB ASC 958-605-50-6 (see paragraph 4.55 of this guide) for each period for
which a statement of financial position is presented.
Other Transfers *, †, ‡, ||, #
11.43 Other transfers may occur among related entities. If the entities
are consolidated or combined, such transfers are eliminated in consolidation or
combination, or both. If the entities are not consolidated or combined (for ex-
ample, in separate subsidiaries or obligated group financial statements),18 the
method of accounting for such transfers is dictated by the substance of the trans-
action as well as the legal form. For example, certain transfers by a foundation
to a related nongovernmental health care entity are reported as contributions,
as discussed in paragraphs 11.52–.55. In other situations, payments may be
made for services provided between not-for-profit entities under common con-
trol, which should be accounted for as revenues and expenses depending on the
types of services provided.
11.44 According to FASB ASC 954-310-25-3, a health care entity may loan
or advance resources to a related entity. If repayment is reasonably assured, a
receivable or payable should be recorded by the entities.
11.45 Subsequent to the time a receivable is recorded, the ability of the
receiving entity to repay the receivable should be considered.
11.46 According to FASB ASC 954-310-40-1, if the receivable from a re-
lated entity is not to be repaid, or if the related entity is perceived as unable to
16 According to FASB ASC 958-20-45-3, if the beneficiary (resource provider) and the recipient
entity are included in consolidated financial statements, the beneficiary's interest in the net assets of
the recipient entity should be eliminated in accordance with FASB ASC 810-10-45-1.
17 According to FASB ASC 958-20-45-3, if the beneficiary (affiliate) and the recipient entity
are included in consolidated financial statements, the beneficiary's interest in the net assets of the
recipient entity should be eliminated in accordance with FASB ASC 810-10-45-1.
* See footnote * in paragraph 11.04.
† See footnote † in paragraph 11.04.
‡ See footnote ‡ in paragraph 11.04.
|| See footnote || in paragraph 11.04.
# See footnote # in paragraph 11.04.
18 See paragraph 12.12 for additional discussion regarding obligated group financial statements.
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repay, the write-off of the receivable may be recognized as an equity transfer
(see FASB ASC 954-225-45-2) with the transferor reducing net assets and the
transferee increasing net assets at the date such determination is made (see
paragraphs 11.37–.38).
11.47 Transfers that result in changes in ownership interest are accounted
for as investments in accordance with FASB ASC 323 and FASB ASC 810.
11.48 Assets transferred from one commonly controlled entity to another
should be recorded by the transferee at the carrying value of the transferring
entity. This treatment is consistent with the guidance prescribed in the "Trans-
actions Between Entities Under Common Control" subsections of FASB ASC
805-50.||||
Related Fund-Raising Entities
11.49 A related entity may act as an agent, trustee, or intermediary for
contributions to the reporting entity. The "Transfers of Assets to a Not-for-Profit
Entity or Charitable Trust that Raises or Holds Contributions for Others" sub-
sections of FASB ASC 958-605 establish standards for transactions in which
a donor makes a contribution by transferring assets to a not-for-profit entity
or a charitable trust—the recipient entity—that accepts the assets from the
donor and agrees to use those assets on behalf of or transfer those assets,
the return on investment of those assets, or both to an unaffiliated entity—
the beneficiary—that is specified by the donor.19,20 FASB ASC 958-605-55-78
states that a donor may specify the beneficiary (a) by name, (b) by stating that
all entities that meet a set of donor-defined criteria are beneficiaries, or (c) by
actions surrounding the transfer that make clear the identity of the beneficiary,
such as by responding to a request from a recipient entity that exists to raise
assets for the beneficiary. Paragraphs 80–115 of FASB ASC 958-605-55 provide
examples of donor stipulations and discuss whether those stipulations specify
a beneficiary.
11.50 According to FASB ASC 958-20-25-1, if a recipient entity and a spec-
ified beneficiary are financially interrelated entities (as defined in FASB ASC
958-20-15-2 and described in paragraph 11.40 of this guide) and the recipient
entity is not a trustee, the recipient entity should recognize a contribution re-
ceived when it receives assets (financial or nonfinancial) from the donor that
are specified for the beneficiary. For example, a foundation that exists to raise,
hold, and invest assets for the specified health care entity (beneficiary) or for a
group of affiliates of which the specified health care entity is a member generally
|||| FASB Statement No. 141(R) is the source for the "Transactions Between Entities Under Com-
mon Control" subsections of FASB ASC 805-50, which are labeled as "Pending Content" due to the
transition and effective dates information in FASB ASC 805-10-65-1. See footnote * in the heading
before paragraph 11.04 for additional discussion on FASB Statement No. 141(R).
19 The "Transfers of Assets to a Not-for-Profit Entity or Charitable Trust that Raises or Holds
Contributions for Others" subsections of FASB ASC 958-605 also establish standards for transactions
that take place in a similar manner but are not contributions because the transfers are revocable,
repayable, or reciprocal. For example, FASB ASC 958-605-55-110 states that if a resource provider
transfers assets to a recipient entity and specifies itself or its affiliate as the beneficiary, a presumption
that the transfer is reciprocal (and therefore not a contribution) is necessary even if the resource
provider explicitly grants the recipient entity variance power. Those standards and transactions are
discussed in paragraphs 4.53–.55, 11.39, and 11.41–.42 of this guide. FASB ASC 958-605 and this
guide do not use the word donor in discussing those transactions because they are not contributions.
20 Governmental health care entities only. This pronouncement is not applicable to governmental
health care entities. (See footnote 1 in chapter 1.)
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is financially interrelated with the not-for-profit entity or entities it supports,
and it recognizes contribution revenue when it receives assets from the donor.21
According to FASB ASC 958-20-25-2 and FASB ASC 958-20-35-1, the specified
health care entity (beneficiary) should recognize its interest in the net assets
of the foundation (the recipient entity) and adjust that interest for its share
of the change in net assets of the recipient entity. Recognizing an interest in
the net asset of the recipient entity and adjusting that interest for a share of
the change in net assets of the recipient entity is similar to the equity method,
which is described in FASB ASC 323-10.22
11.51 According to FASB ASC 958-20-55-11, when measuring its interest
in the foundation (recipient entity), the specified health care entity would in-
clude only the net assets of the recipient entity that are restricted to that health
care entity's use. According to FASB ASC 958-20-55-12, if the recipient entity
supports more than one beneficiary and an agreement with the recipient entity
specifies how unrestricted gifts to the recipient entity should be divided between
the entities supported, the specified health care entity would also include its
share of the recipient entity's unrestricted assets, computed in accordance with
that agreement, when it measured its interest in the recipient entity. Similarly,
if a parent entity controls both the recipient entity and the specified health care
entity and the parent directed that unrestricted gifts would be distributed to
affiliates in accordance with a specified formula, each affiliate would include
its share of unrestricted net assets, computed in accordance with that formula,
when it measured its interest in the recipient entity.
11.52 According to FASB ASC 954-605-25-12, distributions from a finan-
cially interrelated recipient entity to a nongovernmental health care entity that
it supports should generally be reported by the health care entity as a reduc-
tion of its interest in the recipient entity. However, if the distribution is made
from net assets that are not includable in that interest because the health care
entity does not have rights to them (that is, the recipient entity can determine
to whom the assets will be distributed), the health care entity should report a
contribution from the related recipient entity.
11.53 For example, assume a foundation's mission is to raise contributions
for 2 financially interrelated health care entities, Hospital A and Hospital B.
The foundation receives $10,000 in contributions from donors that do not specify
which of the 2 hospitals should benefit from their gifts. There is no agreement
between the foundation and Hospitals A and B that specifies how gifts to the
foundation should be divided between the hospitals if the donor does not specify
a beneficiary. Hospital A would report contribution revenue for any portion of
the $10,000 that it receives from the foundation. Likewise, Hospital B would
report contribution revenue for any portion of the $10,000 that it receives, but
neither Hospital A nor Hospital B would record an interest in those assets before
the foundation either distributes them or unconditionally promises them.
11.54 As discussed in FASB ASC 958-605-25-24, if the recipient entity
and the specified health care entity are not financially interrelated entities as
defined in FASB ASC 958-20-15-2 (see paragraph 11.40 in this guide), a re-
cipient entity that accepts assets from a donor and agrees to use those assets
21 Foundations that are not providers of health care services are not covered by this guide and
should follow the AICPA Audit and Accounting Guide Not-for-Profit Entities.
22 FASB ASC 958-20-45-3 states if the beneficiary and the recipient entity are included in consol-
idated financial statements, the beneficiary's interest in the net assets of the recipient entity should
be eliminated in accordance with FASB ASC 810-10-45-1.
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on behalf of or transfer those assets, the return on investment of those as-
sets, or both to the specified health care entity (beneficiary) should recognize
its liability to the specified health care entity (beneficiary) concurrent with its
recognition of cash or other financial assets received from the donor, unless the
recipient entity is explicitly granted variance power. (See discussion of variance
power at paragraph 10.07 of this guide). Except in cases when the donor grants
variance power or when the entities are financially interrelated (as described
in paragraphs 25–26 of FASB ASC 958-605-25 and FASB ASC 958-605-25-27,
respectively), a recipient entity that receives nonfinancial assets is permitted,
but not required, to recognize its liability and those assets provided that the
recipient entity reports consistently from period to period and discloses its ac-
counting policy. (The FASB ASC glossary defines nonfinancial asset as an as-
set that is not a financial asset. Nonfinancial assets include land, buildings,
use of facilities or utilities, materials and supplies, intangible assets, or ser-
vices.) According to FASB ASC 968-605-25-28, a specified health care entity
(beneficiary) should recognize its rights to the assets (financial or nonfinancial)
held by a recipient entity as an asset unless the recipient entity is explicitly
granted variance power. (See further discussion in paragraphs 5.19–.20 and
10.07.)
11.55 In contrast, if the donor does not specify a beneficiary (see further
discussion at paragraph 11.49) and the foundation and a hospital are under
common control, but they are not financially interrelated, the recipient entity
should recognize contribution revenue when it receives the gift. The gift should
be accounted for as contributions received by the hospital, consistent with the
"Contributions Received" subsections of FASB ASC 958-605, provided that the
foundation is acting other than as an owner.
11.56 Additional guidance regarding accounting for contributions received
by agents, trustees, and intermediaries can be found in chapter 5 of the AICPA
Audit and Accounting Guide Not-for-Profit Entities.
Disclosure
11.57 Significant relationships and transactions not in the ordinary course
of business with directors, management, medical staff, or other related parties
(including unconsolidated related entities) should be disclosed in accordance
with FASB ASC 850, Related Party Disclosures. AU section 334, Related Parties
(AICPA, Professional Standards, vol. 1), establishes requirements and provides
guidance for the auditor when determining the existence of transactions with
related parties and identifying them.
11.58 Hospital boards may contract with management companies to oper-
ate their facilities. Frequently, the management company will employ the ad-
ministrator as well as other key personnel. Further, services may be acquired
from entities related to the management company. The auditor should evalu-
ate the impact of these arrangements on the hospital's internal controls and
disclose related party transactions as required by FASB ASC 850.
11.59 The reporting and disclosure requirements of nongovernmental
health care entities under the circumstances noted in paragraphs 11.09–.36
are summarized as follows:
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Circumstances Requirements
The entity owns a majority of a
for-profit entity's voting stock or has
a controlling general partnership
interest.
Consolidate unless control does not rest
with the majority owner (for instance, if
the other [membership] entity is in
bankruptcy or if other legal or
contractual limitations are so severe
that control does not rest with the sole
corporate member).
The entity is the sole corporate
member of a not-for-profit entity.
(See paragraphs 11.10 and 11.13.)
Consolidate unless control does not rest
with the sole corporate member (for
instance, if the other [membership]
entity is in bankruptcy or if other legal
or contractual limitations are so severe
that control does not rest with the sole
corporate member).
The entity controls another through
a majority voting interest in the
board and an economic interest
exists.
Consolidate unless control does not rest
with the holder of the majority voting
interest.
The reporting entity owns 50
percent or less of the common voting
stock of an investee and can exercise
significant influence over operating
and financial policies.
The investment should be accounted for
under the equity method in accordance
with Financial Accounting Standards
Board (FASB) Accounting Standards
Codification (ASC) 323, Investments—
Equity Method and Joint Ventures,
unless the entity has irrevocably elected
fair value as the initial and subsequent
measure under the "Fair Value"
subsections of FASB ASC 825-10.
The reporting entity has a
noncontrolling interest that
constitutes more than a minor
interest in a for-profit real estate
partnership, limited liability
company, or similar entity.
The investment should be accounted for
under the equity method in accordance
with the "General" subsections of FASB
ASC 970-323 unless the entity has
irrevocably elected fair value as the
initial and subsequent measure under
the "Fair Value" subsections of FASB
ASC 825-10. The reporting entity
should apply the guidance in
paragraphs 1–3 of FASB ASC 970-810
to help determine whether its interests
in for-profit partnerships, LLCs, and
similar entities are controlling interests
or noncontrolling interests. The
reporting entity should apply the
guidance in the "General" subsections
of FASB ASC 323-30 and FASB ASC
272-10 to determine whether an LLC
should be viewed as similar to a
partnership, as opposed to a
corporation, for purposes of
determining whether noncontrolling
(continued)
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Circumstances Requirements
interests in an LLC or a similar entity
should be accounted for in accordance
with the "General" subsections of FASB
ASC 970-323 or FASB ASC 323.
If the reporting entity is an Securities
and Exchange Commission registrant,
the reporting entity must follow the
guidance in FASB ASC 323-30-S55-1
and FASB ASC 323-30-S99-1.
There have been material
transactions between the health
care entity and the related entities.
(This could be present in any of the
foregoing circumstances.)
In the notes to the financial statements
(a) disclose the existence and nature of
the relationship and (b) describe and
quantify the transactions.
An entity has control over another
not-for-profit entity or has an
economic interest in the other, but
not both.
In the notes to the financial statements
(a) disclose the existence and nature of
the relationship and (b) describe and
quantify the transactions.
Consolidation is prohibited.
The reporting entity controls a
separate not-for-profit entity
through a form other than majority
ownership or voting interest and
has an economic interest in that
other entity.
Consolidation permitted but not
required. If consolidated statements are
not presented, the notes to the financial
statements should disclose (a) the
identification of the other entity and the
nature of its relationship with the
reporting entity, (b) summarized
financial data of the other entity, and (c)
the disclosures set forth in FASB ASC
850, Related Party Disclosures.
The entity is a variable interest
entity subject to the provisions of
the "Variable Interest Entities"
subsections of FASB ASC 810-10.
Apply the guidance in "Variable
Interest Entities" subsections of FASB
ASC 810-10, including its disclosure
requirements.23
The reporting entity is a
not-for-profit organization and is
engaged in a leasing transaction
with a special-purpose entity lesor.
The entity should consider whether it
should consolidate the lessor in
accordance with the guidance in FASB
ASC 450-20-60-16, 460-10-60-23,
958-810-25, 958-810-55, and
958-840-55; sections 5 and 25 of FASB
ASC 840-10; and sections 15 and 25 of
FASB ASC 840-40. The third criterion
for consolidation in FASB ASC
958-810-25-8 should be considered met
if the majority owner (or owners) of the
lessor is not an independent third party,
regardless of the level of capital
investment.
23 For information about the "Variable Interest Entities" subsections of FASB ASC 810-10 and
their applicability to not-for-profit entities, see paragraph 11.22 in this chapter.
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Business Combinations *, †, ‡, ||, #, ##
11.60 As discussed in paragraph 11.01, the dynamics of change in the
health care industry have resulted in increased business combinations as new
organizational structures are being formed. FASB ASC 805, Business Combina-
tions, addresses financial accounting and reporting for business combinations.
It prescribes the use of the purchase method for those business combinations.
According to FASB ASC 805-10-15-4, FASB ASC 805 does not apply to certain
combinations, including a combination involving 2 or more not-for-profit en-
tities, or the acquisition of a for-profit business by a not-for-profit entity. For
those combinations, the guidance in Accounting Principles Board (APB) Opin-
ion No. 16, Business Combinations, and No. 17, Intangible Assets, still apply
and provides a useful framework when evaluating similar transactions entered
into by not-for-profit health care business entities.*** A list of possible factors to
be considered when evaluating these transactions in relation to APB Opinion
No. 16 is summarized as follows:
* See footnote * in paragraph 11.04.
† See footnote † in paragraph 11.04.
‡ See footnote ‡ in paragraph 11.04.
|| See footnote || in paragraph 11.04.
# See footnote # in paragraph 11.04.
## In May 2009, FASB issued FASB Statement No. 164, Not-for-Profit Entities: Mergers and
Acquisitions—Including an amendment of FASB Statement No. 142, which supersedes APB Opinion
No. 16, Business Combinations, and provides guidance on an acquisition of a business or nonprofit
activity by a not-for-profit entity. The guidance in FASB Statement No. 164 relating to combinations
of not-for-profit entity combinations should be applied prospectively to
a. mergers for which the merger date is on or after the beginning of an initial reporting
period beginning on or after December 15, 2009.
b. acquisitions for which the acquisition date is on or after the beginning of the first
annual reporting period beginning on or after December 15, 2009.
In addition, the guidance makes effective for not-for-profit entities
a. the requirements of FASB Statement No. 142, Goodwill and Other Intangible Assets,
on subsequent accounting for goodwill and other intangible assets acquired in an ac-
quisition.
b. the amendments FASB Statement No. 160 made to ARB No. 51 and to other existing
pronouncements.
c. the amendments appendix D of FASB Statement No. 164 made to ARB No. 51 on
disclosure and presentation of noncontrolling interests.
d. the amendments FASB Statement No. 141(R) made to existing pronouncements.
Those provisions are effective for reporting periods beginning on or after December 15, 2009.
Until the effective date of the provisions of FASB Statement No. 164, not-for-profit entities should
continue to apply the provisions of APB Opinion No. 16 as well as the guidance in this guide and the
guidance in other pronouncements superseded by FASB Statement No. 141(R). Pronouncements that
were amended by FASB Statement Nos. 141, Business Combinations, and 141(R) should be applied
as though FASB Statement Nos. 141 and 141(R) had not amended them. In addition, in applying
the guidance included in APB Opinion No. 16, not-for-profit entities should continue to apply the
amendments to APB Opinion No. 16 that were included in FASB Statement No. 121, Accounting for
the Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of, even though FASB
Statement No. 121 was superseded by FASB Statement No. 144, Accounting for the Impairment or
Disposal of Long-Lived Assets.
As of the date of this guide, August 1, 2009, this guidance has not yet been included in FASB
ASC. Readers are encouraged to visit the FASB ASC Web site at http://asc.fasb.org/home and monitor
ASUs.
*** In November 2008, FASB issued EITF Issue No. 08-7, "Accounting for Defensive Intangible
Assets." EITF Issue No. 08-7 clarifies how to account for defensive intangible assets subsequent to
initial measurement and is effective for intangible assets acquired on or after the beginning of the
first annual reporting period beginning on or after December 15, 2008.
This guidance is located in sections 15, 20, 25, 35, and 55 of FASB ASC 350-30 and is labeled as
"Pending Content" due to the transition and open effective date information discussed in FASB ASC
350-30-65-2. For more information on FASB ASC, please see the notice to readers in this guide.
AAG-HCO 11.60
P1: G.Shankar
ACPA125-11 ACPA125.cls February 25, 2010 16:7
202 Health Care Entities
Circumstances Accounting and Disclosure Guidance
Monetary consideration received or
paid, change in legal title to assets
or assumption of liabilities, or both.
This is similar to a purchase under APB
Opinion No. 16.24
Change in control (for example,
change in sole corporate member).
This is similar to a pooling of interests
transaction under APB Opinion No. 16.
No step-up in basis.
See paragraphs 1.73–.76 for additional guidance regarding the application of
APB Opinion No. 16 to not-for-profit entities.
Auditing
11.61 The independent auditor may consider the examples of specific au-
diting objectives, control activities, and auditing procedures for related parties,
balances, and transactions that are presented in exhibit 11-1.
24 FASB Statement No. 141(R) is the source for the "Transactions Between Entities Under Com-
mon Control" subsections of FASB ASC 805-50, which are labeled as "Pending Content" due to the
transition and effective dates information in FASB ASC 805-10-65-1. See footnote * in the heading
before paragraph 11.04 for additional discussion on FASB Statement No. 141(R).
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Exhibit 11-1
The following table illustrates the use of assertions in developing au-
dit objectives and designing substantive tests. The examples are not
intended to be all-inclusive, nor is it expected that all the procedures
would necessarily be applied in an audit. The auditor should design
and perform substantive procedures for all relevant assertions related
to each material class of transactions, account balance, and disclosure
to obtain sufficient appropriate audit evidence. The use of assertions in
assessing risks and designing appropriate audit procedures to obtain
audit evidence is described in paragraphs .14–.26 of AU section 326,
Audit Evidence (AICPA, Professional Standards, vol. 1). Various audit
procedures and the purposes for which they may be performed are de-
scribed in paragraph .27–.41 of AU section 326.
Auditing Considerations
Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities
Auditing
Procedures
Reporting Entity and Related Entities
Transactions/Account Balances/Presentation and Disclosure
Existence and
occurrence,
completeness, and
presentation and
disclosure
The reporting
entity is
appropriate.
Procedures
ensure that
investees,
affiliates, and
other related
entities are
accounted for
appropriately.
Review the articles
of incorporation,
bylaws, and minutes
of directors'
meetings,
shareholder lists,
and filings with
regulatory
authorities to
determine the
existence of related
parties.
Obtain
representations from
management as to
whether all
investees, affiliates,
and related entities
have been accounted
for properly or
disclosed.
(continued)
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Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities
Auditing
Procedures
Review transactions
with investees,
affiliates, and other
related entities to
determine that they
are reported properly
and clearly expressed.
Relationships
and transactions
with related
entities are
identified and
disclosed, if
appropriate,
because of
economic
dependence of
the entity.
Procedures
ensure that
conflict-of-
interest policies,
procedures, and
disclosure
requirements
are met.
Test significant
related party
transactions as
follows:
• Determine
substance.
• Examine documents
(invoices, contracts,
and agreements)
• Determine the basis
of pricing.
• Determine the
collectibility of
receivables and
advances.
Review related party
transactions for
completeness by
• considering
previously identified
transactions or
relationships.
• reviewing the
minutes of directors'
and other meetings.
• discussing
related-party
transactions with
entity personnel.
• reviewing unusual
transactions.
• reviewing the
responses to related
party
(conflict-of-interest)
questionnaires.
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Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities
Auditing
Procedures
Presentation and Disclosure
Classification and
understandability
Related party
transactions and
entities are
reported
properly.
Review the
presentation and
disclosure of related
party information for
completeness and
understandability.
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Chapter 12
Independent Auditor’s Reports
Overview
12.01 The guidance in AU section 508, Reports on Audited Financial State-
ments (AICPA, Professional Standards, vol. 1),* applies to audit reports on
the financial statements of health care entities. Such a report may contain an
unqualified opinion, an unqualified opinion with an explanatory paragraph,
a qualified opinion, a disclaimer of opinion, or an adverse opinion. The facts
and circumstances of each particular audit govern the appropriate form of the
report.1 Guidance on the dating of the independent auditor's report is provided
in AU section 530, Dating of the Independent Auditor's Report (AICPA, Profes-
sional Standards, vol. 1).
Considerations for Audits Performed in Accordance with PCAOB Stan-
dards
Paragraph .01 of AU section 508, Reports on Audited Financial
Statements (AICPA, PCAOB Standards and Related Rules, Interim
Standards), states when performing an integrated audit of financial
statements and internal control over financial reporting, refer to para-
graphs 85–98 and appendix C of Public Company Accounting Over-
sight Board (PCAOB) Auditing Standard No. 5, An Audit of Internal
Control Over Financial Reporting That Is Integrated with An Audit of
Financial Statements (AICPA, PCAOB Standards and Related Rules,
Auditing Standards), for direction on reporting on internal control over
financial reporting.
Paragraph .01 of AU section 530, Dating of the Independent Audi-
tor's Report (AICPA, PCAOB Standards and Related Rules, Interim
Standards), states when performing an integrated audit of financial
statements and internal control over financial reporting, the auditor's
reports on the company's financial statements and on internal control
over financial reporting should be dated the same date. If the auditor
concludes that a scope limitation will prevent the auditor from obtain-
ing the reasonable assurance necessary to express an opinion on the
financial statements, then the auditor's report date is the date that
the auditor has obtained sufficient competent evidence to support the
representations in the auditor's report.
* In response to the AICPA governing council's May 18, 2008, vote to designate the Interna-
tional Accounting Standards Board in London as an accounting body for purposes of establishing
international financial accounting and reporting principles, the Auditing Standards Board revised
Interpretation No. 14, "Reporting on Audits Conducted in Accordance With Auditing Standards Gen-
erally Accepted in the United States of America and in Accordance With International Standards on
Auditing," of AU section 508, Reports on Audited Financial Statements (AICPA, Professional Stan-
dards, vol. 1, AU sec. 9508 par. .56–.59). The revision removed mention of the International Auditing
Practices Committee of the International Federation of Accountants and clarified that the Interna-
tional Auditing and Assurance Standards Board promulgates International Standards on Auditing.
1 Paragraph .30 of AU section 508 (AICPA, Professional Standards, vol. 1) eliminates the require-
ment that when certain criteria are met, the auditor add an uncertainties explanatory paragraph to
the auditor's report. AU section 508 (AICPA, Professional Standards, vol. 1) establishes requirements
and provides guidance concerning emphasis paragraphs, uncertainties, and disclaimers of opinion.
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12.02 Interpretation No. 17, "Clarification in the Audit Report of the Ex-
tent of Testing of Internal Control Over Financial Reporting in Accordance
With Generally Accepted Auditing Standards," of AU section 508 (AICPA, Pro-
fessional Standards, vol. 1, AU sec. 9508 par. .85–.88), provides guidance for
audits of nonissuers, including an example of additional language that may be
added to an auditor's standard report to explain that an audit includes consid-
eration of internal control over financial reporting as a basis for designing audit
procedures but not for the purpose of expressing an opinion on the effectiveness
of internal control over financial reporting. (See exhibit 12–1.) Interpretation
No. 18, "Reference to PCAOB Standards in an Audit Report on a Nonissuer,"
of AU section 508 (AICPA, Professional Standards, vol. 1, AU sec. 9508 par.
.89–.92), provides guidance on the appropriate referencing of PCAOB Auditing
Standards in audit reports for those auditors who are engaged to perform an
audit in accordance with PCAOB standards when auditing nonissuers.
12.03 The AICPA Practice Aid Alternative Investments—Audit Consid-
erations provides reporting guidance for auditors of nonissuers with invest-
ments for which a readily determinable fair value does not exist (collectively
referred to in the practice aid as alternative investments), including guidance
concerning inclusion of an emphasis of matter paragraph and auditor's report
modifications.2 The auditing portion of that practice aid is an other auditing
publication as defined in AU section 150, Generally Accepted Auditing Stan-
dards (AICPA, Professional Standards, vol. 1). Other auditing publications
have no authoritative status; however, they may help the auditor understand
and apply Statements on Auditing Standards.
12.04 The Audit and Accounting Guide State and Local Governments pro-
vides guidance on audit reports for state and local governments as well as on as-
sessing materiality (opinion units). (See paragraphs 2.02 and 12.10–.11 of this
guide.) Also, chapter 16 of that guide discusses auditor association with munic-
ipal securities filings and the use of Government Auditing Standards in reports
and references in the offering document—the official statement. Governments
sometimes issue municipal securities to finance facilities for nongovernmental
entities, including not-for-profit health care entities. Those nongovernmental
entities may be considered obligated persons with regard to the securities and
thus also provide audited financial statements for the official statement.
12.05 The report examples appearing in this chapter illustrate the form
of certain auditor's reports issued by the independent auditor when auditing
the financial statements of a health care entity. The forms of report illustrated
are prescribed by AICPA professional standards. The PCAOB provides require-
ments and related interpretive guidance when preparing or issuing any audit
report on the financial statements of an issuer in accordance with the standards
of the PCAOB. For example, PCAOB Auditing Standard No. 1, References in Au-
ditors' Reports to the Standards of the Public Company Accounting Oversight
Board (AICPA, PCAOB Standards and Related Rules, Auditing Standards), re-
places in auditors' reports the sentence "We conducted our audits in accordance
with auditing standards generally accepted in the United States of America"
with the following sentence: "We conducted our audits in accordance with the
standards of the Public Company Accounting Oversight Board (United States)"
in a "Report of Independent Registered Public Accounting Firm." The Securities
2 The AICPA Practice Aid Alternative Investments—Audit Considerations can be found at
www.aicpa.org/download/members/div/auditstd/Alternative_Investments_Practice_Aid.pdf.
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Exchange Commission simultaneously issued interpretive guidance in Release
No. 33-8422 under the Securities Act of 1933 (Release No. 34-49708 under the
Securities Exchange Act of 1934) to address certain implementation issues re-
lating to the standard.
Unqualified Opinion
12.06 The independent auditor's standard report states that the financial
statements present fairly, in all material respects, an entity's financial position,
results of operations, changes in net assets, and cash flows in conformity with
generally accepted accounting principles (GAAP). The opinion should include
an identification of the United States of America as the country of origin of those
accounting principles. This conclusion may be expressed only when the inde-
pendent auditor has formed such an opinion on the basis of an audit performed
in accordance with generally accepted auditing standards and an identification
of the United States of America as the country of origin of those standards, or
in accordance with the standards of the PCAOB (United States), as discussed
in paragraph 12.05. An example of the independent auditor's standard report
is presented in exhibit 12-1 at the end of this chapter.
Qualified Opinion
12.07 AU section 508 (AICPA, Professional Standards, vol. 1) states that
the auditor may express a qualified opinion if the circumstances warrant. A
qualified opinion states that except for the effects of the matter to which the
qualification relates, the financial statements present fairly, in all material re-
spects, the financial position, results of operations, and cash flows in conformity
with GAAP. Such an opinion is expressed when
a. there is a lack of sufficient appropriate audit evidence or there are
restrictions on the scope of the audit that have led the independent
auditor to conclude that an unqualified opinion cannot be expressed
and the independent auditor has concluded not to disclaim an opin-
ion (see exhibit 12-2).
b. the independent auditor believes, on the basis of the audit, that
the financial statements contain a departure from GAAP, the effect
of which is material, and has concluded not to express an adverse
opinion (see exhibit 12-3).
Additional Information
12.08 AU section 551A, Reporting on Information Accompanying the Basic
Financial Statements in Auditor-Submitted Documents (AICPA, Professional
Standards, vol. 1), establishes requirements and provides guidance on the form
and content of reporting on additional information accompanying the client's
basic financial statements and the auditor's report thereon. The information
covered by AU section 551A is presented to accompany the basic financial state-
ments in an independent auditor-submitted document and is not considered
necessary for a fair presentation of financial position, results of operations,
changes in net assets, and cash flows in conformity with GAAP. Such informa-
tion includes additional details or explanations of items in, or related to, the
basic financial statements, consolidating or combining information, historical
summaries of items extracted from the basic financial statements, statistical
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data, and other material, some of which may be from sources outside the ac-
counting system or outside the health care entity.
12.09 With respect to reporting on supplementary and other information,
AU section 551A; AU section 550A, Other Information in Documents Containing
Audited Financial Statements; and AU section 558A, Required Supplementary
Information (AICPA, Professional Standards, vol. 1), establish requirements
and provide guidance for the auditor. AU section 550A and AU section 558A
provide that an auditor may issue a report providing an opinion, in relation
to the basic financial statements taken as a whole, on supplementary informa-
tion and other information that has been subjected to the auditing procedures
applied in the audit of those basic financial statements. AU section 551A clari-
fies the reporting guidance with respect to required supplementary information
(RSI) in an auditor-submitted document. In addition, AU section 552, Reporting
on Condensed Financial Statements and Selected Financial Data (AICPA, Pro-
fessional Standards, vol. 1), establishes requirements and provides guidance on
reporting in a client-prepared document when condensed financial statements
or selected financial data are presented by a public entity.
Auditor Reporting on RSI and Supplementary Information
for Governmental Health Care Entities
12.10 GAAP3 specifies that certain information be presented as RSI. For
governmental health care entities, paragraphs 8–11 of Governmental Account-
ing Standards Board Statement No. 34, Basic Financial Statements—and Man-
agement's Discussion and Analysis—for State and Local Governments, require
presentation of management's discussion and analysis (MD&A) as RSI. Govern-
mental health care entities may be required to present RSI other than MD&A,
as established by GAAP. Governmental health care entities may voluntarily
provide supplementary information other than RSI (known as SI). Only in-
formation required by GAAP to be presented as RSI can be considered RSI.
The auditor may be engaged to audit either or both RSI or SI—that is, ex-
press an opinion on whether the information is fairly presented, in all material
respects, in conformity with GAAP. Chapter 14 in the Audit and Accounting
Guide State and Local Governments provides a discussion of reporting guid-
ance on RSI and SI. Reporting on RSI is discussed in paragraphs 14.54–.57
and paragraphs 14.60–.64 in that guide. As discussed in paragraph 14.56 in
that guide, paragraph .08 of AU section 558A, and paragraph .16 of AU sec-
tion 551A, the auditor's reporting on unaudited RSI4 should be expanded if
(a) the information that GAAP requires to be presented in the circumstances is
omitted; (b) the auditor has concluded that the measurement or presentation of
3 The guidance in paragraphs 12.11–.12 applies to Governmental Accounting Standards Board
(GASB) required supplementary information (RSI), such as that required by GASB Statement No.
5, Disclosure of Pension Information by Public Employee Retirement Systems and State and Local
Governmental Employers. Paragraphs .09–.10 of AU section 552, Reporting on Condensed Financial
Statements and Selected Financial Data (AICPA, Professional Standards, vol. 1), provide an example
of a report on GASB RSI.
4 Unaudited RSI is information that accompanies the basic financial statements on which the
auditor is not engaged to express an opinion whether it is fairly presented in conformity with generally
accepted accounting principles. Unless the auditor is engaged to audit the RSI, this section of this
guide and the Audit and Accounting Guide State and Local Governments refer to the information as
unaudited even though generally accepted auditing standards require the auditor to perform specific
procedures and perhaps to report on the information. See footnote 21 to paragraph 14.54 in the Audit
and Accounting Guide State and Local Governments.
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the information departs materially from prescribed guidelines; (c) the auditor is
unable to complete the prescribed procedures; or (d) the auditor is unable to re-
move substantial doubts about whether the information conforms to prescribed
guidelines. Paragraph .08 of AU section 558A provides example language for
explanatory paragraphs that, except for an explanatory paragraph because all
RSI is omitted, include a disclaimer on the information.
12.11 When an auditor-submitted document contains unaudited RSI, AU
section 551A establishes requirements and provides guidance for the auditor
to report whether the information is stated fairly in all material respects in
relation to the basic financial statements taken as a whole or disclaim such an
opinion. In addition, paragraph .07 of AU section 550A and paragraph .09 of
AU section 558A permit auditors to report on unaudited RSI that accompanies
financial statements in client-prepared documents under the requirements and
guidance of AU section 551A. Paragraphs .12–.14 of AU section 551A provide
example language for the auditor's report. See paragraph 14.60 in the Audit
and Accounting Guide State and Local Governments.
Special Reports
12.12 If a health care entity is required to follow reporting requirements
of a regulatory agency, to report under a cash receipts and disbursements basis
of accounting, or to report on another comprehensive basis of accounting other
than GAAP, AU section 623, Special Reports (AICPA, Professional Standards,
vol. 1), establishes requirements and provides guidance for the auditor. AU sec-
tion 623 also establishes requirements and provides reporting guidance when
reporting on specified elements, accounts, or items of a financial statement;
compliance with aspects of contractual agreements or regulatory requirements
related to audited financial statements; financial presentations to comply with
contractual agreements or regulatory provisions; and financial information pre-
sented in prescribed forms (see exhibit 12-4). Accountants' reports on regulatory
basis financial statements generally are prescribed by professional standards
as restricted-use reports as described in AU section 532, Restricting the Use of
an Auditor's Report (AICPA, Professional Standards, vol. 1). Where obligated
group financial statements exclude entities that are required under GAAP to be
consolidated in order to comply with loan agreements, the accountants' report
should restrict the use to specified parties (see exhibit 12-4).5 Use should be re-
stricted to the entity and other parties to the agreement. Health care providers
that receive federal financial assistance should also refer to the Audit Guide
Government Auditing Standards and Circular A-133 Audits.
5 Obligated group is a term used to denote a group of entities, sometimes a parent corporation
and several of its subsidiaries, that is liable for the repayment of obligations, such as tax-exempt
bonds.
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Exhibit 12-1
Unqualified Opinion—Comparative Financial Statements
Independent Auditor's Report
To the Board of Trustees
XYZ Health Care Entity
We have audited the accompanying balance sheets of XYZ Health Care Entity
as of September 30, 20X2, and 20X1, and the related statements of operations,
changes in net assets, and cash flows for the years then ended. These financial
statements are the responsibility of XYZ Health Care Entity's management.
Our responsibility is to express an opinion on these financial statements based
on our audits.
We conducted our audits in accordance with auditing standards generally ac-
cepted in the United States of America. These standards require that we plan
and perform the audit to obtain reasonable assurance about whether the finan-
cial statements are free of material misstatement. [Optional: An audit includes
consideration of internal control over financial reporting as a basis for design-
ing audit procedures that are appropriate in the circumstances, but not for the
purpose of expressing an opinion on the effectiveness of XYZ Health Care En-
tity's internal control over financial reporting. Accordingly, we express no such
opinion.]6 An audit includes examining, on a test basis, evidence supporting the
amounts and disclosures in the financial statements. An audit also includes as-
sessing the accounting principles used and significant estimates made by man-
agement, as well as evaluating the overall financial statement presentation.
We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of XYZ Health Care Entity as of
September 30, 20X2, and 20X1, and the results of its operations, changes in net
assets, and cash flows for the years then ended in conformity with accounting
principles generally accepted in the United States of America.
[Signature]
[Date]
6 This optional wording may be added to reports on the financial statement audits of health care
entities in accordance with Interpretation No. 17, "Clarification in the Audit Report of the Extent of
Testing of Internal Control Over Financial Reporting in Accordance With Generally Accepted Auditing
Standards," of AU section 508 (AICPA, Professional Standards, vol. 1, AU sec. 9508 par. .85–.88), which
provides reporting guidance for audits of nonissuers. This wording may be added even in a report on
the financial statements in an audit conducted in accordance with Government Auditing Standards
or U.S. Office of Management and Budget Circular A-133, Audits of States, Local Governments, and
Non-Profit Organizations, in which the auditor reports on internal control over financial reporting
but does not express an opinion on that internal control. See the AICPA Audit Guide Government
Auditing Standards and Circular A-133 Audits. Interpretation No. 17 of AU section 508 addresses how
auditors may expand this report to explain that their consideration of internal control was sufficient
to provide the auditor sufficient understanding to plan the audit and determine the nature, timing
and extent of tests to be performed, but was not sufficient to express an opinion on the effectiveness
of the internal control. If this optional wording is added, the remainder of the paragraph should read
as follows:
An audit also includes examining, on a test basis, evidence supporting the amounts and dis-
closures in the financial statements, assessing the accounting principles used and significant
estimates made by management, as well as evaluating the overall financial statement presen-
tation. We believe that our audit provides a reasonable basis for our opinion.
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Exhibit 12-2
Qualified Opinion—Scope Limitation
Independent Auditor's Report
To the Board of Trustees
XYZ Health Care Entity
[Include same first paragraph as the standard report—see exhibit 12-1]
Except as discussed in the following paragraph, we conducted our audits in
accordance with auditing standards generally accepted in the United States
of America. Those standards require that we plan and perform the audit to
obtain reasonable assurance about whether the financial statements are free of
material misstatement. An audit includes examining, on a test basis, evidence
supporting the amounts and disclosures in the financial statements. An audit
also includes assessing the accounting principles used and significant estimates
made by management, as well as evaluating the overall financial statement
presentation. We believe that our audits provide a reasonable basis for our
opinion.
We were unable to obtain audited financial statements supporting XYZ Health
Care Entity's investment in an affiliate stated at $XXX,XXX and $XXX,XXX at
September 30, 20X2, and 20X1, respectively, or its equity in earnings of that
affiliate of $XXX,XXX and $XXX,XXX, which is included in the statement of
operations for the years then ended as described in Note X to the financial
statements; nor were we able to satisfy ourselves as to the carrying value of
the investment in the affiliate or the equity in its earnings by other auditing
procedures.
In our opinion, except for the effects of such adjustments, if any, as might have
been determined to be necessary had we been able to examine evidence regard-
ing the affiliate investment and earnings, the financial statements referred to
in the first paragraph present fairly, in all material respects, the financial po-
sition of XYZ Health Care Entity as of September 30, 20X2, and 20X1, and the
results of its operations, changes in net assets, and cash flows for the years
then ended in conformity with accounting principles generally accepted in the
United States of America.
[Signature]
[Date]
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Exhibit 12-3
Qualified Opinion—Departure From Generally Accepted Accounting
Principles That Have a Material Effect on the Financial Statements
Independent Auditor's Report
To the Board of Trustees
XYZ Health Care Entity
[Include same first and second paragraphs as the
standard report—see exhibit 12-1]
XYZ Health Care Entity has excluded, from property and debt in the accom-
panying balance sheets, certain lease obligations that, in our opinion, should
be capitalized to conform with accounting principles generally accepted in the
United States of America. If these lease obligations were capitalized, property
would be increased by $XXX,XXX and $XXX,XXX, long-term debt would be
increased by $XXX,XXX and $XXX,XXX, and unrestricted net assets would
be increased by $XXX,XXX and $XXX,XXX as of September 30, 20X2, and
20X1, respectively. In addition, earnings would be increased by $XXX,XXX and
$XXX,XXX, respectively, for the years then ended.
In our opinion, except for the effects of not capitalizing certain lease obligations
as discussed in the preceding paragraph, the financial statements referred to
in the first paragraph present fairly, in all material respects, the financial po-
sition of XYZ Health Care Entity as of September 30, 20X2, and 20X1, and the
results of its operations, changes in net assets, and cash flows for the years
then ended in conformity with accounting principles generally accepted in the
United States of America.
[Signature]
[Date]
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Exhibit 12-4
Report on Financial Statements Prepared Pursuant to a Master Trust
Indenture That Results in a Presentation Not in Conformity With
Generally Accepted Accounting Principles or Other Comprehensive
Basis of Accounting
Independent Auditor's Report
To the Board of Directors
Sample Health Care Entity
We have audited the accompanying special-purpose combined balance sheets of
the Obligated Group (as defined in the Master Trust Indenture dated Decem-
ber X, 20X0, between Sample Health Care Entity and Any Bank as Trustee) of
Sample Health Care Entity and Affiliates as of December 31, 20X2, and 20X1,
and the related special-purpose combined statements of operations, changes
in net assets, and cash flows for the years then ended. These financial state-
ments are the responsibility of management. Our responsibility is to express
an opinion on these financial statements based on our audits.
We conducted our audits in accordance with auditing standards generally ac-
cepted in the United States of America. Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the fi-
nancial statements are free of material misstatement. An audit includes exam-
ining, on a test basis, evidence supporting the amounts and disclosures in the
financial statements. An audit also includes assessing the accounting principles
used and significant estimates made by management, as well as evaluating the
overall financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
As described in Note 1, these special-purpose financial statements were pre-
pared in accordance with the accounting requirements set forth in the Master
Trust Indenture and are not intended to be a presentation in conformity with
generally accepted accounting principles.
In our opinion, the special-purpose financial statements of the Obligated Group
as of and for the years ended December 31, 20X2, and 20X1, are fairly presented,
in all material respects, on the basis of accounting described in Note 1.
This report is intended solely for the information and use of the board of di-
rectors and management of Sample Health Care Entity, the Trustee under the
Master Trust Indenture, and bondholders, and is not intended to be and should
not be used by anyone other than these specified parties.
[Signature]
[Date]
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Corporate Compliance Programs
12.13 Statement of Position (SOP) 99-1, Guidance to Practitioners in Con-
ducting and Reporting on an Agreed-Upon Procedures Engagement to Assist
Management in Evaluating the Effectiveness of Its Corporate Compliance Pro-
gram (AICPA, Technical Practice Aids, AUD sec. 14,350), provides guidance
to practitioners in conducting and reporting on an agreed-upon procedures
engagement performed pursuant to the AICPA Statements on Standards for
Attestation Engagements to assist a health care provider in evaluating the
effectiveness of its corporate compliance program consistent with the require-
ments of a Corporate Integrity Agreement entered into with the Office of the
Inspector General of the U.S. Department of Health and Human Services. SOP
99-1 is included as appendix C to this guide.
AAG-HCO 12.13
P1: PjU
ACPA125-13 ACPA125.cls February 25, 2010 16:29
Prepaid Health Care Services 217
Chapter 13
Financial Accounting and Reporting by
Providers of Prepaid Health Care Services
Overview
13.01 This chapter provides guidance on applying generally accepted ac-
counting principles to providers of prepaid health care services for the account-
ing and reporting of health care costs, contract losses (premium deficiencies),
stop-loss insurance (reinsurance), and contract acquisition costs.
Accounting for Health Care Costs
13.02 According to Financial Accounting Standards Board (FASB) Ac-
counting Standards Codification (ASC) 954-405-25-2, health care costs should
be accrued as services are rendered, including estimates of the costs of services
rendered but not yet reported. Furthermore, if a provider of prepaid health care
services is obligated to render services to specific members beyond the premium
period due to provisions in the contract or regulatory requirements, the costs
of such services to be incurred also should be accrued currently. Costs that will
be incurred after a contract is terminated, such as guaranteed salaries, rent,
and depreciation, net of any anticipated revenues, should be accrued when it
is determined that a contract with a sponsoring employer or other group will
be terminated. FASB ASC 420, Exit or Disposal Cost Obligations, provides
accounting and reporting guidance for certain contract termination costs asso-
ciated with an exit or disposal activity.1
13.03 According to FASB ASC 954-405-25-2, amounts payable to hospitals,
physicians, or other health care providers under risk-retention, bonus, or sim-
ilar programs should be accrued during the contract period based on relevant
factors, such as experience to date.
13.04 According to FASB ASC 954-405-50-2, for providers of prepaid
health care services, the basis for accruing health care costs and significant
business and contractual arrangements with hospitals, physicians, or other as-
sociated entities should be disclosed in the notes to the financial statements.
Accounting for Loss Contracts
13.05 FASB ASC 954-450-25-4 states that a prepaid health care provider
enters into contracts to provide members with specified health care services
for specified periods in return for fixed periodic premiums. The premium rev-
enue is expected to cover health care costs and other costs over the terms of
the contracts. Only in unusual circumstances would a provider be able to in-
crease premiums on contracts in force to cover expected losses. A provider may
be able to control or reduce future health care delivery costs to avoid anticipated
1 Governmental health care entities only. This pronouncement is not applicable to governmental
health care entities that do not apply paragraph 7 of Governmental Accounting Standards Board
(GASB) Statement No. 20, Accounting and Financial Reporting for Proprietary Funds and Other
Governmental Entities That Use Proprietary Fund Accounting. (See chapter 1 footnote 1.)
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losses, but the ability to avoid losses under existing contracts may be difficult
to measure or to demonstrate. Associated entities such as hospitals, medical
groups, and individual practice associations may enter into similar contracts
with prepaid health care providers in which they agree to deliver identified
health care services to the providers' members for specified periods in return
for fixed fees.
13.06 FASB ASC 954-450-30-4 requires that losses under prepaid health
care services contracts should be recognized when it is probable that expected
future health care costs and maintenance costs under a group of existing con-
tracts will exceed anticipated future premiums and stop-loss insurance recov-
eries on those contracts. Contracts should be grouped in a manner consistent
with the provider's method of establishing premium rates, for example, by com-
munity rating practices, geographical area, or statutory requirements, to deter-
mine whether a loss has been incurred. According to FASB ASC 954-450-30-3,
the estimated future health care costs and maintenance costs to be considered
in determining whether a loss has been incurred should include fixed and vari-
able, direct and allocable indirect costs.
Accounting for Stop-Loss Insurance
13.07 FASB ASC 954-720-05-3 explains that in stop-loss insurance, pre-
paid health care providers or associated entities transfer portions of their fi-
nancial risks to other entities. A provider typically contracts to recover health
care costs in excess of stated amounts during the contract periods.
13.08 According to FASB ASC 954-720-45-1, stop-loss insurance premi-
ums should be included in reported health care costs. Stop-loss insurance re-
coveries should be reported as reductions of related health care costs. In addi-
tion, FASB ASC 954-720-50-4 states that the nature, amounts, and effects of
significant stop-loss insurance contracts should be disclosed.
13.09 Receivables representing amounts recoverable from insurers should
be reported as assets, reduced by appropriate valuation allowances.
13.10 Governmental health care entities only. For governmental health
care entities, Governmental Accounting Standards Board Statement No. 42,
Accounting and Financial Reporting for Impairment of Capital Assets and for
Insurance Recoveries, provides accounting guidance for insurance recoveries.
Accounting for Contract Acquisition Costs
13.11 FASB ASC 954-720-05-2 explains that many prepaid health care
providers incur costs that vary with, and are primarily related to, the mar-
keting of subscriber contracts and member enrollment. These costs, sometimes
referred to as acquisition costs, consist mainly of commissions paid to agents or
brokers and incentive compensation based on new enrollments. Commissions
and incentive compensation may be paid when the contracts are written, at
later dates, or over the terms of the contracts as premiums are received. Some
providers incur additional costs directly related to the acquisition of specific con-
tracts, such as the costs of specialized brochures, marketing, and advertising.
Providers also incur costs that are related to the acquisition of new members
but that do not relate to specific contracts and are not considered acquisition
costs. These costs include salaries of the marketing director and staff, general
marketing brochures, and general advertising and promotion expenses.
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13.12 FASB ASC 954-720-25-6 explains that although there is theoretical
support for deferring certain acquisition costs, acquisition costs of providers
of prepaid health care services—other than costs of advertising—should be
expensed as incurred. Advertising costs should be accounted for in conformity
with the guidance in FASB ASC 720-35.2
2 Governmental health care entities only. This pronouncement is not applicable to governmen-
tal health care entities that do not apply paragraph 7 of GASB Statement No. 20. (See chapter 1
footnote 1.)
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Chapter 14
Financial Accounting and Reporting by
Continuing Care Retirement Communities
Overview
14.01 This chapter provides guidance on applying generally accepted
accounting principles (GAAP) to continuing care retirement communities
(CCRCs) for refundable and nonrefundable advance fees, for obligations to pro-
vide future services and the use of facilities to current residents, and for the
costs of acquiring initial care contracts.1
14.02 The United States has over 1,800 CCRCs. Most CCRCs are operated
by not-for-profit entities, and many are affiliated with religious entities.
14.03 Financial Accounting Standards Board (FASB) Accounting Stan-
dards Codification (ASC) 954-605-05-7 explains that CCRC facilities may be
independent or they may be affiliated with other health care facilities. They
usually provide less intensive care than do hospitals. They generally supply
required continuous nursing service or appropriate assistance to residents who
have a wide range of medical conditions and needs.
14.04 Some states regulate CCRCs, although most states currently do not.
There is, however, a growing trend toward regulation in this rapidly develop-
ing industry. States that do require some form of regulation specify that the
CCRCs be certified by a state authority, such as a department of insurance or
a department of social services. In addition, some states mandate that escrow
or reserve funds be maintained for the protection of residents.
Types of Contracts
14.05 FASB ASC 954-605-05-8 states that CCRCs use the following three
basic types of contracts:
a. An all-inclusive continuing-care contract includes residential facili-
ties, meals, and other amenities. It also provides long-term nursing
care for little or no increase in periodic fees, except to cover normal
operating costs and inflation.
b. A modified continuing-care contract also includes residential facili-
ties, meals, and other amenities. However, only a specified amount
of long-term nursing care is provided for little or no increase in peri-
odic fees, except to cover normal operating costs and inflation. After
the specified amount of nursing care is used, residents pay either
a discounted rate or the full per diem rates for required nursing
care.
1 Governmental health care entities only. The provisions of this chapter do not apply to govern-
mental health care entities, unless the entity has elected to follow all Financial Accounting Standards
Board pronouncements under paragraph 7 of Governmental Accounting Standards Board Statement
No. 20, Accounting and Financial Reporting for Proprietary Funds and Other Governmental Entities
That Use Proprietary Fund Accounting. (See chapter 1 footnote 1.)
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c. A fee-for-service continuing-care contract includes residential fa-
cilities, meals, and other amenities as well as emergency and infir-
mary nursing care. Access to long-term nursing care is guaranteed,
but it may be required at full per diem rates.
Types of Living Accommodations
14.06 CCRCs offer different types of living accommodations to residents,
such as single or shared apartment units or individual homes. They also pro-
vide a variety of amenities, including social, recreational, dining, and laundry
services.
14.07 CCRCs may provide long-term nursing-care services, either at the
same location or, by agreement, with another facility. Residents are transferred
to or from a nursing center as medical care is required. As the health of a
resident declines, he or she may be transferred permanently to a nursing center.
Fees and Payment Methods
14.08 Continuing-care contracts contain a number of different approaches
to providing delivery of services. Contract provisions, for example, may stipulate
the amount of the advance fee, whether periodic fees will be required, and, if so,
whether they can be adjusted. In addition, contracts generally do the following:
detail the future services that will be provided to residents; explain how a
resident will be charged for services; describe the CCRC's refund policies and
the formula for calculating the amount of the refund, which may be simple or
complex; and describe the obligations of the CCRC and the resident if a contract
is terminated or a residential unit is reoccupied.
14.09 As explained in FASB ASC 954-605-05-10, a CCRC may require
several different payment methods for services and the use of facilities. The
following are the three most prevalent methods:
a. Advance fee only. Under this method, a resident pays an advance
fee in return for future services and the use of facilities. Such ser-
vices generally include CCRC housing-related services (for exam-
ple, meals, laundry, housekeeping, and social services) and health
care. These services usually are provided to the resident for the
remainder of his or her life or until the contract is terminated. Ad-
ditional periodic fees are not paid, regardless of how long a resident
lives or if the resident requires more services than anticipated. Gen-
erally, the resident receives no ownership interest in the facility.
b. Advance fee with periodic fees. Under this method, a resident pays
an advance fee and periodic fees for services and the use of facil-
ities. Such periodic fees may be fixed, or they may be subject to
adjustment for increases in operating costs or inflation or for other
economic reasons.
c. Periodic fees only. Under this method, a resident pays a fee at peri-
odic intervals for services and the use of the facilities provided by
the CCRC. Such fees may be either fixed or adjustable.
14.10 According to FASB ASC 954-605-05-11, an advance fee may be met
by transferring a resident's personal assets (which may include rights to future
income) or by paying a lump sum of cash to the CCRC. Advance fees received for
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future services may be refunded at the occurrence of some future event, such as
death, withdrawal from the CCRC, termination of the contract, or reoccupancy
of a residential unit. The amount of the refund generally is based on contractual
provisions or statutory requirements.
14.11 As explained in FASB ASC 954-605-05-9, many continuing-care con-
tracts are similar to annuity contracts. Under those contracts, the CCRC as-
sumes the risks associated with both of the following: (a) estimating the amount
of the advance fee and other fees to be paid by a resident and (b) determining
whether such fees will be sufficient to cover the cost of providing a resident's
required services and the use of facilities. For some contracts, residents may
share the future costs without limit. The CCRC has an obligation to provide
future services for the length of the contract or the life of the resident. In certain
circumstances, this obligation continues regardless of whether advance fees or
periodic fees are sufficient to meet the costs of providing services to a resident.
Accounting for Refundable Advance Fees
14.12 As explained in FASB ASC 954-605-05-12, payment of an advance
fee generally is required before a resident acquires a right to reside in an apart-
ment or residential unit for life. A portion of advance fees may be refundable
by rescission within a legally set time period or if a certain future event occurs,
such as the death or withdrawal of a resident or termination of the contract.
Some refunds are paid only if a residential unit is reoccupied.
14.13 FASB ASC 954-605-05-13 states that CCRC refund policies vary ei-
ther by region or according to statutory requirements, but generally the amount
of the refund is based on provisions specified in a contract. For example, some
contracts require a refund of the advance fee, less a reasonable processing fee.
Amounts refunded may be based on a fixed amount or percentage, an amount
that declines to a fixed amount over time, an amount that declines to zero, or
an amount based on the resale amount. Refunds may be contingent on vacating
the unit, resale of the unit, or passage of a fixed period of time if the unit is not
resold.
14.14 FASB ASC 954-430-25-1 states that the estimated amount of ad-
vance fees that is expected to be refunded to current residents under the terms
of the contracts should be accounted for and reported as a liability. The remain-
ing amount of refundable advance fees should be accounted for as deferred
revenue within the liability section of the balance sheet. According to FASB
ASC 954-430-30-1, the estimated amount of advance fees that are expected to
be refunded to current residents under the terms of contracts should be based
on the individual facility's own experience or, if records are not available, on
the experience of comparable facilities. FASB ASC 954-430-35-3 states that ad-
justments to the estimated liability for the estimated amount of advance fees
that is expected to be refunded to current residents under the terms of contracts
should be accounted for as deferred revenue and amortized together with nonre-
fundable advance fees as discussed in FASB ASC 954-430-35-1 (see paragraph
14.15). According to FASB ASC 954-430-50-2, the gross amount of contrac-
tual refund obligations under existing contracts and the CCRC's refund policy
should be disclosed in the notes to the financial statements. Amounts refunded
should be disclosed in the statement of cash flows as a financing transaction.
14.15 In accordance with FASB ASC 954-430-35-1, deferred revenue from
advance fees from a resident should be amortized to income over future periods
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based on the estimated life of the resident or on the contract term, if shorter.
The period of amortization should be adjusted annually based on the actuarially
determined, estimated, remaining life expectancy of each individual or on the
joint and last survivor life expectancy of each pair of residents occupying the
same unit. The straight-line method should be used to amortize deferred rev-
enue except in certain circumstances when costs are expected to increase at a
significantly higher rate than future revenues in the later years of residence. In
those situations, deferred revenue may be amortized to income using a method
that reflects the disproportionate ratio between the costs of the expected ser-
vices and the expected revenues. The amortized amount should not exceed the
amount available to the CCRC under state regulations, contract provisions,
or management policy. According to FASB ASC 954-430-40-1, unamortized de-
ferred revenue from nonrefundable advance fees should be recorded as revenue
upon a resident's death or the termination of the contract. The method of amor-
tization should be disclosed in the notes to the financial statements.
Accounting for Fees Refundable to Residents Only From
Reoccupancy Proceeds of a Contract Holder’s Unit
14.16 As explained in FASB ASC 954-605-05-14, some contracts between
a CCRC and a resident stipulate that all or a portion of the advance fee may
be refundable if the contract holder's unit is reoccupied by another person.
The source of money for the payment is from the proceeds of the advance fees
collected by the CCRC from the next resident of the reoccupied unit. The terms
governing how the proceeds from the next resident are to be paid to the previous
resident vary from contract to contract. In effect, the CCRC acts as if it were
an agent for present and future residents.
14.17 According to FASB ASC 954-430-25-1, the portion of the fees that
will be paid to current residents or their designees, only to the extent of the
proceeds of reoccupancy of a contract holder's unit, should be accounted for as
deferred revenue, provided that legal and management policy and practice sup-
port the withholding of refunds under this condition. Similar amounts received
from new residents in excess of the amount to be paid to previous residents or
their designees also should be deferred. According to FASB ASC 954-430-35-4,
the resulting deferred revenue should be amortized to income over future peri-
ods based on the remaining useful life of the facility. The basis and method of
amortization should be consistent with the method for calculating depreciation
and should be disclosed in the notes to the financial statements in accordance
with FASB ASC 954-430-50-4.
Accounting for Nonrefundable Advance Fees
14.18 FASB ASC 954-430-25-1 states that under provisions of continuing-
care contracts entered into by a CCRC and residents, nonrefundable advance
fees represent payment for future services and should be accounted for as de-
ferred revenue. According to FASB ASC 954-430-35-2, if a CCRC has sufficient
historical experience and relevant statistical data about life expectancies, it
should consider that information when determining the remaining life of resi-
dents. A CCRC with insufficient historical experience or reliable actuarial data
may use relevant data of similar communities within that area, relevant na-
tional industry statistics, or other appropriate data. Nonrefundable advance
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fees should be amortized in the manner discussed in FASB ASC 954-430-35-1
(see paragraph 14.15).
14.19 The application of the conclusions in paragraphs 14.17–.18 is pre-
sented in exhibit 14-1 at the end of this chapter.
Accounting for the Obligation to Provide Future Services
and the Use of Facilities to Current Residents
14.20 FASB ASC 954-440 discusses the commitments of continuing care
retirement communities to provide services. This paragraph and paragraphs
14.22–.23 summarize that guidance, but are not intended as a substitute for
the reading of FASB 954-440. A CCRC expects to provide services and the
use of facilities to individuals over their remaining lives under continuing-
care contract agreements. The nature and extent of such services depend on
such variables as the individual's age, health, sex, and economic status upon
entering the CCRC. Thus, the CCRC assumes a risk in estimating the cost of
future services and the use of facilities. Although many CCRCs are allowed
contractually to increase periodic fees, some contracts may restrict increases in
periodic fees and require continuing services without additional compensation.
If the advance fees and periodic fees charged are insufficient to meet the costs
of providing future services and the use of facilities, the CCRC should record
a liability based on actuarial assumptions (such as mortality and morbidity
rates), on estimates of future costs and revenues, and on the specific CCRC's
historical experience and statistical data.
14.21 The liability to provide future services and the use of facilities re-
ferred to in the previous paragraph should include the estimated cost of provid-
ing future services and the use of facilities (defined as amounts that are expected
to be incurred to provide services and the use of facilities to individuals over
their remaining lives under continuing care contracts, including resident-care,
dietary, health care, facility, interest, depreciation, and amortization costs) in
excess of the related anticipated revenues.
14.22 In accordance with paragraphs 1 and 3 of FASB ASC 954-440-35,
the obligation of a CCRC to provide future services and the use of facilities to
current residents should be calculated annually in order to determine whether
a liability should be reported in the financial statements. The liability related
to continuing-care contracts should be the present value of future net cash
flows, minus the balance of unamortized deferred revenue, plus depreciation
of facilities to be charged related to the contracts, plus unamortized costs of
acquiring the related initial continuing-care contracts, if applicable. The calcu-
lation should be made by grouping contracts by type, such as all contracts with
a limit on annual increases in fees, contracts with unlimited fee increases, and
so forth.
14.23 In measuring the liability, FASB ASC 954-440-35-3 states that cash
inflows should include revenue contractually committed to support the resi-
dents and inflows resulting from monthly fees including anticipated increases
in accordance with contract terms. This should include third-party payments,
contractually or statutorily committed investment income from services related
to CCRC activities, contributions pledged by donors to support CCRC activities,
and the volume of deferred nonrefundable advance fees. Cash outflows should
be composed of operating expenses, including interest expense and excluding
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selling, and general and administrative expenses. Anticipated cost increases
affecting these operating expenses should be considered in determining cash
outflows. The expected inflation rate as well as other factors should be consid-
ered in determining the discount rate. In calculating the liability, the specific
CCRC's historical experience or statistical data relating to the residents' life
spans should be used. The life spans used should be the same as those used
to amortize deferred revenue (see FASB ASC 954-430-35-1, discussed in para-
graph 14.15). For a new CCRC, either relevant data of similar communities in
the area or relevant national industry statistics may be used if they are deemed
to be representative.
14.24 FASB Statement of Financial Accounting Concepts No. 7, Using
Cash Flow Information and Present Value in Accounting Measurements, pro-
vides useful discussion of general principles governing the use of present value,
and of the objective of present value in accounting measurements. Statements of
Financial Accounting Concepts are not sources of established accounting prin-
ciples and, thus, do not amend, modify, or justify a change from GAAP currently
in effect.2
14.25 The application of the conclusions in paragraph 14.23 is presented
in exhibit 14-2 at the end of this chapter.
Accounting for the Costs of Acquiring Initial
Continuing-Care Contracts
14.26 Advertising costs incurred in connection with acquiring initial
continuing-care contracts should be accounted for in conformity with the guid-
ance in FASB ASC 720-35. Start-up costs should be expensed as incurred in
accordance with FASB ASC 720-15. However, according to FASB ASC 954-340-
25-1 and FASB ASC 954-720-25-7, costs of acquiring initial continuing-care
contracts that are within the scope of FASB ASC 970, Real Estate—General,
should be expensed or capitalized in accordance with that guidance. According
to FASB ASC 954-340-35-1, capitalized costs should be amortized to expenses
on a straight-line basis over the average expected remaining lives of the resi-
dents under the contract or the contract term, if shorter. According to FASB ASC
954-720-25-7, the costs of acquiring continuing-care contracts after a CCRC is
substantially occupied or one year following completion should be expensed
when incurred.
Financial Statements
14.27 A complete set of illustrative financial statements for a CCRC is
included in appendix A.
14.28 FASB ASC 954-440-50 requires that a CCRC disclose all of the
following in its notes to the financial statements for each year presented:
 A description of the CCRC and the nature of the related
continuing-care contracts entered into by the CCRC.
 The carrying amount of the liability to provide future services
and the use of facilities related to continuing-care contracts that
2 See chapter 1 for additional information regarding the hierarchy of generally accounting prin-
ciples for nongovernmental health care entities.
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is presented at present value in the financial statements (if not
separately disclosed in the balance sheet)
 The interest rate used to discount that liability to provide future
services
 The statutory escrow or similar requirements
 The refund policy of the CCRC and the general amount of refund
obligation under the existing contracts
Auditing
14.29 When auditing a CCRC, the independent auditor may need to con-
sider the examples of specific auditing objectives, selected control activities,
and auditing procedures that are presented in exhibit 14-3 at the end of this
chapter.
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Exhibit 14-1
The following example is reproduced from paragraphs 1–3 of FASB ASC 954-
430-55.
Continuing Care Retirement Community
Accounting for Refundable and Nonrefundable Advance Fees
This example illustrates the guidance in FASB ASC 954-430-25, 954-430-35,
and 954-430-40. This example has the following assumptions for a continuing
care retirement community and a resident of that community:
a. The unit is occupied for 20 years.
b. The facility has an estimated 30-year life.
c. The resident is admitted on the first day of the year indicated and
dies on the last day of year indicated.
d. The estimated remaining life expectancy is taken from an appro-
priate actuarial table.
e. The cost of providing future services is expected to be incurred
equally over the remaining life.
Advance fees are accounted for as follows:
Advance Fees
Year
Admitted Dies Resident
Entry
Age Total
Nonrefundable
25%
Refundable
75%
Refunded to
the Previous
Occupant∗
1 4 A 68 $100,000 $25,000 $75,000 —
5 8 B 82 120,000 30,000 90,000 $75,000
9 13 C 79 150,000 37,500 112,500 90,000
14 — D 80 130,000 32,500 97,500 97,500
∗ Per contact, the amount is limited to 75% of proceeds of reoccupancy up to amount
originally paid by previous occupant.
Amortization of Advance Fees Refundable to Residents
$75,000/30 years = $2,500 per year for years 1–4
15,000/26 years = $577 additional or $3,077 per year for years 5–8
22,500/22 years = $1,023 additional or $4,100 per year for years 9 through next change
in occupancy
The following tables illustrate the amortization of nonrefundable advance fees:
Resident A
Unamortized
Deferred
Revenue
Estimated
Remaining
Life (in Years) Income
Year 1 $25,000 12.1 = $2,066
Year 2 22,934 11.5 = 1,994
Year 3 20,940 11.1 = 1,886
Year 4 19,054 10.6 = 1,798
Unamortized deferred revenue
recognized upon the death of the resident 17,256
Total $25,000
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Resident B
Unamortized
Deferred
Revenue
Estimated
Remaining
Life (in Years) Income
Year 5 $30,000 6.1 = $4,918
Year 6 25,082 5.8 = 4,324
Year 7 20,758 5.5 = 3,774
Year 8 16,984 5.3 = 3,205
Unamortized deferred revenue
recognized upon the death of the resident 13,779
Total $30,000
Resident C
Unamortized
Deferred
Revenue
Estimated
Remaining
Life (in Years) Income
Year 9 $37,500 7.0 = $5,357
Year 10 32,143 6.7 = 4,797
Year 11 27,346 6.4 = 4,273
Year 12 23,073 6.1 = 3,783
Year 13 19,290 5.8 = 3,324
Unamortized deferred revenue
recognized upon the death of the resident 15,966
Total $37,500
Resident D
Unamortized
Deferred
Revenue
Estimated
Remaining
Life (in Years) Income
Year 14 $32,500 6.7 = $4,851
Year 15 27,649 6.4 = 4,321
Year 16 23,328 6.1 = 3,824
Year 17 19,504 5.8 = 3,363
Year 18 16,141 5.5 = 2,935
Year 19 13,206 5.3 = 2,492
Year 20 10,714 5.1 = 2,100
Amortization continues until the death of the resident.
AAG-HCO 14.29
P1: PjU
ACPA125-14 ACPA125.cls February 25, 2010 16:31
230 Health Care Entities
Exhibit 14-2
The following example is reproduced from paragraphs 1–4 of FASB ASC 954-
440-55.
Continuing Care Retirement Community
Accounting for the Obligation to Provide Future Services and the
Use of Facilities to Current Residents
This example illustrates the guidance in FASB ASC 954-440-25 and 954-440-
35. This example has the following assumptions:
a. All residents pay a $50,000 fee, which is refundable less 2 percent
per month for the first 36 months. After that period, none of the fee
is refundable. The CCRC opened on 1/1/X4. (See example 1 [FASB
ASC 954-430-55-1, see exhibit 14-1] for an illustration of how to
compute refundable and deferred revenue.)
b. An additional periodic fee of $1,000 is payable monthly with a 5
percent increase annually.
c. The unamortized (deferred) costs of acquiring related initial con-
tracts on 12/31/X6 are assumed to be $17,000.
d. The unamortized deferred revenue on 12/31/X6 is assumed to be
$27,027.
The following tables illustrate the present value of net cash flow on 12/31/X6:
Estimated Cash Inflows
Resident
Estimated
Remaining Life
(in Months)
on 12/31/X6 19X7 19X8 19X9 20X0
A 36 $12,000 $12,600 $13,230 —
B 22 12,000 10,500 — —
C 27 12,000 12,600 3,308 —
D 38 12,000 12,600 13,230 $2,315
Estimated cash inflows $48,000 $48,300 $29,768 $2,315
Estimated Cash Outflows
Resident
Estimated
Remaining Life
(in Months)
on 12/31/X6 19X7 19X8 19X9 20X0
A 36 $10,000 $12,000 $15,000 —
B 22 15,000 11,000 — —
C 27 14,000 17,000 5,000 —
D 38 8,000 12,000 14,000 $4,000
Estimated cash outflows $47,000 $52,000 $34,000 $4,000
Recapitulation 19X7 19X8 19X9 20X0
Cash inflows $48,000 $48,300 $29,768 $2,315
Cash outflows (47,000) (52,000) (34,000) (4,000)
$1,000 $(3,700) $(4,232) $(1,685)
Present value of net cash flows discounted at
10 percent $(7,137)
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The following tables illustrate the depreciation of facilities to be charged to
current residents:
Original cost of facility $17,000,000
Cost of facility allocable to revenue-producing
service areas $(2,000,000)
Cost of facility to be allocated to residents (including
common areas) $15,000,000
Useful life 40 years
Annual depreciation using straight-line method $375,000
Number of residents expected to occupy the facility 200
Annual depreciation per resident $1,875
Monthly depreciation per resident $156
Resident
Estimated
Remaining Life
(in Months)
on 12/31/X6 19X7 19X8 19X9 20X0
A 36 $1,875 $1,875 $1,875 —
B 22 1,875 1,560 — —
C 27 1,875 1,875 468 —
D 38 1,875 1,875 1,875 $312
Yearly estimated depreciation
of facilities to be charged to
current residents $7,500 $7,185 $4,218 $ 312
Total estimated depreciation of the use of facilities to
be charged to the current residents $19,215
The following table illustrates the liability for providing future services and the
use of facilities to current residents:
Present value of future net cash outflows $7,137
Minus:
Unamortized deferred revenue on 12/31/X6 (27,027)
Plus:
Depreciation to be charged to current residents 19,215
Unamortized costs of acquiring initial
contracts—see FASB ASC 954-440-55-1(c)
[assumption c preceding] 17,0001
Liability for providing future services and the use
of facilities to current residents on 12/31/X6
$16,325
1 These numbers are for illustrative purposes only and no inference has
been made as to the recoverability of the $17,000.
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Exhibit 14-3
The following table illustrates the use of assertions in developing audit ob-
jectives and designing substantive tests. The examples are not intended to
be all-inclusive nor is it expected that all the procedures would necessarily be
applied in an audit. The auditor should design and perform substantive pro-
cedures for all relevant assertions related to each material class of transac-
tions, account balance, and disclosure to obtain sufficient appropriate audit
evidence. The use of assertions in assessing risks and designing appropriate
audit procedures to obtain audit evidence is described in paragraphs .14–.26
of AU section 326, Audit Evidence (AICPA, Professional Standards, vol. 1).
Various audit procedures and the purposes for which they may be performed
are described in paragraph .27–.41 of AU section 326.
Auditing Considerations
Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities
Auditing
Procedures
Continuing Care Retirement Communities
Transactions/Account Balances/Presentation and Disclosure
Existence,
completeness, and
classification and
understandability
Liabilities
relating to
refundable fee
arrangements
are accounted
for and reported
properly.
Written
documentation
is prepared for
refundable fee
arrangements.
Review the
refundable fee
arrangements
regarding
stipulations for
repayments and
determine that
such
arrangements
are classified
and disclosed
properly in the
financial
statements.
Liabilities are
accounted for
and reported
properly.
All liabilities are
classified,
described, and
disclosed
properly in the
financial
statements.
Compare the
account
balances with
the prior
periods' balance
and the
amortization
schedules.
Management
monitors
compliance with
restrictive
covenants.
Confirm any
significant new
obligations.
AAG-HCO 14.29
P1: PjU
ACPA125-14 ACPA125.cls February 25, 2010 16:31
Continuing Care Retirement Communities 233
Financial Statement
Assertions
Specific Auditing
Objectives
Selected Control
Activities
Auditing
Procedures
Deferred Revenue
Transactions/Account Balances/Presentation and Disclosure
Completeness,
rights and
obligations, and
classification and
understandability
Deferred
revenue and the
obligation to
provide future
services to, and
the use of
facilities by,
current
residents of
CCRCs are
recognized and
reported
properly.
Procedures
ensure that
amounts
received as
advance fees are
recognized in
the proper
period and that
the obligation to
provide future
services and the
use of facilities
is reported.
Test the
procedures
related to the
recognition of
advance fees
and determine
that the
obligation to
provide future
services and the
use of facilities
is properly
reported.
Long Term Obligations
Transactions/Account Balances/Presentation and Disclosure
Existence,
completeness, and
classification and
understandability
Liabilities
relating to
refundable fee
arrangements
are accounted
for and reported
properly.
Written
documentation
is prepared for
refundable fee
arrangements.
Review the
refundable fee
arrangements
regarding
stipulations for
repayments and
determine that
such
arrangements
are classified
and disclosed
properly in the
financial
statements.
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Appendix A
Illustrative Financial Statements
The following illustrative financial statements illustrate the applications of the
reporting practices discussed in this guide. Specific types of health care entities
have been selected to illustrate a wide diversity of reporting practices. It is not
intended that these illustrations represent either the only types of disclosure
nor the only statement formats that would be appropriate. For example, the
reporting of revenue, expenses, gains, and losses vary depending on the rela-
tionship of the underlying transaction to the entity's operations. More or less
detail should appear either in the financial statements or in the notes to the
financial statements, depending on the circumstances.
These illustrative financial statements and footnote disclosures have been up-
dated to reflect Financial Accounting Standards Board (FASB) Accounting
Standards Codification™ (ASC). However, in FASB's notice to constituents,
it suggests the use of plain English to describe broad FASB ASC topic ref-
erences. They suggest a reference similar to "as required by the Derivatives
and Hedging topic of the FASB Accounting Standards Codification™." Entities
might consider revising their financial statement references to reflect this plain
English referencing, rather than the use of specific FASB ASC references. We
have provided these detailed references in the 2009 editions as a learning tool
to familiarize constituents with the new system.
Governmental health care entities are required to follow the accounting and
reporting requirements of the Governmental Accounting Standards Board
(GASB). GASB pronouncements may require governmental health care entities
to present information beyond or different from that presented by not-for-profit
and investor-owned entities. For example, GASB Statement No. 3, Deposits
with Financial Institutions, Investments (including Repurchase Agreements),
and Reverse Repurchase Agreements, and GASB Statement No. 40, Deposit and
Investment Risk Disclosures—an amendment of GASB Statement No. 3, require
governmental entities to make certain disclosures about the credit, interest rate
and foreign currency risks of their investments. GASB Statement No. 27, Ac-
counting for Pensions by State and Local Governmental Employers, requires
certain accounting for and disclosures about pension benefits provided to em-
ployees of governmental health care entities. GASB Statement No. 9, Reporting
Cash Flows of Proprietary and Nonexpendable Trust Funds and Governmental
Entities That Use Proprietary Fund Accounting, requires governmental health
care entities to present a statement of cash flows using a format that differs in
some respects from that required by FASB Statement No. 95, Statement of Cash
Flows (which has been codified in FASB ASC 230, Statement of Cash Flows),
and that requires the reporting of cash flow information on both restricted
and unrestricted funds. GASB Statement No. 12, Disclosure of Information on
Postemployment Benefits Other Than Pension Benefits by State and Local Gov-
ernmental Employers, requires certain disclosures about other postemployment
benefits (OPEB) provided to employees of governmental health care entities.*
* In 2004, the Governmental Accounting Standards Board (GASB) issued GASB Statement No.
45, Accounting and Financial Reporting by Employers for Postemployment Benefits Other Than Pen-
sions, that supersedes GASB Statement No. 12, Disclosure of Information on Postemployment Benefits
(continued)
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GASB Statement No. 12 also provides that governmental health care entities
are not required to change their recognition and measurement of OPEB to
comply with FASB Statement No. 106, Employers' Accounting for Postretire-
ment Benefits Other Than Pensions (which has been codified in FASB ASC 715,
Compensation—Retirement Benefits), or FASB Statement No. 112, Employers'
Accounting for Postemployment Benefits—an amendment of FASB Statements
No. 5 and 43 (which has been codified in FASB ASC 712, Compensation—
Nonretirement Postemployment Benefits). GASB Statement No. 34, Basic Fi-
nancial Statements—and Management's Discussion and Analysis—for State
and Local Governments, as amended, establishes new financial reporting re-
quirements for state and local governments, and amends or supersedes various
existing GASB and National Council on Governmental Accounting statements
and interpretations.
Other GASB pronouncements may also have implications for governmental
health care entities. For example, GASB Statement No. 13, Accounting for Op-
erating Leases with Scheduled Rent Increases (paragraph 6.11), may affect the
accounting for and financial reporting of certain lease transactions. Discussed
elsewhere in this Audit and Accounting Guide are GASB Statement No. 7,
Advance Refundings Resulting in Defeasance of Debt (paragraph 7.30), GASB
Statement No. 9 (paragraphs 3.01 and 3.04), GASB Statement No. 10, Account-
ing and Financial Reporting for Risk Financing and Related Insurance Issues,
as amended (paragraphs 8.04 and 8.34), GASB Statement No. 14, The Finan-
cial Reporting Entity (paragraph 11.03), GASB Statement No. 16, Accounting
for Compensated Absences (paragraph 7.04), GASB Statement No. 20, Account-
ing and Financial Reporting for Proprietary Funds and Other Governmental
Entities That Use Proprietary Fund Accounting (chapter 1 footnote 1 and para-
graphs 1.82–.85), GASB Statement No. 23, Accounting and Financial Report-
ing for Refundings of Debt Reported by Proprietary Activities (paragraph 7.30),
GASB Statement No. 28, Accounting and Financial Reporting for Securities
Lending Transactions (paragraphs 4.17 and 4.59), GASB Statement No. 29, The
Use of Not-for-Profit Accounting and Financial Reporting Principles by Govern-
mental Entities (chapter 1 footnote 1 and paragraphs 1.82–.83), GASB State-
ment No. 30, Risk Financing Omnibus—an amendment of GASB Statement No.
10 (paragraph 8.04), GASB Statement No. 31, Accounting and Financial Re-
porting for Certain Investments and for External Investment Pools (paragraph
4.16 and 4.59), GASB Statement No. 33, Accounting and Financial Reporting
for Nonexchange Transactions, as amended (paragraphs 5.29–.30, 7.07, 10.08,
10.22, and 10.26–.27), GASB Statement No. 34 (paragraphs 1.14–.24, 1.85,
3.04, 4.16, 5.42, 6.09, 6.18, 7.19, 8.34, 9.09–.12, and 10.22), GASB Statement
No. 38, Certain Financial Statement Note Disclosures (paragraph 7.19), GASB
Statement No. 39, Determining Whether Certain Organizations Are Component
Units—an amendment of GASB Statement No. 14 (paragraph 11.03), GASB
(footnote continued)
Other Than Pension Benefits by State and Local Governmental Employers. GASB Statement No. 45
establishes standards for the measurement, recognition, and display of other postemployment (OPEB)
benefit expenses and related liabilities (assets). The requirements of GASB Statement No. 45 are
effective in 3 phases based on revenues: periods beginning after December 15, 2006 for phase 1
governments (total annual revenues of $100 million or more); periods beginning after December 15,
2007, for phase 2 governments (total annual revenues of $10 million or more but less than $100
million); and periods beginning after December 31, 2008, for phase 3 governments (total annual
revenues of less than $10 million). Earlier application is encouraged. Conforming changes to reflect
the issuance of GASB Statement No. 45 will be made in a future edition of this guide.
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Statement No. 40 (paragraphs 4.17 and 4.59), GASB Statement No. 42, Ac-
counting and Financial Reporting for Impairment of Capital Assets and for
Insurance Recoveries (paragraphs 6.09, 6.18, and 13.10), GASB Statement No.
45, Accounting and Financial Reporting by Employers for Postemployment Ben-
efits Other Than Pensions (paragraph 7.06), GASB Statement No. 46, Net Assets
Restricted by Enabling Legislation—an amendment of GASB Statement No. 34
(paragraph 9.13), GASB Statement No. 47, Accounting for Termination Ben-
efits (paragraph 7.06), GASB Statement No. 52, Land and Other Real Estate
Held as Investments by Endowments (paragraph 1.26), GASB Statement No.
56, Codification of Accounting and Financial Reporting Guidance Contained
in the AICPA Statements on Auditing Standards (paragraph 11.36), GASB In-
terpretation No. 3 Financial Reporting for Reverse Repurchase Agreements—an
interpretation of GASB Statement No. 3 (paragraph 4.17), and GASB Technical
Bulletin No. 2003-1, Disclosure Requirements for Derivatives Not Reported at
Fair Value on the Statement of Net Assets (paragraphs 4.59 and 5.40).
These illustrative financial statements are not intended to include items that
should be accounted for under the requirements of FASB ASC 815, Derivatives
and Hedging,†,‡ and do not reflect the requirements of that topic. In report-
ing disclosures about investments in securities, investor-owned entities should
comply primarily with the requirements of FASB ASC 320-10-50.
Other disclosure requirements for investments in securities may also be appli-
cable. For example, certain disclosures for investments that are in an unrealized
loss position but for which other-than-temporary impairments have not been
recognized are required by FASB ASC 325-20-50 and FASB ASC 320-10-50.
† In March 2008, the Financial Accounting Standards Board (FASB) issued FASB Statement
No. 161, Disclosures about Derivative Instruments and Hedging Activities—an amendment of FASB
Statement No. 133. This statement requires enhanced disclosures about: i) how and why an entity
uses derivative instruments; ii) how derivative instruments and related hedged items are accounted
for under FASB Statement No. 133, Accounting for Derivative Instruments and Hedging Activities,
and its related interpretations; and iii) how derivative instruments and related hedged items affect an
entity's financial position, financial performance, and cash flows. To meet these objectives, FASB State-
ment No. 161 requires qualitative disclosures about objectives and strategies for using derivatives,
quantitative disclosures about fair value amounts of and gains and losses on derivative instruments,
and disclosures about credit-risk-related contingent features in derivative agreements. These further
disclosures are intended to improve the transparency of financial reporting.FASB Statement No. 161
is effective for fiscal years and interim periods beginning after November 15, 2008. Early adoption is
encouraged. FASB Statement No. 161 encourages, but does not require, comparative disclosures for
earlier periods at initial adoption. FASB Statement No. 161 applies to all entities and derivative in-
struments, including bifurcated derivative instruments and related hedge items accounted for under
FASB Statement No. 133 and its related interpretations.The guidance is located in FASB Accounting
Standards Codification (ASC) 815-10-55 and is labeled as "Pending Content" due to the transition and
open effective date information discussed in FASB ASC 815-10-65-1. For more information on FASB
ASC, please see the notice to readers in this guide.
‡ In June 2008, FASB issued Emerging Issues Task Force (EITF) Issue No. 07-5, "Determining
Whether an Instrument (or Embedded Feature) Is Indexed to an Entity's Own Stock." The objective
of EITF Issue No. 07-5 is to provide guidance for determining whether an equity-linked financial
instrument (or embedded feature) is indexed to an entity's own stock and it applies to any freestanding
financial instrument or embedded feature that has all the characteristics of a derivative in paragraphs
6-9 of FASB Statement No. 133. It also applies to any freestanding financial instrument that is
potentially settled in an entity's own stock.
EITF Issue No. 07-5 is effective for financial statements issued for fiscal years beginning after
December 15, 2008, and interim periods within those fiscal years. Earlier application by an entity
that has previously adopted an alternative accounting policy is not permitted.
This guidance is located in FASB ASC 718-10-60-1B and sections 15, 20, and 55 of FASB ASC
815-40 and is labeled as "Pending Content" due to the transition and open effective date information
discussed in FASB ASC 815-10-65-3. For more information on FASB ASC, please see the notice to
readers in this guide.
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This appendix contains illustrative financial statements for the following types
of health care entities:
1. Not-for-profit hospital
2. Governmental hospital authority (includes illustrative manage-
ment's discussion and analysis)
3. Nursing home
4. Continuing care retirement community
5. Home health agency
6. Health maintenance organization
7. Ambulatory care organization
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A NOT-FOR-PROFIT HOSPITAL
Sample Not-for-Profit Hospital
Balance Sheets||
December 31, 20X7 and 20X6
(in thousands)
20X7 20X6
Assets
Current assets:
Cash and cash equivalents $4,758 $5,877
Short term investments 15,836 10,740
Assets limited as to use 970 1,300
Patient accounts receivable, net of allowance
for doubtful accounts of $2,500 in 20X7 and
$2,400 in 20X6 15,100 14,194
Other current assets 2,670 2,856
Total current assets 39,334 34,967
(continued)
|| The "Fair Value Option" subsections of FASB ASC 825-10 permit all entities, including not-
for-profit organizations, to choose to measure eligible items at fair value at specified election dates.
Notable eligible items include recognized financial assets and financial liabilities (except for those
specifically prohibited), written loan commitments, and rights and obligations under a warranty that
is not a financial instrument (because it requires or permits the insurer to provide goods or services
rather than a cash payment) but whose terms permit the insurer to settle by paying a third party to
provide those goods or services. Prohibited recognized financial assets and liabilities include
a. an investment in a subsidiary that the entity is required to consolidate.
b. an interest in a variable interest entity that the entity is required to consolidate.
c. employers' and plans' obligations (or assets representing net overfunded positions) for
pension benefits, other postretirement benefits (including health care and life insur-
ance benefits), postemployment benefits, employee stock option and stock purchase
plans, and certain other forms of deferred compensation arrangements, as defined by
the applicable FASB pronouncements.
d. financial assets and financial liabilities recognized under leases as defined in FASB
ASC 840, Leases, excluding guarantees of a third-party lease obligation or a contingent
obligation arising from a cancelled lease.
e. deposit liabilities, withdrawable on demand, of banks, savings and loan associations,
credit unions, and other similar depository institutions.
f. financial instruments that are, in whole or in part, classified by the issuer as a compo-
nent of shareholder's equity (including temporary equity). An example is a convertible
debt security with a noncontingent beneficial conversion feature.
Entities shall report assets and liabilities that are measured at fair value pursuant to the fair value
option in this statement in a manner that separates those reported fair values from the carrying
amounts of similar assets and liabilities measured using another measurement attribute. To accom-
plish that, an entity shall either
a. present the aggregate of fair value and non-fair-value amounts in the same line item in
the statement of financial position and parenthetically disclose the amount measured
at fair value included in the aggregate amount, or
b. present two separate line items to display the fair value and non-fair-value carrying
amounts.
For additional discussion on fair value measurements, refer to chapter 1.
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Sample Not-for-Profit Hospital
Balance Sheets—(continued)
December 31, 20X7 and 20X6
(in thousands)
20X7 20X6
Interest in net assets of Sample Hospital
Foundation1 510 462
Assets limited as to use:
Internally designated for capital acquisition 12,000 12,500
Held by trustee 6,949 7,341
18,949 19,841
Less amount required to meet current
obligations (970) (1,300)
17,979 118,541
Long term investments 4,680 4,680
Long term investments restricted for capital
acquisition 320 520
Property and equipment, net 51,038 50,492
Other assets 1,185 908
Total assets $115,046 $110,570
(continued)
1 These illustrative financial statements include a presentation of an interest in the net assets
of a financially interrelated foundation that is based on the particular fact pattern described in note
11 to the illustrative financial statements and the following additional facts:
• Sample Not-for-Profit Hospital can influence the financial decisions of Sample Hospital
Foundation to such an extent that it can determine the timing and amount of distributions
from the foundation. Thus, it is inappropriate for the hospital to imply a time restriction
on amounts held by the foundation.
• Contributions to the foundation are restricted by donors for property acquisitions. Those
restrictions have been met by the hospital even though the net assets remain at the foun-
dation. Thus, the net assets related to the interest in the foundation are classified as unre-
stricted in the hospital's financial statements.
• The hospital's policy is to report restricted revenues as unrestricted if the restriction is met
in the same period as the revenues are recognized.
Because the change in the interest in net assets of the foundation results from contributions restricted
to property acquisitions, this presentation shows the change in that interest reported separately from
the performance indicator, in the spirit of the guidance in paragraphs 10.36–.37 for contributions re-
stricted to property acquisitions. The AICPA has released a group of Technical Questions and Answers
(TISs) (TIS sections 6400.36–6400.42) that addresses recognition of the interests in the net assets of
financially interrelated organizations and the classification of the changes in those interests.
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Sample Not-for-Profit Hospital
Balance Sheets—(continued)
December 31, 20X7 and 20X6
(in thousands)
20X7 20X6
Liabilities and Net Assets
Current liabilities:
Current portion of long term debt $1,470 $1,750
Accounts payable and accrued expenses 5,818 5,382
Estimated third-party payor settlements 2,143 1,942
Other current liabilities 1,969 2,114
Total current liabilities 11,400 11,188
Long term debt, net of current portion 23,144 24,014
Other liabilities 3,953 3,166
Total liabilities 38,497 38,368
Net assets:
Unrestricted 70,846 66,199
Temporarily restricted 2,115 2,470
Permanently restricted 3,588 3,533
Total net assets 76,549 72,202
Total liabilities and net assets $115,046 $110,570
See accompanying notes to financial statements.
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FORMAT A
Sample Not-for-Profit Hospital
Statements of Operations
Years Ended December 31, 20X7 and 20X6
(in thousands)
20X7 20X6
Unrestricted revenues, gains and other support:
Net patient service revenue $85,156 $78,942
Premium revenue 11,150 10,950
Other revenue 2,601 5,212
Net assets released from restrictions used for operations 300
Total revenues, gains and other support 99,207 95,104
Expenses:
Operating expenses 88,521 80,585
Depreciation and amortization 4,782 4,280
Interest 1,752 1,825
Provision for bad debts 1,000 1,300
Other 2,000 1,300
Total expenses 98,055 89,290
Operating income 1,152 5,814
Other income:
Investment income 3,900 3,025
Other expense:
Loss from extinguishment of debt (500)
Excess of revenues over expenses 4,552 8,839
Change in net unrealized gains and losses on other than
trading securities 300 375
Net assets released from restrictions used for purchase of
property and equipment 200
Change in interest in net assets of Sample Hospital
Foundation2 283 536
Transfers to parent (688) (3,051)
Increase in unrestricted net assets $4,647 $6,699
See accompanying notes to financial statements.
2 See footnote 1 in "Illustrative Financial Statements for a Not-for-Profit Hospital."
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FORMAT B
Sample Not-for-Profit Hospital
Statements of Operations
Years Ended December 31, 20X7 and 20X6
(in thousands)
20X7 20X6
Unrestricted revenues, gains and other support:
Net patient service revenue $85,156 $78,942
Premium revenue 11,150 10,950
Other, primarily investment income 6,501 8,237
Net assets released from restrictions used for operations 300
Total revenues, gains and other support 103,107 98,129
Expenses:
Salaries and benefits 53,900 49,938
Medical supplies and drugs 26,532 22,121
Insurance 8,089 8,526
Depreciation and amortization 4,782 4,280
Interest 1,752 1,825
Allowance for bad debts 1,000 1,300
Loss from extinguishment of debt 500
Other 2,000 1,300
Total expenses 98,555 89,290
Excess of revenues, gains, and other support over expenses 4,552 8,839
Change in net unrealized gains and losses on other than
trading securities 300 375
Net assets released from restrictions used for purchase of
property and equipment 200 —
Change in interest in net assets of Sample Hospital
Foundation3 283 536
Transfers to parent (688) (3,051)
Increase in unrestricted net assets $4,647 $6,699
See accompanying notes to financial statements.
3 See footnote 1 in "Illustrative Financial Statements for a Not-for-Profit Hospital."
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Sample Not-for-Profit Hospital
Statements of Changes in Net Assets
Years Ended December 31, 20X7 and 20X6
(in thousands)
20X7 20X6
Unrestricted net assets:
Excess of revenues over expenses $4,552 $8,839
Net unrealized gains on investments, other than trading
securities 300 375
Change in interest in net assets of Sample Hospital
Foundation4 283 536
Transfer to parent (688) (3,051)
Net assets released from restrictions used for purchase
of property and equipment 200
Increase in unrestricted net assets 4,647 6,699
Temporarily restricted net assets:
Contributions for charity care 140 996
Net realized and unrealized gains on investments 5 8
Net assets released from restrictions (500)
Increase (decrease) in temporarily restricted net assets (355) 1,004
Permanently restricted net assets:
Contributions for endowment funds 50 411
Net realized and unrealized gains on investments 5 2
Increase in permanently restricted net assets 55 413
Increase in net assets 4,347 8,116
Net assets, beginning of year 72,202 64,086
Net assets, end of year $76,549 $72,202
See accompanying notes to financial statements.
4 See footnote 1 in "Illustrative Financial Statements for a Not-for-Profit Hospital."
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Sample Not-for-Profit Hospital
Statements of Cash Flows (Indirect Method)
Years Ended December 31, 20X7 and 20X6
(in thousands)
20X7 20X6
Cash flows from operating activities:
Change in net assets $4,347 $8,116
Adjustments to reconcile change in net assets to net cash
provided by operating activities:
Loss from extinguishment of debt 500
Depreciation and amortization 4,782 4,280
Net realized and unrealized gains on investments, other
than trading (450) (575)
Undistributed portion of change in interest in net assets
of Sample Hospital Foundation (48) (51)
Transfers to parent 688 3,051
Allowance for bad debts 1,000 1,300
Restricted contributions and investment income
received (290) (413)
(Increase) decrease in:
Patient accounts receivable (1,906) (2,036)
Trading securities 215
Other current assets 186 (2,481)
Other assets (277) (190)
Increase (decrease) in:
Accounts payable and accrued expenses 436 679
Estimated third-party payor settlements 201 305
Other current liabilities (145) (257)
Other liabilities 787 (128)
Net cash provided by operating activities 10,026 11,600
Cash flows from investing activities:
Proceeds from sale of investments 45,100 50,650
Purchase of investments (48,869) (52,800)
Capital expenditures (4,728) (5,860)
Net cash used in investing activities (8,497) (8,010)
Cash flows from financing activities:
Transfer to parent (688) (3,051)
Proceeds from restricted contributions and restricted
investment income 290 413
Payments on long term debt (24,700) (804)
Payments on capital lease obligations (150) (100)
Proceeds from issuance of long term debt 22,600 500
Net cash used in financing activities (2,648) (3,042)
Net (decrease) increase in cash and cash equivalents (1,119) 548
Cash and cash equivalents, beginning of year 5,877 5,329
Cash and cash equivalents, end of year $4,758 $5,877
(continued)
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Sample Not-for-Profit Hospital
Statements of Cash Flows (Indirect Method)—(continued)
Years Ended December 31, 20X7 and 20X6
(in thousands)
Supplemental disclosures of cash flow information:
The hospital entered into capital lease obligations in the amount of $600,000
for new equipment in 20X7.
Cash paid for interest (net of amount capitalized) in 20X7 and 20X6 was
$1,780,000 and $1,856,000, respectively.
See accompanying notes to financial statements.
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Sample Not-for-Profit Hospital
Notes to Financial Statements#
December 31, 20X7 and 20X6
1. Description of Organization and Summary of Significant
Accounting Policies5
Organization. The Sample Not-for-Profit Hospital (the hospital), located in
Tulsa, Oklahoma, is a not-for-profit acute care hospital. The hospital provides
inpatient, outpatient and emergency care services for residents of northeastern
Oklahoma. Admitting physicians are primarily practitioners in the local area.
The hospital was incorporated in Oklahoma in 20X1 and is affiliated with the
Sample Health System.
Use of estimates. The preparation of financial statements in conformity with
generally accepted accounting principles requires management to make esti-
mates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include certain in-
vestments in highly liquid debt instruments with original maturities of three
months or less.
The hospital routinely invests its surplus operating funds in money market
mutual funds. These funds generally invest in highly liquid U.S. government
and agency obligations.
# FASB ASC 820, Fair Value Measurements and Disclosures, defines fair value, establishes a
framework for measuring fair value in generally accepted accounting principles (GAAP), and expands
disclosures about fair value measurements. This guidance applies under other accounting pronounce-
ments that require or permit fair value measurements, the FASB having previously concluded in
those accounting pronouncements that fair value is the relevant measurement attribute. Accordingly,
FASB ASC 820 does not require any new fair value measurements, but the application of it will change
current practice.
FASB ASC 820 retains the exchange price notion already established within GAAP but clarifies,
among other matters, that fair value is the price that would be received to sell the asset or paid to
transfer the liability (for example, an exit price) and not the price that would be paid to acquire the
asset or paid to transfer the liability (for example, an entry price). Additionally, FASB ASC 820 estab-
lishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair
value into 3 broad levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical
assets or liabilities that the reporting entity has the ability to access at the measurement date and
shall be used to measure fair value when available, with limited exceptions. Level 2 inputs are inputs
other than quoted prices included within level 1 that are observable for the asset or liability, either
directly or indirectly, and may include, for example, quoted prices for similar assets or liabilities in
active markets. Level 3 inputs are unobservable inputs for the asset or liability. Unobservable inputs
shall be used to measure fair value to the extent that observable inputs are not available, thereby
allowing for situations in which there is little, if any, market activity. Unobservable inputs shall be
developed based on the best information available in the circumstances, which might include the re-
porting entity's own data.
FASB ASC 820-10-50 expands disclosures about the use of fair value to measure assets and lia-
bilities in interim and annual periods subsequent to initial recognition. The disclosures focus on the
fair value hierarchy and the effect of the measurements on earnings (or changes in net assets) for the
period. Entities are encouraged to combine the fair value information disclosed under this statement
with other required fair value information, including that required by FASB ASC 825-10-50 about
financial instruments.
For additional discussion on fair value measurements, refer to chapter 1.
5 FASB ASC 310-10-50 provides guidance on accounting policy disclosures for loans, trade re-
ceivables, and doubtful accounts that should be included in the summary of significant accounting
policies.
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Investments. Investments in equity securities with readily determinable fair
values and all investments in debt securities are measured at fair value in the
balance sheet. Investment income or loss (including realized gains and losses
on investments, interest and dividends) is included in the excess of revenues
over expenses unless the income or loss is restricted by donor or law. Unrealized
gains and losses on investments are excluded from the excess of revenues over
expenses unless the investments are trading securities.
Assets limited as to use. Assets limited as to use primarily include assets held
by trustees under indenture agreements and designated assets set aside by the
board of trustees for future capital improvements, over which the board retains
control and may at its discretion subsequently use for other purposes. Amounts
required to meet current liabilities of the hospital have been reclassified in the
balance sheet at December 31, 20X7 and 20X6.
Property and equipment. Property and equipment acquisitions are recorded at
cost. Depreciation is provided over the estimated useful life of each class of
depreciable asset and is computed using the straight-line method. Equipment
under capital lease obligations is amortized on the straight-line method over
the shorter period of the lease term or the estimated useful life of the equip-
ment. Such amortization is included in depreciation and amortization in the
financial statements. Interest cost incurred on borrowed funds during the pe-
riod of construction of capital assets is capitalized as a component of the cost of
acquiring those assets.
Gifts of long-lived assets such as land, buildings, or equipment are reported
as unrestricted support, and are excluded from the excess of revenues over
expenses, unless explicit donor stipulations specify how the donated assets must
be used. Gifts of long-lived assets with explicit restrictions that specify how the
assets are to be used and gifts of cash or other assets that must be used to
acquire long-lived assets are reported as restricted support. Absent explicit
donor stipulations about how long those long-lived assets must be maintained,
expirations of donor restrictions are reported when the donated or acquired
long-lived assets are placed in service.
Temporarily and permanently restricted net assets.** Temporarily restricted net
assets are those whose use by the hospital has been limited by donors to a
specific time period or purpose. Permanently restricted net assets have been
restricted by donors to be maintained by the hospital in perpetuity.
Excess of revenues over expenses. The statement of operations includes excess of
revenues over expenses. Changes in unrestricted net assets which are excluded
** In August 2008, FASB issued FASB Staff Position (FSP) FAS 117-1, Endowments of Not-for-
Profit Organizations: Net Asset Classification of Funds Subject to an Enacted Version of the Uniform
Prudent Management of Institutional Funds Act, and Enhanced Disclosures for All Endowment Funds.
FSP FAS 117-1 is effective for fiscal years ending after December 15, 2008. Earlier application is per-
mitted provided that annual financial statements for that fiscal year have not been previously issued.
FSP FAS 117-1 provides guidance on the net asset classification of donor-restricted endowment funds
for a not-for-profit entity (NFP) that is subject to an enacted version of the Uniform Prudent Manage-
ment of Institutional Funds Act of 2006 (UPMIFA). The FSP also improves disclosures about an NFP's
endowment funds (both donor-restricted endowment funds and board-designated endowment funds),
whether or not the NFP is subject to an enacted version of UPMIFA. Paragraphs 16–17 of the FSP
discuss the display of the reclassification upon implementation of the guidance and the reinstatement
of purpose restrictions on unappropriated net appreciation if the NFP is subject to an enacted version
of UPMIFA.
FSP FAS 117-1 is located primarily in sections 45, 50, and 55 of FASB ASC 958-205 and is
labeled as "Pending Content" due to the transition and open effective date information discussed in
FASB ASC 958-205-65-1. For more information on FASB ASC, please see the notice to readers in this
guide.
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from excess of revenues over expenses, consistent with industry practice, in-
clude unrealized gains and losses on investments other than trading securities,
permanent transfers of assets to and from affiliates for other than goods and
services, and contributions of long-lived assets (including assets acquired us-
ing contributions which by donor restriction were to be used for the purposes
of acquiring such assets).
Net patient service revenue. The hospital has agreements with third-party pay-
ors that provide for payments to the hospital at amounts different from its
established rates. Payment arrangements include prospectively determined
rates per discharge, reimbursed costs, discounted charges, and per diem pay-
ments. Net patient service revenue is reported at the estimated net realizable
amounts from patients, third-party payors, and others for services rendered, in-
cluding estimated retroactive adjustments under reimbursement agreements
with third-party payors. Retroactive adjustments are accrued on an estimated
basis in the period the related services are rendered and adjusted in future
periods as final settlements are determined.
Premium revenue. The hospital has agreements with various health manage-
ment organizations (HMOs) to provide medical services to subscribing partici-
pants. Under these agreements, the hospital receives monthly capitation pay-
ments based on the number of each HMO's participants, regardless of services
actually performed by the hospital. In addition, the HMOs make fee-for-service
payments to the hospital for certain covered services based upon discounted fee
schedules.
Charity care. The hospital provides care to patients who meet certain crite-
ria under its charity care policy without charge or at amounts less than its
established rates. Because the hospital does not pursue collection of amounts
determined to qualify as charity care, they are not reported as revenue.
Donor-restricted gifts. Unconditional promises to give cash and other assets to
the hospital are reported at fair value at the date the promise is received. Condi-
tional promises to give and indications of intentions to give are reported at fair
value at the date the gift is received. The gifts are reported as either temporarily
or permanently restricted support if they are received with donor stipulations
that limit the use of the donated assets. When a donor restriction expires, that
is, when a stipulated time restriction ends or purpose restriction is accom-
plished, temporarily restricted net assets are reclassified as unrestricted net
assets and reported in the statement of operations as net assets released from
restrictions. Donor-restricted contributions whose restrictions are met within
the same year as received are reported as unrestricted contributions in the
accompanying financial statements.
Estimated malpractice costs. The provision for estimated medical malpractice
claims includes estimates of the ultimate costs for both reported claims and
claims incurred but not reported.
Income taxes. The hospital is a not-for-profit corporation and has been recog-
nized as tax-exempt pursuant to Section 501(c)(3) of the Internal Revenue Code.
2. Net Patient Service Revenue
The hospital has agreements with third-party payors that provide for payments
to the hospital at amounts different from its established rates. A summary of
the payment arrangements with major third-party payors follows:
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 Medicare. Inpatient acute care services and outpatient services
rendered to Medicare program beneficiaries are paid at prospec-
tively determined rates. These rates vary according to a patient
classification system that is based on clinical, diagnostic, and other
factors. Inpatient nonacute services and defined capital and med-
ical education costs related to Medicare beneficiaries are paid
based on a cost reimbursement methodology. The hospital is reim-
bursed for cost reimbursable items at a tentative rate with final
settlement determined after submission of annual cost reports by
the hospital and audits thereof by the Medicare fiscal intermedi-
ary. Beginning in 20X3, the hospital claimed Medicare payments
based on an interpretation of certain "disproportionate share"
rules. The intermediary disagreed and declined to pay the excess
reimbursement claimed under that interpretation. Through 1996,
the hospital has not included the claimed excess in net patient rev-
enues pending resolution of the matter. In 20X7, the intermediary
accepted the claims and paid the outstanding claims, including
$950,000 applicable to 20X6 and $300,000 applicable to 20X5 and
prior, which has been included in 20X7 net revenues.
 Medicaid. Inpatient and outpatient services rendered to Medicaid
program beneficiaries are reimbursed under a cost reimbursement
methodology. The hospital is reimbursed at a tentative rate with
final settlement determined after submission of annual cost re-
ports by the hospital and audits thereof by the Medicaid fiscal
intermediary.
Revenue from the Medicare and Medicaid programs accounted for approxi-
mately XX percent and XX percent, respectively, of the hospital's net patient
revenue for the year ended 20X7, and XX percent and XX percent, respectively,
of the hospital's net patient revenue, for the year ended 20X6. Laws and regu-
lations governing the Medicare and Medicaid programs are extremely complex
and subject to interpretation. As a result, there is at least a reasonable possibil-
ity that recorded estimates will change by a material amount in the near term.
The 20X6 net patient service revenue increased approximately $XXX due to re-
moval of allowances previously estimated that are no longer necessary as a re-
sult of final settlements and years that are no longer subject to audits, reviews,
and investigations. The 20X7 net patient service revenue decreased approxi-
mately $XXX due to prior-year retroactive adjustments in excess of amounts
previously estimated.
The hospital also has entered into payment agreements with certain commer-
cial insurance carriers, HMOs, and preferred provider organizations. The basis
for payment to the hospital under these agreements includes prospectively de-
termined rates per discharge, discounts from established charges, and prospec-
tively determined daily rates.
3. Investments
Assets Limited as to Use
The composition of assets limited as to use at December 31, 20X7 and 20X6, is
set forth in the following table. Investments are stated at fair value.
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20X7 20X6
Internally designated for capital acquisition:
Cash $545,000 $350,000
U.S. Treasury obligations 11,435,000 12,115,000
Interest receivable 20,000 35,000
12,000,000 12,500,000
Held by trustee under indenture agreement:
Cash and short term investments 352,000 260,000
U.S. Treasury obligation 6,505,000 7,007,000
Interest receivable 92,000 74,000
6,949,000 7,341,000
$18,949,000 $19,841,000
Other Investments
Other investments, stated at fair value, at December 31, 20X7 and 20X6,
include:
20X7 20X6
Trading:
U.S. Corporate Bonds $1,260,000 $1,475,000
Other
U.S. Treasury obligations $19,266,000 $14,233,000
Interest receivable 310,000 232,000
20,836,000 15,940,000
Less:
Long term investments 4,680,000 4,680,000
Long term investments restricted for capital
acquisitions 320,000 520,000
Short term investments $15,836,000 $10,740,000
Investment income and gains for assets limited as to use, cash equivalents, and
other investments are comprised of the following for the years ending December
31, 20X7 and 20X6:
20X7 20X6
Income:
Interest income $3,585,000 $2,725,000
Realized gains on sales of securities 150,000 200,000
Unrealized gains on trading securities 165,000 100,000
$3,900,000 $3,025,000
Other Changes in Unrestricted Net Assets:
Unrealized gains on other than trading
securities $300,000 $375,000
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4. Property and Equipment
A summary of property and equipment at December 31, 20X7 and 20X6, follows:
20X7 20X6
Land $3,000,000 $3,000,000
Land improvements 472,000 472,000
Buildings and improvements 46,852,000 46,636,000
Equipment 29,190,000 26,260,000
Equipment under capital lease obligations 2,851,000 2,752,000
82,365,000 79,120,000
Less accumulated depreciation and amortization 34,928,000 30,661,000
47,437,000 48,459,000
Construction in progress 3,601,000 2,033,000
Property and equipment, net $51,038,000 $50,492,000
Depreciation expense for the years ended December 31, 20X7 and 20X6
amounted to approximately $4,782,000 and $4,280,000. Accumulated amortiza-
tion for equipment under capital lease obligations was $689,000 and $453,000
at December 31, 20X7 and 20X6, respectively. Construction contracts of ap-
proximately $7,885,000 exist for the remodeling of hospital facilities. At De-
cember 31, 20X7, the remaining commitment on these contracts approximated
$4,625,000.
5. Long Term Debt
A summary of long term debt and capital lease obligations at December 31,
20X7 and 20X6, follows:
20X7 20X6
7.25 percent 20X7 Tax-Exempt Revenue Bonds,
principal maturing in varying annual
amounts, due November 1, 20XX,
collateralized by a pledge of the hospital's
gross receipts $21,479,000
8.50 percent 20X2 Tax-Exempt Revenue Bonds,
principal maturing in varying annual
amounts, due June 1, 20XX $22,016,000
7.75 percent mortgage loan, principal maturing
in varying annual amounts, due January
20XX, collateralized by a mortgage on certain
property and equipment 2,010,000 2,127,000
7.75 percent note payable, payable in monthly
installments of $12,000, including interest,
due March 20XX, unsecured 125,000 671,000
Capital lease obligations, at varying rates of
imputed interest from 6.8 percent to 9.3
percent collateralized by leased equipment 1,000,000 950,000
24,614,000 25,764,000
Less current portion 1,470,000 1,750,000
$23,144,000 $24,014,000
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Under the terms of the 20X7 and 20X2 revenue bond indentures, the hospital
is required to maintain certain deposits with a trustee. Such deposits are in-
cluded with assets limited as to use. The revenue note indenture also places
limits on the incurrence of additional borrowings and requires that the hospi-
tal satisfy certain measures of financial performance as long as the notes are
outstanding.
Scheduled principal repayments on long term debt and payments on capital
lease obligations are as follows:
Year Ending
December 31, Long Term Debt
Capital Leases
Obligations
20X8 $970,000 $550,000
20X9 912,000 260,000
20Y0 983,000 260,000
20Y1 1,060,000 45,000
20Y2 1,143,000 —
Thereafter 18,546,000 —
$23,614,000 1,115,000
Less amount representing interest
under capital leases obligations 115,000
$1,000,000
A summary of interest cost and investment income on borrowed funds held by
the trustee under the 20X7 and 20X2 revenue bond indentures during the years
ended December 31, 20X7 and 20X6, follows:
20X7 20X6
Interest cost:
Capitalized $740,000 $700,000
Charged to operations 1,752,000 1,825,000
Total $2,492,000 $2,525,000
Investment income:
Capitalized $505,000 $663,000
Credited to other revenue 330,000 386,000
Total $835,000 $1,049,000
6. Temporarily and Permanently Restricted Net Assets
Temporarily restricted net assets are available for the following purposes or
periods at December 31, 20X7 and 20X6:
20X7 20X6
Health care services
Purchase of equipment $320,000 $520,000
Indigent care 840,000 950,000
Health education 350,000 400,000
For periods after December 31, 20X9 605,000 600,000
$2,115,000 $2,470,000
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Permanently restricted net assets at December 31, 20X7 and 20X6, are re-
stricted to:
20X7 20X6
Investments to be held in perpetuity, the income
from which is expendable to support health care
services (reported as operating income) $2,973,000 $2,923,000
Endowment requiring income to be added to
original gift until fund value is $1,500,000 615,000 610,000
$3,588,000 $3,533,000
During 20X7, net assets were released from donor restrictions by incurring
expenses satisfying the restricted purposes of indigent care and health care
education in the amounts of $250,000 and $50,000, respectively.
7. Medical Malpractice Claims
The hospital purchases professional and general liability insurance to cover
medical malpractice claims. There are known claims and incidents that may
result in the assertion of additional claims, as well as claims from unknown
incidents that may be asserted arising from services provided to patients. The
hospital has employed independent actuaries to estimate the ultimate costs,
if any, of the settlement of such claims. Accrued malpractice losses have been
discounted at seven percent and in management's opinion provide an adequate
reserve for loss contingencies.
On March 15, 20X7, a patient filed a suit against the hospital for malpractice
during care received as an inpatient. The hospital believes it has meritorious
defenses against the suit; however, the ultimate resolution of the matter could
result in a loss. The patient has claimed $16 million in actual damages. Under
state law, punitive damages are determined at trial. The hospital maintains in-
surance coverage for malpractice claims. The coverage does not include punitive
damages awards. Trial is scheduled to occur within the next year.
8. Pension Plan and Other Postretirement Benefit Plans6,7
[The following two paragraphs are encouraged but not required.]
The hospital has a defined benefit pension plan covering substantially all of its
employees. The plan benefits are based on years of service and the employees'
6 This note to the financial statements illustrates the financial statement disclosures about pen-
sion and postretirement benefit plans for a public entity. Readers should refer to FASB ASC 715-20-50
when considering disclosure requirements for nonpublic entities.
FASB Statement No. 158, Employers' Accounting for Defined Benefit Pension and Other Postre-
tirement Plans—an amendment of FASB Statements No. 87, 88, 106, and 132(R), as amended, is
incorporated in FASB ASC 715, Compensation—Retirement Benefits, subject to the effective date and
transition guidance in FASB ASC 715-20-65-1. An employer with publicly traded equity securities
shall initially apply the requirement to recognize the funded status of a benefit plan and the dis-
closure requirements as of the end of the fiscal year ending after December 15, 2006. An employer
without publicly traded equity securities shall initially apply the requirement to recognize the funded
status of a benefit plan and the disclosure requirements as of the end of the fiscal year ending after
June 15, 2007. An employer without publicly traded equity securities shall provide the disclosures
in paragraph 14 in the notes to the financial statements for a fiscal year ending after December 15,
2006, but before June 16, 2007, unless it has applied the recognition provisions of this statement in
preparing those financial statements; the requirement to measure plan assets and benefit obligations
as of the date of the employer's fiscal year-end statement of financial position shall be effective for
fiscal years ending after December 15, 2008.
7 Readers may also need to consider the accounting and disclosure requirements of the "Medicare
Prescription Drug, Improvement and Modernization Act" subsections of FASB ASC 715-60 when an
employer provides postretirement prescription drug coverage.
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compensation during the last five years of covered employment. Contributions
are intended to provide not only for benefits attributed to service to date but
also for those expected to be earned in the future.
The hospital also sponsors 2 defined benefit postretirement plans that cover
both salaried and nonsalaried employees. One plan provides medical and dental
benefits, and the other provides for the payment of life insurance premiums.
The postretirement health care plan is contributory, with retiree contributions
adjusted annually; the life insurance plan is noncontributory. The accounting
for the health care plan anticipates future cost-sharing changes to the written
plan that are consistent with the hospital's expressed intent to increase retiree
contributions each year to 50 percent of the excess of the expected general
inflation rate over 6 percent. Beginning in 20X7, the hospital adopted a funding
policy for its postretirement health care plan similar to its funding policy for its
life insurance plan—an amount equal to a level percentage of the employees'
salaries is contributed to the plan annually. For 20X7, that percentage was 4.25,
and the aggregate contribution for both plans was $34,000. The hospital uses
a December 31 measurement date for its plans.
The following table sets forth the changes in benefit obligations, changes in
plan assets, and components of net periodic benefit cost for both the pension
plan and the other postretirement benefit plans:
Pension Benefits Other Benefits
20X7 20X6 20X7 20X6
Change in benefit obligation:
Benefit obligation at beginning of
year $9,710 $9,700 $585 $500
Service cost 905 770 14 15
Interest cost 700 650 50 44
Plan participants' contributions 34 34
Actuarial gain (20) (7)
Benefits paid (375) (1,410) (66) (8)
Benefit obligation at end of year 10,920 9,710 610 585
Change in plan assets:
Fair value of plan assets at
beginning of year 9,800 9,610 89 40
Actual return on plan assets 759 810 4 4
Employer contribution 866 790 39 19
Plan participants' contributions 34 34
Benefits paid (375) (1,410) (66) (8)
Fair value of plan assets at end of
year 11,050 9,800 100 89
Funded status 130 90 (510) (496)
Unrecognized net actuarial gain (30) (40) (30) (40)
Unrecognized prior service cost 50 55 16 19
Unrecognized transition obligation 445 470
Unrecognized transition asset (15) (20)
Prepaid (accrued) benefit cost $135 $85 ($79) ($47)
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The accumulated benefit obligation for the defined benefit pension plan was
$XXX and $XXX at December 31, 20X7, and 20X6, respectively.
Pension Benefits Other Benefits
20X7 20X6 20X7 20X6
Components of net periodic benefit
cost:
Service cost $905 $770 $14 $15
Interest cost 700 650 50 44
Expected return on plan assets (784) (769) (6) (3)
Amortization of prior service cost 5 7 3 2
Recognized net actuarial (gain) (5) (2) (15) (1)
Amortization of transition
obligation 25 25
Amortization of transition asset (5) (1)
Net periodic benefit cost $816 $655 $71 $82
Additional Information
Assumptions
Weighted-average assumptions
used to determine benefit
obligations at December 31
Discount rate 7.00% 7.00% 7.00% 7.00%
Rate of compensation increase 6.00% 6.00%
Weighted-average assumptions
used to determine net
periodic benefit cost for
years ended December 31
Discount rate 7.00% 7.00% 7.00% 7.00%
Expected long term return on plan
assets 8.00% 8.00% 6.60% 6.60%
Rate of compensation increase 6.00% 6.00%
(Entity specific narrative description of the basis used to determine the overall
expected long term rate of return on assets, as described in FASB ASC 715-20-
50-1(d)(3) would be included here.)
Assumed health care cost
trend rates at December 31
Health care cost trend rate
assumed for next year 7% 7%
Rate to which the cost trend
rate is assumed to decline
(the ultimate trend rate) 5% 5%
Year that the rate reaches the
ultimate trend rate 20Y2 20Y2
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Assumed health care cost trend rates have a significant effect on the amounts
reported for the health care plans. A one-percentage-point change in assumed
health care cost trend rates would have the following effects:
1-Percentage-
Point Increase
1-Percentage-
Point Decrease
Effect on total of service and interest cost $13 ($11)
Effect on postretirement benefit obligation 73 (67)
Plan Assets
The composition of plan assets at December 31, 20X7, and 20X6, is as follows:
Pension Benefits Other Benefits
20X7 20X6 20X7 20X6
Asset Category XX% XX% XX% XX%
Equity securities XX XX XX XX
Debt securities XX XX XX XX
Real estate XX XX XX XX
Other XX XX XX XX
Total 100% 100% 100% 100%
(Entity specific narrative description of investment policies and strategies for
plan assets, including weighted-average target asset allocations [if used as part
of those policies and strategies] as described in FASB ASC 715-10-50-1(d)(2)
would be included here.)
Cash Flows
Contributions
The hospital expects to contribute $XXX to its pension plan and $XXX to its
other postretirement benefit plan in 20X8.
Estimated Future Benefit Payments
The following benefit payments, which reflect expected future service, as ap-
propriate, are expected to be paid:
Pension
Benefits
Other
Benefits
20X8 $XXX $XXX
20X9 XXX XXX
20Y0 XXX XXX
20Y1 XXX XXX
20Y2 XXX XXX
Years 20Y3–20Y7 XXX XXX
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9. Concentrations of Credit Risk
The hospital grants credit without collateral to its patients, most of whom are
local residents and are insured under third-party payor agreements. The mix
of receivables from patients and third-party payors at December 31, 20X7 and
20X6, was as follows:
20X7 20X6
Medicare 51% 53%
Medicaid 17 14
Blue Cross 18 17
Other third-party payors 7 9
Patients 7 7
100% 100%
10. Commitments and Contingencies
Operating leases. The hospital leases various equipment and facilities under
operating leases expiring at various dates through April 20Y2. Total rental
expense in 20X7 and 20X6 for all operating leases was approximately $859,000
and $770,000, respectively.
The following is a schedule by year of future minimum lease payments under
operating leases as of December 31, 20X7, that have initial or remaining lease
terms in excess of 1 year.
Year Ending
December 31, Amount
20X8 $517,000
20X9 506,000
20Y0 459,000
20Y1 375,000
20Y2 343,000
Litigation. The hospital is involved in litigation and regulatory investigations
arising in the course of business. After consultation with legal counsel, manage-
ment estimates that these matters will be resolved without material adverse
effect on the hospital's future financial position or results from operations.
Allowance for doubtful accounts. Beginning in 20X5, the hospital has provided
care under an agreement with Associated HMO. The HMO currently owes the
hospital $950,000, substantially all of which is overdue. The hospital has no-
tified the HMO that further services under the contract cannot be provided
without payment on the outstanding balance. The HMO has assured the hos-
pital that additional funds are being obtained in order to pay the overdue bal-
ance and continue service under the agreement, however, if the HMO is un-
able to make payments, additional allowances for bad debts would need to be
accrued.
11. Related Party Transactions
During the years ended December 31, 20X7 and 20X6, the hospital contributed
capital to Sample Health System, an affiliate with some board members in com-
mon with the hospital, in the amounts of $688,000 and $3,051,000, respectively.
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The Sample Hospital Foundation (the foundation), which is controlled by Sam-
ple Health System, was established to solicit contributions from the general
public solely for the funding of capital acquisitions by the hospital. Funds are
distributed to the hospital as determined by the foundation's board of directors.
A summary of the foundation's assets, liabilities, net assets, results of opera-
tions, and changes in net assets follows. The hospital's interest in the net assets
of the foundation is reported as a noncurrent asset in the balance sheets.
At December 31,
20X7 20X6
Assets principally cash and cash equivalents $521,000 $472,000
Liabilities 11,000 10,000
Unrestricted net assets 510,000 462,000
Total liabilities and net assets $521,000 $472,000
Support and revenue $269,000 $535,000
Expenses
Distributions to Sample Hospital for property
acquisitions 235,000 485,000
Other 13,000 16,000
Total expenses 248,000 501,000
Excess of support and revenue over expenses 21,000 34,000
Other changes in net assets 27,000 17,000
Unrestricted net assets, beginning of year 462,000 411,000
Unrestricted net assets, end of year $510,000 $462,000
Liabilities include $10,000 payable at the end of each year to Sample Hospital.
These amounts were paid after the end of each year.
12. Functional Expenses
The hospital provides general health care services to residents within its geo-
graphic location. Expenses related to providing these services are as follows (in
thousands):
At December 31,
20X7 20X6
Health care services $86,000 $78,647
General and administrative 12,055 10,643
$98,055 $89,290
13. Fair Value of Financial Instruments
The following methods and assumptions were used by the hospital in estimating
the fair value of its financial instruments:
Cash and cash equivalents: The carrying amount reported in the bal-
ance sheet for cash and cash equivalents approximates its fair value.
Investments: Fair values, which are the amounts reported in the bal-
ance sheet, are based on quoted market prices, if available, or esti-
mated using quoted market prices for similar securities.
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Assets limited as to use: These assets consist primarily of cash and
short term investments and interest receivable. The carrying amount
reported in the balance sheet is fair value.
Accounts payable and accrued expenses: The carrying amount reported
in the balance sheet for accounts payable and accrued expenses approx-
imates its fair value.
Estimated third-party payor settlements: The carrying amount re-
ported in the balance sheet for estimated third-party payor settlements
approximates its fair value.
Long term debt: Fair values of the hospital's revenue notes are based
on current traded value. The fair value of the hospital's remaining long
term debt is estimated using discounted cash flow analyses, based on
the hospital's current incremental borrowing rates for similar types of
borrowing arrangements.
The carrying amounts and fair values of the hospital's financial instruments at
December 31, 20X7 and 20X6, are as follows (in thousands):
20X7 20X6
Carrying
Amount
Fair
Value
Carrying
Amount
Fair
Value
Cash and cash equivalents $4,758 $4,758 $5,877 $5,877
Short term investments 15,836 15,836 10,740 10,740
Assets limited as to use 18,949 18,949 19,841 19,841
Long term investments 4,680 4,680 4,680 4,680
Long term investments
restricted for capital
acquisition 320 320 520 520
Accounts payable and accrued
expenses 5,818 5,818 5,382 5,382
Estimated third-party payor
settlements 2,143 2,143 1,942 1,942
Long term debt 24,614 23,980 25,764 24,918
14. Promises to Contribute
At December 31, 20X7, the hospital had received $1,500,000 of conditional
promises to contribute to the building of a new facility for outpatient services.
These contributions will be recorded as temporarily restricted support when
received. The hospital had no material outstanding unconditional promises of
support at December 31, 20X7.
15. Charity Care
The amount of charges foregone for services and supplies furnished under
the hospital's charity care policy aggregated approximately $4,500,000 and
$4,100,000 in 20X7 and 20X6, respectively.
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16. Subsequent Event††
On February 9, 20X8, the hospital signed a contract in the amount of $1,050,000
for the purchase of certain real estate.
Illustrative Management’s Discussion and Analysis
and Financial Statements
Sample Governmental Hospital Authority
A Component Unit of Feeling County, State of Union
Management's Discussion and Analysis
Our discussion and analysis of Sample Hospital Authority's (authority's) finan-
cial performance provides an overview of the authority's financial activities for
the fiscal years ended December 31, 20X7 and 20X6. Please read it in conjunc-
tion with the authority's financial statements, which begin on page XXX. Unless
otherwise indicated, amounts are in thousands.
Financial Highlights
 The authority's net assets increased in each of the past 2 years
with a $4,225 or 6.6 percent increase in 20X7 and a $9,460 or 17.4
percent increase in 20X6.
 The authority reported increased operating losses in both 20X7
($24,403) and 20X6 ($13,365). Losses in 20X7 increased by $11,038
or 82.6 percent over the loss reported in 20X6. Operating losses in
20X6 increased by $4,020 or 43.0 percent.
 Nonoperating revenues increased by $7,890 or 39.6 percent in
20X7 compared to 20X6. Nonoperating revenues also increased
in 20X6 by $1,139 or 6 percent compared to 20X5.
Using This Annual Report
The authority's financial statements consist of three statements—a balance
sheet; a statement of revenues, expenses, and changes in net assets; and a
†† In May 2009, FASB issued FASB Statement No. 165, Subsequent Events, which establishes
general standards of accounting for and disclosure of events that occur after the balance sheet date
but before financial statements are issued or are available to be issued. This statement sets forth the
following:
1. The period after the balance sheet date during which management of a reporting
entity should evaluate events or transactions that may occur for potential recognition
or disclosure in the financial statements.
2. The circumstances under which an entity should recognize events or transactions
occurring after the balance sheet date in its financial statements.
3. The disclosures that an entity should make about events or transactions that occurred
after the balance sheet date.
FASB Statement No. 165 introduces the concept of financial statements being available to be issued.
It also requires disclosure of the date through which an entity has evaluated subsequent events and
the basis for that date (that is, whether that date represents the date the financial statements were
issued or were available for issue).
FASB Statement No. 165 is effective for interim or annual financial periods ending after June
15, 2009. For additional information please visit the FASB Web site at www.fasb.org.
FASB Statement No. 165 has been codified at FASB ASC 855, Subsequent Events.
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statement of cash flows. These financial statements and related notes provide
information about the activities of the authority, including resources held by
the authority but restricted for specific purposes by contributors, grantors, or
enabling legislation.
The Balance Sheet and Statement of Revenues, Expenses,
and Changes in Net Assets
Our analysis of the authority finances begins on page XXX. One of the most
important questions asked about the authority's finances is, "Is the authority
as a whole better or worse off as a result of the year's activities?" The balance
sheet and the statement of revenues, expenses, and changes in net assets report
information about the authority's resources and its activities in a way that helps
answer this question. These statements include all restricted and unrestricted
assets and all liabilities using the accrual basis of accounting. All of the current
year's revenues and expenses are taken into account regardless of when cash
is received or paid.
These two statements report the authority's net assets and changes in them.
You can think of the authority's net assets—the difference between assets and
liabilities—as one way to measure the authority's financial health, or financial
position. Over time, increases or decreases in the authority's net assets are one
indicator of whether its financial health is improving or deteriorating. You will
need to consider other nonfinancial factors, however, such as changes in the
authority's patient base and measures of the quality of service it provides to
the community, as well as local economic factors to assess the overall health of
the authority.
The Statement of Cash Flows
The final required statement is the statement of cash flows. The statement
reports cash receipts, cash payments, and net changes in cash resulting from
operations, investing, and financing activities. It provides answers to such ques-
tions as "Where did cash come from?" "What was cash used for?" and "What was
the change in cash balance during the reporting period?"
The Authority’s Net Assets
The authority's net assets are the difference between its assets and liabilities
reported in the balance sheet on page X. The authority's net assets increased
in each of the past 2 years by $4,225 (6.6 percent) in 20X7 and $9,460 (17.4
percent) in 20X6, as you can see from table 1.
Table 1: Assets, Liabilities, and Net Assets
20X7 20X6 20X5
Assets:
Current assets $32,382 $30,135 $26,070
Capital assets, net 43,382 42,918 42,445
Other noncurrent assets 25,118 23,494 19,767
Total assets 100,882 96,547 88,282
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20X7 20X6 20X5
Liabilities
Long term liabilities 23,033 23,102 24,349
Other 9,690 9,511 9,459
Total liabilities 32,723 32,613 33,808
Net assets:
Invested in capital assets, net of
related debt 22,460 21,018 18,649
Restricted for debt service 1,945 2,005 2,035
Restricted expendable net assets 1,845 2,100 2,075
Restricted nonexpendable net
assets 3,003 2,919 2,652
Unrestricted 38,906 35,892 29,063
Total net assets $68,159 $63,934 $54,474
A significant component of the change in the authority's assets is the increase in
patient accounts receivable. Although operating revenues decreased in 20X7 by
$3,445 (5.7 percent), patient accounts receivable, net of estimated uncollectible
amounts, increased by $3,107 or 18.6 percent in 20X7. In addition, patient
service revenue decreased by $2,105 in 20X6 compared to 20X5, but receivables
increased by $2,114 or 14.5 percent. In both cases, the increase in accounts
receivable is primarily the result of overall slowdowns by health insurers in
making payments in attempting to cut costs by managing their cash flows.
Operating Results and Changes in The Authority’s
Net Assets
In 20X7, the authority's net assets increased by $4,225 or 6.6 percent, as shown
in table 2. This increase is made up of very different components. And it rep-
resents a decline of 55.3 percent compared with the increase in net assets for
20X6 of $9,460.
Table 2: Operating Results and Changes in Net Assets
20X7 20X6 20X5
Operating Revenues:
Net patient service revenues $43,305 $43,736 $45,841
Premium revenues 9,876 13,058 12,976
Other operating revenues 3,416 3,248 2,910
Total operating revenues 56,597 60,042 61,727
Operating Expenses:
Salaries and benefits 46,845 43,235 40,640
Medical supplies and drugs 12,746 7,986 6,788
Depreciation and amortization 4,065 3,638 3,508
Other operating expenses 17,344 18,548 20,136
Total operating expenses 81,000 73,407 71,072
Operating loss (24,403) (13,365) (9,345)
(continued)
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20X7 20X6 20X5
Nonoperating Revenues and
Expenses
Property taxes 23,895 15,309 14,875
Investment income 5,653 5,304 5,108
Noncapital grants and contributions 170 853 510
Other nonoperating revenues and
expenses, net (1,914) (1,552) (1,718)
Total nonoperating revenues
(expenses) 27,804 19,914 18,775
Excess of revenues over
expenses before capital grants,
contributions, and additions to
permanent endowments 3,401 6,549 9,430
Grants, Contributions, and
Endowments
Capital grants and contributions 824 2,560 1,980
Additions to permanent endowments 351
Increase in net assets $4,225 $9,460 $11,410
Net assets end of year $68,159 $63,934 $4,474
Operating Losses
The first component of the overall change in the authority's net assets is its
operating income (loss)—generally, the difference between net patient service
and Premium revenues and the expenses incurred to perform those services.
In each of the past two years, the authority has reported an operating loss.
This is consistent with the authority's entire operating history. The authority's
hospital operations were begun in 19XX as a municipal hospital, when it was
agreed that a portion of its costs would be subsidized by property tax revenues,
making the facility more affordable for the County's lower income residents.
However, in each of the past 2 years, operating losses have increased. Losses
in 20X7 increased by $11,038 or 82.6 percent higher than the loss reported in
20X6. Operating losses in 20X6 increased by $4,020 or 43.0 percent.
The primary components of these increased operating losses are
 a decrease in premium revenue of $3,182 or 24.4 percent in 20X7.
(Premium revenues in 20X6 were roughly the same as in the pre-
vious year.)
 increases in salary and benefit costs for the hospital's employees
($3,610 or 8.4 percent in 20X7 and $2,595 or 6.4 percent in 20X6).
 increases in medical supply and drug costs of $4,760 or 59.6 per-
cent in 20X7 and of $1,198 or 17.6 percent in 20X6.
 an increase in the level of uncompensated care provided. These are
services provided for which there is no expectation of payment.
Premium revenues from contracts with HMOs decreased in 20X7 primarily be-
cause of changes in the fixed amount per individual per month (capitation rate)
paid by the Acme Health Maintenance Group. Acme is the HMO for the county's
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largest employer, the XYZ Motor Company. The authority, (with the assistance
of the county), negotiated a new 4 year contract with Acme in 20X6. Those
negotiations resulted in a 15 percent reduction in capitation rates in 20X7. Un-
der the contract, capitation rates increase by 3 percent each year for the next
3 years. At the same time, the authority (with the county's approval) agreed
to increase its property tax levy by 10 percent, as discussed in the following
paragraphs.
Employee salary and benefits costs increased in 20X6 and again in 20X7 based
on rates established in labor contracts negotiated in 20X5 and 20X6. Current
labor contracts for all of the authority's unionized employees extend until 20Y1.
The rate of health care inflation has a direct effect on the cost of services pro-
vided by the authority. A component of the authority's costs are expenses for
medical supplies and prescription drugs. In 20X5, medical supplies and pre-
scription drug costs totaled $6.8 million. In 20X6, they totaled $8.0 million or
10.7 percent of total expenses and an increase of 17.6 percent over 20X5. And,
in 20X7, medical supplies and prescription drug costs totaled $12.7 million,
representing 15.6 percent of total expenses and an increase of 59.6 percent
over 20X6. Some of the major factors contributing to the increased medical
supply and drug costs include the introduction of new drugs that cannot be
obtained in generic form, and changes in therapeutic mix. In addition, in 20X7,
the company that the authority used as its major wholesale drug supplier filed
for bankruptcy. The authority negotiated new contracts with other suppliers at
substantially higher costs. At its August 20X7 meeting, the authority's board
of trustees authorized management to explore other supplier options.
The authority sometimes provides care for patients who have little or no health
insurance or other means of repayment. As discussed, this service to the com-
munity is consistent with the goals established for the authority when it was
established in 19XX. The level of services provided to these patients increased
by $1,200 in 20X6 compared to 20X5. In 20X7, the costs of uncompensated care
increased by $255. Because there is no expectation of repayment, charity care
is not reported as patient service revenues of the authority.
Nonoperating Revenues and Expenses
Nonoperating revenues consist primarily of property taxes levied by the au-
thority and interest revenue and investment earnings. During its negotiations
with Acme and XYZ, discussed earlier, the authority agreed—with the county's
approval—to increase its property tax levy to county residents by 10 percent.
County voters approved this increase in November 20X6. In addition, a 35 per-
cent increase in the sales of new homes in the county in 20X6 and 20X5 as
well as additions of new commercial and manufacturing facilities resulted in
an increase in the county's grand list. The grand list is calculated as of July 1
each year and used as the basis for tax levies on January 1. As a result of both
of these factors, nonoperating tax revenues increased by $8,586 or 56.1 percent
in 20X7 compared to a $434 (2.9 percent) increase in 20X6.
Grants, Contributions, and Endowments
The authority receives both capital and operating grants from various state
and federal agencies for specific programs. These are discussed in detail in note
2 to the financial statements. Capital and operating grants received in 20X7
from the State of Union declined due to fiscal/budgetary issues at the state
from $3,085 in 20X6 ($2,300 capital and $785 operating) to $800 in 20X7 ($650
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capital and $150 operating). Although $1,640 in grants have been budgeted by
the state for the authority in 20X8, it is not clear whether monies to fund these
grants will be appropriated.
The authority received $351 in permanent endowments in 20X6 from the AIA
Foundation. Earnings from investing the principal of this endowment must be
used to support expenditures for Program A research. This is in contrast to an
increase in state funding of $580 in 20X6 compared to 20X5. The authority has
received other permanent endowments in the past. Restrictions established by
these endowments are detailed in note 2 to the financial statements.
The Authority’s Cash Flows
Changes in the authority's cash flows are consistent with changes in operating
losses and nonoperating revenues and expenses, discussed earlier, with 1 ex-
ception. Cash flows used by operating activities increased slightly more than
operating losses in both 20X7 and 20X6 due to increases in the authority's
patient accounts receivable, discussed earlier.
Capital Asset and Debt Administration
Capital Assets
At the end of 20X7, the authority had $43.3 million invested in capital as-
sets, net of accumulated depreciation, as detailed in note 7 to the financial
statements. In 20X7, the authority purchased new equipment costing $4,529.
Of this, $510 was acquired through capital leases. Nearly the same amount—
$4,111—was spent to acquire new equipment in 20X6. Both of these amounts
are less than 20X5, when the authority spent $7,308 for new equipment. The
authority has recently found it more economical to lease much of its equipment.
This allows the authority to avoid some of the costs of obsolescence caused by
technological changes.
In August 20X5, the authority's board of trustees approved a resolution setting
aside $15 million of its unrestricted net assets for future expansion of the hos-
pital and possible addition of a cancer care wing. The board of trustees held a
special meeting in September 20X7 to reconsider the feasibility of the project
and held initial meetings with several local architectural firms in January 20X8.
No decisions have been reached as of the date of this annual report.
Debt
At year-end, the authority had $20.9 in revenue notes, mortgage loans, and
capital lease obligations outstanding as detailed in note 8 to the financial state-
ments. Except for capital leases of $510 initiated in 20X7, the authority issued
no new debt in 20X7 or 20X6. The authority's formal debt issuances—revenue
notes—cannot be issued without approval of the Feeling County board of com-
missioners. The amount of debt issued is subject to limitations that apply to
the county and its component units as a whole. There have been no changes in
the authority's debt ratings in the past 2 years.8
8 If the authority's ability to issue additional debt is significantly impacted by such debt limita-
tion, those facts should be disclosed.
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Other Economic Factors
The county's largest employer, the XYZ Motor Company, has a number of op-
erating plants throughout the country. In late 20X5, XYZ announced that it
would close its plant in New City, Ohio, and move the majority of that plant's
operations (including up to 2,000 full-time employees) to its Feeling County
plant. Work on that move began in May 20X6. The impact of this closure on the
authority's operations has not been determined. Management has anticipated
a 5 percent reduction in patient volumes in its budget for 20XX and has devel-
oped strategies to address staffing levels and other operating expenses in the
event of a significant additional reduction in patient volumes.
Contacting The Authority’s Financial Management
This financial report is designed to provide our patients, suppliers, taxpayers,
and creditors with a general overview of the authority's finances and to show
the authority's accountability for the money it receives. If you have questions
about this report or need additional financial information, contact the authority
controller's office at Sample Hospital Authority, 92 Third Street, Anytown, UN
01000.
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ILLUSTRATIVE FINANCIAL STATEMENTS
FOR A GOVERNMENTAL HOSPITAL AUTHORITY
Sample Governmental Hospital Authority
A Component Unit of Feeling County, State of Union
Balance Sheets9
December 31, 20X7 and 20X6
(in thousands)
20X7 20X6
Assets
Current assets:
Cash and cash equivalents $7,136 $7,557
Short term investments 3,142 3,423
Patient accounts receivable, net of estimated
uncollectibles of $2,125 (20X7) and $2,040
(20X6) 19,834 16,727
Supplies and other current assets 2,270 2,428
Total current assets 32,382 30,135
Noncurrent cash and investments:
Internally designated for capital acquisitions 15,000 15,000
Other long term investments 2,605 1,327
Held by trustee for debt service 1,945 2,005
Restricted by contributors and grantors for capital
acquisitions and research 1,124 1,078
Principal of permanent endowments 3,003 2,919
Delinquent property taxes 385 229
Capital Assets:
Land 3,590 3,590
Depreciable capital assets, net of accumulated
depreciation 39,792 39,328
Total capital assets, net of accumulated
depreciation 43,382 42,918
Other assets 1,056 936
Total assets $100,882 $96,547
(continued)
9 As discussed in paragraph 1.18 in this guide, either a balance sheet or a statement of net assets
format may be used.
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20X7 20X6
Liabilities and Net Assets
Current liabilities:
Current maturities of long term debt $1,250 $1,488
Accounts payable and accrued expenses 4,945 4,575
Estimated third-party payor settlements 1,822 1,651
Other current liabilities 1,673 1,797
Total current liabilities 9,690 9,511
Long term debt, net of current maturities 19,672 20,412
Other long term liabilities 3,361 2,690
Total liabilities 32,723 32,613
Net Assets:10
Invested in capital assets net of related debt 22,460 21,018
Restricted:
For debt service 1,945 2,005
Expendable for capital acquisitions 733 628
Expendable for research 781 899
Expendable for specific operating activities 331 573
Nonexpendable permanent endowments 3,003 2,919
Unrestricted 38,906 35,892
Total net assets 68,159 63,934
Total liabilities and net assets $100,882 $96,547
See accompanying notes to financial statements.
10 As discussed in paragraph 1.20 in this guide, either "net assets" or "equity" may be used as
the label for the difference between assets and liabilities.
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Sample Governmental Hospital Authority
A Component Unit of Feeling County, State of Union
Statements of Revenues, Expenses, and Changes in Net Assets11
Years Ended December 31, 20X7 and 20X6
(in thousands)
20X7 20X6
Operating revenues:
Net patient service revenue (net of provision
for bad debts of $859 in 20X7 and $938 in 20X6) $43,305 $43,736
Premium revenue 9,876 13,058
Other 3,416 3,248
Total operating revenues 56,597 60,042
Operating expenses:
Salaries and benefits 46,845 43,235
Medical supplies and drugs 12,746 7,986
Insurance 7,030 7,382
Other supplies 10,314 11,166
Depreciation and amortization 4,065 3,638
Total operating expenses 81,000 74,407
Operating loss (24,403) (13,365)
Nonoperating revenues (expenses):
Property taxes 23,895 15,309
Investment income 5,653 5,304
Interest expense (1,489) (1,552)
Noncapital grants and contributions 170 853
Other (425) —
Total nonoperating revenues (expenses) 27,804 19,914
Excess of revenues over expenses before
capital grants, contributions, and additions
to permanent endowments 3,401 6,549
Capital grants and contributions 824 2,560
Additions to permanent endowments — 351
Increase in net assets $4,225 $9,460
Net assets beginning of the year 63,934 54,474
Net assets end of the year $68,159 $63,934
See accompanying notes to financial statements.
11 As discussed in paragraph 1.22 of this guide, GASB Statement No. 34, Basic Financial
Statements—and Management's Discussion and Analysis—for State and Local Governments, para-
graph 101 requires proprietary funds and special purpose governments engaged only in business-type
activities to present an operating statement that uses an "all-inclusive" format, presenting all changes
in both restricted and unrestricted net assets and presenting a final total, "Increase (decrease) in net
assets/equity." As discussed in paragraph 1.20 of this guide, governmental health care entities may
use either the term net assets or equity as a label for the difference between assets and liabilities.
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Sample Governmental Hospital Authority
A Component Unit of Feeling County, State of Union
Statements of Cash Flows
Years Ended December 31, 20X7 and 20X6
(in thousands)
20X7 20X6
Cash flows from operating activities:
Receipts from and on behalf of patients $50,074 $54,680
Payments to suppliers and contractors (30,029) (26,634)
Payments to employees (46,955) (43,460)
Other receipts and payments, net 4,591 3,597
Net cash provided by operating activities (22,319) (11,817)
Cash flows from noncapital financing
activities:
Property taxes 20,739 12,224
Noncapital grants and contributions 170 853
Contributions to permanent endowments — 351
Other (425) —
Net cash provided by noncapital financing
activities 20,484 13,428
Cash flows from capital and related
financing activities:
Capital grants and contributions 824 2,560
Property taxes restricted to capital acquisitions 3,000 3,000
Principal paid on long term debt (1,488) (1,896)
Interest paid on long term debt (1,489) (1,552)
Purchase of capital assets (4,019) (4,111)
Net cash used by capital and related
financing activities (3,172) (1,999)
Cash flows from investing activities:
Interest and dividends on investments 2,737 2,124
Purchases of investments (1,045) (289)
Proceeds from sale of investments 2,327 683
Net cash provided by investing activities 4,019 2,518
Net increase (decrease) in cash and cash
equivalents (988) 2,130
(continued)
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Sample Governmental Hospital Authority
A Component Unit of Feeling County, State of Union
Statements of Cash Flows—continued
Years Ended December 31, 20X7 and 20X6
(in thousands)
20X7 20X6
Cash and cash equivalents, beginning of year 9,101 6,971
Cash and cash equivalents, end of year $8,113 $9,101
Reconciliation of cash and cash equivalents to
the statement of net assets:
Cash and cash equivalents in current assets 7,136 7,557
Restricted cash and cash equivalents 977 1,544
Total cash and cash equivalents $8,113 $9,101
Reconciliation of operating income (loss) to net cash
provided (used) by operating activities:
Operating loss ($24,403) ($13,365)
Adjustments to reconcile operating income
to net cash flows used in operating activities:
Depreciation and amortization 4,065 3,638
Provision for bad debts 859 938
Changes in:
Patient accounts receivable (3,966) (2,909)
Supplies and other current assets 158 100
Other assets (120) —
Accounts payable, accrued expenses, and
other current Liabilities 246 (225)
Estimated third-party payor settlements 171 (235)
Other liabilities related to operating activities 671 241
Net cash used in operating activities ($22,319) ($11,817)
Noncash Investing, Capital, and Financing Activities:
The authority entered into capital lease obligations of $510,000 for
new equipment in 20X7.
The authority held investments at December 31, 20X7, with a fair
value of $XXX. During 20X7, the net increase in the fair value of
these investments was $XXX.
See accompanying notes to financial statements.
AAG-HCO APP A
P1: PjU
ACPA125-AppA(ii) ACPA125.cls February 25, 2010 16:35
Illustrative Financial Statements 273
Sample Governmental Hospital Authority
A Component Unit of Feeling County, State of Union
Notes to Financial Statements12
December 31, 20X7 and 20X6
(in thousands)
1. Description of Reporting Entity and Summary of Significant
Accounting Policies
Reporting entity. The Sample Hospital Authority (the authority) is a public
corporation. It was created on January 1, 19XX, by the board of county com-
missioners of Feeling County, State of Union, to operate, control, and manage
all matters concerning the county's health care functions. The board of county
commissioners appoints the board of trustee members of the authority, and
the authority may not issue debt or levy taxes without the county's approval.
For this reason, the authority is considered to be a component unit of Feeling
County and is included as a discretely presented component unit in the basic
financial statements of the county.
Use of estimates. The preparation of financial statements in conformity with
generally accepted accounting principles (GAAP) requires management to
make estimates and assumptions that affect the reported amounts of assets
and liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from those estimates.
Enterprise fund accounting. The authority uses enterprise fund accounting.
Revenues and expenses are recognized on the accrual basis using the economic
resources measurement focus. Based on GASB Statement No. 20, as amended,
the authority has elected to apply the provisions of all relevant pronouncements
of the FASB, including those issued after November 30, 1989, that do not conflict
with or contradict GASB pronouncements.
Cash and cash equivalents. Cash and cash equivalents include investments in
highly liquid debt instruments with an original maturity of three months or
less.
Capital assets. The authority's capital assets are reported at historical cost.
Contributed capital assets are reported at their estimated fair value at the time
of their donation. All capital assets other than land are depreciated or amortized
(in the case of capital leases) using the straight-line method of depreciation
using these asset lives:
Land improvements 15–20 years
Buildings and building improvements 20–40 years
Equipment, computers, and furniture 3–7 years
12 The notes to the financial statements in these illustrative financial statements generally in-
clude only disclosures unique to a governmental hospital. The disclosures regarding the accounting
policies for the use of estimates and cost of borrowing in note 1 and charity care in note 5 are not
unique to a governmental hospital. Also, the notes to the financial statements include disclosures that
are not required.
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Costs of borrowing. Except for capital assets acquired through gifts, contribu-
tions, or capital grants, interest cost on borrowed funds during the period of
construction of capital assets is capitalized as a component of the cost of ac-
quiring those assets. None of the authority's interest cost was capitalized in
either 20X7 or 20X6.
Property taxes. The authority received approximately 29 percent in 20X7 and
19 percent in 20X6 of its financial support from property taxes. These funds
were used as follows:
20X7 20X6
Used to support operations $20,895 $12,309
Levied for debt service 3,000 3,000
Property taxes are levied by the county on the authority's behalf on January
1 and are intended to finance the authority's activities of the same calendar
year. Amounts levied are based on assessed property values as of the preceding
July 1.
Property taxes are considered delinquent on the day following each payment
due date.
Grants and contributions. From time to time, the authority receives grants
from Feeling County and the State of Union as well as contributions from in-
dividuals and private organizations. Revenues from grants and contributions
(including contributions of capital assets) are recognized when all eligibility
requirements, including time requirements are met. Grants and contributions
may be restricted for either specific operating purposes or for capital purposes.
Amounts that are unrestricted or that are restricted to a specific operating
purpose are reported as nonoperating revenues. Amounts restricted to capital
acquisitions are reported after nonoperating revenues and expenses.
Endowments. Endowments are provided to the authority on a voluntary basis by
individuals and private organizations. Permanent endowments require that the
principal or corpus of the endowment be retained in perpetuity. If a donor has
not provided specific instructions, Union state law permits the authority's board
of trustees to authorize for expenditure the net appreciation of the investments
of endowment funds, as discussed in note 2.
Restricted resources. When the authority has both restricted and unrestricted
resources available to finance a particular program, it is the authority's policy
to use restricted resources before unrestricted resources.
Net assets. Net assets of the authority are classified in four components. Net
assets invested in capital assets net of related debt consist of capital assets
net of accumulated depreciation and reduced by the current balances of any
outstanding borrowings used to finance the purchase or construction of those
assets. Restricted expendable net assets are noncapital net assets that must be
used for a particular purpose, as specified by creditors, grantors, or contributors
external to the authority, including amounts deposited with trustees as required
by revenue bond indentures, discussed in note 8. Restricted nonexpendable net
assets equal the principal portion of permanent endowments. Unrestricted net
assets are remaining net assets that do not meet the definition of invested in
capital assets net of related debt or restricted.
Operating revenues and expenses. The authority's statement of revenues, ex-
penses and changes in net assets distinguishes between operating and non-
operating revenues and expenses. Operating revenues result from exchange
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transactions associated with providing health care services—the authority's
principal activity. Nonexchange revenues, including taxes, grants, and contri-
butions received for purposes other than capital asset acquisition, are reported
as nonoperating revenues. Operating expenses are all expenses incurred to
provide health care services, other than financing costs.
Compensated absences. The authority's employees earn vacation days at vary-
ing rates depending on years of service. Vacation time does not accumulate.
Generally, any days not used at year-end expire. Employees also earn sick leave
benefits based on varying rates depending on years of service. Employees may
accumulate sick leave up to a specified maximum. Employees are not paid for
accumulated sick leave if they leave before retirement. However, employees
who retire from the authority may convert accumulated sick leave to termi-
nation payments at varying rates, depending on the employee's contract. The
estimated amount of sick leave payable as termination payments is reported
as a noncurrent liability in both 20X7 and 20X6.
Risk management. The authority is exposed to various risks of loss from torts;
theft of, damage to, and destruction of assets; business interruption; errors and
omissions; employee injuries and illnesses; natural disasters; medical malprac-
tice; and employee health, dental, and accident benefits. Commercial insurance
coverage is purchased for claims arising from such matters. Settled claims have
not exceeded this commercial coverage in any of the three preceding years.
Investments in debt and equity securities. Investments in debt and equity secu-
rities are reported at fair value except for short term highly liquid investments
that have a remaining maturity at the time they are purchased of one year
or less. These investments are carried at amortized cost. Interest, dividends,
and gains and losses, both realized and unrealized, on investments in debt and
equity securities are included in nonoperating revenue when earned.
2. Endowments and Restricted Net Assets
Restricted, expendable net assets are available for the following purposes:
20X7 20X6
Program A activities:
Purchase of equipment $404 $321
Research 553 683
General 46 63
Program B activities:
Purchase of equipment 235 235
Research 184 151
General 79 110
Program C activities:
General 206 400
Buildings and equipment 94 72
Research 44 65
Total expendable, restricted net assets $1,845 $2,100
Unless the contributor provides specific instructions, Union state law permits
the authority's board of trustees to authorize for expenditure the net appreci-
ation (realized and unrealized) of the investments in its endowments. When
administering its power to spend net appreciation, the board of trustees is re-
quired to consider the authority's "long- and short-term needs, present and
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anticipated financial requirements, expected total return on its investments,
price-level trends, and general economic conditions." Any net appreciation that
is spent is required to be spent for the purposes designated by the contributor.
The board of trustees chooses to spend only a portion of the investment income
(including changes in the value of investments) each year. Under the policy
established by the board, 5 percent of the average market value of endowment
investments at the end of the previous 3 years has been authorized for expen-
diture. The authority retains the remaining amount, if any, to be used in future
years when the amount computed using the spending policy exceeds investment
income. At December 31, 20X7 and 20X6, net appreciation of $864 and $953,
respectively, is available to be spent, of which $402 and $682, respectively, is
reported as restricted expendable net assets, and the balance is in unrestricted
net assets.
Restricted nonexpendable net assets as of December 31, 20X7 and 20X6, rep-
resent the principal amounts of permanent endowments, restricted to invest-
ment in perpetuity. Investment earnings from the authority's permanent en-
dowments are expendable to support these programs as established by the
contributor:
20X7 20X6
Program A activities $158 $158
Program B activities 176 176
Program C activities 423 423
Any activities of the authority 854 854
1,611 1,611
Endowment requiring income to be added to
original gift until the fund's value is $2,125 1,392 1,308
Total restricted nonexpendable net assets 3,003 2,919
3. Designated Net Assets
Of the $40,851 and $37,897 of unrestricted net assets reported in 20X7 and
20X6, respectively, $15,000 has been designated by the authority's board of
trustees for capital acquisitions. Designated funds remain under the control of
the board of trustees, which may at its discretion later use the funds for other
purposes.
4. Deposits and Investments
State law requires collateralization of all deposits with federal depository insur-
ance and other acceptable collateral in specific amounts. The authority's bylaws
require that all bank balances be insured or collateralized by U.S. government
securities held by the pledging financial institution's trust department in the
name of the authority.
The authority's investments generally are reported at fair value, as discussed
in note 1. At December 31, 20X7 and 20X6, the authority had the following
investments and maturities, all of which were held in the authority's name by
a custodial bank that is an agent of the authority:13
13 This illustrative note presents interest rate information using the segmented time distribution
method. Other methods for illustrating interest rate information are described in paragraph 15 of
GASB Statement No. 40, Deposit and Investment Risk Disclosures—an amendment of GASB Statement
No. 3.
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December 31, 20X7 Investment Maturities (in Years)
Investment Type
Carrying
Amount
Less
Than 1 1–5 6–10
More
Than 10
U.S. Treasuries $21,7749 $XXX $XXX $XXX $XXX
Federal National
Mortgage Association 3,580 XXX XXX XXX XXX
Government National
Mortgage Association 3,5806 XXX XXX XXX XXX
Total $28,934 $XXX $XXX $XXX $XXX
December 31, 20X6 Investment Maturities (in Years)
Investment Type
Carrying
Amount
Less
Than 1 1–5 6–10
More
Than 10
U.S. Treasuries $20,039 $XXX $XXX $XXX $XXX
Federal National
Mortgage Association 3,365 XXX XXX XXX XXX
Government National
Mortgage Association 3,366 XXX XXX XXX XXX
Total $26,770 $XXX $XXX $XXX $XXX
Interest Rate Risk. The authority does not have a formal investment policy that
limits investment maturities as a means of managing its exposure to fair value
losses arising from changing interest rates.
Credit Risk. Statutes authorize the authority to invest in obligations of the
U.S. Treasury, agencies, and instrumentalities, commercial paper rated A-1 by
Standard & Poor's Corporation or P-1 by Moody's Commercial Paper Record,
and bankers' acceptances. However, the authority's bylaws require that invest-
ments be made only in U.S. government obligations held by the authority's
third-party agent. As of December 31, 20X7 and 20X6, the authority's invest-
ments in Federal National Mortgage Association were rated AAA by Standard
and Poor's and Fitch Ratings and Aaa by Moody's Investor Services.
Concentration of Credit Risk. The authority places no limit on the amount it
may invest in any 1 issuer. More than 5 percent of the authority's investments
at December 31, 20X7 and 20X6 are invested in the Federal National Mortgage
Association. These investments are 12.37 percent and 12.57 percent, respec-
tively, of the authority's total investments at December 31, 20X7 and 20X6.
The carrying amounts of deposits and investments are included in the author-
ity's balance sheets as follows:
20X7 20X6
Carrying amount
Deposits $5,021 $6,539
Investments 28,934 26,770
$33,955 $33,309
Included in the following balance sheet captions
Cash and cash equivalents $7,136 $7,557
Short term investments 3,142 3,423
Noncurrent cash and investments:
Other long term investments 2,605 1,327
Restricted by contributors and grantors for
capital acquisitions and research 1,124 1,078
Internally designated for capital acquisitions 15,000 15,000
Held by trustee for debt service 1,945 2,005
Principal of permanent endowments 3,003 2,919
$33,955 $33,309
AAG-HCO APP A
P1: PjU
ACPA125-AppA(ii) ACPA125.cls February 25, 2010 16:35
278 Health Care Entities
5. Charity Care
Charges excluded from revenue under the authority's charity care policy were
$7,100 and $6,845 for 20X7 and 20X6, respectively.
6. Accounts Receivable and Payable
Patient accounts receivable and accounts payable (including accrued expenses)
reported as current assets and liabilities by the authority at December 31, 20X7
and 20X6 consisted of these amounts:
Patient Accounts Receivable
20X7 20X6
Receivable from patients and their insurance carriers $13,976 $11,868
Receivable from Medicare 4,286 3,002
Receivable from Medicaid 3,697 3,897
Total patient accounts receivable 21,959 18,767
Less allowance for uncollectibles amounts 2,125 2,040
Patient accounts receivable, net $19,834 $16,727
Accounts Payable and Accrued Expenses
20X7 20X6
Payable to employees (including payroll taxes) $2,437 $1,970
Payable to suppliers 2,481 2,591
Other 27 14
Total accounts payable and accrued expenses $4,945 $4,575
7. Capital Assets
Capital asset additions, retirements, and balances for the years ended Decem-
ber 31, 20X7 and 20X6 were as follows:
Balance
December 31,
20X6 Additions Retirements
Balance
December 31,
20X7
Land14 $3,590 — — $3,590
Land improvements 645 17 — 662
Buildings and
improvements 29,265 965 (810) 29,420
Equipment 30,375 3,547 (1,860) 32,062
Totals at historical
cost $63,875 $4,529 ($2,670) $65,734
Less accumulated
depreciation for:
Land improvements (291) (65) — (356)
Buildings and
improvements (5,352) (582) 810 (5,124)
Equipment (15,314) (3,418) 1,860 (16,872)
Total accumulated
depreciation (20,957) (4,065) 2,670 (22,352)
Capital assets, net $42,918 $464 $0 $43,382
14 When present, construction-in-progress should be reported in a separate line in this sched-
ule. (See the GASB staff document Comprehensive Implementation Guide—2005, item 7.353). See
paragraph 1.12 in this guide regarding references to GASB staff Implementation Guides. Also, GASB
Statement No. 34 paragraph 20 requires nondepreciable capital assets to be shown separately on the
face of the balance sheet when these balances are significant.
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Balance
December 31,
20X5 Additions Retirements
Balance
December 31,
20X6
Land $3,590 — — $3,590
Land improvements 608 112 (75) 645
Buildings and
improvements 29,187 78 — 29,265
Equipment 26,710 3,921 (256) 30,375
Totals at historical
cost $60,095 $4,111 ($331) $63,875
Less accumulated
depreciation for:
Land improvements (309) (57) 75 (291)
Buildings and
improvements (4,826) (526) — (5,352)
Equipment (12,515) (3,055) 256 (15,314)
Total accumulated
depreciation (17,650) (3,638) 331 (20,957)
Capital assets, net $42,445 $473 $0 $42,918
8. Long Term Debt and Other Noncurrent Liabilities
A schedule of changes in the authority's noncurrent liabilities for 20X7 and
20X6 follows:
Balance
December 31,
20X6 Additions Reductions
Balance
December 31,
20X7
Amounts
Due Within
One Year
Bonds and Notes
Payable:
Revenue notes $18,714 — ($457) $18,257 $620
Mortgage loan 1,808 — (99) 1,709 99
Note payable 570 — (464) 106 106
Total long term
debt 21,092 — (1,020) 20,072 825
Capital lease
obligations 808 510 (468) 850 425
Other Liabilities:
Compensated
absences 2,625 662 (6) 3,281 —
Net pension
obligation 65 15 — 80 See note 9
Total other
liabilities 2,690 677 (6) 3,361 —
Total noncurrent
liabilities $24,590 $1,187 ($1,494) $24,283 $1,250
(continued)
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Balance
December 31,
20X5 Additions Reductions
Balance
December 31,
20X6
Amounts
Due Within
One Year
Bonds and Notes
Payable:
Revenue notes 19,568 — (854) 18,714 457
Mortgage loan 1,907 — (99) 1,808 99
Note payable 1,045 — (475) 570 464
Total long term
debt 22,520 — (1,428) 21,092 1,020
Capital lease
obligations 1,276 — (468) 808 468
Other Liabilities:
Compensated
absences 2,400 236 (11) 2,625 —
Net pension
obligation 49 16 — 65 See note 9
Total other
liabilities 2,449 252 (11) 2,690 —
Total
noncurrent
liabilities $26,245 $252 ($1,907) $24,590 $1,488
Long term debt. The terms and due dates of the authority's long term debt,
including capital lease obligations, at December 31, 20X7 and 20X6, follow:
 7.25 percent revenue notes, due November 1, 20Z7, collateralized
by a pledge of the authority's gross receipts. Thus all operating and
nonoperating revenues of the authority are similarly pledged.
 9.25 percent mortgage loan, due January 20Y4, collateralized by
a mortgage on property and equipment with a depreciated cost of
$1,530 at December 31, 20X7
 9.75 percent note payable, due March 20X8, unsecured
 Capital lease obligations, at varying rates of imputed interest from
9.8 percent to 12.3 percent collateralized by leased equipment with
cost of $1,275 at December 31, 20X7
Under the terms of the revenue note indenture, the authority is required to
maintain certain deposits with a trustee. Such deposits are included with re-
stricted cash and investments in the balance sheet. The revenue note indenture
also places limits on the incurrence of additional borrowings and requires that
the authority satisfy certain measures of financial performance as long as the
notes are outstanding.
Scheduled principal and interest repayments on long term debt and payments
on capital lease obligations are as follows:
Long Term Debt Capital Lease Obligations
Year Ending December 31: Principal Interest Principal Interest
20X8 $825 $553 $425 $58
20X9 775 487 213 27
20Y0 836 465 212 13
20Y1 900 448
20Y2 972 432
20Y3–20Y7 5,764 1,769
20Y8–20Z2 4,824 1,492
20Z3–20Z7 5,176 1,116
Total $20,072 $6,762 $850 $98
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9. Commitments under Noncancelable Operating Leases
The authority is committed under various noncancelable operating leases, all of
which are for equipment and computers. These expire in various years through
20Y9. Future minimum operating lease payments are as follows:
Year ending December 31:
20X8 $3,109
20X9 2,898
20Y0 2,795
20Y1 2,780
20Y2 2,575
20Y3–20Y7 4,215
20Y8–20Y9 1,065
Total $19,437
10. Pension Plan15
Plan description. Sample Hospital Pension Plan (SHPP) provides retirement
and disability benefits, annual cost-of-living adjustments, and death benefits
to plan members and beneficiaries. SHPP is affiliated with County Employees
Pension Plan (CEPP), an agent multiple-employer pension plan administered
by the Union Retirement System. Article 39 of the Regulations of the State
of Union assigns the authority to establish and amend the benefit provisions
of the plans that participate in CEPP to the respective employer entities; for
CEPP, that authority rests with the County of Feeling, Union. The Union Retire-
ment System issues a publicly available financial report that includes financial
statements and required supplementary information for SHPP. That report
may be obtained by writing to Union Retirement System, State Government
Lane, Anytown, Union 01000 or by calling 1-800-555-PLAN.
Funding policy. The contribution requirements of plan members and the au-
thority are established and may be amended by the CEPP board of trustees.
Plan members are required to contribute 7.8 percent of their annual covered
salary. The authority is required to contribute at an actuarially determined
rate; the current rate for both 20X7 and 20X6 is 11.9 percent of annual covered
payroll.
Annual pension cost and net pension obligation. The authority's annual pension
cost and net pension obligation to SHPP for 20X7 and 20X6 were as follows:
20X7 20X6
Annual required contribution $26 $23
Interest on net pension obligation 3 2
Adjustment to annual required contribution (3) (2)
Annual pension cost 26 23
Contributions made (11) (7)
Increase (decrease) in net pension obligation 15 16
Net pension obligation beginning of year 65 49
Net pension obligation, end of year $80 $65
15 The preparer of the financial statements should consider the need for required supplementary
information as required by GASB Statement No. 27, Accounting for Pensions by State and Local
Governmental Employers, paragraph 22.
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The annual required contribution for the current year was determined as part of
the December 31, 20X6, actuarial valuation using the entry age actuarial cost
method. The actuarial assumptions included (a) 7.5 percent investment rate
of return (net of administrative expenses) and (b) projected salary increases
ranging from 5.5 percent to 9.5 percent per year. Both (a) and (b) included an
inflation component of 5.5 percent. The actuarial assumptions also include a
2 percent per year cost-of-living adjustment. The actuarial value of assets was
determined using techniques that smooth the effects of short term volatility
in the market value of investments over a 4 year period. The same actuarial
assumptions were used to determine the actuarial required contributions for
20X6. The unfunded actuarial accrued liability is being amortized as a level
percentage of projected payroll on an open basis. The remaining amortization
period at December 31, 20X6, was 23 years.
Three-Year Trend Information
Fiscal Year Ending
Annual
Pension Cost
(APC)
Percentage
of APC
Contributed
Net Pension
Obligation
12/31/X5 $20 94% $49
12/31/X6 23 30 65
12/31/X7 26 42 80
11. Postretirement Plan‡‡
In addition to the pension benefits previously described, the authority provides
postretirement health care benefits, in accordance with the authority's bylaws,
to all employees who retire from the authority on or after attaining age 60 with
at least 15 years of service. Currently 250 retirees (245 in 20X6) meet these
eligibility requirements. The authority reimburses 75 percent of the amount of
validated claims for medical, dental, and hospitalization costs incurred by pre-
Medicare retirees and their dependents. The authority also reimburses a fixed
amount of $25 per month for a Medicare supplement for each retiree eligible
for Medicare. Expenses for postretirement health care benefits are recognized
as retirees report claims and include a provision for estimated claims incurred
but not yet reported to the authority. Expenses of $764 were recognized for
postretirement health care in 20X7; expenses recognized in 20X6 were $636.
‡‡ In 2004, the GASB issued GASB Statement No. 45 that would supersede or amend previous
authoritative guidance on accounting and financial reporting for an employer's OPEB expense and
related information, including GASB Statement No. 12. GASB Statement No. 45 requires reporting
of the annual cost of OPEB, and the outstanding obligations and commitments related to OPEB in
essentially the same manner as required for pensions in GASB Statement No. 27. Paragraphs 24–25
of GASB Statement No. 45 require disclosures in the notes to the financial statements for OPEB plans.
Conforming changes to modify these illustrative financial statements to reflect the issuance of GASB
Statement No. 45 will be made in a future edition of this guide.
GASB issued Technical Bulletin No. 2006-1, Accounting and Financial Reporting by Employers
and OPEB Plans for Payments from the Federal Government Pursuant to the Retiree Drug Subsidy
Provisions of Medicare Part D, in June 2006. This technical bulletin is effective immediately, except for
portions of answers pertaining specifically to measurement, recognition, or required supplementary
information requirements of GASB Statement No. 43, Financial Reporting for Postemployment Benefit
Plans Other Than Pension Plans, or GASB Statement No. 45. Those provisions should be applied
simultaneously with the implementation of GASB Statement Nos. 43 or 45. This technical bulletin
clarifies the application of existing standards of accounting and financial reporting to payments that
an employer or a defined benefit OPEB plan receives from the federal government pursuant to the
retiree drug subsidy provisions of Medicare Part D, as established in the Medicare Prescription Drug,
Improvement, and Modernization Act of 2003.
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Approximately $64 of the $128 increase in expenses over the previous year was
caused by the addition of dental benefits, effective July 1, 20X7.
Note: Although not presented in these sample illustrative financial statements,
other disclosures required by GASB pronouncements may be applicable, includ-
ing the following:
 Short term debt (GASB Statement No. 38 paragraph 12)
 Interfund balances and transfers (GASB Statement No. 38 para-
graph 14 when a governmental health care entity reports multiple
enterprise funds or is reported as an enterprise fund of a general
purpose government.)
 Segment information (GASB Statement No. 34, as amended, para-
graphs 122–123)
 Violations of finance-related legal or contractual provisions (GASB
Statement No. 38 paragraph 9)
 Risk financing (Requirements for disclosures about claims and
judgments and risk financing by governmental health care enti-
ties that retain a portion of risk for claims and judgments (in-
cluding malpractice claims and judgments) are provided in GASB
Statement No. 10, as amended). Additionally, GASB Statement
No. 34 paragraph 119 requires disclosure of certain information
about the long term portion of accrued claims and judgments, if
applicable.
Other required disclosures, which may be applicable and would be similar to
the disclosures contained in the notes to the sample illustrative financial state-
ments for a not-for-profit hospital, are not repeated here. They include the
following:
 Off-Balance Sheet Risk and Concentration of Credit Risk
 Fair Value of Financial Instruments
 Commitments and Contingencies
 Subsequent Events ††
 Net patient service revenue
 Related party transactions
 Description of Reporting Entity and Summary of Significant Ac-
counting Policies—Supplies, Net Patient Service Revenue, Charity
Care, Premium Revenue
†† See footnote †† in this paragraph.
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A NURSING HOME
Sample For-Profit Nursing Home, Inc.
Balance Sheets||
December 31, 20X5 and 20X4
20X5 20X4
Assets
Current assets:
Cash and cash equivalents $95,000 $129,000
Investments 150,000
Assets limited as to use 50,000 50,000
Patient accounts receivable, net of allowance for
doubtful accounts of $6,700 in 20X5 and $5,300
in 20X4 162,000 152,000
Estimated third-party payor settlements 71,000 62,000
Interest receivable 7,000
Supplies 47,000 43,000
Prepaid expenses 3,000 2,000
Deferred tax asset 12,000 14,000
Total current assets 597,000 452,000
Assets limited as to use, net of amount required
for current liabilities 173,000 150,000
Property and equipment:
Land 205,000 205,000
Land improvements 37,000 32,000
Buildings 1,399,000 1,399,000
Furniture, fixtures, and equipment 228,000 189,000
1,869,000 1,825,000
Less accumulated depreciation 210,000 141,000
Property and equipment, net 1,659,000 1,684,000
Other assets 150,000 127,000
Total assets $2,579,000 $2,413,000
|| See footnote || in "Illustrative Financial Statements for a Not-for-Profit Hospital."
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Sample For-Profit Nursing Home, Inc.
Balance Sheets—continued
December 31, 20X5 and 20X4
20X5 20X4
Liabilities and Shareholders' Equity
Current liabilities:
Current maturities of long term debt $50,000 $50,000
Accounts payable 78,000 52,000
Accrued expenses 175,000 188,000
Deposits from patients 50,000 45,000
Other current liabilities 74,000 15,000
Total current liabilities 427,000 350,000
Deferred tax liability 6,000 14,000
Long term debt, net of current maturities 1,700,000 1,750,000
Shareholders' equity:
Common stock $20 par value; authorized 5,000
shares; issued and outstanding 3,500 shares 70,000 70,000
Retained earnings 376,000 229,000
Total shareholders' equity 446,000 299,000
Total liabilities and shareholders' equity $2,579,000 $2,413,000
See accompanying notes to financial statements.
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Sample For-Profit Nursing Home, Inc.
Statements of Income and Retained Earnings
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Revenue:
Net patient service revenue $2,163,000 $1,949,000
Other revenue 67,000 22,000
Interest on investments held by trustee 13,000 7,000
Total revenue 2,243,000 1,978,000
Expenses:
Salaries and benefits 969,000 919,000
Medical supplies and drugs 511,000 499,000
Insurance and other 216,000 176,000
Provision for bad debts 92,000 83,000
Depreciation 69,000 57,000
Interest 164,000 172,000
Total expenses 2,021,000 1,906,000
Operating income 222,000 72,000
Nonoperating income:
Other interest income 5,000
Income before provision for income taxes 227,000 72,000
Provision for income taxes 80,000 29,000
Net income 147,000 43,000
Retained earnings, beginning of year 229,000 186,000
Retained earnings, end of year $376,000 $229,000
See accompanying notes to financial statements.
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Sample For-Profit Nursing Home, Inc.
Statements of Cash Flows
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Cash flows from operating activities:
Cash received from residents and third party
payors $2,019,000 $1,796,000
Cash received from others 67,000 22,000
Cash paid to employees and suppliers (1,679,000) (1,495,000)
Interest and dividends received, 10,000 10,000 10,000
Interest paid (160,000) (170,000)
Taxes paid (29,000) (30,000)
Deposits received from patients 35,000 15,000
Deposits refunded to patients (30,000) (20,000)
Net cash provided by operating activities 233,000 128,000
Cash flows from investing activities:
Purchase of investments (150,000)
Proceeds from sale of property 2,000
Capital expenditures (44,000) (79,000)
Purchase of assets limited as to use (23,000)
Net cash used in investing activities (217,000) (77,000)
Cash flows from financing activities:
Repayment of long term debt (50,000) (50,000)
Net cash used in financing activities (50,000) (50,000)
Net increase (decrease) in cash and cash
equivalents (34,000) 1,000
Cash and cash equivalents, beginning of year 129,000 128,000
Cash and cash equivalents, end of year $95,000 $129,000
Reconciliation of net income to net cash provided
by operating activities:
Net income $147,000 $43,000
Adjustments to reconcile net income to net cash
provided by operating activities:
Depreciation 69,000 57,000
Provision for bad debts 92,000 83,000
Loss on sale of property — 11,000
Change in deferred income taxes (6,000) (14,000)
(Increase) decrease in:
Patient accounts receivable (102,000) (41,000)
Other current assets (21,000) (15,000)
Estimated third-party payor settlements (9,000) (10,000)
Interest receivable (7,000) (3,000)
Other assets (7,000) (10,000)
Increase (decrease) in:
Accounts payable and accrued expenses 13,000 43,000
Deposits from patients 5,000 (5,000)
Other current liabilities 59,000 (11,000)
Net cash provided by operating activities $233,000 $128,000
See accompanying notes to financial statements.
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Sample For-Profit Nursing Home, Inc.
Notes to Financial Statements#
December 31, 20X5 and 20X4
1. Description of Organization and Summary of Significant
Accounting Policies16
Organization. The Sample Nursing Home, Inc. (the company) was incorporated
in New State in 20X1 and operates a 128-bed nursing home in Abacus, New
State. A summary of the company's significant accounting policies follows:
Use of estimates. The preparation of financial statements in conformity with
GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets
and liabilities at the date of the financial statements and the reported amounts
of revenues and expenses during the reporting period. Actual results could
differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments in
highly liquid debt instruments with an original maturity of three months or
less, excluding amounts whose use is limited by note indenture.
Investments. Investments in debt instruments, including assets limited as to
use, are classified as held-to-maturity because the company has the positive
intent and ability to hold the securities until maturity. Held-to-maturity secu-
rities are carried at cost adjusted for amortization of premiums and accretion
of discounts.
Assets limited as to use. Assets deposited with a trustee under terms of the
note indenture and assets set aside by the board of directors for capital im-
provements are classified as assets limited as to use. Amounts required to meet
current liabilities have been reclassified in the balance sheet.
Property and equipment. Property and equipment are recorded at cost. Depre-
ciation is calculated on the straight-line method over the estimated useful lives
of depreciable assets.
Bond issuance costs. Costs incurred in issuing the Series 20X1 bonds are being
amortized based on the effective interest method.
Net patient service revenue. Net patient service revenue is reported at the es-
timated net realizable amounts from residents, third-party payors, and others
for service rendered.
Revenue under third-party payor agreements is subject to audit and retroac-
tive adjustment. Provisions for estimated third-party payor settlements are
provided in the period the related services are rendered. Differences between
the estimated amounts accrued and interim and final settlements are reported
in operations in the year of settlement.
Income taxes. The provisions for income taxes are based on amounts estimated
to be currently payable and those deferred because of temporary differences
between the financial statement and tax bases of assets and liabilities. These
differences consist principally of bad debts and depreciation.
# See footnote # in "Illustrative Financial Statements for a Not-for-Profit Hospital."
16 FASB ASC 310-10-50 provides guidance on accounting policy disclosures about loans, trade
receivables, and doubtful accounts that should be included in the summary of significant accounting
policies.
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2. Assets Limited as to Use
Assets limited as to use include assets held by trustee under the Series 20X1
note indenture agreement at December 31, 20X5 and 20X4.
20X5 20X4
U.S. Government obligations $150,000 $130,000
Cash 24,000 21,000
Accrued interest income 2,000 2,000
176,000 153,000
Internally designated by the board of directors
for capital improvements
Certificate of deposit $45,000 $45,000
Accrued interest 2,000 2,000
47,000 47,000
$223,000 $200,000
3. Investments||||
4. Long Term Debt
Long term debt at December 31, 20X5 and 20X4, was as follows:
20X5 20X4
9.5 percent bonds payable to the City of Abacus,
maturing $50,000 annually through
November 1, 20YY, with a final maturity of $1
million on November 1, 20YY $1,750,000 $1,800,000
Less current maturities 50,000 50,000
$1,700,000 $1,750,000
The notes are collateralized by a first mortgage lien on all property and equip-
ment of the company and a security interest in all of its receipts. The note
indenture requires the maintenance of certain deposits with a trustee, which
are included in assets limited as to use.
Future maturities of long term debt as of December 31, 20X5, follow:
Year Ending December 31, Amount
20X6 $50,000
20X7 50,000
20X8 50,000
20X9 50,000
20Y0 50,000
Thereafter 1,500,000
Total $1,750,000
|||| In reporting disclosures about investments in securities, entities should comply primarily
with the requirements of FASB ASC 320-10-50. Other disclosure requirements may also be applicable.
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5. Income Taxes
The provisions for income taxes are as follows:##
20X5 20X4
Current:
Federal $72,000 $15,000
State 2,000
Total current 74,000 15,000
Deferred:
Federal 6,000 13,000
State 1,000
Total deferred 6,000 14,000
Total provision for income taxes $80,000 $29,000
Deferred income taxes are provided for the temporary differences between the
financial reporting basis and the tax basis of the company's assets and liabili-
ties.
For the years ended December 31, 20X5 and 20X4, the effective tax rate ap-
proximated the statutory rate of 34 percent and 40 percent, respectively.
The net current and noncurrent components of deferred income taxes recog-
nized in the balance sheet at December 31, 20X5 and 20X4, follows:
20X5 20X4
Net current assets $12,000 $14,000
Net noncurrent liabilities 6,000 14,000
$6,000 0
Management has determined that no valuation allowance related to deferred
tax assets is necessary at December 31, 20X5 and 20X4, respectively.
6. Concentration in State Medicaid Program
The company has 100 of its 128 beds designated for care of patients under
the state's Medicaid program. The current funding of that program is 90 days
## FASB ASC 740-10 includes guidance from FASB Interpretation No. 48, Accounting for Uncer-
tainty in Income Taxes—an interpretation of FASB Statement No. 109. This interpretation is effective
for fiscal years beginning after December 15, 2006. The interpretation clarifies the accounting for
uncertainty in income taxes recognized in an organization's financial statements in accordance with
FASB Statement No. 109, Accounting for Income Taxes. This interpretation prescribes a recognition
threshold and measurement attribute for the financial statement recognition, measurement and dis-
closures of a tax position taken or expected to be taken in a tax return. This interpretation also
provides guidance on derecognition, classification, interest and penalties, accounting in interim peri-
ods, disclosure, and transition.
However, FSP FIN 48-3, Effective Date of FASB Interpretation No. 48 for Certain Nonpublic
Enterprises, defers the effective date of that interpretation to fiscal years beginning after December
15, 2008, for certain nonpublic enterprises as defined by the glossary of FASB ASC 740-10, including
nonpublic not-for-profit health care entities. If a nonpublic health care entity decides to defer in accor-
dance with the FSP, it should disclose that fact and its accounting policy for evaluating uncertain tax
positions. Earlier application of FASB Interpretation No. 48 is permitted. Health care entities that
have already adopted the provisions of FASB Interpretation No. 48 are not eligible for the deferral.
This guidance is located in sections 15 and 65 of FASB ASC 740-10. The AICPA has prepared a prac-
tice guide to help in understanding the interpretation. The practice guide is available by following the
link "Professional Standards and Ethics" at http://tax.aicpa.org/Resources.
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behind filed claims. The current state budget has no provision for reducing that
lag and, although the proposed budget for 20X6 includes additional funding,
there is no assurance that the final budget will include the needed additional
funds.
7. Third Party Rate Adjustments and Revenue
Revenue from the Medicaid program accounted for approximately XX percent
for the year ended 20X5, and XX percent for the year ended 20X4, of the com-
pany's net patient revenue. Laws and regulations governing the Medicaid pro-
gram are extremely complex and subject to interpretation. As a result, there
is at least a reasonable possibility that recorded estimates will change by a
material amount in the near term. The 20X5 net patient service revenue in-
creased approximately $XXX due to removal of allowances previously estimated
that are no longer necessary as a result of final settlements and years that are
no longer subject to audits, reviews, and investigations. The 20X4 net patient
service revenue decreased approximately $XXX due to prior-year retroactive
adjustments in excess of amounts previously estimated.
8. Risks and Uncertainties Disclosures***
9. Pension Plan∗∗∗
10. Postretirement Benefits∗∗∗
11. Fair Values of Financial Instruments∗∗∗
12. Concentrations of Credit Risk∗∗∗
*** The disclosures contained in these notes would be similar to the disclosures contained in the
notes to the financial statements for the not-for-profit hospital and, therefore, are not repeated here.
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A CONTINUING CARE
RETIREMENT COMMUNITY
Sample Not-for-Profit Continuing Care Retirement Community
Balance Sheets†
December 31, 20X5 and 20X4
20X5 20X4
Assets
Current assets:
Cash $375,000 $330,000
Assets limited as to use 265,000 170,000
Accounts receivable, net of allowance for
doubtful accounts of $4,000 in 20X5 and
$5,000 in 20X4 187,000 197,000
Supplies 40,000 21,000
Prepaid expenses 115,000 73,000
Total current assets 982,000 791,000
Assets limited as to use, net of amount required
for current liabilities 1,865,000 1,583,000
Property and equipment, net 14,893,000 15,280,000
Deferred financing costs, net of accumulated
amortization of $28,000 in 20X5 and $21,000
in 20X4 83,000 90,000
Total assets $17,823,000 $17,744,000
Liabilities and Net Assets
Liabilities:
Current maturities of long term debt $90,000 $77,000
Accounts payable 180,000 174,000
Accrued expenses 161,000 178,000
Deposits on unoccupied units 22,000 40,000
Total current liabilities 453,000 469,000
Long term debt, less current maturities 8,871,000 8,935,000
Refundable fees 59,000 144,000
Estimated obligation to provide future services,
in excess of amounts received or to be
received 88,000 100,000
Deferred revenue from advance fees 6,304,000 6,585,000
Total liabilities 15,775,000 16,233,000
Net assets:
Unrestricted 1,286,000 833,000
Temporarily restricted 311,000 294,000
Permanently restricted 451,000 384,000
Total net assets 2,048,000 1,511,000
Total liabilities and net assets $17,823,000 $17,744,000
See accompanying notes to financial statements.
† See footnote † in "Illustrative Financial Statements for a Not-for-Profit Hospital."
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Sample Not-for-Profit Continuing Care Retirement Community
Statements of Operations
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Revenue, gains, and other support:
Resident services, including amortization of
advance fees of $935,000 in 20X5 and $915,000
in 20X4 $3,946,000 $3,152,000
Patient revenue from nonresidents 249,000 275,000
Change in obligation to provide future services 12,000 (82,000)
Contributions 54,000 39,000
Net assets released from restrictions used for
operations 24,000 50,000
Investment income 29,000 30,000
Other 75,000 68,000
Total revenue, gains, and other support 4,389,000 3,532,000
Expenses:
Salaries and benefits 1,708,000 1,250,000
Medical supplies and drugs 543,000 742,000
Insurance 291,000 311,000
Depreciation 452,000 447,000
Interest 967,000 955,000
Total expenses 3,961,000 3,705,000
Operating income (loss) 428,000 (173,000)
Net assets released from restriction—purchase of
equipment 25,000 45,000
Increase (decrease) in unrestricted net assets $453,000 $(128,000)
See accompanying notes to financial statements.
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Sample Not-for-Profit Continuing Care Retirement Community
Statements of Changes in Net Assets
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Unrestricted net assets:
Operating income (loss) $428,000 $(173,000)
Net assets released from restriction—purchase of
equipment 25,000 45,000
Increase (decrease) in unrestricted net assets 453,000 (128,000)
Temporarily restricted net assets:
Contributions 40,000 15,000
Net assets released from restrictions used for
operations (24,000) (50,000)
Net assets released from restriction—purchase of
equipment (25,000) (45,000)
Investment income 26,000 15,000
Increase (decrease) in temporarily restricted net
assets 17,000 (65,000)
Permanently restricted net assets:
Contributions 67,000 52,000
Increase in permanently restricted net assets 67,000 52,000
Increase (decrease) in net assets 537,000 (141,000)
Net assets, beginning of year 1,511,000 1,652,000
Net assets, end of year $2,048,000 $1,511,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Continuing Care Retirement Community
Statements of Cash Flows
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Cash flows from operating activities:
Cash received from residents and third party
payors $3,252,000 $2,341,000
Advance fees received 654,000 857,000
Other receipts from operations 75,000 68,000
Investment income received 68,000 53,000
Contributions received 51,000 44,000
Cash paid to employees and suppliers (2,576,000) (2,040,000)
Interest paid (950,000) (945,000)
Net cash provided by operating activities 574,000 378,000
Cash flows from investing activities:
Purchase of property and equipment (65,000) (250,000)
Purchase of assets limited as to use (377,000) 229,000
Net cash used in investing activities (442,000) (21,000)
Cash flows from financing activities:
Permanently restricted funds received 67,000 52,000
Refunds of deposits and refundable fees (103,000) (52,000)
Proceeds from issuance of long term debt 26,000
Principal payments of long term debt (77,000) (307,000)
Net cash used in financing activities (87,000) (307,000)
Net increase in cash 45,000 50,000
Cash, beginning of year 330,000 280,000
Cash, end of year $375,000 $330,000
Reconciliation of change in net assets to net
cash provided by operating activities:
Change in net assets $537,000 $(141,000)
Adjustments to reconcile change in net assets to
net cash provided by operating activities:
Advance fees received 654,000 857,000
Restricted net assets received (67,000) (52,000)
Amortization of advance fees (935,000) (915,000)
Loss (gain) on obligation to provide future
services (12,000) 82,000
Depreciation 452,000 447,000
Amortization of deferred financing costs 7,000 34,000
Provision for bad debts 3,000 3,000
(Increase) decrease in:
Accounts receivable 7,000 (33,000)
Other assets (61,000) (4,000)
Increase (decrease) in:
Accounts payable and accrued expenses (11,000) 100,000
Net cash provided by operating activities $574,000 $378,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Continuing Care Retirement Community
Notes to Financial Statements17,#
December 31, 20X5 and 20X4
1. Description of Organization and Summary of Significant
Accounting Policies†††,18
Organization. The Sample Continuing Care Retirement Community (CCRC).
The CCRC is a nonprofit organization that principally provides housing, health
care, and other related services to residents through the operation of a retire-
ment facility containing 249 apartments and a 78-bed health care facility lo-
cated in Evergreen Park, Illinois. The CCRC was incorporated in Illinois in
20X1. A summary of significant accounting policies follows.
Use of estimates. The preparation of financial statements in conformity with
generally accepted accounting principles requires management to make esti-
mates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
Investments. Investments, which consist of U.S. Treasury obligations, are mea-
sured at fair value in the balance sheet. Investment income (including realized
gains and losses on investments, interest, and dividends) is included in operat-
ing income (loss) unless restricted by donor or law. Unrealized gains and losses
on investments, if any, are excluded from operating income (loss).
Deferred financing costs. Deferred financing costs are amortized using the ef-
fective interest method over the term of the related financing agreement.
Advance fees. Fees paid by a resident upon entering into a continuing care con-
tract, net of the portion thereof that is refundable to the resident, are recorded
as deferred revenue and are amortized to income using the straight-line method
over the estimated remaining life expectancy of the resident.
Obligation to provide future services. The CCRC annually calculates the present
value of the net cost of future services and the use of facilities to be provided to
current residents and compares that amount with the balance of deferred rev-
enue from advance fees. If the present value of the net cost of future services and
the use of facilities exceeds the deferred revenue from advance fees, a liability
is recorded (obligation to provide future services and use of facilities) with the
corresponding charge to income. The obligation is discounted at nine percent,
based on the expected long term rate of return on government obligations.
Donor restrictions. The CCRC reports gifts of cash and other assets as restricted
support if they are received with donor stipulations that limit the use of the
donated assets. When a donor restriction expires (that is, when a stipulated
17 SOP 00-1, Auditing Health Care Third-Party Revenues and Related Receivables (AICPA, Tech-
nical Practice Aids, AUD sec. 14,360), provides auditors with guidance regarding uncertainties in
health care revenue recognition and includes a sample disclosure in paragraph .37 of the SOP for
material differences between an original estimate and subsequent revisions regarding third-party
payments. SOP 00-1 is included in appendix D to this guide.
# See footnote # in "Illustrative Financial Statements for a Not-for-Profit Hospital."
††† Does not include all disclosures common to all health care entities.
18 FASB ASC 310-10-50 provides guidance on accounting policy disclosures about loans, trade
receivables, and doubtful accounts that should be included in the summary of significant accounting
policies.
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time restriction ends or a purpose restriction is accomplished), temporarily
restricted net assets are reclassified as unrestricted net assets and reported
in the statement of operations as net assets released from restrictions. Donor-
restricted contributions whose restrictions are met within the same year as
received are reflected as unrestricted contributions in the accompanying finan-
cial statements.
The CCRC reports gifts of property and equipment (or other long-lived assets) as
unrestricted support unless explicit donor stipulations specify how the donated
assets must be used. Gifts of long-lived assets with explicit restrictions that
specify how the assets are to be used and gifts of cash or other assets that
must be used to acquire long-lived assets are reported as restricted support.
Absent explicit donor stipulations about how long those long-lived assets must
be maintained, the CCRC reports expirations of donor restrictions when the
donated or acquired long-lived assets are placed in service.
Income taxes. The CCRC has been recognized by the IRS as a not-for-profit
corporation as described in Section 501(c)(3) of the Internal Revenue Code (IRC)
and is exempt from federal income taxes pursuant to Section 501(a) of the IRC.
Property and equipment. Property and equipment are stated at cost. Donated
property is recorded at its estimated fair value at the date of receipt. Deprecia-
tion is computed on the straight-line method based on the following estimated
useful lives:
Land improvements 20 years
Buildings and improvements 40 years
Furniture and equipment 5–15 years
Operating income (loss). The statement of operations includes operating income
(loss). Changes in unrestricted net assets which are excluded from operating
income (loss), consistent with industry practice, include unrealized gains and
losses on investments other than trading securities, permanent transfers of
assets to and from affiliates for other than goods and services, and contributions
of long-lived assets (including assets acquired using contributions which by
donor restriction were to be used for the purposes of acquiring such assets).
2. Property and Equipment
A summary of property and equipment at December 31, 20X5 and 20X4, follows:
20X5 20X4
Land $557,000 $557,000
Land improvements 205,000 203,000
Buildings and improvements 14,573,000 14,564,000
Furniture and equipment 752,000 698,000
16,087,000 16,022,000
Less accumulated depreciation (1,194,000) (742,000)
$14,893,000 $15,280,000
3. Temporarily Restricted Net Assets
Temporarily restricted net assets are available for the following purposes:
20X5 20X4
Purchase of equipment $169,000 $152,000
Charity care 142,000 142,000
$311,000 $294,000
AAG-HCO APP A
P1: G.Shankar
ACPA125-AppA(iii) ACPA125.cls February 25, 2010 16:37
298 Health Care Entities
Net assets were released from donor restrictions by incurring expenses sat-
isfying the restricted purposes or by occurrence of other events specified by
donors:
20X5 20X4
Charity care $24,000 $50,000
Purchase of equipment $25,000 $45,000
4. Permanently Restricted Net Assets
Permanently restricted net assets are restricted to investment in perpetuity,
the income from which is expendable to support:
20X5 20X4
Charity care $168,000 $168,000
Community activities 283,000 216,000
$451,000 $384,000
5. Long Term Debt
Long term debt at December 31, 20X5 and 20X4, is as follows:
20X5 20X4
10.75 percent mortgage note payable $8,901,000 $8,965,000
Notes payable to bank—unsecured 34,000 14,000
Other 26,000 33,000
8,961,000 9,012,000
Less current maturities 90,000 77,000
$8,871,000 $8,935,000
The mortgage note is payable in consecutive monthly installments of principal
and interest of $85,425 to May 20XX. The note is collateralized by a first mort-
gage on property and equipment with a depreciated cost at December 31, 20X5,
of $14,893,000 and by a pledge of all operating revenue.
As required by the mortgage note agreement, the CCRC established an initial
debt service reserve fund of $1,000,000 at April 15, 20X3. All resident fees
received thereafter, net of resident fee refunds and debt service payments not to
exceed $300,000 annually in the first 4 years and $200,000 annually thereafter,
are to be added to the debt service reserve fund until the total sum of $2,050,000
is accumulated. Since June 1, 20X4, the CCRC has been required to deliver
to the trustee $5,500 per month to establish maintenance reserves until the
aggregate of such payments equals a residential unit reserve and a health care
center reserve of $240,000 and $90,000, respectively. At December 31, 20X5 and
20X4, the trustee held investments aggregating $2,130,000 and $1,753,000,
respectively. Such amount has been classified as assets limited as to use.
Scheduled annual principal maturities of long term debt for the next five years
are as follows:
Year Ending December 31, Amount
20X6 $90,000
20X7 90,000
20X8 95,000
20X9 105,000
20Y0 105,000
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6. Classification of Expenses
20X5 20X4
Program activities 3,368,000 3,135,000
General and administrative 593,000 570,000
$3,961,000 $3,705,000
7. Assets Limited as to Use∗∗∗
8. Risks and Uncertainties Disclosures∗∗∗
9. Pension Plan∗∗∗
10. Postretirement Benefits∗∗∗
11. Fair Values of Financial Instruments∗∗∗
12. Concentrations of Credit Risk∗∗∗
13. Investments∗∗∗
∗∗∗ See footnote ∗ ∗ ∗ in "Illustrative Financial Statements for a Nursing Home."
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A HOME HEALTH AGENCY
Sample Not-for-Profit Home Health Agency
Balance Sheets‡,||
December 31, 20X5 and 20X4
20X5 20X4
Assets
Current assets:
Cash and cash equivalents $74,000 $41,000
Investments 147,000 137,000
Accounts receivable, net of allowance for
doubtful accounts of $61,000 in 20X5 and
$30,000 in 20X4 752,000 476,000
Other receivables 27,000 22,000
Total current assets 1,000,000 676,000
Investments 100,000 100,000
Equipment:
Medical and office equipment 56,000 39,000
Vehicles 50,000 37,000
106,000 76,000
Less accumulated depreciation (45,000) (24,000)
Equipment, net 61,000 52,000
Deferred finance charges, net of accumulated
amortization of $15,000 in 20X5 and $10,000
in 20X4 20,000 25,000
Total assets $1,181,000 $853,000
Liabilities and Net Assets
Current liabilities:
Current maturities of long term debt $13,000 $13,000
Accounts payable 40,000 21,000
Accrued payroll and vacation costs 496,000 352,000
Estimated third-party payor settlements 28,000 31,000
Advances from third-party payors 70,000 66,000
Total current liabilities 647,000 483,000
Long term debt, less current maturities 105,000 118,000
Total liabilities 752,000 601,000
Net assets:
Unrestricted 330,000 167,000
Temporarily restricted 9,000 5,000
Permanently restricted 90,000 80,000
Total net assets 429,000 252,000
Total liabilities and net assets $1,181,000 $853,000
See accompanying notes to financial statements.
‡ See footnote ‡ in this paragraph.
|| See footnote || in "Illustrative Financial Statements for a Not-for-Profit Hospital."
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FORMAT A
Sample Not-for-Profit Home Health Agency
Statements of Operations
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Revenue, gains, and other support:
Net patient service revenue $4,042,000 $2,687,000
Contributions 5,000 22,000
Net assets released from restrictions 5,000 —
Investment income 13,000 6,000
Other revenue 27,000 32,000
Total revenue, gains, and other support 4,092,000 2,747,000
Expenses:
Salaries and benefits 2,714,000 1,835,000
Medical supplies and drugs 1,042,000 675,000
Insurance and other 90,000 83,000
Provision for bad debts 46,000 21,000
Depreciation 21,000 15,000
Interest 16,000 19,000
Total expenses 3,929,000 2,648,000
Excess of revenue over expenses and change in
unrestricted net assets $163,000 $99,000
See accompanying notes to financial statements.
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FORMAT B
Sample Not-for-Profit Home Health Agency
Statements of Operations
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Revenue, gains, and other support:
Net patient service revenue $4,042,000 $2,687,000
Contributions 5,000 22,000
Net assets released from restrictions 5,000 —
Other revenue 27,000 32,000
Total revenue, gains, and other support 4,079,000 2,741,000
Expenses:
Salaries and benefits 2,714,000 1,835,000
Medical supplies and drugs 1,042,000 675,000
Insurance and other 90,000 83,000
Provision for bad debts 46,000 21,000
Depreciation 21,000 15,000
Interest 16,000 19,000
Total expenses 3,929,000 2,648,000
Operating income 150,000 93,000
Other income:
Investment income 13,000 6,000
Excess of revenue over expenses and change in
unrestricted net assets $163,000 $99,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Home Health Agency
Statements of Changes in Net Assets
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Unrestricted net assets:
Excess of revenue over expenses $163,000 $99,000
Increase in unrestricted net assets 163,000 99,000
Temporarily restricted net assets:
Contributions 9,000 5,000
Net assets released from restrictions (5,000) —
Increase in temporarily restricted net assets 4,000 5,000
Permanently restricted net assets:
Contributions 10,000 6,000
Increase in permanently restricted net assets 10,000 6,000
Increase in net assets 177,000 110,000
Net assets, beginning of year 252,000 142,000
Net assets, end of year $429,000 $252,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Home Health Agency
Statements of Cash Flows
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Cash flows from operating activities:
Cash received from patients and third party
payors $3,721,000 $2,542,000
Other receipts from operations 22,000 32,000
Cash paid to employees and suppliers (3,679,000) (2,541,000)
Interest paid (11,000) (14,000)
Nonoperating revenue 23,000 22,000
Net cash provided by operating activities 76,000 41,000
Cash flows from investing activities:
Purchase of equipment (30,000) (19,000)
Purchase of investments (10,000) (15,000)
Net cash used in investing activities (40,000) (34,000)
Cash flows from financing activities:
Proceeds from contributions restricted for:
Endowment 10,000 6,000
Other financing activities:
Payment of long term debt (13,000) —
Net cash provided by (used in) financing
activities (3,000) 6,000
Net increase in cash and cash equivalents 33,000 13,000
Cash and cash equivalents, beginning of year 41,000 28,000
Cash and cash equivalents, end of year $74,000 $41,000
Reconciliation of change in net assets to net cash
provided by operating activities:
Change in net assets $177,000 $110,000
Adjustments to reconcile change in net assets to
net cash provided by operating activities:
Increase in permanently restricted net assets (10,000) (6,000)
Provision for bad debts 46,000 21,000
Depreciation 21,000 15,000
Amortization of deferred financing charges 5,000 5,000
(Increase) decrease in:
Accounts receivable (322,000) (150,000)
Other receivables (5,000) 4,000
Increase (decrease) in:
Accounts payable, accrued payroll, and
vacation costs 163,000 38,000
Estimated third-party payor settlements 1,000 4,000
Net cash provided by operating activities $76,000 $41,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Home Health Agency
Notes to Financial Statements#
Years Ended December 31, 20X5 and 20X4
1. Description of Organization and Summary of Significant
Accounting Policies19
Organization. The Sample Home Health Agency (the agency) was incorporated
in 20X0 in New State as a not-for-profit corporation. The agency provides health
and supportive services to individuals at their homes, primarily in the New
State area.
Use of estimates. The preparation of financial statements in conformity with
generally accepted accounting principles requires management to make esti-
mates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments in
highly liquid debt instruments with an original maturity of three months or
less.
Investments. Investments, which consist of U.S. Treasury obligations, are mea-
sured at fair value in the balance sheet. Investment income (including realized
gains and losses on investments, interest and dividends) is included in excess
of revenues over expenses unless restricted by donor or law. Unrealized gains
and losses on investments, if any, are excluded from excess of revenues over
expenses.
Equipment. Equipment is recorded at cost. Depreciation is computed using the
straight-line method over the estimated useful lives of the assets.
Deferred financing costs. Deferred financing costs are being amortized using
the effective interest method over the term of the related financing agreement.
Donor restrictions. The agency reports gifts of cash and other assets as re-
stricted support if they are received with donor stipulations that limit the use
of the donated assets. When a donor restriction expires, that is, when a stipu-
lated time restriction ends or purpose restriction is accomplished, temporarily
restricted net assets are reclassified as unrestricted net assets and reported
in the statement of operations as net assets released from restrictions. When
long-lived assets are placed in service, thus satisfying purpose restrictions,
the amount is included as a change in net assets, restricted and unrestricted.
Donor-restricted contributions whose restrictions are met within the same year
as received are reflected as unrestricted contributions in the accompanying fi-
nancial statements.
The agency reports gifts of equipment (or other long-lived assets) as unre-
stricted support unless explicit donor stipulations specify how the donated
assets must be used. Gifts of long-lived assets with explicit restrictions that
specify how the assets are to be used and gifts of cash or other assets that
# See footnote # in "Illustrative Financial Statements for a Not-for-Profit Hospital."
19 FASB ASC 310-10-50 provides guidance on accounting policy disclosures about loans, trade
receivables, and doubtful accounts that should be included in the summary of significant accounting
policies.
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must be used to acquire long-lived assets are reported as restricted support.
Absent explicit donor stipulations about how long those long-lived assets must
be maintained, the agency reports expirations of donor restrictions when the
donated or acquired long-lived assets are placed in service.
Net patient service revenue. Net patient service revenue represents the esti-
mated net realizable amounts from patients, third-party payors, and others for
services rendered.
Charity care. The agency has a policy of providing charity care to patients who
are unable to pay. Such patients are identified based on financial information
obtained from the patient and subsequent analysis. Because the agency does
not expect payment, estimated charges for charity care are not included in
revenue.
Income taxes. The agency has been recognized by the IRS as a not-for-profit
corporation as described in Section 501(c)(3) of the IRC and is exempt from
federal income taxes on related income pursuant to Section 501(a) of the IRC.
Excess of revenue over expenses. The statement of operations includes excess of
revenue over expenses. Changes in unrestricted net assets which are excluded
from excess of revenue over expenses, consistent with industry practice, include
unrealized gains and losses on investments other than trading securities, per-
manent transfers of assets to and from affiliates for other than goods and ser-
vices, and contributions of long-lived assets (including assets acquired using
contributions which by donor restriction were to be used for the purposes of
acquiring such assets).
2. Temporarily Restricted Net Assets
Temporarily restricted net assets are available for the following purposes:
20X5 20X4
Charity care $— $5,000
Purchase of equipment 9,000 —
$9,000 $5,000
Net assets were released from donor restrictions by incurring expenses sat-
isfying the restricted purposes or by occurrence of other events specified by
donors:
20X5 20X4
Charity care expenditures $5,000 $—
3. Permanently Restricted Net Assets
Permanently restricted net assets are restricted in perpetuity, the income from
which is expendable to support:
20X5 20X4
Program A activities $10,000 $—
Any activities of the agency 80,000 80,000
$90,000 $80,000
4. Third-Party Rate Adjustments and Revenue
Approximately 38 percent in 20X5 and 37 percent in 20X4 of net patient ser-
vice revenue was derived under federal and state third-party reimbursement
programs. These revenues are based, in part, on cost reimbursement principles
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and are subject to audit and retroactive adjustment by the respective third-
party fiscal intermediaries. Laws and regulations governing these programs
are extremely complex and subject to interpretation. As a result, there is at
least a reasonable possibility that recorded estimates will change by a material
amount in the near term. The 20X5 net patient service revenue increased ap-
proximately $XXX due to removal of allowances previously estimated that are
no longer necessary as a result of final settlements and years that are no longer
subject to audits, reviews, and investigations. The 20X4 net patient service rev-
enue decreased approximately $XXX due to prior-year retroactive adjustments
in excess of amounts previously estimated.
5. Internally Designated Assets
The board of directors has designated investments aggregating $100,000 to be
used for future major capital improvements. Those assets are classified in the
balance sheet as long term investments.
6. Long Term Debt
Long term debt at December 31, 20X5 and 20X4, is as follows:
20X5 20X4
Note payable to bank, interest at 15 percent,
payable in monthly installments of $2,200 per
month, including interest, collateralized by
equipment with a depreciated cost of $42,000 $118,000 $131,000
Less current maturities 13,000 13,000
$105,000 $118,000
Scheduled maturities of long term debt at December 31, 20X5, are as follows:
Year Ending December 31, Amount
20X6 $13,000
20X7 13,000
20X8 13,000
20X9 13,000
20Y0 13,000
Thereafter 53,000
Total $118,000
7. Classification of Expenses
Program
Total A B C
General and
Administrative
Expenses incurred for the
year ended December
31, 20X5, were for:
Salaries and benefits $2,714,000 $1,363,000 $699,000 $363,000 $289,000
Medical supplies and
drugs 1,042,000 511,000 246,000 285,000
Insurance and other 90,000 58,000 32,000
Provision for bad debts 46,000 16,000 30,000
Depreciation 21,000 5,000 16,000
Interest 16,000 10,000 3,000 3,000
Total expenses $3,929,000 $1,963,000 $978,000 $648,000 $340,000
(continued)
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Program
Total A B C
General and
Administrative
Expenses incurred for the
year ended December
31, 20X4, were for:
Salaries and benefits $1,835,000 $915,000 $463,000 $216,000 $241,000
Medical supplies and
drugs 675,000 335,000 211,000 129,000
Insurance and other 83,000 64,000 19,000
Provision for bad debts 21,000 21,000
Depreciation 15,000 6,000 9,000
Interest 19,000 12,000 5,000 2,000
Total expenses $2,648,000 $1,353,000 $679,000 $345,000 $271,000
(The preparer of the financial statements may wish to include a brief description
of the types of programs.)
8. Charity Care
Charity care represented approximately 3 percent and 4 percent of visits in
20X5 and 20X4, respectively.
9. Risks and Uncertainties Disclosures∗∗∗
10. Pension Plan∗∗∗
11. Postretirement Benefits∗∗∗
12. Fair Value of Financial Statements∗∗∗
13. Concentrations of Credit Risk∗∗∗
14. Investments∗∗∗
∗∗∗ See footnote ∗ ∗ ∗ in "Illustrative Financial Statements for a Nursing Home."
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR A
HEALTH MAINTENANCE ORGANIZATION
Sample Not-for-Profit Health Maintenance Organization
Balance Sheets||
June 30, 20X5 and 20X4
20X5 20X4
Assets
Current assets:
Cash and cash equivalents $2,937,000 $1,021,000
Premiums receivable, net of allowance for
doubtful accounts of $36,000 in 20X5 and
$42,000 in 20X4 358,000 407,000
Other receivables 263,000 261,000
Supplies 190,000 184,000
Prepaid expenses 197,000 99,000
Total current assets 3,945,000 1,972,000
Property and equipment, net 5,756,000 5,626,000
State guaranty fund deposit 150,000 150,000
Debt issuance costs, net of accumulated amorti-
zation of $42,000 in 20X5 and $39,000 in 20X4 18,000 21,000
Total assets $9,869,000 $7,769,000
Liabilities and Net Assets
Current liabilities:
Unsecured 12 percent note payable to a bank $— $44,000
Current maturities of long term debt 241,000 109,000
Accounts payable—medical services 2,245,000 1,471,000
Other accounts payable and accrued expenses 829,000 661,000
Unearned premium revenue 141,000 202,000
Total current liabilities 3,456,000 2,487,000
Long term debt, less current maturities 4,295,000 2,382,000
Total liabilities 7,751,000 4,869,000
Net assets—unrestricted 2,118,000 2,900,000
Total liabilities and net assets $9,869,000 $7,769,000
See accompanying notes to financial statements.
|| See footnote ||in "Illustrative Financial Statements for a Not-for-Profit Hospital."
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Sample Not-for-Profit Health Maintenance Organization
Statements of Operations and Changes in Net Assets
Years Ended June 30, 20X5 and 20X4
20X5 20X4
Revenue:
Premiums earned $27,682,000 $22,500,000
Coinsurance 689,000 500,000
Interest and other income 242,000 100,000
Total revenue 28,613,000 23,100,000
Expenses:
Salaries and benefits 16,154,000 13,328,000
Medical supplies and drugs 8,507,000 5,988,000
Insurance 3,963,000 2,463,000
Provision for bad debts 19,000 20,000
Depreciation 367,000 336,000
Interest 385,000 375,000
Total expenses 29,395,000 22,510,000
Operating income (loss) (782,000) 590,000
Net assets, beginning of year 2,900,000 2,310,000
Net assets, end of year $2,118,000 $2,900,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Health Maintenance Organization
Statements of Cash Flows
Years Ended June 30, 20X5 and 20X4
20X5 20X4
Cash flows from operating activities:
Cash received from premiums, stop-loss
insurance recoveries, and coinsurance $28,969,000 $24,410,000
Cash paid to employees and to providers of
health care services (28,405,000) (22,818,000)
Interest and other income received 230,000 90,000
Interest paid (382,000) (372,000)
Net cash provided by operating activities 412,000 1,310,000
Cash flows from investing activities:
Capital expenditures (497,000) (121,000)
Net cash used in investing activities (497,000) (121,000)
Cash flows from financing activities:
Proceeds from long term debt 2,300,000 —
Principal payments on long term debt (255,000) (1,000,000)
Principal payments on note payable (44,000) —
Net cash provided by (used in) financing
activities 2,001,000 (1,000,000)
Net increase in cash and cash equivalents 1,916,000 189,000
Cash and cash equivalents, beginning of year 1,021,000 832,000
Cash and cash equivalents, end of year $2,937,000 $1,021,000
Reconciliation of change in net assets to net
cash provided by operating activities:
Change in net assets $(782,000) $590,000
Adjustments to reconcile change in net
assets to net cash provided by operating
activities:
Depreciation and amortization 370,000 339,000
Provision for bad debts 19,000 20,000
(Increase) decrease in:
Premiums receivables 30,000 64,000
Other current assets 230,000 (93,000)
Increase (decrease) in:
Accounts payable—medical services 774,000 335,000
Other accounts payable and accrued
expenses (168,000) (60,000)
Unearned premium revenue (61,000) 115,000
Net cash provided by operating activities $412,000 $1,310,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Health Maintenance Organization
Notes to Financial Statements20,#
June 30, 20X5 and 20X4
1. Organization
The Sample Health Maintenance Organization (the HMO) was incorporated in
20X0 in New State as a not-for-profit corporation for the purpose of providing
comprehensive health care services on a prepaid basis and for the purpose
of establishing and operating organized health maintenance and health care
delivery systems.
The HMO has been determined to be a qualified HMO under Title XIII of the
Public Health Service Act.
2. Summary of Significant Accounting Policies21
Use of estimates. The preparation of financial statements in conformity with
generally accepted accounting principles requires management to make esti-
mates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
Cash and cash equivalents. Cash and cash equivalents include investments in
highly liquid debt instruments with an original maturity of three months or
less.
Supplies. Inventories of drugs and other supplies are stated at the lower of cost
(first-in, first-out) or market.
Property and equipment. Property and equipment are recorded at cost. Main-
tenance and repairs are charged to expense, and betterments are capitalized.
Property and equipment costing approximately $700,000 was financed by HMO
initial development grants received in 20X1 and 20X2 from the U.S. Depart-
ment of Health and Human Services (HHS). This property will be owned by
the HMO as long as the equipment and facilities are used for projects related
to the objectives of the Public Health Service Act.
Depreciation is computed using the straight-line method over the estimated
useful lives of the related assets as follows:
Building 40 years
Improvements 20–25 years
Data processing and laboratory
equipment and automobiles 3–7 years
Medical equipment 10 years
Office equipment 5–10 years
20 SOP 00-1 provides auditors with guidance regarding uncertainties in health care revenue
recognition and includes a sample disclosure in paragraph .37 of the SOP for material differences
between an original estimate and subsequent revisions regarding third-party payments. SOP 00-1 is
included in appendix D to this guide.
# See footnote # in "Illustrative Financial Statements for a Not-for-Profit Hospital."
21 FASB ASC 310-10-50 provides guidance on accounting policy disclosures about loans, trade
receivables, and doubtful accounts that should be included in the summary of significant accounting
policies.
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Amortization of debt issuance costs. Debt issuance costs are deferred and amor-
tized using the effective interest method over the term of the related debt.
Health care service cost recognition. The HMO contracts with various health
care providers for the provision of certain medical care services to its members.
The HMO compensates these providers on a capitation basis. As part of a cost
control incentive program, the HMO retains up to 20 percent of the capitation
as a risk-sharing fund. In the event of hospital utilization in excess of bud-
get, those providers bear the risk to the extent of 15 percent of the capitation
fee. Operating expenses include all amounts incurred by the HMO under the
aforementioned contracts.
The cost of other health care services provided or contracted for is accrued in the
period in which it is provided to a member based in part on estimates, including
an accrual for medical services provided but not reported to the HMO.
Premiums revenue. Membership contracts are on a yearly basis subject to can-
cellation by the employer group or the HMO upon 30 days written notice. Pre-
miums are due monthly and are recognized as revenue during the period in
which the HMO is obligated to provide services to members.
Reinsurance (stop-loss insurance). Reinsurance premiums are reported as
health care costs, and reinsurance recoveries are reported as a reduction of
related health care costs.
Federal income tax. The HMO is exempt from federal income taxes under Sec-
tion 501(c)(4) of the Internal Revenue Code; accordingly, no provision for federal
income taxes has been made in the accompanying financial statements.
3. Property and Equipment
Property and equipment at June 30, 20X5 and 20X4, consists of the following:
20X5 20X4
Land $300,000 $300,000
Buildings and improvements 5,473,000 5,459,000
Furniture and equipment 1,786,000 1,303,000
7,559,000 7,062,000
Less accumulated depreciation (1,803,000) (1,436,000)
$5,756,000 $5,626,000
4. Long Term Debt
Long term debt is collateralized by assets with a depreciated cost of $4,943,000.
A summary of long term debt at June 30, 20X5 and 20X4, follows.
20X5 20X4
HHS loan, interest at 7.5 percent, payable in
monthly installments of $50,000, including
interest $2,020,000 $111,000
HHS loan, interest at 9.25 percent, payable in
monthly installments of $10,000, including
interest 1,658,000 1,694,000
Secured equipment loans, payable in monthly
installments of $15,000, including interest 858,000 686,000
4,536,000 2,491,000
Less current maturities 241,000 109,000
$4,295,000 $2,382,000
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Scheduled principal payments on long term debt are as follows:
Year Ending December 31, Amount
20X6 $241,000
20X7 259,000
20X8 280,000
20X9 800,000
20Y0 2,956,000
$4,536,000
5. State Guarantee Fund Deposit
In August 20X4, the state in which the HMO is domiciled enacted legislation
specifically governing HMOs. Under this legislation, the corporation is required
to maintain a deposit of $150,000 with the director of the division of insurance
of the state.
6. Employee Retirement Plan
The HMO has a contributory defined contribution retirement plan covering
substantially all employees. Expense determined in accordance with the plan
formula (4 percent to 10 percent of eligible covered compensation) was $354,000
and $275,000 for the years ended June 30, 20X5 and 20X4, respectively.
7. Stop-Loss Insurance
The HMO entered into a stop-loss insurance agreement with an insurance com-
pany to limit its losses on individual claims. Under the terms of this agreement,
the insurance company will reimburse the HMO approximately 25 percent of
the cost of each member's annual hospital services, in excess of a $1,000 de-
ductible, up to a lifetime limitation of $500,000 per member. In the event the
HMO ceases operations, (a) plan benefits will continue for members who are
confined in an acute care hospital on the date of insolvency until their discharge,
and (b) plan benefits will continue for any other member until the end of the
contract period for which premiums have been paid.
Stop-loss insurance premiums of approximately $700,000 and $500,000 are
included in insurance expense (note 9) in 20X5 and 20X4, respectively. Approx-
imately $600,000 and $400,000 in stop-loss insurance recoveries are deducted
from insurance expense in 20X5 and 20X4, respectively.
Included in other receivables is approximately $50,000 recoverable from
insurers.
8. Malpractice Claims
Malpractice claims have been asserted against the HMO by various claimants.
The claims are in various stages of processing, and some may ultimately be
brought to trial. In the opinion of counsel, the outcome of these actions will not
have a significant effect on the financial position or the operating income of the
HMO. Incidents occurring through June 30, 20X5, may result in the assertion
of additional claims. Other claims may be asserted arising from past services
provided. Management believes that these claims, if asserted, would be settled
within the limits of insurance coverage.
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9. Classification of Expenses
20X5 20X4
Program activities 26,921,000 20,909,000
General and administrative 2,474,000 1,601,000
$29,395,000 $22,510,000
10. Risks and Uncertainties Disclosures∗∗∗
11. Pension Plan∗∗∗
12. Postretirement Benefits∗∗∗
13. Fair Value of Financial Instruments∗∗∗
14. Concentrations of Credit Risk∗∗∗
∗∗∗ See footnote ∗ ∗ ∗ in "Illustrative Financial Statements for a Nursing Home."
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ILLUSTRATIVE FINANCIAL STATEMENTS FOR AN
AMBULATORY CARE ORGANIZATION
Sample Not-for-Profit Ambulatory Care, Inc.
Balance Sheets||
December 31, 20X5 and 20X4
20X5 20X4
Assets
Current assets:
Cash $65,000 $76,000
Patient accounts receivable, net of allowance
for doubtful accounts of $15,000 in 20X5 and
$5,000 in 20X4 290,000 278,000
Estimated retroactive adjustments—
third-party payors 19,000 32,000
Accounts receivable—other 13,000 8,000
Supplies 21,000 18,000
Prepaid expenses and deposits 5,000 9,000
Total current assets 413,000 421,000
Property and equipment, at cost:
Land 100,000 100,000
Land improvements 322,000 322,000
Buildings 682,000 682,000
Equipment 1,390,000 1,389,000
2,494,000 2,493,000
Less accumulated depreciation 217,000 100,000
Property and equipment, net 2,277,000 2,393,000
Other assets:
Advances receivable 14,000 5,000
Total assets $2,704,000 $2,819,000
Liabilities and Net Assets
Current liabilities:
Notes payable $138,000 $144,000
Accounts payable 42,000 77,000
Accrued payroll, benefits, and taxes 33,000 22,000
Estimated retroactive adjustments—
third-party payors 30,000 24,000
Financing advance from third-party payors — 1,000
Total current liabilities 243,000 268,000
Guarantee liability 10,000 10,000
Total liabilities 253,000 278,000
Net assets—unrestricted 2,451,000 2,541,000
Total liabilities and net assets $2,704,000 $2,819,000
See accompanying notes to financial statements.
|| See footnote ||in "Illustrative Financial Statements for a Not-for-Profit Hospital."
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Sample Not-for-Profit Ambulatory Care, Inc.
Statements of Operations and Changes in Net Assets
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Revenue and gains:
Net patient service revenue $860,000 $357,000
Other 29,000 15,000
Total revenue and gains 889,000 372,000
Expenses:
Salaries and benefits 485,000 243,000
Medical supplies and drugs 189,000 66,000
Insurance 154,000 98,000
Provision for bad debts 14,000 4,000
Depreciation 117,000 100,000
Interest 20,000 18,000
Total expenses 979,000 529,000
Operating loss (90,000) (157,000)
Net assets, beginning of year 2,541,000 2,698,000
Net assets, end of year $2,451,000 $2,541,000
See accompanying notes to financial statements.
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Sample Not-for-Profit Ambulatory Care, Inc.
Statements of Cash Flows
Years Ended December 31, 20X5 and 20X4
20X5 20X4
Cash flows from operating activities:
Cash received from patients and third-party
payors $866,000 $368,000
Cash received from others 21,000 6,000
Interest received 3,000 11,000
Interest paid (15,000) (16,000)
Cash paid to employees and suppliers (870,000) (432,000)
Net cash provided by (used in) operating
activities 5,000 (63,000)
Cash flows from investing activities:
Purchase of equipment (1,000) (4,000)
Advances made to XYZ Affiliate (9,000) (5,000)
Net cash used in investing activities (10,000) (9,000)
Cash flows from financing activities:
Proceeds from notes payable — 144,000
Payments on notes payable (6,000) —
Net cash provided by (used in) financing
activities (6,000) 144,000
Net increase (decrease) in cash (11,000) 72,000
Cash, beginning of year 76,000 4,000
Cash, end of year $65,000 $76,000
Reconciliation of change in net assets to net
cash provided by (used in) operating
activities:
Change in net assets $(90,000) $(157,000)
Adjustments to reconcile change in net assets
to net cash provided by (used in) operating
activities:
Depreciation 117,000 100,000
Provision for bad debts 14,000 4,000
(Increase) decrease in:
Patient accounts receivable (12,000) (19,000)
Other current assets 1,000 (2,000)
Increase (decrease) in:
Accounts payable and accrued payroll,
benefits, and taxes (24,000) 10,000
Other current liabilities (1,000) 1,000
Net cash provided by (used in) operating
activities
$5,000 $(63,000)
See accompanying notes to financial statements.
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Sample Not-for-Profit Ambulatory Care, Inc.
Notes to Financial Statements#
December 31, 20X5 and 20X4
1. Description of Organization and Summary of Significant
Accounting Policies22
Organization. Ambulatory Care, Inc. was incorporated on September 7, 20X3,
in New State, to operate an ambulatory care health facility to treat or prevent
injury and disease, to provide funds or to expend funds to further the treatment
or prevention of injury or disease, and to develop and participate in activities
designed to promote the general health of the community.
Three area hospitals—ABC Hospital and Health Center, DEF Hospital, and
GHI Hospital—entered into a members' agreement to develop this ambula-
tory care center. In accordance with this agreement, each hospital contributed
capital of $947,000 to Ambulatory Care, Inc. Ambulatory Care, Inc. began op-
erations in October 20X3.
Use of estimates. The preparation of financial statements in conformity with
generally accepted accounting principles requires management to make esti-
mates and assumptions that affect the reported amounts of assets and liabilities
and disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.
Supplies. Supplies are stated at the lower of cost (first-in, first-out) or net real-
izable value.
Depreciation. Depreciation of property and equipment is computed on the
straight-line method over the estimated lives of depreciable assets.
Third-party contractual adjustments. Retroactively calculated third-party con-
tractual adjustments are accrued on an estimated basis in the period the related
services are rendered. Net patient service revenue is adjusted as required in
subsequent periods based on final settlements.
Net patient service revenue. Patient service revenue is reported at the estimated
net realizable amounts from patients, third-party payors, and others for ser-
vices rendered.
Charity care. Ambulatory Care, Inc. has a policy of providing charity care to
patients who are unable to pay. Such patients are identified and related charges
are estimated, based on financial information obtained from the patient and
subsequent analysis. Because management does not expect payment for charity
care, the estimated charges are excluded from revenue.
Income taxes. Ambulatory Care, Inc. has been recognized by the IRS as a not-
for-profit corporation as described in Section 501(c)(3) of the IRC and is exempt
from federal income taxes on related income pursuant to Section 501(a) of the
IRC.
# See footnote # in "Illustrative Financial Statements for a Not-for-Profit Hospital."
22 FASB ASC 310-10-50 provides guidance on accounting policy disclosures about loans, trade
receivables, and doubtful accounts that should be included in the summary of significant accounting
policies.
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2. Advances Receivable
In May 20X4, Ambulatory Care, Inc. entered into a 5 year agreement with XYZ
Affiliates (XYZ). Under this agreement, XYZ is to provide emergency medical
services as well as charge and bill each patient treated at Ambulatory Care,
Inc. Ambulatory Care, Inc. has guaranteed that XYZ will collect at least $18,000
per month during the term of this agreement. In any month in which XYZ does
not collect the minimum guarantee, Ambulatory Care, Inc. advances funds to
XYZ to cover the deficiency. Such advances are to be repaid to the extent XYZ's
net cash collections exceed the minimum guarantee amount. Management es-
timates that the advances will be fully recovered in 20X8.
3. Related-Party Transactions
During 20X3, Ambulatory Care, Inc. entered into a contract with 1 of the mem-
ber hospitals (the managing hospital) for the management of the business and
affairs of Ambulatory Care, Inc. Under this agreement, Ambulatory Care, Inc.
pays $4,000 per month to the managing hospital. The agreement with the man-
aging hospital was to remain in effect through December 31, 20X5, but has been
extended on a month-to-month basis.
In addition, during 20X4 each hospital loaned $48,000 to Ambulatory Care, Inc.
in the form of promissory notes at an interest rate of prime rate plus 1 percent
(effective rates of 10 percent and 9 percent in 20X5 and 20X4, respectively). Of
the total $144,000 liability, $48,000 is payable on demand after November 28,
20X5, to one member hospital, with the remaining portion ($96,000) payable on
demand after December 8, 20X5, to the other 2 member hospitals. During 20X5,
Ambulatory Care, Inc. paid $2,000 to each member hospital, thereby reducing
the obligation to $138,000.
4. Revenue From Contracting Agencies
Ambulatory Care, Inc. participates as a provider of health care services to Blue
Cross, Medicare, and County Indigent Plan patients. Reimbursement for cov-
ered services is based on tentative payment rates. Final reimbursement is deter-
mined after submission of annual cost reports and audits thereof by the fiscal
intermediaries. Provisions for estimated reimbursement adjustments are re-
ported in the financial statements in the period that the services are rendered.
Revenue from the Medicare program accounted for approximately XX percent
for the year ended 20X5, and XX percent for the year ended 20X4, of Ambulatory
Care, Inc.'s net patient revenue. Laws and regulations governing the Medicare
program are extremely complex and subject to interpretation. As a result, there
is at least a reasonable possibility that recorded estimates will change by a ma-
terial amount in the near term. The 20X5 net patient service revenue increased
approximately $XXX due to removal of allowances previously estimated that
are no longer necessary as a result of final settlements and years that are
no longer subject to audits, reviews, and investigations. The 20X4 net patient
service revenue decreased approximately $XXX due to prior-year retroactive
adjustments in excess of amounts previously estimated.
5. Charity Care
Ambulatory Care, Inc. has a policy of providing charity care to indigent pa-
tients in emergency situations. These services, which are excluded from rev-
enues, amounted to $27,000 and $13,000 in 20X5 and 20X4, respectively, when
measured at Ambulatory Care, Inc.'s established rates.
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6. Classification of Expenses
Program
Total A B C
General and
Administrative
Expenses incurred for
the year ended
December 31, 20X5,
were for:
Salaries and benefits $485,000 $216,000 $102,000 $121,000 $46,000
Medical supplies and
drugs 189,000 98,000 43,000 48,000
—
Insurance 154,000 79,000 45,000 14,000 16,000
Provision for bad debts 14,000 9,000 — 5,000 —
Depreciation 117,000 100,000 — 17,000 —
Interest 20,000 9,000 — — 11,000
Total expenses $979,000 $511,000 $190,000 $205,000 $73,000
Program
Total A B C
General and
Administrative
Expenses incurred for
the year ended
December 31, 20X4,
were for:
Salaries and benefits $243,000 $111,000 $46,000 $57,000 $29,000
Medical supplies and
drugs 66,000 31,000 15,000 20,000 —
Insurance 98,000 45,000 19,000 26,000 8,000
Provision for bad debts 4,000 — 4,000 — —
Depreciation 100,000 56,000 — 44,000 —
Interest 18,000 7,000 — — 11,000
Total expenses $529,000 $250,000 $84,000 $147,000 $48,000
(The preparer of the financial statements may wish to include a brief description
of the types of programs.)
7. Risks and Uncertainties Disclosures∗∗∗
8. Pension Plan∗∗∗
9. Postretirement Benefits∗∗∗
10. Fair Value of Financial Instruments∗∗∗
11. Concentrations of Credit Risk∗∗∗
∗∗∗ See footnote ∗ ∗ ∗ in "Illustrative Financial Statements for a Nursing Home."
AAG-HCO APP A
P1: G.Shankar
ACPA125-AppA(iv) ACPA125.cls February 25, 2010 16:39
322
P1: G.Shankar
ACPA125-AppB ACPA125.cls February 25, 2010 16:41
Statement of Position 98-2 323
Appendix B
Statement of Position 98-2,
Accounting for Costs of
Activities of Not-for-Profit
Organizations and State and
Local Governmental Entities
That Include Fund Raising
March 11, 1998
Amendment to
AICPA Audit and Accounting Guides
Health Care Organizations,
Not-for-Profit Organizations, and
Audits of State and Local Governmental Units
Issued by the Accounting
Standards Executive Committee
AAG-HCO APP B
P1: G.Shankar
ACPA125-AppB ACPA125.cls February 25, 2010 16:41
324 Health Care Entities
NOTE
Statements of Position on accounting issues present the conclusions
of at least two-thirds of the Accounting Standards Executive Commit-
tee, which is the senior technical body of the Institute authorized to
speak for the Institute in the areas of financial accounting and report-
ing. AU section 411, The Meaning of Present Fairly in Conformity With
Generally Accepted Accounting Principles, identifies AICPA Statements
of Position that have been cleared by either the Financial Accounting
Standards Board (for financial statements of nongovernmental entities)
or the Governmental Accounting Standards Board (for financial state-
ments of state and local governmental entities), as sources of established
accounting principles in category b of the hierarchy of generally accepted
accounting principles that it establishes. AICPA members should con-
sider the accounting principles in this Statement of Position if a differ-
ent accounting treatment of a transaction or event is not specified by a
pronouncement covered by Rule 203 of the AICPA Code of Professional
Conduct. In such circumstances, the accounting treatment specified by
this Statement of Position should be used, or the member should be pre-
pared to justify a conclusion that another treatment better presents the
substance of the transaction in the circumstances.
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Summary
This Statement of Position (SOP) applies to all nongovernmental not-for-profit
organizations (NPOs) and all state and local governmental entities that solicit
contributions.
This SOP requires—
 If the criteria of purpose, audience, and content as defined in this
SOP are met, the costs of joint activities that are identifiable with
a particular function should be charged to that function and joint
costs should be allocated between fund raising and the appropriate
program or management and general function.
 If any of the criteria of purpose, audience, and content are not met,
all costs of the activity should be reported as fund-raising costs,
including costs that otherwise might be considered program or
management and general costs if they had been incurred in a dif-
ferent activity, subject to the exception in the following sentence.
Costs of goods or services provided in exchange transactions that
are part of joint activities, such as costs of direct donor benefits
of a special event (for example, a meal), should not be reported as
fund raising.
 Certain financial statement disclosures if joint costs are allocated.
 Some commonly used and acceptable allocation methods are de-
scribed and illustrated although no methods are prescribed or pro-
hibited.
This SOP amends existing guidance in AICPA Audit and Accounting Guides
Health Care Organizations, Not-for-Profit Organizations (which was issued in
August 1996 and supersedes SOP 87-2, Accounting for Joint Costs of Informa-
tional Materials and Activities of Not-for-Profit Organizations That Include a
Fund-Raising Appeal, because the provisions of SOP 87-2 are incorporated into
the Guide), and Audits of State and Local Governmental Units.*
This SOP is effective for financial statements for years beginning on or after
December 15, 1998. Earlier application is encouraged in fiscal years for which
financial statements have not been issued. If comparative financial statements
are presented, retroactive application is permitted but not required.
* The AICPA Audit and Accounting Guide State and Local Governments supersedes the 1994
AICPA Audit and Accounting Guide Audits of State and Local Governmental Units and subsequent
editions of that Guide with conforming changes made by the AICPA staff. The AICPA Audit and Ac-
counting Guide State and Local Governments provides guidance on the application of this Statement
of Position (SOP) to state and local governments. [Footnote added, June 2004, to reflect conforming
changes necessary due to the issuance of the AICPA Audit and Accounting Guide State and Local
Governments.]
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Foreword
The accounting guidance contained in this document has been cleared by the
Financial Accounting Standards Board (FASB) and the Governmental Account-
ing Standards Board (GASB). The procedure for clearing accounting guidance
in documents issued by the Accounting Standards Executive Committee (Ac-
SEC) involves the FASB and the GASB reviewing and discussing in public board
meetings (1) a prospectus for a project to develop a document, (2) a proposed
exposure draft that has been approved by at least ten of AcSEC's fifteen mem-
bers, and (3) a proposed final document that has been approved by at least ten
of AcSEC's fifteen members. The document is cleared if at least five of the seven
FASB members and three of the five GASB members do not object to AcSEC
undertaking the project, issuing the proposed exposure draft or, after consid-
ering the input received by AcSEC as a result of the issuance of the exposure
draft, issuing the final document.†
The criteria applied by the FASB and the GASB in their review of proposed
projects and proposed documents include the following:
1. The proposal does not conflict with current or proposed accounting
requirements, unless it is a limited circumstance, usually in spe-
cialized industry accounting, and the proposal adequately justifies
the departure.
2. The proposal will result in an improvement in practice.
3. The AICPA demonstrates the need for the proposal.
4. The benefits of the proposal are expected to exceed the costs of
applying it.
In many situations, prior to clearance, the FASB and the GASB will propose
suggestions, many of which are included in the documents.
† This document was cleared prior to July 1, 1997. In July 1997, the GASB increased to seven
members. Documents considered by the GASB after July 1, 1997 are cleared if at least four of the
seven GASB members do not object. [Footnote renumbered, June 2004, to reflect conforming changes
necessary due to the issuance of the AICPA Audit and Accounting Guide State and Local Governments.]
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Introduction
.01 Some nongovernmental not-for-profit organizations (NPOs) and some
state and local governmental entities,1 such as governmental colleges and uni-
versities and governmental health care providers, solicit support through a
variety of fund-raising activities.2 These activities include direct mail, tele-
phone solicitation, door-to-door canvassing, telethons, special events, and oth-
ers. Sometimes fund-raising activities are conducted with activities related to
other functions, such as program activities or supporting services, such as
management and general activities.3 Sometimes fund-raising activities in-
clude components that would otherwise be associated with program or support-
ing services, but in fact support fund raising.
.02 External users of financial statements—including contributors, credi-
tors, accreditation agencies, and regulators—want assurance that fund-raising
costs, as well as program costs and management and general costs, are stated
fairly.
.03 In 1987, the AICPA issued Statement of Position (SOP) 87-2, Account-
ing for Joint Costs of Informational Materials and Activities of Not-for-Profit Or-
ganizations That Include a Fund-Raising Appeal.4 SOP 87-2 required that all
circumstances concerning informational materials and activities that include a
fund-raising appeal be considered in accounting for joint costs of those mate-
rials and activities and that certain criteria be applied in determining whether
joint costs of those materials and activities should be charged to fund raising
or allocated to program or management and general. Those criteria include re-
quiring verifiable indications of the reasons for conducting the activity, such as
the content, audience, and action, if any, requested of the participant, as well
1 This Statement of Position (SOP) uses the term entity to refer to both nongovernmental not-
for-profit organizations (NPOs) and state and local governments.
2 Terms that appear in the Glossary [paragraph .30] are set in boldface type the first time
they appear.
3 The functional classifications of fund raising, program, and management and general are dis-
cussed throughout this SOP for purposes of illustrating how the guidance in this SOP would be applied
by entities that use those functional classifications. Some entities have a functional structure that
does not include fund raising, program, or management and general, or that includes other functional
classifications, such as membership development. This SOP is not intended to require reporting the
functional classifications of fund raising, program, and management and general. In circumstances in
which entities that have a functional structure that includes other functional classifications conduct
joint activities, all costs of those joint activities should be charged to fund raising (or the category in
which fund raising is reported—see the following two parenthetical sentences), unless the purpose,
audience, and content of those joint activities are appropriate for achieving those other functions. (An
example of an entity that reports fund raising in a category other than fund raising is a state and
local governmental entity applying the accounting and financial reporting principles in the AICPA
Industry Audit Guide Audits of Colleges and Universities, as amended by SOP 74-8. As discussed in
paragraph D.5 of this SOP [paragraph .24], those entities are required to report fund raising as part
of the "institutional support" function. See also footnote # to paragraph D.5.) [Footnote revised, June
2004, to reflect conforming changes necessary due to the issuance of GASB Statements No. 34 and
No. 35.]
4 In August 1996, the AICPA issued the Audit and Accounting Guide Not-for-Profit Organiza-
tions. The Guide supersedes SOP 87-2, Accounting for Joint Costs of Informational Materials and
Activities of Not-for-Profit Organizations That Include a Fund-Raising Appeal, because the provisions
of SOP 87-2 are incorporated into paragraphs 13.36 to 13.45 of Not-for-Profit Organizations. Not-
for-Profit Organizations applies to all nongovernmental NPOs other than those required to follow
the Audit and Accounting Guide Health Care Organizations. The discussion in this SOP of SOP 87-2
refers to both SOP 87-2 and the guidance included in paragraphs 13.36 to 13.45 of Not-for-Profit Or-
ganizations. Also, SOP 87-2 was not applicable to entities that are within the scope of Governmental
Accounting Standards Board (GASB) Statement No. 29, The Use of Not-for-Profit Accounting and
Financial Reporting Principles by Governmental Entities.
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as other corroborating evidence. Further, SOP 87-2 required that all joint costs
of those materials and activities be charged to fund raising unless the appeal
is designed to motivate its audience to action other than providing financial
support to the organization.
.04 The provisions of SOP 87-2 have been difficult to implement and have
been applied inconsistently in practice. (Appendix B [paragraph .22], "Back-
ground," discusses this further.)
.05 This SOP establishes financial accounting standards for accounting for
costs of joint activities. In addition, this SOP requires financial statement
disclosures about the nature of the activities for which joint costs have been
allocated and the amounts of joint costs. Appendix F [paragraph .26] provides
explanations and illustrations of some acceptable allocation methods.
Scope
.06 This SOP applies to all nongovernmental NPOs and all state and local
governmental entities that solicit contributions.
Conclusions
Accounting for Joint Activities
.07 If the criteria of purpose, audience, and content are met, the costs of a
joint activity that are identifiable with a particular function should be charged
to that function and joint costs should be allocated between fund raising and
the appropriate program or management and general function. If any of the
criteria are not met, all costs of the joint activity should be reported as fund-
raising costs, including costs that otherwise might be considered program or
management and general costs if they had been incurred in a different activity,
subject to the exception in the following sentence. Costs of goods or services
provided in exchange transactions that are part of joint activities, such as costs
of direct donor benefits of a special event (for example, a meal), should not be
reported as fund raising.
Purpose
.08 The purpose criterion is met if the purpose of the joint activity includes
accomplishing program or management and general functions. ( Paragraphs .09
and .10 provide guidance that should be considered in determining whether
the purpose criterion is met. Paragraph .09 provides guidance pertaining to
program functions only. Paragraph .10 provides guidance pertaining to both
program and management and general functions.)
.09 Program functions. To accomplish program functions, the activity
should call for specific action by the audience that will help accomplish
the entity's mission. For purposes of applying the guidance in this SOP, the
following are examples of activities that do and do not call for specific action by
the audience that will help accomplish the entity's mission:
 An entity's mission includes improving individuals' physical
health. For that entity, motivating the audience to take specific
action that will improve their physical health is a call for spe-
cific action by the audience that will help accomplish the entity's
mission. An example of an activity that motivates the audience to
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take specific action that will improve their physical health is send-
ing the audience a brochure that urges them to stop smoking and
suggests specific methods, instructions, references, and resources
that may be used to stop smoking.
 An entity's mission includes educating individuals in areas other
than the causes, conditions, needs, or concerns that the entity's
programs are designed to address (referred to hereafter in this
SOP as "causes"). For that entity, educating the audience in areas
other than causes or motivating the audience to otherwise engage
in specific activities that will educate them in areas other than
causes is a call for specific action by the audience that will help
accomplish the entity's mission. Examples of entities whose mis-
sion includes educating individuals in areas other than causes are
universities and possibly other entities. An example of an activity
motivating individuals to engage in education in areas other than
causes is a university inviting individuals to attend a lecture or
class in which the individuals will learn about the solar system.
 Educating the audience about causes or motivating the audience
to otherwise engage in specific activities that will educate them
about causes is not a call for specific action by the audience that
will help accomplish the entity's mission. Such activities are con-
sidered in support of fund raising. (However, some educational
activities that might otherwise be considered as educating the au-
dience about causes may implicitly call for specific action by the
audience that will help accomplish the entity's mission. For ex-
ample, activities that educate the audience about environmental
problems caused by not recycling implicitly call for that audience
to increase recycling. If the need for and benefits of the specific
action are clearly evident from the educational message, the mes-
sage is considered to include an implicit call for specific action by
the audience that will help accomplish the entity's mission.)
 Asking the audience to make contributions is not a call for spe-
cific action by the audience that will help accomplish the entity's
mission.
If the activity calls for specific action by the audience that will help accomplish
the entity's mission, the guidance in paragraph .10 should also be considered
in determining whether the purpose criterion is met.
.10 Program and management and general functions. The following fac-
tors should be considered, in the order in which they are listed,5 to determine
whether the purpose criterion is met:
a. Whether compensation or fees for performing the activity are
based on contributions raised. The purpose criterion is not met if
a majority of compensation or fees for any party's performance of
5 In considering the guidance in paragraph .10, the factor in paragraph .10a (the compensation or
fees test) is the preeminent guidance. If the factor in paragraph .10a is not determinative, the factor
in paragraph .10b (whether a similar program or management and general activity is conducted
separately and on a similar or greater scale) should be considered. If the factor in paragraph .10b is
not determinative, the factor in paragraph .10c (other evidence) should be considered.
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any component of the discrete joint activity varies based on contri-
butions raised for that discrete joint activity.6,7
b. Whether a similar program or management and general activity is
conducted separately and on a similar or greater scale. The purpose
criterion is met if either of the following two conditions is met:
(1) Condition 1:
— The program component of the joint activity calls
for specific action by the recipient that will help
accomplish the entity's mission and
— A similar program component is conducted with-
out the fund-raising component using the same
medium and on a scale that is similar to or
greater than the scale on which it is conducted
with the fund raising.8
(2) Condition 2:
A management and general activity that is similar to the man-
agement and general component of the joint activity being ac-
counted for is conducted without the fund-raising component
using the same medium and on a scale that is similar to or
greater than the scale on which it is conducted with the fund
raising
If the purpose criterion is met based on the factor in paragraph .10b,
the factor in paragraph .10c should not be considered.
c. Other evidence. If the factors in paragraph .10a or .10b do not de-
termine whether the purpose criterion is met, other evidence may
determine whether the criterion is met. All available evidence, both
positive and negative, should be considered to determine whether,
based on the weight of that evidence, the purpose criterion is met.
.11 The following are examples of indicators that provide evidence for
determining whether the purpose criterion is met:
a. Evidence that the purpose criterion may be met includes—
 Measuring program results and accomplishments of the
activity. The facts may indicate that the purpose criterion
6 Some compensation contracts provide that compensation for performing the activity is based on
a factor other than contributions raised, but not to exceed a specified portion of contributions raised.
For example, a contract may provide that compensation for performing the activity is $10 per contact
hour, but not to exceed 60 percent of contributions raised. In such circumstances, compensation is not
considered based on amounts raised, unless the stated maximum percentage is met. In circumstances
in which it is not yet known whether the stated maximum percentage is met, compensation is not
considered based on amounts raised, unless it is probable that the stated maximum percentage will
be met.
7 The compensation or fees test is a negative test in that it either (a) results in failing the purpose
criterion or (b) is not determinative of whether the purpose criterion is met. Therefore, if the activity
fails the purpose criterion based on this factor (the compensation or fees test), the activity fails the
purpose criterion and the factor in paragraph .10b should not be considered. If the purpose criterion
is not failed based on this factor, this factor is not determinative of whether the purpose criterion is
met and the factor in paragraph .10b should be considered.
8 Determining the scale on which an activity is conducted may be a subjective determination.
Factors to consider in determining the scale on which an activity is conducted may include dollars
spent, the size of the audience reached, and the degree to which the characteristics of the audience
are similar to the characteristics of the audience of the activity being evaluated.
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is met if the entity measures program results and accom-
plishments of the activity (other than measuring the ex-
tent to which the public was educated about causes).
 Medium. The facts may indicate that the purpose crite-
rion is met if the program component of the joint activ-
ity calls for specific action by the recipient that will help
accomplish the entity's mission and if the entity conducts
the program component without a significant fund-raising
component in a different medium. Also, the facts may indi-
cate that the purpose criterion is met if the entity conducts
the management and general component of the joint ac-
tivity without a significant fund-raising component in a
different medium.
b. Evidence that the purpose criterion may not be met includes—
 Evaluation or compensation. The facts may indicate that
the purpose criterion is not met if (a) the evaluation of
any party's performance of any component of the discrete
joint activity varies based on contributions raised for that
discrete joint activity or (b) some, but less than a majority,
of compensation or fees for any party's performance of any
component of the discrete joint activity varies based on
contributions raised for that discrete joint activity.
c. Evidence that the purpose criterion may be either met or not met
includes—
 Evaluation of measured results of the activity. The entity
may have a process to evaluate measured program results
and accomplishments of the activity (other than measur-
ing the extent to which the public was educated about
causes). If the entity has such a process, in evaluating the
effectiveness of the joint activity, the entity may place sig-
nificantly greater weight on the activity's effectiveness in
accomplishing program goals or may place significantly
greater weight on the activity's effectiveness in raising
contributions. The former may indicate that the purpose
criterion is met. The latter may indicate that the purpose
criterion is not met.
 Qualifications. The qualifications and duties of those per-
forming the joint activity should be considered.
— If a third party, such as a consultant or contractor,
performs part or all of the joint activity, such as
producing brochures or making telephone calls,
the third party's experience and the range of ser-
vices provided to the entity should be considered
in determining whether the third party is per-
forming fund-raising, program (other than edu-
cating the public about causes), or management
and general activities on behalf of the entity.
— If the entity's employees perform part or all of
the joint activity, the full range of their job du-
ties should be considered in determining whether
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those employees are performing fund-raising,
program (other than educating the public about
causes), or management and general activities on
behalf of the entity. For example, (a) employees
who are not members of the fund-raising depart-
ment and (b) employees who are members of the
fund-raising department but who perform non-
fund-raising activities are more likely to perform
activities that include program or management
and general functions than are employees who
otherwise devote significant time to fund raising.
 Tangible evidence of intent. Tangible evidence indicating
the intended purpose of the joint activity should be con-
sidered. Examples of such tangible evidence include
— The entity's written mission statement, as stated
in its fund-raising activities, bylaws, or annual
report.
— Minutes of board of directors', committees', or
other meetings.
— Restrictions imposed by donors (who are not re-
lated parties) on gifts intended to fund the joint
activity.
— Long-range plans or operating policies.
— Written instructions to other entities, such as
script writers, consultants, or list brokers, con-
cerning the purpose of the joint activity, audience
to be targeted, or method of conducting the joint
activity.
— Internal management memoranda.
Audience
.12 A rebuttable presumption exists that the audience criterion is not met
if the audience includes prior donors or is otherwise selected based on its ability
or likelihood to contribute to the entity. That presumption can be overcome if
the audience is also selected for one or more of the reasons in paragraph .13a,
.13b, or .13c. In determining whether that presumption is overcome, entities
should consider the extent to which the audience is selected based on its ability
or likelihood to contribute to the entity and contrast that with the extent to
which it is selected for one or more of the reasons in paragraph .13a, .13b,
or .13c. For example, if the audience's ability or likelihood to contribute is a
significant factor in its selection and it has a need for the action related to the
program component of the joint activity, but having that need is an insignificant
factor in its selection, the presumption would not be overcome.
.13 In circumstances in which the audience includes no prior donors and
is not otherwise selected based on its ability or likelihood to contribute to the
entity, the audience criterion is met if the audience is selected for one or more
of the following reasons:
a. The audience's need to use or reasonable potential for use of the
specific action called for by the program component of the joint
activity
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b. The audience's ability to take specific action to assist the entity in
meeting the goals of the program component of the joint activity
c. The entity is required to direct the management and general compo-
nent of the joint activity to the particular audience or the audience
has reasonable potential for use of the management and general
component
Content
.14 The content criterion is met if the joint activity supports program or
management and general functions, as follows:
a. Program. The joint activity calls for specific action by the recipient
that will help accomplish the entity's mission. If the need for and
benefits of the action are not clearly evident, information describing
the action and explaining the need for and benefits of the action is
provided.
b. Management and general. The joint activity fulfills one or more
of the entity's management and general responsibilities through a
component of the joint activity.9
.15 Information identifying and describing the entity, causes, or how the
contributions provided will be used is considered in support of fund raising.
Allocation Methods
.16 The cost allocation methodology used should be rational and system-
atic, it should result in an allocation of joint costs that is reasonable, and it
should be applied consistently given similar facts and circumstances.
Incidental Activities
.17 Some fund-raising activities conducted in conjunction with program or
management and general activities are incidental to such program or manage-
ment and general activities. For example, an entity may conduct a fund-raising
activity by including a generic message, "Contributions to Organization X may
be sent to [address]" on a small area of a message that would otherwise be con-
sidered a program or management and general activity based on its purpose,
audience, and content. That fund-raising activity likely would be considered in-
cidental to the program or management and general activity being conducted.
Similarly, entities may conduct program or management and general activities
in conjunction with fund-raising activities that are incidental to such fund-
raising activities. For example, an entity may conduct a program activity by
including a generic program message such as "Continue to pray for [a partic-
ular cause]" on a small area of a message that would otherwise be considered
fund raising based on its purpose, audience, and content. That program ac-
tivity would likely be considered incidental to the fund-raising activity being
conducted. Similarly, an entity may conduct a management and general activity
by including a brief management and general message—"We recently changed
our phone number. Our new number is 123-4567"—on a small area of a message
that would otherwise be considered a program or fund-raising activity based
9 Some states or other regulatory bodies require that certain disclosures be included when solic-
iting contributions. For purposes of applying the guidance in this SOP, communications that include
such required disclosures are considered fund-raising activities and are not considered management
and general activities.
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on its purpose, audience, and content. That management and general activity
would likely be considered incidental to the program or fund-raising activity
being conducted. In circumstances in which a fund-raising, program, or man-
agement and general activity is conducted in conjunction with another activity
and is incidental to that other activity, and the conditions in this SOP for alloca-
tion are met, joint costs are permitted but not required to be allocated and may
therefore be charged to the functional classification related to the activity that
is not the incidental activity. However, in circumstances in which the program
or management and general activities are incidental to the fund-raising activi-
ties, it is unlikely that the conditions required by this SOP to permit allocation
of joint costs would be met.
Disclosures
.18 Entities that allocate joint costs should disclose the following in the
notes to their financial statements:
a. The types of activities for which joint costs have been incurred
b. A statement that such costs have been allocated
c. The total amount allocated during the period and the portion allo-
cated to each functional expense category
.19 This SOP encourages, but does not require, that the amount of joint
costs for each kind of joint activity be disclosed, if practical.
Effective Date
.20 This SOP is effective for financial statements for years beginning on
or after December 15, 1998. Earlier application is encouraged in fiscal years
for which financial statements have not been issued. If comparative financial
statements are presented, retroactive application is permitted but not required.
The provisions of this Statement of Position need not be applied to
immaterial items.
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Appendix A
Accounting for Joint Activities10
10 Note: This flowchart summarizes certain guidance in this SOP and is not intended as a sub-
stitute for the SOP.
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Appendix B
Background
B.1. As stated in paragraph .04, the provisions of Statement of Position (SOP)
87-2, Accounting for Joint Costs of Informational Materials and Activities of
Not-for-Profit Organizations That Include a Fund-Raising Appeal, have been
difficult to implement and applied inconsistently in practice. That difficulty has
been due in part to the following:
 The second sentence of paragraph 1 of SOP 87-2 stated that "some
of the costs incurred by such organizations are clearly identifiable
with fundraising, such as the cost of fund-raising consulting ser-
vices." It is unclear whether activities that would otherwise be
considered program activities should be characterized as program
activities if they are performed or overseen by professional fund
raisers. Also, it is unclear whether activities would be reported
differently (for example, as program rather than fund raising) de-
pending on whether the fund-raising consultant is compensated
by a predetermined fee or by some other method, such as a per-
centage of contributions raised.
 SOP 87-2 was unclear about whether allocation of costs to fund-
raising expense is required if the activity for which the costs
were incurred would not have been undertaken without the fund-
raising component.
 SOP 87-2 defined joint costs through examples, and it is therefore
unclear what kinds of costs were covered by SOP 87-2. For exam-
ple, it is unclear whether salaries and indirect costs can be joint
costs.
 Some believe the guidance in SOP 87-2 was inadequate to deter-
mine whether joint activities, such as those that request contri-
butions and also list the warning signs of a disease, are designed
to motivate their audiences to action other than to provide con-
tributions to the entity. It is unclear what attributes the targeted
audience should possess in order to conclude that a program func-
tion is being conducted.
B.2. In 1992, the Accounting Standards Executive Committee (AcSEC) un-
dertook a project to supersede SOP 87-2, to provide clearer guidance than that
provided by SOP 87-2, as well as to provide guidance that would improve on the
guidance in SOP 87-2. In September 1993, AcSEC released an exposure draft
of a proposed SOP, Accounting for Costs of Materials and Activities of Not-for-
Profit Organizations and State and Local Governmental Entities That Include
a Fund-Raising Appeal, for public comment. AcSEC received more than 300
comment letters on the exposure draft. AcSEC redeliberated the issues based
on the comments received.
B.3. In 1996, after redeliberating the issues based on the comments received
and making certain revisions to the draft SOP, AcSEC conducted a field test of
the draft SOP. The objectives of the field test were to determine whether the
provisions of the draft SOP were sufficiently clear and definitive to generate con-
sistent and comparable application of the SOP. Based on the field test results,
AcSEC concluded that the provisions of the draft SOP, with certain revisions,
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were sufficiently clear and definitive to generate consistent and comparable
application of the SOP.
B.4. Some respondents who commented on the exposure draft, as well as
some interested parties who followed the project through its due process sub-
sequent to the exposure draft, commented that the SOP should be reexposed
for public comment. Reasons cited include:
 Approximately three years had passed between the end of the
comment period and AcSEC's decision to issue the SOP.
 AcSEC made significant revisions to the SOP subsequent to re-
leasing the exposure draft for comment.
Considering whether a proposed standard should be reexposed for public
comment is inherently a subjective process. Factors that AcSEC considered
include—
 The significance of changes made to the exposure draft and
whether those changes result in guidance that the public did not
have an opportunity to consider.
 Whether the scope was revised in such a way that affected entities
did not have an opportunity to comment.
 New information about or changes in the nature of the transac-
tions being considered, practice, or other factors.
AcSEC believes that the length of time between exposure and final issuance is
not pertinent to whether the SOP should be reexposed for public comment.
B.5. Based on consideration of the factors identified, AcSEC believes that the
SOP should not be reexposed for public comment. AcSEC notes that although
the SOP has been revised based on comments received on the exposure draft,
those revisions do not change the overall model in the SOP. Those revisions
were made primarily to clarify the SOP and improve its operationality. Further,
AcSEC believes that the project received a high level of attention from inter-
ested parties. AcSEC provided working drafts to interested parties and those
parties provided input throughout the process, up to and including the Finan-
cial Accounting Standard Board's and the Governmental Accounting Standards
Board's clearance of the SOP for issuance.
B.6. Appendix C [paragraph .23] discusses the key issues in the exposure
draft and comments received on those issues, as well as the basis for AcSEC's
conclusions on those and certain other issues.
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Appendix C
Basis for Conclusions
C.1. This section discusses considerations that were deemed significant by
members of the Accounting Standards Executive Committee (AcSEC) in reach-
ing the conclusions in this Statement of Position (SOP). It includes reasons for
accepting certain views and rejecting others. Individual AcSEC members gave
greater weight to some factors than to others.
Overall Framework
C.2. This SOP uses the model in SOP 87-2, Accounting for Joint Costs of
Informational Materials and Activities of Not-for-Profit Organizations That In-
clude a Fund-Raising Appeal, as a starting point and clarifies guidance that
was unclear, provides more detailed guidance, revises some guidance, and ex-
pands the scope of costs covered to include all costs of joint activities. The model
established by SOP 87-2 was to account for joint costs as fund raising unless an
entity could demonstrate that a program or management and general function
had been conducted. SOP 87-2 used verifiable indications of the reasons for
conducting the activity, such as content, audience, the action requested, if any,
and other corroborating evidence as a basis for determining whether a program
or management and general function had been conducted.
C.3. On an overall basis, the majority of respondents who commented on
the September 1993 exposure draft of a proposed SOP, Accounting for Costs
of Materials and Activities of Not-for-Profit Organizations and State and Local
Governmental Entities That Include a Fund-Raising Appeal, opposed it, for
various reasons, including the following:
 The guidance in SOP 87-2 is operational, results in sound financial
reporting, and should be retained.
 The guidance in SOP 87-2 should be retained but clarified.
 The guidance proposed in the exposure draft should be revised.
(Some commented that it overstates fund raising; others com-
mented that it understates fund raising.)
C.4. AcSEC concluded that it supports the model in the exposure draft, sub-
ject to certain revisions. AcSEC believes that this SOP provides clear, detailed
accounting guidance that, when applied, will increase comparability of financial
statements. Those statements will also include more meaningful disclosures
without incurring increased costs.
C.5. Some respondents commented that the model in the exposure draft
would adversely affect entities both financially and operationally. Various rea-
sons were given, including the following:
 It would inhibit the ability of entities, particularly small entities
and entities that raise contributions through direct solicitations,
to generate the necessary revenue to perform their program ser-
vices.
 Most entities would not meet the criteria in this SOP for reporting
costs of joint activities as program or management and general,
because they must combine their mission statements, public in-
formation and education, and fund-raising appeals due to a lack
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of resources. Some noted that this may result in unsatisfactory
ratings from public watchdog groups.
AcSEC did not find these arguments compelling. This SOP provides accounting
guidance; it provides no guidance concerning how entities should undertake
their activities. Also, this SOP does not prohibit allocation merely because ac-
tivities carrying out different functions are combined. In fact, this SOP provides
guidance for reporting costs as program or management and general in circum-
stances in which those activities are combined with fund-raising. Moreover,
actions taken by financial statement users are not the direct result of the re-
quirements of this SOP. Rather, those actions may result from more relevant
and useful information on which to base decisions.
C.6. Some respondents commented that the exposure draft is biased toward
reporting expenses as fund raising. AcSEC believes that determining whether
the costs of joint activities should be classified as program, management and
general, or fund raising sometimes is difficult, and such distinctions sometimes
are subject to a high degree of judgment. AcSEC believes that external finan-
cial statement users focus on and have perceptions about amounts reported as
program, management and general, and fund raising. That focus and those per-
ceptions provide incentives for entities to report expenses as program or man-
agement and general rather than fund raising. Therefore, in circumstances in
which joint activities are conducted, a presumption exists that expenses should
be reported as fund raising rather than as program or management and gen-
eral. The criteria in this SOP provide guidance for entities to overcome that
presumption.
Accounting for Joint Activities
C.7. This SOP requires that if any of the criteria of purpose, audience, and
content are not met, all costs of the activity should be reported as fund raising,
including costs that otherwise might be considered program or management
and general costs if they had been incurred in a different activity, subject to
the exception in the following sentence. Costs of goods or services provided in
exchange transactions that are part of joint activities, such as costs of direct
donor benefits of a special event (for example, a meal), should not be reported
as fund raising. (This SOP expands on the model established by SOP 87-2 by
including all costs of joint activities other than costs of goods or services pro-
vided in exchange transactions, rather than merely joint costs.) AcSEC believes
that the criteria of purpose, audience, and content are each relevant in deter-
mining whether a joint activity should be reported as fund raising, program,
or management and general because each provides significant evidence about
the benefits expected to be obtained by undertaking the activity.
C.8. Some respondents commented that reporting costs that otherwise might
be considered program or management and general costs if they had been in-
curred in a different activity as fund raising is misleading and that the scope
of the SOP should include only joint costs of joint activities. Some commented
that reporting costs that otherwise might be considered program or manage-
ment and general costs if they had been incurred in a different activity as fund
raising conflicts with Financial Accounting Standards Board (FASB) Statement
of Financial Accounting Standards No. 117, Financial Statements of Not-for-
Profit Organizations, which defines fund raising, program, and management
and general and requires not-for-profit organizations (NPOs) to report infor-
mation about expenses using those functional classifications.
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C.9. AcSEC believes that the purpose for which costs other than joint costs
are incurred may be fund raising, program, or management and general, de-
pending on the context in which they are used in the activity undertaken. For
example, a program-related pamphlet may be sent to an audience in need of
the program. In that context, the pamphlet is used for program purposes. How-
ever, in order to demonstrate to potential donors that the entity's programs are
worthwhile, that same pamphlet may be sent to an audience that is likely to
contribute, but that has no need or reasonable potential for use of the program.
In that context, the pamphlet is used for fund raising. AcSEC believes this
broader scope will result in more comparability and more meaningful financial
reporting by covering all costs of activities that include fund raising and by as-
signing those costs to the function for which they are incurred, consistent with
the guidance in Statement No. 117.
C.10. AcSEC believes that costs of goods or services provided in exchange
transactions should not be charged to fund raising because those costs are
incurred in exchange for revenues other than contributions.
Criteria of Purpose, Audience, and Content
Call For Action
C.11. The definition of program in FASB Statement No. 117 includes public
education. As noted in paragraph C.6, AcSEC believes that in circumstances in
which joint activities are conducted, a presumption exists that expenses should
be reported as fund raising rather than as program or management and general.
AcSEC believes that in order to overcome that presumption, it is not enough
that (a) the purpose of the activity include educating the public about causes,
(b) the audience has a need or reasonable potential for use of any educational
component of the activity pertaining to causes, or (c) the audience has the
ability to assist the entity in meeting the goals of the program component of
the activity by becoming educated about causes. Therefore, AcSEC concluded
that for purposes of this SOP, in order to conclude that the criteria of purpose,
audience, and content are met program activities are required to call for specific
action by the recipient (other than becoming educated about causes) that will
help accomplish the entity's mission. As discussed in paragraph .09, in certain
circumstances educational activities may call for specific action by the recipient
that will help accomplish the entity's mission.
Purpose
C.12. AcSEC believes meeting the purpose criterion demonstrates that the
purpose of the activity includes accomplishing program or management and
general functions. Inherent in the notion of a joint activity is that the activity
has elements of more than one function. Accordingly, the purpose criterion
provides guidance for determining whether the purpose of the activity includes
accomplishing program or management and general functions in addition to
fund raising.
Compensation and Evaluation Tests
C.13. The exposure draft proposed that all costs of the joint activity should
be charged to fund raising if (a) substantially all compensation or fees for per-
forming the activity are based on amounts raised or (b) the evaluation of the
party performing the activity is based on amounts raised. Some respondents
commented that basing the method of compensation or evaluating the perfor-
mance of the party performing the activity based on contributions raised should
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not lead to the conclusion that all costs of the activity should be charged to fund
raising. Others commented that the method of compensation is unrelated to
whether the purpose criterion is met. The reasons given included the following:
 It is counterintuitive to imply that those performing multipurpose
activities that include fund raising would not be compensated or
evaluated based on amounts raised.
 Such guidance would create a bias toward entities that use em-
ployees to raise contributions and against entities that hire pro-
fessional fund raisers and public relations firms and is therefore
not neutral.
Some respondents gave examples of circumstances in which substantially all
compensation is based on contributions raised and asserted that the activity
was nevertheless a program activity. In each of those examples, AcSEC consid-
ered all the facts presented and concluded that the activity was fund raising.
C.14. AcSEC continues to support the spirit of the proposed guidance, be-
cause AcSEC believes that basing a majority of compensation on funds raised
is persuasive evidence that the activity is a fund-raising activity. Nevertheless,
AcSEC believes that the proposed guidance was unclear and would be difficult
to implement, primarily because of the broad definition of "based on contri-
butions raised" included in the glossary of the exposure draft. In connection
with that issue, AcSEC was concerned that any joint activities performed by
a fund-raising department or by individuals whose duties include fund rais-
ing, such as executive officers of small NPOs who are employed based on their
ability to raise contributions, would be required to be reported as fund raising
because the compensation of the parties performing those activities is based
on amounts raised. Also, AcSEC had concerns that it would be difficult to de-
termine whether fixed contract amounts were negotiated based on expected
contributions. Therefore, AcSEC concluded that the compensation test should
be revised to provide that the purpose criterion is not met if a majority of com-
pensation or fees for any party's performance of any component of the discrete
joint activity varies based on contributions raised for that discrete joint activity.
AcSEC believes that guidance is sound and is operational.
C.15. AcSEC believes that the guidance in paragraph .10a is not biased
against entities that hire professional fund raisers, because it applies to the
entity's employees as well as professional fund raisers. For example, if a ma-
jority of an employee's compensation or fees for performing a component of a
discrete joint activity varies based on contributions raised for that discrete joint
activity, the purpose criterion is not met.
Similar Function-Similar Medium Test
C.16. Some respondents misinterpreted the exposure draft as providing that,
in order to meet the purpose criterion, the program or management and gen-
eral activity must be conducted without the fund-raising component, using the
same medium and on a scale that is similar to or greater than the program or
management and general component of the activity being accounted for. That
was not a requirement proposed by the exposure draft. The exposure draft pro-
posed that meeting that condition would result in meeting the purpose criterion.
Failing the criterion merely leads to consideration of other evidence, such as
the indicators in paragraph .11. AcSEC has revised the SOP to state this more
clearly.
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Other Evidence
C.17. The compensation test and the similar function-similar medium test
may not always be determinative because the attributes that they consider
may not be present. Therefore, this SOP includes indicators that should be
considered in circumstances in which the compensation test and the similar
function-similar medium test are not determinative. The nature of those in-
dicators is such that they may be present in varying degrees. Therefore, all
available evidence, both positive and negative, should be considered to deter-
mine whether, based on the weight of that evidence, the purpose criterion is
met.
Audience
C.18. The exposure draft proposed that if the audience for the materials or
activities is selected principally on its ability or likelihood to contribute, the
audience criterion is not met and all the costs of the activity should be charged
to fund raising. Further, the exposure draft proposed that if the audience is
selected principally based on its need for the program or because it can assist
the entity in meeting its program goals other than by financial support provided
to the entity, the audience criterion is met. Some respondents commented that
that audience criterion is too narrow, because it is based on the principal reason
for selecting the audience. They asserted that for some activities no principal
reason exists for selecting an audience; entities select the audience for those
activities for multiple reasons, such as both the audience's ability to contribute
and its ability to help meet program goals. Some commented that for some
activities, entities select audiences that have provided past financial support
because, by providing financial support, those audiences have expressed an
interest in the program.
C.19. AcSEC believes that meeting the audience criterion should demon-
strate that the audience is selected because it is a suitable audience for accom-
plishing the activity's program or management and general functions. There-
fore, the reasons for selecting the audience should be consistent with the
program or management and general content of the activity. However, AcSEC
believes it is inherent in the notion of joint activities that the activity has ele-
ments of more than one function, including fund raising, and acknowledges that
it may be difficult to determine the principal reason for selecting the audience.
Accordingly, AcSEC concluded that if the audience includes prior donors or is
otherwise selected based on its ability or likelihood to contribute, a rebuttable
presumption should exist that the audience was selected to raise funds. AcSEC
believes that the reasons for selecting the audience that can overcome that pre-
sumption, which are included in paragraph .13 of this SOP, demonstrate that
the audience is selected because it is a suitable audience for accomplishing the
activity's program or management and general functions based on the program
or management and general content of the activity.
Content
C.20. AcSEC believes that meeting the content criterion demonstrates that
the content of the activity supports program or management and general func-
tions. AcSEC believes that accounting guidance should not impose value judg-
ments about whether the entity's mission, programs, and responsibilities are
worthwhile. Therefore, whether the content criterion is met depends on the
relationship of the content to the entity's mission, programs, and management
and general responsibilities.
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C.21. Paragraph .14 provides that, to meet the content criterion, program
activities should call for specific action by the recipient that will help accom-
plish the entity's mission. The exposure draft proposed that slogans, general
calls to prayer, and general calls to protest do not meet the content criterion;
some respondents disagreed. AcSEC concluded that this SOP should be silent
concerning whether slogans, general calls to prayer, and general calls to protest
are calls to action that meet the content criterion. AcSEC believes that deter-
mining whether those items are calls to action that meet the content criterion
requires judgments based on the particular facts and circumstances.
C.22. Some respondents commented that educating the public about causes
without calling for specific action should satisfy the content criterion. They
noted that this is particularly relevant for NPOs subject to Internal Revenue
Code (IRC) Section 501(c)4, because those NPOs are involved in legislative
reform. Also, some noted that it may be the entity's mission or goal to educate
the public about causes. They believe that, in those cases, the NPO's program is
to educate the public about causes without necessarily calling for specific action
by the recipient.
C.23. As discussed in paragraph C.11, AcSEC concluded that education that
does not motivate the audience to action is in fact done in support of fund raising.
However, this SOP acknowledges that some educational messages motivate
the audience to specific action, and those messages meet the content criterion.
AcSEC believes that that provision will result in the activities of some NPOs
subject to IRC Section 501(c)4 (and some other entities, whose mission or goal
is to educate the public) meeting the content criterion.
C.24. Paragraph .13c provides that one way that the audience criterion is met
is if the entity is required to direct the management and general component
of the activity to the particular audience. Further, as discussed in paragraph
D.13, in Discussion of Conclusions, an audience that includes prior donors and
is selected because the entity is required to send them certain information to
comply with requirements of the Internal Revenue Service (IRS) is an example
of an audience that is selected because the entity is required to direct the man-
agement and general component of the activity to that audience. Paragraph
.14b provides that one way that the content criterion is met is if the activity
fulfills one or more of the entity's management and general responsibilities
through a component of the joint activity. However, footnote 9 to paragraph
.14b provides that disclosures made when soliciting contributions to comply
with requirements of states or other regulatory bodies are considered fund-
raising activities, and are not considered management and general activities.
AcSEC considered whether it is inconsistent to conclude both that (a) activ-
ities conducted to comply with requirements of regulatory bodies concerning
contributions that have been received are management and general activities,
and that (b) activities conducted to comply with requirements of regulatory
bodies concerning soliciting contributions are fund-raising activities. AcSEC
believes that those provisions are not inconsistent. AcSEC believes there is a
distinction between (a) requirements that must be met as a result of receiv-
ing contributions and (b) requirements that must be met in order to solicit
contributions. AcSEC believes that activities that are undertaken as a result
of receiving contributions are management and general activities while ac-
tivities that are undertaken in order to solicit contributions are fund-raising
activities.
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Incidental Activities
C.25. Many entities conduct fund-raising activities in conjunction with pro-
gram or management and general activities that are incidental to such program
or management and general activities. Similarly, entities may conduct program
or management and general activities in conjunction with fund-raising activ-
ities that are incidental to such fund-raising activities. Such efforts may be
a practical and efficient means for entities to conduct activities, although the
principal purpose of the activity may be to fulfill either fund-raising, program,
or management and general functions. The exposure draft proposed that inci-
dental activities need not be considered in applying this SOP. Some respondents
disagreed with that guidance, while others commented that it was confusing.
AcSEC continues to support that guidance. AcSEC believes that guidance is
necessary to avoid requiring complex allocations in circumstances in which the
criteria of purpose, audience, and content are met but the activity is overwhelm-
ingly either fund raising, program, or management and general.
Allocation Methods
C.26. Respondents had various comments concerning allocation methods, in-
cluding the following:
 The SOP should focus on allocation methods rather than on cir-
cumstances in which entities should allocate.
 The SOP should prescribe allocation methods.
 The approach taken in the SOP—discussing, rather than requir-
ing or prohibiting allocation methods—is sound.
 Certain allocation methods should be prohibited.
 The SOP should set maximum allocation percentages.
AcSEC believes that no particular allocation method or methods are neces-
sarily more desirable than other methods in all circumstances. Therefore, this
SOP neither prescribes nor prohibits any particular allocation methods. AcSEC
believes entities should apply the allocation methods that result in the most
reasonable cost allocations for their activities. Appendix F [paragraph .26] of
this SOP illustrates several allocation methods, any one of which may result
in a reasonable or unreasonable allocation of costs in particular circumstances.
The methods illustrated are not the only acceptable methods. However, AcSEC
believes that the methods illustrated in this SOP are among those most likely
to result in meaningful cost allocations.
C.27. Accounting Principles Board (APB) Opinion No. 20, Accounting
Changes, states in paragraph 7 that "the term accounting principle includes
'not only accounting principles and practices but also the methods of applying
them.'" APB Opinion 20 also states in paragraphs 15 and 16 that
...In the preparation of financial statements there is a presumption
that an accounting principle once adopted should not be changed in
accounting for events and transactions of a similar type....The pre-
sumption that an entity should not change an accounting principle
may be overcome only if the enterprise justifies the use of an alterna-
tive acceptable accounting principle [allocation method] on the basis
that it is preferable.
A change in cost allocation methodology may be a change in accounting principle
for entities covered by this SOP. Accordingly, paragraph .16 of this SOP provides
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that the cost allocation methodology used should be applied consistently, given
similar facts and circumstances.
Disclosures
C.28. Respondents made various comments concerning the required and en-
couraged disclosures, including recommendations for additional disclosures and
recommendations that certain disclosures be deleted. AcSEC was not persuaded
that the costs of the other disclosures recommended by respondents are justified
by their benefits. AcSEC believes that, with the exception of one disclosure, the
disclosures prescribed by the exposure draft provide relevant information about
the kinds of activities for which joint costs have been incurred and the man-
ner in which those costs are reported in the financial statements. In considering
disclosures proposed by the exposure draft about the allocation method, AcSEC
observed that there are no requirements to disclose methods of allocating other
expenses and questioned the utility of disclosing the allocation method in this
circumstance. AcSEC concluded that the requirement to disclose the allocation
method should be deleted.
C.29. Paragraph .19 encourages, but does not require, certain disclosures. Ac-
SEC believes those disclosures provide useful information but that they should
be encouraged rather than required because the costs of making them may not
be justified by the benefits in all cases.
Effective Date
C.30. Some respondents commented that the effective date should be de-
ferred. AcSEC believes that the accounting systems required to implement this
SOP are already in place and that implementation should be relatively straight-
forward. However, AcSEC acknowledges that some entities may change their
operations based on the reporting that would result from this SOP. Therefore,
AcSEC concluded that this SOP should be effective for financial statements for
years beginning on or after December 15, 1998.
Cost-Benefit
C.31. Some respondents commented that the guidance would increase record
keeping costs. AcSEC believes that implementing this SOP will not significantly
increase record keeping costs, which are primarily the costs of documenting rea-
sons for undertaking joint activities. Further, AcSEC believes that the costs of
making the disclosures required by this SOP should be minimal, because enti-
ties should already have the information that is required to be disclosed. AcSEC
believes that implementing this SOP will result in more relevant, meaningful,
and comparable financial reporting and that the cost of implementing this SOP
will be justified by its benefits.
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Appendix D
Discussion of Conclusions
Scope
D.1. This Statement of Position (SOP) applies only to costs of joint activities.
It does not address allocations of costs in other circumstances.
Reporting Models and Related Requirements
D.2. Paragraph 26 of Financial Accounting Standards Board (FASB) State-
ment of Financial Accounting Standards No. 117, Financial Statements of Not-
for-Profit Organizations, specifies that a statement of activities or notes to the
financial statements should provide information about expenses reported by
their functional classification, such as major classes of program services and
supporting activities. Paragraph 13.34 of the AICPA Audit and Accounting
Guide Not-for-Profit Organizations provides that the financial statements of
not-for-profit organizations (NPOs) should disclose the total fund-raising ex-
penses. [Revised, June 2004, to reflect conforming changes necessary due to
conforming changes made to the AICPA Audit and Accounting Guide Not-for-
Profit Organizations.]
D.3. Governmental Accounting Standards Board (GASB) Statement No. 29,
The Use of Not-for-Profit Accounting and Financial Reporting Principles by Gov-
ernmental Entities, provides that governmental entities should not change their
accounting and financial reporting to apply the provisions of FASB Statements
No. 116, Accounting for Contributions Received and Contributions Made, and
No. 117. GASB Statement No. 29 permits governmental entities that have ap-
plied the accounting and financial reporting principles in SOP 78-10, Account-
ing Principles and Reporting Practices for Certain Nonprofit Organizations, or
in the AICPA Industry Audit Guide Audits of Voluntary Health and Welfare Or-
ganizations modified by all applicable FASB pronouncements issued through
November 30, 1989, and by most applicable GASB pronouncements) to con-
tinue to do so, pending GASB pronouncements on the accounting and financial
reporting model for governmental entities. Alternatively, those governmental
entities are permitted to change to the current governmental financial report-
ing model.‡
D.4. GASB Statement No. 15, Governmental College and University Account-
ing and Financial Reporting Models, requires governmental colleges and uni-
versities to use one of two accounting and financial reporting models. One
model, referred to as the "AICPA College Guide Model," encompasses the ac-
counting and financial reporting guidance in the 1973 AICPA Industry Audit
Guide Audits of Colleges and Universities, as amended by SOP 74-8, Finan-
cial Accounting and Reporting by Colleges and Universities, and as modified by
‡ GASB Statement No. 34, Basic Financial Statements—and Management's Discussion and
Analysis—for State and Local Governments, supersedes the provisions of GASB Statement No. 29,
The Use of Not-for-Profit Accounting and Financial Reporting Principles by Governmental Entities,
relating to the use of the AICPA Not-for-Profit model. See GASB Statement No. 34, including para-
graph 147. The AICPA Audit and Accounting Guide State and Local Governments provides guidance
on the application of this SOP to state and local governments. [Footnote revised, June 2004, to reflect
conforming changes necessary due to the issuance of GASB Statement No. 34.]
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applicable FASB pronouncements issued through November 30, 1989, and all
applicable GASB pronouncements. (The other model, referred to as the "Gov-
ernmental Model," is based on the pronouncements of the National Council on
Governmental Accounting [NCGA] and the GASB.)||
D.5. For state and local governmental entities, some are required to report
expenses by function using the functional classifications of program, manage-
ment and general, and fund raising. Other state and local governmental entities
that report expenses or expenditures by function have a functional structure
that does not include fund raising, program, or management and general. Still
other state and local governmental entities do not report expenses or expen-
ditures by function. Examples of those various reporting requirements are as
follows:#
 Entities applying the accounting and financial reporting prin-
ciples in the AICPA Industry Audit Guide Audits of Voluntary
Health and Welfare Organizations, as well as those that follow
SOP 78-10 and that receive significant amounts of contributions
from the public, are required to report separately the costs of the
fund-raising, program, and management and general functions.
 Entities applying the accounting and financial reporting princi-
ples in the AICPA Industry Audit Guide Audits of Colleges and
Universities, as amended by SOP 74-8, are required to report fund
raising as part of the "institutional support" function.
D.6. As discussed in footnote 3 to paragraph .01 of this SOP, this SOP is
not intended to require reporting the functional classifications of fund raising,
program, and management and general. Rather, those functional classifica-
tions are discussed throughout this SOP for purposes of illustrating how the
guidance in this SOP would be applied by entities that use those functional
classifications. Entities that do not use the functional classifications of fund
raising, program, and management and general should apply the guidance in
this SOP for purposes of accounting for joint activities, using their reporting
model. For example, some entities may conduct membership-development ac-
tivities. As discussed in the Glossary [paragraph .30] of this SOP, if there are
no significant benefits or duties connected with membership, the substance of
the membership-development activities may, in fact, be fund raising. In such
circumstances, the costs of those activities should be charged to fund raising.
To the extent that member benefits are received, membership is an exchange
transaction. In circumstances in which membership development is in part
soliciting revenues from exchange transactions and in part soliciting contribu-
tions and the purpose, audience, and content of the activity are appropriate for
achieving membership development, joint costs should be allocated between
fund raising and the exchange transaction.
|| GASB Statement No. 35, Basic Financial Statements—and Management's Discussion and
Analysis—for Public Colleges and Universities, supersedes GASB Statement No. 15, Governmental
College and University Accounting and Financial Reporting Models. See GASB Statements No. 34
and No. 35. The AICPA Audit and Accounting Guide State and Local Governments provides guidance
on the application of this SOP to governmental (public) colleges and universities. [Footnote revised,
June 2004, to reflect conforming changes necessary due to the issuance of GASB Statement No. 35.]
# This discussion is no longer applicable. See footnotes ‡ and || in paragraphs D.3 and D.4,
respectively. [Footnote added, June 2004, to reflect conforming changes necessary due to the issuance
of GASB Statements No. 34 and No. 35.]
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Assigning Costs of Joint Activities
D.7. Paragraph .07 provides: "If the criteria of purpose, audience, and con-
tent are met, the costs of a joint activity that are identifiable with a particular
function should be charged to that function and joint costs should be allocated
between fund raising and the appropriate program or management and general
function. If any of the criteria are not met, all costs of the joint activity should
be reported as fund-raising costs, including costs that otherwise might be con-
sidered program or management and general costs if they had been incurred in
a different activity...." For example, if the criteria are met, the costs of materi-
als that accomplish program goals and that are unrelated to fund raising, such
as the costs of a program-related pamphlet included in a joint activity, should
be charged to program, while joint costs, such as postage, should be allocated
between fund raising and program. However, if the pamphlet is used in fund-
raising packets and the criteria are not met, the costs of the pamphlets used in
the fund-raising packets, as well as the joint costs, should be charged to fund
raising. (If some pamphlets are used in program activities that include no fund
raising, the cost of the pamphlets used in those separate program activities
that include no fund raising should be charged to program.)
Educational Activities
D.8. Some entities have missions that include educating the public (students)
in areas other than causes. Paragraph .09 provides that, for those entities,
educating the audience in areas other than causes or motivating the audience
to engage in specific activities, such as attending a lecture or class, that will
educate them in areas other than causes is considered a call for specific action
by the recipients that will help accomplish the entity's mission. Educating the
audience about causes or motivating the audience to engage in specific activities
that will educate them about causes without educating them in other subjects is
not considered a call for specific action by the audience that will help accomplish
the entity's mission. An example of a lecture or class that will educate students
in an area other than causes is a lecture on the nesting habits of the bald eagle,
given by the Save the Bald Eagle Society, an NPO whose mission is to save
the bald eagle from extinction and educate the public about the bald eagle. An
example of a lecture or class that will address particular causes is a lecture by
the Bald Eagle Society on the potential extinction of bald eagles and the need
to raise contributions to prevent their extinction. For purposes of applying the
guidance in this SOP, motivating the audience to attend a lecture on the nesting
habits of the bald eagle is a call for specific action that will help accomplish the
entity's mission. If the lecture merely addresses the potential extinction of bald
eagles and the need to raise contributions to prevent their extinction, without
addressing the nesting habits of the bald eagle, motivating the audience to
attend the lecture is not considered a call for specific action by the recipient
that will help accomplish the entity's mission.
D.9. AcSEC notes that most transactions in which a student attends a lecture
or class are exchange transactions and are not joint activities. Such transactions
are joint activities only if the activity includes fund raising.
Audience
D.10. Paragraph .12 provides that a rebuttable presumption exists that the
audience criterion is not met if the audience includes prior donors or is other-
wise selected based on its ability or likelihood to contribute to the entity. That
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presumption can be overcome if the audience is also selected for the program
or management and general reasons specified in paragraph .13. Further, para-
graph .12 provides that in determining whether that presumption is overcome,
entities should consider the extent to which the audience is selected based on
its ability or likelihood to contribute to the entity and contrast that with the
extent to which it is selected for the reasons that may overcome that presump-
tion. Some organizations conduct joint activities that are special events, such
as symposia, dinners, dances, and theater parties, in which the attendee re-
ceives a direct benefit (for example, a meal or theater ticket) and for which the
admission price includes a contribution. For example, it may cost $500 to at-
tend a dinner with a fair value of $50. In that case, the audience is required to
make a $450 contribution in order to attend. In circumstances in which the au-
dience is required to make a contribution to participate in a joint activity, such
as attending a special event, the audience's ability or likelihood to contribute
is a significant factor in its selection. Therefore, in circumstances in which the
audience is required to make a contribution to participate in a joint activity, the
extent to which the audience is selected for the program or management and
general reasons in paragraph .13 must be overwhelmingly significant in order
to rebut the presumption that the audience criterion is not met.
D.11. The source of the names and the characteristics of the audience should
be considered in determining the reason for selecting the audience. Some en-
tities use lists compiled by others to reach new audiences. The source of such
lists may indicate the purpose or purposes for which they were selected. For
example, lists acquired from entities with similar or related programs are more
likely to meet the audience criterion than are lists acquired from entities with
dissimilar or unrelated programs. Also, the characteristics of those on the lists
may indicate the purpose or purposes for which they were selected. For example,
a list based on a consumer profile of those who buy environmentally friendly
products may be useful to an entity whose mission addresses environmental
concerns and could therefore indicate that the audience was selected for its
ability to take action to assist the entity in meeting program goals. However, a
list based on net worth would indicate that the audience was selected based on
its ability or likelihood to contribute, unless there was a correlation between net
worth and the program or management and general components of the activity.
D.12. Some audiences may be selected because they have an interest in or
affinity to the program. For example, homeowners may have an interest in the
homeless because they are sympathetic to the plight of the homeless. Never-
theless, including homeowners in the audience of a program activity to provide
services to the homeless would not meet the audience criterion, because they
do not have a need or reasonable potential for use of services to the homeless.
D.13. Paragraph .13c provides that the audience criterion is met if the en-
tity is required to direct the management and general component of the joint
activity to the particular audience or the audience has reasonable potential for
use of the management and general component. An example of a joint activ-
ity in which the audience is selected because the entity is required to direct
the management and general component of the joint activity to the particular
audience is an activity in which the entity sends a written acknowledgment or
other information to comply with requirements of the Internal Revenue Service
to prior donors and includes a request for contributions. An example of a joint
activity in which the audience is selected because the audience has reasonable
potential for use of the management and general component is an activity in
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which the entity sends its annual report to prior donors and includes a request
for contributions.
Content
D.14. Paragraph .14 provides that, to meet the content criterion, program
activities should call for specific action by the recipient that will help accomplish
the entity's mission. As discussed in the Glossary [paragraph .30], the action
should benefit the recipient or society. Examples of actions that benefit the
recipient (such as by improving the recipient's physical, mental, emotional,
or spiritual health and well-being) or society (such as by addressing societal
problems) include the following:
a. Actions that benefit the recipient:
 Stop smoking. Specific methods, instructions, references,
and resources should be suggested.
 Do not use alcohol or drugs. Specific methods, instructions,
references, and resources should be suggested.
b. Actions that benefit society:
 Write or call. The party to communicate with and the sub-
ject matter to be communicated should be specified.
 Complete and return the enclosed questionnaire. The re-
sults of the questionnaire should help the entity achieve
its mission. For example, if the entity discards the ques-
tionnaire, it does not help the entity achieve its mission.
 Boycott. The particular product or company to be boy-
cotted should be specified.
D.15. Paragraph .14b provides that to meet the content criterion, manage-
ment and general functions are required to fulfill one or more of the entity's
management and general responsibilities through a component of the joint ac-
tivity. Some states or other regulatory bodies require that certain disclosures
be included when soliciting contributions. Paragraph .14, footnote 9, of this
SOP provides that for purposes of applying the guidance in this SOP, commu-
nications that include such required disclosures are considered fund-raising
activities and are not considered management and general activities. Some
examples of such disclosures include the following:
 Information filed with the attorney general concerning this chari-
table solicitation may be obtained from the attorney general of [the
state] by calling 123-4567. Registration with the attorney general
does not imply endorsement.
 A copy of the registration and financial information may be ob-
tained from the Division of Consumer Services by calling toll-free,
within [the state], 1-800-123-4567. Registration does not imply en-
dorsement, approval, or recommendation by [the state].
 Information about the cost of postage and copying, and other infor-
mation required to be filed under [the state] law, can be obtained
by calling 123-4567.
 The organization's latest annual report can be obtained by calling
123-4567.
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Allocation Methods
D.16. Paragraph .16 of this SOP states, "The cost allocation methodology
used should be rational and systematic, it should result in an allocation of joint
costs that is reasonable, and it should be applied consistently given similar facts
and circumstances." The allocation of joint costs should be based on the degree
to which costs were incurred for the functions to which the costs are allocated
(that is, program, management and general, or fund raising). For purposes of
determining whether the allocation methodology for a particular joint activity
should be consistent with methodologies used for other particular joint activi-
ties, facts and circumstances that may be considered include factors related to
the content and relative costs of the components of the activity. The audience
should not be considered in determining whether the facts and circumstances
are similar for purposes of determining whether the allocation methodology
for a particular joint activity should be consistent with methodologies used for
other particular joint activities.
Practicability of Measuring Joint Costs
D.17. The Glossary [paragraph .30] of this SOP includes a definition of joint
costs. Some costs, such as utilities, rent, and insurance, commonly referred to
as indirect costs, may be joint costs. For example, the telephone bill for a de-
partment that, among other things, prepares materials that include both fund-
raising and program components may commonly be referred to as an indirect
cost. Such telephone bills may also be joint costs. However, for some entities, it
is impracticable to measure and allocate the portion of the costs that are joint
costs. Considerations about which joint costs should be measured and allocated,
such as considerations about materiality and the costs and benefits of develop-
ing and providing the information, are the same as considerations about cost
allocations in other circumstances.
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Appendix E
Illustrations of Applying the Criteria of Purpose, Audience, and
Content to Determine Whether a Program or Management and
General Activity Has Been Conducted
Illustration 1
Facts
E.1. Entity A's mission is to prevent drug abuse. Entity A's annual report
states that one of its objectives in fulfilling that mission is to assist parents in
preventing their children from abusing drugs.
E.2. Entity A mails informational materials to the parents of all junior high
school students explaining the prevalence and dangers of drug abuse. The ma-
terials encourage parents to counsel children about the dangers of drug abuse
and inform them about how to detect drug abuse. The mailing includes a re-
quest for contributions. Entity A conducts other activities informing the public
about the dangers of drug abuse and encouraging parents to counsel their chil-
dren about drug abuse that do not include requests for contributions and that
are conducted in different media. Entity A's executive director is involved in
the development of the informational materials as well as the request for con-
tributions. The executive director's annual compensation includes a significant
bonus if total annual contributions exceed a predetermined amount.
Conclusion
E.3. The purpose, audience, and content criteria are met, and the joint costs
should be allocated.
E.4. The activity calls for specific action by the recipient (encouraging par-
ents to counsel children about the dangers of drug abuse and informing them
about how to detect drug abuse) that will help accomplish the entity's mission.
Therefore, the guidance in paragraph .10 should be considered. Neither of the
factors in paragraph .10a or .10b is determinative of whether the purpose cri-
terion is met. (Although Entity A's executive director's annual compensation
varies based on annual contributions, the executive director's compensation
does not vary based on contributions raised for this discrete joint activity.)
Therefore, other evidence, such as the indicators in paragraph .11, should be
considered. The purpose criterion is met based on the other evidence, because
(a) the program component of this activity calls for specific action by the recipi-
ent (encouraging parents to counsel children about the dangers of drug abuse)
that will help accomplish the entity's mission, and it otherwise conducts the
program activity in this illustration without a request for contributions, and
(b) performing such programs helps accomplish Entity A's mission. (Note that
had Entity A conducted the activity using the same medium on a scale that is
similar to or greater than the scale on which it is conducted with the request
for contributions, the purpose criterion would have been met under paragraph
.10b.)
E.5. The audience criterion is met because the audience (parents of junior
high school students) is selected based on its need to use or reasonable potential
for use of the action called for by the program component.
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E.6. The content criterion is met because the activity calls for specific action
by the recipient (encouraging parents to counsel children about the dangers of
drug abuse and informing them about how to detect drug abuse) that will help
accomplish the entity's mission (assisting parents in preventing their children
from abusing drugs), and it explains the need for and benefits of the action (the
prevalence and dangers of drug abuse).
Illustration 2
Facts
E.7. Entity B's mission is to reduce the incidence of illness from ABC disease,
which afflicts a broad segment of the population. One of Entity B's objectives
in fulfilling that mission is to inform the public about the effects and early
warning signs of the disease and specific action that should be taken to prevent
the disease.
E.8. Entity B maintains a list of its prior donors and sends them donor re-
newal mailings. The mailings include messages about the effects and early
warning signs of the disease and specific action that should be taken to pre-
vent it. That information is also sent to a similar-sized audience but without
the request for contributions. Also, Entity B believes that recent donors are
more likely to contribute than nondonors or donors who have not contributed
recently. Prior donors are deleted from the mailing list if they have not con-
tributed to Entity B recently, and new donors are added to the list. There is no
evidence of a correlation between recent contributions and participation in the
program component of the activity. Also, the prior donors' need to use or rea-
sonable potential for use of the messages about the effects and early warning
signs of the disease and specific action that should be taken to prevent it is an
insignificant factor in their selection.
Conclusion
E.9. The purpose and content criteria are met. The audience criterion is not
met.11 All costs, including those that might otherwise be considered program or
management and general costs if they had been incurred in a different activity,
should be charged to fund raising.
E.10. The activity calls for specific action by the recipient (action that should
be taken to prevent ABC disease) that will help accomplish the entity's mission.
Therefore, the guidance in paragraph .10 should be considered. The purpose
criterion is met because (a) the program component of the activity calls for
specific action by the recipient that will help accomplish the entity's mission
(to reduce the incidence of illness from the disease), and (b) the program is
also conducted using the same medium on a scale that is similar to or greater
than the scale on which it is conducted with the request for contributions (a
similar mailing is done without the request for contributions, to a similar-sized
audience).
E.11. The audience criterion is not met. The rebuttable presumption that the
audience criterion is not met because the audience includes prior donors is not
11 Paragraph .07 of this SOP provides that all costs of joint activities, except for costs of goods
or services provided in exchange transactions that are part of joint activities, such as costs of direct
donor benefits of a special event (for example, a meal), should be charged to fund raising if any of
the criteria of purpose, audience, or content are not met. Accordingly, if one or more criteria are not
met, the other criteria need not be considered. However, the illustrations in this Appendix provide
conclusions about whether each of the criteria would be met in circumstances in which one or more
criteria are not met in order to provide further guidance.
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overcome in this illustration. Although the audience has a need to use or rea-
sonable potential for use of the program component, that was an insignificant
factor in its selection.
E.12. The content criterion is met because the activity calls for specific action
by the recipient (actions to prevent ABC disease) that will help accomplish the
entity's mission (to reduce the incidence of ABC disease), and it explains the
need for and benefits of the action (to prevent ABC disease).
Illustration 3
Facts
E.13. Entity C's mission is to reduce the incidence of illness from ABC dis-
ease, which afflicts a broad segment of the population. One of Entity C's objec-
tives in fulfilling that mission is to increase governmental funding for research
about ABC disease.
E.14. Entity C maintains a list of its prior donors and its employees call
them on the telephone reminding them of the effects of ABC disease, asking for
contributions, and encouraging them to contact their elected officials to urge
increased governmental funding for research about ABC disease. The callers
are educated about ABC, do not otherwise perform fund-raising functions, and
are not compensated or evaluated based on contributions raised. Entity C's
research indicates that recent donors are likely to contact their elected officials
about such funding while nonrecent donors are not. Prior donors are deleted
from the calling list if they have not contributed to Entity C recently, and new
donors are added to the list.
Conclusion
E.15. The purpose, audience, and content criteria are met, and the joint costs
should be allocated.
E.16. The activity calls for specific action by the recipient (contacting elected
officials concerning funding for research about ABC disease) that will help ac-
complish the entity's mission. Therefore, the guidance in paragraph .10 should
be considered. Neither of the factors in paragraph .10a or .10b is determina-
tive of whether the purpose criterion is met. Therefore, other evidence, such as
the indicators in paragraph .11, should be considered. The purpose criterion
is met based on the other evidence, because (a) the qualifications and duties
of the personnel performing the activity indicate that it is a program activity
(the callers are educated about ABC and do not otherwise perform fund-raising
functions), (b) the method of compensation for performing the activity does not
indicate that it is a fund-raising activity (the employees are not compensated
or evaluated based on contributions raised), and (c) performing such programs
helps accomplish Entity C's mission.
E.17. The audience criterion is met because the audience (recent donors)
is selected based on its ability to assist Entity C in meeting the goals of the
program component of the activity (recent donors are likely to contact their
elected officials about such funding while nonrecent donors are not).
E.18. The content criterion is met because the activity calls for specific action
by the recipient (contacting elected officials concerning funding for research
about ABC disease) that will help accomplish the entity's mission (to reduce
the incidence of ABC disease), and it explains the need for and benefits of the
action (to prevent ABC disease).
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Illustration 4
Facts
E.19. Entity D's mission is to improve the quality of life for senior citizens.
One of Entity D's objectives included in that mission is to increase the physical
activity of senior citizens. One of Entity D's programs to attain that objective
is to send representatives to speak to groups about the importance of exercise
and to conduct exercise classes.
E.20. Entity D mails a brochure on the importance of exercise that encour-
ages exercise in later years to residents over the age of sixty-five in three zip code
areas. The last two pages of the four-page brochure include a perforated contri-
bution remittance form on which Entity D explains its program and makes an
appeal for contributions. The content of the first two pages of the brochure is
primarily educational; it explains how seniors can undertake a self-supervised
exercise program and encourages them to undertake such a program. In addi-
tion, Entity D includes a second brochure on various exercise techniques that
can be used by those undertaking an exercise program.
E.21. The brochures are distributed to educate people in this age group about
the importance of exercising, to help them exercise properly, and to raise contri-
butions for Entity D. These objectives are documented in a letter to the public
relations firm that developed the brochures. The audience is selected based on
age, without regard to ability to contribute. Entity D believes that most of the
recipients would benefit from the information about exercise.
Conclusion
E.22. The purpose, audience, and content criteria are met, and the joint
costs should be allocated. (Note that the costs of the second brochure should
be charged to program because all the costs of the brochure are identifiable
with the program function.)
E.23. The activity calls for specific action by the recipient (exercising) that
will help accomplish the entity's mission. Therefore, the guidance in paragraph
.10 should be considered. Neither of the factors in paragraph .10a or .10b is de-
terminative of whether the purpose criterion is met. Therefore, other evidence,
such as the indicators in paragraph .11, should be considered. The purpose cri-
terion is met based on the other evidence, because (a) performing such programs
helps accomplish Entity D's mission, and (b) the objectives of the program are
documented in a letter to the public relations firm that developed the brochure.
E.24. The audience criterion is met because the audience (residents over
sixty-five in certain zip codes) is selected based on its need to use or reasonable
potential for use of the action called for by the program component.
E.25. The content criterion is met because the activity calls for specific action
by the recipient (exercising) that will help accomplish the entity's mission (in-
creasing the physical activity of senior citizens), and the need for and benefits
of the action are clearly evident (explains the importance of exercising).
Illustration 5
Facts
E.26. The facts are the same as those in Illustration 4, except that Entity E
employs a fund-raising consultant to develop the first brochure and pays that
consultant 30 percent of contributions raised.
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Conclusion
E.27. The content and audience criteria are met. The purpose criterion is not
met, however, because a majority of compensation or fees for the fund-raising
consultant varies based on contributions raised for this discrete joint activity
(the fund-raising consultant is paid 30 percent of contributions raised). All costs
should be charged to fund raising, including the costs of the second brochure and
any other costs that otherwise might be considered program or management
and general costs if they had been incurred in a different activity.
Illustration 6
Facts
E.28. Entity F's mission is to protect the environment. One of Entity F's
objectives included in that mission is to take action that will increase the portion
of waste recycled by the public.
E.29. Entity F conducts a door-to-door canvass of a community that recycles a
low portion of its waste. The purpose of the activity is to help increase recycling
by educating the community about environmental problems created by not re-
cycling, and to raise contributions. Based on the information communicated by
the canvassers, the need for and benefits of the action are clearly evident. The
ability or likelihood of the residents to contribute is not a basis for communi-
ties selected, and all neighborhoods in the geographic area are covered if their
recycling falls below a predetermined rate. The canvassers are selected from
individuals who are well-informed about the organization's environmental con-
cerns and programs and who previously participated as volunteers in program
activities such as answering environmental questions directed to the organi-
zation and developing program activities designed to influence legislators to
take actions addressing those concerns. The canvassers have not previously
participated in fund-raising activities.
Conclusion
E.30. The purpose, audience, and content criteria are met, and the joint costs
should be allocated.
E.31. The activity calls for specific action by the recipient (implicitly—to help
increase recycling) that will help accomplish the entity's mission. Therefore, the
guidance in paragraph .10 should be considered. Neither of the factors in para-
graph .10a or .10b is determinative of whether the purpose criterion is met.
Therefore, other evidence, such as the indicators in paragraph .11, should be
considered. The purpose criterion is met based on the other evidence, because
(a) the qualifications and duties of the personnel performing the activity indi-
cate that it is a program activity (the canvassers are selected from individuals
who are well-informed about the organization's environmental concerns and
programs and who previously participated as volunteers in program activities
such as answering environmental questions directed to the organization and
developing program activities designed to influence legislators to take actions
addressing those concerns), and (b) performing such programs helps accomplish
Entity F's mission (to protect the environment).
E.32. The audience criterion is met because the audience (neighborhoods
whose recycling falls below a predetermined rate) is selected based on its need
to use or reasonable potential for use of the action called for by the program
component.
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E.33. The content criterion is met because the activity calls for specific action
by the recipient (implicitly—to help increase recycling) that will help accom-
plish the entity's mission (to protect the environment), and the need for and
benefits of the action are clearly evident (increased recycling will help alleviate
environmental problems).
Illustration 7
Facts
E.34. Entity G's mission is to provide summer camps for economically disad-
vantaged youths. Educating the families of ineligible youths about the camps
is not one of the program objectives included in that mission.
E.35. Entity G conducts a door-to-door solicitation campaign for its camp
programs. In the campaign, volunteers with canisters visit homes in middle-
class neighborhoods to collect contributions. Entity G believes that people in
those neighborhoods would not need the camp's programs but may contribute.
The volunteers explain the camp's programs, including why the disadvantaged
children benefit from the program, and distribute leaflets to the residents re-
gardless of whether they contribute to the camp. The leaflets describe the camp,
its activities, who can attend, and the benefits to attendees. Requests for con-
tributions are not included in the leaflets.
Conclusion
E.36. The purpose, audience, and content criteria are not met. All costs
should be charged to fund raising.
E.37. The activity does not include a call for specific action because it only
educates the audience about causes (describing the camp, its activities, who
can attend, and the benefits to attendees). Therefore, the purpose criterion is
not met.
E.38. The audience criterion is not met, because the audience is selected
based on its ability or likelihood to contribute, rather than based on (a) its need
to use or reasonable potential for use of the action called for by the program
component, or (b) its ability to take action to assist the entity in meeting the
goals of the program component of the activity. (Entity G believes that people in
those neighborhoods would not need the camp's programs but may contribute.)
E.39. The content criterion is not met because the activity does not call for
specific action by the recipient. (The content educates the audience about causes
that the program is designed to address without calling for specific action.)
Illustration 8
Facts
E.40. Entity H's mission is to educate the public about lifesaving techniques
in order to increase the number of lives saved. One of Entity H's objectives in
fulfilling that mission, as stated in the minutes of the board's meetings, is to
produce and show television broadcasts including information about lifesaving
techniques.
E.41. Entity H conducts an annual national telethon to raise contributions
and to reach the American public with lifesaving educational messages, such
as summary instructions concerning dealing with certain life-threatening situ-
ations. Based on the information communicated by the messages, the need for
and benefits of the action are clearly evident. The broadcast includes segments
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describing Entity H's services. Entity H broadcasts the telethon to the entire
country, not merely to areas selected on the basis of giving potential or prior
fund raising results. Also, Entity H uses national television broadcasts devoted
entirely to lifesaving educational messages to conduct program activities with-
out fund raising.
Conclusion
E.42. The purpose, audience, and content criteria are met, and the joint costs
should be allocated.
E.43. The activity calls for specific action by the recipient (implicitly—to save
lives) that will help accomplish the entity's mission. Therefore, the guidance in
paragraph .10 should be considered. The purpose criterion is met because (a)
the program component of the activity calls for specific action by the recipient
that will help accomplish Entity H's mission (to save lives by educating the
public), and (b) a similar program activity is conducted without the fund rais-
ing using the same medium and on a scale that is similar to or greater than the
scale on which it is conducted with the appeal (Entity H uses national televi-
sion broadcasts devoted entirely to lifesaving educational messages to conduct
program activities without fund raising).
E.44. The audience criterion is met because the audience (a broad segment
of the population) is selected based on its need to use or reasonable potential
for use of the action called for by the program activity.
E.45. The content criterion is met because the activity calls for specific action
by the recipient (implicitly—to save lives) that will help accomplish the entity's
mission (to save lives by educating the public), and the need for and benefits of
the action are clearly evident (saving lives is desirable).
Illustration 9
Facts
E.46. Entity I's mission is to provide food, clothing, and medical care to chil-
dren in developing countries.
E.47. Entity I conducts television broadcasts in the United States that de-
scribe its programs, show the needy children, and end with appeals for con-
tributions. Entity I's operating policies and internal management memoranda
state that these programs are designed to educate the public about the needs
of children in developing countries and to raise contributions. The employees
producing the programs are trained in audiovisual production and are familiar
with Entity I's programs. Also, the executive producer is paid $25,000 for this
activity, with a $5,000 bonus if the activity raises over $1,000,000.
Conclusion
E.48. The purpose, audience, and content criteria are not met. All costs
should be charged to fund raising.
E.49. The activity does not include a call for specific action because it only
educates the audience about causes (describing its programs and showing the
needy children). Therefore, the purpose criterion is not met. (Also, note that if
the factor in paragraph .10a were considered, it would not be determinative of
whether the purpose criterion is met. Although the executive producer will be
paid $5,000 if the activity raises over $1,000,000, that amount would not be a
majority of the executive producer's total compensation for this activity, because
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$5,000 would not be a majority of the executive producer's total compensation of
$30,000 for this activity. Also, note that if other evidence, such as the indicators
in paragraph .11, were considered, the purpose criterion would not be met based
on the other evidence. Although the qualifications and duties of the personnel
performing the activity indicate that the employees producing the program are
familiar with Entity I's programs, the facts that some, but less than a majority,
of the executive producer's compensation varies based on contributions raised,
and that the operating policies and internal management memoranda state
that these programs are designed to educate the public about the needs of
children in developing countries [with no call for specific action by recipients]
and to raise contributions, indicate that the purpose is fund raising.)
E.50. The audience criterion is not met because the audience is selected based
on its ability or likelihood to contribute, rather than based on (a) its need to
use or reasonable potential for use of the action called for by the program com-
ponent, or (b) its ability to take action to assist the entity in meeting the goals
of the program component of the activity. (The audience is a broad segment of
the population of a country that is not in need of or has no reasonable potential
for use of the program activity.)
E.51. The content criterion is not met because the activity does not call for
specific action by the recipient that will help accomplish the entity's mission.
(The content educates the audience about the causes without calling for specific
action.)
Illustration 10
Facts
E.52. Entity J is a university that distributes its annual report, which in-
cludes reports on mission accomplishments, to those who have made signif-
icant contributions over the previous year, its board of trustees, and its em-
ployees. The annual report is primarily prepared by management and general
personnel, such as the accounting department and executive staff. The activ-
ity is coordinated by the public relations department. Internal management
memoranda indicate that the purpose of the annual report is to report on how
management discharged its stewardship responsibilities, including the univer-
sity's overall performance, goals, financial position, cash flows, and results of
operations. Included in the package containing the annual report are requests
for contributions and donor reply cards.
Conclusion
E.53. The purpose, audience, and content criteria are met, and the joint costs
should be allocated.
E.54. The activity has elements of management and general functions.
Therefore, no call for specific action is required. Neither of the factors in para-
graph .10a or .10b is determinative of whether the purpose criterion is met.
Therefore, other evidence, such as the indicators in paragraph .11, should be
considered. The purpose criterion is met based on the other evidence, because
(a) the employees performing the activity are not members of the fund-raising
department and perform other non-fund-raising activities and (b) internal man-
agement memoranda indicate that the purpose of the annual report is to fulfill
one of the university's management and general responsibilities.
E.55. The audience criterion is met because the audience is selected based
on its reasonable potential for use of the management and general component.
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Although the activity is directed primarily at those who have previously made
significant contributions, the audience was selected based on its presumed in-
terest in Entity J's annual report (prior donors who have made significant con-
tributions are likely to have an interest in matters discussed in the annual
report).
E.56. The content criterion is met because the activity (distributing annual
reports) fulfills one of the entity's management and general responsibilities
(reporting concerning management's fulfillment of its stewardship function).
Illustration 11
Facts
E.57. Entity K is an NPO. In accordance with internal management mem-
oranda documenting its policies requiring it to comply with Internal Revenue
Service (IRS) regulations, it mails prior donors who have made quid pro quo
payments in excess of $75 documentation required by the IRS. The documen-
tation is included on a perforated piece of paper. The information above the
perforation line pertains to the documentation required by the IRS. The infor-
mation below the perforation line includes a request for contributions and may
be used as a donor reply card.
Conclusion
E.58. The purpose, audience, and content criteria are met, and the joint costs
should be allocated. (Note that the costs of the information below the perforation
line are identifiable with fund raising and therefore should be charged to fund
raising.)
E.59. The activity has elements of management and general functions.
Therefore, no call for specific action is required. Neither of the factors in para-
graph .10a or .10b is determinative of whether the purpose criterion is met.
Therefore, other evidence, such as the indicators in paragraph .11, should be
considered. The purpose criterion is met based on the other evidence, because
internal management memoranda indicate that the purpose of the activity is
to fulfill one of Entity K's management and general responsibilities.
E.60. The audience criterion is met because the entity is required to direct the
management and general component of the activity to the particular audience.
Although the activity is directed at those who have previously contributed, the
audience was selected based on its need for the documentation.
E.61. The content criterion is met because the activity (sending documenta-
tion required by the IRS) fulfills one of the entity's management and general
responsibilities (complying with IRS regulations).
Illustration 12
Facts
E.62. Entity L is an animal rights organization. It mails a package of material
to individuals included in lists rented from various environmental and other
organizations that support causes that Entity L believes are congruent with
its own. In addition to donor response cards and return envelopes, the package
includes (a) materials urging recipients to contact their legislators and urge
the legislators to support legislation to protect those rights, and (b) postcards
addressed to legislators urging support for legislation restricting the use of
animal testing for cosmetic products. The mail campaign is part of an overall
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strategy that includes magazine advertisements and the distribution of similar
materials at various community events, some of which are undertaken without
fund-raising appeals. The advertising and community events reach audiences
similar in size and demographics to the audience reached by the mailing.
Conclusion
E.63. The purpose, audience, and content criteria are met, and the joint costs
should be allocated.
E.64. The activity calls for specific action by the recipient (mailing postcards
to legislators urging support for legislation restricting the use of animal testing
for cosmetic products) that will help accomplish the entity's mission. Therefore,
the guidance in paragraph .10 should be considered. Neither of the factors in
paragraph .10a or .10b is determinative of whether the purpose criterion is met.
Therefore, other evidence, such as the indicators in paragraph .11, should be
considered. The purpose criterion is met based on the other evidence, because (a)
the program component of this activity calls for specific action by the recipient
that will help accomplish the entity's mission, and it otherwise conducts the
program activity in this illustration without a request for contributions, and
(b) performing such programs helps accomplish Entity L's mission.
E.65. The audience criterion is met because the audience (individuals in-
cluded in lists rented from various environmental and other organizations that
support causes that Entity L believes are congruent with its own) is selected
based on its ability to take action to assist the entity in meeting the goals of the
program component of the activity.
E.66. The content criterion is met because the activity calls for specific action
by the recipient (mailing postcards to legislators urging support for legislation
restricting the use of animal testing for cosmetic products) that will help ac-
complish the entity's mission (to protect animal rights), and the need for and
benefits of the action are clearly evident (to protect animal rights).
Illustration 13
Facts
E.67. Entity M is a performing arts organization whose mission is to make
the arts available to residents in its area. Entity M charges a fee for attending
performances and sends advertisements, including subscription forms, for the
performances to residents in its area. These advertisements include a return
envelope with a request for contributions. Entity M evaluates the effectiveness
of the advertising based on the number of subscriptions sold as well as contri-
butions received. In performing that evaluation, Entity M places more weight
on the number of subscriptions sold than on the contributions received. Also,
Entity M advertises the performances on local television and radio without a
request for contributions but on a smaller scale than the mail advertising.
Conclusion
E.68. The purpose, audience, and content criteria are met, and the joint costs
should be allocated.
E.69. The activity calls for specific action by the recipient (attending the per-
formances) that will help accomplish the entity's mission. Therefore, the guid-
ance in paragraph .10 should be considered. Neither of the factors in paragraph
.10a or .10b is determinative of whether the purpose criterion is met. Therefore,
other evidence, such as the indicators in paragraph .11, should be considered.
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The purpose criterion is met based on the other evidence, because (a) the en-
tity measures program results and accomplishments of the joint activity and
in evaluating the effectiveness of the activity, the entity places significantly
greater weight on the activity's effectiveness in accomplishing program goals
than on the activity's effectiveness in raising contributions (Entity M evaluates
the effectiveness of the advertising based on the number of subscriptions sold
as well as contributions received and places more weight on the number of sub-
scriptions sold than on the contributions received), (b) it otherwise conducts the
program activity without a request for contributions, and (c) performing such
programs helps accomplish Entity M's mission (to make the arts available to
residents in its area).
E.70. The audience criterion is met because the audience (a broad segment
of the population in Entity M's area) is selected based on its need to use or
reasonable potential for use of the action called for by the program component.
E.71. The content criterion is met because the activity calls for specific action
by the recipient (attending the performances) that will help accomplish the
entity's mission (making the arts available to area residents), and the need
for and benefits of the action are clearly evident (attending the performance is
a positive cultural experience). (Note that the purchase of subscriptions is an
exchange transaction and, therefore, is not a contribution.)
Illustration 14
Facts
E.72. Entity N is a university whose mission is to educate the public (stu-
dents) in various academic pursuits. Entity N's political science department
holds a special lecture series in which prominent world leaders speak about
current events. The speakers command relatively high fees and, in order to
cover costs and make a modest profit, the university sets a relatively expensive
fee to attend. However, the tickets are priced at the fair value of the lecture and
no portion of the ticket purchase price is a contribution. Entity N advertises
the lectures by sending invitations to prior attendees and to prior donors who
have contributed significant amounts, and by placing advertisements in local
newspapers read by the general public. At some of the lectures, including the
lecture being considered in this illustration, deans and other faculty members
of Entity N solicit significant contributions from attendees. Other lectures in
the series are conducted on a scale similar to the scale of the lecture in this
illustration without requesting contributions. Entity N's records indicate that
historically 75 percent of the attendees have attended prior lectures. Of the 75
percent who have attended prior lectures, 15 percent have made prior contri-
butions to Entity N. Of the 15 percent who have made prior contributions to
Entity N, 5 percent have made contributions in response to solicitations made at
the events. (Therefore, one-half of one percent of attendees make contributions
in response to solicitations made at the events. However, those contributions
are significant.) Overall, the audience's ability or likelihood to contribute is an
insignificant factor in its selection. Entity N evaluates the effectiveness of the
activity based on the number of tickets sold, as well as contributions received.
In performing that evaluation, Entity N places more weight on the number of
tickets sold than on the contributions received.
Conclusion
E.73. The purpose, audience, and content criteria are met, and the joint costs
should be allocated.
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E.74. The activity calls for specific action by the recipient (attending the
lecture) that will help accomplish the entity's mission. Therefore, the guidance
in paragraph .10 should be considered. The purpose criterion is met because (a)
the program component of the activity calls for specific action by the recipient
that will help accomplish the entity's mission (educating the public [students]
in various academic pursuits), and (b) the program is also conducted using the
same medium on a scale that is similar to or greater than the scale on which
it is conducted with the request for contributions (other lectures in the series
are conducted on a scale similar to the scale of the lecture in this illustration
without requesting contributions).
E.75. The audience criterion is met. The rebuttable presumption that the au-
dience criterion is not met because the audience includes prior donors is over-
come in this illustration because the audience (those who have shown prior
interest in the lecture series, prior donors, a broad segment of the population
in Entity N's area, and those attending the lecture) is also selected for its rea-
sonable potential for use of the program component (attending the lecture).
Although the audience may make significant contributions, that was an in-
significant factor in its selection.
E.76. The content criterion is met because the activity calls for specific action
by the recipient (attending the lecture) that will help accomplish the entity's
mission (educating the public [students] in various academic pursuits), and the
need for and benefits of the action are clearly evident (attending the lecture
is a positive educational experience). (Note that the purchase of the tickets
is an exchange transaction and, therefore, is not a contribution. As discussed
in paragraph .07 of this SOP, costs of goods or services provided in exchange
transactions that are part of joint activities, such as costs of direct donor benefits
of a special event, should not be reported as fund raising.12)
Illustration 15
Facts
E.77. Entity O is a university whose mission is to educate the public (stu-
dents) in various academic pursuits. Entity O's political science department
holds a special lecture series in which prominent world leaders speak about
current events. Admission is priced at $250, which is above the $50 fair value
of the lecture and, therefore, $200 of the admission price is a contribution.
Therefore, the audience's likelihood to contribute to the entity is a significant
factor in its selection. Entity O advertises the lectures by sending invitations to
prior attendees and to prior donors who have contributed significant amounts,
and by placing advertisements in local newspapers read by the general public.
Entity O presents similar lectures that are priced at the fair value of those
lectures.
Conclusion
E.78. The purpose and content criteria are met. The audience criterion is not
met. All costs, including those that might otherwise be considered program or
management and general costs if they had been incurred in a different activity,
12 Paragraphs 13.21-13.26 of the Audit and Accounting Guide Not-for-Profit Organizations pro-
vide guidance concerning reporting special events. [Footnote revised, June 2004, to reflect conforming
changes necessary due to conforming changes made to the AICPA Audit and Accounting Guide Not-
for-Profit Organizations.]
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except for the costs of the direct donor benefit (the lecture), should be charged
to fund raising.
E.79. The activity calls for specific action by the recipient (attending the
lecture) that will help accomplish the entity's mission. Therefore, the guidance
in paragraph .10 should be considered. The purpose criterion is met because (a)
the program component of the activity calls for specific action by the recipient
that will help accomplish the entity's mission (educating the public [students]
in various academic pursuits), and (b) the program is also conducted using the
same medium on a scale that is similar to or greater than the scale on which
it is conducted with the request for contributions (other lectures in the series
are conducted on a scale similar to the scale of the lecture in this illustration
without including a contribution in the admission price.)
E.80. The audience criterion is not met. The rebuttable presumption that the
audience criterion is not met because the audience is selected based on its like-
lihood to contribute to the entity is not overcome in this illustration. The fact
that the $250 admission price includes a $200 contribution leads to the conclu-
sion that the audience's ability or likelihood to contribute is an overwhelmingly
significant factor in its selection, whereas there is no evidence that the extent
to which the audience is selected for its need to use or reasonable potential for
use of the action called for by the program component (attending the lecture)
is overwhelmingly significant.
E.81. The content criterion is met because the activity calls for specific action
by the recipient (attending the lecture) that will help accomplish the entity's
mission (educating the public [students] in various academic pursuits), and the
need for and benefits of the action are clearly evident (attending the lecture
is a positive educational experience). (Note that the purchase of the tickets
is an exchange transaction and, therefore, is not a contribution. As discussed
in paragraph .07 of this SOP, costs of goods or services provided in exchange
transactions that are part of joint activities, such as costs of direct donor benefits
of a special event, should not be reported as fund raising.13)
Illustration 16
Facts
E.82. Entity P's mission is to reduce the incidence of illness from ABC disease,
which primarily afflicts people over sixty-five years of age. One of Entity P's
objectives in fulfilling that mission is to have all persons over sixty-five screened
for ABC disease.
E.83. Entity P rents space at events attended primarily by people over sixty-
five years of age and conducts free screening for ABC disease. Entity P's em-
ployees, who are educated about ABC disease and screening procedures and do
not otherwise perform fund-raising functions, educate interested parties about
the effects of ABC disease and the ease and benefits of screening for it. Entity P
also solicits contributions at the events. The effectiveness of the activity is eval-
uated primarily based on how many screening tests are performed, and only
minimally based on contributions raised. The employees are not compensated
or evaluated based on contributions raised.
13 Paragraphs 13.21-13.26 of the Audit and Accounting Guide Not-for-Profit Organizations pro-
vide guidance concerning reporting special events. [Footnote revised, June 2004, to reflect conforming
changes necessary due to conforming changes made to the AICPA Audit and Accounting Guide Not-
for-Profit Organizations.]
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Conclusion
E.84. The purpose, audience, and content criteria are met, and the joint costs
should be allocated.
E.85. The activity calls for specific action by the recipient (being screened
for ABC disease) that will help accomplish the entity's mission. Therefore, the
guidance in paragraph .10 should be considered. Neither of the factors in para-
graph .10a or .10b is determinative of whether the purpose criterion is met.
Therefore, other evidence, such as the indicators in paragraph .11, should be
considered. The purpose criterion is met based on the other evidence, because
(a) a process exists to evaluate measured program results and accomplishments
and in evaluating the effectiveness of the joint activity, the entity places signif-
icantly greater weight on the activity's effectiveness in accomplishing program
goals than on the activity's effectiveness in raising contributions (Entity P eval-
uates the effectiveness of the activity based on the number of screening tests
conducted as well as contributions received and places more weight on the
number of tests conducted than on the contributions received); (b) the quali-
fications and duties of the personnel performing the activity indicate that it
is a program activity (the employees are educated about ABC disease and the
testing procedures and do not otherwise perform fund-raising functions); (c) the
method of compensation for performing the activity does not indicate that it is
a fund-raising activity (the employees are not compensated or evaluated based
on contributions raised); and (d) performing such programs helps accomplish
Entity P's mission (to prevent ABC disease).
E.86. The audience criterion is met because the audience (people over sixty-
five years of age) is selected based on its need to use or reasonable potential for
use of the action called for by the program component.
E.87. The content criterion is met because the activity calls for specific action
by the recipient (being screened for ABC disease) that will help accomplish the
entity's mission (to reduce the incidence of ABC disease), and it explains the
need for and benefits of the action (to prevent ABC disease).
Illustration 17
Facts
E.88. Entity Q's mission is to provide cultural and educational television
programming to residents in its area. Entity Q owns a public television station
and holds a membership drive in which it solicits new members. The drive is
conducted by station employees and consists of solicitations that are shown
during long breaks between the station's regularly scheduled programs. Entity
Q's internal management memoranda state that these drives are designed to
raise contributions. Entity Q evaluates the effectiveness of the activity based
on the amount of contributions received. Entity Q shows the programs on a
similar scale, without the request for contributions. The audience is members
of the general public who watch the programs shown during the drive. Station
member benefits are given to those who contribute and consist of tokens of
appreciation with a nominal value.
Conclusion
E.89. The purpose, audience, and content criteria are met, and the joint costs
should be allocated. (Note that there would be few, if any, joint costs. Costs as-
sociated with the fund-raising activities, such as costs of airtime, would be
separately identifiable from costs of the program activities, such as licensing
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costs for a particular television program. Also, note that because no significant
benefits or duties are associated with membership, member dues are contribu-
tions. Therefore, the substance of the membership-development activities is, in
fact, fund raising.)
E.90. The activity calls for specific action by the recipient (watching the tele-
vision program) that will help accomplish the entity's mission. Therefore, the
guidance in paragraph .10 should be considered. The purpose criterion is met
because (a) the program component of the activity calls for specific action by the
recipient that will help accomplish the entity's mission, and (b) the program is
also conducted using the same medium on a scale that is similar to or greater
than the scale on which it is conducted with the request for contributions (En-
tity Q shows the television programs on a similar scale, without the request for
contributions).
E.91. The audience criterion is met. The rebuttable presumption that the
audience criterion is not met because the audience is selected based on its like-
lihood to contribute is overcome in this illustration because the audience (mem-
bers of the general public who watch the television programs shown during the
drive) is also selected for its reasonable potential for use of the program com-
ponent (watching the television programs). Although the audience may make
contributions, that was an insignificant factor in its selection.
E.92. The content criterion is met because the activity calls for specific action
by the recipient (watching the television programs) that will help accomplish
the entity's mission (providing cultural and educational television program-
ming to residents in its area), and the need for and benefits of the action are
clearly evident (watching the programs is a positive cultural and educational
experience).
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.26
Appendix F
Illustrations of Allocation Methods
F.1. Some commonly used cost allocation methods follow.
Physical Units Method
F.2. Joint costs are allocated to materials and activities in proportion to the
number of units of output that can be attributed to each of the materials and
activities. Examples of units of output are lines, square inches, and physical
content measures. This method assumes that the benefits received by the fund-
raising, program, or management and general component of the materials or ac-
tivity from the joint costs incurred are directly proportional to the lines, square
inches, or other physical output measures attributed to each component of the
activity. This method may result in an unreasonable allocation of joint costs if
the units of output, for example, line counts, do not reflect the degree to which
costs are incurred for the joint activity. Use of the physical units method may
also result in an unreasonable allocation if the physical units cannot be clearly
ascribed to fund raising, program, or management and general. For example,
direct mail and telephone solicitations sometimes include content that is not
identifiable with fund raising, program, or management and general; or the
physical units of such content are inseparable.
Illustration
F.3. Assume a direct mail campaign is used to conduct programs of the entity
and to solicit contributions to support the entity and its programs. Further,
assume that the appeal meets the criteria for allocation of joint costs to more
than one function.
F.4. The letter and reply card include a total of one hundred lines. Forty-five
lines pertain to program because they include a call for action by the recipient
that will help accomplish the entity's mission, while fifty-five lines pertain to
the fund-raising appeal. Accordingly, 45 percent of the costs are allocated to
program and 55 percent to fund-raising.
Relative Direct Cost Method
F.5. Joint costs are allocated to each of the components on the basis of their
respective direct costs. Direct costs are those costs that are incurred in con-
nection with the multipurpose materials or activity and that are specifically
identifiable with a function (program, fund raising, or management and gen-
eral). This method may result in an unreasonable allocation of joint costs if the
joint costs of the materials and activity are not incurred in approximately the
same proportion and for the same reasons as the direct costs of the materials
and activity. For example, if a relatively costly booklet informing the reader
about the entity's mission (including a call for action by the recipient that will
help accomplish the entity's mission) is included with a relatively inexpensive
fund-raising letter, the allocation of joint costs based on the cost of these pieces
may be unreasonable, particularly if the booklet and letter weigh approximately
the same and therefore contribute equally to the postage costs.
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Illustration
F.6. The costs of a direct mail campaign that can be specifically identified
with program services are the costs of separate program materials and a post-
card which calls for specific action by the recipient that will help accomplish
the entity's mission. They total $20,000. The direct costs of the fund-raising
component of the direct mail campaign consist of the costs to develop and pro-
duce the fund-raising letter. They total $80,000. Joint costs associated with the
direct mail campaign total $40,000 and would be allocated as follows under the
relative direct cost method:
Program $20,000/$100,000 x $40,000 = $8,000
Fund raising $80,000/$100,000 x $40,000 = $32,000
Stand-Alone Joint-Cost-Allocation Method
F.7. Joint costs are allocated to each component of the activity based on a ratio
that uses estimates of costs of items included in joint costs that would have been
incurred had the components been conducted independently. The numerator
of the ratio is the cost (of items included in joint costs) of conducting a single
component independently; the denominator is the cost (of items included in joint
costs) of conducting all components independently. This method assumes that
efforts for each component in the stand-alone situation are proportionate to the
efforts actually undertaken in the joint cost situation. This method may result
in an unreasonable allocation because it ignores the effect of each function,
which is performed jointly with other functions, on other such functions. For
example, the programmatic impact of a direct mail campaign or a telemarketing
phone message may be significantly lessened when performed in conjunction
with a fund-raising appeal.
Illustration
F.8. Assume that the joint costs associated with a direct mail campaign in-
cluding both program and fund-raising components are the costs of stationery,
postage, and envelopes at a total of $100,000. The costs of stationery, postage,
and envelopes to produce and distribute each component separately would have
been $90,000 for the program component and $70,000 for the fund-raising com-
ponent. Under the stand-alone joint-cost-allocation method, the $100,000 in
joint costs would be allocated as follows: $90,000/$160,000 x $100,000 = $56,250
to program services and $70,000/$160,000 x $100,000 = $43,750 to fund raising.
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Appendix G
Illustrations of Disclosures
G.1. The disclosures discussed in paragraphs .18 and .19 are illustrated
below. Alternative 1 reports the required and encouraged information in nar-
rative format. Alternative 2 reports that information in tabular format, as well
as information concerning joint costs incurred for each kind of activity by func-
tional classification, which is neither required nor encouraged, but which is not
prohibited.
Alternative 1
Note X. Allocation of Joint Costs
In 19XX, the organization conducted activities that included requests
for contributions, as well as program and management and general
components. Those activities included direct mail campaigns, special
events, and a telethon. The costs of conducting those activities included
a total of $310,000 of joint costs, which are not specifically attributable
to particular components of the activities (joint costs). [Note to reader:
The following sentence is encouraged but not required.] Joint costs for
each kind of activity were $50,000, $150,000, and $110,000 respec-
tively. These joint costs were allocated as follows:
Fund raising $180,000
Program A 80,000
Program B 40,000
Management and general 10,000
Total $310,000
Alternative 2
Note X. Allocation of Joint Costs
In 19XX, the organization conducted activities that included appeals
for contributions and incurred joint costs of $310,000. These activities
included direct mail campaigns, special events, and a telethon. Joint
costs were allocated as follows:
Direct Mail
Special
Events Telethon Total
Fund raising $40,000 $50,000 $90,000 $180,000
Program A 10,000 65,000 5,000 80,000
Program B 25,000 15,000 40,000
Management and general 10,000 10,000
Total $50,000 $150,000 $110,000 $310,000
[Note to reader: Shading is used to highlight information that is neither re-
quired nor encouraged, but which is not prohibited. However, entities may prefer
to disclose it. Disclosing the total joint costs for each kind of activity ($50,000,
$150,000, and $110,000) is encouraged but not required.]
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Appendix H
Contrast of Guidance in This SOP With the Guidance
in SOP 87-214,**
This SOP SOP 87-2
Applies to all entities that solicit con-
tributions, including state and local
governments.
Applied to entities that follow the
AICPA Industry Audit Guide Au-
dits of Voluntary Health and Welfare
Organizations or SOP 78-10. (SOP
87-2 was not applicable to entities
that are within the scope of Govern-
mental Accounting Standards Board
Statement No. 29, The Use of Not-for-
Profit Accounting and Financial Re-
porting Principles by Governmental
Entities.)
Covers all costs of joint activities.
(Costs that otherwise might be con-
sidered program or management
and general costs if they had been
incurred in a different activity, ex-
cept for costs of goods or services pro-
vided in exchange transactions that
are part of joint activities, such as
costs of direct donor benefits of a
special event [for example, a meal],
should be charged to fund raising un-
less the criteria in the SOP are met.)
Covers only joint costs of joint activ-
ities.
Criteria of purpose, audience, and
content should all be met in order
to charge costs of the activity to pro-
gram or management and general.
Unclear concerning whether all cri-
teria should be met in order to charge
costs of the activity to program or
management and general.
14 In August 1996, the AICPA issued the Audit and Accounting Guide Not-for-Profit Organiza-
tions, which superseded SOP 87-2, Accounting for Joint Costs of Informational Materials and Activities
of Not-for-Profit Organizations That Include a Fund-Raising Appeal, because the guidance in SOP 87-2
is incorporated into paragraphs 13.36 to 13.45 of the Guide. Also, Not-for-Profit Organizations super-
seded the AICPA Industry Audit Guide Audits of Voluntary Health and Welfare Organizations and
SOP 78-10. Not-for-Profit Organizations applies to all nongovernmental not-for-profit organizations
other than those required to follow the Audit and Accounting Guide Health Care Organizations. There-
fore, incorporating the guidance in SOP 87-2 into Not-for-Profit Organizations broadened the scope
of the guidance previously included in SOP 87-2 to all not-for-profit organizations other than those
required to follow Health Care Organizations. The discussion in this SOP of SOP 87-2 refers to both
SOP 87-2 and the guidance included in paragraphs 13.36 to 13.45 of Not-for-Profit Organizations, ex-
cept that the guidance in Not-for-Profit Organizations applies to all not-for-profit organizations other
than those required to follow Health Care Organizations.
** See footnotes ‡ and || in paragraphs D.3 and D.4, respectively. [Footnote revised, June 2004,
to reflect conforming changes necessary due to the issuance of GASB Statements No. 34 and No. 35.]
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This SOP SOP 87-2
Neither prescribes nor prohibits any
allocation methods. Includes a dis-
cussion to help users determine
whether an allocation is reasonable,
and provides some illustrations.
Neither prescribes nor prohibits any
allocation methods. No illustrations
are provided.
Requires note disclosures about the
types of activities for which joint
costs have been incurred, amounts
allocated during the period, and
amounts allocated to each functional
expense or expenditure category.
Requires less extensive note disclo-
sures: total amount allocated during
the period and amounts allocated to
each functional expense category.
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Appendix I
Effects on Other Guidance
I.1. For nongovernmental organizations, this Statement of Position (SOP)
amends the AICPA Audit and Accounting Guide Health Care Organizations
and paragraphs 13.35 to 13.44 of the AICPA Audit and Accounting Guide Not-
for-Profit Organizations. [Revised, June 2004, to reflect conforming changes
necessary due to conforming changes made to the AICPA Audit and Accounting
Guide Not-for-Profit Organizations.]
I.2. Also, this SOP amends the AICPA Audit and Accounting Guide Not-
for-Profit Organizations to clarify that costs of goods or services provided in
exchange transactions that are part of joint activities, such as costs of direct
donor benefits of a special event (for example, a meal), should not be reported as
fund-raising. In particular, paragraphs 13.21, 13.23, and 13.24 of Not-for-Profit
Organizations are amended as follows:
13.21 Some organizations conduct joint activitiesfn 9 that are spe-
cial events, including special social and educational events (such as
symposia, dinners, dances, and theater parties) in which the attendee
receives a direct benefit (for example, a meal or theater ticket). FASB
Statement No. 117 requires the reporting of the gross amounts of rev-
enues and expenses from special events and other fund-raising activi-
ties that are ongoing major or central activities, but permits (but does
not require) reporting net amounts if the receipts and related costs
result from special events that are peripheral or incidental activities.
13.23 For example, assume that an organization has a special event
that is an ongoing and major activity with a ticket price of $100. As-
sume that the activity does not meet the audience criterion in SOP
98-2, Accounting for Costs of Activities of Not-for-Profit Organizations
and State and Local Governmental Entities That Include Fund Rais-
ing, and, therefore, all costs of the activity, other than the direct donor
benefits, should be reported as fund raising. The event includes a din-
ner that costs the organization $25 and that has a fair value of $30.
(Chapter 5, "Contributions Received and Agency Transactions," of this
Guide, discusses the appropriate reporting if the meal or other items of
value are donated to the organization for resale.) In addition, the orga-
nization incurs other direct costs of the event in connection with pro-
moting and conducting the event, including incremental direct costs
incurred in transactions with independent third parties and the pay-
roll and payroll-related costs for the activities of employees who are di-
rectly associated with, and devote time to, the event. Those other direct
costs, which include (a) $5 that otherwise might be considered manage-
ment and general costs if they had been incurred in a different activity,
and (b) fund-raising costs of $10, are unrelated to the direct benefits
to donors and, accordingly, should not be included as costs of benefits
to donors. In addition, the organization has the following transactions,
which are unrelated to the special event: unrestricted contributions of
$200, program expenses of $60, management and general expenses of
$20, and fund-raising expenses of $20.
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13.24 Some ways in which the organization could display the results
of the special event as part of its statement of activities are illustrated
as follows:
Illustration 1
Changes in unrestricted net assets:
Contributions $200
Special event revenue 100
Less: Costs of direct benefits to donors (25)
Net revenues from special events 75
Contributions and net revenues
from special events
275
Other expenses:
Program 60
Management and general 20
Fund raising 35
Total other expenses 115
Increase in unrestricted net assets $160
Illustration 2
Changes in unrestricted net assets:
Revenues:
Contributions $200
Special event revenue 100
Total revenues 300
Expenses:
Program 60
Costs of direct benefits to donors 25
Management and general 20
Fund raising 35
Total expenses 140
Increase in unrestricted net assets $160
Illustration 3
Changes in unrestricted net assets:
Contributions $270
Dinner sales 30
Less: Costs of direct benefits to donors (25)
Gross profit on special events 5
Contributions and net revenues
from special events
275
Other expenses:
Program 60
Management and general 20
Fund raising 35
Total other expenses 115
Increase in unrestricted net assets $160
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fn 9 See footnote 1.
[Revised, June 2004, to reflect conforming changes necessary due to conform-
ing changes made to the AICPA Audit and Accounting Guide Not-for-Profit
Organizations.]
I.3. For governmental entities that have applied the accounting and financial
reporting principles in SOP 78-10, Accounting Principles and Reporting Prac-
tices for Certain Nonprofit Organizations, or the AICPA Industry Audit Guide
Audits of Voluntary Health and Welfare Organizations (modified by all appli-
cable Financial Accounting Standards Board [FASB] pronouncements issued
through November 30, 1989, and by most applicable Governmental Accounting
Standards Board [GASB] pronouncements) in conformity with GASB State-
ment No. 29, The Use of Not-for-Profit Accounting and Financial Reporting
Principles by Governmental Entities, this SOP amends the principles—based
on SOP 78-10 andAudits of Voluntary Health and Welfare Organizations, as
modified—that those entities apply. For governmental entities that have ap-
plied the accounting and financial reporting principles in the 1973 AICPA In-
dustry Audit Guide Audits of Colleges and Universities, as amended by SOP
74-8, Financial Accounting and Reporting by Colleges and Universities, and
as modified by applicable FASB pronouncements issued through November 30,
1989, and all applicable GASB pronouncements in conformity with GASB State-
ment No. 15, Governmental College and University Accounting and Financial
Reporting Models, this SOP amends the principles—based on Audits of Colleges
and Universities, as amended and modified—that those entities apply. For other
governmental organizations, this SOP amends the Audit and Accounting Guide
Audits of State and Local Governmental Units. ††
†† See footnotes ‡ and ||in paragraphs D.3 and D.4, respectively. Also, the AICPA Audit and
Accounting Guide State and Local Governments supersedes the 1994 AICPA Audit and Accounting
Guide Audits of State and Local Governmental Units and subsequent editions of that Guide with
conforming changes made by the AICPA staff. The AICPA Audit and Accounting Guide State and
Local Governments, provides guidance on the application of this SOP to state and local governments.
[Footnote added, June 2004, to reflect conforming changes necessary due to the issuance of GASB
Statements No. 34, No. 35, and the AICPA Audit and Accounting Guide Audits of State and Local
Governmental Units.]
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Glossary
Activities. Activities are efforts to accomplish specific objectives. Some activi-
ties include producing and distributing materials. For example, if an entity
undertakes a mass mailing that includes a letter and a pamphlet, produc-
ing and distributing the letter and pamphlet are part of the activity. Other
activities may include no materials, such as an annual dinner or a radio
commercial.
Compensation or fees. Reciprocal transfers of cash or other assets in ex-
change for services performed.
Contributions. Contributions are unconditional transfers of cash or other as-
sets to an entity or a settlement or cancellation of its liabilities in a vol-
untary nonreciprocal transfer by another entity acting other than as an
owner.
Costs of joint activities. Costs of joint activities are costs incurred for a joint
activity. Costs of joint activities may include joint costs and costs other
than joint costs. Costs other than joint costs are costs that are identifiable
with a particular function, such as fund raising, program, management and
general, and cost of sales. For example, some costs incurred for printing,
paper, professional fees, and salaries to produce donor cards are not joint
costs, although they may be incurred in connection with conducting joint
activities.
Fund-raising activities. Fund-raising activities are activities undertaken to
induce potential donors to contribute money, securities, services, materi-
als, facilities, other assets, or time. They include publicizing and conducting
fund-raising campaigns; maintaining donor mailing lists; conducting spe-
cial fund-raising events; preparing and distributing fund-raising manuals,
instructions, and other materials; and conducting other activities involved
with soliciting contributions from individuals, foundations, governments,
and others.
Help accomplish the entity's mission. Actions that help accomplish the
entity's mission are actions that either benefit the recipient (such as by
improving the recipient's physical, mental, emotional, or spiritual health
and well-being) or benefit society (by addressing societal problems).
Joint activity. A joint activity is an activity that is part of the fund-raising
function and has elements of one or more other functions, such as pro-
gram, management and general, membership development, or any other
functional category used by the entity.
Joint costs. Joint costs are the costs of conducting joint activities that are
not identifiable with a particular component of the activity. For example,
the cost of postage for a letter that includes both fund-raising and program
components is a joint cost. Joint costs may include the costs of salaries, con-
tract labor, consultants, professional fees, paper, printing, postage, event
advertising, telephones, airtime, and facility rentals.
Management and general activities. Management and general activities
are those that are not identifiable with a single program, fund-raising ac-
tivity, or membership-development activity but that are indispensable to
the conduct of those activities and to an organization's existence. They
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include oversight, business management, general recordkeeping, budget-
ing, financing, soliciting revenue from exchange transactions, such as gov-
ernment contracts and related administrative activities, and all manage-
ment and administration except for direct conduct of program services or
fund-raising activities. Disseminating information to inform the public of
the organization's "stewardship" of contributed funds, announcements con-
cerning appointments, and the annual report, among other activities, are
management and general activities, as are soliciting funds other than con-
tributions, including exchange transactions (whether program-related or
not).
Medium. A medium is a means of mass communication, such as direct mail,
direct response advertising, or television.
Membership-development activities. Membership-development activities
include soliciting for prospective members and membership dues, member-
ship relations, and similar activities. If there are no significant benefits or
duties connected with membership, however, the substance of membership-
development activities may, in fact, be fund-raising.
Program activities. Program activities are the activities that result in goods
or services being distributed to beneficiaries, customers, or members that
fulfill the purposes or mission for which the organization exists. Those ser-
vices are the major purpose for and the major output of the organization
and often relate to several major programs. For example, a large univer-
sity may have programs for student instruction, research, and patient care,
among others. Similarly, a health and welfare organization may have pro-
grams for health and family services, research, disaster relief, and public
education, among others.
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Appendix C
Statement of Position 99-1,
Guidance to Practitioners in Conducting
and Reporting on an Agreed-Upon
Procedures Engagement to Assist
Management in Evaluating the Effectiveness
of Its Corporate Compliance Program
May 21, 1999
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NOTE
This Statement of Position (SOP) is an interpretive publication and
represents the recommendations of the AICPA Health Care Pilot Task
Force of the AICPA Auditing Standards Board (ASB) regarding the ap-
plication of Statements on Standards for Attestation Engagements to
agreed-upon procedures attestation engagements performed to assist
a health care provider in evaluating the effectiveness of its corporate
compliance program consistent with the requirements of a Corporate
Integrity Agreement entered into with the Office of Inspector General
of the U.S. Department of Health and Human Services. The ASB has
found the recommendations in this SOP to be consistent with existing
standards covered by Rule 202, Compliance With Standards (AICPA,
Professional Standards, vol. 2, ET sec. 202 par. .01), of the AICPA Code
of Professional Conduct.
Interpretive publications are not as authoritative as pronouncements
of the ASB; however, if a practitioner does not apply the attestation
guidance included in this SOP, the practitioner should be prepared to
explain how he or she complied with the provisions of this SOP.
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Summary
This Statement of Position (SOP) provides guidance to practitioners in con-
ducting and reporting on an agreed-upon procedures engagement performed
pursuant to the AICPA Statements on Standards for Attestation Engagements
to assist a health care provider in evaluating the effectiveness of its corporate
compliance program consistent with the requirements of a Corporate Integrity
Agreement (CIA) entered into with the Office of Inspector General (OIG) of the
U.S. Department of Health and Human Services. CIAs are specific to the entity
involved; consequently, users of this SOP should be familiar with the specific
requirements of the entity's CIA.
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Introduction and Background
.01 Within the past several years, the health care industry has experi-
enced a significant increase in the number and magnitude of allegations of fraud
and abuse involving federal health care programs (for example, Medicare and
Medicaid) and private health care insurance. These allegations have triggered
regulatory scrutiny, litigation, significant monetary settlements, and negative
publicity related to—among other things—coding and billing practices, patient
referrals, cost reporting, quality of care, and clinical practices. Typically, as
part of the global resolution of these allegations, the entity enters into a Cor-
porate Integrity Agreement (CIA) with the Office of Inspector General (OIG) of
the U.S. Department of Health and Human Services. Such agreements require
that management annually report on its compliance with the terms of the CIA
and that there be an assessment of the entity's compliance with the CIA. This
assessment includes a billing analysis, which may be performed by an indepen-
dent review organization (such as a practitioner or consultant) or the provider
(if permitted by the OIG), and an agreed-upon procedures engagement.
.02 This SOP provides guidance to practitioners in conducting and re-
porting on an agreed-upon procedures engagement performed pursuant to the
American Institute of Certified Public Accountants (AICPA) Statements on
Standards for Attestation Engagements (SSAEs) to assist an entity in eval-
uating the effectiveness of its corporate compliance program consistent with
the requirements of a CIA.1 The terms of a CIA are unique to the entity; con-
sequently, users of this SOP need to be familiar with the actual CIA and its
requirements.
.03 This SOP applies to agreed-upon procedures engagements to as-
sist in evaluating an entity's compliance for a specified period. Such engage-
ments should follow the AICPA attestation standards, including AT section 201,
Agreed-Upon Procedures Engagements (AICPA, Professional Standards, vol. 1),
and the applicable sections of AT section 101, Attest Engagements, and AT sec-
tion 601, Compliance Attestation (AICPA, Professional Standards, vol. 1). The
engagement should be conducted in accordance with standards established by
the AICPA, including the criteria set forth in this SOP. However, this SOP is not
intended to provide all the required criteria set forth in individual CIAs, nor all
the applicable standards established by the AICPA. Additionally, the SOP con-
tains some guidance that may be applied in evaluating an organization's corpo-
rate compliance program, even though the program was not imposed by a CIA.
Overview of a Typical Corporate Integrity Agreement
.04 A CIA is an agreement between a health care provider and the OIG in
conjunction with a global settlement of a fraud investigation. Such an agree-
ment typically seeks to establish a compliance program within the health care
provider (for example, hospital, clinical lab, physician group) that will promote
compliance with the requirements of Medicare, Medicaid, and all other federal
health care programs.
1 The practitioner also might be engaged to assist in other areas beyond an agreed-upon pro-
cedures engagement such as providing consulting services in connection with evaluating the com-
pany's billing practices, policies, and procedures as required by the CIA or in implementing, assessing,
and reporting on voluntarily adopted compliance programs. In addition, the practitioner may assist
in preparing an entity's self-disclosure reports to federal health agencies related to billing errors
and other compliance matters. Similarly, practitioners may be involved in an entity's preparation of
government-required (but not CIA-imposed) compliance reporting (for example, contract requirements
for Medicare part C) beyond an agreed-upon procedures engagement.
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.05 CIAs are case-specific. Their terms are tailored to address the organi-
zational and operating deficiencies related to providing and billing for health
care services that have been identified by the OIG, the entity, or others. Detailed
compliance requirements are imposed as a condition for continued participa-
tion in federal health care programs. A sample CIA, provided by the OIG and
intended to identify potential requirements, is included in appendix A [para-
graph .32], "Sample Corporate Integrity Agreement." Typical agreements cover
five years and require the entity to address the following areas:
 Appointment of a compliance officer and establishment of a com-
pliance committee
 Establishment of a code of conduct
 Establishment of policies and procedures regarding the compli-
ance program
 Development of an information and education program as to the
CIA requirements, compliance program and code of conduct
 Annual assessment of billing policies, procedures, and practices
 Establishment of a confidential disclosure program
 Prohibition of employment of excluded or convicted persons
 Notification to OIG of investigation or legal proceedings
 Reporting of credible evidence of misconduct
 Notifications to OIG of new provider locations
 Provision of implementation and annual reports
 Proper notification and submission of required reports
 Granting of OIG access to documents and individuals to conduct
assessments
 Documentation of record retention requirements
 Awareness of disclosure criteria
 Agreement to comply with certain default provisions, penalties,
and remedies
 Review of rights as to dispute resolution
 Review of effective and binding agreement clauses
Conditions for Engagement Performance
.06 A practitioner may perform an agreed-upon procedures engagement
related to management's compliance with a CIA if all of the conditions specified
in AT sections 201 and 601 are met.
.07 As discussed more fully in the AT sections identified in paragraph .06,
management's assertions as to its compliance must be capable of evaluation
against reasonable criteria that either have been established by a recognized
body or are stated in or attached to the practitioner's report in a sufficiently
clear and comprehensive manner. Generally, to avoid confusion, management's
assertions, which are based on the specific terms of its CIA, should be attached
to the practitioner's report. If the entity is not required to have a CIA, man-
agement may develop its assertions using the model CIA. A sample based on
the model CIA, which is not meant to be all-inclusive, is included as appendix
B (paragraph .33), "Sample Statement of Management's Assertions." [Revised,
June 2009, to reflect conforming changes necessary due to the issuance of recent
authoritative literature.]
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Establishing an Understanding With the Client
.08 The practitioner should document the understanding in the working
papers, preferably through a written communication with the client, such as
an engagement letter. Appendix C [paragraph .34], "Sample Engagement Let-
ter," contains a sample engagement letter that may be used for this kind of
engagement.
Responsibilities of Specified Parties
.09 AT section 201 identifies the users of an agreed-upon procedures re-
port as specified parties. The specified parties to the agreed upon procedures
report described in this SOP typically would be the management of the health
care provider and the OIG. Management is responsible for ensuring that the
entity complies with the requirements of the CIA. That responsibility encom-
passes (a) identifying applicable compliance requirements, (b) establishing and
maintaining internal control policies and procedures to provide reasonable as-
surance that the entity complies with those requirements, (c) evaluating and
monitoring the entity's compliance, and (d) preparing reports that satisfy le-
gal, regulatory, or contractual requirements. Management's evaluation may
include documentation such as accounting or statistical data, policy manuals,
accounting manuals, narrative memoranda, procedural write-ups, flowcharts,
completed questionnaires, internal auditors' reports, and other special studies
or analyses. The form and extent of documentation will vary depending on the
nature of the compliance requirements and the size and complexity of the en-
tity. Management may engage the practitioner to gather information to assist it
in evaluating the entity's compliance. Regardless of the procedures performed
by the practitioner, management must accept responsibility for its assertions
and must not base such assertions solely on the practitioner's procedures. [Re-
vised, June 2009, to reflect conforming changes necessary due to the issuance
of recent authoritative literature.]
.10 The specified parties are responsible for the sufficiency (nature, timing,
and extent) of the agreed-upon procedures because they best understand their
own needs. The specified parties assume the risk that such procedures might
be insufficient for their purposes. In addition, the specified parties assume the
risk that they might misunderstand or otherwise inappropriately use findings
properly reported by the practitioner. Use of an agreed-upon procedures report
is restricted to the specified parties. [Revised, June 2009, to reflect conforming
changes necessary due to the issuance of recent authoritative literature.]
Practitioner’s Responsibilities
.11 The objective of the practitioner's agreed-upon procedures is to present
specific findings to assist the specified parties in evaluating an entity's compli-
ance with the requirements specified in the CIA. (See appendix D [paragraph
.35], "Sample Procedures.") [Revised, June 2009, to reflect conforming changes
necessary due to the issuance of recent authoritative literature.]
.12 The practitioner's procedures generally may be as limited or extensive
as the specified parties desire, as long as the specified parties s agree upon
the procedures performed or to be performed and take responsibility for the
sufficiency of the agreed-upon procedures for their purposes. [Revised, June
2009, to reflect conforming changes necessary due to the issuance of recent
authoritative literature.]
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.13 To satisfy the requirements that the practitioner and the specified
parties agree upon the procedures performed or to be performed and that the
specified parties take responsibility for the sufficiency of the agreed-upon pro-
cedures for their purposes, ordinarily the practitioner should communicate di-
rectly with and obtain affirmative acknowledgment from each of the specified
parties. For the purposes of these engagements, an effective way to obtain this
agreement ordinarily is to distribute a draft of the report, detailing the proce-
dures, that is expected to be issued to the OIG with a request for any comments
it may have. [Revised, June 2009, to reflect conforming changes necessary due
to the issuance of recent authoritative literature.]
.14 To avoid possible misunderstandings, the practitioner should circulate
the draft with a legend stating that these are the procedures expected to be
performed, and unless informed otherwise, the practitioner assumes that there
are no additional procedures that he or she is expected to perform. A legend
such as the following might be used.
This draft is furnished solely for the purpose of indicating the form
of report that we would expect to be able to furnish pursuant to the
request by Management of [Provider] for our performance of limited
procedures relating to [Provider's] compliance with the Corporate In-
tegrity Agreement with the Office of Inspector General (OIG) of the
U.S. Department of Heath and Human Services. Based on our dis-
cussions with [Provider], it is our understanding that the procedures
outlined in this draft report are those we are expected to follow. Un-
less informed otherwise within ninety (90) days of this transmittal, we
shall assume that there are no additional procedures that we are ex-
pected to follow. The text of the definitive report will depend, of course,
on the results of the procedures.
Involvement of a Specialist2
.15 The practitioner's education and experience enable him or her to be
knowledgeable about business matters in general, but he or she is not expected
to have the expertise of a person trained for or qualified to engage in the prac-
tice of another profession or occupation. In certain circumstances, it may be
appropriate to involve a specialist to assist the practitioner in the performance
of one or more procedures. The following are examples:
 An attorney might provide assistance concerning the application
of laws, regulations, or rules to a client's situation.
 A medical specialist might provide assistance in understanding
the characteristics of diagnosis codes documented in patient med-
ical records.
.16 The practitioner and the specified parties should agree to the involve-
ment of a specialist in assisting a practitioner in the performance of an agreed-
upon procedures engagement. This agreement may be reached when obtaining
agreement on the procedures performed or to be performed and acknowledg-
ment of responsibility for the sufficiency of the procedures, as discussed pre-
viously. The practitioner's report should describe the nature of the assistance
2 A specialist is a person (or firm) possessing special skill or knowledge in a particular field
other than the attest function. As used herein, a specialist does not include a person employed by the
practitioner's firm who participates in the attestation engagement.
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provided by the specialist. [Revised, June 2009, to reflect conforming changes
necessary due to the issuance of recent authoritative literature.]
.17 A practitioner may agree to apply procedures to the report or work
product of a specialist that does not constitute assistance by the specialist to
the practitioner in an agreed-upon procedures engagement. For example, the
practitioner may make reference to information contained in a report of a spe-
cialist in describing an agreed-upon procedure. However, it is inappropriate
for the practitioner to agree to merely read the specialist's report solely to de-
scribe or repeat the findings, or to take responsibility for all or a portion of any
procedures performed by a specialist or the specialist's work product.
Internal Auditors and Other Personnel3
.18 The agreed-upon procedures to be enumerated or referred to in the
practitioner's report are to be performed entirely by the practitioner except
as discussed in paragraphs .16–.18 of this SOP. However, internal auditors or
other personnel may prepare schedules, accumulate data, perform an internal
assessment of management's compliance, or provide other information for the
practitioner's use in performing the agreed-upon procedures.
.19 A practitioner may agree to perform procedures on information docu-
mented in the working papers of internal auditors. For example, the practitioner
may agree to—
 Repeat all or some of the procedures.
 Determine whether the internal auditors' working papers contain
documentation of procedures performed and whether the findings
documented in the working papers are presented in a report by
the internal auditors.
.20 However, it is inappropriate for the practitioner to—
 Agree to merely read the internal auditor's report solely to describe
or repeat its findings.
 Take responsibility for all or a portion of any procedures per-
formed by internal auditors by reporting those findings as the
practitioner's own.
 Report in any manner that implies shared responsibility for the
procedures with the internal auditors.
Planning the Engagement
.21 Planning an agreed-upon procedures engagement involves working
with the specified parties to develop an overall strategy for the expected conduct
and scope of the engagement. To develop such a strategy, practitioners should
have adequate technical training and proficiency in the attestation standards
and have adequate knowledge in health care regulatory matters to enable them
to sufficiently understand the events, transactions, and practices that, in their
judgment, have a significant effect on the presentation of the assertions. [Re-
vised, June 2009, to reflect conforming changes necessary due to the issuance
of recent authoritative literature.]
3 AU sec. 322, The Auditor's Consideration of the Internal Audit Function in an Audit of Finan-
cial Statements (AICPA, Professional Standards, vol. 1,), does not apply to agreed-upon procedures
engagements.
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Documentation
.22 The practitioner should prepare and maintain attest documentation,
the form and content of which should be designed to meet the circumstances of
the particular attest engagement. Attest documentation is the principal record
of attest procedures applied, information obtained, and conclusions or findings
reached by the practitioner in the engagement. The quantity, type, and content
of attest documentation are matters of the practitioner's professional judgment
and are discussed in paragraphs .100–.103 of AT section 101. Paragraphs .104–
.107 of AT section 101 present further requirements and guidance regarding
attest documentation. [Revised, June 2009, to reflect conforming changes nec-
essary due to the issuance of recent authoritative literature.]
.23 Concern over access to the practitioner's documentation might cause
some clients to inquire about documentation requirements. In situations
where the practitioner is requested to not maintain copies of certain client
documentation, or to not prepare and maintain documentation similar to client
documents, the practitioner may refer to the Auditing Interpretation No. 3,
"The Auditor's Consideration of the Completeness Assertion," of AU section
326, Audit Evidence (AICPA, Professional Standards, vol. 1, AU sec. 9326.24–
.27), for guidance. See Attestation Interpretation No. 4, "Providing Access to
or Copies of Attest Documentation to a Regulator," of AT section 101 (AICPA,
Professional Standards, vol. 1, AT sec. 9101.43–.46) for guidance related to pro-
viding access to or copies of attest documentation to a regulator in connection
with work performed on an attestation engagement. [Revised, June 2009, to re-
flect conforming changes necessary due to the issuance of recent authoritative
literature.]
Management’s Representations
.24 The practitioner should obtain written representation from manage-
ment on various matters including the following:
a. Acknowledging management's responsibility for complying with
the CIA
b. Acknowledging management's responsibility for establishing and
maintaining effective internal control over compliance
c. Stating that management has performed an evaluation of the en-
tity's compliance with CIA-specified requirements
d. Stating management's assertions about the entity's compliance
with all aspects of the CIA, including the specific issues that gave
rise to the CIA4,5
4 Footnote 21 in paragraph .100 of AT section 101, Attest Engagements (AICPA, Professional
Standards, vol. 1), indicates that attest documentation may also be referred to as working papers.
[Footnote added, June 2009, to reflect conforming changes necessary due to the issuance of recent
authoritative literature.]
5 Depending on the circumstances, representations in the following areas might be appropriate.
• Violations or possible violations of laws or regulations, such as those related to the Medicare
and Medicaid antifraud and abuse statutes
• Compliance of third-party billings with applicable coding guidelines (for example, ICD-9-
CM, CPT) and laws and regulations (including medical necessity, proper approvals, and
proper rendering of care)
(continued)
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e. Stating that management has disclosed to the practitioner all
known noncompliance with the CIA
f. Stating that management has made available all documentation
relating to compliance with the CIA
g. Stating management's interpretation of any compliance require-
ments that have varying interpretations
h. Stating that management has disclosed any communication from
regulatory agencies, internal auditors, legal counsel, and other par-
ties concerning matters regarding the design, implementation, and
monitoring of the policies and procedures in place, including com-
munication received between the end of the reporting period and
the date of the practitioner's report (the date of signature)
i. Stating that management has disclosed any known noncompliance
occurring subsequent to the end of the reporting period
j. Describing any related material fraud or abuse, other fraud, abuse
or illegal acts that, whether or not material, involve management or
other employees who have a significant role in the entity's design,
implementation, and monitoring of the policies and procedures in
place upon which compliance is based
k. Stating that management has disclosed to the practitioners, orally
or in writing, information about past noncompliance issues cov-
ered in the settlement agreement that gave rise to the CIA and the
related corrective measures taken to support compliance in those
areas
Management's refusal to furnish all appropriate written representations con-
stitutes a limitation on the scope of the engagement sufficient to require with-
drawal from the engagement.6
Reporting Considerations
.25 A practitioner should present the results of applying agreed-upon pro-
cedures to the specific subject matter in the form of findings. The practitioner
should not provide negative assurance about whether the assertion is fairly
stated in accordance with established or stated criteria. For example, the prac-
titioner should not include a statement that "nothing came to my attention that
caused me to believe that the assertion is not fairly stated in accordance with
(established or stated) criteria."
.26 The practitioner should report all findings from the application of the
agreed-upon procedures. The concept of materiality does not apply to findings
to be reported in an agreed-upon procedures engagement unless the definition
of materiality is agreed to by the specified parties. Any agreed-upon materiality
(footnote continued)
• Proper filing of all required Medicare, Medicaid, and similar reports under the applicable
reimbursement rules and regulations (including nature of costs—allowable, patient-related,
properly allocated, in accordance with applicable rules and regulations, properly adjusted to
reflect prior audit adjustments) and adequacy of disclosures (including disputed costs) [Foot-
note renumbered, June 2009, to reflect conforming changes necessary due to the issuance
of recent authoritative literature.]
6 See paragraph .62 of AT section 101. [Footnote added, June 2009, to reflect conforming changes
necessary due to the issuance of recent authoritative literature.]
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limits should be described in the practitioner's report. [Revised, June 2009, to
reflect conforming changes necessary due to the issuance of recent authoritative
literature.]
.27 The practitioner has no obligation to perform procedures beyond the
agreed-upon procedures. However, if noncompliance related to management's
assertion comes to the practitioner's attention by other means, such information
ordinarily should be included in his or her report.
.28 The practitioner may become aware of noncompliance related to man-
agement's assertion that occurs subsequent to the reporting period but before
the date of the practitioner's report. The practitioner should consider including
information regarding such noncompliance in his or her report. However, the
practitioner has no responsibility to perform procedures to detect such noncom-
pliance other than obtaining management's representation about noncompli-
ance in the subsequent period.
.29 practitioner should follow the reporting guidance in AT section 201. A
sample report is included in appendix E (paragraph .36), "Sample Report."
.30 Evaluating compliance with certain requirements may require inter-
pretation of the laws, regulations, rules, contracts, or other agreements that
establish those requirements. In such situations, the practitioner should con-
sider whether he or she is provided with the reasonable criteria required to
evaluate an assertion under the third general attestation standard. If these in-
terpretations are significant, the practitioner may include a paragraph stating
the description and the source of interpretations made by the entity's manage-
ment. An example of such a paragraph, which should precede the procedures
and findings paragraph(s), follows:
We have been informed that, under [name of entity's] interpretation of
[identify the compliance requirement], [explain the nature and source
of the relevant interpretation].
.31 The date of completion of the agreed-upon procedures should be used
as the date of the practitioner's report.
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.32
Appendix A
Sample Corporate Integrity Agreement
Between the Office of Inspector General
of the Department of Health and
Human Services and [Provider]
I. Preamble
[Provider] ("[Provider]") hereby enters into this Corporate Integrity Agreement
("CIA") with the Office of Inspector General ("OIG") of the United States De-
partment of Health and Human Services ("HHS") to ensure compliance by its
employees with the requirements of Medicare, Medicaid and all other Federal
health care programs (as defined in 42 U.S.C. 1320a-7b(f)) (hereinafter collec-
tively referred to as the "Federal health care programs"). [Provider's] compli-
ance with the terms and conditions in this CIA shall constitute an element of
[Provider's] present responsibility with regard to participation in the Federal
health care programs. Contemporaneously with this CIA, [Provider] is entering
into a Settlement Agreement with the United States, and this CIA is incorpo-
rated by reference into the Settlement Agreement.
II. Term of the CIA
The period of the compliance obligations assumed by [Provider] under this CIA
shall be 5 years from the effective date of this CIA (unless otherwise specified).
The effective date of this CIA will be the date on which the final signatory of
this CIA executes this CIA (the "effective date").*
III. Corporate Integrity Obligations
[Provider] shall establish a compliance program that includes the following
elements:
A. Compliance Officer
Within ninety (90) days after the effective date of this CIA, [Provider]
shall appoint an individual to serve as Compliance Officer, who shall
be responsible for developing and implementing policies, procedures,
and practices designed to ensure compliance with the requirements set
forth in this CIA and with the requirements of the Federal health care
programs. The Compliance Officer shall be a member of senior man-
agement of [Provider], shall make regular (at least quarterly) reports
regarding compliance matters directly to the CEO and/or to the Board
of Directors of [Provider] and shall be authorized to report to the Board
of Directors at any time. The Compliance Officer shall be responsible
for monitoring the day-to-day activities engaged in by [Provider] to
further its compliance objectives as well as any reporting obligations
created under this CIA. In the event a new Compliance Officer is ap-
pointed during the term of this CIA, [Provider] shall notify the OIG,
in writing, within fifteen (15) days of such a change.
* Source: Office of the Inspector General of the United States Department of Health and Human
Services.
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[Provider] shall also appoint a Compliance Committee within ninety
(90) days after the effective date of this CIA. The Compliance Com-
mittee shall, at a minimum, include the Compliance Officer and any
other appropriate officers as necessary to meet the requirements of this
CIA within the provider's corporate structure (e.g., senior executives
of each major department, such as billing, clinical, human resources,
audit, and operations). The Compliance Officer shall chair the Com-
pliance Committee and the Committee shall support the Compliance
Officer in fulfilling his/her responsibilities.
B. Written Standards
1. Code of Conduct. Within ninety (90) days of the effective date of
this CIA, [Provider] shall establish a Code of Conduct. The Code
of Conduct shall be distributed to all employees within ninety (90)
days of the effective date of this CIA. [Provider] shall make the
promotion of, and adherence to, the Code of Conduct an element in
evaluating the performance of managers, supervisors, and all other
employees. The Code of Conduct shall, at a minimum, set forth:
a. [Provider's] commitment to full compliance with all
statutes, regulations, and guidelines applicable to Fed-
eral health care programs, including its commitment to
prepare and submit accurate billings consistent with Fed-
eral health care program regulations and procedures or
instructions otherwise communicated by the Health Care
Financing Administration ("HCFA") (or other appropriate
regulatory agencies) and/or its agents;
b. [Provider's] requirement that all of its employees shall
be expected to comply with all statutes, regulations, and
guidelines applicable to Federal health care programs and
with [Provider's] own policies and procedures (including
the requirements of this CIA);
c. the requirement that all of [Provider's] employees shall
be expected to report suspected violations of any statute,
regulation, or guideline applicable to Federal health care
programs or with [Provider's] own policies and procedures;
d. the possible consequences to both [Provider] and to any em-
ployee of failure to comply with all statutes, regulations,
and guidelines applicable to Federal health care programs
and with [Provider's] own policies and procedures or of fail-
ure to report such non-compliance; and
e. the right of all employees to use the confidential disclosure
program, as well as [Provider's] commitment to confiden-
tiality and non-retaliation with respect to disclosures.
Within ninety (90) days of the effective date of the CIA, each em-
ployee shall certify, in writing, that he or she has received, read,
understands, and will abide by [Provider's] Code of Conduct. New
employees shall receive the Code of Conduct and shall complete the
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required certification within two (2) weeks after the commencement
of their employment or within ninety (90) days of the effective date
of the CIA, whichever is later.
[Provider] will annually review the Code of Conduct and will make
any necessary revisions. These revisions shall be distributed within
thirty (30) days of initiating such a change. Employees shall certify
on an annual basis that they have received, read, understand and
will abide by the Code of Conduct.
2. Policies and Procedures. Within ninety (90) days of the effective
date of this CIA, [Provider] shall develop and initiate implemen-
tation of written Policies and Procedures regarding the operation
of [Provider's] compliance program and its compliance with all fed-
eral and state health care statutes, regulations, and guidelines, in-
cluding the requirements of the Federal health care programs. At
a minimum, the Policies and Procedures shall specifically address
[insert language relevant to allegations in the case]. In addition,
the Policies and Procedures shall include disciplinary guidelines
and methods for employees to make disclosures or otherwise report
on compliance issues to [Provider] management through the Con-
fidential Disclosure Program required by section III.E. [Provider]
shall assess and update as necessary the Policies and Procedures
at least annually and more frequently, as appropriate. A summary
of the Policies and Procedures will be provided to OIG in the Imple-
mentation Report. The Policies and Procedures will be available to
OIG upon request.
Within ninety (90) days of the effective date of the CIA, the relevant
portions of the Policies and Procedures shall be distributed to all
appropriate employees. Compliance staff or supervisors should be
available to explain any and all policies and procedures.
C. Training and Education
1. General Training. Within ninety (90) days of the effective date of
this CIA, [Provider] shall provide at least two (2) hours of training
to each employee. This general training shall explain [Provider's]:
a. Corporate Integrity Agreement requirements;
b. Compliance Program (including the Policies and Proce-
dures as they pertain to general compliance issues); and
c. Code of Conduct.
These training materials shall be made available to the OIG, upon
request.
New employees shall receive the general training described above
within thirty (30) days of the beginning of their employment
or within ninety (90) days after the effective date of this CIA,
whichever is later. Each year, every employee shall receive such
general training on an annual basis.
2. Specific Training. Within ninety (90) days of the effective date of
this CIA, each employee who is involved directly or indirectly in
the delivery of patient care and/or in the preparation or submission
of claims for reimbursement for such care (including, but not limited
to, coding and billing) for any Federal health care programs shall
receive at least [insert number of training hours] hours of training
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in addition to the general training required above. This training
shall include a discussion of:
a. the submission of accurate bills for services rendered to
Medicare and/or Medicaid patients;
b. policies, procedures and other requirements applicable to
the documentation of medical records;
c. the personal obligation of each individual involved in the
billing process to ensure that such billings are accurate;
d. applicable reimbursement rules and statutes;
e. the legal sanctions for improper billings; and
f. examples of proper and improper billing practices.
These training materials shall be made available to OIG, upon re-
quest. Persons providing the training must be knowledgeable about
the subject area.
Affected new employees shall receive this training within thirty
(30) days of the beginning of their employment or within ninety
(90) days of the effective date of this CIA, whichever is later. If
a new employee has any responsibility for the delivery of patient
care, the preparation or submission of claims and/or the assign-
ment of procedure codes prior to completing this specific training,
a [Provider] employee who has completed the substantive train-
ing shall review all of the untrained person's work regarding the
assignment of billing codes.
Each year, every employee shall receive such specific training on an
annual basis.
3. Certification. Each employee shall certify, in writing, that he or she
has attended the required training. The certification shall specify
the type of training received and the date received. The Compliance
Officer shall retain the certifications, along with specific course ma-
terials. These shall be made available to OIG upon request.
D. Review Procedures
[Provider] shall retain an entity, such as an accounting, auditing or
consulting firm (hereinafter "Independent Review Organization"), to
perform review procedures to assist [Provider] in assessing the ade-
quacy of its billing and compliance practices pursuant to this CIA. This
shall be an annual requirement and shall cover a twelve (12) month
period. The Independent Review Organization must have expertise
in the billing, coding, reporting and other requirements of the Federal
health care programs from which [Provider] seeks reimbursement. The
Independent Review Organization must be retained to conduct the as-
sessment of the first year within ninety (90) days of the effective date
of this CIA. For purposes of complying with this review procedures
requirement, the OIG at its discretion, may permit the [Provider] to
utilize internal auditors to perform the review(s). In such case, the
[Provider] will engage the Independent Review Organization to verify
the propriety of the internal auditors' methods and accuracy of their
results. The [Provider] will request the Independent Review Organiza-
tion to produce a report on its findings which report shall be included
in the Annual Report to the OIG.
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The Independent Review Organization (or the [Provider], if permit-
ted by the OIG, as set forth above) will conduct two separate engage-
ments. One will be an analysis of [Provider's] billing to the Federal
health care programs to assist the [Provider] and OIG in determin-
ing compliance with all applicable statutes, regulations, and direc-
tives/guidance ("billing engagement"). The second engagement will
assist the [Provider] and OIG in determining whether [Provider] is
in compliance with this CIA ("compliance engagement").
1. Billing Engagement. The billing engagement shall consist of a re-
view of a statistically valid sample of claims for the relevant period.
The sample size shall be determined through the use of a probe
sample.1 At a minimum, the full sample must be within a ninety
(90) percent confidence level and a precision of twenty-five (25) per-
cent. The probe sample must contain at least thirty (30) sample
units and cannot be used as part of the full sample. Both the probe
sample and the sample must be selected through random numbers.
[Provider] shall use OIG's Office of Audit Services Statistical Sam-
pling Software, also known as "RAT-STATS", which is available
through the Internet at www.hhs.gov/progorg/ratstat.html.
Each annual billing engagement analysis shall include the follow-
ing components in its methodology:
a. Billing Engagement Objective: Provide a statement stat-
ing clearly the objective intended to be achieved by the
billing engagement and the procedure or combination of
procedures that will be applied to achieve the objective.
b. Billing Engagement Population: Identify the population,
which is the group about which information is needed. Ex-
plain the methodology used to develop the population and
provide the basis for this determination.
c. Sources of Data: Provide a full description of the source of
the information upon which the billing engagement conclu-
sions will be based, including the legal or other standards
applied, documents relied upon, payment data, and/or any
contractual obligations.
d. Sampling Unit: Define the sampling unit, which is any of
the designated elements that comprise the population of
interest.
e. Sampling Frame: Identify the sampling frame, which is
the totality of the sampling units from which the sample
will be selected.
As part of the billing engagement:
a. Inquire of management as to the procedures and controls
affecting the billing process subject to the annual assess-
ment as specified in the CIA. Document that aspect of the
billing process (e.g., flow of documents, processing activi-
ties), and those controls that will be tested in the sample.
The documentation may consist of flow charts, excerpts
from policies and procedures manuals, control question-
naires, etc.
1 Probe sample is defined as a small, random preliminary sample.
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b. Report the sample results, including the overall error rate
and the nature of the errors found (e.g., no documentation,
inadequate documentation, assignment of incorrect code).
c. Document findings related to [Provider's] procedures to
correct inaccurate billings and codings to the Federal
health care programs and findings regarding the steps
[Provider] is taking to bring its operations into compliance
or to correct problems identified by the audit.
2. Agreed-upon Procedures or Compliance Engagement. An Indepen-
dent Review Organization (or the [Provider], if permitted by the
OIG) shall also conduct an agreed-upon procedures or compliance
engagement, which shall assist the users in determining whether
[Provider's] program, policies, procedures, and operations comply
with the terms of this CIA. This engagement shall include a section
by section analysis of the requirements of this CIA.
A complete copy of the Independent Review Organization's billing
and agreed-upon procedures or compliance engagement shall be
included in each of [Provider's] Annual Reports to OIG.
3. Disclosure of Overpayments and Material Deficiencies. If, as a result
of these engagements, [Provider] or the Independent Review Orga-
nization identifies any billing, coding or other policies, procedures
and/or practices that result in an overpayment, [Provider] shall no-
tify the payor (e.g., Medicare fiscal intermediary or carrier) within
30 days of discovering the deficiency or overpayment and take re-
medial steps within 60 days of discovery (or such additional time
as may be agreed to by the payor) to correct the problem, including
preventing the deficiency from recurring. The notice to the payor
shall include:
a. a statement that the refund is being made pursuant to this
CIA;
b. a description of the complete circumstances surrounding
the overpayment;
c. the methodology by which the overpayment was deter-
mined;
d. the amount of the overpayment;
e. any claim-specific information used to determine the over-
payment (e.g., beneficiary health insurance number, claim
number, service date, and payment date);
f. the cost reporting period; and
g. the provider identification number under which the repay-
ment is being made.
If [Provider] determines an overpayment represents a material de-
ficiency, contemporaneous with [Provider's] notification to the payor
as provided above, [Provider] shall also notify OIG of:
a. a complete description of the material deficiency;
b. amount of overpayment due to the material deficiency;
c. [Provider's] action(s) to correct and prevent such material
deficiency from recurring;
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d. the payor's name, address, and contact person where the
overpayment was sent;
e. the date of the check and identification number (or elec-
tronic transaction number) on which the overpayment was
repaid.
For purposes of this CIA, an "overpayment" shall mean the amount
of money the provider has received in excess of the amount due
and payable under the Federal health care programs' statutes, reg-
ulations or program directives, including carrier and intermediary
instructions.
For purposes of this CIA, a "material deficiency" shall mean any-
thing that involves: (i) a substantial overpayment or improper pay-
ment relating to the Medicare and/or Medicaid programs; (ii) con-
duct or policies that clearly violate the Medicare and/or Medicaid
statute, regulations or directives issued by HCFA and/or its agents;
or (iii) serious quality of care implications for federal health care
beneficiaries or recipients. A material deficiency may be the result
of an isolated event or a series of occurrences.
4. Verification/Validation. In the event that the OIG determines that
it is necessary to conduct an independent review to determine
whether or the extent to which [Provider] is complying with its
obligations under this CIA, [Provider] agrees to pay for the reason-
able cost of any such review or engagement by the OIG or any of its
designated agents.
E. Confidential Disclosure Program
Within ninety (90) days after the effective date of this CIA, [Provider]
shall establish a Confidential Disclosure Program, which must include
measures (e.g., a toll-free compliance telephone line) to enable employ-
ees, contractors, agents or other individuals to disclose, to the Compli-
ance Officer or some other person who is not in the reporting individ-
ual's chain of command, any identified issues or questions associated
with [Provider's] policies, practices or procedures with respect to the
Federal health care program, believed by the individual to be inap-
propriate. [Provider] shall publicize the existence of the hotline (e.g.,
e-mail to employees or post hotline number in prominent common ar-
eas).
The Confidential Disclosure Program shall emphasize a non-
retribution, non-retaliation policy, and shall include a reporting mech-
anism for anonymous, confidential communication. Upon receipt of a
complaint, the Compliance Officer (or designee) shall gather the infor-
mation in such a way as to elicit all relevant information from the in-
dividual reporting the alleged misconduct. The Compliance Officer (or
designee) shall make a preliminary good faith inquiry into the allega-
tions set forth in every disclosure to ensure that he or she has obtained
all of the information necessary to determine whether a further review
should be conducted. For any disclosure that is sufficiently specific so
that it reasonably: (1) permits a determination of the appropriateness
of the alleged improper practice, and (2) provides an opportunity for
taking corrective action, [Provider] shall conduct an internal review of
the allegations set forth in such a disclosure and ensure that proper
follow-up is conducted.
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The Compliance Officer shall maintain a confidential disclosure log,
which shall include a record and summary of each allegation received,
the status of the respective investigations, and any corrective action
taken in response to the investigation.
F. Ineligible Persons
[Provider] shall not hire or engage as contractors any "Ineligible Per-
son." For purposes of this CIA, an "Ineligible Person" shall be any indi-
vidual or entity who: (i) is currently excluded, suspended, debarred or
otherwise ineligible to participate in the Federal health care programs;
or (ii) has been convicted of a criminal offense related to the provision
of health care items or services and has not been reinstated in the
Federal health care programs after a period of exclusion, suspension,
debarment, or ineligibility.
Within ninety (90) days of the effective date of this CIA, [Provider]
will review its list of current employees and contractors against the
General Services Administration's List of Parties Excluded from Fed-
eral Programs (available through the Internet at http://www.arnet.gov/
epls) and the HHS/OIG Cumulative Sanction Report (available
through the Internet at http://www.dhhs.gov/progorg/oig) to ensure
that it is not currently employing or contracting with any Ineligible
Person. Thereafter, [Provider] will review the list once semi-annually
to ensure that no current employees or contractors are or have become
Ineligible Persons.
To prevent hiring or contracting with any Ineligible Person, [Provider]
shall screen all prospective employees and prospective contractors
prior to engaging their services by (i) requiring applicants to disclose
whether they are Ineligible Persons, and (ii) reviewing the General
Services Administration's List of Parties Excluded from Federal Pro-
grams (available through the Internet at http://www.arnet.gov/epls)
and the HHS/OIG Cumulative Sanction Report (available through the
Internet at http://www.dhhs.gov/progorg/oig).
If [Provider] has notice that an employee or agent is charged with
a criminal offense related to any Federal health care program, or is
suspended or proposed for exclusion during his or her employment
or contract with [Provider], within 10 days of receiving such notice
[Provider] will remove such employee from responsibility for, or in-
volvement with, [Provider's] business operations related to the Fed-
eral health care programs until the resolution of such criminal action,
suspension, or proposed exclusion. If [Provider] has notice that an em-
ployee or agent has become an Ineligible Person, [Provider] will remove
such person from responsibility for, or involvement with, [Provider's]
business operations related to the Federal health care programs and
shall remove such person from any position for which the person's
salary or the items or services rendered, ordered, or prescribed by the
person are paid in whole or in part, directly or indirectly, by Federal
health care programs or otherwise with Federal funds at least until
such time as the person is reinstated into participation in the Federal
health care programs.
G. Notification of Proceedings
Within thirty (30) days of discovery, [Provider] shall notify OIG, in
writing, of any ongoing investigation or legal proceeding conducted or
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brought by a governmental entity or its agents involving an allegation
that [Provider] has committed a crime or has engaged in fraudulent
activities or any other knowing misconduct. This notification shall in-
clude a description of the allegation, the identity of the investigating
or prosecuting agency, and the status of such investigation or legal
proceeding. [Provider] shall also provide written notice to OIG within
thirty (30) days of the resolution of the matter, and shall provide OIG
with a description of the findings and/or results of the proceedings,
if any.
H. Reporting
1. Credible evidence of misconduct. If [Provider] discovers credible evi-
dence of misconduct from any source and, after reasonable inquiry,
has reason to believe that the misconduct may violate criminal,
civil, or administrative law concerning [Provider's] practices re-
lating to the Federal health care programs, then [Provider] shall
promptly report the probable violation of law to OIG. Defendants
shall make this disclosure as soon as practicable, but, not later
than thirty (30) days after becoming aware of the existence of the
probable violation. The [Provider's] report to OIG shall include:
a. the findings concerning the probable violation, including
the nature and extent of the probable violation;
b. [Provider's] actions to correct such probable violation; and
c. any further steps it plans to take to address such probable
violation and prevent it from recurring.
To the extent the misconduct involves an overpayment, the report
shall include the information listed in section III.D.3 regarding ma-
terial deficiencies.
2. Inappropriate Billing. If [Provider] discovers inappropriate or in-
correct billing through means other than the Independent Review
Organization's engagement, the provider shall follow procedures in
section III.D.3 regarding overpayments and material deficiencies.
IV. New Locations
In the event that [Provider] purchases or establishes new business units after
the effective date of this CIA, [Provider] shall notify OIG of this fact within
thirty (30) days of the date of purchase or establishment. This notification shall
include the location of the new operation(s), phone number, fax number, Federal
health care program provider number(s) (if any), and the corresponding payor(s)
(contractor specific) that has issued each provider number. All employees at
such locations shall be subject to the requirements in this CIA that apply to
new employees (e.g., completing certifications and undergoing training).
V. Implementation and Annual Reports
A. Implementation Report
Within one hundred and twenty (120) days after the effective date of
this CIA, [Provider] shall submit a written report to OIG summarizing
the status of its implementation of the requirements of this CIA. This
Implementation Report shall include:
1. the name, address, phone number and position description
of the Compliance Officer required by section III.A;
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2. the names and positions of the members of the Compliance
Committee required by section III.A;
3. a copy of [Provider's] Code of Conduct required by section
III.B.1;
4. the summary of the Policies and Procedures required by
section III.B.2;
5. a description of the training programs required by section
III.C including a description of the targeted audiences and
a schedule of when the training sessions were held;
6. a certification by the Compliance Officer that:
a. the Policies and Procedures required by sec-
tion III.B have been developed, are being imple-
mented, and have been distributed to all perti-
nent employees;
b. all employees have completed the Code of Conduct
certification required by section III.B.1; and
c. all employees have completed the training and ex-
ecuted the certification required by section III.C;
7. a description of the confidential disclosure program re-
quired by section III.E;
8. the identity of the Independent Review Organization(s)
and the proposed start and completion date of the first
audit; and
9. a summary of personnel actions taken pursuant to section
III.F.
B. Annual Reports
[Provider] shall submit to OIG an Annual Report with respect to the
status and findings of [Provider's] compliance activities. The Annual
Reports shall include:
1. any change in the identity or position description of the
Compliance Officer and/or members of the Compliance
Committee described in section III.A;
2. a certification by the Compliance Officer that:
a. all employees have completed the annual Code of
Conduct certification required by section III.B.1;
and
b. all employees have completed the training and ex-
ecuted the certification required by section III.C;
3. notification of any changes or amendments to the Policies
and Procedures required by section III.B and the reasons
for such changes (e.g., change in contractor policy);
4. a complete copy of the report prepared pursuant to the In-
dependent Review Organization's billing and compliance
engagement, including a copy of the methodology used;
5. [Provider's] response/corrective action plan to any issues
raised by the Independent Review Organization;
AAG-HCO APP C
P1: PjU
ACPA125-AppC ACPA125.cls February 25, 2010 16:44
Statement of Position 99-1 403
6. a summary of material deficiencies reported throughout
the course of the previous twelve (12) months pursuant to
III.D.3 and III.H;
7. a report of the aggregate overpayments that have been
returned to the Federal health care programs that were
discovered as a direct or indirect result of implementing
this CIA. Overpayment amounts should be broken down
into the following categories: Medicare, Medicaid (report
each applicable state separately) and other Federal health
care programs;
8. a copy of the confidential disclosure log required by section
III.E;
9. a description of any personnel action (other than hiring)
taken by [Provider] as a result of the obligations in section
III.F;
10. a summary describing any ongoing investigation or legal
proceeding conducted or brought by a government entity
involving an allegation that [Provider] has committed a
crime or has engaged in fraudulent activities, which have
been reported pursuant to section III.G. The statement
shall include a description of the allegation, the identity of
the investigating or prosecuting agency, and the status of
such investigation, legal proceeding or requests for infor-
mation;
11. a corrective action plan to address the probable violations
of law identified in section III.H; and
12. a listing of all of the [Provider's] locations (including lo-
cations and mailing addresses), the corresponding name
under which each location is doing business, the corre-
sponding phone numbers and fax numbers, each location's
Federal health care program provider identification num-
ber(s) and the payor (specific contractor) that issued each
provider identification number.
The first Annual Report shall be received by the OIG no
later than one year and thirty (30) days after the effective
date of this CIA. Subsequent Annual Reports shall be sub-
mitted no later than the anniversary date of the due date
of the first Annual Report.
C. Certifications
The Implementation Report and Annual Reports shall include a cer-
tification by the Compliance Officer under penalty of perjury, that: (1)
[Provider] is in compliance with all of the requirements of this CIA,
to the best of his or her knowledge; and (2) the Compliance Officer
has reviewed the Report and has made reasonable inquiry regarding
its content and believes that, upon such inquiry, the information is
accurate and truthful.
VI. Notifications and Submission of Reports
Unless otherwise stated in writing subsequent to the effective date of this CIA,
all notifications and reports required under this CIA shall be submitted to the
entities listed below:
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OIG:
Civil Recoveries Branch—Compliance Unit
Office of Counsel to the Inspector General
Office of Inspector General
U.S. Department of Health and Human Services
Cohen Building, Room 5527
330 Independence Avenue, SW
Washington, DC 20201
Phone 202-619-2078; Fax 202-205-0604
[Provider]:
[Address and Telephone number of Provider's Compliance Contact]
VII. OIG Inspection, Audit and Review Rights
In addition to any other rights OIG may have by statute, regulation, or contract,
OIG or its duly authorized representative(s), may examine [Provider's] books,
records, and other documents and supporting materials for the purpose of ver-
ifying and evaluating: (a) [Provider's] compliance with the terms of this CIA;
and (b) [Provider's] compliance with the requirements of the Federal health care
programs in which it participates. The documentation described above shall be
made available by [Provider] to OIG or its duly authorized representative(s)
at all reasonable times for inspection, audit or reproduction. Furthermore, for
purposes of this provision, OIG or its duly authorized representative(s) may
interview any of [Provider's] employees who consent to be interviewed at the
employee's place of business during normal business hours or at such other
place and time as may be mutually agreed upon between the employee and
OIG. [Provider] agrees to assist OIG in contacting and arranging interviews
with such employees upon OIG's request. [Provider's] employees may elect to
be interviewed with or without a representative of [Provider] present.
VIII. Document and Record Retention
[Provider] shall maintain for inspection all documents and records relating to
reimbursement from the Federal health care programs or to compliance with
this CIA one year longer than the term of this CIA (or longer if otherwise
required by law).
IX. Disclosures
Subject to HHS's Freedom of Information Act ("FOIA") procedures, set forth in
45 C.F.R. Part 5, the OIG shall make a reasonable effort to notify [Provider]
prior to any release by OIG of information submitted by [Provider] pursuant
to its obligations under this CIA and identified upon submission by [Provider]
as trade secrets, commercial or financial information and privileged and confi-
dential under the FOIA rules. [Provider] shall refrain from identifying any in-
formation as trade secrets, commercial or financial information and privileged
and confidential that does not meet the criteria for exemption from disclosure
under FOIA.
X. Breach and Default Provisions
[Provider] is expected to fully and timely comply with all of the obligations
herein throughout the term of this CIA or other time frames herein agreed to.
A. Stipulated Penalties for Failure to Comply with Certain Obligations
As a contractual remedy, [Provider] and OIG hereby agree that failure
to comply with certain obligations set forth in this CIA may lead to the
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imposition of the following monetary penalties (hereinafter referred to
as "Stipulated Penalties") in accordance with the following provisions.
1. A Stipulated Penalty of $2,500 (which shall begin to accrue
on the day after the date the obligation became due) for
each day, beginning 120 days after the effective date of
this CIA and concluding at the end of the term of this CIA,
[Provider] fails to have in place any of the following:
a. a Compliance Officer;
b. a Compliance Committee;
c. a written Code of Conduct;
d. written Policies and Procedures;
e. a training program; and
f. a Confidential Disclosure Program;
2. A Stipulated Penalty of $2,500 (which shall begin to accrue
on the day after the date the obligation became due) for
each day [Provider] fails to meet any of the deadlines to
submit the Implementation Report or the Annual Reports
to the OIG.
3. A Stipulated Penalty of $2,000 (which shall begin to ac-
crue on the date the failure to comply began) for each day
[Provider]:
a. hires or contracts with an Ineligible Person after
that person has been listed by a federal agency as
excluded, debarred, suspended or otherwise in-
eligible for participation in the Medicare, Medi-
caid or any other Federal health care program (as
defined in 42 U.S.C. 1320a7b(f)). This Stipulated
Penalty shall not be demanded for any time period
if [Provider] can demonstrate that it did not dis-
cover the person's exclusion or other ineligibility
after making a reasonable inquiry (as described
in section III.F) as to the status of the person;
b. employs or contracts with an Ineligible Person
and that person: (i) has responsibility for, or in-
volvement with, [Provider's] business operations
related to the Federal health care programs or (ii)
is in a position for which the person's salary or the
items or services rendered, ordered, or prescribed
by the person are paid in whole or in part, directly
or indirectly, by the Federal health care programs
or otherwise with Federal funds (this Stipulated
Penalty shall not be demanded for any time period
during which [Provider] can demonstrate that it
did not discover the person's exclusion or other in-
eligibility after making a reasonable inquiry (as
described in III.F) as to the status of the person);
c. employs or contracts with a person who: (i) has
been charged with a criminal offense related
to any Federal health care program, or (ii) is
suspended or proposed for exclusion, and that
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person has responsibility for, or involvement with,
[Provider's] business operations related to the
Federal health care programs (this Stipulated
Penalty shall not be demanded for any time pe-
riod before 10 days after [Provider] received no-
tice of the relevant matter or after the resolution
of the matter).
4. A Stipulated Penalty of $1,500 (which shall begin to accrue
on the date the [Provider] fails to grant access) for each
day [Provider] fails to grant access to the information or
documentation as required in section V of this CIA.
5. A Stipulated Penalty of $1,000 (which shall begin to accrue
ten (10) days after the date that OIG provides notice to
[Provider] of the failure to comply) for each day [Provider]
fails to comply fully and adequately with any obligation of
this CIA. In its notice to [Provider], the OIG shall state the
specific grounds for its determination that the [Provider]
has failed to comply fully and adequately with the CIA
obligation(s) at issue.
B. Payment of Stipulated Penalties
1. Demand Letter. Upon a finding that [Provider] has failed to com-
ply with any of the obligations described in section X.A and deter-
mining that Stipulated Penalties are appropriate, OIG shall notify
[Provider] by personal service or certified mail of (a) [Provider's]
failure to comply; and (b) the OIG's exercise of its contractual right
to demand payment of the Stipulated Penalties (this notification is
hereinafter referred to as the "Demand Letter").
Within fifteen (15) days of the date of the Demand Letter, [Provider]
shall either (a) cure the breach to the OIG's satisfaction and pay
the applicable stipulated penalties, or (b) request a hearing before
an HHS administrative law judge ("ALJ") to dispute the OIG's de-
termination of noncompliance, pursuant to the agreed-upon provi-
sions set forth below in section X.D. In the event [Provider] elects
to request an ALJ hearing, the Stipulated Penalties shall continue
to accrue until [Provider] cures, to the OIG's satisfaction, the al-
leged breach in dispute. Failure to respond to the Demand Letter
in one of these two manners within the allowed time period shall
be considered a material breach of this CIA and shall be grounds
for exclusion under section X.C.
2. Timely Written Requests for Extensions. [Provider] may submit a
timely written request for an extension of time to perform any act or
file any notification or report required by this CIA. Notwithstand-
ing any other provision in this section, if OIG grants the timely
written request with respect to an act, notification, or report, Stip-
ulated Penalties for failure to perform the act or file the notification
or report shall not begin to accrue until one day after [Provider]
fails to meet the revised deadline as agreed to by the OIG-approved
extension. Notwithstanding any other provision in this section, if
OIG denies such a timely written request, Stipulated Penalties for
failure to perform the act or file the notification or report shall not
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begin to accrue until two (2) business days after [Provider] receives
OIG's written denial of such request. A "timely written request" is
defined as a request in writing received by OIG at least five (5) busi-
ness days prior to the date by which any act is due to be performed
or any notification or report is due to be filed.
3. Form of Payment. Payment of the Stipulated Penalties shall be
made by certified or cashier's check, payable to "Secretary of the
Department of Health and Human Services," and submitted to OIG
at the address set forth in section VI.
4. Independence from Material Breach Determination. Except as oth-
erwise noted, these provisions for payment of Stipulated Penalties
shall not affect or otherwise set a standard for the OIG's deter-
mination that [Provider] has materially breached this CIA, which
decision shall be made at the OIG's discretion and governed by the
provisions in section X.C, below.
C. Exclusion for Material Breach of this CIA
1. Notice of Material Breach and Intent to Exclude. The parties
agree that a material breach of this CIA by [Provider] consti-
tutes an independent basis for [Provider's] exclusion from partici-
pation in the Federal health care programs (as defined in 42 U.S.C.
1320a7b(f)). Upon a determination by OIG that [Provider] has ma-
terially breached this CIA and that exclusion should be imposed,
the OIG shall notify [Provider] by certified mail of (a) [Provider's]
material breach; and (b) OIG's intent to exercise its contractual
right to impose exclusion (this notification is hereinafter referred
to as the "Notice of Material Breach and Intent to Exclude").
2. Opportunity to Cure. [Provider] shall have thirty-five (35) days from
the date of the Notice of Material Breach and Intent to Exclude
Letter to demonstrate to the OIG's satisfaction that:
a. [Provider] is in full compliance with this CIA;
b. the alleged material breach has been cured; or
c. the alleged material breach cannot be cured within the
35-day period, but that: (i) [Provider] has begun to take
action to cure the material breach, (ii) [Provider] is pur-
suing such action with due diligence, and (iii) [Provider]
has provided to OIG a reasonable timetable for curing the
material breach.
3. Exclusion Letter. If at the conclusion of the thirty-five (35) day pe-
riod, [Provider] fails to satisfy the requirements of section X.C.2,
OIG may exclude [Provider] from participation in the Federal
health care programs. OIG will notify [Provider] in writing of its
determination to exclude [Provider] (this letter shall be referred to
hereinafter as the "Exclusion Letter"). Subject to the Dispute Res-
olution provisions in section X.D, below, the exclusion shall go into
effect thirty (30) days after the date of the Exclusion Letter. The
exclusion shall have national effect and will also apply to all other
federal procurement and non-procurement programs. If [Provider]
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is excluded under the provisions of this CIA, [Provider] may seek
reinstatement pursuant to the provisions at 42 C.F.R. §§1001.3001–
.3004.
4. Material Breach. A material breach of this CIA means:
a. a failure by [Provider] to report a material deficiency, take
corrective action and pay the appropriate refunds, as pro-
vided in section III.D;
b. repeated or flagrant violations of the obligations under
this CIA, including, but not limited to, the obligations ad-
dressed in section X.A of this CIA;
c. a failure to respond to a Demand Letter concerning the
payment of Stipulated Penalties in accordance with section
X.B above; or
d. a failure to retain and use an Independent Review Orga-
nization for review purposes in accordance with section
III.D.
D. Dispute Resolution
1. Review Rights. Upon the OIG's delivery to [Provider] of its Demand
Letter or of its Exclusion Letter, and as an agreed-upon contractual
remedy for the resolution of disputes arising under the obligation
of this CIA, [Provider] shall be afforded certain review rights com-
parable to the ones that are provided in 42 U.S.C. §§1320a7(f) and
42 C.F.R. §1005 as if they applied to the Stipulated Penalties or
exclusion sought pursuant to this CIA. Specifically, the OIG's de-
termination to demand payment of Stipulated Penalties or to seek
exclusion shall be subject to review by an ALJ and, in the event of
an appeal, the Departmental Appeals Board ("DAB"), in a manner
consistent with the provisions in 42 C.F.R. §§1005.2–.21. Notwith-
standing the language in 42 C.F.R. §1005.2(c), the request for a
hearing involving stipulated penalties shall be made within fifteen
(15) days of the date of the Demand Letter and the request for a
hearing involving exclusion shall be made within thirty (30) days
of the date of the Exclusion Letter.
2. Stipulated Penalties Review. Notwithstanding any provision of Ti-
tle 42 of the United States Code or Chapter 42 of the Code of Federal
Regulations, the only issues in a proceeding for stipulated penalties
under this CIA shall be (a) whether [Provider] was in full and timely
compliance with the obligations of this CIA for which the OIG de-
mands payment; and (b) the period of noncompliance. [Provider]
shall have the burden of proving its full and timely compliance
and the steps taken to cure the noncompliance, if any. If the ALJ
finds for the OIG with regard to a finding of a breach of this CIA
and orders [Provider] to pay Stipulated Penalties, such Stipulated
Penalties shall become due and payable twenty (20) days after the
ALJ issues such a decision notwithstanding that [Provider] may
request review of the ALJ decision by the DAB.
3. Exclusion Review. Notwithstanding any provision of Title 42 of the
United States Code or Chapter 42 of the Code of Federal Regu-
lations, the only issues in a proceeding for exclusion based on a
material breach of this CIA shall be (a) whether [Provider] was in
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material breach of this CIA; (b) whether such breach was contin-
uing on the date of the Exclusion Letter; and (c) the alleged ma-
terial breach cannot be cured within the 35-day period, but that
(i) [Provider] has begun to take action to cure the material breach,
(ii) [Provider] is pursuing such action with due diligence, and (iii)
[Provider] has provided to OIG a reasonable timetable for curing
the material breach.
For purposes of the exclusion herein, exclusion shall take effect only
after an ALJ decision that is favorable to the OIG. [Provider's] elec-
tion of its contractual right to appeal to the DAB shall not abrogate
the OIG's authority to exclude [Provider] upon the issuance of the
ALJ's decision. If the ALJ sustains the determination of the OIG
and determines that exclusion is authorized, such exclusion shall
take effect twenty (20) days after the ALJ issues such a decision,
notwithstanding that [Provider] may request review of the ALJ de-
cision by the DAB.
4. Finality of Decision. The review by an ALJ or DAB provided for
above shall not be considered to be an appeal right arising un-
der any statutes or regulations. Consequently, the parties to this
CIA agree that the DAB's decision (or the ALJ's decision if not ap-
pealed) shall be considered final for all purposes under this CIA and
[Provider] agrees to waive any right it may have to appeal the de-
cision administratively, judicially or otherwise seek review by any
court or other adjudicative forum.
XI. Effective and Binding Agreement
Consistent with the provisions in the Settlement Agreement pursuant to which
this CIA is entered, and into which this CIA is incorporated, [Provider] and OIG
agree as follows:
a. This CIA shall be binding on the successors, assigns and transferees
of [Provider];
b. This CIA shall become final and binding on the date the final sig-
nature is obtained on the CIA;
c. Any modifications to this CIA shall be made with the prior written
consent of the parties to this CIA; and
d. The undersigned [Provider] signatories represent and warrant that
they are authorized to execute this CIA. The undersigned OIG sig-
natory represents that he is signing this CIA in his official capacity
and that he is authorized to execute this CIA.
On Behalf of [Provider]
Date
Date
Date
[Please identify all signatories]
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ON BEHALF OF THE OFFICE OF INSPECTOR GENERAL
OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
Lewis Morris [Date]
Assistant Inspector General for Legal Affairs
Office of Inspector General
U.S. Department of Health and Human Services
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Appendix B
Sample Statement of Management’s Assertions
[Date]
In connection with the Corporate Integrity Agreement (CIA) entered into with
the Office of the Inspector General of the United States Department of Health
and Human Services dated [date], we make the following assertions, which are
true to the best of our knowledge and belief.
Governance
Within 90 days of the date of the CIA, we—
1. Established a Compliance Committee, which meets at least
monthly and requires a quorum to meet.
2. Appointed to our Compliance Committee members who include at
a minimum those individuals specified in the CIA.
3. Delegated to the Compliance Committee the authority to imple-
ment and monitor the CIA, as evidenced by the organization chart
or the Compliance Committee's charter.
4. Appointed a compliance officer, who reports directly to the individ-
ual specified in the CIA.
We appointed a compliance officer who—
1. Has sufficient staff and resources to carry out his or her responsi-
bilities.
2. Actively participates in compliance training.
3. Has authority to conduct full and complete internal investigations
without restriction.
4. Periodically revises the compliance program to meet changing cir-
cumstances and risks.
Billing Practices, Policies, and Procedures
Although no system of internal controls can provide absolute assurance that all
bills comply in all respects with Medicare, Medicaid, and other federal health
care program guidelines, we are not aware of any material weaknesses in our
billing practices, policies, and procedures. Billings to third-party payors comply
in all material respects with applicable coding principles and laws and regula-
tions (including those dealing with Medicare and Medicaid antifraud and abuse)
and only reflect charges for goods and services that were medically necessary,
properly approved by regulatory bodies (e.g., the Food and Drug Administra-
tion), if required and properly rendered. [Insert other assertions as necessary to
address matters covered in the CIA.] Any Medicare, Medicaid, and other fed-
eral health program billing deficiencies that we identified have been properly
reported to the applicable payor within 60 days of discovery of the deficiency.
Corporate Integrity Policy
1. Our policy was developed and implemented within [number] days
of execution of the CIA.
2. The policy addresses the Company's commitment to preparation
and submission of accurate billings consistent with the standards
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set forth in federal health care program statutes, regulations, proce-
dures and guidelines or as otherwise communicated by Health Care
Financing Administration (HCFA), its agents or any other agency
engaged in the administration of the applicable federal health care
program.
3. The policy addressed the specific issues that gave rise to the settle-
ment, as well as other risk areas identified by the OIG in published
Fraud Alerts issued through [date].
4. Further details on the development and implementation of our pol-
icy were provided to the OIG in our letter dated [date].
5. Our policy was distributed to all employees, physicians and inde-
pendent contractors involved in submitting or preparing requests
for reimbursement.
6. We have prominently displayed a copy of our policy on the Com-
pany's premises.
Information and Education Program
As discussed more fully in our letter to the OIG dated [date], we conducted an
Information and Education Program within [number] days of the CIA. The In-
formation and Education Program requires that each officer, employee, agent
and contractor charged with administering federal health care programs (in-
cluding, but not limited to billers, coders, nurses, physicians, medical records,
hospital administration and other individuals directly involved in billing fed-
eral health care programs) receive at least [number] hours of training.
The training provided to employees involved in billing, coding, and/or charge
capture consisted of instructions on submitting accurate bills, the personal
obligations of each individual to ensure billings are accurate, the nature of
company-imposed disciplinary actions on individuals who violate company poli-
cies and/or laws and regulations, applicable federal health care program rules,
legal sanctions against the company for submission of false or fraudulent in-
formation, and how to report potential abuses or fraud. The training material
addresses those issues underlying our settlement with the OIG.
The experience of the trainers is consistent with the topics presented.
Confidential Disclosure Program
Our Confidential Disclosure Program—
1. Was established within [number] days of the CIA.
2. Enables any employee to disclose any practices or billing procedures
relating to federal health care programs.
3. Provides a toll-free telephone line maintained by the Company,
which Company representatives have indicated is maintained
twenty-four hours a day, seven days a week, for the purpose of
making any disclosures regarding compliance with the Company's
Compliance Program, the obligations in the CIA, and Company's
overall compliance with federal and state standards.
4. Includes policies requiring the review of any disclosures to permit a
determination of the appropriateness of the billing practice alleged
to be involved and any corrective action to be taken to ensure that
proper follow-up is conducted.
5. A detailed summary of the communications (including the num-
ber of disclosures by employees and the dates of such disclosures)
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concerning billing practices reported as, and found to be, inappro-
priate under the Confidential Disclosure Program, and the results
of any internal review and the follow-up on such disclosures are
summarized in Attachment [title] to our Annual Report.
Excluded Individuals or Entities
Company policy—
1. Prohibits the employment of or contracting with an individual or
entity that is listed by a federal agency as convicted of abuse or
excluded, suspended or otherwise ineligible for participation in fed-
eral health care programs.
2. Includes a process to make an inquiry into the status of any poten-
tial employee or independent contractor.
3. Provides for an annual review of the status of all existing employ-
ees and contractors to verify whether any individual had been sus-
pended or excluded or charged with a criminal offense relating to
the provision of federal health care services.
We are not aware of any individuals employed in contravention of the prohibi-
tions in the CIA.
Record Retention
Our record retention policy is consistent with the requirements of the CIA.
Signed by:
_____________________________________
[Chief Executive Officer]
_____________________________________
[Chief Financial Officer]
_____________________________________
[Corporate Compliance Officer]
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Appendix C
Sample Engagement Letter
The following is an illustration of a sample engagement letter that may be used
for this kind of engagement.
[CPA Firm Letterhead]
[Client's Name and Address]
Dear _____________________:
This will confirm our understanding of the arrangements for our performance of
certain agreed-upon procedures in connection with management's compliance
with the terms of the Corporate Integrity Agreement (CIA) with the Office of
Inspector General (OIG) of the U.S. Department of Health and Human Services
(HHS) dated [date of CIA] for the period ending [date].
We will perform those procedures enumerated in the attachment to this letter.
Our responsibility is to carry out these procedures and report our findings. We
will conduct our engagement in accordance with standards established by the
American Institute of Certified Public Accountants. Our planned procedures
were agreed to by management and will be communicated to the OIG for its
review and are based on the terms specified in the CIA. The sufficiency of these
procedures is solely the responsibility of the specified parties to the report.
Consequently, it is understood that we make no representation regarding the
sufficiency of the procedures described in the attachment for the purpose for
which this report has been requested or for any other purpose.
Management is responsible for the Company's compliance with all applicable
laws, regulations, and contracts and agreements, including the CIA. Manage-
ment also is responsible for the design, implementation, and monitoring of the
policies and procedures upon which compliance is based.
Our engagement to perform agreed-upon procedures is substantially less in
scope than an examination, the objective of which is the expression of an opinion
on management's compliance with the CIA. Accordingly, we will not express
such an opinion or any other form of assurance thereon.1
Working papers that are prepared in connection with this engagement are the
property of the independent accountant. The working papers are prepared for
the purpose of providing the principal support for the independent accountant's
report. At the completion of our work, we expect to issue an agreed-upon pro-
cedures report in the attached form.
1 The independent accountant may wish to include an understanding with the client about any
limitation or other arrangements regarding liability of the practitioner or the client in the engagement
letter. For example, the following might be included in the letter:
Our maximum liability relating to services rendered under this letter (regardless of form
of action, whether in contract, negligence or otherwise) shall be limited to the charges paid
to us for the portion of the services or work products giving rise to liability. We will not
be liable for consequential or punitive damages (including lost profits or savings) even if
aware of their possible existence.
You will indemnify us against any damage or expense that may result from any third-
party claim relating to our services or any use by you of any work product, and you will
reimburse us for all expenses (including counsel fees) as incurred by us in connection with
any such claim, except to the extent such claim (i) is finally determined to have resulted
from our gross negligence or willful misconduct or (ii) is covered by any of the preceding
indemnities.
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If, however, we are not able to complete all of the specified procedures, we will
so advise you. At that time, we will discuss with you the form of communication,
if any, that you desire for our findings. We will ask you to confirm your request
in writing at that time. If you request that we delay issuance of our report until
corrective action is taken that will result in compliance with all aspects of the
CIA, we will do so only at your written request. Our working papers will be
retained in accordance with our firm's working paper retention policy.
The distribution of the independent accountant's report will be restricted to the
governing board and management of the Company and the OIG.
Our fees will be billed as work progresses and are based on the amount of time
required at various levels of responsibility plus actual out-of-pocket expenses.
Invoices are payable upon presentation. We will notify you immediately of any
circumstances we encounter that could significantly affect our initial estimate
of total fees.
We agree that to the extent required by law, we will allow the Comptroller
General of the United States, HHS, and their duly authorized representatives
to have access to this engagement letter and our documents and records to
the extent necessary to verify the nature and amount of costs of the services
provided to the Company, until the expiration of four years after we have con-
cluded providing services to the Company that are performed pursuant to this
Engagement Letter. In the event the Comptroller General, HHS, or their duly
authorized representatives request such records, we agree to notify the Com-
pany of such request as soon as practicable.
In the event we are requested or authorized by the Company or are required
by government regulation, subpoena, or other legal process to produce our doc-
uments or our personnel as witnesses with respect to our engagements for the
Company, the Company will, so long as we are not a party to the proceeding in
which the information is sought, reimburse us for our professional time and ex-
penses, as well as the fees and expenses of our counsel, incurred in responding
to such requests.
If this letter correctly expresses your understanding of this engagement, please
sign the enclosed copy where indicated and return it to us. We appreciate the
opportunity to serve you.
Sincerely,______________________________
[Partner's Signature]
[Firm Name or Firm Representative]
Accepted and agreed to:___________________
[Client Representative's Signature]
[Title] ________________________________
[Date] ________________________________
[Revised, June 2009, to reflect conforming changes necessary due to the is-
suance of recent authoritative literature.]
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Appendix D
Sample Procedures
Procedure Findings
Governance
1. We read the Company's corporate minutes and organization
chart and ascertained that, within [number] days of the date of
the Corporate Integrity Agreement (CIA), the Company—
a. Established a Compliance Committee, which is to
meet meets at least monthly and requires a quorum
to meet.
b. Appointed to its Compliance Committee members who
include, at a minimum, those individuals specified in
the CIA.
c. Delegated to the Compliance Committee the authority
to implement and monitor the CIA, as evidenced by
the organization chart or the Compliance Committee's
charter.
d. Appointed a compliance officer who reports directly to
the individual specified in the CIA.
2. We interviewed the compliance officer and were informed that,
in his or her opinion, the Compliance Officer—
a. Has sufficient staff and resources to carry out his or
her responsibilities.
b. Actively participates in compliance training.
c. Has the authority to conduct full and complete inter-
nal investigations without restriction.
d. Periodically revises the compliance program to meet
changing circumstances and risks.
3. We read the OIG notification letter as specified in the CIA and
noted that the appropriate official signed the letter, that it was
addressed to the OIG, that it covered items (a) through (d) in Step
1, and that it was dated within [number of] days of the execution
of the CIA.
Billing Practices, Policies, and Procedures
The practitioner might be engaged to provide consulting services in
connection with the evaluation of the company's billing practices,
policies, and procedures. If so, generally no agreed-upon procedures
would be performed relating to this area.
Alternatively, if the procedures relating to the Company's billing
practices, policies, and procedures are performed by others such as
the Company's internal audit staff, the practitioner performs Steps
4 through 9.
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Procedure Findings
4. We read the compliance work plan and noted the following:
a. The work plan's stated objectives include the deter-
mination that billings are accurate and complete, for
services rendered that have been deemed by medical
specialists as being necessary, and are submitted in
accordance with federal program guidelines.
b. The work plan sampling methodology sets confidence
levels consistent with those defined in the CIA.
c. The work plan identifies risk areas, as defined in the
CIA (if applicable), and specifies testing procedures by
risk area.
d. The work plan specifies that samples are taken in risk
areas (if applicable) identified by the CIA.
e. The work plan includes testing procedures, which the
practitioner should modify as required by the CIA, for
the following risks areas (if applicable) identified in
the CIA:
(1) Clinical documentation, as follows:
(i) No documentation of service
(ii) Insufficient documentation of
service
(iii) Improper diagnosis or treat-
ment plan giving rise to the pro-
vision of a medically unneces-
sary service or treatment
(iv) Service or treatment does not
conform medically with the doc-
umented diagnosis or treatment
plan
(v) Services incorrectly coded
(2) Billing and coding, as follows:
(i) Noncovered or unallowable ser-
vice
(ii) Duplicate payment
(iii) DRG window error
(iv) Unbundling
(v) Utilization
(vi) Medicare credit balances
[Note to Practitioner: Modify the preceding list as required by the
CIA.]
5. We selected [quantity] probe samples performed by the inde-
pendent review organization for the following risk areas [list risk
areas tested]. For the probe samples selected, we noted that the—
a. Sample patient billing files were randomly selected.
b. Sample size reflected confidence levels specified in the
CIA.
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c. Sample plan describes how missing items (if any)
would be treated.
d. Patient billing files tested were pulled per the listing
of random numbers and all patient billing files were
accounted for in the working papers.
e. Work plans for the specific sample described the risk
areas (if applicable) being tested and the testing ap-
proach/procedures.
f. Working papers noted the completion of each work
plan step.
g. Working papers contained a summary of findings for
the sample.
6. We reperformed the work plan steps [list of specific steps per-
formed] for the sample patient billing files. The reperformance of
work plan steps related to the medical review of the sample patient
billing files was performed by the following individuals [note the
professional qualifications of individuals without listing names].
Any exceptions between our findings and the Company's are sum-
marized in the Attachment to this report.
7. We read the summary findings of all internal compliance re-
views that the Company's Internal Audit department indicated
it had performed for the Company and noted that all material
billing deficiencies [specify material threshold as defined by the
Company] noted therein were discussed in written communica-
tions addressed to the appropriate payor (for example, Medicare
Part B carrier) and were dated within 60 days from the time the
deficiency occurred.1
8. We inquired of [individual] as to whether the Company took
remedial steps within [number of] days (or such additional time as
agreed to by the payor) to correct all material billing deficiencies
noted in Step 7. We were informed that such remedial steps had
been taken.
9. By reading applicable correspondence, we noted that any ma-
terial billing deficiencies noted in Step 7 were communicated to
the OIG, including specific findings relative to the deficiency, the
Company's actions taken to correct the deficiency, and any further
steps the Company plans to take to prevent any similar deficien-
cies from recurring.
Corporate Integrity Policy
10. We read the Company's Corporate Integrity Policy and noted
the following.
a. The policy was developed and implemented within
[number of] days of execution of the CIA.
1 The CIA provides its own legal definition of a "material deficiency." Determination of whether a
billing or other act meets this definition is normally beyond the auditor's professional competence and
may have to await final determination by a court of law. Accordingly, to avoid confusion, a working
definition different from that provided in the CIA (e.g., a specified dollar threshold) may be necessary.
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b. The policy addressed the Company's commitment to
preparation and submission of accurate billings con-
sistent with the standards set forth in federal health
care program statutes, regulations, procedures, and
guidelines or as otherwise communicated by HCFA,
its agents, or any other agency engaged in the admin-
istration of the applicable federal health care program.
c. The policy addressed the specific issues that gave rise
to the settlement, as well as other risk areas identified
by the OIG in published Fraud Alerts issued through
[agency].
d. Correspondence addressed to the OIG covered the de-
velopment and implementation of the policy.
e. Documentation indicating that the policy was dis-
tributed to all employees, physicians, and indepen-
dent contractors involved in submitting or preparing
requests for reimbursement.
f. The prominent display of a copy of the policy on the
Company's premises.
11. We selected a sample of ten employees (involved in submitting
and preparing requests for reimbursement) and examined written
confirmation in the employee's personnel file indicating receipt of
a copy of the Corporate Integrity Policy.
Information and Education Program
12. We read the Company's Information and Education Program
and noted the following.
a. The Information and Education Program agenda was
dated within [number of] days of execution of the CIA.
b. Correspondence covering the development and imple-
mentation of the Information and Education Program
was addressed to the OIG.
c. The Information and Education Program requires that
each officer, employee, agent, and contractor charged
with administering federal health care programs (in-
cluding, but not limited to billers, coders, nurses,
physicians, medical records, hospital administration
and other individuals directly involved in billing fed-
eral health care programs) receive at least [number of]
hours of training.
13. We selected a sample of ten employees involved in billing,
coding and/or charge capture and examined sign-in logs of the
training classes and noted that each had signed indicating that
they had received at least [number of] hours of training as specified
in the Information and Education Program. We also reviewed tests
and surveys completed by each of the ten trained employees noting
evidence that they were completed.
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14. We inquired as to the training of individuals not present dur-
ing the regularly scheduled training programs and were informed
that each such individual is trained either individually or in a
separate make-up session. We inquired as to the names of in-
dividuals not initially present and selected one such individual
and examined that individual's post-training test and survey for
completion.
15. We read the course agenda and noted that the training pro-
vided to employees involved in billing, coding, and/or charge cap-
ture consisted of instructions on submitting accurate bills, the per-
sonal obligations of each individual to ensure billings are accurate,
the nature of company-imposed disciplinary actions on individuals
who violate company policies and/or laws and regulations appli-
cable to federal health care program rules, legal sanctions against
the company for submission of false or fraudulent information,
and how to report potential abuses or fraud. We also noted that
the training material addressed the following issues which gave
rise to the settlement [practitioner list].
16. We inquired of the Corporate Compliance Officer as to the
qualifications and experience of the trainers and were informed
that, in the Corporate Compliance Officer's opinion, they were con-
sistent with the topics presented.
17. We noted that the Company's draft Annual Report to the OIG
dated [date] addresses certification of training.
Confidential Disclosure Program
18. We read documentation of the Company's Confidential Dis-
closure Program and noted that it—
a. Includes the printed effective date that was within
[number of] days of execution of the CIA.
b. Consists of a confidential disclosure program enabling
any employee to disclose any practices or billing pro-
cedures relating to federal health care programs.
c. Provides a toll-free telephone line maintained by the
Company, which Company representatives have indi-
cated is maintained twenty-four hours a day, seven
days a week, for the purpose of making any disclosures
regarding compliance with the Company's Compliance
Program, the obligations in the CIA, and Company's
overall compliance with federal and state standards.
d. Includes policies requiring the review of any disclo-
sures to permit a determination of the appropriate-
ness of the billing practice alleged to be involved and
any corrective action to be taken to ensure that proper
follow-up is conducted.
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19. We made five test calls to the toll free telephone line (hotline)
and noted the following.
a. Each call was captured in the hotline logs and reported
with all other incoming calls.
b. Anonymity is not discouraged.
20. We noted that the Company included in its draft Annual Re-
port addressed to OIG dated [date] a detailed summary of the
communications (including the number of disclosures by employ-
ees and the dates of such disclosures) concerning billing practices
reported as, and found to be, inappropriate under the Confidential
Disclosure Program, and the results of any internal review and the
follow-up on such disclosures.
21. We observed the display of the Company's Confidential Dis-
closure Program, including notice of the availability of its hotline,
on the Company's premises.
Excluded Individuals or Entities
22. We read the Company's written policy relating to dealing
with excluded or convicted persons or entities and noted that the
policy—
a. Prohibits the hiring of or contracting with an individ-
ual or entity that is listed by a federal agency as con-
victed of abuse or excluded, suspended, or otherwise
ineligible for participation in federal health care pro-
grams.
b. Includes a process to make an inquiry into the status
of any potential employee or independent contractor.
c. Provides for a semi-annual review of the status of all
existing employees and contractors to verify whether
any individual had been suspended or excluded or
charged with a criminal offense relating to the pro-
vision of federal health care services.
23. We selected a sample of ten employees hired over the course
of the test period as defined in the CIA and examined support in
the employee's personnel file documenting inquiries made into the
status of the employee, including documentation of comparison to
the [source specified in the CIA].
24. We performed the following procedures related to the Com-
pany's semi-annual review of employee status.
a. Read documentation of the semi-annual review as ev-
idence that a review was performed.
b. Selected and reviewed the lesser of ten or all excep-
tions and determined that such employees were re-
moved from responsibility for or involvement with
Provider business operations related to the Federal
health care programs.
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c. Examined a notification letter addressed to the OIG
and dated within 30 days of the employee's removal
from employment.
d. Inquired of [officer] as to whether he or she was aware
of any individuals employed in contravention of the
prohibitions in the CIA. If so, we further noted that
[indicate specific procedures] to confirm that such sit-
uation was cured within 30 days by [indicate how sit-
uation was cured].
Annual Report
25. We read the Company's draft Annual Report dated [date] and
determined that it included the following items, to be modified as
appropriate, by the practitioner:
a. Compliance Program Charter and organization chart
b. Amendments to policies
c. Detailed descriptions of reviews and audits
d. Summary of hotline communications
e. Summary of annual review of employees
f. Cross-referencing to items noted in the CIA
Record Retention
26. We read the Company's record retention policy and noted that
it was consistent with the requirements as outlined in the CIA.
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Appendix E
Sample Report
Independent Accountant's Report
[Date]
[Sample Health Care Provider]
Office of Inspector General of the U.S. Department of Health and Human Ser-
vices
We have performed the procedures enumerated in the Attachment, which were
agreed to by Sample Health Care Provider (Company) and the Office of In-
spector General (OIG) of the U.S. Department of Health and Human Services,
solely to assist the users in evaluating management's assertion about [name
of entity's] compliance with the Corporate Integrity Agreement (CIA) with the
OIG dated [date of CIA] for the [period] ending [date], which is included as
Attachment A to this report. This agreed-upon procedures engagement was
performed in accordance with standards established by the American Institute
of Certified Public Accountants. The sufficiency of these procedures is solely
the responsibility of the specified users of the report. Consequently, we make
no representation regarding the sufficiency of the procedures described in At-
tachment B either for the purpose for which this report has been requested or
for any other purpose.
We were not engaged to and did not perform an examination, the objective of
which would be the expression of an opinion on management's compliance with
the CIA. Accordingly, we do not express such an opinion. Had we performed
additional procedures, other matters might have come to our attention that
would have been reported to you.
This report is intended solely for the information and use of the Compliance
Committee and management of the Company and the OIG, and is not intended
to be and should not be used by anyone other than those specified parties.
[Include as Attachments the CIA and the summary that enumerates procedures
and findings.]
[Signature]
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Appendix D
Statement of Position 00-1,
Auditing Health Care Third-Party
Revenues and Related Receivables
March 10, 2000
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NOTE
This Statement of Position (SOP) is an interpretive publication and rep-
resents the recommendations of the AICPA Health Care Third-Party
Revenue Recognition Task Force of the Auditing Standards Board (ASB)
with regard to auditing financial statement assertions about third-party
revenues and related receivables of health care entities. The ASB has
found the recommendations in this SOP to be consistent with existing
standards covered by Rule 202, Compliance With Standards, (AICPA,
Professional Standards, vol. 2, ET sec. 202 par. .01) of the AICPA Code
of Professional Conduct.
Interpretive publications are not as authoritative as pronouncements of
the ASB; however, if an auditor does not apply the guidance included
in this SOP, the auditor should be prepared to explain how he or she
complied with the provisions of Statements on Auditing Standards ad-
dressed by this SOP.
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Summary
This Statement of Position (SOP) provides guidance to auditors regarding un-
certainties inherent in health care third-party revenue recognition. It discusses
auditing matters related to testing third-party revenues and related receiv-
ables, and provides guidance regarding the sufficiency and appropriateness of
audit evidence and reporting on financial statements of health care entities
exposed to material uncertainties. [Revised, June 2009, to reflect conforming
changes necessary due to the issuance of recent authoritative literature.]
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Introduction and Background
.01 Most health care providers participate in payment programs that pay
less than full charges for services rendered. For example, some cost-based pro-
grams retrospectively determine the final amounts reimbursable for services
rendered to their beneficiaries based on allowable costs. With increasing fre-
quency, even non-cost-based programs (such as the Medicare Prospective Pay-
ment System) have become subject to retrospective adjustments (for example,
billing denials and coding changes). Often, such adjustments are not known for
a considerable period of time after the related services were rendered.
.02 The lengthy period of time between rendering services and reaching
final settlement, compounded further by the complexities and ambiguities of
reimbursement regulations, makes it difficult to estimate the net patient service
revenue associated with these programs. This situation has been compounded
due to the frequency of changes in federal program guidelines.
.03 Financial Accounting Standards Board (FASB) Accounting Standards
Codification™ (ASC) 954-605-45-2 states, in part, that "service revenue shall
be reported net of contractual and other adjustments in the statement of op-
erations, including patient service revenue." As a result, patient receivables,
including amounts due from third-party payors, are also reported net of ex-
pected contractual and other adjustments. However, amounts ultimately real-
izable will not be known until some future date, which may be several years
after the period in which the services were rendered. [Revised, June 2009, to re-
flect conforming changes necessary due to the issuance of recent authoritative
literature.]
.04 This SOP provides guidance to auditors regarding uncertainties in-
herent in health care third-party revenue recognition. It discusses auditing
matters related to testing third-party revenue and related receivables, includ-
ing the effects of settlements (both cost-based and non-cost-based third-party
payment programs), and provides guidance regarding the sufficiency and ap-
propriateness of audit evidence and reporting on financial statements of health
care entities exposed to material uncertainties. [Revised, June 2009, to reflect
conforming changes necessary due to the issuance of recent authoritative liter-
ature.]
Scope and Applicability
.05 This SOP applies to audits of health care entities falling within the
scope of the AICPA Audit and Accounting Guide Health Care Entities (the
guide). Its provisions are effective for audits of periods ending on or after June
30, 2000. Early application of the provisions of this SOP is permitted.
Third-Party Revenues and Related Receivables—
Inherent Uncertainties
.06 Health care entities need to estimate amounts that ultimately will be
realizable in order for revenues to be fairly stated in accordance with generally
accepted accounting principles (GAAP). The basis for such estimates may range
from relatively straightforward calculations using information that is readily
available to highly complex judgments based on assumptions about future de-
cisions.
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.07 Entities doing business with governmental payors (for example, Medi-
care and Medicaid) are subject to risks unique to the government-contracting
environment that are hard to anticipate and quantify and that may vary from
entity to entity. For example—
 A health care entity's revenues may be subject to adjustment as
a result of examination by government agencies or contractors.
The audit process and the resolution of significant related mat-
ters (including disputes based on differing interpretations of the
regulations) often are not finalized until several years after the
services were rendered.
 Different fiscal intermediaries (entities that contract with the fed-
eral government to assist in the administration of the Medicare
program) may interpret governmental regulations differently.
 Differing opinions on a patient's principal medical diagnosis, in-
cluding the appropriate sequencing of codes used to submit claims
for payment, can have a significant effect on the payment amount.1
 Otherwise valid claims may be determined to be nonallowable af-
ter the fact due to differing opinions on medical necessity.
 Claims for services rendered may be nonallowable if they are later
determined to have been based on inappropriate referrals.2
 Governmental agencies may make changes in program interpreta-
tions, requirements, or "conditions of participation," some of which
may have implications for amounts previously estimated.
.08 Such factors often result in retrospective adjustments to interim pay-
ments. Reasonable estimates of such adjustments are central to the third-party
revenue recognition process in health care, in order to avoid recognizing rev-
enue that the provider will not ultimately realize. The delay between rendering
services and reaching final settlement, as well as the complexities and ambi-
guities of billing and reimbursement regulations, makes it difficult to estimate
net realizable third-party revenues.
Management’s Responsibilities
.09 Management is responsible for the fair presentation of its financial
statements in conformity with GAAP. Management also is responsible for adopt-
ing sound accounting policies and for establishing and maintaining internal
control that will, among other things, enable the entity to initiate, authorize,
record, process, and report transactions (as well as events and conditions) con-
sistent with management's assertions embodied in the financial statements.
Despite the inherent uncertainties, management is responsible for estimating
1 Historically, the Health Care Financing Administration (HCFA) contracted with Peer Review
Organizations (PROs) to validate the appropriateness of admissions and the clinical coding from
which reimbursement was determined. Such reviews were typically performed within ninety days
of the claim submission date. However, the government has modified its policies with respect to
such reviews and now analyzes coding errors through other means, including in conjunction with
investigations conducted by the Office of the Inspector General (OIG) of the U. S. Department of
Health and Human Services.
2 Effective January 1, 1995, the Limitation on Certain Physician Referrals law prohibited physi-
cians from referring Medicare and Medicaid patients to health care entities with which they had a
financial relationship for the furnishing of designated health services. Implementing regulations have
not yet been adopted as of the date of this publication.
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the amounts recorded in the financial statements and making the required dis-
closures in accordance with GAAP, based on management's analysis of existing
conditions. [Revised, June 2009, to reflect conforming changes necessary due to
the issuance of recent authoritative literature.]
.10 Management's assertions regarding proper valuation of its revenues
and receivables are embodied in the financial statements. Management is re-
sponsible for recognizing revenues when their realization is reasonably assured.
As a result, management makes a reasonable estimate of amounts that ulti-
mately will be realized, considering—among other things—adjustments asso-
ciated with regulatory reviews, audits, billing reviews, investigations, or other
proceedings. Estimates that are significant to management's assertions about
revenue include the provision for third-party payor contractual adjustments
and allowances. [Revised, June 2009, to reflect conforming changes necessary
due to the issuance of recent authoritative literature.]
.11 Management also is responsible for preparing and certifying cost re-
ports submitted to federal and state government agencies in support of claims
for payment for services rendered to government program beneficiaries.
The Auditor’s Responsibilities
.12 The auditor's responsibility is to express an opinion on the financial
statements taken as a whole. In reaching this opinion, the auditor should con-
clude whether sufficient appropriate evidence has been obtained to reduce to
an appropriately low level the risks of material misstatement in the financial
statements. In developing an opinion, the auditor should consider all relevant
audit evidence, including
 the evidence in support of recorded amounts.
 the reasonableness of management's estimates in the present cir-
cumstances,
 the fairness of the presentation and adequacy of the disclosures
made by management,
[Revised, June 2009, to reflect conforming changes necessary due to the is-
suance of recent authoritative literature.]
.13 Current industry conditions, as well as specific matters affecting the
entity.3 provide relevant information when planning the audit. Among a num-
ber of procedures, the auditor's procedures may include an analysis of historical
results (for example, prior fiscal intermediary audit adjustments and compar-
isons with industry benchmarks and norms) that enable the auditor to better
assess the risk of material misstatements in the current period. When there
are heightened risks, the auditor should perform audit procedures that respond
to those risks, for example, more extensive tests covering the current period.
Exhibit 5-1 of the guide includes examples of procedures auditors may per-
form. [Revised, June 2009, to reflect conforming changes necessary due to the
issuance of recent authoritative literature.]
.14 With respect to auditing third-party revenues, a relevant considera-
tion in addition to the usual revenue recognition considerations, is whether ul-
timately realizable amounts are known or will be presently known, or whether
3 Risk factors, including ones related to legislative and regulatory matters, are discussed annu-
ally in the AICPA Audit Risk Alert Health Care Industry Developments.
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those amounts are uncertain because they are dependent on some other fu-
ture, prospective actions or confirming events. For example, under a typical
fee-for-service contract with a commercial payor, if the provider has performed
a service for a covered individual, the revenue to which the provider is entitled
should be determinable at the time the service is rendered. On the other hand, if
the service was provided under a cost-based government contract, the revenue
ultimately collectible may not be known until certain future events occur (for
example, a cost report has been submitted and finalized after desk review or
audit). In this case, management estimates the effect of such potential future
adjustments. [Revised, June 2009, to reflect conforming changes necessary due
to the issuance of recent authoritative literature.]
.15 As stated previously, management is responsible for preparing the
estimates contained in the financial statements. The auditor should evaluate
the sufficiency and appropriateness of the evidence supporting those estimates,
including the facts supporting management's judgments, and the judgments
made based on conditions existing at the time of the audit. The fact that net rev-
enues recorded at the time services are rendered differ materially from amounts
that ultimately are realized does not necessarily mean the audit was not prop-
erly planned or carried out. Similarly, the fact that future events may differ
materially from management's assumptions or estimates does not necessarily
mean that management's estimates were not valid or the auditor did not fol-
low generally accepted auditing standards (GAAS) as described in this SOP
with respect to auditing estimates. [Revised, June 2009, to reflect conforming
changes necessary due to the issuance of recent authoritative literature.]
Audit Evidence
.16 The measurement of estimates is inherently uncertain and depends on
the outcome of future events. AU section 342, Auditing Accounting Estimates,
and AU section 508, Reports on Audited Financial Statements (AICPA, Profes-
sional Standards, vol. 1), provide guidance to the auditor when the valuation
of revenues is uncertain, pending the outcome of future events. In the current
health care environment, conclusive evidence concerning amounts ultimately
realizable cannot be expected to exist at the time of the financial statement
audit because the uncertainty associated with future program audits, admin-
istrative reviews, billing reviews, regulatory investigations, or other actions
will not be resolved until sometime in the future. [Revised, June 2009, to re-
flect conforming changes necessary due to the issuance of recent authoritative
literature.]
.17 The fact that information related to the effects of future program au-
dits, administrative reviews, regulatory investigations, or other actions does
not exist does not lead to a conclusion that the evidence supporting manage-
ment's assertions is not sufficient to support management's estimates. Rather,
the auditor's judgment regarding the sufficiency and appropriateness of the
evidence is based on the evidence that is available or can reasonably be ex-
pected to be available in the circumstances. If, after considering the existing
conditions and available evidence, the auditor concludes that the evidence is
sufficient and appropriate and supports management's assertions about the
valuation of revenues and receivables, and their presentation and disclosure in
the financial statements, an unqualified opinion ordinarily is appropriate. [Re-
vised, June 2009, to reflect conforming changes necessary due to the issuance
of recent authoritative literature.]
AAG-HCO APP D
P1: G.Shankar
ACPA125-AppD ACPA125.cls February 25, 2010 16:46
Statement of Position 00-1 433
.18 The inability to obtain relevant evidence that the auditor needs may
require the auditor to express a qualified opinion or to disclaim an opinion be-
cause of a scope limitation. For example, if an entity has conducted an internal
evaluation (for example, of coding or other billing matters) under attorney–
client privilege and management and its legal counsel refuse to respond to the
auditor's inquiries and the auditor determines the information is necessary, or-
dinarily the auditor would qualify his or her opinion for a scope limitation. [Re-
vised, June 2009, to reflect conforming changes necessary due to the issuance
of recent authoritative literature.]
.19 The accuracy of management's assumptions will not be known until
future events occur. In evaluating the accuracy of those assumptions, the audi-
tor normally should consider the entity's historical experience in making past
estimates and the auditor's experience in the industry. For certain matters, the
best evidence available to the auditor (particularly as it relates to clinical and
legal interpretations) may be the representations of management and its le-
gal counsel, as well as information obtained through reviewing correspondence
from regulatory agencies. [Revised, June 2009, to reflect conforming changes
necessary due to the issuance of recent authoritative literature.]
.20 Pursuant to AU sec. 333, Management Representations (AICPA, Pro-
fessional Standards, vol. 1.), the auditor should obtain written representations
from management concerning the absence of violations or possible violations
of laws or regulations whose effects should be considered for disclosure in the
financial statements or as a basis for recording a loss contingency. Examples of
specific representations include the following:
 Receivables
— Adequate consideration has been given to, and appro-
priate provision made for, estimated adjustments to rev-
enue, such as for denied claims and changes to diagnosis-
related group (DRG) assignments.
— Recorded valuation allowances are necessary, appropri-
ate, and properly supported.
— All peer review organizations, fiscal intermediary, and
third-party payor reports and information have been
made available.
 Cost reports filed with third parties
— All required Medicare, Medicaid, and similar reports
have been properly filed.
— Management is responsible for the accuracy and propri-
ety of all cost reports filed.
— All costs reflected on such reports are appropriate and al-
lowable under applicable reimbursement rules and regu-
lations and are patient-related and properly allocated to
applicable payors.
— The reimbursement methodologies and principles em-
ployed are in accordance with applicable rules and regu-
lations.
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— Adequate consideration has been given to, and appropri-
ate provision made for, audit adjustments by intermedi-
aries, third-party payors, or other regulatory agencies.
— All items required to be disclosed, including disputed
costs that are being claimed to establish a basis for a
subsequent appeal, have been fully disclosed in the cost
report.
— Recorded third-party settlements include differences be-
tween filed (and to be filed) cost reports and calculated
settlements, which are necessary based on historical ex-
perience or new or ambiguous regulations that may be
subject to differing interpretations. While management
believes the entity is entitled to all amounts claimed on
the cost reports, management also believes the amounts
of these differences are appropriate.
 Contingencies
— There are no violations or possible violations of laws or
regulations, such as those related to the Medicare and
Medicaid antifraud and abuse statutes, including but
not limited to the Medicare and Medicaid Anti-Kickback
Statute, Limitations on Certain Physician Referrals (the
Stark law), and the False Claims Act, in any jurisdic-
tion, whose effects should be considered for disclosure in
the financial statements or as a basis for recording a loss
contingency other than those disclosed or accrued in the
financial statements.
— Billings to third-party payors comply in all material re-
spects with applicable coding guidelines (for example,
ICD-9-CM and CPT-4) and laws and regulations (includ-
ing those dealing with Medicare and Medicaid antifraud
and abuse), and billings reflect only charges for goods
and services that were medically necessary; properly ap-
proved by regulatory bodies (for example, the Food and
Drug Administration), if required; and properly rendered.
— There have been no communications (oral or written)
from regulatory agencies, governmental representatives,
employees, or others concerning investigations or allega-
tions of noncompliance with laws and regulations in any
jurisdiction (including those related to the Medicare and
Medicaid antifraud and abuse statutes), deficiencies in
financial reporting practices, or other matters that could
have a material adverse effect on the financial state-
ments.
.21 Management's refusal to furnish written representations constitutes
a limitation on the scope of the audit sufficient to preclude an unqualified opin-
ion and is ordinarily sufficient to cause an auditor to disclaim an opinion or
withdraw from the engagement. However, based on the nature of the repre-
sentations not obtained or the circumstances of the refusal, the auditor may
conclude that a qualified opinion is appropriate.
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Potential Departures From GAAP Related to Estimates
and Uncertainties
.22 The auditor also is responsible for determining whether financial state-
ment assertions and disclosures related to accounting estimates have been pre-
sented in conformity with GAAP. Departures from GAAP related to accounting
estimates generally fall into one of the following categories:
 Unreasonable accounting estimates
 Inappropriate accounting principles
 Inadequate disclosure
Therefore, in order to render an opinion, the auditor's responsibility is to eval-
uate the reasonableness of management's estimates based on present circum-
stances and to determine that estimates are reported in accordance with GAAP
and adequately disclosed. [Revised, June 2009, to reflect conforming changes
necessary due to the issuance of recent authoritative literature.]
.23 As discussed in AU section 326, Audit Evidence (AICPA, Professional
Standards, vol. 1), the auditor's objective is to obtain sufficient appropriate
audit evidence to provide him or her with a reasonable basis for forming an
opinion. As discussed previously, Exhibit 5-1 of the guide provides a number of
sample procedures that the auditor may perform in auditing an entity's patient
revenues and accounts receivable, including those derived from third-party pay-
ors. For example, the guide notes that the auditor might "test the reasonable-
ness of settlement amounts, including specific and unallocated reserves, in light
of the payors involved, the nature of the payment mechanism, the risks associ-
ated with future audits, and other relevant factors."4 [Revised, September 2008,
to reflect conforming changes necessary due to the issuance of Statement on
Auditing Standards No. 105. Revised, June 2009, to reflect conforming changes
necessary due to the issuance of recent authoritative literature.]
Unreasonable Accounting Estimates
.24 The basis for management's assumptions regarding the nature of fu-
ture adjustments and calculations as to the effects of such adjustments are rel-
evant factors when evaluating the reasonableness of management's estimates.5
The auditor cannot determine with certainty whether such estimates are right
or wrong, because the accuracy of management's assumptions cannot be con-
firmed until future events occur. [Revised, June 2009, to reflect conforming
changes necessary due to the issuance of recent authoritative literature.]
.25 Though difficult to predict, it is reasonable for the auditor to expect
that management has made certain assumptions (either in detail or in the
aggregate) in developing its estimates regarding conditions likely to result in
adjustments (for example, consistency with historical experience and basis of
management's underlying assumptions). In evaluating reasonableness, the au-
ditor should obtain an understanding of how management developed the esti-
mate. Based on that understanding, the auditor should use one or a combination
of the following approaches:
4 See paragraphs .25–.28.
5 The lack of such analyses may call into question the reasonableness of recorded amounts.
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a. Review and test the process used by management to develop the
estimate.
b. Develop an independent expectation of the estimate to corroborate
the reasonableness of management's estimates.
c. Review subsequent events or transactions occurring prior to com-
pletion of fieldwork (AU sec. 342.10).
[Revised, June 2009, to reflect conforming changes necessary due to the is-
suance of recent authoritative literature.]
.26 Because no one accounting estimate can be considered accurate with
certainty, the auditor may determine that a difference between an estimated
amount best supported by the audit evidence and the estimated amount in-
cluded in the financial statements may be significant and such difference would
not be considered to be a likely misstatement. However, if the auditor believes
the estimated amount included in the financial statements is unreasonable, he
or she should treat the difference between that estimate and the closest reason-
able estimate as a likely misstatement. (Paragraph .56 of AU section 312, Audit
Risk and Materiality in Conducting an Audit [AICPA, Professional Standards,
vol. 1]). The auditor also should consider whether the difference between esti-
mates best supported by the audit evidence and the estimates included in the
financial statements, which are individually reasonable, indicate a possible bias
on the part of the entity's management. For example, if each accounting esti-
mate included in the financial statements was individually reasonable, but the
effect of the difference between each estimate and the estimate best supported
by the audit evidence was to increase income, the auditor should reconsider the
reasonableness of the estimates taken as a whole (Paragraph .58 of AU section
312 [AICPA, Professional Standards, vol. 1.]). [Revised, June 2009, to reflect
conforming changes necessary due to the issuance of recent authoritative liter-
ature.]
.27 Approaches and estimates will vary from entity to entity. Some entities
with significant prior experience may attempt to quantify the effects of indi-
vidual potential intermediary or other governmental (for example, the Office of
Inspector General and the Department of Justice) or private payor adjustments,
basing their estimates on very detailed calculations and assumptions regarding
potential future adjustments. Some may prepare cost report6 analyses to esti-
mate the effect of potential adjustments. Others may base their estimates on
an analysis of potential adjustments in the aggregate, in light of the payors in-
volved; the nature of the payment mechanism; the risks associated with future
audits; and other relevant factors. [Revised, June 2009, to reflect conforming
changes necessary due to the issuance of recent authoritative literature.]
.28 One of the key factors in evaluating the estimate is the historical ex-
perience of the entity (for example, the aggregate amount of prior cost-report
6 Medicare cost reimbursement is based on the application of highly complex technical rules,
some of which are ambiguous and subject to different interpretations even among Medicare's fiscal
intermediaries. It is not uncommon for fiscal intermediaries to reduce claims for reimbursement that
were based on management's good faith interpretations of pertinent laws and regulations. Addition-
ally, the Provider Reimbursement Review Board (PRRB) or the courts may be required to resolve
controversies regarding the application of certain rules. To avoid recognizing revenues before their
realization is reasonably assured, providers estimate the effects of such potential adjustments. This
is occasionally done by preparing a cost report based on alternative assumptions to help estimate con-
tractual allowances required by generally accepted accounting principles. The existence of reserves
or a reserve cost report does not by itself mean that a cost report was incorrectly or fraudulently filed.
AAG-HCO APP D
P1: G.Shankar
ACPA125-AppD ACPA125.cls February 25, 2010 16:46
Statement of Position 00-1 437
adjustments and previous regulatory settlements) as well as the risk of poten-
tial future adjustments. The fact that an entity currently is not subject to a
governmental investigation does not mean that a recorded valuation allowance
for potential billing adjustments is not warranted. Nor do these emerging in-
dustry trends necessarily indicate that an accrual for a specific entity is war-
ranted. [Revised, June 2009, to reflect conforming changes necessary due to the
issuance of recent authoritative literature.]
.29 In evaluating valuation allowances, the auditor may consider the en-
tity's historical experience and potential future adjustments in the aggregate.
For example, assume that over the past few years after final cost report audits
were completed, a hospital's adjustments averaged 3 percent to 5 percent of
total filed reimbursable costs. Additionally, the hospital is subject to potential
billing adjustments, including errors (for example, violations of the three-day
window, discharge and transfer issues, and coding errors). Even though spe-
cific incidents are not known, it may be reasonable for the hospital to estimate
and accrue a valuation allowance for such potential future retrospective adjust-
ments, both cost-based and non-cost-based. Based on this and other information
obtained, the auditor may conclude that a valuation allowance for the year un-
der audit of 3 percent to 5 percent of reimbursable costs plus additional amounts
for potential non-cost-based program billing errors is reasonable.
.30 Amounts that ultimately will be realized by an entity are dependent on
a number of factors, many of which may be unknown at the time the estimate
is first made. Further, even if two entities had exactly the same clinical and
coding experience, amounts that each might realize could vary materially due
to factors outside of their control (for example, differing application of payment
rules by fiscal intermediaries, legal interpretations of courts, local enforcement
initiatives, timeliness of reviews, and quality of documentation). As a result, be-
cause estimates are a matter of judgment and their ultimate accuracy depends
on the outcome of future events, different entities in seemingly similar circum-
stances may develop materially different estimates. The auditor may conclude
that both estimates are reasonable in light of the differing assumptions.
Inappropriate Accounting Principles
.31 As previously stated, the auditor also is responsible for determining
whether financial statement assertions and disclosures related to accounting
estimates are presented in accordance with GAAP. When the financial state-
ments are materially affected by a departure from GAAP, the auditor should
expresses a qualified or adverse opinion. [Revised, June 2009, to reflect conform-
ing changes necessary due to the issuance of recent authoritative literature.]
.32 Valuation allowances should be recorded so that revenues are not
recognized until the revenues are realizable. Valuation allowances are not es-
tablished based on the provisions of FASB ASC 450, Contingencies. [Revised,
June 2009, to reflect conforming changes necessary due to the issuance of recent
authoritative literature.]
.33 Indicators of possible measurement bias related to valuation al-
lowances include
 valuation allowances that are not associated with any particular
program, issue, or time period (for example, cost-report year or
year the service was rendered).
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 distorted earnings trends over time (for example, building up spe-
cific or unallocated valuation allowances in profitable years and
drawing them down in unprofitable years).
[Revised, June 2009, to reflect conforming changes necessary due to the is-
suance of recent authoritative literature.]
Inadequate Disclosure
.34 If the auditor concludes that a matter involving a risk or an uncer-
tainty is not adequately disclosed in the financial statements in conformity
with GAAP, the auditor should express a qualified or adverse opinion. FASB
ASC 275-10-50 provides guidance on the information that reporting entities
should disclose regarding risks and uncertainties existing as of the date of the
financial statements. [Revised, June 2009, to reflect conforming changes nec-
essary due to the issuance of recent authoritative literature.]
.35 In the health care environment, it is almost always at least reason-
ably possible that estimates regarding third-party payments could change in
the near term as a result of one or more future confirming events (for example,
regulatory actions reflecting local or national audit or enforcement initiatives).
For most entities with significant third-party revenues, the effect of the change
could be material to the financial statements. Where material exposure ex-
ists, the uncertainty regarding revenue realization should be disclosed in the
notes to the financial statements. Because representations from legal counsel
are often key audit evidence in evaluating the reasonableness of management's
estimates of potential future adjustments, the inability of an attorney to form
an opinion on matters about which he or she has been consulted may be in-
dicative of an uncertainty that should be specifically disclosed in the financial
statements. [Revised, June 2009, to reflect conforming changes necessary due
to the issuance of recent authoritative literature.]
.36 Differences between original estimates and subsequent revisions
might arise due to final settlements, ongoing audits and investigations, or pas-
sage of time in relation to the statute of limitations. FASB ASC 954-605 requires
that these differences be included in the statement of operations in the period
in which the revisions are made and disclosed. Such differences are not treated
as prior period adjustments unless they meet the criteria for prior period ad-
justments as set forth in FASB ASC 250-10-45. [Revised, June 2009, to reflect
conforming changes necessary due to the issuance of recent authoritative liter-
ature.]
.37 Disclosures such as the following may be appropriate:
General Hospital (the Hospital) is a (not-for-profit, for-profit, or gov-
ernmental hospital or health care system) located in (City, State). The
Hospital provides health care services primarily to residents of the
region.
Net patient service revenue is reported at estimated net realizable
amounts from patients, third-party payors, and others for services ren-
dered and includes estimated retroactive revenue adjustments due to
future audits, reviews, and investigations. Retroactive adjustments
are considered in the recognition of revenue on an estimated basis in
the period the related services are rendered, and such amounts are
adjusted in future periods as adjustments become known or as years
are no longer subject to such audits, reviews, and investigations.
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Revenue from the Medicare and Medicaid programs accounted for ap-
proximately 40 percent and 10 percent, respectively, of the Hospital's
net patient revenue for the year ended 1999. Laws and regulations
governing the Medicare and Medicaid programs are extremely complex
and subject to interpretation. As a result, there is at least a reasonable
possibility that recorded estimates will change by a material amount in
the near term. The 1999 net patient service revenue increased approxi-
mately $10,000,000 due to removal of allowances previously estimated
that are no longer necessary as a result of final settlements and years
that are no longer subject to audits, reviews, and investigations. The
1998 net patient service revenue decreased approximately $8,000,000
due to prior-year retroactive adjustments in excess of amounts previ-
ously estimated.
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Other Considerations Related to Government Investigations
In recent years, the federal government and many states have aggressively in-
creased enforcement efforts under Medicare and Medicaid anti-fraud and abuse
legislation. Broadening regulatory and legal interpretations have significantly
increased the risk of penalties for providers; for example, broad interpretations
of "false claims" laws are exposing ordinary billing mistakes to scrutiny and
penalty consideration. In such circumstances, evaluating the adequacy of ac-
cruals for or disclosure of the potential effects of illegal acts in the financial
statements of health care entities is a matter that is likely to require a high
level of professional judgment.
As previously discussed in this SOP, the far-reaching nature of alleged fraud
and abuse violations creates an uncertainty with respect to the valuation of
revenues, because future allegations of illegal acts could, if proven, result in a
subsequent reduction of revenues. In addition, management makes provisions
in the financial statements and disclosures for any contingent liabilities asso-
ciated with fines and penalties due to violations of such laws. FASB ASC 450,
Contingencies, provides guidance in evaluating contingent liabilities, such as
fines and penalties under applicable laws and regulations. Estimates of poten-
tial fines and penalties are not accrued unless their payment is probable and
reasonably estimable.
The auditor's expertise is in accounting and auditing matters rather than oper-
ational, clinical, or legal matters. Accordingly, the auditor's procedures focus on
areas that normally are subject to internal controls relevant to financial report-
ing. However, the further that potential illegal acts are removed from the events
and transactions ordinarily reflected in the financial statements, the less likely
the auditor is to become aware of the act, to recognize its possible illegality, and
to evaluate the effect on the financial statements. For example, determining
whether a service was medically necessary, obtained through a legally appro-
priate referral, properly performed (including using only approved devices, ren-
dered in a quality manner), adequately supervised, accurately documented and
classified, or rendered and billed by nonsanctioned individuals typically is not
within the auditor's professional expertise. As a result, an audit in accordance
with generally accepted auditing standards (GAAS) is not designed to detect
such matters.
Further, an audit conducted in accordance with GAAS does not include render-
ing an opinion or any form of assurance on an entity's compliance with laws
and regulations.1
Nor does an audit under GAAS include providing any assurance on an entity's
billings or cost report. In fact, cost reports typically are not prepared and sub-
mitted until after the financial statement audit has been completed.
Certain audit procedures, although not specifically designed to detect illegal
acts, may bring possible illegal acts to an auditor's attention. When a potentially
1 Even when auditors undertake a special engagement designed to attest to compliance with
certain provisions of laws, regulations, contracts, and grants (for example, an audit in accordance
with OMB Circular A-133), the auditor's procedures do not extend to testing compliance with laws
and regulations related to Medicare and Medicaid fraud and abuse.
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illegal act is detected, the auditor's responsibilities are addressed in AU sec.
317, Illegal Acts by Clients (AICPA, Professional Standards, vol. 1). Disclosure
of an illegal act to parties other than the client's senior management and its
audit committee or board of directors is not ordinarily part of the auditor's
responsibility, and such disclosure would be precluded by the auditor's ethical
or legal obligation of confidentiality, unless the matter affects the auditor's
opinion on the financial statements.2 [Revised, June 2009, to reflect conforming
changes necessary due to the issuance of recent authoritative literature.]
2 Statement on Auditing Standards No. 54, Illegal Acts by Clients (AICPA, Professional Stan-
dards, vol. 1, AU sec. 317.23) discusses circumstances in which a duty to notify parties outside the
client of detected illegal acts may exist.
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Appendix E
Information Sources
Further information on matters addressed in this guide is available through
various publications and services listed in the table that follows. Many non-
government and some government publications and services involve a charge
or membership requirement.
Fax services allow users to follow voice cues and request that selected docu-
ments be sent by fax machine. Some fax services require the user to call from
the handset of the fax machine, others allow the user to call from any phone.
Most fax services offer an index document, which lists titles and other informa-
tion describing available documents.
Recorded announcements allow users to listen to announcements about a vari-
ety of recent or scheduled actions or meetings.
All telephone numbers listed are voice lines, unless otherwise designated as fax
(f) or data (d) lines.
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Appendix F
References to AICPA Technical Practice Aids
The following nonauthoritative questions and answers, commonly referred to as
Technical Questions and Answers (TISs), have been prepared by AICPA staff
and are included in AICPA Technical Practice Aids. The TISs have not been
approved, disapproved, or otherwise acted upon by the Accounting Standards
Executive Committee or any other senior technical committee of the AICPA.
They are not sources of established accounting principles1 nor are they sources
of authoritative generally accepted auditing standards. Staff believes the TPAs
listed below may be useful and relevant for users of this guide. Other TISs,
as well as consensus positions of the Financial Accounting Standards Board's
Emerging Issues Task Force, may also be useful and relevant to users of this
guide depending on the facts and circumstances.
TIS Reference No. Title
6400.04 "Hospital as Collecting Agent for Physicians"
6400.12 "General Obligation Bonds Issued for Current Use
by City Owned Hospital"
6400.17 "Elimination of Profit on Intercompany Sales"
6400.19 "Offsetting of Limited Use Assets"
6400.20 "Format of Combined or Consolidated Financial
Statements"
6400.25 "Accounting for Transfer of Assets From
Not-for-Profit to For-Profit Entities"
6400.26 "Transfer of Assets From Subsidiary For-Profit
Entity to Not-for-Profit Stockholder Parent"
6400.29 "Timing of Recording Transfers Between Related
Entities"
6400.30 "Accounting for Transactions Involving Medicaid
Voluntary Contribution or Taxation Programs"
6400.33 "Accounting for a Joint Operating Agreement"
6400.34 "Accounting for Computer Systems Costs Incurred in
Connection With the Health Insurance Portability
and Accountability Act of 1996 (HIPAA)"
6400.35 "Note to Sections 6400.36–.42—Implementation of
FASB ASC 958—Classification of a Beneficiary's
Interest in the Net Assets of a Financially
Interrelated Fund-Raising Foundation (in the
Beneficiary's Financial Statements)"
(continued)
1 See chapter 1 for additional information regarding the hierarchy of generally accounting prin-
ciples for nongovernmental health care entities.
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TIS Reference No. Title
6400.36 "Application of FASB ASC 958—Classification of a
Beneficiary's Interest in the Net Assets of a
Financially Interrelated Fund-Raising Foundation
(The beneficiary can influence the operating and
financial decisions of the foundation to such an
extent that the beneficiary can determine the timing
and amount of distributions from the foundation.)"
6400.37 "Application of FASB ASC 958—Classification of a
Beneficiary's Interest in the Net Assets of a
Financially Interrelated Fund-Raising Foundation
(The beneficiary cannot influence the operating and
financial decisions of the foundation to such an
extent that the beneficiary can determine the timing
and amount of distributions from the foundation.)"
6400.38 "Application of FASB ASC 958—Classification of a
Beneficiary's Interest in the Net Assets of a
Financially Interrelated Fund-Raising
Foundation—Does Common Control Lead to the
Conclusion That the Beneficiary Can Determine the
Timing and Amount of Distributions from the
Recipient?"
6400.39 "Application of FASB ASC 958—Classification of a
Beneficiary's Interest in the Net Assets of a
Financially Interrelated Fund-Raising Foundation
(More Than One Beneficiary—Some Contributions
Are Designated)"
6400.40 "Application of FASB ASC 958—Classification of a
Beneficiary's Interest in the Net Assets of a
Financially Interrelated Fund-Raising Foundation
(The beneficiary makes an expenditure that meets a
purpose restriction on net assets held for its benefit
by the recipient entity—The beneficiary can
influence the operating and financial decisions of the
recipient to such an extent that the beneficiary can
determine the timing and amount of distributions
from the recipient.)"
6400.41 "Application of FASB ASC 958—Classification of a
Beneficiary's Interest in the Net Assets of a
Financially Interrelated Fund-Raising Foundation
(The beneficiary makes an expenditure that is
consistent with a purpose restriction on net assets
held for its benefit by the recipient entity—The
beneficiary cannot influence the operating and
financial decisions of the recipient to such an extent
that the beneficiary can determine the timing and
amount of distributions from the recipient.)"
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TIS Reference No. Title
6400.42 "Application of FASB ASC 958—Classification of a
Beneficiary's Interest in the Net Assets of a
Financially Interrelated Fund-Raising Foundation
(Recipient Entity)—Accounting for Unrealized Gains
and Losses on Investments Held by the Foundation"
6400.43 "Application of FASB ASC 958—Classification of
Distributions From a Financially Interrelated
Fund-Raising Foundation (Recipient Entity) to a
Health Care Beneficiary"
6400.45 "Applicability of FASB ASC 460—Accounting and
Disclosure Requirements for Guarantees, Including
Indirect Guarantees of Indebtedness of Others"
6400.46 "Applicability of FASB ASC 460—Guarantor's
Accounting and Disclosure Requirements for
Guarantees, Including Indirect Guarantees of
Indebtedness of Others—Mortgage Guarantees"
9110.15 "Reporting on Medicaid/Medicare Cost Reports"
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Appendix G
Major Existing Differences Between AICPA
Standards and PCAOB Standards
The Public Company Accounting Oversight Board (PCAOB) adopted, and the
Securities and Exchange Commission (SEC) approved, interim standards that
were essentially the generally accepted auditing standards (GAAS), attestation
standards, and quality control standards issued by the Auditing Standards
Board (ASB); certain former AICPA SEC Practice Section (SECPS) membership
requirements; certain AICPA ethics and independence rules; and Independence
Standards Board (ISB) rules, as they existed on April 16, 2003.
In its Release No. 2003-006, dated April 18, 2003, the PCAOB adopted on an
initial, transitional basis these interim standards (known as the Interim Pro-
fessional Auditing Standards) consisting of five rules that are applicable to
registered public accounting firms and that govern the conduct of audits of
issuers and, where applicable, interim reviews of the financial statements of is-
suers. The five rules include PCAOB Rule 3200T, Interim Auditing Standards;
Rule 3300T, Interim Attestation Standards; Rule 3400T, Interim Quality Con-
trol Standards; Rule 3500T, Interim Ethics Standards; and Rule 3600T, Interim
Independence Standards (AICPA, PCAOB Standards and Related Rules, Select
Rules of the Board).
These interim standards will remain in effect while the PCAOB conducts a re-
view of standards applicable to registered public accounting firms. Based on this
review, the PCAOB may modify, repeal, replace, or adopt, in part or in whole,
the interim standards. If a provision of a PCAOB standard addresses a subject
matter that also is addressed in the interim standards, the affected position of
the interim standard should be considered superseded or effectively amended.
Moreover, as clarification, the PCAOB's interim independence standards are
not to be interpreted to supersede the SEC's independence requirements.
The ASB is the senior technical committee of the AICPA that is designated
to issue auditing, attestation, and quality control standards applicable to the
performance and issuance of audit and attestation reports for nonissuers. The
PCAOB is a private, nonprofit corporation created by the Sarbanes-Oxley Act
of 2002 (the act) and is in many respects the ASB's counterpart for issuers.
At the time of this writing, the following major differences existed between
AICPA standards, as issued and approved by the ASB, and final PCAOB stan-
dards approved by the SEC:
 Risk Assessment Standards. Statements on Auditing Stan-
dards (SAS) Nos. 104–111, collectively referred to as the risk as-
sessment standards, provide extensive guidance concerning the
auditor's assessment of the risks of material misstatement in a
financial statement audit and the design and performance of au-
dit procedures whose nature, timing, and extent are responsive to
the assessed risks. Additionally, the SASs establish standards and
provide guidance on planning and supervision, the nature of au-
dit evidence, and evaluating whether the audit evidence obtained
affords a reasonable basis for an opinion regarding the financial
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statements under audit. SASs do not apply to audits conducted in
accordance with PCAOB standards.*
 Auditors' Reports. In its Release No. 2003-025, dated Decem-
ber 17, 2003, the PCAOB issued Auditing Standard No. 1, Refer-
ences in Auditors' Reports to the Standards of the Public Company
Accounting Oversight Board (AICPA, PCAOB Standards and Re-
lated Rules, Auditing Standards), that directs auditors to state
that the engagement was conducted in accordance with "the stan-
dards of the Public Company Accounting Oversight Board (United
States)" whenever the registered public accounting firm has per-
formed the engagement in accordance with the PCAOB's stan-
dards. Numerous other conforming amendments related to audi-
tors' reports have been made to the PCAOB's interim standards.
 Audit Documentation. In its Release No. 2004-006, dated June
9, 2004, the PCAOB issued Auditing Standard No. 3, Audit Docu-
mentation (AICPA, PCAOB Standards and Related Rules, Audit-
ing Standards), and related conforming amendments that, among
other significant provisions, establish the following requirements:
— An audit documentation retention period of seven years
from the date the auditor grants permission to use the
auditor's report in connection with the issuance of the is-
suer's financial statements unless a longer period of time
is required by law
— A documentation completion date of not more than 45
days after the release date of the auditor's report, at which
time the auditor must have completed all necessary au-
diting procedures and obtained sufficient evidence to sup-
port the representations in the auditor's report
— The principal auditor's unconditional responsibility to ob-
tain certain information from the other auditor when the
principal auditor decides not to make reference to the au-
dit of the other auditor
 Audit of Internal Control. PCAOB Auditing Standard No. 5,
An Audit of Internal Control Over Financial Reporting That Is In-
tegrated with An Audit of Financial Statements (AICPA, PCAOB
Standards and Related Rules, Auditing Standards), establishes
requirements and provides guidance that applies when an audi-
tor is engaged to audit an issuer's internal control over financial
* In its Release No. 2008-006 dated October 21, 2008, the Public Company Accounting Over-
sight Board (PCAOB) issued a series of 7 proposed Auditing Standards related to the auditor's as-
sessment of and responses to risk and related conforming amendments. If issued in final form, the
proposed standards would supersede the PCAOB's interim Auditing Standards related to audit risk
and materiality, audit planning and supervision, consideration of internal control in an audit of fi-
nancial statements, audit evidence, and performing tests of accounts and disclosures before year end.
The proposed standards establish requirements and provide direction on audit procedures performed
throughout the audit, from the initial planning stages through the evaluation of the audit results in
forming the opinions in the auditor's report. The proposals build upon and attempt to improve the
existing framework for risk assessment by, among other things, taking account of improvements in
risk assessment methodologies, enhancing the integration of the risk assessment standards with the
PCAOB's standard for the audit of internal control over financial reporting, emphasizing the audi-
tor's responsibilities for considering the risk of fraud as being a central part of the audit process,
and reducing unnecessary differences with the risk assessment standards of other auditing standard
setters.
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reporting that is integrated with the audit of that issuer's finan-
cial statements. Section 404(b) of the act requires an integrated
audit for issuers whereas an integrated audit is not required for
nonissuers under GAAS; however, practitioners may perform an
examination of a nonissuer's internal control over financial re-
porting in the context of an integrated audit under Statement on
Standards for Attestation Engagements No. 15, An Examination
of an Entity's Internal Control Over Financial Reporting That Is
Integrated With an Audit of Its Financial Statements (AICPA, Pro-
fessional Standards, vol. 1, AT sec. 501). Auditing Standard No. 5
superseded PCAOB Auditing Standard No. 2, An Audit of Internal
Control Over Financial Reporting Performed in Conjunction With
An Audit of Financial Statements, and contains several conform-
ing amendments to other PCAOB auditing standards and interim
standards.
 Attestation Matters. PCAOB Rule 3300T has been amended by
PCAOB Auditing Standard No. 4, Reporting on Whether a Pre-
viously Reported Material Weakness Continues to Exist (AICPA,
PCAOB Standards and Related Rules, Auditing Standards). The
conforming amendment adds another type of engagement not cov-
ered by the interim attestation standards. The exempted engage-
ment is one in which the practitioner is engaged to report on
whether a material weakness in internal control over financial re-
porting continues to exist and is conducted for any purpose other
than the entity's internal use. Such engagements must be con-
ducted pursuant to PCAOB Auditing Standard No. 4.
 Quality Control Matters. PCAOB Rule 3400T incorporates the
following SECPS membership requirements in the interim stan-
dards:
— Continuing professional education of audit firm person-
nel
— Concurring partner review of the audit report and the
financial statements of SEC registrants
— Written communication statement to all professional per-
sonnel of firm policies and procedures on the recommen-
dation and approval of accounting principles, present and
potential client relationships, and the types of services
provided
— Notification to the SEC of resignations and dismissals
from audit engagements for SEC registrants†
† In its Release No. 2009-001 dated March 1, 2009, the PCAOB issued a proposed Auditing
Standard, Engagement Quality Review, that if issued in final form would be applicable to all registered
firms and would supersede the PCAOB's interim concurring partner review requirement. The proposed
standard requires an engagement quality review (EQR) and concurring approval of issuance for audits
and reviews of interim financial information but not for other engagements performed according to the
standards of the PCAOB. In this proposal, the PCAOB refines the requirements that an engagement
quality reviewer may be a partner of the firm that issues the engagement report (or communicates
an engagement conclusion, if no report is issued), another individual in an equivalent position in
the firm, or an individual outside the firm. The proposed standard also revises the description of the
procedures required in an EQR and clarifies the scope of the documentation requirements.
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— Audit firm obligations with respect to the policies and
procedures of correspondent firms and other members of
international firms or international associations of firms
— Policies and procedures to comply with applicable inde-
pendence requirements
Statements on Quality Control Standards (SQCSs) No. 7, A Firm's
System of Quality Control (AICPA, Professional Standards, vol. 2,
QC sec. 10), is effective for a CPA firm's system of quality control
for its accounting and auditing practice as of January 1, 2009, and
supersedes all previously issued SQCSs. This standard defines
engagement quality control review and requires firms to estab-
lish criteria to determine which engagements are to be subject to
an engagement quality control review. SQCS No. 7 also describes
certain policies and procedures that should be included in a firm's
system of quality control for each of following elements:
— Leadership responsibilities for quality within the firm
(the "tone at the top")
— Relevant ethical requirements
— Acceptance and continuance of client relationships and
specific engagements
— Human resources
— Engagement performance
— Monitoring
SQCS No. 7 provides additional information regarding each of
these elements. The additional guidance generally exceeds the
current requirements of the PCAOB's interim rules and the
SECPS membership requirements. For example, this standard
provides more detailed guidance on client acceptance and con-
tinuance, engagement supervision and review, and consultation
policies and procedures. SQCS No. 7 also requires documentation
of the resolution of significant issues. SQCSs do not apply to that
portion of a CPA firm's practice subject to the quality control stan-
dards of the PCAOB.
 Ethics Matters. In addition to PCAOB Rule 3500T, the PCAOB
has adopted other ethics rules applicable to registered public ac-
counting firms and their associated persons. PCAOB Rule 3501,
Definitions of Terms Employed in Section 3, Part 5 of the Rules
(AICPA, PCAOB Standards and Related Rules, Select Rules of
the Board), sets forth certain definitions and PCAOB Rule 3502,
Responsibility Not to Knowingly or Recklessly Contribute to Viola-
tions (AICPA, PCAOB Standards and Related Rules, Select Rules
of the Board), addresses certain responsibilities of persons associ-
ated with registered public accounting firms.
 Independence Matters. In addition to PCAOB Rule 3600T, the
PCAOB has adopted other independence rules concerning tax
transactions and tax services, contingent fees, and audit commit-
tees. See PCAOB Rule 3520, Auditor Independence; Rule 3521,
Contingent Fees; Rule 3522, Tax Transactions; Rule 3523, Tax
Services for Persons in Financial Reporting Oversight Roles; Rule
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3524, Audit Committee Pre-approval of Certain Tax Services; Rule
3525, Audit Committee Pre-approval of Non-audit Services Re-
lated to Internal Control Over Financial Reporting; and Rule 3526,
Communication with Audit Committees Concerning Independence
(AICPA, PCAOB Standards and Related Rules, Select Rules of the
Board). Pursuant to PCAOB Release No. 2008-003, dated April 22,
2008, Rule 3526 establishes, among other requirements, the fol-
lowing provisions:
— Requires a registered public accounting firm, before ac-
cepting an initial engagement pursuant to the standards
of the PCAOB, to describe in writing to the audit com-
mittee all relationships between the registered public ac-
counting firm or any affiliates of the firm and the poten-
tial audit client or persons in financial reporting oversight
roles at the potential audit client that, as of the date of
the communication, may reasonably be thought to bear
on independence
— Requires that a registered firm, at least annually with re-
spect to each of its issuer audit clients, describe in writing
to the audit committee of the issuer all relationships be-
tween the registered public accounting firm or any affili-
ates of the firm and the audit client or persons in financial
reporting oversight roles at the audit client that, as of the
date of the communication, may reasonably be thought to
bear on independence
— Supersedes ISB Standard No. 1, Independence Discus-
sions with Audit Committees, and two related interpreta-
tions, ISB Interpretation 00-1, The Applicability of ISB
Standard No. 1 When "Secondary Auditors" Are Involved
in the Audit of a Registrant, and ISB Interpretation 00-2,
The Applicability of ISB Standard No. 1 When "Secondary
Auditors" Are Involved in the Audit of a Registrant, An
Amendment of Interpretation 00-1
Please note that in the time since publication, these differences might have
been eliminated and others might have arisen.
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Appendix H
Schedule of Changes Made to the Text
From the Previous Edition
As of August 1, 2009
This schedule of changes identifies areas in the text and footnotes of this guide
that have changed since the previous edition. Entries in the table of this ap-
pendix reflect current numbering, lettering (including that in appendix names),
and character designations that resulted from the renumbering or reordering
that occurred in the updating of this guide.
Terms Used to Define Professional Requirements
AICPA Audit and Accounting Guides, including this guide, have been updated
to conform with AU section 120, Defining Professional Requirements in State-
ments on Auditing Standards, AT section 20, Defining Professional Require-
ments in Statements on Standards for Attestation Engagements, and AR sec-
tion 20, Defining Professional Requirements in Statements on Standards for
Accounting and Review Services (AICPA, Professional Standards), in which pro-
fessional requirements are categorized as either unconditional requirements or
presumptively mandatory requirements, each of which is associated with spe-
cific wording such as must or is required or should. These standards distinguish
professional requirements set forth in the standards from explanatory material
contained in the standards, the latter of which requires only the auditor's, prac-
titioner's, or accountant's "attention and understanding." Whether the auditor,
practitioner, or accountant performs the suggested procedures or actions in the
engagement (as stated in the explanatory material) depends on the exercise of
professional judgment in the circumstances consistent with the objective of the
standard.
Because interpretive publications (including AICPA Audit and Accounting
Guides, for example) are recommendations, the publications cannot establish
requirements. Paragraph .06 of AU Section 150, Generally Accepted Auditing
Standards (AICPA, Professional Standards, vol. 1), states, "The auditor should
be aware of and consider interpretive publications applicable to his or her audit.
If the auditor does not apply the auditing guidance included in an interpretive
publication, the auditor should be prepared to explain how he or she complied
with the SAS provisions addressed by such auditing guidance."
An interpretive publication, such as this guide, should state the requirement of
the standard and then give recommendations on the application of the require-
ment in the specific circumstances. The terms must, is required, or should may
be used in an interpretive publication only when it is clear that the require-
ment originated in a standard. Otherwise, the user may be uncertain whether a
requirement or a recommendation is intended. The following conventions were
used to conform the AICPA Audit and Accounting Guides to these standards,
which define professional requirements:
 Terms to replace the use of must, should, and is required consist
only of those explanatory material terms included in AU section
120, AT section 20, and AR section 20: could, may, and might, and
these variations of those terms: could consider, may consider, and
might consider.
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 When referring guide users to interpretive publications (which
consist of interpretations of the Statement on Auditing Standards
(SASs), appendixes to the SASs, auditing guidance in AICPA Audit
and Accounting Guides, and AICPA auditing Statements of Posi-
tion) or to nonauthoritative knowledge sources, if an auditor can
perform an adequate risk assessment without the recommended
knowledge, explanatory material terms are used; if not, should or
should consider are used.
 Specific auditing procedures generally are explanatory in nature
(the standards generally do not include specific audit procedures).
As such, explanatory material terms (could, may, might, could con-
sider, may consider, or might consider) are used, unless the specific
audit procedure is the established way or only way of achieving a
generally accepted auditing standard objective for this industry,
in which case should is used.
 If the recommendation is that the auditor consult or familiarize
himself or herself with other sources of information, such as Se-
curities and Exchange Commission (SEC) regulations, income tax
laws, and industry developments including regulatory, economic,
and legislative developments, then the following considerations
were used in developing which terms to use in the guides:
— If the purpose of the recommendation is for the auditor,
practitioner, or accountant to develop the required under-
standing of the entity and its environment for risk assess-
ment purposes, and an auditor can perform an adequate
risk assessment without the recommended knowledge,
explanatory material terms are used within the recom-
mendation; if not, should or must is used depending upon
the associated standard requirement.
— If the purpose of the recommendation is for the auditor,
practitioner, or accountant to perform the engagement in
accordance with AICPA professional standards, and the
knowledge is available only from the source cited (such as
SEC regulations or income tax law), then should is used.
If the knowledge is available from other sources as well,
explanatory material terms are used.
 The guides contain guidance for management which includes best
practices for the industry. Because the recommendations are best
practices, the terms ordinarily should or generally should are
used.
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Reference Change
General Accounting guidance conformed to reflect
reference to Financial Accounting Standards
Board (FASB) Accounting Standards
Codifcation™ (ASC) as it existed on August 1,
2009 (through FASB Accounting Standards
Update 2009-02). See preface for additional
information about FASB ASC.
Notice to readers and
preface
Updated.
Chapter 1 title Revised for clarification.
Text box before
paragraph 1.01
Deleted for clarification.
Former footnote * in
paragraph 1.01
Deleted.
Paragraph 1.01 Revised to reflect the issuance of FASB
Statement No. 168.
Footnote * in paragraph
1.10
Revised for clarification.
Paragraph 1.26 Added to reflect the issuance of Governmental
Accounting Standards Board (GASB) Statement
No. 52.
Heading before
paragraph 1.33
Revised for clarification.
Former paragraph 1.40 Deleted due to the issuance of FASB Statement
No. 168.
Footnote 6 in
paragraph 1.41
Added to reflect the issuance of FSP FAS 117-1.
Former paragraph 1.42,
former footnote 6 in
paragraph 1.43, and
former paragraph 1.46
Deleted due to the issuance of FASB Statement
No. 168.
Former footnote ‡ in
paragraph 1.46
Deleted for clarification.
Former footnote 8 in
paragraph 1.48 and
former paragraph 1.48
Deleted due to the issuance of FASB Statement
No. 168.
Former footnote || in
heading before
paragraph 1.50
Deleted due to the issuance of FASB Statement
No. 164.
Heading before
paragraph 1.52
Revised for clarification.
(continued)
AAG-HCO APP H
P1: G.Shankar
ACPA125-AppH ACPA125.cls February 25, 2010 16:51
460 Health Care Entities
Reference Change
Former heading before
paragraph 1.52 and
former paragraph 1.52
Deleted due to the issuance of FASB Statement
No. 168.
Paragraphs 1.51–.65
and heading before
paragraph 1.66
Added to reflect the issuance of FASB
Statement No. 168.
Former paragraphs
1.56–.61 (chapter
appendixes A–F)
Deleted due to the issuance of FASB Statement
No. 168.
Former paragraph 1.62
(chapter appendix G)
and all footnotes
contained therein
Deleted due to the issuance of FASB Statement
No. 168 and GASB Statement No. 55.
Paragraph 1.72 Added to reflect the issuance of FASB
Statement No. 168.
Footnotes † and ‡ in
heading before
paragraph 1.73 and
footnotes ||and # in
paragraph 1.76
Added.
Heading before
paragraph 1.77
Revised for clarification.
Paragraph 1.77 Revised due to the issuance of GASB Statement
No. 55.
Paragraphs 1.78–.81
and footnote 8 in
paragraph 1.78
Added due to the issuance of GASB Statement
No. 55.
Paragraphs 1.85–.86 Added due to the issuance of GASB Statement
No. 56.
Footnote ** in heading
before paragraph 1.87,
footnotes †† and ‡‡ in
paragraph 1.87, and
footnote |||| in
paragraph 1.91
Added.
Heading before
paragraph 1.87 and
paragraphs 1.87–.104
(including all headings
within the paragraph
range)
Moved from chapter 3.
Paragraph 1.101–.102 Revised due to the issuance of FSP FAS 157-4.
Paragraphs 1.105–.115 Added due to the issuance of FSP FAS 157-4.
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Reference Change
Heading before
paragraph 1.116 and
paragraphs 1.116–.119
(including all headings
within the paragraph
range)
Moved from chapter 3.
Footnote ## in
paragraph 1.116
Added.
Footnote 13 in heading
before paragraph 1.119
Added.
Heading before
paragraph 1.119
Revised for clarification.
Paragraphs 1.120–.122 Added due to the issuance of FSP FAS 107-1
and APB 28-1.
Text box before
paragraph 2.01
Deleted for clarification.
Footnote 1 in
paragraph 2.06
Added.
Paragraph 2.06 Revised.
Paragraphs 2.09–.10 Revised to reflect the appropriate use of terms
used to define the professional requirements of
auditors, practitioners, and accountants in AU
section 120, AT section 20, and AR section 20 of
AICPA Professional Standards.
Subsequently, these changes are referred to as
"defining professional requirements" in the
Schedule of Changes.
Paragraphs 2.13 and
2.20
Revised.
Paragraphs 2.25, 2.29,
and 2.32–.33
Revised to define professional requirements.
Paragraphs 2.34 and
2.37
Revised.
Footnote 3 in heading
before paragraph 2.50
Added.
Paragraphs 2.44, 2.54,
2.58–.59, 2.70–.71, and
2.88 and footnote 7 in
paragraph 2.89
Revised to define professional requirements.
Footnote 8 in
paragraph 2.89
Revised.
Paragraph 2.90 Revised.
(continued)
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Reference Change
Paragraph 2.91 Revised to define professional requirements.
Paragraph 2.93 Revised to define professional requirements.
Former paragraph 2.94 Deleted for the passage of time.
Paragraph 2.96 Revised.
Paragraphs 2.101,
2.106, 2.113, and 2.115
Revised to define professional requirements.
Paragraphs 2.120–.122 Revised.
Paragraphs 2.122–.123 Added due to the issuance of FASB Statement
No. 165.
Heading before former
paragraph 2.123
Deleted.
Footnote 10 in
paragraph 2.122
Added.
Footnote * in paragraph
2.124
Added.
Paragraph 2.124 Revised.
Paragraphs 2.125–.126 Revised to define professional requirements.
Paragraph 2.127 Revised.
Paragraphs 2.135 and
2.139
Revised to define professional requirements.
Former footnote 1 in
paragraph 3.01
Deleted.
Former paragraphs
3.02–.03 and former
footnotes 2 and 3 in
paragraph 3.03
Moved to chapter 10.
Former paragraph 3.04 Moved to chapter 1.
Former paragraph 3.05 Deleted for the passage of time.
Former paragraphs
3.06–.26
Moved to chapter 1.
Former footnotes * and
† in paragraph 3.23 and
former footnote ‡ in
heading before
paragraph 3.26
Deleted.
Footnote * in paragraph
3.07
Added.
Footnote 1 in chapter 4
title, footnote * in
paragraph 4.08
Revised.
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Reference Change
Footnotes †, ‡, and || in
paragraph 4.08
Added.
Former footnote 2 in
paragraph 4.07 and
former footnote 4 in
paragraph 4.10
Deleted.
Footnote 5 in paragraph
4.12, footnote # in
paragraph 4.17,
footnote ** in heading
before paragraph 4.18,
and footnote †† in
paragraph 4.20
Added.
Paragraph 4.21 Revised due to the issuance of FSP FAS 115-2
and FAS 124-2.
Footnote ‡‡ in
paragraph 4.22
Added.
Former paragraph 4.21 Deleted due to the issuance of FSP FAS 115-2
and FAS 124-2.
Paragraph 4.23 Added due to the issuance of FSP FAS 115-2
and FAS 124-2.
Paragraph 4.24 Revised due to the issuance of FSP FAS 115-2
and FAS 124-2.
Paragraphs 4.25–.33 Added due to the issuance of FSP FAS 115-2
and FAS 124-2.
Paragraph 4.34 Revised due to the issuance of FSP FAS 115-2
and FAS 124-2.
Paragraphs 4.35–.39 Added due to the issuance of FSP FAS 115-2
and FAS 124-2.
Paragraph 4.40 Revised due to the issuance of FSP FAS 115-2
and FAS 124-2.
Paragraphs 4.41–.45 Added due to the issuance of FSP FAS 115-2
and FAS 124-2.
Paragraphs 4.46–.47 Revised due to the issuance of FSP FAS 115-2
and FAS 124-2.
Paragraphs 4.48–.49 Added due to the issuance of FSP FAS 115-2
and FAS 124-2.
Paragraph 4.50 Revised due to the issuance of FSP FAS 115-2
and FAS 124-2.
Paragraphs 4.51–.52 Added due to the issuance of FSP FAS 115-2
and FAS 124-2.
(continued)
AAG-HCO APP H
P1: G.Shankar
ACPA125-AppH ACPA125.cls February 25, 2010 16:51
464 Health Care Entities
Reference Change
Footnote 8 in
paragraph 4.56
Revised.
Former text box before
paragraph 4.30
Deleted for clarification.
Paragraph 4.61 Revised.
Footnote 11 in
paragraph 4.61
Added.
Exhibit 4-1 Updated due to the issuance of AU section 326.
Former footnote * in
heading within exhibit
4-1
Deleted due to passage of time.
Former footnote 2 in
paragraph 5.08 and
former footnote 3 in
paragraph 5.12
Deleted.
Footnote 4 in
paragraph 5.20
Revised.
Former footnote * in
paragraph 5.12 and
former footnote 8 in
paragraph 5.16
Deleted.
Former paragraph 5.17 Deleted for the passage of time.
Footnote * in paragraph
5.33
Added.
Former footnote † in
paragraph 5.22
Deleted.
Footnote † in paragraph
5.38
Revised.
Footnotes ‡, ||, and # in
paragraph 5.38 and
footnote ** in
paragraph 5.40
Added.
Former footnote || in
heading before
paragraph 5.30
Deleted.
Paragraphs 5.45–.53
and footnote 12 in
paragraph 5.55
Added to reflect revisions related to FASB
Statement No. 48.
Former text box before
paragraph 5.33
Deleted for clarification.
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Reference Change
Footnote 13 in
paragraph 5.58 and
footnote 14 in
paragraph 5.59
Added.
Exhibit 5-1 Updated due to the issuance of AU section 326.
Former footnote * in
heading within exhibit
5-1
Deleted due to passage of time.
Former footnote 3 in
paragraph 6.08
Deleted.
Footnote * in paragraph
6.10
Added.
Former text box before
paragraph 6.12
Deleted for clarification.
Former footnote 4 in
paragraph 6.13
Deleted.
Former footnote 5 in
paragraph 6.16
Deleted.
Former paragraph 6.17 Deleted for clarification.
Exhibit 6-1 Updated due to the issuance of AU section 326.
Former footnote * in
heading within exhibit
6-1
Deleted due to passage of time.
Table note 1 in exhibit
6-1
Revised.
Footnotes † and 4 in
exhibit 6-1
Added.
Paragraph 7.02 and
footnote 1 in paragraph
7.02
Added for clarification.
Footnote * in paragraph
7.05, footnote † in
paragraph 7.10, and
footnote ‡ in paragraph
7.26
Added.
Former footnote 1 in
paragraph 7.22
Deleted.
Exhibit 7-1 Updated due to the issuance of AU section 326.
Former footnote * in
heading within exhibit
7-1
Deleted due to passage of time.
(continued)
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Reference Change
Footnote * in paragraph
8.04 and footnote 2 in
paragraph 8.18
Added.
Footnote † in paragraph
8.27
Revised.
Footnote ‡ in paragraph
8.27
Added.
Paragraphs 8.45, 8.49,
and 8.57
Revised to define professional requirements.
Exhibit 8-1 Updated due to the issuance of AU section 326.
Former footnote * in
heading within exhibit
8-1
Deleted due to passage of time.
Footnote 2 in
paragraph 9.07
Added.
Exhibit 9-1 Updated due to the issuance of AU section 326.
Former footnote * in
heading within exhibit
9-1
Deleted due to passage of time.
Paragraph 10.14 Added for clarification.
Footnote 6 in paragraph
10.15 and footnote 7 in
paragraph 10.17
Added.
Paragraph 10.24 Added for clarification.
Paragraphs 10.30–.33
and footnotes 8 and 9
Moved from chapter 3.
Footnote 10 in
paragraph 10.32
Added.
Footnote * in paragraph
10.38
Revised.
Exhibit 10-1 Updated due to the issuance of AU section 326.
Former footnote * in
heading within exhibit
10-1
Deleted due to passage of time.
Footnote * in heading
before paragraph 11.04
Revised.
Footnotes †, ‡, ||, and #
in heading before
paragraph 11.04
Added.
Footnote 1 in
paragraph 11.04
Revised to define professional requirements.
Former paragraph
11.06
Deleted for clarification.
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Reference Change
Paragraph 11.07 Revised due to the issuance of FSP SOP 94-3-1
and AAG HCO-1.
Former footnote 4 in
paragraph 11.10
Moved into text due to issuance of FASB
Statement No. 168.
Former footnotes 2 and
3 in paragraph 11.08
and former footnotes 5
and 6 in paragraph
11.10
Deleted.
Footnote 3 in
paragraph 11.09
Revised.
Footnote 4 in
paragraph 11.09
Added.
Former footnotes 8 and
9 in paragraph 11.11
and former footnotes 11
and 12 in paragraph
11.12
Deleted.
Former footnote 10 in
paragraph 11.12
Moved to paragraph 11.20.
Former footnote 13 in
paragraph 11.13
Moved to footnote 9 in paragraph 11.18.
Paragraph 11.13 Added due to issuance of FASB Statement No.
168 (formerly was footnote 4 in paragraph
11.10).
Paragraphs 11.14–.15 Added due to the issuance of FSP SOP 94-3-1
and AAG HCO-1.
Paragraph 11.16 Revised due to the issuance of FSP SOP 94-3-1
and AAG HCO-1.
Paragraphs 11.17–.18 Added due to the issuance of FSP SOP 94-3-1
and AAG HCO-1.
Footnote 8 in
paragraph 11.17
Added.
Footnote 9 in
paragraph 11.18
Moved from former footnote 13 in paragraph
11.13.
Paragraph 11.20 Added (formerly was footnote 10 in paragraph
11.12).
Footnote ** in
paragraph 11.25
Added.
Former footnote 14 in
paragraph 11.17
Deleted.
(continued)
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Reference Change
Paragraph 11.26 and
footnotes 11 and 12
Added due to the issuance of FSP SOP 94-3-1
and AAG HCO-1.
Footnote †† in
paragraph 11.29 and
footnote ‡‡ in
paragraph 11.31
Added.
Footnote 14 in heading
before paragraph 11.33
and paragraphs
11.33–.35
Added due to the issuance of FSP SOP 94-3-1
and AAG HCO-1.
Paragraph 11.36 Added due to the issuance of GASB Statement
No. 56.
Former footnote 25 in
paragraph 11.36,
former footnote 26 in
paragraph 11.37, and
former footnote # in
paragraph 11.38
Deleted.
Paragraph 11.57 Revised to define professional requirements.
Table in paragraph
11.59
Revised due to the issuance of FSP SOP 94-3-1
and AAG HCO-1.
Footnote ## in heading
before paragraph 11.60
and footnote *** in
paragraph 11.60
Added.
Exhibit 12-1 Updated due to the issuance of AU section 326.
Former footnote * in
heading within exhibit
12-1
Deleted due to passage of time.
Footnote * in paragraph
12.01
Added.
Footnote 1 in
paragraph 12.01
Revised to define professional requirements.
Paragraph 12.01 Revised.
Paragraphs 12.08–.09 Revised to define professional standards.
Footnote 3 in
paragraph 12.10
Added.
Paragraphs 12.11–.12 Revised to define professional standards.
Former footnote 2 in
paragraph 13.11
Deleted.
Footnote 2 in
paragraph 14.24
Revised due to the issuance of FASB Statement
No. 168.
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Reference Change
Former footnote 2 in
former paragraph 14.33
Deleted.
Exhibit 14-3 Updated due to the issuance of AU section 326.
Former footnote * in
heading within exhibit
14-3
Deleted due to passage of time.
Footnote † in appendix
A
Revised.
Footnote ‡ in appendix
A
Added.
Footnote || in appendix
A
Revised.
Footnotes ** and †† in
appendix A
Added.
Footnote ## in appendix
A
Revised due to the issuance of FSP FIN 48-3.
Former appendix B Deleted.
Former appendix F Deleted.
Footnote 1 in appendix
F
Added.
Appendixes F and G Updated.
Former appendix J Deleted.
Glossary Updated.
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Glossary
The following terms can be found in Financial Accounting Standards Board
(FASB) Accounting Standards Codification (ASC) glossary:
activities. Activities are efforts to accomplish specific objectives. Some activ-
ities include producing and distributing materials. For example, if a not-
for-profit entity undertakes a mass mailing that includes a letter and a
pamphlet, producing and distributing the letter and pamphlet are part of
the activity. Other activities may include no materials, such as an annual
dinner or a radio commercial.
advance refunding. A transaction involving the issuance of new debt to re-
place existing debt with the proceeds from the new debt placed in trust
or otherwise restricted to retire the existing debt at a determinable future
date or dates.
affiliate. A party that, directly or indirectly through one or more intermedi-
aries, controls, is controlled by, or is under common control with an entity.
agent. An entity that acts for and on behalf of another. Although the term
agency has a legal definition, the term is used broadly to encompass not
only legal agency, but also the relationships described in FASB ASC topic
958, Not-for-Profit Entities. A recipient entity acts as an agent for and on
behalf of a donor if it receives assets from the donor and agrees to use
those assets on behalf of or transfer those assets, the return on investment
of those assets, or both to a specified beneficiary. A recipient entity acts
as an agent for and on behalf of a beneficiary if it agrees to solicit assets
from potential donors specifically for the beneficiary's use and to distribute
those assets to the beneficiary. A recipient entity also acts as an agent if
a beneficiary can compel the recipient entity to make distributions to it or
on its behalf.
capitation fee. A fixed amount per individual that is paid periodically (usually
monthly) to a provider as compensation for providing comprehensive health
care services for the period. The fee is set by contract between a prepaid
health care plan and the provider. These contracts are generally with med-
ical groups, independent practice associations, hospitals, and other similar
providers. Capitation fees may be determined actuarially or negotiated
based on expected costs to be incurred.
charity care. Health care services that are provided but that are never ex-
pected to result in cash flows. Charity care is provided to a patient with
demonstrated inability to pay. Each entity establishes its own criteria for
charity care consistent with its mission statement and financial ability.
compensation or fees. Reciprocal transfers of cash or other assets in exchange
for services performed.
conditional promise to give. A promise to give that depends on the occur-
rence of a specified future or uncertain event to bind the promisor.
contribution. An unconditional transfer of cash or other assets to an entity or
a settlement or cancellation of its liabilities in a voluntary nonreciprocal
transfer by another entity acting other than as an owner. Those charac-
teristics distinguish contributions from exchange transactions, which are
reciprocal transfers in which each party receives and sacrifices approxi-
mately equal value; from investments by owners and distributions to own-
ers, which are nonreciprocal transfers between an entity and its owners;
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and from other nonreciprocal transfers, such as impositions of taxes or fines
and thefts, which are not voluntary transfers. In a contribution transac-
tion, the value, if any, returned to the resource provider is incidental to
potential public benefits. In an exchange transaction, the potential public
benefits are secondary to the potential proprietary benefits to the resource
provider. The term contribution revenue is used to apply to transactions
that are part of the entity's ongoing major or central activities (revenues),
or are peripheral or incidental to the entity (gains).
costs of joint activities. Costs incurred for a joint activity. Costs of joint ac-
tivities may include joint costs and costs other than joint costs. Costs other
than joint costs are costs that are identifiable with a particular function,
such as fund raising, program, management and general, and cost of sales.
For example, some costs incurred for printing, paper, professional fees, and
salaries to produce donor cards are not joint costs, although they may be
incurred in connection with conducting joint activities.
diagnosis-related group (DRG). A patient classification scheme that cate-
gorizes patients who are related medically with respect to primary and
secondary diagnosis, age, or complications.
donor-imposed condition. A donor stipulation that specifies a future and
uncertain event whose occurrence or failure to occur gives the promisor
a right of return of the assets it has transferred or releases the promisor
from its obligation to transfer its assets.
donor-imposed restriction. A donor stipulation that specifies the use for a
contributed asset that is more specific than broad limits resulting from the
following: (a) the nature of the not-for-profit entity, (b) the environment in
which it operates, and (c) the purposes specified in its articles of incorpora-
tion or bylaws, or comparable documents for an unincorporated association.
A donor-imposed restriction on a not-for-profit entity's use of the asset con-
tributed may be temporary or permanent. Some donor-imposed restrictions
impose limits that are permanent, for example, stipulating that resources
be invested in perpetuity (not used up). Others are temporary, for exam-
ple, stipulating that resources may be used only after a specified date, for
particular programs or services, or to acquire buildings and equipment.
endowment fund. An established fund of cash, securities, or other assets
used to provide income for the maintenance of a not-for-profit entity. The
use of the assets of the fund may be permanently restricted, temporarily
restricted, or unrestricted. Endowment funds generally are established by
donor-restricted gifts and bequests to provide either of the following: (a) a
permanent endowment, which is to provide a permanent source of income,
or (b) a term endowment, which is to provide income for a specific period.
functional classification. A method of grouping expenses according to the
purpose for which costs are incurred. The primary functional classifications
are program services and supporting activities.
fundraising activities. Activities undertaken to induce potential donors to
contribute money, securities, services, materials, facilities, other assets, or
time.
health maintenance organization (HMO). A generic group of medical care
entities organized to provide defined health care services to members in
return for fixed, periodic premiums (usually paid monthly) that are paid
in advance.
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incurred but not reported. Losses incurred by the insured entity that have
not yet been reported to the insurance entity (further industry-specific
information provided in the following list of terms).
intermediary. Although in general usage the term intermediary encompasses
a broad range of situations in which an entity acts between two or more
other parties, in this usage, it refers to situations in which a recipient entity
acts as a facilitator for the transfer of assets between a potential donor and
a potential beneficiary (donee) but is neither an agent or trustee nor a donee
and donor.
joint activity. An activity that is part of the fundraising function and has
elements of one or more other functions, such as program, management
and general, membership development, or any other functional category
used by the entity.
joint costs. The costs of conducting joint activities that are not identifiable with
a particular component of the activity. For example, the cost of postage for
a letter that includes both fund-raising and program components is a joint
cost. Joint costs may include the following costs: salaries, contract labor,
consultants, professional fees, paper, printing, postage, event advertising,
telephones, airtime, and facility rentals.
maintenance costs. Costs associated with maintaining records relating to
insurance contracts and with the processing of premium collections and
commissions (further industry-specific information provided in the follow-
ing list of terms).
management and general activities. Activities that are not identifiable with
a single program, fundraising activity, or membership-development activ-
ity but that are indispensable to the conduct of those activities and to an
entity's existence.
medium. A medium is a means of mass communication, such as direct mail,
direct response advertising, or television.
membership-development activities. Membership-development activities
include soliciting for prospective members and membership dues, member-
ship relations, and similar activities. If there are no significant benefits or
duties connected with membership, however, the substance of membership-
development activities may, in fact, be fund-raising.
natural expense classification. A method of grouping expenditures accord-
ing to kinds of economic benefits received in incurring those expenses.
Examples of natural expense classifications include salaries and wages,
employee benefits, supplies, rent, and utilities.
nonfinancial assets. An asset that is not a financial asset. Nonfinancial assets
include land, buildings, use of facilities or utilities, materials and supplies,
intangible assets, or services.
not-for-profit entity. An entity that possesses the following characteristics,
in varying degrees, that distinguish it from a business entity:
a. Contributions of significant amounts of resources from resource
providers that do not expect commensurate or proportionate pe-
cuniary return
b. Operating purposes other than to provide goods or services at a profit
c. Absence of ownership interests like those of business entities
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Entities that clearly fall outside this definition include the following:
a. All investor-owned enterprises
b. Entities that provide dividends, lower costs, or other economic ben-
efits directly and proportionately to their owners, members, or par-
ticipants, such as mutual insurance entities, credit unions, farm
and rural electric cooperatives, and employee benefit plans
permanent restriction. A donor-imposed restriction that stipulates that re-
sources be maintained permanently but permits the not-for-profit entity
to use up or expend part or all of the income (or other economic benefits)
derived from the donated assets.
permanently restricted net assets. The part of the net assets of a not-for-
profit entity resulting from the following: (a) contributions and other in-
flows of assets whose use by the not-for-profit entity is limited by donor-
imposed stipulations that neither expire by the passage of time nor can be
fulfilled or otherwise removed by the actions of the not-for-profit entity, (b)
other asset enhancements and diminishments subject to the same kinds of
stipulations, and (c) reclassification from or to other classes of net assets
as a consequence of donor-imposed stipulations.
prepaid health care plan. A plan in which the provider is compensated in
advance by the sponsoring entity. The sponsoring entity pays or compen-
sates the provider based on either a fixed sum or a per-enrollee amount.
Prepaid health care plans include health maintenance organizations, pre-
ferred provider organizations, eye care plans, dental care plans, and similar
plans. Under such plans, the financial risk of delivering the health care is
transferred to the provider of services.
prepaid health care services. Any form of health care service provided to a
member in exchange for a scheduled payment (or payments) established
before care is provided, regardless of the level of service subsequently pro-
vided.
program services. The activities that result in goods or services being dis-
tributed to beneficiaries, customers, or members that fulfill the purposes
or mission for which the not-for-profit entity exists. Those services are the
major purpose for and the major output of the not-for-profit entity and often
relate to several major programs.
stop-loss (or reinsurance) insurance. A contract in which an entity agrees
to indemnify providers for certain health care costs incurred by members.
temporarily restricted net assets. The part of the net assets of a not-for-
profit entity resulting from the following: (a) contributions and other in-
flows of assets whose use by the not-for-profit entity is limited by donor-
imposed stipulations that either expire by passage of time or can be fulfilled
and removed by actions of the not-for-profit entity pursuant to those stip-
ulations, (b) other asset enhancements and diminishments subject to the
same kinds of stipulations, or (c) reclassification from or to other classes
of net assets as a consequence of donor-imposed stipulations, their expira-
tion by passage of time, or their fulfillment and removal by actions of the
not-for-profit entity pursuant to those stipulations.
trustee. An entity that has a duty to hold and manage assets for the benefit
of a specified beneficiary in accordance with a charitable trust agreement.
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In some states, not-for-profit entities (NFPs) are organized under trust
law rather than as corporations. Those NFPs are not trustees as defined
because, under those statutes, they hold assets in trust for the commu-
nity or some other broadly described group, rather than for a specific
beneficiary.
unrestricted net assets. The part of net assets of a not-for-profit entity
that is neither permanently restricted nor temporarily restricted by donor-
imposed stipulations. The only limits on the use of unrestricted net assets
are the broad limits resulting from the following: (a) the nature of the NFP,
(b) the environment in which the NFP operates, (c) the purposes specified
in the NFP's articles of incorporation or bylaws, and (d) limits resulting
from contractual agreements with suppliers, creditors, and others entered
into by the NFP in the course of its business. Unrestricted net assets gener-
ally result from revenues from providing services, producing and delivering
goods, receiving unrestricted contributions, and receiving dividends or in-
terest from investing in income-producing assets, less expenses incurred in
providing services, producing and delivering goods, raising contributions,
and performing administrative functions.
voluntary health and welfare entity. A not-for-profit entity that is formed
for the purpose of performing voluntary services for various segments of
society and that is tax-exempt (organized for the benefit of the public), sup-
ported by the public, and operated on a not-for-profit basis. Most voluntary
health and welfare entities concentrate their efforts and expend their re-
sources in an attempt to solve health and welfare problems of society and,
in many cases, those of specific individuals. As a group, voluntary health
and welfare entities include those not-for-profit entities that derive their
revenue primarily from voluntary contributions from the general public to
be used for general or specific purposes connected with health, welfare, or
community services.
The following is a list of additional terms that have been used in this guide:
acquisition costs. Marketing costs that are (a) directly related to the acquisi-
tion of specific subscriber contracts and member enrollment and (b) incre-
mental to general marketing activities.
acute care. Inpatient general routine care provided to patients who are in
a phase of illness that does not require the concentrated and continuous
observation and treatment provided in intensive-care units.
advance fee. A payment required to be made by a continuing care retirement
community (CCRC) resident prior to, or at the time of, admission to the
CCRC for future services and the use of facilities specified in a contract
that remains in effect for as long as the resident resides in the CCRC.
allocated loss adjustment expense (ALAE). Claim expense that can be as-
signed to individual claims (for example, attorney's fees, claim adjusting
service fees, or court costs).
ambulatory care organization. A partnership, association, corporation, or
other legal entity organized to deliver health care services to patients that
come or are brought to a health care facility for a purpose other than admis-
sion as an inpatient (for example, emergency room services, clinic services,
or outpatient surgery).
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ancillary services. Services performed for diagnostic or therapeutic purposes.
Ancillary services generally are those special services for which charges in
addition to routine charges customarily are made (for example, laboratory,
radiology, surgical, or other services).
anticipated revenues. Amounts including third-party payments (for exam-
ple, those from Blue Cross), contractually or statutorily committed invest-
ment income from sources related to the activities of a continuing care
retirement community (CCRC), contributions pledged by donors to sup-
port CCRC activities, periodic fees expected to be collected, or the balance
of deferred nonrefundable advance fees.
asserted claim. A claim made against a health care entity by or on behalf of
a patient alleging improper professional service.
assets limited as to use. Assets that are segregated and limited either by
the board or management (for example, designated for expenditure in the
acquisition of property and equipment or for the liquidation of long term
debt) or by outside third parties other than a donor or grantor (for example,
funds under bond agreements or malpractice arrangements) as to how the
assets may be used.
associated entity. An individual practice association, hospital, medical group,
or similar health care entity that contracts with a prepaid health care
provider to provide health care services.
bad-debt expense. The current period charge for actual or expected doubtful
accounts resulting from the extension of credit.
claims-made insurance policy. A policy that covers only malpractice claims
reported to the insurance carrier during the policy term, regardless of the
date of the incident giving rise to the claim.
clinic. A freestanding facility or part of another health care entity used for
diagnosis and treatment of outpatients.
commercial paper. Short term, unsecured promissory notes that represent
a flexible and low-cost form of short term financing. Taxable commercial
paper is sold on a discount basis, rather than on an interest-bearing basis,
with the discount determined by the maturity of the notes, the creditwor-
thiness of the issuer or its credit support, and general market demand. The
primary risk is the variable interest rate exposure. Issuance often requires
some form of credit enhancement or liquidity support.
comprehensive medical plan (CMP). A health plan option that may be avail-
able to Medicare beneficiaries and provides a more limited range of services
than health maintenance organizations but includes physician services,
laboratory, radiology, emergency, preventive, and inpatient services. A CMP
assumes the financial risk for the provision of services and for out-of-area
coverage.
contract period. The period (typically one year) for which premium rates are
fixed by contract.
contractual adjustments. The differences between revenue at established
rates and the amounts realizable from third-party payors under contrac-
tual agreements.
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costs of acquiring initial continuing-care contracts. Costs incurred to
originate a contract that result from and are essential to the acquisition
of the initial contracts and are incurred through the date of substantial
occupancy but no later than one year from the date of completion of con-
struction.
These costs include
 the costs of processing the contract, such as evaluating the
prospective resident's financial condition; evaluating and record-
ing guarantees, collateral, and other security arrangements; ne-
gotiating contract terms; preparing and processing contract docu-
ments; and closing the transaction.
 the costs from activities in connection with soliciting potential
initial residents (such as model units and their furnishings, sales
brochures, semipermanent signs, tours, grand openings, and sales
salaries). These costs do not include advertising, interest, admin-
istrative costs, rent, depreciation, or any other occupancy or equip-
ment costs.
 the portion of an employee's compensation and benefits that re-
lates to the initial contract acquisitions.
courtesy and policy discounts. The differences between revenue recorded at
established rates and amounts realizable for services provided to specific
individuals such as employees, medical staff, and clergy.
credibility. A measure of the statistical significance of a provider's own data,
dependent on its stability and volume in relation to the stability and volume
of the industry data. Actuaries use credibility to blend an estimate from
a provider's own experience with a broader estimate based on the experi-
ence of similar institutions. A provider's own experience may be assigned a
credibility weight less than 100 percent due to year-to-year volatility. Such
volatility is often a function of the size of the provider. Large providers
generally have less volatility than small providers. In such an instance, a
broader and more stable body of experience of similar providers would be
used to supplement the specific provider's experience.
credit enhancement. Typically, a bank letter of credit that guarantees in-
vestors will receive principal and interest in the event of an issuer default.
A line of credit provides liquidity support to an issuer but does not provide
a guarantee of the repayment of principal and interest in the event of is-
suer default. The liquidity support provides a loan to issuers in the event
the issuer is unable to place large amounts of maturing commercial paper
with investors.
crossover refunding (also called a delayed defeasance). A type of advance
refunding in which the old debt is not immediately replaced. The proceeds
from the new debt, additional cash deposits (if any), and the income earned
on the related investments are sufficient to pay the principal and any call
premium of the old debt and the interest on the new debt until the date
of crossover. Until the crossover, the proceeds from the new debt serve as
collateral for that debt. The old debt is serviced by the entity until the date
of crossover, at which time the proceeds from the new debt are used to retire
the old debt and the entity becomes obligated to service the new debt. The
old debt remains as a liability on the issuer's books until the crossover,
when it is called in accordance with the call provisions of its indenture.
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deductions from revenue. Reductions in gross revenue arising from contrac-
tual adjustments, courtesy and policy discounts, or other adjustments and
deductions.
defeasance. Legal satisfaction of refunded debt without the debt necessarily
being retired.
development factor. A computed factor used to project future changes in
estimated losses from the date of the occurrence of the incident to the date-
of-claim payment resulting from inflation, claimed cost growth, industry
trends, and court awards. The development factor can be applied to in-
curred losses, paid losses, claim counts, and average values.
enrollee. An individual who is a subscriber or an eligible dependent of a sub-
scriber in a prepaid health care plan.
estimated costs of future services. Amounts that are expected to be incurred
to provide services and the use of facilities to individuals over their remain-
ing lives under continuing-care contracts. Examples include resident care,
dietary, health care, facility, general and administrative, interest, depreci-
ation, and amortization costs.
exposure. The amount of potential claim risk. The basis for reflecting differ-
ences in the claim potential among providers' bases for charging insurance
premiums or allocating member contributions to a captive. Exposure bases
for hospital professional liability include number of occupied beds, outpa-
tient visits, emergency room visits, and number of residents by specialty.
floating rate note (FRN). A debt instrument that allows issuers to borrow at
a floating short term rate with a long term stated maturity without some
of the risks traditionally associated with commercial paper. The investor
is subject to principal risk to the degree the issuer's credit deteriorates or
investor demand for FRNs decreases. Most health care issuers of FRNs
require credit enhancement and a bank liquidity facility in conjunction
with an FRN program.
fund. A self-contained accounting entity set up to account for a specific activity
or project.
gross service revenues. All revenues from the provision of health care ser-
vices excluding charity care.
health care services. Services provided to individuals related to the diagnosis
or treatment of physical or mental illness.
help accomplish the entity's mission. Actions that help accomplish the
entity's mission are actions that either benefit the recipient (such as
by improving the recipient's physical, mental, emotional, or spiritual
health and well-being) or benefit society (by addressing societal pro-
blems).
home health agency. An agency organized to provide health and supportive
services in a person's home. These services may include nursing, nutri-
tional, and therapeutic aid (such as physical therapy and dialysis) and the
rental, as well as sale of medical equipment.
increased limit factor. The relationship between losses limited to a per-
occurrence limit at which the provider's own experience is meaningful to
losses limited to the provider's total retained limit per occurrence.
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incremental costs. Costs that vary with and are directly attributable to
changes in business, such as an additional employer or health maintenance
organization (HMO) contract. Fixed costs such as building depreciation or
general overhead that do not change with the addition or loss of a contract
are not incremental costs.
incurred but not reported (IBNR). Costs associated with health care ser-
vices incurred during a financial reporting period but not reported to the
health care entity until after the financial reporting date (defined in FASB
ASC glossary, as presented in the first section of this glossary).
indenture. An agreement between two or more persons specifying the recip-
rocal rights and duties of the parties under a contract (such as a lease,
mortgage, or contract between bondholders and the issuer of the bond).
individual practice association (IPA). A partnership, association, corpora-
tion, or other legal entity organized to provide or arrange for the delivery
of health care services to members of a prepaid health care plan and non-
member patients. In return, the IPA receives either a capitation fee or a
specified fee for services rendered.
inpatient. Under most circumstances, a patient who is provided with room,
board, and general nursing service and is expected to remain in the health
care facility at least overnight and occupy a bed.
in-substance defeasance. A form of advance refunding in which the debtor
places into an irrevocable trust an amount of assets estimated to be suf-
ficient to satisfy all future principal and interest payments of a specific
obligation. In such cases, the debt is not considered extinguished because
the debtor is not legally released from being the primary obligor.
integrated delivery system. A provider or group of providers that is orga-
nized to deliver and finance acute and preventive health care services. An
integrated delivery system generally will provide (or arrange to provide)
a complete continuum of health care services (inpatient acute care, am-
bulatory care, outpatient surgery, home health care, including long term
care) to an enrolled population, generally for fixed prepaid fees called
premiums.
interest rate swaps. An agreement to exchange interest payments without
actually exchanging the underlying principal. The two parties each agree
to make interest payments based on the calculation formula for the other's
debt. Swaps can be used for a variety of purposes, such as to reduce the
overall cost of borrowing, lock in forward rates, reduce interest rate risk,
or adjust the ratio of variable and fixed-rate debt liabilities. Interest rate
swaps do not change the amount or type of debt outstanding, but they do
affect the issuer's debt portfolio and risk profile.
intermediate care facility (ICF). A facility that provides care to individuals
whose mental or physical conditions require services that are above the
level of room and board and that can be made available only through insti-
tutional facilities. The care provided at an ICF does not require hospitals
or skilled nursing facilities.
maintenance costs. Costs associated with maintaining enrollment records
and processing premium collections and payments (defined in FASB ASC
glossary, as presented in the first section of this glossary).
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margin for risk of adverse deviation. Actuarially determined estimate of
the additional funding requirement to obtain a specific confidence level
that losses will not exceed the amount paid into the self-insurance fund.
Margins are determined using statistical simulation techniques.
medical group. An association of physicians and other licensed health care
professionals organized on a group basis to practice medicine.
medium-term notes. An intermediate-term security offered on a continuous
basis providing flexibility for an issuer to vary the amount of outstanding
notes as its funding requirements change. The broad range of possible
maturities enables an issuer to borrow at the most attractive yield at the
time of each issuance. They can be issued domestically or abroad.
member. An individual who is enrolled as a subscriber or as an eligible depen-
dent of a subscriber in a prepaid health care plan.
multiprovider captive. An insurance entity owned by two or more health
care entities that underwrites malpractice insurance for its owners.
net advance refunding. A type of advance refunding in which the proceeds
from the new debt, additional cash deposits (if any) and the income earned
on the related investments are sufficient to pay the interest, principal, and
call premium on the old debt. After the advance refunding, the old debt is
serviced by the investments in trust and the new debt is serviced by the
entity.
net service revenue. Gross service revenue less provisions for contractual
adjustments with third-party payors.
nonexchange transaction. An external transaction in which a government
gives (or receives) value without directly receiving (or giving) equal value
in exchange.
nursing center. A facility that provides nursing care to residents with a vari-
ety of needs or medical conditions. A nursing center may be a component
of a continuing care retirement community. (Also called a health center,
skilled-nursing facility, intermediate-care facility, continuing-care facility,
or basic-care home.)
occurrence-basis policy. A policy that covers claims resulting from incidents
that occur during the policy term, regardless of when the claims are re-
ported to the insurance carrier.
outliers. In referring to the Medicare Prospective Payment System, additional
payments that are made for cases that either have unusually long lengths
of stay or have charges in excess of the cost outlier threshold.
outpatient. A patient who is not confined overnight in a health care institution.
peer review organization (PRO). Under federal statutory provision, PROs
are required in each state to monitor hospital activity under the prospec-
tive payment system. Each hospital must contract with a PRO, which will
review (a) the validity of diagnostic information, which establishes the
diagnosis-related group; (b) the appropriateness of admissions; (c) the ap-
propriateness of care to outliers; and (d) the adequacy of care provided.
periodic fees. Amounts paid to a continuing care retirement community by a
resident at periodic intervals for continuing-care services. Such fees may
be fixed or adjustable. (Also called maintenance fees or monthly fees.)
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periodic interim payment (PIP). A plan under which the health care entity
receives cash payments from a third-party payor (usually Medicare) in
constant amounts periodically.
premium. The consideration paid for providing contract coverage. (Also called
a subscriber fee.)
premium period. The period to which a premium payment applies (generally
one month) that entitles a member to health care services according to the
contract provisions.
prevailing charge. A charge that falls within the range of charges most fre-
quently used in a locality for a particular service or procedure.
primary care. Care that is rendered in an ambulatory fashion, such as in an
emergency room, an outpatient clinic, or other outpatient department.
prospective payment system (PPS). Medicare payment made at a prede-
termined, specific rate for each Medicare discharge, based on the patient's
diagnosis. Each discharge is classified according to a series of diagnosis-
related groups. See also diagnosis-related group.
provider. A person or entity that undertakes to provide health care services.
providers of prepaid health care services (prepaid health care
providers). Entities that provide or arrange for the delivery of health
care services in accordance with the terms and provisions of a prepaid
health care plan. Providers assume the financial risk of the cost of de-
livering health care services in excess of preestablished fixed premiums.
However, some or all of the financial risk may be contractually transferred
to other providers (affiliated entities) or by purchasing stop-loss insurance.
Other providers of prepaid health care services may include comprehen-
sive medical plans, physicians groups (for example, independent practice
associations), and hospitals.
refundable advance fees. The portion of an advance fee that is payable to
a resident of a continuing care retirement community or the resident's
estate.
refunded debt. Debt for which payment at a specified future date has been
provided by the issuance of refunding debt.
refunding debt. Debt issued to provide funds to pay for refunded debt at a
specified future date.
reported incident. An occurrence identified by a health care entity as one in
which improper professional service may be alleged at a future time that
would result in a malpractice claim.
retrospectively rated insurance policy. An insurance policy with a pre-
mium that is adjustable based on the experience of the insured health care
entity or group of health care entities during the policy term.
risk contract. A contract between a provider of health care services and a
prepaid health care plan that exposes the provider to the uncertainty of
financial gain or loss by obligating the provider to provide specified health
care services to enrollees of the plan for a negotiated price, which may be an
amount per case, service, or day. The price may vary based on the volume
of services furnished during the contract period.
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secondary care. Care that is rendered to inpatients in hospitals that offer
short term, acute-care services of either a general or a specialized nature.
self-insurance. That portion of risk or loss assumed by a health care entity.
There is no external insurance coverage.
skilled nursing facilities (SNF). These facilities provide services on a daily,
inpatient basis. The services provided by an SNF are ordered by a physician
and require the skilled services of technical or professional personnel.
subscriber. The person who is responsible for the payment of premiums or
whose employment is the basis for eligibility for membership in a prepaid
health care plan.
tail coverage. Insurance designed to cover malpractice claims incurred before,
but reported after, cancellation or expiration of a claims-made insurance
policy.
taxable variable rate demand notes. Issuers may call the notes on any
monthly interest payment date, which provides issuers the opportunity to
refinance short term obligations with long term bonds if market conditions
make this alternative attractive.
tertiary care. Care that is rendered in hospitals that possess the personnel,
equipment, and expertise to handle complex cases.
third-party payor. Any agency (such as Blue Cross, Medicare, or commercial
insurance entities) that contracts with health care entities and patients to
pay for the care of covered patients.
trend factor. A factor used in actuarial methodology to adjust ultimate losses
from historical experience periods to the loss cost levels of the projection
period, due to the impact of economic, jurisdictional, and social changes
affecting hospital professional liability loss costs.
trust fund. A fund established with an outside entity to be used for a specific
purpose, such as to pay malpractice claims and related expenses as they
arise.
ultimate cost. Total claims payments, including costs associated with litigat-
ing or setting claims.
unasserted claim. A medical malpractice claim that has not been asserted
formally against a health care provider by or on behalf of a patient alleging
improper professional service. It may relate to either reported incidents or
to unreported incidents.
unreported incident. An occurrence in which improper professional service
may have been administered by a health care provider, which may result
in a malpractice claim of which the provider is not yet aware.
wholly owned captive. An insurance entity subsidiary of a health care entity
that provides malpractice insurance primarily to its parent entity.
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